Citrus Sinensis ID: 046461

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380---
Protein Sequence
MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY
Secondary Structure (PSIPRED)
ccccHHHHHHccccccccccccccccccEEEcccccccccccHHHHHHHccccccccccccHHHHccccccEEEEEccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHccccccccEEcccccccccccccEEEEEccccEEEEEEcccccccHHHHHHcHHHHHHHHHHHHHHHHHHHcccccccEEcccccccEEccccccEEcccccccccccccccEEEcccccccccccccccccccHHHHHHHHHHccccccccccccccccccEEEEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccEEHHHcccccccccHHHccccccEEEEcccccccccccHHHHHHHHcccccccccccHHHccccccEEEEEcccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHcccccccEcHHHHHHHHccccHccEccccccccEcccEEEEEEEEcccccEEEEEEccccccHHHHHccHHHHHHHHHHHHHHHHHHHcccHcccccccccHHHEEEcccccEEEcccccccccccHHccccEEEEcccccccccccccHHHHHHHHHHHHcccccccccccccccccEEEEEEccHHcccccHHHHHHHHHHHHHHHcccHcHcccHHHHHHHHHccccccccccc
Coil and Loop (DISEMBL)
mphtqkkilirdnlgmppiipknlnelphldlscNKLNGEISTFLSHILGILGLYvqfkippdlcnlvqlEYFDFsmnmlgghipeknidLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIqrgnrqqhlsinlamfepslgkltYDQIVAGTNKFyeknvirgddFGIAFKNIVQLLgycpvgekKLIVYEYMVKGSLNDWLRNQAKHCIIAcgtargitflhhrfqphiihrdinasnillnedfevkvsdFGLVRLIsdceshtstdvaGTIGYILLACGGDIYSFSVVLLELVIrkqptgpefkdknggnlvDWVLDSTilnayskpsMLKMLQIVVGcifdnpttrptMLRVQEFLEKYhtgenfgry
Flexible Loop (DISEMBL)
mphtqkkilirdnlgmppIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQptgpefkdknggnlVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFlekyhtgenfgry
Low Complexity Region (SEG)
MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY
Disordered region (IsUnstruct)
*******ILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH********
Disordered Region (DISOPRED)
**HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKI************LALFGTVVGSVLAIAIIVSMLWWI********************GKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGP*FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK**********
Disordered Region (DISEMBL)
MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY
Disordered Region (DISPRO)
*PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQ**LSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY*T*E*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	383	2.2.26 [Sep-21-2011]
Q9LYN8	1192	Leucine-rich repeat recep	yes	no	0.950	0.305	0.380	4e-75
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.926	0.294	0.308	1e-43
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.926	0.294	0.308	2e-43
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.929	0.297	0.298	3e-43
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.924	0.309	0.303	1e-41
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.900	0.295	0.296	1e-40
Q9LJF3	1164	Receptor-like protein kin	no	no	0.613	0.201	0.353	6e-40
Q9ASS4	620	Probably inactive leucine	no	no	0.966	0.596	0.279	1e-38
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.911	0.346	0.287	1e-36
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.890	0.333	0.291	4e-35

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  282 bits (721), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 194/510 (38%), Positives = 252/510 (49%), Gaps = 146/510 (28%)

Query: 9    LIRDNLGMP-PIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPP 62
            L ++ L  P P    NL EL H+DLS N L+GE+S+ LS +  ++GLY++      +IP 
Sbjct: 683  LTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPS 742

Query: 63   DLCNLVQLEYFDFSMNMLGGHIPEK----------------------------------- 87
            +L NL QLEY D S N+L G IP K                                   
Sbjct: 743  ELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALL 802

Query: 88   --NIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIV-----SMLWWI------QR- 133
              N +LCG+++G D ++   +KL     + G +L   IIV     S+  W       QR 
Sbjct: 803  SGNKELCGRVVGSDCKI-EGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRD 861

Query: 134  ----------------------GNRQQH-LSINLAMFEPSLGKLTYDQIVAGTNKFYEKN 170
                                  G+R +  LSIN+AMFE  L K+    IV  T+ F +KN
Sbjct: 862  DPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKN 921

Query: 171  VIRGDDFGIAFK--------------------------------------NIVQLLGYCP 192
            +I    FG  +K                                      N+V LLGYC 
Sbjct: 922  IIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS 981

Query: 193  VGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIH 243
              E+KL+VYEYMV GSL+ WLRNQ         +K   IA G ARG+ FLHH F PHIIH
Sbjct: 982  FSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041

Query: 244  RDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GD 295
            RDI ASNILL+ DFE KV+DFGL RLIS CESH ST +AGT GYI    G        GD
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGD 1101

Query: 296  IYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSM 343
            +YSF V+LLELV  K+PTGP+FK+  GGNLV W            V+D  +++   K S 
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQ 1161

Query: 344  LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            L++LQI + C+ + P  RP ML V + L++
Sbjct: 1162 LRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  177 bits (449), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 152/493 (30%), Positives = 216/493 (43%), Gaps = 138/493 (27%)

Query: 20   IPKNLNELPHL---DLSCNKLNGEISTFLSHI--LGILGL-YVQFK--IPPDLCNLVQLE 71
            IPK L  + +L   +L  N L+G I   L  +  + IL L Y +F   IP  L +L  L 
Sbjct: 679  IPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLG 738

Query: 72   YFDFSMNMLGGHIPEK------------NIDLCG-------------------------- 93
              D S N L G IPE             N  LCG                          
Sbjct: 739  EIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQA 798

Query: 94   KIMGLDYQVLTFSKLALFGTVVGSVL-------------------AIAIIVSMLWWIQRG 134
             + G     L FS   +FG ++ ++                    + +   +  W     
Sbjct: 799  SLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSA 858

Query: 135  NRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK------------ 182
              ++ LSINLA FE  L KLT+  ++  TN F+  +++    FG  +K            
Sbjct: 859  --REALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIK 916

Query: 183  --------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ 216
                                      N+V LLGYC VGE++L+VYEYM  GSL D L ++
Sbjct: 917  KLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDR 976

Query: 217  AKHCI---------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV 267
             K  I         IA G ARG+ FLHH   PHIIHRD+ +SN+LL+E+ E +VSDFG+ 
Sbjct: 977  KKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMA 1036

Query: 268  RLISDCESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFK 318
            RL+S  ++H S + +AGT GY+          +  GD+YS+ VVLLEL+  KQPT  +  
Sbjct: 1037 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPT--DSA 1094

Query: 319  DKNGGNLVDW-----------VLDSTIL--NAYSKPSMLKMLQIVVGCIFDNPTTRPTML 365
            D    NLV W           V D  +L  +A  +  +L+ L++   C+ D    RPTM+
Sbjct: 1095 DFGDNNLVGWVKLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMI 1154

Query: 366  RVQEFLEKYHTGE 378
            +V    ++   G 
Sbjct: 1155 QVMAMFKEIQAGS 1167

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  176 bits (447), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 152/493 (30%), Positives = 216/493 (43%), Gaps = 138/493 (27%)

Query: 20   IPKNLNELPHL---DLSCNKLNGEISTFLSHI--LGILGL-YVQFK--IPPDLCNLVQLE 71
            IPK L  + +L   +L  N L+G I   L  +  + IL L Y +F   IP  L +L  L 
Sbjct: 679  IPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLG 738

Query: 72   YFDFSMNMLGGHIPEK------------NIDLCG-------------------------- 93
              D S N L G IPE             N  LCG                          
Sbjct: 739  EIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPIPCSSGPKSDANQHQKSHRRQA 798

Query: 94   KIMGLDYQVLTFSKLALFGTVVGSVL-------------------AIAIIVSMLWWIQRG 134
             + G     L FS   +FG ++ ++                    + +   +  W     
Sbjct: 799  SLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSA 858

Query: 135  NRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK------------ 182
              ++ LSINLA FE  L KLT+  ++  TN F+  +++    FG  +K            
Sbjct: 859  --REALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIK 916

Query: 183  --------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ 216
                                      N+V LLGYC VGE++L+VYEYM  GSL D L ++
Sbjct: 917  KLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDR 976

Query: 217  AKHCI---------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV 267
             K  I         IA G ARG+ FLHH   PHIIHRD+ +SN+LL+E+ E +VSDFG+ 
Sbjct: 977  KKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMA 1036

Query: 268  RLISDCESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFK 318
            RL+S  ++H S + +AGT GY+          +  GD+YS+ VVLLEL+  KQPT  +  
Sbjct: 1037 RLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPT--DSA 1094

Query: 319  DKNGGNLVDW-----------VLDSTIL--NAYSKPSMLKMLQIVVGCIFDNPTTRPTML 365
            D    NLV W           V D  +L  +A  +  +L+ L++   C+ D    RPTM+
Sbjct: 1095 DFGDNNLVGWVKLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMI 1154

Query: 366  RVQEFLEKYHTGE 378
            +V    ++   G 
Sbjct: 1155 QVMAMFKEIQAGS 1167

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  176 bits (446), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 148/496 (29%), Positives = 215/496 (43%), Gaps = 140/496 (28%)

Query: 20   IPKNLNELPHL---DLSCNKLNGEISTFLSHILG--ILGLY---VQFKIPPDLCNLVQLE 71
            IPK +  +P+L   +L  N ++G I   +  + G  IL L    +  +IP  +  L  L 
Sbjct: 670  IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 729

Query: 72   YFDFSMNMLGGHIPE-------------KNIDLCG------------------------- 93
              D S N L G IPE              N  LCG                         
Sbjct: 730  EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRP 789

Query: 94   -KIMGLDYQVLTFSKLALFGTVVGSVLAIAIIVSMLWWIQ--------RGNR-------- 136
              + G     L FS + +FG ++               ++         G+R        
Sbjct: 790  ASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWK 849

Query: 137  ----QQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK---------- 182
                ++ LSINLA FE  L KLT+  ++  TN F+  ++I    FG  +K          
Sbjct: 850  LTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVA 909

Query: 183  ----------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR 214
                                        N+V LLGYC VG+++L+VYE+M  GSL D L 
Sbjct: 910  IKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLH 969

Query: 215  NQAKHCI---------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG 265
            +  K  +         IA G+ARG+ FLHH   PHIIHRD+ +SN+LL+E+ E +VSDFG
Sbjct: 970  DPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFG 1029

Query: 266  LVRLISDCESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPT-GP 315
            + RL+S  ++H S + +AGT GY+          +  GD+YS+ VVLLEL+  K+PT  P
Sbjct: 1030 MARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSP 1089

Query: 316  EFKDKNGGNLVDWVLDSTILN---------AYSKPS----MLKMLQIVVGCIFDNPTTRP 362
            +F D    NLV WV     L              P+    +L+ L++ V C+ D    RP
Sbjct: 1090 DFGDN---NLVGWVKQHAKLRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRP 1146

Query: 363  TMLRVQEFLEKYHTGE 378
            TM++V    ++   G 
Sbjct: 1147 TMVQVMAMFKEIQAGS 1162

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  171 bits (433), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 156/514 (30%), Positives = 222/514 (43%), Gaps = 160/514 (31%)

Query: 20   IPKNLNE---LPHLDLSCNKLNGEISTFLSHILGILGLY------VQFKIPPDLCNLVQL 70
            IP  + E   L  L+LS N+L+GEI  F    L  LG++      +Q +IP    NL  L
Sbjct: 627  IPDEIGEMIALQVLELSHNQLSGEI-PFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFL 685

Query: 71   EYFDFSMNMLGGHIPEK-------------NIDLCG--------------------KIMG 97
               D S N L G IP++             N  LCG                    K   
Sbjct: 686  VQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAK 745

Query: 98   LDYQVLTFSKLALFGTVVGS-------VLAIAIIV-------------------SMLWWI 131
               +  +++   + G ++ +       V AIA+                     +  W I
Sbjct: 746  HGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSATTWKI 805

Query: 132  QRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK--------- 182
            ++   ++ LSIN+A F+  L KL + Q++  TN F   ++I    FG  FK         
Sbjct: 806  EK--EKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSV 863

Query: 183  -----------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL 213
                                         N+V LLGYC +GE++L+VYE+M  GSL + L
Sbjct: 864  AIKKLIRLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVL 923

Query: 214  ---RNQAKHCI--------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVS 262
               R   K  I        IA G A+G+ FLHH   PHIIHRD+ +SN+LL++D E +VS
Sbjct: 924  HGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVS 983

Query: 263  DFGLVRLISDCESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPT 313
            DFG+ RLIS  ++H S + +AGT GY+             GD+YS  VV+LE++  K+PT
Sbjct: 984  DFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPT 1043

Query: 314  G-PEFKDKNGGNLVDW------------VLDSTILNAYSKPS---------------MLK 345
               EF D    NLV W            V+D  +L   S  S               ML+
Sbjct: 1044 DKEEFGDT---NLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLR 1100

Query: 346  MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
             L+I + C+ D P+ RP ML+V   L +    EN
Sbjct: 1101 YLEIALRCVDDFPSKRPNMLQVVASLRELRGSEN 1134

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  167 bits (423), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 143/482 (29%), Positives = 208/482 (43%), Gaps = 137/482 (28%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHI--LGILGLY---VQFKIPPDLCNLVQLEYFDFSM 77
            N+  L  L+L  N++ G I      +  +G+L L    +Q  +P  L +L  L   D S 
Sbjct: 661  NMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSN 720

Query: 78   NMLGGHIP-------------EKNIDLCG----------------KIMGLDYQVLTFSKL 108
            N L G IP               N  LCG                +I      V T    
Sbjct: 721  NNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVAT---- 776

Query: 109  ALFGTVVGSVLAIAIIVSMLWWIQRGNRQQH-------------------------LSIN 143
            A+   +  S +   ++V  L+ +++  +++                          LSIN
Sbjct: 777  AVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSIN 836

Query: 144  LAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK--------------------- 182
            +A FE  L KLT+  ++  TN F  + ++    FG  +K                     
Sbjct: 837  VATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQG 896

Query: 183  -----------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------- 214
                             N+V LLGYC VGE++L+VYEYM  GSL   L            
Sbjct: 897  DREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYL 956

Query: 215  NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
            N A    IA G ARG+ FLHH   PHIIHRD+ +SN+LL+EDFE +VSDFG+ RL+S  +
Sbjct: 957  NWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALD 1016

Query: 275  SHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGP-EFKDKNGGN 324
            +H S + +AGT GY+             GD+YS+ V+LLEL+  K+P  P EF + N  N
Sbjct: 1017 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDN--N 1074

Query: 325  LVDW------------VLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            LV W            +LD  ++   S    +   L+I   C+ D P  RPTM+++    
Sbjct: 1075 LVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMF 1134

Query: 372  EK 373
            ++
Sbjct: 1135 KE 1136

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  165 bits (417), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/308 (35%), Positives = 153/308 (49%), Gaps = 73/308 (23%)

Query: 137  QQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK-------------- 182
             + LSIN+A FE  L KLT+  ++  TN F   ++I    FG  +K              
Sbjct: 829  HEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKL 888

Query: 183  ------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK 218
                                    N+V LLGYC +GE++L+VYEYM  GSL   L  + K
Sbjct: 889  IQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTK 948

Query: 219  ----------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
                         IA G ARG+ FLHH   PHIIHRD+ +SN+LL++DF  +VSDFG+ R
Sbjct: 949  KGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMAR 1008

Query: 269  LISDCESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGP-EFK 318
            L+S  ++H S + +AGT GY+             GD+YS+ V+LLEL+  K+P  P EF 
Sbjct: 1009 LVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFG 1068

Query: 319  DKNGGNLVDW------------VLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTML 365
            + N  NLV W            +LD  ++   S    +L  L+I   C+ D P  RPTM+
Sbjct: 1069 EDN--NLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMI 1126

Query: 366  RVQEFLEK 373
            +V    ++
Sbjct: 1127 QVMTMFKE 1134

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASS4|Y5838_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g48380 OS=Arabidopsis thaliana GN=At5g48380 PE=1 SV=1

 Score =  160 bits (405), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 137/491 (27%), Positives = 210/491 (42%), Gaps = 121/491 (24%)

Query: 9   LIRDNLGMPPIIPKNLNEL----PHLDLSCNKLNGEISTFLSHILGILGLYVQFK----- 59
           L R+N   P  +P N++ L      LDLS N  +GEI   +S+I  +  L +Q       
Sbjct: 107 LSRNNFSGP--LPANISTLIPLVTILDLSYNSFSGEIPMLISNITFLNTLMLQHNQFTGT 164

Query: 60  IPPDLCNLVQLEYFDFSMNMLGGHIPE-------------KNIDLCGKIMGLDYQVLTFS 106
           +PP L  L +L+ F  S N L G IP               N+DLCGK +       +  
Sbjct: 165 LPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLDLCGKPLDDCKSASSSR 224

Query: 107 KLALFGTVVGSVLAIAIIVSMLWWI--------------QRGNR-----QQHLSINLAMF 147
              +    VG + A A++V ++ +                 GNR     +    + + MF
Sbjct: 225 GKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKKQDDPEGNRWAKSLKGQKGVKVFMF 284

Query: 148 EPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK------------------------- 182
           + S+ K+    ++  T +F + N+I     G  +K                         
Sbjct: 285 KKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGSLLMIKRLQDSQRSEKEFD 344

Query: 183 ------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------- 221
                       N+V LLGYC   +++L++YEYM  G L D L    +            
Sbjct: 345 AEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQLHPADEESFKPLDWPSRL 404

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
            IA GTA+G+ +LHH   P IIHR+I++  ILL  +FE K+SDFGL RL++  ++H ST 
Sbjct: 405 KIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPKISDFGLARLMNPIDTHLSTF 464

Query: 281 VAGTIG-----------YILLACGGDIYSFSVVLLELVIRKQPTG------PEFKDKN-G 322
           V G  G            ++    GD+YSF VVLLELV  ++ T        + +++N  
Sbjct: 465 VNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTGQKATSVTKVSEEKAEEENFK 524

Query: 323 GNLVDWV------------LDSTILNAYSKPSMLKMLQIVVGCIFDN-PTTRPTMLRVQE 369
           GNLV+W+            +D ++L       + K+L++   C+       RPTM  V +
Sbjct: 525 GNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVACNCVLPEIAKQRPTMFEVYQ 584

Query: 370 FLEKYHTGENF 380
            L       NF
Sbjct: 585 LLRAIGESYNF 595

Arabidopsis thaliana (taxid: 3702)

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  154 bits (389), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 133/463 (28%), Positives = 205/463 (44%), Gaps = 114/463 (24%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHILGILGL-----YVQFKIPPDLCNLVQLEYFDFSM 77
            NL +L   DL  N L+G I + LS +  +  L      +   IP  L  L  L  F  + 
Sbjct: 545  NLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAY 604

Query: 78   NMLGGHIPE------------KNIDLCGK-----IMGLDYQVLTFSKLA-------LFGT 113
            N L G IP             ++  LCG+       G +  ++  S+ +         G 
Sbjct: 605  NNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALIKRSRRSRGGDIGMAIGI 664

Query: 114  VVGSVLAIAIIVSMLWWIQRG--------------NRQQHLSIN---LAMFEPSLGKLTY 156
              GSV  + ++  ++   +R               NR++   I    + +F+ +  +L+Y
Sbjct: 665  AFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSNDKELSY 724

Query: 157  DQIVAGTNKFYEKNVIRGDDFGIAFK---------------------------------- 182
            D ++  TN F + N+I    FG+ +K                                  
Sbjct: 725  DDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSR 784

Query: 183  ----NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL--RNQAKHCI-------IACGTARG 229
                N+V L G+C     +L++Y YM  GSL+ WL  RN     +       IA G A+G
Sbjct: 785  AQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKG 844

Query: 230  ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL 289
            + +LH    PHI+HRDI +SNILL+E+F   ++DFGL RL+S  E+H STD+ GT+GYI 
Sbjct: 845  LLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIP 904

Query: 290  LACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL----------- 330
               G        GD+YSF VVLLEL+  K+P     K K   +L+ WV+           
Sbjct: 905  PEYGQASVATYKGDVYSFGVVLLELLTDKRPVD-MCKPKGCRDLISWVVKMKHESRASEV 963

Query: 331  -DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             D  I +  +   M ++L+I   C+ +NP  RPT  ++  +L+
Sbjct: 964  FDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLD 1006

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  149 bits (376), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 137/470 (29%), Positives = 197/470 (41%), Gaps = 129/470 (27%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHI--LGILGLY---VQFKIPPDLCNLVQLEYFDFSM 77
            +L +L  L+L  N L+G I   LS +  L +L L    +   IPP L  L  L  F  + 
Sbjct: 555  DLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFLSTFSVAY 614

Query: 78   NMLGGHIP-------------EKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAII 124
            N L G IP             E N  LCG+           +  +  G+ V S   I  I
Sbjct: 615  NKLSGPIPTGVQFQTFPNSSFEGNQGLCGE----HASPCHITDQSPHGSAVKSKKNIRKI 670

Query: 125  VSMLWW-----------------------------------IQRGNRQQHLSINLAMFEP 149
            V++                                      I+ G+R    S+ L   + 
Sbjct: 671  VAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGSR----SVVLFHNKD 726

Query: 150  SLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK--------------------------- 182
            S  +L+ D I+  T+ F + N+I    FG+ +K                           
Sbjct: 727  SNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQA 786

Query: 183  -----------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK---------HCII 222
                       N+V LLGYC     KL++Y YM  GSL+ WL  +              I
Sbjct: 787  EVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPPSLDWKTRLRI 846

Query: 223  ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
            A G A G+ +LH   +PHI+HRDI +SNILL++ F   ++DFGL RLI   ++H +TD+ 
Sbjct: 847  ARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLV 906

Query: 283  GTIGYILLACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL---- 330
            GT+GYI    G        GD+YSF VVLLEL+  ++P     K +   +L+ WVL    
Sbjct: 907  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMD-VCKPRGSRDLISWVLQMKT 965

Query: 331  --------DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                    D  I +      ML +L+I   C+ +NP TRPT  ++  +LE
Sbjct: 966  EKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQLVSWLE 1015

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	383
224136952	1215	predicted protein [Populus trichocarpa]	0.892	0.281	0.415	1e-83
224120068	1237	predicted protein [Populus trichocarpa]	0.921	0.285	0.395	7e-83
356534151	1269	PREDICTED: leucine-rich repeat receptor	0.913	0.275	0.405	4e-78
255539505	1303	leucine-rich repeat receptor protein kin	0.913	0.268	0.404	4e-77
356574479	1268	PREDICTED: leucine-rich repeat receptor	0.913	0.276	0.399	3e-76
297741086	961	unnamed protein product [Vitis vinifera]	0.934	0.372	0.396	4e-76
225455406	1299	PREDICTED: leucine-rich repeat receptor	0.937	0.276	0.403	7e-76
297806755	1180	extra sporogenous cells [Arabidopsis lyr	0.932	0.302	0.382	4e-74
23304947	1192	extra sporogenous cells [Arabidopsis tha	0.950	0.305	0.380	1e-73
15240747	1192	leucine-rich repeat receptor protein kin	0.950	0.305	0.380	2e-73

>gi|224136952|ref|XP_002322457.1| predicted protein [Populus trichocarpa] gi|222869453|gb|EEF06584.1| predicted protein [Populus trichocarpa]

 Score =  316 bits (810), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 203/488 (41%), Positives = 252/488 (51%), Gaps = 146/488 (29%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLGG 82
            +L EL HLDLS N+L+GE+ + LS +L ++GLY        L NLVQL YFD S N + G
Sbjct: 731  DLKELTHLDLSYNELDGELPSSLSGMLNLVGLY--------LGNLVQLAYFDVSGNRISG 782

Query: 83   HIPEK-------------------------------------NIDLCGKIMGLDYQVLTF 105
             IPEK                                     N DLCGKIMGLD ++ +F
Sbjct: 783  QIPEKLCALVNLFYLNLAENSLEGPVPGSGICLNLSKISLAGNKDLCGKIMGLDCRIKSF 842

Query: 106  SK------LALFGTVVGS-VLAIAIIVSMLWWIQRGNRQ--------------------- 137
             K        L G  VG  ++ ++I  ++  WI + + Q                     
Sbjct: 843  DKSYYLNAWGLAGIAVGCMIVTLSIAFALRKWILKDSGQGDLDERKLNSFLDQNLYFLSS 902

Query: 138  ------QHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK--------- 182
                  + LSIN+AMFE  L K+T   I+  TN F + N+I    FG  +K         
Sbjct: 903  SSSRSKEPLSINIAMFEQPLLKITLVDILEATNNFCKTNIIGDGGFGTVYKATLPDVKTV 962

Query: 183  -----------------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL 213
                                         N+V LLGYC  GE+KL+VYEYMV GSL+ WL
Sbjct: 963  AVKKLSQAKTQGNREFIAEMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWL 1022

Query: 214  RNQA---------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF 264
            RNQ+         K   IA G ARG+ FLHH F PHIIHRDI ASNILLNEDFE KV+DF
Sbjct: 1023 RNQSRALDVLDWPKRVKIATGAARGLAFLHHGFTPHIIHRDIKASNILLNEDFEPKVADF 1082

Query: 265  GLVRLISDCESHTSTDVAGTIGYILLACG--------GDIYSFSVVLLELVIRKQPTGPE 316
            GL RLIS CE+H STD+AGT GYI    G        GD+YSF V+LLELV  K+PTGP+
Sbjct: 1083 GLARLISACETHVSTDIAGTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPD 1142

Query: 317  FKDKNGGNLVDW------------VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM 364
            FK+  GGNLV W            VLD T+L+A SK  ML++LQI   C+ DNP  RPTM
Sbjct: 1143 FKEVEGGNLVGWVFQKIKKGQAADVLDPTVLSADSKQMMLQVLQIAAICLSDNPANRPTM 1202

Query: 365  LRVQEFLE 372
            L+V +FL+
Sbjct: 1203 LKVLKFLK 1210

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120068|ref|XP_002318234.1| predicted protein [Populus trichocarpa] gi|222858907|gb|EEE96454.1| predicted protein [Populus trichocarpa]

 Score =  313 bits (803), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 201/508 (39%), Positives = 262/508 (51%), Gaps = 155/508 (30%)

Query: 20   IPKNLNELP---HLDLSCNKLNGEISTFLSHILGILGLYVQ-------------FKIPPD 63
            +P++L +L    HLDLS N+L+GE+ + +S +L ++GLYVQ               +P +
Sbjct: 725  VPRSLGDLKALTHLDLSYNELDGELPSSVSQMLNLVGLYVQQNRLSGPLDELLSRTVPVE 784

Query: 64   LCNLVQLEYFDFSMNMLGGHIPEK------------------------------------ 87
            L NL+QLEYFD S N L G IPE                                     
Sbjct: 785  LGNLMQLEYFDVSGNRLSGKIPENICVLVNLFYLNLAENSLEGPVPRSGICLNLSKISLA 844

Query: 88   -NIDLCGKIMGLDYQVLTFSK------LALFGTVVGS-VLAIAIIVSMLWWIQRGNRQ-- 137
             N DLCG+I+GLD ++ +F+K        L G  VG  ++A++   ++  WI R + Q  
Sbjct: 845  GNKDLCGRILGLDCRIKSFNKSYFLNAWGLAGIAVGCMIVALSTAFALRKWIMRDSGQGD 904

Query: 138  --------------------------QHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNV 171
                                      + LSIN+AMFE  L K+T   I+  TN F + N+
Sbjct: 905  PEEIEERKLNSFIDKNLYFLSSSRSKEPLSINIAMFEQPLLKITLVDILEATNNFCKTNI 964

Query: 172  IRGDDFGIAFK--------------------------------------NIVQLLGYCPV 193
            I    FG  +K                                      N+V LLGYC +
Sbjct: 965  IGDGGFGTVYKATLRDGKTVAVKKLSQAKTQGDREFIAEMETLGKVKHQNLVALLGYCSL 1024

Query: 194  GEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITFLHHRFQPHIIHR 244
            GE+KL+VYEYMV GSL+ WLRN++         K   IA G A G+ FLHH F PHIIHR
Sbjct: 1025 GEEKLLVYEYMVNGSLDLWLRNRSGALDVLDWPKRFKIATGAACGLAFLHHGFTPHIIHR 1084

Query: 245  DINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GDI 296
            DI ASNILLNE+FE +V+DFGL RLIS CE+H STD+AGT GYI    G        GD+
Sbjct: 1085 DIKASNILLNENFEPRVADFGLARLISACETHVSTDIAGTFGYIPPEYGQSGRSTSRGDV 1144

Query: 297  YSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSML 344
            YSF V+LLELV  K+PTGP+FK+  GGNLV W            VLD T+L+A SKP ML
Sbjct: 1145 YSFGVILLELVTGKEPTGPDFKEVEGGNLVGWVSQKIKKGQTADVLDPTVLSADSKPMML 1204

Query: 345  KMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            ++LQI   C+ DNP  RPTML+V +FL+
Sbjct: 1205 QVLQIAAVCLSDNPANRPTMLKVLKFLK 1232

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534151|ref|XP_003535621.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max]

 Score =  298 bits (762), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 190/468 (40%), Positives = 242/468 (51%), Gaps = 118/468 (25%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHIL-----GILGLYVQFKIPPDLCNLVQLEYFDFSM 77
            NL+ L +LDL  N L GEI   L  ++      + G  +  +IP  LC+LV L + D S 
Sbjct: 797  NLSYLTNLDLHGNMLTGEIPLDLGDLMQLEYFDVSGNQLSGRIPDKLCSLVNLNHLDLSQ 856

Query: 78   NMLGGHIPEKNI-------------DLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAII 124
            N L G IP   I             +LCG+++G+D Q  +  +  L+     +V+A+ II
Sbjct: 857  NRLEGPIPRNGICQNLSRVRLAGNKNLCGQMLGIDSQDKSIGRSILYNAWRLAVIAVTII 916

Query: 125  VSMLW-------WIQR--------------------------GNRQQHLSINLAMFEPSL 151
            +  L        WI R                             ++ LSIN+AMFE  L
Sbjct: 917  LLSLSVAFLLHKWISRRQNDPEELKERKLNSYVDHNLYFLSSSRSKEPLSINVAMFEQPL 976

Query: 152  GKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK----------------------------- 182
             KLT   I+  T+ F + N+I    FG  +K                             
Sbjct: 977  LKLTLVDILEATDNFSKANIIGDGGFGTVYKATLPNGKTVAVKKLSEAKTQGHREFMAEM 1036

Query: 183  ---------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIAC 224
                     N+V LLGYC +GE+KL+VYEYMV GSL+ WLRN+          K   IA 
Sbjct: 1037 ETLGKVKHHNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLRNRTGALEILDWNKRYKIAT 1096

Query: 225  GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
            G ARG+ FLHH F PHIIHRD+ ASNILLNEDFE KV+DFGL RLIS CE+H +TD+AGT
Sbjct: 1097 GAARGLAFLHHGFIPHIIHRDVKASNILLNEDFEPKVADFGLARLISACETHITTDIAGT 1156

Query: 285  IGYILLACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW-------- 328
             GYI    G        GD+YSF V+LLELV  K+PTGP+FK+  GGNLV W        
Sbjct: 1157 FGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEIEGGNLVGWACQKIKKG 1216

Query: 329  ----VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                VLD T+L+A SK  ML+MLQI   CI DNP  RPTML+V +FL+
Sbjct: 1217 QAVDVLDPTVLDADSKQMMLQMLQIACVCISDNPANRPTMLQVHKFLK 1264

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255539505|ref|XP_002510817.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis] gi|223549932|gb|EEF51419.1| leucine-rich repeat receptor protein kinase exs precursor, putative [Ricinus communis]

 Score =  294 bits (753), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 190/470 (40%), Positives = 243/470 (51%), Gaps = 120/470 (25%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHIL-----GILGLYVQFKIPPDLCNLVQLEYFDFSM 77
            NL+ L +LDL  NKL GEI   L +++      + G  +  +IP  +C LV L Y +F+ 
Sbjct: 827  NLSYLTYLDLHGNKLTGEIPPELGNLMQLQYFDVSGNRLSGQIPEKICTLVNLFYLNFAE 886

Query: 78   NMLGGHIPEKNI-------------DLCGKIMGLDYQVLTFSKLALF------GTVVGSV 118
            N L G +P   I             +LCG+I G   ++  F +L+L       G  VG +
Sbjct: 887  NNLEGPVPRSGICLSLSKISLAGNKNLCGRITGSACRIRNFGRLSLLNAWGLAGVAVGCM 946

Query: 119  LAIAIIVSMLW-WIQRGNRQ----------------------------QHLSINLAMFEP 149
            + I  I  +L  W  RG+RQ                            + LSIN+AMFE 
Sbjct: 947  IIILGIAFVLRRWTTRGSRQGDPEDIEESKLSSFIDQNLYFLSSSRSKEPLSINIAMFEQ 1006

Query: 150  SLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK--------------------------- 182
             L K+T   I+  TN F + N+I    FG  +K                           
Sbjct: 1007 PLLKITLVDILEATNNFCKTNIIGDGGFGTVYKAILPDGRRVAVKKLSEAKTQGNREFIA 1066

Query: 183  -----------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCII 222
                       N+V LLGYC  GE+KL+VYEYMV GSL+ WLRN++         K   I
Sbjct: 1067 EMETLGKVKHQNLVPLLGYCSFGEEKLLVYEYMVNGSLDLWLRNRSGALEILNWTKRLKI 1126

Query: 223  ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
            A G+ARG+ FLHH F PHIIHRDI ASNILLNEDFE KV+DFGL RLIS CE+H STD+A
Sbjct: 1127 AIGSARGLAFLHHGFIPHIIHRDIKASNILLNEDFEPKVADFGLARLISACETHVSTDIA 1186

Query: 283  GTIGYILLACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------ 328
            GT GYI    G        GD+YSF V+LLELV  K+PTGP+FK+  GGNLV W      
Sbjct: 1187 GTFGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEVEGGNLVGWVFQKIK 1246

Query: 329  ------VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                  VLD T++N+ SK  ML+ L+I   C+ DNP  RPTML V + L+
Sbjct: 1247 KGHAADVLDPTVVNSDSKQMMLRALKIASRCLSDNPADRPTMLEVLKLLK 1296

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574479|ref|XP_003555374.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Glycine max]

 Score =  291 bits (746), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 187/468 (39%), Positives = 240/468 (51%), Gaps = 118/468 (25%)

Query: 23   NLNELPHLDLSCNKLNGEISTFLSHIL-----GILGLYVQFKIPPDLCNLVQLEYFDFSM 77
            NL+ L +LDL  N L GEI   L  ++      + G  +  +IP  LC+LV L Y D S 
Sbjct: 796  NLSYLTNLDLHGNMLTGEIPLDLGDLMQLEYFDVSGNQLSGRIPDKLCSLVNLNYLDLSR 855

Query: 78   NMLGGHIPEKNI-------------DLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAII 124
            N L G IP   I             +LCG+++G++ Q  +  +  L+     +V+ + II
Sbjct: 856  NRLEGPIPRNGICQNLSRVRLAGNKNLCGQMLGINCQDKSIGRSVLYNAWRLAVITVTII 915

Query: 125  VSMLW-------WIQR--------------------------GNRQQHLSINLAMFEPSL 151
            +  L        WI R                             ++ LSIN+AMFE  L
Sbjct: 916  LLTLSFAFLLHKWISRRQNDPEELKERKLNSYVDHNLYFLSSSRSKEPLSINVAMFEQPL 975

Query: 152  GKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK----------------------------- 182
             KLT   I+  T+ F + N+I    FG  +K                             
Sbjct: 976  LKLTLVDILEATDNFSKTNIIGDGGFGTVYKATLPNGKTVAVKKLSEAKTQGHREFMAEM 1035

Query: 183  ---------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIAC 224
                     N+V LLGYC +GE+KL+VYEYMV GSL+ WLRN+          K   IA 
Sbjct: 1036 ETLGKVKHQNLVALLGYCSIGEEKLLVYEYMVNGSLDLWLRNRTGALEILDWNKRYKIAT 1095

Query: 225  GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
            G ARG+ FLHH F PHIIHRD+ ASNILL+ DFE KV+DFGL RLIS CE+H +TD+AGT
Sbjct: 1096 GAARGLAFLHHGFTPHIIHRDVKASNILLSGDFEPKVADFGLARLISACETHITTDIAGT 1155

Query: 285  IGYILLACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW-------- 328
             GYI    G        GD+YSF V+LLELV  K+PTGP+FK+  GGNLV W        
Sbjct: 1156 FGYIPPEYGQSGRSTTRGDVYSFGVILLELVTGKEPTGPDFKEIEGGNLVGWVCQKIKKG 1215

Query: 329  ----VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                VLD T+L+A SK  ML+MLQI   CI DNP  RPTML+V +FL+
Sbjct: 1216 QAADVLDPTVLDADSKQMMLQMLQIAGVCISDNPANRPTMLQVHKFLK 1263

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297741086|emb|CBI31817.3| unnamed protein product [Vitis vinifera]

 Score =  291 bits (744), Expect = 4e-76,   Method: Compositional matrix adjust.
 Identities = 199/502 (39%), Positives = 248/502 (49%), Gaps = 144/502 (28%)

Query: 15  GMPPIIPKNLNELPHLDLSCNKLNGEISTF--LSHILGILGLYVQF--KIPPDLCNLVQL 70
           G  P    NL  L H DLS N+L+G   +   LS++  +   +  F  +IP +L +L+QL
Sbjct: 455 GSIPFSFGNLTGLTHFDLSSNELDGLPRSLGNLSYLTNLDLHHNMFTGEIPTELGDLMQL 514

Query: 71  EYFDFSMNMLGGHIPEK-------------------------------------NIDLCG 93
           EYFD S N L G IPEK                                     N DLCG
Sbjct: 515 EYFDVSGNRLCGQIPEKICSLVNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCG 574

Query: 94  KIMGLDYQVLTFSKLA-------LFGTVVG-SVLAIAIIVSMLWWIQRGNRQ-------- 137
           + +GL+ Q  TF + +       L G VVG +++ + I   +  W+ R +RQ        
Sbjct: 575 RNLGLECQFKTFGRKSSLVNTWVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEE 634

Query: 138 --------------------QHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDF 177
                               + LSIN+AMFE  L KLT   I+  TN F + NVI    F
Sbjct: 635 SKLNSSIDQNLYFLSSSRSKEPLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGF 694

Query: 178 GIAFK--------------------------------------NIVQLLGYCPVGEKKLI 199
           G  +K                                      N+V LLGYC  GE+K +
Sbjct: 695 GTVYKAALPNGKIVAVKKLNQAKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFL 754

Query: 200 VYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITFLHHRFQPHIIHRDINASN 250
           VYEYMV GSL+ WLRN+          K   IA G ARG+ FLHH F PHIIHRDI ASN
Sbjct: 755 VYEYMVNGSLDLWLRNRTGALEALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASN 814

Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GDIYSFSVV 302
           ILLNEDFE KV+DFGL RLIS CE+H STD+AGT GYI    G        GD+YSF V+
Sbjct: 815 ILLNEDFEAKVADFGLARLISACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVI 874

Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSMLKMLQIV 350
           LLELV  K+PTGP+FKD  GGNLV W            VLD T++ A  K  ML++LQI 
Sbjct: 875 LLELVTGKEPTGPDFKDFEGGNLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIA 934

Query: 351 VGCIFDNPTTRPTMLRVQEFLE 372
             C+ +NP  RPTML V +FL+
Sbjct: 935 AICLSENPAKRPTMLHVLKFLK 956

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455406|ref|XP_002273978.1| PREDICTED: leucine-rich repeat receptor protein kinase EXS-like [Vitis vinifera]

 Score =  290 bits (743), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 194/481 (40%), Positives = 245/481 (50%), Gaps = 122/481 (25%)

Query: 13   NLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHIL-----GILGLYVQFKIPPDLCNL 67
            N G+P  +  NL+ L +LDL  N   GEI T L  ++      + G  +  +IP  +C+L
Sbjct: 815  NGGLPRSL-GNLSYLTNLDLHHNMFTGEIPTELGDLMQLEYFDVSGNRLCGQIPEKICSL 873

Query: 68   VQLEYFDFSMNMLGGHIPEK-------------NIDLCGKIMGLDYQVLTFSKLA----- 109
            V L Y + + N L G IP               N DLCG+ +GL+ Q  TF + +     
Sbjct: 874  VNLLYLNLAENRLEGSIPRSGVCQNLSKDSLAGNKDLCGRNLGLECQFKTFGRKSSLVNT 933

Query: 110  --LFGTVVG-SVLAIAIIVSMLWWIQRGNRQ----------------------------Q 138
              L G VVG +++ + I   +  W+ R +RQ                            +
Sbjct: 934  WVLAGIVVGCTLITLTIAFGLRKWVIRNSRQSDTEEIEESKLNSSIDQNLYFLSSSRSKE 993

Query: 139  HLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFK---------------- 182
             LSIN+AMFE  L KLT   I+  TN F + NVI    FG  +K                
Sbjct: 994  PLSINVAMFEQPLLKLTLVDILEATNNFCKTNVIGDGGFGTVYKAALPNGKIVAVKKLNQ 1053

Query: 183  ----------------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--- 217
                                  N+V LLGYC  GE+K +VYEYMV GSL+ WLRN+    
Sbjct: 1054 AKTQGHREFLAEMETLGKVKHRNLVPLLGYCSFGEEKFLVYEYMVNGSLDLWLRNRTGAL 1113

Query: 218  ------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
                  K   IA G ARG+ FLHH F PHIIHRDI ASNILLNEDFE KV+DFGL RLIS
Sbjct: 1114 EALDWTKRFKIAMGAARGLAFLHHGFIPHIIHRDIKASNILLNEDFEAKVADFGLARLIS 1173

Query: 272  DCESHTSTDVAGTIGYILLACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGG 323
             CE+H STD+AGT GYI    G        GD+YSF V+LLELV  K+PTGP+FKD  GG
Sbjct: 1174 ACETHVSTDIAGTFGYIPPEYGLSWRSTTRGDVYSFGVILLELVTGKEPTGPDFKDFEGG 1233

Query: 324  NLVDW------------VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            NLV W            VLD T++ A  K  ML++LQI   C+ +NP  RPTML V +FL
Sbjct: 1234 NLVGWVFEKMRKGEAAEVLDPTVVRAELKHIMLQILQIAAICLSENPAKRPTMLHVLKFL 1293

Query: 372  E 372
            +
Sbjct: 1294 K 1294

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297806755|ref|XP_002871261.1| extra sporogenous cells [Arabidopsis lyrata subsp. lyrata] gi|297317098|gb|EFH47520.1| extra sporogenous cells [Arabidopsis lyrata subsp. lyrata]

 Score =  285 bits (728), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 192/502 (38%), Positives = 250/502 (49%), Gaps = 145/502 (28%)

Query: 15   GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPPDLCNLVQ 69
            G  P    NL EL H+DLS N L+GE+S+ LS ++ ++GLY++      +IP +L NL Q
Sbjct: 678  GSVPASLGNLKELTHMDLSFNNLSGELSSELSTMVKLVGLYIEQNKFTGEIPSELGNLTQ 737

Query: 70   LEYFDFSMNMLGGHIPEK-------------------------------------NIDLC 92
            LEY D S N+L G IP K                                     N +LC
Sbjct: 738  LEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELC 797

Query: 93   GKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIV-----SMLWWI------QR-------- 133
            G+++G D ++   +KL     + G +L   IIV     S+  W+      QR        
Sbjct: 798  GRVIGSDCKI-DGTKLTHAWGIAGLMLGFTIIVFVFVFSLRRWVITKRVKQRDDPERMEE 856

Query: 134  ---------------GNRQQH-LSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDF 177
                           G+R +  LSIN+AMFE  L K+    IV  T+ F +KN+I    F
Sbjct: 857  SRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGF 916

Query: 178  GIAFK--------------------------------------NIVQLLGYCPVGEKKLI 199
            G  +K                                      N+V LLGYC   ++KL+
Sbjct: 917  GTVYKACLPGGKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSDEKLL 976

Query: 200  VYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASN 250
            VYEYMV GSL+ WLRNQ         +K   IA G ARG+ FLHH F PHIIHRDI ASN
Sbjct: 977  VYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASN 1036

Query: 251  ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GDIYSFSVV 302
            ILL+ DFE KV+DFGL RLIS CESH ST +AGT GYI    G        GD+YSF V+
Sbjct: 1037 ILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVI 1096

Query: 303  LLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSMLKMLQIV 350
            LLELV  K+PTGP+FK+  GGNLV W            VLD  +++   K S+L++LQI 
Sbjct: 1097 LLELVTGKEPTGPDFKESEGGNLVGWVTQKINQGKAVDVLDPLLVSVALKNSLLRLLQIA 1156

Query: 351  VGCIFDNPTTRPTMLRVQEFLE 372
            + C+ + P  RP ML V + L+
Sbjct: 1157 MVCLAETPANRPNMLDVLKALK 1178

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|23304947|emb|CAD42912.1| extra sporogenous cells [Arabidopsis thaliana]

 Score =  283 bits (723), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 194/510 (38%), Positives = 253/510 (49%), Gaps = 146/510 (28%)

Query: 9    LIRDNLGMP-PIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPP 62
            L ++ L  P P    NL EL H+DLS N L+GE+S+ LS +  ++GLY++      +IP 
Sbjct: 683  LTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPS 742

Query: 63   DLCNLVQLEYFDFSMNMLGGHIPEK----------------------------------- 87
            +L NL QLEY D S N+L G IP K                                   
Sbjct: 743  ELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALL 802

Query: 88   --NIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIV-----SMLWWI------QR- 133
              N +LCG+++G D ++   +KL     + G +L   IIV     S+  W+      QR 
Sbjct: 803  SGNKELCGRVVGSDCKI-EGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWVMTKRVKQRD 861

Query: 134  ----------------------GNRQQH-LSINLAMFEPSLGKLTYDQIVAGTNKFYEKN 170
                                  G+R +  LSIN+AMFE  L K+    IV  T+ F +KN
Sbjct: 862  DPERIEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKN 921

Query: 171  VIRGDDFGIAFK--------------------------------------NIVQLLGYCP 192
            +I    FG  +K                                      N+V LLGYC 
Sbjct: 922  IIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS 981

Query: 193  VGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIH 243
              E+KL+VYEYMV GSL+ WLRNQ         +K   IA G ARG+ FLHH F PHIIH
Sbjct: 982  FSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041

Query: 244  RDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GD 295
            RDI ASNILL+ DFE KV+DFGL RLIS CESH ST +AGT GYI    G        GD
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLARLISACESHISTVIAGTFGYIPPEYGQSARATTKGD 1101

Query: 296  IYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSM 343
            +YSF V+LLELV  K+PTGP+FK+  GGNLV W            V+D  +++   K S 
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQ 1161

Query: 344  LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            L++LQI + C+ + P  RP ML V + L++
Sbjct: 1162 LRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240747|ref|NP_196345.1| leucine-rich repeat receptor protein kinase EXS [Arabidopsis thaliana] gi|30913045|sp|Q9LYN8.1|EXS_ARATH RecName: Full=Leucine-rich repeat receptor protein kinase EXS; AltName: Full=Extra sporogenous cells protein; AltName: Full=Protein EXCESS MICROSPOROCYTES 1; Flags: Precursor gi|7546706|emb|CAB87284.1| receptor-like protein kinase-like protein [Arabidopsis thaliana] gi|22138765|emb|CAD32463.1| receptor-like protein kinase-like protein [Arabidopsis thaliana] gi|224589665|gb|ACN59364.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332003749|gb|AED91132.1| leucine-rich repeat receptor protein kinase EXS [Arabidopsis thaliana]

 Score =  282 bits (721), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 194/510 (38%), Positives = 252/510 (49%), Gaps = 146/510 (28%)

Query: 9    LIRDNLGMP-PIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPP 62
            L ++ L  P P    NL EL H+DLS N L+GE+S+ LS +  ++GLY++      +IP 
Sbjct: 683  LTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPS 742

Query: 63   DLCNLVQLEYFDFSMNMLGGHIPEK----------------------------------- 87
            +L NL QLEY D S N+L G IP K                                   
Sbjct: 743  ELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALL 802

Query: 88   --NIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIV-----SMLWWI------QR- 133
              N +LCG+++G D ++   +KL     + G +L   IIV     S+  W       QR 
Sbjct: 803  SGNKELCGRVVGSDCKI-EGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRD 861

Query: 134  ----------------------GNRQQH-LSINLAMFEPSLGKLTYDQIVAGTNKFYEKN 170
                                  G+R +  LSIN+AMFE  L K+    IV  T+ F +KN
Sbjct: 862  DPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKN 921

Query: 171  VIRGDDFGIAFK--------------------------------------NIVQLLGYCP 192
            +I    FG  +K                                      N+V LLGYC 
Sbjct: 922  IIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS 981

Query: 193  VGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIH 243
              E+KL+VYEYMV GSL+ WLRNQ         +K   IA G ARG+ FLHH F PHIIH
Sbjct: 982  FSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIH 1041

Query: 244  RDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG--------GD 295
            RDI ASNILL+ DFE KV+DFGL RLIS CESH ST +AGT GYI    G        GD
Sbjct: 1042 RDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGD 1101

Query: 296  IYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDSTILNAYSKPSM 343
            +YSF V+LLELV  K+PTGP+FK+  GGNLV W            V+D  +++   K S 
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQ 1161

Query: 344  LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            L++LQI + C+ + P  RP ML V + L++
Sbjct: 1162 LRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	383
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.386	0.124	0.606	5.3e-68
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.381	0.112	0.536	3.4e-51
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.386	0.123	0.476	1.3e-46
TAIR|locus:2041150	1143	BRL2 "BRI1-like 2" [Arabidopsi	0.383	0.128	0.461	2.3e-46
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.430	0.147	0.446	2.1e-43
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.383	0.141	0.436	3.7e-40
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.342	0.134	0.435	2.4e-38
TAIR|locus:2170668	604	AT5G62710 [Arabidopsis thalian	0.451	0.286	0.421	3.1e-38
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.383	0.145	0.442	3.4e-37
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.386	0.234	0.381	1.7e-36

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 484 (175.4 bits), Expect = 5.3e-68, Sum P(3) = 5.3e-68
 Identities = 100/165 (60%), Positives = 115/165 (69%)

Query:   183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFL 233
             N+V LLGYC   E+KL+VYEYMV GSL+ WLRNQ         +K   IA G ARG+ FL
Sbjct:   972 NLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFL 1031

Query:   234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
             HH F PHIIHRDI ASNILL+ DFE KV+DFGL RLIS CESH ST +AGT GYI    G
Sbjct:  1032 HHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYG 1091

Query:   294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
                     GD+YSF V+LLELV  K+PTGP+FK+  GGNLV W +
Sbjct:  1092 QSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAI 1136

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 423 (154.0 bits), Expect = 3.4e-51, Sum P(3) = 3.4e-51
 Identities = 88/164 (53%), Positives = 111/164 (67%)

Query:   183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK---------HCIIACGTARGITFL 233
             N+V LLGYC  G+++ ++YEYM  GSL  WLRN+A             I  G+ARG+ FL
Sbjct:  1058 NLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGSARGLAFL 1117

Query:   234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
             HH F PHIIHRD+ +SNILL+E+FE +VSDFGL R+IS CE+H STD+AGT GYI    G
Sbjct:  1118 HHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTFGYIPPEYG 1177

Query:   294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
                     GD+YSF VV+LEL+  + PTG E + + GGNLV WV
Sbjct:  1178 LTMKSTTKGDVYSFGVVMLELLTGRPPTGQE-EVQGGGNLVGWV 1220

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 361 (132.1 bits), Expect = 1.3e-46, Sum P(3) = 1.3e-46
 Identities = 81/170 (47%), Positives = 109/170 (64%)

Query:   179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------IACGTARG 229
             I  +N+V LLGYC VG+++L+VYE+M  GSL D L +  K  +         IA G+ARG
Sbjct:   934 IKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARG 993

Query:   230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGYI 288
             + FLHH   PHIIHRD+ +SN+LL+E+ E +VSDFG+ RL+S  ++H S   +AGT GY+
Sbjct:   994 LAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1053

Query:   289 ------LLACG--GDIYSFSVVLLELVIRKQPT-GPEFKDKNGGNLVDWV 329
                      C   GD+YS+ VVLLEL+  K+PT  P+F D N   LV WV
Sbjct:  1054 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNN---LVGWV 1100

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 328 (120.5 bits), Expect = 2.3e-46, Sum P(4) = 2.3e-46
 Identities = 79/171 (46%), Positives = 105/171 (61%)

Query:   179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL---RNQAKHCI--------IACGTA 227
             I  +N+V LLGYC +GE++L+VYE+M  GSL + L   R   K  I        IA G A
Sbjct:   889 IKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGWEERKKIAKGAA 948

Query:   228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIG 286
             +G+ FLHH   PHIIHRD+ +SN+LL++D E +VSDFG+ RLIS  ++H S   +AGT G
Sbjct:   949 KGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTHLSVSTLAGTPG 1008

Query:   287 YI------LLACG--GDIYSFSVVLLELVIRKQPTGPE-FKDKNGGNLVDW 328
             Y+         C   GD+YS  VV+LE++  K+PT  E F D N   LV W
Sbjct:  1009 YVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTN---LVGW 1056

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0010233 "phloem transport" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009734 "auxin mediated signaling pathway" evidence=RCA;IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 347 (127.2 bits), Expect = 2.1e-43, Sum P(3) = 2.1e-43
 Identities = 84/188 (44%), Positives = 111/188 (59%)

Query:   179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK---------HCIIACGTARG 229
             I  +N+V LLGYC  GE++L+VY+YM  GSL D L ++ K            IA G ARG
Sbjct:   858 IKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARG 917

Query:   230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGYI 288
             + FLHH   PHIIHRD+ +SN+L++E  E +VSDFG+ RL+S  ++H S   +AGT GY+
Sbjct:   918 LAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYV 977

Query:   289 ------LLACG--GDIYSFSVVLLELVIRKQPT-GPEFKDKNGGNLVDWVLDSTILNAYS 339
                      C   GD+YS+ VVLLEL+  K PT   +F + N  NLV WV   T L    
Sbjct:   978 PPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSADFGEDN--NLVGWVKQHTKLKITD 1035

Query:   340 --KPSMLK 345
                P +LK
Sbjct:  1036 VFDPELLK 1043

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 319 (117.4 bits), Expect = 3.7e-40, Sum P(3) = 3.7e-40
 Identities = 72/165 (43%), Positives = 102/165 (61%)

Query:   182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------IACGTARGITF 232
             KN+V L GYC  G  +L++Y +M  GSL+ WL  +    +         IA G ARG+ +
Sbjct:   808 KNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAY 867

Query:   233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---- 288
             LH   +P++IHRD+ +SNILL+E FE  ++DFGL RL+   ++H +TD+ GT+GYI    
Sbjct:   868 LHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEY 927

Query:   289 ---LLA-CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
                L+A C GD+YSF VVLLELV  ++P     K K+  +LV  V
Sbjct:   928 SQSLIATCRGDVYSFGVVLLELVTGRRPV-EVCKGKSCRDLVSRV 971

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 297 (109.6 bits), Expect = 2.4e-38, Sum P(4) = 2.4e-38
 Identities = 64/147 (43%), Positives = 93/147 (63%)

Query:   182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLH 234
             KN+V L+G+C    ++++VYEYM  GSL D L  ++       +   +A G+ARG+ +LH
Sbjct:   692 KNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKRRLRVALGSARGLAYLH 751

Query:   235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYI----- 288
                 P IIHRD+ ++NILL+E+   KV+DFGL +L+SDC + H ST V GT+GY+     
Sbjct:   752 ELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLGYLDPEYY 811

Query:   289 ---LLACGGDIYSFSVVLLELVIRKQP 312
                 L    D+YSF VV++EL+  KQP
Sbjct:   812 TTQKLTEKSDVYSFGVVMMELITAKQP 838

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)]

 Score = 346 (126.9 bits), Expect = 3.1e-38, Sum P(2) = 3.1e-38
 Identities = 83/197 (42%), Positives = 120/197 (60%)

Query:   157 DQIVAGTNKFYEKNV-IRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN 215
             D+   G+++ +E+ V I G    +   N+V L GYC +   +L++Y+Y+  GSL+D L  
Sbjct:   343 DRSRQGSDRVFEREVEILGS---VKHINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHE 399

Query:   216 QAKH---------CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
             +A+            IA G+ARG+ +LHH   P I+HRDI +SNILLN+  E +VSDFGL
Sbjct:   400 RAQEDGLLNWNARLKIALGSARGLAYLHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGL 459

Query:   267 VRLISDCESHTSTDVAGTIGYIL---LACG-----GDIYSFSVVLLELVIRKQPTGPEFK 318
              +L+ D ++H +T VAGT GY+    L  G      D+YSF V+LLELV  K+PT P F 
Sbjct:   460 AKLLVDEDAHVTTVVAGTFGYLAPEYLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIFV 519

Query:   319 DKNGGNLVDWVLDSTIL 335
              K G N+V W+  +T+L
Sbjct:   520 -KRGLNVVGWM--NTVL 533

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 317 (116.6 bits), Expect = 3.4e-37, Sum P(3) = 3.4e-37
 Identities = 73/165 (44%), Positives = 99/165 (60%)

Query:   183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL--RNQAKHCI-------IACGTARGITFL 233
             N+V L G+C     +L++Y YM  GSL+ WL  RN     +       IA G A+G+ +L
Sbjct:   789 NLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYL 848

Query:   234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
             H    PHI+HRDI +SNILL+E+F   ++DFGL RL+S  E+H STD+ GT+GYI    G
Sbjct:   849 HEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYG 908

Query:   294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
                     GD+YSF VVLLEL+  K+P     K K   +L+ WV+
Sbjct:   909 QASVATYKGDVYSFGVVLLELLTDKRPVDM-CKPKGCRDLISWVV 952

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 282 (104.3 bits), Expect = 1.7e-36, Sum P(3) = 1.7e-36
 Identities = 63/165 (38%), Positives = 99/165 (60%)

Query:   182 KNIVQLLGYCPVGEKKLIVYEYMVKGS----LNDWLRNQ-----AKHCIIACGTARGITF 232
             +N+++L G+C   +++++VY YM  GS    L D +R +     ++   IA GTARG+ +
Sbjct:   356 RNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVY 415

Query:   233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
             LH +  P IIHRD+ A+NILL+EDFE  V DFGL +L+   +SH +T V GT+G+I    
Sbjct:   416 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 475

Query:   290 LACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
             L+ G      D++ F ++LLEL+  ++           G ++DWV
Sbjct:   476 LSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWV 520

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_XV001111 hypothetical protein (1215 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	383
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-25
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-24
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-23
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-13
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-13
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-12
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-07
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-06
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-05
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-05
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-04
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-04
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-04
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-04
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.001
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	0.001
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.001
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.001
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.001
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.001
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.002
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.002
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	0.002
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.002
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.002
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.003
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	0.003
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.004
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.004
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.004

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 60/229 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------------IACGTA 227
            N+V+LLG C   E   +V EYM  G L D+LR                      A   A
Sbjct: 56  PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           +G+ +L  +     +HRD+ A N L+ ED  VK+SDFGL R + D + +           
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT------- 165

Query: 288 ILLACGG---------------------DIYSFSVVLLELVIR-KQPTGPEFKDKNGGNL 325
                GG                     D++SF V+L E+      P    +   +   +
Sbjct: 166 -----GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----YPGLSNEEV 216

Query: 326 VDWVLDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           ++++     L    KP     ++ ++++ C   +P  RPT   + E LE
Sbjct: 217 LEYLRKGYRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (255), Expect = 5e-25
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            N+V+LLG C   E   IV EYM  G L  +LR              A   ARG+ +L  
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +   + IHRD+ A N L+ E+  VK+SDFGL R + D + +        I ++       
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 293 -----GGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                  D++SF V+L E+    +QP    +   +   +++++ +   L         ++
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLEYLKNGYRLPQPPNCPP-EL 232

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFL 371
             +++ C  ++P  RPT   + E L
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 35/205 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NIV+L+      +   +V EY   G L D+L        ++AK   IA    RG+ +LH 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKK--IALQILRGLEYLHS 116

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
                IIHRD+   NILL+E+  VK++DFGL + +    S + T   GT  Y    +LL 
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLG 172

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGN---LVDWVL----DSTILNAYS 339
             G     D++S  V+L EL+  K P    F  +N  +   L+  +L    +       S
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGPPLEFDEPKWSS 228

Query: 340 KPSMLKMLQIVVGCIFDNPTTRPTM 364
                K   ++  C+  +P+ RPT 
Sbjct: 229 GSEEAK--DLIKKCLNKDPSKRPTA 251

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 99.2 bits (248), Expect = 5e-24
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            NIV+LLG C   E  +IV EYM  G L D+LR      +        A   ARG+ +L 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-- 292
            +   + IHRD+ A N L+ E+  VK+SDFGL R + D + +        I ++      
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 293 ------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM--L 344
                   D++SF V+L E+    +   P   +     +++++     L    KP     
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---EVLEYLKKGYRL---PKPPNCPP 231

Query: 345 KMLQIVVGCIFDNPTTRPTMLRVQEFL 371
           ++ ++++ C  ++P  RPT   + E L
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 95.8 bits (239), Expect = 4e-23
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 20/144 (13%)

Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITF 232
           +   NIV+L G         +V EY   GSL D L+             I      G+ +
Sbjct: 48  LNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEY 107

Query: 233 LHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGY---- 287
           LH      IIHRD+   NILL+ D  +VK++DFGL +L++  +      + GT  Y    
Sbjct: 108 LHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPE 163

Query: 288 ILLACGG-----DIYSFSVVLLEL 306
           +LL  G      DI+S  V+L EL
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 96.1 bits (240), Expect = 8e-23
 Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 28/199 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLH 234
            NIV+L       +K  +V EY   G L D L+        +A+           + +LH
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLH 114

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLA 291
            +    I+HRD+   NILL+ED  VK++DFGL R +        T   GT  Y+   +L 
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLL 169

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML-- 344
             G     DI+S  V+L EL+  K P    F   +    +   +             +  
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 345 KMLQIVVGCIFDNPTTRPT 363
           +   ++   +  +P  R T
Sbjct: 226 EAKDLIRKLLVKDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 40/214 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            NIV+LLG C  GE   IV EYM  G L D+LR      +       +A   A+G+ +L 
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE 119

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI------ 288
            +   + +HRD+ A N L+ E+  VK+SDFGL R I +             G +      
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWMA 172

Query: 289 --LLACGG-----DIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              L  G      D++SF V+L E+    +QP    +   +   +++ + D   L     
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP----YPGMSNEEVLELLEDGYRLPRPEN 228

Query: 341 -PSMLK--MLQIVVGCIFDNPTTRPTMLRVQEFL 371
            P  L   MLQ    C   +P  RPT   + E L
Sbjct: 229 CPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 29/211 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCI-IACGTARGITFLH 234
           K+++ L   C VGE   I+ E M KGSL  +LR+           I +AC  A G+ +L 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD---CESHTSTDVAGT----IGY 287
            +   + IHRD+ A NIL+ ED   KV+DFGL RLI +     S        T      +
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK-- 345
              +   D++SF ++L E+    Q   P       G     V D  I   Y  P   K  
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP-------GMNNHEVYDQ-ITAGYRMPCPAKCP 230

Query: 346 --MLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
             + +I++ C    P  RP+   ++E L+  
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 47/146 (32%), Positives = 69/146 (47%), Gaps = 21/146 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK---HCIIAC---GTARGITFLHH 235
            NIV+  G     ++  IV E+   GSL D L++  +      IA       +G+ +LH 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTDVAGTIGYI---LLA 291
                IIHRDI A+NILL  D EVK+ DFGL  +L      +T   + GT  ++   ++ 
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVIN 170

Query: 292 CGG-----DIYSFSVVLLELVIRKQP 312
                   DI+S  +  +EL   K P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 49/223 (21%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACG---------------TA 227
           ++V+LLG    G+  L+V E M KG L  +LR++        G                A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L  +     +HRD+ A N ++ ED  VK+ DFG+ R I +      TD     G 
Sbjct: 130 DGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE------TDYYRKGGK 180

Query: 288 ILL---------------ACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLD 331
            LL                   D++SF VVL E+  + +QP    ++  +   ++ +V+D
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP----YQGLSNEEVLKFVID 236

Query: 332 STILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
              L+    P     K+L+++  C   NP  RPT L +   L+
Sbjct: 237 GGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 5e-17
 Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 40/217 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLH 234
             +VQL   C   E   IV EYM KGSL D+L++         +   +A   A G+ +L 
Sbjct: 61  DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE--SHTSTD--VAGT----IG 286
            R   + IHRD+ A NIL+ E+   K++DFGL RLI D E  +       +  T      
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 287 YILLACGGDIYSFSVVLLELVIRKQ-P----TGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
           Y       D++SF ++L E+V   + P    T  E            VL+  +   Y  P
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------------VLEQ-VERGYRMP 224

Query: 342 SML----KMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
                  ++  +++ C   +P  RPT   +Q FLE Y
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.9 bits (198), Expect = 5e-17
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTA---RGITFLHHRF 237
            +V+  G      +  IV EYM  GSL D L+   K    ++A       +G+ +LH   
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT-- 117

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-----ILLAC 292
           + HIIHRDI  SN+L+N   EVK++DFG+ +++ +     +T V GT+ Y     I    
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 293 ---GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN---LVDWVLDSTILNAYSKPSMLKM 346
                DI+S  + LLE  + K P    F      +   L+  + D    +  ++    + 
Sbjct: 177 YSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232

Query: 347 LQIVVGCIFDNPTTRPT--MLRVQEFLEKYH 375
              +  C+  +P  RP+   L    F++K  
Sbjct: 233 RDFISACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 10/94 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            N+VQLLG    G    IV EYM KGSL D+LR++ +  I        A     G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
            +   + +HRD+ A N+L++ED   KVSDFGL +
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.1 bits (184), Expect = 2e-15
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 61  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG------- 286
               + + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I        
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 287 -YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
            Y       D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 227

Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C    P  RPT   +Q FLE Y T
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 18/140 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHH 235
            ++QL   C + E   IV E M  GSL ++L+  A   +       +A   A G+ +L  
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI--SDCESHTSTD--VAGT----IGY 287
           +   + IHRD+ A N+L+ E+   KV+DFGL R+I     E+       +  T      Y
Sbjct: 122 Q---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY 178

Query: 288 ILLACGGDIYSFSVVLLELV 307
              +   D++SF ++L E+V
Sbjct: 179 NRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 47/139 (33%), Positives = 67/139 (48%), Gaps = 20/139 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCII-----ACGTARGITFLHHR 236
           NI++L G        +I+ EYM  GSL+ +LR N  K  +        G A G+ +L   
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
              + +HRD+ A NIL+N +   KVSDFGL R + D E+ T T   G           I 
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTTKGGKIPIRWTAPEAIA 181

Query: 287 YILLACGGDIYSFSVVLLE 305
           Y       D++SF +V+ E
Sbjct: 182 YRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 41/213 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           N+VQL G C       IV EYM  G L ++LR +            C   C     + +L
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC---EAMEYL 116

Query: 234 H-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-------- 284
             + F    IHRD+ A N L+ ED  VKVSDFGL R + D +  +S    GT        
Sbjct: 117 ESNGF----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ---GTKFPVKWAP 169

Query: 285 ---IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
                Y   +   D++SF V++ E+    K P    ++  +   +V+ V     L    +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP----YERFSNSEVVESVSAGYRLY---R 222

Query: 341 PSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
           P +   ++  I+  C  + P  RP   ++   L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)

Query: 184 IVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHH 235
           +VQL  Y  V E+ + IV EYM KGSL D+L++     +       +A   A G+ ++  
Sbjct: 63  LVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG--------Y 287
             + + IHRD+ ++NIL+ +    K++DFGL RLI D E          I         Y
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP----SM 343
                  D++SF ++L ELV + +   P   ++        VL+  +   Y  P      
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQ-VERGYRMPCPQDCP 229

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
           + + ++++ C   +P  RPT   +Q FLE Y
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 24/146 (16%)

Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT 172

Query: 284 ---TIGYILLACGGDIYSFSVVLLEL 306
              ++ Y   +   D+++F V+L E+
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 48/208 (23%)

Query: 195 EKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHHRFQPHIIHRDIN 247
           E   I+ EYM  GSL D+L+      +       +A   A G+ F+  +   + IHRD+ 
Sbjct: 73  EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLR 129

Query: 248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYS 298
           A+NIL++E    K++DFGL RLI D E +T+ + A           I Y       D++S
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188

Query: 299 FSVVLLELVIRKQ-P----TGPEFKDKNGGNLVDWVLDSTILN---AYSKPS----MLKM 346
           F ++L E+V   + P    T PE                 I N    Y  P       ++
Sbjct: 189 FGILLTEIVTYGRIPYPGMTNPE----------------VIQNLERGYRMPRPDNCPEEL 232

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
            +++  C  + P  RPT   ++  LE +
Sbjct: 233 YELMRLCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 190 YCPVGEKKL-IVYEYMVKGSLNDWLRN-QAKHCII------ACGTARGITFLHHRFQPHI 241
           Y  V E+ + IV E+M KGSL D+L+    K+  +      A   A G+ ++    + + 
Sbjct: 67  YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123

Query: 242 IHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG--------YILLACG 293
           IHRD+ A+NIL+ ++   K++DFGL RLI D E          I         Y      
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 294 GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP-------SMLKM 346
            D++SF ++L ELV + +   P   ++     V+          Y  P       S+ ++
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE--------RGYRMPCPQGCPESLHEL 235

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
           +++   C   +P  RPT   +Q FLE Y
Sbjct: 236 MKL---CWKKDPDERPTFEYIQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 104/440 (23%), Positives = 186/440 (42%), Gaps = 92/440 (20%)

Query: 20  IPKNLN---ELPHLDLSCNKLNGEISTFLSH--ILGILGL---YVQFKIPPDLCNLVQLE 71
           IP  L+   +L  LDLS N+L+G+I    S   +L  L L    +  +IP +L N+  L 
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574

Query: 72  YFDFSMNMLGGHIP-------------EKNIDLCG--KIMGL-DYQVLTFSKLALF--GT 113
             + S N L G +P               NIDLCG     GL   + +  +    F    
Sbjct: 575 QVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITC 634

Query: 114 VVGSVLAIAIIVSMLWWIQRGN-------RQQHLSINLAMFEPSLGK-LTYDQIVAGTNK 165
            +G+ L +A++     +I+  N         +  +  L  F+  + K +T + I++    
Sbjct: 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLK- 693

Query: 166 FYEKNVIRGDDFGIAFK-----------------------------------NIVQLLGY 190
             E+NVI     G ++K                                   NIV+L+G 
Sbjct: 694 --EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGL 751

Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA--KHCIIACGTARGITFLHHRFQPHIIHRDINA 248
           C   +   +++EY+   +L++ LRN +  +   IA G A+ + FLH R  P ++  +++ 
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 249 SNILLNEDFE--VKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLEL 306
             I+++   E  +++S  GL+   + C   ++     T     +    DIY F ++L+EL
Sbjct: 812 EKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871

Query: 307 VIRKQPTGPEFKDKNGGNLVDWV------------LDSTILNAYS--KPSMLKMLQIVVG 352
           +  K P   EF     G++V+W             +D +I    S  +  +++++ + + 
Sbjct: 872 LTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929

Query: 353 CIFDNPTTRPTMLRVQEFLE 372
           C   +PT RP    V + LE
Sbjct: 930 CTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-------ACGTARGITFLHHR 236
           +V+L       E   I+ EYM KGSL D+L++     ++       +   A G+ ++  +
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGY 287
              + IHRD+ A+N+L++E    K++DFGL R+I D E +T+ + A           I +
Sbjct: 123 ---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINF 178

Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM---- 343
                  D++SF ++L E+V   +   P   + +        + S +   Y  P M    
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMPRMENCP 230

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
            ++  I+  C  +    RPT   +Q  L+ +
Sbjct: 231 DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 180 AFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH--CIIACGTARGITF-LHHR 236
           +  NI++L G     +  +I+ EYM  G+L+ +LR+           G  RGI   + + 
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
              + +HRD+ A NIL+N + E KVSDFGL R++ D    T T   G           I 
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 287 YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML-- 344
           Y       D++SF +V+ E++         F ++   ++ +  +   I + +  P+ +  
Sbjct: 184 YRKFTSASDVWSFGIVMWEVM--------SFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235

Query: 345 --KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              + Q+++ C   +   RP  + +   L+K
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 38/200 (19%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIA--CG-TARGITFLHH 235
            NIV       VG++  +V EYM  GSL D +     +     IA  C    +G+ +LH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGY 287
           +   ++IHRDI + NILL++D  VK++DFG    ++  +S  ++ V GT        I  
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190

Query: 288 ILLACGGDIYSFSVVLLELV-----------------IRKQPTGPEFKDKNG--GNLVDW 328
                  DI+S  ++ +E+                  I  +   P  K+         D+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-PPLKNPEKWSPEFKDF 249

Query: 329 VLDSTILNAYSKPSMLKMLQ 348
           +    + +   +PS  ++LQ
Sbjct: 250 LNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 38/162 (23%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------IA 223
           NIV+  G C  G+  ++V+EYM  G LN +LR+                         IA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG 283
              A G+ +L  +   H +HRD+   N L+  D  VK+ DFG+ R +   + +    V G
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGG 182

Query: 284 T------------IGYILLACGGDIYSFSVVLLEL-VIRKQP 312
                        I Y       D++SF VVL E+    KQP
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 44/220 (20%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHH 235
            IV   G         I  EYM  GSL+  L+ + +  I       IA    +G+T+LH 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------ 289
             +  IIHRD+  SNIL+N   ++K+ DFG+   + +  S   T V GT  Y+       
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN--SLAKTFV-GTSSYMAPERIQG 173

Query: 290 --LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--STILN--------- 336
              +   DI+S  + L+EL   + P  PE    +G      + +    I+N         
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------IFELLQYIVNEPPPRLPSG 227

Query: 337 AYSKPSMLKMLQIVVGCIFDNPTTRPT--MLRVQEFLEKY 374
            +S          V  C+  +P  RP+   L    F++KY
Sbjct: 228 KFSPD----FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 69.4 bits (168), Expect = 6e-13
 Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 35/215 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH--------CIIACGTARGITFL 233
            NIV+L  +        +V EY+  GSL D L+   +           I       + +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 234 HHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTS-----TDVAGTIGY 287
           H +    IIHRDI   NILL+ D   VK+ DFGL +L+ D  S +S     +   GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 288 I-----------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD--WVLDSTI 334
           +             +   DI+S  + L EL+    P   E         +     L +  
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 335 LNAYSKPSM-----LKMLQIVVGCIFDNPTTRPTM 364
           L +   PS           ++   +  +P  R + 
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 27/200 (13%)

Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQAKHC----IIACG--TARGITFLHH 235
           N++ LLG C P     L+V  YM  G L +++R++  +     +I  G   A+G+ +L  
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE---SHTSTDVAGTIGYILL-- 290
           +     +HRD+ A N +L+E F VKV+DFGL R I D E    H  T     + ++ L  
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 291 ------ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS-TILNAYSKPSM 343
                     D++SF V+L EL+ R  P  P   D +  ++  ++L    +L     P  
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVDSFDITVYLLQGRRLLQPEYCPDP 230

Query: 344 LKMLQIVVGCIFDNPTTRPT 363
           L   ++++ C    P  RPT
Sbjct: 231 L--YEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 30/115 (26%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------------------- 221
           NIV+LLG C VG+   +++EYM  G LN++LR+++                         
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 222 ------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                 IA   A G+ +L  R     +HRD+   N L+ E+  VK++DFGL R I
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 180

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 42/152 (27%), Positives = 66/152 (43%), Gaps = 29/152 (19%)

Query: 182 KNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARG 229
            NIV+  G     EK    I  EY+  GSL+  L+   K            I+      G
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EG 113

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGYI 288
           + +LH      I+HRDI  +NIL++ D  VK++DFG  + + D      +  V GT  ++
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQP 312
              ++         DI+S    ++E+   K P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 67.3 bits (164), Expect = 8e-13
 Identities = 46/138 (33%), Positives = 69/138 (50%), Gaps = 17/138 (12%)

Query: 182 KNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITF 232
            N+VQLLG   V EK    IV EYM KGSL D+LR++ +  +        +      + +
Sbjct: 59  SNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           L      + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L   
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 174

Query: 290 -LACGGDIYSFSVVLLEL 306
             +   D++SF ++L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIAC-----GTARGITFLHHR 236
           NI+ L G     +  +IV EYM  GSL+ +LR +  +  +I       G A G+ +L   
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
                +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I 
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 287 YILLACGGDIYSFSVVLLELV 307
           Y       D++S+ +V+ E++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 21/150 (14%)

Query: 182 KNIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLR------NQAKHCIIACGTARGITFL 233
           +NIV+  G C   G + L ++ EY+  GSL D+L+      N  +  + +    +G+ +L
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT-IGYILLA 291
             +     IHRD+ A NIL+  +  VK+SDFGL +++  D + +   +   + I +    
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 292 C--------GGDIYSFSVVLLELVIRKQPT 313
           C          D++SF V L EL     P+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 35/202 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
            +VQL G C       IV EYM  G L ++LR   K          C   C    G+ +L
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC---EGMAYL 116

Query: 234 H-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----I 288
              +F    IHRD+ A N L+++   VKVSDFGL R + D E  +S      + +    +
Sbjct: 117 ESKQF----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Query: 289 LLAC----GGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           LL        D+++F V++ E+  + K P    ++  N    V+ V  S  L  Y +P +
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMP----YERFNNSETVEKV--SQGLRLY-RPHL 225

Query: 344 L--KMLQIVVGCIFDNPTTRPT 363
              K+  I+  C  +    RPT
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPT 247

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 24/142 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKHCIIACGTARGITFLHH 235
             IV+  G         IV EY   GS++D ++       + +   I   T +G+ +LH 
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------- 284
                 IHRDI A NILLNE+ + K++DFG+   ++D  +  +T V GT           
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQE 173

Query: 285 IGYILLACGGDIYSFSVVLLEL 306
           IGY       DI+S  +  +E+
Sbjct: 174 IGY---NNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 29/150 (19%)

Query: 182 KNIVQLLGYCPVGEKKL----IVYEYMVKGSLNDWLRN--------QAKHCIIACGTARG 229
            NIV+L     V  K      +V+EYM    L   L +        Q K          G
Sbjct: 58  PNIVRL--KEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKC--YMKQLLEG 112

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-- 287
           + +LH      I+HRDI  SNIL+N D  +K++DFGL R  +   S   T+   T+ Y  
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169

Query: 288 --ILLAC---GG--DIYSFSVVLLELVIRK 310
             +LL     G   D++S   +L EL + K
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 18/130 (13%)

Query: 199 IVYEYMVKGSL-NDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF 257
           ++ E+M  GSL    + ++     +A     GI +LH R   HI+HRDI  SN+L+N   
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205

Query: 258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYI-------------LLACGGDIYSFSVVLL 304
            VK++DFG+ R+++      ++ V GTI Y+                  GDI+S  V +L
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264

Query: 305 ELVIRKQPTG 314
           E  + + P G
Sbjct: 265 EFYLGRFPFG 274

Length = 353

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 65.6 bits (161), Expect = 4e-12
 Identities = 52/188 (27%), Positives = 76/188 (40%), Gaps = 36/188 (19%)

Query: 198 LIVYEYMVKGSLNDWLRNQAKHCI---------IACGTARGITFLHHRFQPHIIHRDINA 248
            IV EY   G L+  ++ Q K                    + +LH R    I+HRDI  
Sbjct: 75  CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKP 131

Query: 249 SNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---CGG-------DIYS 298
            NI L  +  VK+ DFG+ +++S       T V GT  Y  L+   C         DI+S
Sbjct: 132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYY--LSPELCQNKPYNYKSDIWS 188

Query: 299 FSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSMLKMLQIVVGCIF 355
              VL EL   K P    F+ +N   L   +L      I + YS     ++  +V   + 
Sbjct: 189 LGCVLYELCTLKHP----FEGENLLELALKILKGQYPPIPSQYSS----ELRNLVSSLLQ 240

Query: 356 DNPTTRPT 363
            +P  RP+
Sbjct: 241 KDPEERPS 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 9/108 (8%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTA---RGITFLHHR 236
            NIV+ +G     +   I+ EY   GSL   ++        ++A       +G+ +LH  
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
            +  +IHRDI A+NIL  +D  VK++DFG+   ++D  S     V GT
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 37/158 (23%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------------------AKHCI 221
           KNI+ LLG C       +V EY   G+L D+LR +                     K  +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD-L 134

Query: 222 IACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
           ++     ARG+ FL  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 280 DVAGTIGYILLA----------CGGDIYSFSVVLLELV 307
              G +    +A             D++SF V+L E+ 
Sbjct: 192 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 45/216 (20%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----------QA-----KHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+          QA     K   +A   A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
            G+ +L+ ++F    +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G
Sbjct: 130 DGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKG 181

Query: 287 YI-------------LLACGGDIYSFSVVLLEL-VIRKQPTGPEFKDKNGGNLVDWVLDS 332
            +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++ 
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGMSNEQVLRFVMEG 237

Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
            +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 238 GLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 64/218 (29%), Positives = 89/218 (40%), Gaps = 57/218 (26%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIAC---GTARGITFLH 234
           N+V+      VG++  +V  Y+  GSL D +++          IIA       +G+ +LH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS---DCESHTSTDVAGT------- 284
              Q   IHRDI A NILL ED  VK++DFG+   ++   D          GT       
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 285 -----IGYILLACGGDIYSFSVVLLELVIRKQP--TGPEFKDKNGGNLVDWVLDSTILNA 337
                 GY   A   DI+SF +  +EL     P    P  K          VL  T+ N 
Sbjct: 177 VMEQVHGYDFKA---DIWSFGITAIELATGAAPYSKYPPMK----------VLMLTLQND 223

Query: 338 ------------YSKPSMLKMLQIVVGCIFDNPTTRPT 363
                       YSK S  KM   +  C+  +P+ RPT
Sbjct: 224 PPSLETGADYKKYSK-SFRKM---ISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 46/151 (30%), Positives = 65/151 (43%), Gaps = 27/151 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGIT--------FLH 234
           NIV LLG C   +   +++EY+  G L+++L   + H  +   +             FLH
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 235 HRFQ----------PHIIHRDINASNILLNEDFEVKVSDFGLVRLI--SDCESHTSTDV- 281
              Q           H +HRD+ A N L+ E   VK+SDFGL R I  +D     S  + 
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 282 ------AGTIGYILLACGGDIYSFSVVLLEL 306
                    I Y       DI+SF VVL E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 66/289 (22%)

Query: 111 FGTVVGSVLAIAIIVSMLWWIQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFY-EK 169
           FG+VV              ++ +  ++    + +A+       L  + I AG  +F  E 
Sbjct: 8   FGSVVKG-----------VYLMKSGKE----VEVAV-----KTLKQEHIAAGKKEFLREA 47

Query: 170 NVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC 224
           +V+   D       IV+L+G C  GE  ++V E    G L  +L+ +     +    +A 
Sbjct: 48  SVMAQLDH----PCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH 102

Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG- 283
             A G+ +L  +   H +HRD+ A N+LL    + K+SDFG+ R +     +     AG 
Sbjct: 103 QVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159

Query: 284 ---------TIGYILLACGGDIYSFSVVLLELVIRKQP-----TGPEFKDK--NGGNLVD 327
                     I Y   +   D++S+ V L E             G E      +G  L  
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-- 217

Query: 328 WVLDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
                       +P     ++  I++ C    P  RPT   ++    + 
Sbjct: 218 -----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 15/95 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR---------NQAKHCIIACGTARGITFL 233
           NIV+L+G C   +   IV E +  GSL  +LR            +  + A     G+ +L
Sbjct: 53  NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA---GMEYL 109

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
             +   + IHRD+ A N L+ E+  +K+SDFG+ R
Sbjct: 110 ESK---NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 23/144 (15%)

Query: 183 NIVQLLGY----CPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGITF-LHH 235
           NI+ L G      PV    +I+ E+M  G+L+ +LR N  +  +I   G  RGI   + +
Sbjct: 66  NIIHLEGVVTKSRPV----MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAG----------- 283
             + + +HRD+ A NIL+N +   KVSDFGL R + D  S  T T   G           
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 284 TIGYILLACGGDIYSFSVVLLELV 307
            I Y       D++S+ +V+ E++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 43/140 (30%), Positives = 69/140 (49%), Gaps = 23/140 (16%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHRF 237
           +VQL G C       +V+E+M  G L+D+LR Q      +  +  C     G+ +L    
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE--- 117

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-----------IG 286
             ++IHRD+ A N L+ E+  VKVSDFG+ R + D +  +ST   GT             
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST---GTKFPVKWSSPEVFS 174

Query: 287 YILLACGGDIYSFSVVLLEL 306
           +   +   D++SF V++ E+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 11/97 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CI--IACGTARGITFLH 234
            NIV   G     +K  IV EY   GSL D +    +       I  +   T +G+ +LH
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
                  IHRDI  +NILL ED +VK++DFG+   ++
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 24/196 (12%)

Query: 195 EKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDIN 247
           E   I+ E+M KGSL D+L++         K    +   A G+ F+  R   + IHRD+ 
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLR 129

Query: 248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYS 298
           A+NIL++     K++DFGL R+I D E +T+ + A           I +       D++S
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188

Query: 299 FSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNP 358
           F ++L+E+V   +   P   +      V   L+        +    ++  I++ C  + P
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPE----VIRALERGYRMPRPENCPEELYNIMMRCWKNRP 244

Query: 359 TTRPTMLRVQEFLEKY 374
             RPT   +Q  L+ +
Sbjct: 245 EERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 52/167 (31%), Positives = 70/167 (41%), Gaps = 45/167 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-------ACG--------- 225
           ++IV+  G C  G   L+V+EYM  G LN +LR+      I       A G         
Sbjct: 67  QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 226 ----TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD- 280
                A G+ +L      H +HRD+   N L+ +   VK+ DFG+ R I       STD 
Sbjct: 127 IASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDY 177

Query: 281 --VAG------------TIGYILLACGGDIYSFSVVLLELVIR-KQP 312
             V G            +I Y       DI+SF VVL E+    KQP
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 49/229 (21%)

Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--------------QAKHCI-I 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+                +  I +
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I +      TD  
Sbjct: 125 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE------TDYY 175

Query: 283 GTIGYILLACGG---------------DIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLV 326
              G  LL                   D++SF VVL E+  + +QP    ++  +   ++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVL 231

Query: 327 DWVLDSTILNAYSK--PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +V+D   L+        +  ++++   C   NP  RPT L +   L+ 
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 19/147 (12%)

Query: 182 KNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHH 235
           +NIV+  G C     K   ++ EY+  GSL D+L     N A+  + A     G+ +LH 
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLAC- 292
           +   H IHRD+ A N+LL+ D  VK+ DFGL + + +   +     D    + +  + C 
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 293 -------GGDIYSFSVVLLELVIRKQP 312
                    D++SF V L EL+     
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 61.7 bits (151), Expect = 1e-10
 Identities = 44/147 (29%), Positives = 61/147 (41%), Gaps = 28/147 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYM----------VKGSLNDWLRNQAKHCIIACGTARGITF 232
           NIV+LL       K  +V+EY             G L+    N  K   I     RG+ +
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLS---PNLIKS--IMYQLLRGLAY 113

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----I 288
            H      I+HRD+   NIL+N D  +K++DFGL R        T T    T+ Y    I
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVVTLWYRAPEI 169

Query: 289 LLAC-----GGDIYSFSVVLLELVIRK 310
           LL         DI+S   +  E++  K
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 36/139 (25%), Positives = 70/139 (50%), Gaps = 19/139 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++V+LLG C    +  ++ + M  G L D++RN      +++ +  C   A+G+++L  +
Sbjct: 70  HVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-IGYILLAC--- 292
               ++HRD+ A N+L+     VK++DFGL +L+   E     +     I ++ L     
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 293 -----GGDIYSFSVVLLEL 306
                  D++S+ V + EL
Sbjct: 186 RIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 30/211 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHH 235
           NIV LLG C +G   L++ EY   G L ++LR + +  +        +   A+G+ FL  
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---------GTIG 286
           +   + IHRD+ A N+LL     VK+ DFGL R I +  ++     A          +I 
Sbjct: 160 K---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216

Query: 287 YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--SKPSML 344
             +     D++S+ ++L E+        P       G  VD      I   Y  ++P   
Sbjct: 217 NCVYTFESDVWSYGILLWEIFSLGSNPYP-------GMPVDSKFYKLIKEGYRMAQPEHA 269

Query: 345 --KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             ++  I+  C   +P  RPT  ++ + + K
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 15/136 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
           KN+V+LLG   +     IV E M KG+L ++LR + +  +        +   A G+ +L 
Sbjct: 59  KNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL----L 290
            +    ++HRD+ A NIL++ED   KVSDFGL R+ S    ++   V  T    L     
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKF 174

Query: 291 ACGGDIYSFSVVLLEL 306
           +   D++S+ V+L E+
Sbjct: 175 SSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 24/184 (13%)

Query: 194 GEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR-------GITFLHHRFQPHIIHRDI 246
             K  IV EY   G L+  L+ Q    +      R       G+  LH +    I+HRDI
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDI 127

Query: 247 NASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-C-------GGDIYS 298
            + N+ L+    VK+ D G+ +L+SD  +  +T V GT  Y+    C         D+++
Sbjct: 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSDVWA 186

Query: 299 FSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNP 358
             VVL E    K P    F   N G L+  ++   +    S+    ++ Q++  C+  + 
Sbjct: 187 LGVVLYECCTGKHP----FDANNQGALILKIIRG-VFPPVSQMYSQQLAQLIDQCLTKDY 241

Query: 359 TTRP 362
             RP
Sbjct: 242 RQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 31/159 (19%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------------------NQAKHCIIA 223
           ++IV+  G C  G+  ++V+EYM  G LN +LR                   Q++   IA
Sbjct: 67  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-----SHTS 278
              A G+ +L  +   H +HRD+   N L+ E+  VK+ DFG+ R +   +      HT 
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 279 TDV----AGTIGYILLACGGDIYSFSVVLLELVIR-KQP 312
             +      +I Y       D++S  VVL E+    KQP
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 41/106 (38%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-RNQAKHCIIA--CGTA-RGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +         IA  C    + + FLH    
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
             +IHRDI + NILL  D  VK++DFG    I+  +S  ST V GT
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 25/154 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHR 236
            NIVQ LG+    E   I  EY+  GS+   LR   +               G+ +LH +
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS-TDVAGTI---------- 285
               I+HRD+ A N+L++ D   K+SDFG+ +   D   +     + G++          
Sbjct: 128 ---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184

Query: 286 ---GYILLACGGDIYSFSVVLLELVIRKQPTGPE 316
              GY   +   DI+S   V+LE+   ++P   E
Sbjct: 185 YSQGY---SAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 16/137 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV++     VG++  +V E++  G+L D +     N+ +   +     + ++FLH +  
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYILL 290
             +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  +  
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 291 ACGGDIYSFSVVLLELV 307
               DI+S  ++++E+V
Sbjct: 193 GTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 24/119 (20%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
           +C    ARG+ +L  R     IHRD+ A N+L+ ED  +K++DFGL R + D + +  T
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 14/94 (14%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS--TDVAGTI 285
           RG+ +LH     ++IHRD+  SNIL+N + ++K+ DFGL R +   E      T+   T 
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 286 GY----ILLACGG-----DIYSFSVVLLELVIRK 310
            Y    +LL+        DI+S   +  EL+ RK
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 33/200 (16%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFLH 234
           +VQL G C   +   IV E+M  G L ++LR +            C   C    G+ +L 
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVC---EGMEYLE 117

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI--------G 286
              +   IHRD+ A N L++    VKVSDFG+ R + D E  +S+     +         
Sbjct: 118 ---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
           +   +   D++SF V++ E+    K P    F+ K+   +V+ +     L    +P +  
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVEMISRGFRL---YRPKLAS 227

Query: 346 ML--QIVVGCIFDNPTTRPT 363
           M   +++  C  + P  RPT
Sbjct: 228 MTVYEVMYSCWHEKPEGRPT 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----------------NQAKHC--II 222
           KNI+ LLG C       ++ EY  KG+L ++LR                  +      ++
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R + + + +  T 
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193

Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 15/93 (16%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIG 286
           RG+ +LH  F   IIHRD+  SN+LL +   +K++DFGL R      +  T   V  T+ 
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLW 173

Query: 287 Y----ILLACGG-----DIYSFSVVLLELVIRK 310
           Y    +LL C       D+++   +L EL+  K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 19/144 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--QAKHCIIACGTAR---GITFLHHRF 237
           NIVQ LG     +   I  E +  GSL   L+        +I   T +   G+ +LH R 
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR- 121

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG 293
             + +HRDI  +NIL++ +  VK++DFG+ + +   E   +    G+  +    ++   G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 294 G-----DIYSFSVVLLELVIRKQP 312
           G     DI+S    +LE+   K P
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 35/156 (22%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHC---------------II 222
           KNI+ LLG C       ++ EY  KG+L ++LR +     ++C               ++
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 199

Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 13/94 (13%)

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T RG+ +LH  +   I+HRD+  +N+L+  D  +K++DFGL R         +  V  T 
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TR 166

Query: 286 GY----ILLAC-----GGDIYSFSVVLLELVIRK 310
            Y    +L        G D++S   +  EL++R 
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 42/197 (21%)

Query: 155 TYDQIVAGTNKFYEKNVIRGDDF--------GIAFKNIVQLLGYCPVGEKKLIVYEYMVK 206
           T D+++       +  +    DF         +  ++IV+  G C  G+  ++V+EYM  
Sbjct: 32  TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91

Query: 207 GSLNDWLRNQAKHCI---------------------IACGTARGITFLHHRFQPHIIHRD 245
           G LN +LR      +                     IA   A G+ +L  +   H +HRD
Sbjct: 92  GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRD 148

Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCE-----SHTSTDV----AGTIGYILLACGGDI 296
           +   N L+  +  VK+ DFG+ R +   +      HT   +      +I Y       D+
Sbjct: 149 LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208

Query: 297 YSFSVVLLELVIR-KQP 312
           +SF V+L E+    KQP
Sbjct: 209 WSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 32/87 (36%), Positives = 44/87 (50%), Gaps = 13/87 (14%)

Query: 192 PVGEKKL-IVYEYMVKGSLNDW---LRNQAK----HCI--IACGTARGITFLHHRFQPHI 241
           P  + +L +V E    GS+ D    LR + K      I  I   T RG+ +LH      +
Sbjct: 78  PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KV 134

Query: 242 IHRDINASNILLNEDFEVKVSDFGLVR 268
           IHRDI   NILL ++ EVK+ DFG+  
Sbjct: 135 IHRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 19/179 (10%)

Query: 196 KKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           K  I+ EY+  GS  D L     ++ +   I     +G+ +LH   +   IHRDI A+N+
Sbjct: 76  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANV 132

Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVVLL 304
           LL+E  EVK++DFG+   ++D +   +T V          I         DI+S  +  +
Sbjct: 133 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 192

Query: 305 ELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
           EL  + +P   E        L+      T+   YSKP    + + V  C+   P+ RPT
Sbjct: 193 ELA-KGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 39/198 (19%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR-------GITFLHHR 236
           IVQ  G     E   I  EYM  GS+ D L+  A   +    T +       G+ +LH  
Sbjct: 66  IVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLV-RLISDCESHTST-DVAGTIGY----ILL 290
               I+HRDI  +NIL +    VK+ DFG   RL + C S T    V GT  +    ++ 
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 291 ACG----GDIYSFSVVLLELV-----------------IRKQPTGPEFKDKNGGNLVDWV 329
             G     D++S    ++E++                 I  QPT P+       +  +++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240

Query: 330 LDSTILNAYSKPSMLKML 347
             + + NA  +PS  ++L
Sbjct: 241 RRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 36/144 (25%), Positives = 61/144 (42%), Gaps = 20/144 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            NI++LL          +V+E+M    L   ++++ +               +G+ F H 
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH- 115

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
                I+HRD+   N+L+N +  +K++DFGL R          T    T  Y    +LL 
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLG 172

Query: 292 CGG-----DIYSFSVVLLELVIRK 310
             G     DI+S   +  EL+ R+
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 7/71 (9%)

Query: 199 IVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           I+ EY   GS  D L+    ++     I      G+ +LH   +   IHRDI A+NILL+
Sbjct: 76  IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLS 132

Query: 255 EDFEVKVSDFG 265
           E+ +VK++DFG
Sbjct: 133 EEGDVKLADFG 143

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 29/150 (19%)

Query: 183 NIVQLLGYCPVGEKKLI--VYEYM-------VKGSLNDWLRNQAKHCIIACGTARGITFL 233
           NIV+LL        K I  V+EYM       ++ ++   L +  K  I+     + + ++
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI---LEDVHKRYIM-YQLLKALKYI 123

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS----TDVAGTIGY-- 287
           H     ++IHRD+  SNILLN D  VK++DFGL R +S+ E +      TD   T  Y  
Sbjct: 124 HSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 288 --ILLAC-----GGDIYSFSVVLLELVIRK 310
             ILL       G D++S   +L E+++ K
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 38/102 (37%), Positives = 49/102 (48%), Gaps = 13/102 (12%)

Query: 183 NIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKH-------CIIACGTARGITFLH 234
           N+++L G   V    L +V E    GSL D LR  A         C  A   A G+ +L 
Sbjct: 57  NLIRLYGV--VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH 276
                  IHRD+ A NILL  D +VK+ DFGL+R +   E H
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 27/203 (13%)

Query: 194 GEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINAS 249
           G K  I+ EY+  GS  D L+     +     I     +G+ +LH   +   IHRDI A+
Sbjct: 74  GTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK---IHRDIKAA 130

Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTST----------DVAGTIGYILLACGGDIYSF 299
           N+LL+E  +VK++DFG+   ++D +   +T          +V     Y   A   DI+S 
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA---DIWSL 187

Query: 300 SVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPT 359
            +  +EL  + +P   +        L+      T+   YSKP      + V  C+  +P 
Sbjct: 188 GITAIELA-KGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP----FKEFVEACLNKDPR 242

Query: 360 TRPTM--LRVQEFLEKYHTGENF 380
            RPT   L   +F+ +Y    +F
Sbjct: 243 FRPTAKELLKHKFITRYTKKTSF 265

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 183 NIVQLLGYCPVGEKK------LIVYEYMVKGSLNDWL-----RNQAKHCII------ACG 225
           N+++L+G C            +++  +M  G L+ +L         +   +         
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT- 284
            A G+ +L +R   + IHRD+ A N +L ED  V V+DFGL + I   + +    +A   
Sbjct: 122 IALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 285 IGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN 336
           + +I +            D+++F V + E+  R Q   P  ++     + D++     L 
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRHGNRLK 235

Query: 337 AYSKPS--MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              +P   + ++  ++  C   +P  RPT  +++E LE 
Sbjct: 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 47/193 (24%)

Query: 202 EYMVKGSLNDWLRNQAKHCI-----IACGTARGITFLHHRFQPHIIHRDINASNILLNED 256
           E+M  GSL+   +      +     IA     G+T+L++     I+HRDI  SNIL+N  
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSR 140

Query: 257 FEVKVSDFG----LVRLISDCESHTSTDVAGT-IGYILLACGGDIYSFSVVLLELVIRKQ 311
            ++K+ DFG    L+  I+D    TST ++   I         D++S  + ++EL + K 
Sbjct: 141 GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200

Query: 312 PTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVG------------------- 352
           P    F   N     D   D  +        +L +LQ +V                    
Sbjct: 201 P----FAFSNI---DDDGQDDPM-------GILDLLQQIVQEPPPRLPSSDFPEDLRDFV 246

Query: 353 --CIFDNPTTRPT 363
             C+  +PT RPT
Sbjct: 247 DACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 18/121 (14%)

Query: 159 IVAGTNKFYEKNVIRGDDFGIAFK--NIVQLLGYCPVGEKKL---IVYEYMVKGSLNDWL 213
           I    N   +K ++R  +   + K   IV+  G   + E      I  EY   GSL+   
Sbjct: 34  ITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF-LDESSSSIGIAMEYCEGGSLDSIY 92

Query: 214 RNQAK-------HCI--IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF 264
           +   K         +  IA    +G+++LH R    IIHRDI  SNILL    +VK+ DF
Sbjct: 93  KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDF 149

Query: 265 G 265
           G
Sbjct: 150 G 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 28/149 (18%)

Query: 183 NIVQLLGYC--PVGEKKL---IVYEYMVKGSLNDWLRNQAKHCIIACGTA-------RGI 230
           NIV+LL  C  P  +++L   +V+E+ V   L  +L    K  +             RG+
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 231 TFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-- 287
            FLH HR    I+HRD+   NIL+  D +VK++DFGL R+ S   + TS  V  T+ Y  
Sbjct: 121 DFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRA 174

Query: 288 --ILLACGG----DIYSFSVVLLELVIRK 310
             +LL        D++S   +  EL  R+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 23/150 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTAR---GITFL 233
           +NIVQ LG         I  E +  GSL+  LR++          I   T +   G+ +L
Sbjct: 65  RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 234 HHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           H      I+HRDI   N+L+N     VK+SDFG  + ++     T T   GT+ Y+    
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEV 180

Query: 290 -------LACGGDIYSFSVVLLELVIRKQP 312
                       DI+S    ++E+   K P
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 24/119 (20%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R +++ + +  T
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 16/142 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++A+   +     + + FLH    
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + N+LL  D  VK++DFG    I+  +S  ST V GT  ++        A 
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E+V  + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 56/223 (25%), Positives = 84/223 (37%), Gaps = 45/223 (20%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI----------IACGTARGITF 232
           N++Q LG C      L+V E+   G L ++LR+                +AC  A G+ +
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR--------LISDCES----HTSTD 280
           LH   Q   IH D+   N  L  D  VK+ D+GL          +  DC +      + +
Sbjct: 116 LH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172

Query: 281 VAGTIGYILLACG----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN 336
           +    G  LL        +I+S  V + EL        P+  D+        VL   +  
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVRE 225

Query: 337 ---AYSKPSMLKML-----QIVVGCIFDNPTTRPTMLRVQEFL 371
                 KP +         +++  C  D P TRPT   V E L
Sbjct: 226 QDIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 13/100 (13%)

Query: 221 IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
              C     + +LH +    IIHRDI   NILL+E   V ++DF +   ++      +T 
Sbjct: 104 FWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTS 158

Query: 281 VAGTIGY----ILLACGG----DIYSFSVVLLELVIRKQP 312
            +GT GY    +L   G     D +S  V   E +  K+P
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 58/199 (29%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTAR-------GITFL------HHRFQPHIIHRD 245
           +V +Y   G L   ++++AK       T R       G+ F+      HH    H+IHRD
Sbjct: 116 LVLDYANAGDLRQEIKSRAK-------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG------------ 293
           I ++NILL  +  VK+ DFG  ++ +   +  S DV  T       CG            
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTF------CGTPYYVAPEIWRR 219

Query: 294 ------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSML-- 344
                  D++S  V+L EL+  K+P        +G N+ + V+  T+   Y   P  +  
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPF-------DGENMEE-VMHKTLAGRYDPLPPSISP 271

Query: 345 KMLQIVVGCIFDNPTTRPT 363
           +M +IV   +  +P  RP+
Sbjct: 272 EMQEIVTALLSSDPKRRPS 290

Length = 496

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 16/142 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  ST V GT  ++        A 
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E+V  + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 26/155 (16%)

Query: 175 DDFG-IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------------KHC 220
           D F  ++ KN+V+LLG C   E   ++ EY   G L  +LR                K  
Sbjct: 60  DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 221 IIACG-TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
           +  C   A G   + H      +HRD+ A N L++   EVKVS   L + + + E +   
Sbjct: 120 VALCTQIALG---MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176

Query: 280 DVAGTIGYILLAC--------GGDIYSFSVVLLEL 306
           +    + ++              D++SF V++ E+
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 33/186 (17%)

Query: 166 FYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCI 221
             E+N++      I    IV+L  Y    E+KL +V EY   G L   L  + +      
Sbjct: 41  LTERNILSR----INHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA 95

Query: 222 --IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
              A      + +LH      II+RD+   NILL+ D  +K++DFGL + +S   S T+T
Sbjct: 96  RFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152

Query: 280 DVAGTIGY----ILL------ACGGDIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDW 328
              GT  Y    +LL      A   D +S  V+L E++     TG P F  ++   + + 
Sbjct: 153 FC-GTPEYLAPEVLLGKGYGKAV--DWWSLGVLLYEML-----TGKPPFYAEDRKEIYEK 204

Query: 329 VLDSTI 334
           +L   +
Sbjct: 205 ILKDPL 210

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 19/102 (18%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKH--------CIIACGT-- 226
           NI +LLG C V     ++ EYM  G LN +L+      +             ++   T  
Sbjct: 80  NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           A G+ +L      + +HRD+   N L+ +++ +K++DFG+ R
Sbjct: 140 ASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 30/198 (15%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI--IACGTARGITFLHHRFQPHIIHRDINASNILLNED 256
           I  E+M  GSL D  R   +H +  IA    +G+T+L   +   I+HRD+  SN+L+N  
Sbjct: 76  ICTEFMDGGSL-DVYRKIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTR 131

Query: 257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLELVI 308
            +VK+ DFG+   + +  + T     GT  Y+              D++S  +  +EL +
Sbjct: 132 GQVKLCDFGVSTQLVNSIAKT---YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188

Query: 309 RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML-------KMLQIVVGCIFDNPTTR 361
            + P  P+ + KN G+L+   L   I++    P +L       K +  +  C+   P  R
Sbjct: 189 GRFPY-PQIQ-KNQGSLMPLQLLQCIVD--EDPPVLPVGQFSEKFVHFITQCMRKQPKER 244

Query: 362 PT--MLRVQEFLEKYHTG 377
           P    L    F+ +Y+ G
Sbjct: 245 PAPENLMDHPFIVQYNDG 262

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 44/160 (27%), Positives = 65/160 (40%), Gaps = 44/160 (27%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR---------------------NQAKHC 220
            NI+ LLG C       +  EY   G+L D+LR                     +  +  
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 221 IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             A   ARG+ +L    Q   IHRD+ A NIL+ E++  K++DFGL R            
Sbjct: 128 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVY 177

Query: 281 VAGTIG-------------YILLACGGDIYSFSVVLLELV 307
           V  T+G             Y +     D++S+ V+L E+V
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 37/201 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---KH-CIIACGTARGITFLHHRF 237
            NI +  G    G +  I+ EY   GS+   ++      K+  +I       + ++H   
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV- 120

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT------------I 285
              +IHRDI A+NIL+     VK+ DFG+  L++   S  ST   GT             
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGK 177

Query: 286 GYILLACGGDIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDWVLDSTI----LNAYSK 340
            Y   A   DI+S  + + E+      TG P + D +    +  +  S       N YSK
Sbjct: 178 YYDTKA---DIWSLGITIYEMA-----TGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229

Query: 341 PSMLKMLQIVVGCIFDNPTTR 361
                + + V  C+ + P  R
Sbjct: 230 ----LLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 42/126 (33%), Positives = 58/126 (46%), Gaps = 16/126 (12%)

Query: 199 IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           +V EY + GS +D L    K         I  G  +G+ +LH     ++IHRDI A NIL
Sbjct: 102 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNIL 157

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------DIYSFSVVLLEL 306
           L E  +VK++DFG   + S   S   T        IL    G      D++S  +  +EL
Sbjct: 158 LTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Query: 307 VIRKQP 312
             RK P
Sbjct: 218 AERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 30/151 (19%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--------QAK---HCIIACGTARGI 230
             +V+LL   P G   ++V EYM    L++ LR+        Q K     ++     +G+
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL-----KGV 112

Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY--- 287
            ++H      I+HRD+  +N+L++ D  +K++DFGL RL S+ E    +    T  Y   
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Query: 288 -ILLAC-----GGDIYSFSVVLLELVIRKQP 312
            +L        G D+++   +  EL +   P
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAEL-LNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 34/155 (21%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG     +   +++EY+ +G L+++L  ++ H  + C +                
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 227 ------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
                 A G+ +L   F    +H+D+ A NIL+ E   VK+SD GL R I   + +    
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLEL 306
            +           I Y   +   DI+SF VVL E+
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 21/142 (14%)

Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLH 234
           NIV+  G C   G + L +V EY+  GSL D+L+   +        + A    +G+ +L 
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTD---------VAGT 284
            +     +HRD+   NIL+  +  VK+ DFGL +++  D E +   +            +
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 285 IGYILLACGGDIYSFSVVLLEL 306
           +     +   D++SF VVL EL
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V +     VG++  +V E++  G+L D +     N+ +   +     R +++LH++ 
Sbjct: 79  ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ- 137

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  +K+SDFG    +S  E      + GT        I  + 
Sbjct: 138 --GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLP 194

Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E++  + P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  S  + GT  ++        A 
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAY 193

Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 144 LAMFEPS-LGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYE 202
            A+ E   L  L +  I+A  N F + N +                         LI  E
Sbjct: 45  DALNEIVILSLLQHPNIIAYYNHFMDDNTL-------------------------LIEME 79

Query: 203 YMVKGSLNDWL-RNQAKH----CIIAC--GTARGITFLHHRFQPHIIHRDINASNILLNE 255
           Y   G+L D + R + +      ++         ++++H   +  I+HRDI   NI L +
Sbjct: 80  YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTK 136

Query: 256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-CGG-------DIYSFSVVLLELV 307
              +K+ DFG+ +++    S   T V GT  Y+    C G       DI++   VL EL+
Sbjct: 137 AGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Query: 308 IRKQPTGPEFKDKNGGNLVDWVLD---STILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
             K+     F   N  NLV  ++    + +++ YS     +++ +V   +  +P  RPT
Sbjct: 196 TLKR----TFDATNPLNLVVKIVQGNYTPVVSVYSS----ELISLVHSLLQQDPEKRPT 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 9/96 (9%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHHR 236
           NIV+L+G C   +   IV E +  G    +LR +     +          A G+ +L  +
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
              H IHRD+ A N L+ E   +K+SDFG+ R   D
Sbjct: 114 ---HCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 21/144 (14%)

Query: 182 KNIVQLLGYCPVGEKKLI--VYEYMVKGSLNDWL-RNQAKHCI-----IACGTARGITFL 233
           +NIV+  G C       I  + E++  GSL ++L RN+ K  +      A    +G+ +L
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTD-----VAGTIGY 287
             R     +HRD+ A N+L+  + +VK+ DFGL + I +D E +T  D     V      
Sbjct: 126 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Query: 288 ILLAC----GGDIYSFSVVLLELV 307
            L+        D++SF V L EL+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 18/143 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           N+V++     VGE+  ++ E++  G+L D +     N+ +   +     + + +LH +  
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ-- 136

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT--------IGYIL 289
             +IHRDI + +ILL  D  VK+SDFG    IS D     S  + GT        I    
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTP 193

Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 53/233 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACG----------------- 225
           ++++L G C      L++ EY   GSL  +LR   K   +                    
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRK---VGPSYLGSDGNRNSSYLDNPD 120

Query: 226 ---------------TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                           +RG+ +L    +  ++HRD+ A N+L+ E  ++K+SDFGL R +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 271 SDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDK 320
            + +S+      G I    +A             D++SF V+L E+V       P    +
Sbjct: 178 YEEDSYVKRS-KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 321 NGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              NL    L +       +    +M  +++ C    P  RPT   + + LEK
Sbjct: 237 RLFNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 42/126 (33%), Positives = 57/126 (45%), Gaps = 16/126 (12%)

Query: 199 IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           +V EY + GS +D L    K         I  G  +G+ +LH     ++IHRDI A NIL
Sbjct: 98  LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNIL 153

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------DIYSFSVVLLEL 306
           L E  +VK++DFG     S   S   T        IL    G      D++S  +  +EL
Sbjct: 154 LTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Query: 307 VIRKQP 312
             RK P
Sbjct: 214 AERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 22/133 (16%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHHRFQPHIIHRDINASNI 251
           I  E+M  GSL+  L+   +  I       I+    RG+T+L  + +  I+HRD+  SNI
Sbjct: 76  ICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNI 131

Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVL 303
           L+N   E+K+ DFG+   + D  S  ++ V GT  Y+              DI+S  + L
Sbjct: 132 LVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 304 LELVIRKQPTGPE 316
           +E+ I + P  P 
Sbjct: 189 VEMAIGRYPIPPP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 17/97 (17%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
            + FLH      +IHRD+ A NILL  D +VK++DFG+            T + GT  ++
Sbjct: 115 ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWM 170

Query: 289 ---LLAC----------GGDIYSFSVVLLELVIRKQP 312
              ++AC            DI+S  + L+EL   + P
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 12/93 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC---------IIACGTARGITFL 233
           NI+Q LG C      L+V+EY   G L  +L  +  H           +AC  A G+T +
Sbjct: 56  NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           H   + + +H D+   N  L  D  VKV D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 39/197 (19%)

Query: 151 LGKLTYDQIV----AGTNKFY-----EKNVIRGDD-----------FGIAFKNIVQLLGY 190
           LGK ++ +++     GTN+F+     +K+V+  DD             +A+++      +
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 191 CPVGEKK--LIVYEYMVKGSL----NDWLR-NQAKHCIIACGTARGITFLHHRFQPHIIH 243
           C    K+    V EY+  G L        R ++A+    A     G+ FLH +    II+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIY 119

Query: 244 RDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------LLACGGD 295
           RD+   N+LL++D  +K++DFG+ +   + E   ST   GT  YI              D
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVD 178

Query: 296 IYSFSVVLLELVIRKQP 312
            +SF V+L E++I + P
Sbjct: 179 WWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 21/182 (11%)

Query: 194 GEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINAS 249
           G K  I+ EY+  GS  D LR    ++ +   +     +G+ +LH   +   IHRDI A+
Sbjct: 74  GTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAA 130

Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYILLACGGDIYSFSV 301
           N+LL+E  +VK++DFG+   ++D +   +T V GT        I         DI+S  +
Sbjct: 131 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGI 189

Query: 302 VLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
             +EL  + +P   +        L+      T+   +SK       + +  C+  +P+ R
Sbjct: 190 TAIELA-KGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----PFKEFIDACLNKDPSFR 244

Query: 362 PT 363
           PT
Sbjct: 245 PT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ- 135

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLP 192

Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 43/126 (34%), Positives = 56/126 (44%), Gaps = 16/126 (12%)

Query: 199 IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           +V EY + GS +D L    K         I  G  +G+ +LH       IHRDI A NIL
Sbjct: 92  LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNIL 147

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------DIYSFSVVLLEL 306
           L E   VK++DFG   L+S   S   T        IL    G      D++S  +  +EL
Sbjct: 148 LTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 307 VIRKQP 312
             RK P
Sbjct: 208 AERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 32/103 (31%), Positives = 42/103 (40%), Gaps = 18/103 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------------CIIACGTARGI 230
           NIV+L+G       + I+ E M  G L  +LR                    A   A+G 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 231 TFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLI 270
            +L      H IHRDI A N LL         K++DFG+ R I
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIA------CGTARGITFLHHR 236
           NIV+L G    G   +IV EYM  G+L+ +LR      +         G A G+ +L   
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS-- 124

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
            +   +H+ + A  +L+N D   K+S F   RL  D      T ++G           I 
Sbjct: 125 -EMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 287 YILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSML 344
           Y   +   D++SF +V+ E++   ++P    + D +G +++  V D   L A    P++L
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP----YWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237

Query: 345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              Q+++ C       RP   ++   L K
Sbjct: 238 H--QLMLDCWQKERGERPRFSQIHSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 35/218 (16%)

Query: 183 NIVQLLGYCPVGEKK------LIVYEYMVKGSLNDWL-RNQAKHCIIACGT--------- 226
           N+++L+G C    +       +++  +M  G L+ +L  ++   C     T         
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 227 -ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT- 284
            A G+ +L  +     IHRD+ A N +LNE+  V V+DFGL + I + + +    +A   
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 285 IGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN 336
           + +I +            D++SF V + E+  R Q   P  ++     + D++     L 
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLRQGNRLK 234

Query: 337 AYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEK 373
               P  L  L  ++  C   NP  RP+   ++  LEK
Sbjct: 235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 16/126 (12%)

Query: 199 IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           +V EY + GS +D L    K         +  G  +G+ +LH     ++IHRD+ A NIL
Sbjct: 92  LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNIL 147

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------DIYSFSVVLLEL 306
           L+E   VK+ DFG   +++       T        IL    G      D++S  +  +EL
Sbjct: 148 LSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Query: 307 VIRKQP 312
             RK P
Sbjct: 208 AERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 20/131 (15%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           I  E+M  GSL+  L+ +AK         ++    RG+ +L  + Q  I+HRD+  SNIL
Sbjct: 80  ICMEHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNIL 136

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLL 304
           +N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 305 ELVIRKQPTGP 315
           EL I + P  P
Sbjct: 194 ELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 12/91 (13%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           G+ + H +   + +HRDI  SNILLN   ++K++DFGL RL +  ES   T+   T+ Y 
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 288 ---ILL-----ACGGDIYSFSVVLLELVIRK 310
              +LL         D++S   +L EL  +K
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 25/140 (17%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRF------ 237
           IV+++G C   E  ++V E    G LN +L+ + KH      T + IT L H+       
Sbjct: 58  IVRMIGICE-AESWMLVMELAELGPLNKFLQ-KNKHV-----TEKNITELVHQVSMGMKY 110

Query: 238 --QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------I 285
             + + +HRD+ A N+LL      K+SDFGL + +   E++      G           +
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 286 GYILLACGGDIYSFSVVLLE 305
            Y   +   D++SF V++ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHRF 237
           + +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R 
Sbjct: 71  VCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER- 128

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC----- 292
              ++HRD+ A N+L+     VK++DFGL +L+   E     +  G +    +A      
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-GGKVPIKWMALESILH 185

Query: 293 -----GGDIYSFSVVLLELV 307
                  D++S+ V + EL+
Sbjct: 186 RIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 12/97 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLH 234
           +NIV L        +  +V+EY+ +  L     +         +  I      + I + H
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--LLQAIAYCH 117

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
                +IIHRDI   NIL++E   +K+ DFG  R + 
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 26/153 (16%)

Query: 178 GIAFKNIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRN------QAKHCI-------IA 223
           G++ +NI+ +L  C   GE   ++Y YM  G+L  +L+            +       +A
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--- 280
              A G+++LH R    +IH+DI A N +++E+ +VK++D  L R +   + H   D   
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180

Query: 281 ------VAGTIGYILLACGGDIYSFSVVLLELV 307
                    ++     +   D++SF V+L EL+
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 30/96 (31%), Positives = 52/96 (54%), Gaps = 15/96 (15%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTS--TDVAGT 284
           RG+ ++H     ++IHRD+  SN+L+NED E+++ DFG+ R + S    H    T+   T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 285 IGY----ILLACGG-----DIYSFSVVLLELVIRKQ 311
             Y    +LL+        D++S   +  E++ R+Q
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 10/75 (13%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHHRFQPHIIHRDINASNI 251
           +V E+   GS+ D ++N   + +       I     RG+  LH      +IHRDI   N+
Sbjct: 96  LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV 152

Query: 252 LLNEDFEVKVSDFGL 266
           LL E+ EVK+ DFG+
Sbjct: 153 LLTENAEVKLVDFGV 167

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 50/196 (25%), Positives = 78/196 (39%), Gaps = 29/196 (14%)

Query: 202 EYMVKGSLNDWLRNQAKHCI--------IACGTARGITFLHHRFQPHIIHRDINASNILL 253
           EYM  GSL+                   I     +G+ FL       IIHRD+  +N+L+
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV 136

Query: 254 NEDFEVKVSDFG----LVRLISD----CESHTSTD---VAGTIGYILLACGGDIYSFSVV 302
           N + +VK+ DFG    LV  ++     C+S+ + +     G           D++S  + 
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLS 196

Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDS--TILNAYSKPSMLKMLQIVVGCIFDNPTT 360
           +LE+ + + P  PE        L   V     T+ + YS  +       V  C+   P  
Sbjct: 197 ILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ----DFVAKCLNKIPNR 252

Query: 361 RPT--MLRVQEFLEKY 374
           RPT   L    +L KY
Sbjct: 253 RPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 3/45 (6%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           RG+ ++H      IIHRD+  SNI +NED E+K+ DFGL R   D
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 27/143 (18%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFLH 234
           IV+LLG CP G    +V +    GSL D +R              C+     A+G+ +L 
Sbjct: 71  IVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV---QIAKGMYYLE 126

Query: 235 -HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTIGYILLAC 292
            HR    ++HR++ A NILL  D  V+++DFG+  L+  D + +  ++    I ++ L  
Sbjct: 127 EHR----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 293 --------GGDIYSFSVVLLELV 307
                     D++S+ V + E++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 13/92 (14%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           RG+ ++H     +++HRD+  SN+LLN + ++K+ DFGL R  S+     +  V  T  Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 288 ----ILLACGG-----DIYSFSVVLLELVIRK 310
               +LL C       D++S   +  EL+ RK
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 51/225 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------------IACGTARGI 230
           NIV+LLG C + E + I+ E M  G L  +LR+                  I    A+G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 231 TFLHHRFQPHIIHRDINASNILLNE-----DFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
            +L    Q H IHRD+ A N L++E     D  VK+ DFGL R I        +D     
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI------YKSDYYRKE 170

Query: 286 GYILL---------------ACGGDIYSFSVVLLE-LVIRKQPTGPEFKDKNGGNLVDWV 329
           G  LL                   D++SF V++ E L + +QP    +   N   ++  V
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP----YPALNNQEVLQHV 226

Query: 330 LDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                L    KP     K+ Q++  C   +P+ RPT  R+QE L+
Sbjct: 227 TAGGRLQ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 18/106 (16%)

Query: 182 KNIVQLLGYCPV-----GEKKLIVY---EYMVKGSLNDWLRNQA---KHCIIACGTAR-- 228
            N+V L+            K+  VY    YM    L+  L N +       I C   +  
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 229 -GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
            GI +LH   + HI+HRDI A+NIL++    +K++DFGL R     
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 15/100 (15%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           RG+ +LH      I+HRDI   N+L+N +  +K+ DFGL R+    ES   T    T  Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 288 ----ILLAC-----GGDIYSFSVVLLELVIRK---QPTGP 315
               IL+         DI+S   +  EL+ R+   Q   P
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 38/156 (24%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGI-- 230
           NI+ LLG C       I  EY   G+L D+LR             +H   +  T++ +  
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 231 ------TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
                 T + +  +   IHRD+ A N+L+ E+   K++DFGL R            V  T
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKT 176

Query: 285 IG-------------YILLACGGDIYSFSVVLLELV 307
           +G             Y +     D++SF V+L E+V
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 19/131 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFLH 234
           NIV+L        K ++V+EYM    L  ++        +   T +        GI F H
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILL 290
              +  ++HRD+   N+L+N+  E+K++DFGL R      +  S +V  T+ Y    +LL
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 291 ACGGDIYSFSV 301
             G   YS S+
Sbjct: 174 --GSRTYSTSI 182

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 18/41 (43%), Positives = 25/41 (60%), Gaps = 3/41 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
            G+  LH  +   I+HRD+  SN+LLN    +K+ DFGL R
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 31/162 (19%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTI 285
           ARG+ FL  R     IHRD+ A NILL+E+  VK+ DFGL R I  D +     D    +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 286 GYI--------LLACGGDIYSFSVVLLELVIRKQPTGP------EFKDKNGGNLVDWVLD 331
            ++        +     D++SF V+L E+        P      EF  +        + +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--------LKE 291

Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P    +  I++ C  +NP  RPT   + E L
Sbjct: 292 GTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 18/130 (13%)

Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 80  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 137

Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194

Query: 306 LVIRKQPTGP 315
           + I + P  P
Sbjct: 195 MAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 15/92 (16%)

Query: 229 GITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ Y
Sbjct: 112 GLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWY 166

Query: 288 ----ILLAC-----GGDIYSFSVVLLELVIRK 310
               ILL C       DI+S   +  E+V R+
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 17/41 (41%), Positives = 28/41 (68%), Gaps = 3/41 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+ + H R    ++HRD+   N+L++E  E+K++DFGL R
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 14/94 (14%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS--TDVAGTI 285
           RG+ ++H     +++HRD+  SN+LLN + ++K+ DFGL R+      HT   T+   T 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 286 GY----ILLACGG-----DIYSFSVVLLELVIRK 310
            Y    I+L   G     DI+S   +L E++  +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 19/114 (16%)

Query: 174 GDDFGI-----------AFKNIVQLLGYCPVGEKKLIVYEYMVKGSLND--WLRNQAKHC 220
           GDDF +              NIV   G     EK  I  EY   GSL D   +       
Sbjct: 47  GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL 106

Query: 221 IIA--C-GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
            IA  C  T +G+ +LH + +   +HRDI  +NILL ++ +VK++DFG+   I+
Sbjct: 107 QIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 24/126 (19%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH-HRFQPHIIHRDINASN 250
            V+EYM +G+L   ++++            I     +G+  +H H F     HRD+   N
Sbjct: 75  FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF----FHRDLKPEN 129

Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG-----DIYSFSV 301
           +L++    VK++DFGL R I     +  TD   T  Y    ILL         DI++   
Sbjct: 130 LLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187

Query: 302 VLLELV 307
           ++ EL 
Sbjct: 188 IMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 25/143 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           ++V+LLG C +     +V + M  G L D++     +         C+     A+G+ +L
Sbjct: 70  HLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV---QIAKGMMYL 125

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-IGYILLAC 292
             R    ++HRD+ A N+L+     VK++DFGL RL+   E   + D     I ++ L C
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 293 --------GGDIYSFSVVLLELV 307
                     D++S+ V + EL+
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 19/156 (12%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  R     IHRD+ A NILL+E+  VK+ DFGL R I     +     A    
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 TI   +     D++SF V+L E+        P  K          + + T + A
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA 303

Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
             Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 304 PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 30/152 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--------------------QAKHCI- 221
           NI+ LLG C       +  EY   G+L D+LR                      ++  + 
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
            A   ARG+ +L  +     IHRD+ A NIL+ E++  K++DFGL R        T   +
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 282 A------GTIGYILLACGGDIYSFSVVLLELV 307
                   ++ Y +     D++S+ V+L E+V
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 13/97 (13%)

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           TA+ I+ L H  Q  II+RD+   N+LL+ D  V++SD GL   + D +S T    AGT 
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-GYAGTP 161

Query: 286 GYI---LLACGGDIYSFS-------VVLLELVIRKQP 312
           G++   LL   G+ Y FS       V L E++  + P
Sbjct: 162 GFMAPELLQ--GEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 22/96 (22%)

Query: 183 NIVQLLGYCPVGEKKL-IVYEYMVKGS----LNDW-------LRNQAKHCIIACGTARGI 230
           NIVQ LG   +    L I  EY+  GS    LN++       +RN  +         +G+
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGL 119

Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +LH+R    IIHRDI  +NIL++    +K+SDFG+
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 21/146 (14%)

Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGIT 231
           G+    + +LLG C     +L V + M  G L D++R       ++  +  C   A+G++
Sbjct: 65  GVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA 291
           +L    +  ++HRD+ A N+L+     VK++DFGL RL+   E+    D  G +    +A
Sbjct: 124 YLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-GGKVPIKWMA 179

Query: 292 C----------GGDIYSFSVVLLELV 307
                        D++S+ V + EL+
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 23/137 (16%)

Query: 194 GEKKLIVY-EYMVKGSLNDWLRNQAKHCIIACGTAR-------GITFLHHRFQPHIIHRD 245
            EK L ++ EYM  GS+ D L+  A   +    T +       G+++LH      I+HRD
Sbjct: 77  AEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRD 131

Query: 246 INASNILLNEDFEVKVSDFGLV-RLISDCESHTST-DVAGTIGYI---LLACGG-----D 295
           I  +NIL +    VK+ DFG   RL + C S T    V GT  ++   +++  G     D
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKAD 191

Query: 296 IYSFSVVLLELVIRKQP 312
           ++S    ++E++  K P
Sbjct: 192 VWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 26/183 (14%)

Query: 198 LIVYEYMVKGSLNDWLRNQAKHCI----IACGTARGITFLHHRFQPHIIHRDINASNILL 253
           +IV EY   G+L ++++ +    +    I     + +  LHH     I+HRD+   NILL
Sbjct: 75  MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134

Query: 254 NE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-CGG-------DIYSFSVVLL 304
           ++    VK+ DFG+ +++S  +S   T V GT  YI    C G       DI++   VL 
Sbjct: 135 DKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLY 192

Query: 305 ELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           EL   K+     F+  N   LV  ++  T   I + YS    L+ L  ++  +  +P+ R
Sbjct: 193 ELASLKRA----FEAANLPALVLKIMSGTFAPISDRYSPD--LRQL--ILSMLNLDPSKR 244

Query: 362 PTM 364
           P +
Sbjct: 245 PQL 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 12/94 (12%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYM---VKGSLNDWLRNQAKHCIIACGT---ARGITFLH 234
           KNIV+L       +KKL +V+EY    +K    D         I+        +G+ F H
Sbjct: 59  KNIVRLYDVLH-SDKKLTLVFEYCDQDLKKYF-DSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
                +++HRD+   N+L+N++ E+K++DFGL R
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 29/139 (20%)

Query: 195 EKKLIVY-EYMVKGSLNDWLRNQAKHCIIACGTAR-------GITFLHHRFQPHIIHRDI 246
           EKKL ++ EYM  GS+ D L+  A   +    T R       G+++LH      I+HRDI
Sbjct: 78  EKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDI 132

Query: 247 NASNILLNEDFEVKVSDFGLVRLISD-CESHT------------STDVAGTIGYILLACG 293
             +NIL +    VK+ DFG  + I   C S T            S +V    GY   A  
Sbjct: 133 KGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA-- 190

Query: 294 GDIYSFSVVLLELVIRKQP 312
            D++S +  ++E++  K P
Sbjct: 191 -DVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 18/42 (42%), Positives = 30/42 (71%), Gaps = 3/42 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL 269
           RG+ ++H      ++HRD+  SNIL+NE+ ++K+ DFGL R+
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 23/60 (38%), Positives = 40/60 (66%), Gaps = 4/60 (6%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           RG++++H R+   I+HRD+   N+L+++  E+K++DFGL R  S   SHT ++   T+ Y
Sbjct: 114 RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVVTLWY 169

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 16/104 (15%)

Query: 221 IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
            IA    + + +LH +    +IHRD+  SN+L+N + +VK+ DFG+   + D  S   T 
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTI 162

Query: 281 VAGTIGYI--------LLACG----GDIYSFSVVLLELVIRKQP 312
            AG   Y+        L   G     D++S  + ++EL   + P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 30/151 (19%)

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA 291
           +LH   +  I+HRD+  +NI+L ED +V ++DFGL +        TS  V GTI Y   +
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILY---S 180

Query: 292 C-----------GGDIYSFSVVLLELVIRKQPTGPEFKDKN----GGNLVDWVLDSTILN 336
           C             D+++F  +L ++   +    P F   N       +V+ V +     
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQ----PPFYSTNMLSLATKIVEAVYEPLPEG 236

Query: 337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV 367
            YS+     +  ++  C+  +   RP +++V
Sbjct: 237 MYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 179

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 27/75 (36%), Positives = 41/75 (54%), Gaps = 10/75 (13%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHHRFQPHIIHRDINASNI 251
           +V E+   GS+ D ++N   + +       I     RG++ LH   Q  +IHRDI   N+
Sbjct: 86  LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 142

Query: 252 LLNEDFEVKVSDFGL 266
           LL E+ EVK+ DFG+
Sbjct: 143 LLTENAEVKLVDFGV 157

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 31/168 (18%)

Query: 233 LHHRFQPH-IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL-- 289
           LH+  + H +IHRD+  SNILL+    VK+ DFG+   + D ++ T +  AG   Y+   
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPE 184

Query: 290 ----------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--- 336
                          D++S  + L+EL      TG +F  KN     ++ + + IL    
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELA-----TG-QFPYKN--CKTEFEVLTKILQEEP 236

Query: 337 ---AYSKPSMLKMLQIVVGCIFDNPTTRPT--MLRVQEFLEKYHTGEN 379
                ++         V  C+  +   RP    L    F+ +Y T E 
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 24/44 (54%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
           ARG+ FL  R     IHRD+ A NILL+E+  VK+ DFGL R I
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 29/163 (17%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A+G+ FL  +   + IHRD+ A N+LL +    K+ DFGL R   D  + ++  V G   
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSNYVVKGNAR 275

Query: 284 ---------TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
                    +I   +     D++S+ ++L E+    +   P       G LV+      +
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP-------GILVNSKFYKMV 328

Query: 335 LNAY--SKP--SMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              Y  S+P  +  ++  I+  C    PT RPT  ++ + +++
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 38/167 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------------AKHCI------- 221
           NI++LLG C   +   ++ EYM  G LN +L +                 HC+       
Sbjct: 80  NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139

Query: 222 ---IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISDCESHT 277
              +A   A G+ +L      + +HRD+   N L+ E+  +K++DFG+ R L +      
Sbjct: 140 LLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196

Query: 278 STDVAGTIGYILLAC--------GGDIYSFSVVLLEL--VIRKQPTG 314
                  I ++   C          D+++F V L E+  + ++QP G
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 19/102 (18%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-RNQAKH---------------CIIACGT 226
           NI++LL  C   +   ++ EYM  G LN +L R++ +                  +A   
Sbjct: 80  NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           A G+ +L      + +HRD+   N L+ +++ +K++DFG+ R
Sbjct: 140 ASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 20/103 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-----RNQAKH-----CI-------IACG 225
           NI++LLG C   +   ++ EYM  G LN +L      +   H      +       +A  
Sbjct: 78  NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
            A G+ +L      + +HRD+   N L+   + +K++DFG+ R
Sbjct: 138 IASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.6 bits (110), Expect = 8e-06
 Identities = 19/41 (46%), Positives = 29/41 (70%), Gaps = 3/41 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+++ H R    I+HRD+   N+L+NE  E+K++DFGL R
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 20/178 (11%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHC----IIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           IV EY   G L   ++ Q         I     +    + H  +  ++HRDI + NI L 
Sbjct: 75  IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134

Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--------GGDIYSFSVVLLEL 306
           ++ +VK+ DFG  RL++   ++  T V GT  Y+              DI+S   +L EL
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Query: 307 VIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFD-NPTTRPT 363
              K P    F+  +  NL+  V   +     S  S    L+ ++  +F  NP +RP+
Sbjct: 194 CTLKHP----FQANSWKNLILKVCQGSYKPLPSHYSY--ELRSLIKQMFKRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 43/169 (25%), Positives = 65/169 (38%), Gaps = 36/169 (21%)

Query: 168 EKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL---RNQAKHCI--I 222
           E  V+      +   N+V+  G     EK  I  EY   G+L + L   R   +H I   
Sbjct: 49  EMKVLEL----LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY 104

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
                 G+ +LH      I+HRDI  +NI L+ +  +K+ DFG    + +     +T   
Sbjct: 105 TLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-----NTTTM 156

Query: 283 GTIGYILLAC-----------------GG--DIYSFSVVLLELVIRKQP 312
           G     L                    G   DI+S   V+LE+   K+P
Sbjct: 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 47/201 (23%)

Query: 151 LGKLTYDQI----VAGTNKFY-----EKNVIRGDD-----------FGIAFKNIVQLLGY 190
           LGK ++ ++    + GTN+F+     +K+V+  DD             +A+++      Y
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 191 CPVGEKK--LIVYEYMVKGSLN---------DWLRNQAKHCIIACGTARGITFLHHRFQP 239
           C    K+    V EY+  G L          D  R       I CG    + FLH +   
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK--- 115

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA---- 291
            I++RD+   NILL+ D  +K++DFG+ +     ++ T T   GT  Y    ILL     
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYN 174

Query: 292 CGGDIYSFSVVLLELVIRKQP 312
              D +SF V+L E++I + P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 46.1 bits (109), Expect = 9e-06
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCI-IACGTARGITFLHHR 236
           NIV+L+G C   +   IV E +  G    +LR +      K  +  A   A G+ +L  +
Sbjct: 53  NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
              + IHRD+ A N L+ E+  +K+SDFG+ R
Sbjct: 113 ---NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 22/56 (39%), Positives = 30/56 (53%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           L H  Q  II+RDI   NILL+ +  V ++DFGL +     E   +    GTI Y+
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 16/84 (19%)

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           I CG    +  LH R    I++RD+   N+LL++   V++SD GL   +           
Sbjct: 104 IICG----LEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154

Query: 282 AGTIGY----ILLACGGDIYSFSV 301
           AGT GY    +L    G++Y FSV
Sbjct: 155 AGTPGYMAPEVLQ---GEVYDFSV 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 10/110 (9%)

Query: 181 FKNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCI--IACGTARGITFLH 234
              I++L  Y    E+ L  V EY   G L  ++R        C    A      + +LH
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
            +    IIHRD+   NILL++D  +K++DFG  +++    S  S     T
Sbjct: 120 SK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 16/98 (16%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIG 286
           RG+ ++H +   HI+HRD+   N+L++   E+K++DFGL R  S   ++++S  V  T+ 
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168

Query: 287 Y----ILLACGG-----DIYSFSVVLLELVIRKQPTGP 315
           Y    +LL         DI+    + +E++ + QP  P
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEML-QGQPAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 31/195 (15%)

Query: 192 PVGEKKLIVYEYMVKG-SLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASN 250
              E K ++ +   +G +  D L    +        ARG+ FL  +   + +HRD+ A N
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQ-------VARGMEFLASK---NCVHRDLAARN 267

Query: 251 ILLNEDFEVKVSDFGLVRLI---SDCESHTSTDV------AGTIGYILLACGGDIYSFSV 301
           +LL +   VK+ DFGL R I   S+  S  ST +        +I   L     D++S+ +
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 302 VLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--SKP--SMLKMLQIVVGCIFDN 357
           +L E+        P       G +VD    + I + Y  +KP  +  ++  I+V C    
Sbjct: 328 LLWEIFSLGGTPYP-------GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSE 380

Query: 358 PTTRPTMLRVQEFLE 372
           P  RP+ L + + +E
Sbjct: 381 PEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 22/118 (18%)

Query: 211 DWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
           DW +      ++      G+  LH R    IIHRDI   N+L+++   +K++DFGL R  
Sbjct: 97  DWAKQYIAEVVL------GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147

Query: 271 SDCESHTSTDVAGTIGY----ILLACG----GDIYSFSVVLLELVIRKQPTGPEFKDK 320
                  +    GT  Y     +L  G     D +S   V+ E +    P   E  D 
Sbjct: 148 -----LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 25/94 (26%), Positives = 46/94 (48%), Gaps = 12/94 (12%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A G+ +L  +   + IHRD+ A N +LNE+  V V+DFGL + I   + +     +    
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 284 ------TIGYILLACGGDIYSFSVVLLELVIRKQ 311
                 ++   +     D+++F V + E++ R Q
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 20/45 (44%), Positives = 29/45 (64%), Gaps = 3/45 (6%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           RG+ ++H      IIHRD+  SN+ +NED E+++ DFGL R   D
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 16/103 (15%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 289 ---LLACG------GDIYSFSVVLLELVIRKQPT-GPEFKDKN 321
              +L  G       D +S   +L +L+    P    + KDK+
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 19/145 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL---RNQAKHCII---ACGTARGITFLHHR 236
           +IV+L+G         IV E    G L  +L   +       +   +   +  + +L  +
Sbjct: 68  HIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GTIGYI 288
                +HRDI A N+L++    VK+ DFGL R + D   + ++            +I + 
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 289 LLACGGDIYSFSVVLLELVIR-KQP 312
                 D++ F V + E+++   +P
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 20/114 (17%)

Query: 190 YCPVGEKKL-IVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHI 241
           Y   G+K L +V EY+  G L   L N        A+  I        + +LH      I
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE--IVLALEYLH---SNGI 114

Query: 242 IHRDINASNILLNEDFEVKVSDFGL-----VRLISDCESHTSTD--VAGTIGYI 288
           IHRD+   NIL++ +  +K++DFGL     VR   +       D  + GT  YI
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 19/106 (17%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS---TDVAGT 284
            G+ ++H     +++HRD+   N+L+N D E+K+ DFGL R  S+     +   T+   T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 285 IGY----ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
             Y    I+L+        D++S   +L EL+ RK    P FK K+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--L 290
           L H  +  II+RDI   NILL+ +  V ++DFGL +   + E   +    GTI Y+   +
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 291 ACGG--------DIYSFSVVLLELVIRKQP 312
             GG        D +S  V++ EL+    P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 20/53 (37%), Positives = 31/53 (58%), Gaps = 3/53 (5%)

Query: 234 HHRFQPH--IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
           H+R  P   ++HRD+  +NI L+ +  VK+ DFGL +++    S   T V GT
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NIV   G     +K  I  E+   GSL D        ++++   ++  T +G+ +LH + 
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
           +   +HRDI  +NILL ++  VK++DFG+   I+
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 15/92 (16%)

Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ FLH HR    ++HRD+   NIL+    ++K++DFGL R+ S       T V  T+ 
Sbjct: 121 RGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174

Query: 287 Y----ILL----ACGGDIYSFSVVLLELVIRK 310
           Y    +LL    A   D++S   +  E+  RK
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 12/92 (13%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+ FLH +    II+RD+   N++L+ D  +K++DFG+ +     ++  ST   GT  YI
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163

Query: 289 L--------LACGGDIYSFSVVLLELVIRKQP 312
                         D +SF V+L E++I + P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHC--IIACGTARGITFLHHRF 237
           NIV L       +   +V+EY+   +K  ++D     + H   I      RG+ + H R 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
              ++HRD+   N+L+NE  E+K++DFGL R
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 33/138 (23%), Positives = 62/138 (44%), Gaps = 20/138 (14%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIAC------GTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L  +     ++         + G+ +L  + 
Sbjct: 57  IVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK- 114

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
             + +HRD+ A N+LL      K+SDFGL + +   +S+     AG           I +
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++S+ + + E
Sbjct: 173 RKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 13/91 (14%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           RG+ FLH      I+HRD+   NIL+    +VK++DFGL R+ S C+    T V  T+ Y
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQM-ALTPVVVTLWY 173

Query: 288 ----ILL----ACGGDIYSFSVVLLELVIRK 310
               +LL    A   D++S   +  E+  RK
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 20/58 (34%), Positives = 33/58 (56%), Gaps = 10/58 (17%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           +G+ ++H      IIHRD+   N+ +NED E+K+ DFGL R        T +++ G +
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYV 176

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 40/172 (23%), Positives = 81/172 (47%), Gaps = 35/172 (20%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFLHHRFQPHIIHRDINASN 250
           ++ EY+  G L  +LRN  +    +  T           + +LH +    I++RD+   N
Sbjct: 78  MLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPEN 131

Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG-----DIYSFSVV 302
           ILL+++  +K++DFG  + + D    T T + GT  Y+   ++   G     D ++  ++
Sbjct: 132 ILLDKEGHIKLTDFGFAKKLRD---RTWT-LCGTPEYLAPEVIQSKGHNKAVDWWALGIL 187

Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-----LNAYSKPSMLKMLQI 349
           + E+++      P F D N   + + +L   +     L+ Y+K  + K+L +
Sbjct: 188 IYEMLVGY----PPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVV 235

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 21/75 (28%), Positives = 37/75 (49%), Gaps = 9/75 (12%)

Query: 199 IVYEYM---VKGSLNDWLR--NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           +V + M   +K  ++  +R       CI+      G+  LH  +    +HRD++ +NI +
Sbjct: 97  LVMDIMASDLKKVVDRKIRLTESQVKCILL-QILNGLNVLHKWY---FMHRDLSPANIFI 152

Query: 254 NEDFEVKVSDFGLVR 268
           N     K++DFGL R
Sbjct: 153 NSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 18/50 (36%), Positives = 32/50 (64%), Gaps = 4/50 (8%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESH 276
           RG+ ++H     +++HRD+  +N+ +N ED  +K+ DFGL R++    SH
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 45/191 (23%), Positives = 74/191 (38%), Gaps = 34/191 (17%)

Query: 194 GEKKLIVYEYMVKGSLNDWLRNQAKHCI---------IACGTARGITFLHHRFQPHIIHR 244
           G K  IV EY   G L+  +  + K            I     RG+  LH +    I+HR
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHR 127

Query: 245 DINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDI 296
           D+ ++NILL  +  VK+ D G+ +++    + T     GT  Y+          +   DI
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPYSYKSDI 184

Query: 297 YSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSMLKMLQIVVGC 353
           +S   +L E+     P    F+ ++  +L   V       I   YS+     +   +   
Sbjct: 185 WSLGCLLYEMATFAPP----FEARSMQDLRYKVQRGKYPPIPPIYSQ----DLQNFIRSM 236

Query: 354 IFDNPTTRPTM 364
           +   P  RP  
Sbjct: 237 LQVKPKLRPNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 43/176 (24%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHI 241
           K I  L+ YC  GE   I+ +   +G  +++    A+  I AC       +LH+R    I
Sbjct: 66  KYIYMLMEYCLGGELWTILRD---RGLFDEY---TARFYI-ACVV-LAFEYLHNR---GI 114

Query: 242 IHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG---- 293
           I+RD+   N+LL+ +  VK+ DFG  + +   +  T T   GT  Y    I+L  G    
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK-TWTFC-GTPEYVAPEIILNKGYDFS 172

Query: 294 GDIYSFSVVLLELVIRKQPTG----------------------PEFKDKNGGNLVD 327
            D +S  ++L EL+  + P G                      P + DK   +L+ 
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 45/153 (29%), Positives = 67/153 (43%), Gaps = 30/153 (19%)

Query: 182 KNIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR-------GITF 232
           + IVQ  G    P+     I  E+M  GS+ D L++     +    T +       G+++
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSY 121

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV-RLISDCESHT------------ST 279
           LH      I+HRDI  +NIL +    VK+ DFG   RL + C S T            S 
Sbjct: 122 LHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 280 DVAGTIGYILLACGGDIYSFSVVLLELVIRKQP 312
           +V    GY   A   DI+S    ++E++  K P
Sbjct: 179 EVISGEGYGRKA---DIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 45/206 (21%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-RNQAKHCIIACGTAR----GITFLHHR 236
            NIVQ LG C       I  E++  GS++  L R       + C   +    G+ +LH+ 
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS----------------TD 280
               ++HRDI  +N++L  +  +K+ DFG  R ++    H +                 +
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 281 VAGTIGYILLACGGDIYSFSVVLLELVIRKQPTG------------------PEFKDKNG 322
           V    GY       DI+S    + E+   K P                    P   D   
Sbjct: 179 VINESGY---GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235

Query: 323 GNLVDWVLDSTILNAYSKPSMLKMLQ 348
              +D+V      + + +PS L++L+
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 215 NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
           ++A+    A      + FLH +    II+RD+   N+LL+ +   K++DFG+ +      
Sbjct: 94  DEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFN 149

Query: 275 SHTSTDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV 326
             T++   GT  YI        L     D ++  V+L E++    P    F+ +N  +L 
Sbjct: 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP----FEAENEDDLF 205

Query: 327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           + +L+  ++  Y        + I+   +  NPT R
Sbjct: 206 EAILNDEVV--YPTWLSQDAVDILKAFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 15/95 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII----------ACGTARGITF 232
           N++Q LG C      L+V E+   G L  +LR+  K  ++          AC  A G+  
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 233 LH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           LH + F    IH D+   N LL  D  VK+ D+GL
Sbjct: 116 LHKNNF----IHSDLALRNCLLTADLTVKIGDYGL 146

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 33/81 (40%), Positives = 40/81 (49%), Gaps = 10/81 (12%)

Query: 20  IPKNLNELP---HLDLSCNKLNGEISTFLSHI--LGILGLYVQFK----IPPDLCNLVQL 70
           IP  +  L    HLDL  N L G I + L ++  L  L LY Q K    IPP + +L +L
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY-QNKLSGPIPPSIFSLQKL 286

Query: 71  EYFDFSMNMLGGHIPEKNIDL 91
              D S N L G IPE  I L
Sbjct: 287 ISLDLSDNSLSGEIPELVIQL 307

Length = 968

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 17/46 (36%), Positives = 25/46 (54%), Gaps = 7/46 (15%)

Query: 229 GITFLHHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLI 270
           G+ +LH      ++HRD+  +NIL+     E   VK+ D GL RL 
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 23/51 (45%), Positives = 30/51 (58%), Gaps = 4/51 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISDCESHT 277
           RGI F H     +IIHRDI   NIL+++   VK+ DFG  R L +  E +T
Sbjct: 111 RGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+ + H R    ++HRD+   N+L+NE  E+K++DFGL R
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 23/113 (20%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--VAGTI 285
            G+ +LH      IIHRD+   NI +N+  +V + D G  +              +AGT+
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ----FPVVAPAFLGLAGTV 220

Query: 286 ---GYILLA-----CGGDIYSFSVVLLEL------VIRKQPTGPEFKDKNGGN 324
                 +LA        DI+S  +VL E+      +    P+ PE   K+  +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273

Length = 357

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 22/67 (32%), Positives = 33/67 (49%), Gaps = 9/67 (13%)

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           I CG       L    Q  I++RD+   NILL++   +++SD GL   +   E  T    
Sbjct: 111 ICCG-------LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGR 161

Query: 282 AGTIGYI 288
            GT+GY+
Sbjct: 162 VGTVGYM 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 9/82 (10%)

Query: 196 KKL-IVYEYMVKGSLNDWLRNQA---KHCI--IACGTARGITFLHHRFQPHIIHRDINAS 249
           +KL +V+EY     LN+  +N     +H I  I   T + + F H   + + IHRD+   
Sbjct: 73  RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPE 129

Query: 250 NILLNEDFEVKVSDFGLVRLIS 271
           NIL+ +  ++K+ DFG  R+++
Sbjct: 130 NILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 6/60 (10%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 195 EKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITF---------LHHRFQPHIIHRD 245
           +K L++ EY   G LN  ++ + K  +       G+ F         +H R    ++HRD
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRD 194

Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA----GTIGYIL--------LACG 293
           + ++NI L     +K+ DFG  +  SD     S DVA    GT  Y+          +  
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDS---VSLDVASSFCGTPYYLAPELWERKRYSKK 251

Query: 294 GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGC 353
            D++S  V+L EL+   +P    FK  +   ++  VL     + +  P    M  ++   
Sbjct: 252 ADMWSLGVILYELLTLHRP----FKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALLDPL 306

Query: 354 IFDNPTTRPTMLRV--QEFLEKY 374
           +  NP  RPT  ++   EFL KY
Sbjct: 307 LSKNPALRPTTQQLLHTEFL-KY 328

Length = 478

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 39/118 (33%), Positives = 54/118 (45%), Gaps = 11/118 (9%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-IIACGTARGITF-LHHRFQPHI 241
           IV L+     G K  ++ EY+  G L   L  +       AC     I+  L H  Q  I
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 242 IHRDINASNILLNEDFEVKVSDFGLVR--LISDCESHTSTDVAGTIGY----ILLACG 293
           I+RD+   NILL+    VK++DFGL +  +     +HT     GTI Y    IL+  G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRSG 176

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 32/87 (36%), Positives = 41/87 (47%), Gaps = 11/87 (12%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           R I +LH      IIHRDI A NI +N   +V + DFG      D  ++     AGTI  
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249

Query: 288 ---ILLA-----CGGDIYSFSVVLLEL 306
               LLA        DI+S  +VL E+
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 29/163 (17%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A+G++FL  +   + IHRD+ A NILL      K+ DFGL R   D  + ++  V G   
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYVVKGNAR 277

Query: 284 ---------TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
                    +I   +     D++S+ ++L E+        P       G  VD      I
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-------GMPVDSKFYKMI 330

Query: 335 LNAYSKPS----MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              Y   S      +M  I+  C   +P  RPT  ++ + +E+
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 19/40 (47%), Positives = 24/40 (60%), Gaps = 3/40 (7%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           GI  LH      IIHRD+  SNI++  D  +K+ DFGL R
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 30/139 (21%)

Query: 199 IVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           +V EY+  G L   LR         A+    A      + +LH      I++RD+   N+
Sbjct: 78  LVMEYVPGGELFSHLRKSGRFPEPVAR--FYAAQVVLALEYLHSL---DIVYRDLKPENL 132

Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG----GDIYSFSVVL 303
           LL+ D  +K++DFG  + +      T T + GT  Y    I+L+ G     D ++  +++
Sbjct: 133 LLDSDGYIKITDFGFAKRVKG---RTYT-LCGTPEYLAPEIILSKGYGKAVDWWALGILI 188

Query: 304 LELVIRKQPTG-PEFKDKN 321
            E++      G P F D N
Sbjct: 189 YEMLA-----GYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 20/148 (13%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTI 285
           + G+  +H R    I+HRDI + NI L+++  V K+ DFG+ R ++D      T   GT 
Sbjct: 111 SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTP 166

Query: 286 GYILLA-CGG-------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
            Y+    C         DI+S   VL EL   K P    F+  N   LV  +       A
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGNNLHQLVLKICQGYF--A 220

Query: 338 YSKPSMLKMLQIVVGCIFD-NPTTRPTM 364
              P+  + L+ ++  +F  +P  RP++
Sbjct: 221 PISPNFSRDLRSLISQLFKVSPRDRPSI 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 9/92 (9%)

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-- 287
           I  L H  +  I++RDI   NILL+ +  V ++DFGL +     E   +    GTI Y  
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 288 --ILLACGG-----DIYSFSVVLLELVIRKQP 312
             I+   GG     D +S  +++ EL+    P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 9/83 (10%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC 292
           L H     II+RD+   NILL+E+  +K++DFGL +   D E    +   GT+ Y+    
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEV 169

Query: 293 --------GGDIYSFSVVLLELV 307
                     D +SF V++ E++
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
              G+ ++H      IIHRD+   N+ +NED E+K+ DFGL R
Sbjct: 126 MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 13/91 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           GI F H R    ++HRD+   N+L++    +K++DFGL R          T    T+ Y 
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYR 168

Query: 288 ---ILL-----ACGGDIYSFSVVLLELVIRK 310
              +LL     +   DI+S   +  E+  +K
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 14/27 (51%), Positives = 20/27 (74%)

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGL 266
            IIHRD+  SNILL+ +  +K+ DFG+
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGI 154

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 38/161 (23%)

Query: 179 IAFKN---IVQLLGYCPVGEKKL-IVYEYMVKGSL----------NDWLRNQAKHCIIAC 224
           +A  N   IVQL  Y    +K L +V EYM  G L            W R      ++A 
Sbjct: 97  MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLAL 155

Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTDVAG 283
                + F         IHRD+   N+LL++   +K++DFG  +++ ++      T V G
Sbjct: 156 DAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-G 205

Query: 284 TIGYI----LLACGGDIY--------SFSVVLLELVIRKQP 312
           T  YI    L + GGD Y        S  V L E+++   P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 9/67 (13%)

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           I CG       L    + + ++RD+   NILL++   +++SD GL   I + ES      
Sbjct: 111 ILCG-------LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-- 161

Query: 282 AGTIGYI 288
            GT+GY+
Sbjct: 162 VGTVGYM 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 47/210 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------KHCIIACGTARGITFLH 234
           +I+++LG         +  E+M  GS++  L             +        RG+++LH
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLH 120

Query: 235 HRFQPHIIHRDINASNILLNEDFE-VKVSDFG-LVRLISDCESHTSTD-----VAGTIGY 287
                 IIHRD+  +N+L++   + ++++DFG   RL +     T        + GTI +
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG---TGAGEFQGQLLGTIAF 174

Query: 288 IL----------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
           +            +C  D++S   V++E+   K P   E K  N   L+       I +A
Sbjct: 175 MAPEVLRGEQYGRSC--DVWSVGCVIIEMATAKPPWNAE-KHSNHLALI-----FKIASA 226

Query: 338 YSKPSMLKMLQ-----IVVGCIFDNPTTRP 362
            + PS+ + L      + + C+   P  RP
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 16/41 (39%), Positives = 25/41 (60%), Gaps = 3/41 (7%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           R + ++H     ++ HRD+   NIL N D ++K+ DFGL R
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 16/42 (38%), Positives = 28/42 (66%), Gaps = 5/42 (11%)

Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           +GI + H HR    ++HRD+   N+L++ +  +K++DFGL R
Sbjct: 110 QGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 14/76 (18%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTARGITF--------LHHRFQPHIIHRDINASN 250
           +V EYM  G L + L    +  +    TAR   F        L    +   IHRDI   N
Sbjct: 78  LVMEYMPGGDLMNLL---IRKDVFPEETAR---FYIAELVLALDSVHKLGFIHRDIKPDN 131

Query: 251 ILLNEDFEVKVSDFGL 266
           IL++ D  +K++DFGL
Sbjct: 132 ILIDADGHIKLADFGL 147

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 9/76 (11%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+ FLH R    II+RD+   N+LL+ +  +K++DFG+ +        T++   GT  YI
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYI 163

Query: 289 ---LLACGGDIYSFSV 301
              +L+     Y  +V
Sbjct: 164 APEILS--YQPYGPAV 177

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 37/152 (24%), Positives = 70/152 (46%), Gaps = 28/152 (18%)

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-----T 277
           A   + G+ FLH R    II+RD+   N++L+ +  +K++DFG+      C+ H     T
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM------CKEHMVDGVT 157

Query: 278 STDVAGT--------IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
           +    GT        I Y       D +++ V+L E++  + P   E +D+    L   +
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSI 213

Query: 330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           ++  +  +Y K    + + I  G +  +P+ R
Sbjct: 214 MEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 33/124 (26%), Positives = 64/124 (51%), Gaps = 14/124 (11%)

Query: 199 IVYEYMVKGSLNDWLR-NQAKHCIIACGTARGITFLHHRFQP-HIIHRDINASNILLNED 256
           +V E+++ G    +LR N+     + C  A  I  +    Q  +I++RD+   N+LL++D
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD 167

Query: 257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG----GDIYSFSVVLLELVI 308
             +K++DFG  +++   ++ T T + GT  Y    ILL  G     D ++  + + E+++
Sbjct: 168 GFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223

Query: 309 RKQP 312
              P
Sbjct: 224 GCPP 227

Length = 340

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 14/25 (56%), Positives = 18/25 (72%)

Query: 242 IHRDINASNILLNEDFEVKVSDFGL 266
           IHRDI   N+LL+    +K+SDFGL
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 21/106 (19%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-IG--YIL 289
           L H     I+HRDI + NI L +D  +K+ DFG+ R++     +++ ++A T IG  Y L
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYL 168

Query: 290 LA--C-------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV 326
               C         DI++   VL E+   K      F+  N  NLV
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHA----FEAGNMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
           G+ ++H      I+HRD+ A+NIL+ +D  +K++DFGL R  S
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 45/160 (28%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------------------- 221
           NIV LLG     +   +++ Y     L+++L  ++ H                       
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           I    A G+ FL      H++H+D+   N+L+ +   VK+SD GL R +       + D 
Sbjct: 129 IVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV------YAADY 179

Query: 282 AGTIGYILL---------------ACGGDIYSFSVVLLEL 306
              +G  LL               +   DI+S+ VVL E+
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 45/176 (25%), Positives = 60/176 (34%), Gaps = 66/176 (37%)

Query: 12  DNLGMPPIIPKNLNELPHL---DLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLV 68
           DN G+   IP ++++L HL   +LS N + G I                   PP L ++ 
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI-------------------PPSLGSIT 466

Query: 69  QLEYFDFSMNMLGGHIPEK---------------------------------------NI 89
            LE  D S N   G IPE                                        N 
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526

Query: 90  DLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAIIV--SMLWWIQRGN--RQQHLS 141
            LCG I GL       S  A  G   G  +A   +V  +M WW +R N  R Q ++
Sbjct: 527 GLCG-IPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIA 581

Length = 623

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 3/37 (8%)

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           + +LH      IIHRD+ A N+LL  D ++K++DFG+
Sbjct: 123 LQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGV 156

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 15/87 (17%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISDCESHTSTDVAGTIGY 287
           G+ ++H R    I+HRD+ A NI L  +  +K+ DFG+ R L+  C+   +T   GT  Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYY 171

Query: 288 I---LLACGG-----DIYSFSVVLLEL 306
           +    L   G     DI+S   +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 28/152 (18%)

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-----T 277
           A   A G+ FLH +    II+RD+   N++L+ +  +K++DFG+      C+ +     T
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM------CKENIFGGKT 157

Query: 278 STDVAGTIGYIL--------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
           +    GT  YI              D ++F V+L E++  + P   E +D+    L   +
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQSI 213

Query: 330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           ++  +  +Y K    + + I  G +  +P  R
Sbjct: 214 MEHNV--SYPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 38/125 (30%), Positives = 54/125 (43%), Gaps = 28/125 (22%)

Query: 195 EKKLIVYEYMVKGSLNDWLRNQAKHCII-------ACGTARGITFLHHRFQPHIIHRDIN 247
           EK   V +Y+  G L  +   Q + C +       A   A  I +LH     +II+RD+ 
Sbjct: 69  EKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLK 123

Query: 248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELV 307
             NILL+    V ++DFGL +   + E  TST            CG   Y     L   V
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGVEPEETTST-----------FCGTPEY-----LAPEV 167

Query: 308 IRKQP 312
           +RK+P
Sbjct: 168 LRKEP 172

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 33/106 (31%), Positives = 45/106 (42%), Gaps = 28/106 (26%)

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           A   A  + +LH     +II+RD+   NILL+    V ++DFGL +   +    TST   
Sbjct: 102 AAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST--- 155

Query: 283 GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW 328
                    CG   Y     L   V+RKQP      D+     VDW
Sbjct: 156 --------FCGTPEY-----LAPEVLRKQPY-----DRT----VDW 179

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 13/152 (8%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           + H     ++HRDI  +N+ +     VK+ D GL R  S  ++  +  + GT  Y+    
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177

Query: 290 -----LACGGDIYSFSVVLLELVIRKQPTGPEFKDK-NGGNLVDWVLDSTILNAYSKPSM 343
                     DI+S   +L E+   + P    + DK N  +L   +         ++   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH 375
            K+ ++V  CI+ +P  RP +  V +  ++ H
Sbjct: 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 3/41 (7%)

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           T   + +LH   +  IIHRD+ A NIL   D ++K++DFG+
Sbjct: 112 TLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGV 149

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 10/110 (9%)

Query: 198 LIVYEYMVKGSLNDWLRNQAK----HC-IIACGTARGITFLHHRFQPHIIHRDINASNIL 252
            +V EY+  G L   ++ Q K    H    A      + FLH R    II+RD+   N+L
Sbjct: 72  FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVL 128

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-GGDIYSFSV 301
           L+ D  +K++D+G+ +        TST   GT  YI      G+ Y FSV
Sbjct: 129 LDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSV 177

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 11/73 (15%)

Query: 200 VYEYMVKGSL------NDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           V EY   G L      + +   +A     A     G+ +LH      I++RD+   N+LL
Sbjct: 80  VMEYAAGGDLMMHIHTDVFSEPRA--VFYAACVVLGLQYLHEN---KIVYRDLKLDNLLL 134

Query: 254 NEDFEVKVSDFGL 266
           + +  VK++DFGL
Sbjct: 135 DTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 20/152 (13%)

Query: 179 IAFKN---IVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRN-QAKHCIIACGTARGITF 232
           +AF N   +VQL  +C   + K   +V EYM  G L + + N           TA  +  
Sbjct: 97  MAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---- 288
           L       +IHRD+   N+LL++   +K++DFG    + +          GT  YI    
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 289 LLACGGDIY--------SFSVVLLELVIRKQP 312
           L + GGD Y        S  V L E+++   P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 29/160 (18%)

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---L 289
           L H     I+HRDI  +N+ +     VK+ D GL R  S  ++  +  + GT  Y+    
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPER 177

Query: 290 LACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA------- 337
           +   G     DI+S   +L E+   + P    F   +  NL    L   I          
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP----FY-GDKMNLYS--LCKKIEKCDYPPLPA 230

Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH 375
             YS+     +  +V  CI  +P  RP +  V +  ++ H
Sbjct: 231 DHYSEE----LRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 14/119 (11%)

Query: 170 NVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------HCIIA 223
           NV++   +G+ +K  V+       G++  +V E    GS+ D ++   K        IIA
Sbjct: 76  NVVKF--YGMYYKKDVK------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
                 +  L H      IHRD+  +NILL  +  VK+ DFG+   ++      +T V 
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 14/25 (56%), Positives = 18/25 (72%)

Query: 242 IHRDINASNILLNEDFEVKVSDFGL 266
           IHRDI   NIL++    +K+SDFGL
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 12/89 (13%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI---SDCESHTSTDV-- 281
           A G+ FL  +   + +HRD+ A N+L+ E   VK+ DFGL R I   S+  S  ST +  
Sbjct: 249 ANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 282 ----AGTIGYILLACGGDIYSFSVVLLEL 306
                 +I   L     D++SF ++L E+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 28/97 (28%), Positives = 41/97 (42%), Gaps = 22/97 (22%)

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI- 288
           + +LH R    IIHRD+   NI L+E     + DFG     + C+     D     G+  
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG-----AACKLDAHPDTPQCYGWSG 249

Query: 289 --------LLA----CGG-DIYSFSVVLLELVIRKQP 312
                   LLA    C   DI+S  +VL E+ ++   
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 13/87 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           GI  LH      IIHRD+  SNI++  D  +K+ DFGL R  + C +   T    T  Y 
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYR 189

Query: 288 ---ILLACGG----DIYSFSVVLLELV 307
              ++L  G     DI+S   ++ ELV
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	383
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.98
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.98
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.98
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.98
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.98
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.98
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.94
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.94
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.91
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.9
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.84
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.84
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG1152	772	consensus Signal transduction serine/threonine kin	99.82
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.82
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.8
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.68
PRK09188	365	serine/threonine protein kinase; Provisional	99.66
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.62
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.61
PRK12274	218	serine/threonine protein kinase; Provisional	99.57
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.53
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.52
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.52
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.51
PLN03150	623	hypothetical protein; Provisional	99.5
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.46
PRK10345	210	hypothetical protein; Provisional	99.45
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.45
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.44
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.33
PRK14879	211	serine/threonine protein kinase; Provisional	99.32
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.3
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.28
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.25
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.18
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.14
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.07
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.04
PLN03150	623	hypothetical protein; Provisional	98.98
smart00090	237	RIO RIO-like kinase.	98.93
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.84
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	98.73
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.57
KOG1243	690	consensus Protein kinase [General function predict	98.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.52
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.32
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.29
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.16
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.14
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.08
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.0
COG4248	637	Uncharacterized protein with protein kinase and he	97.96
KOG3087	229	consensus Serine/threonine protein kinase [General	97.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.85
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.84
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.83
KOG0617	264	consensus Ras suppressor protein (contains leucine	97.81
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.76
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.71
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.69
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.64
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.61
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.56
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.43
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.39
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.39
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.36
PLN03210	1153	Resistant to P. syringae 6; Provisional	97.35
PLN03210	1153	Resistant to P. syringae 6; Provisional	97.28
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.27
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.25
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	97.25
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.24
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.14
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.06
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	97.01
PRK09902	216	hypothetical protein; Provisional	96.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	96.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	96.92
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.87
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	96.87
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	96.8
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	96.67
KOG4237	498	consensus Extracellular matrix protein slit, conta	96.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.35
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.34
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	96.34
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	96.34
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	96.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.27
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	96.24
KOG2982	418	consensus Uncharacterized conserved protein [Funct	96.18
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	96.11
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	96.09
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	95.56
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	95.36
KOG1235	538	consensus Predicted unusual protein kinase [Genera	94.94

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-49  Score=429.47  Aligned_cols=366  Identities=26%  Similarity=0.435  Sum_probs=266.6

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|++ +.+|..++++++|+.|+|++|+++|.+|..+.++++|+.|+|     +|.+|..+.++++|+.++
T Consensus       498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~  577 (968)
T PLN00113        498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN  577 (968)
T ss_pred             hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence            45788888888888 788888888999999999999999999999999999988887     557899999999999999


Q ss_pred             cccccccccCCCC-------------CcCCccccCC---CCCccccc--ccceeeehhhhhHHHHHHHhhhhhhhhcccc
Q 046461           75 FSMNMLGGHIPEK-------------NIDLCGKIMG---LDYQVLTF--SKLALFGTVVGSVLAIAIIVSMLWWIQRGNR  136 (383)
Q Consensus        75 ~s~N~l~g~ip~~-------------n~~lcg~~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (383)
                      +++|+++|.+|..             |+.+||....   .+|....+  .+..+++.+++++++++++++++++++++++
T Consensus       578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  657 (968)
T PLN00113        578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN  657 (968)
T ss_pred             ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            9999999999953             6778875421   13432111  1222333333333333333323333333221


Q ss_pred             cc--ccc---ccccc--cC-CCCCcccHHHHHHHhhCccccCeeecCCccccc---------------------------
Q 046461          137 QQ--HLS---INLAM--FE-PSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------  181 (383)
Q Consensus       137 ~~--~~~---~~~~~--~~-~~~~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------  181 (383)
                      .+  ...   .....  +. .....++++++.   ..|...++||+|+||.||                           
T Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~  734 (968)
T PLN00113        658 LELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI  734 (968)
T ss_pred             ccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHH
Confidence            11  100   00000  00 111234555554   457788999999999998                           


Q ss_pred             --------cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc--chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 --------KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 --------~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                              ||||+++|+|.+++..++||||+++|+|.++++.  +.++..++.|+|+|++|||+.+.++++|||+||+||
T Consensus       735 ~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni  814 (968)
T PLN00113        735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI  814 (968)
T ss_pred             HHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence                    7999999999999999999999999999999974  566788999999999999988788999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.++.+++. ||.......     .....++..|+|||        .++|||||||++|||++|+.|++..+..  ..
T Consensus       815 l~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~  886 (968)
T PLN00113        815 IIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HG  886 (968)
T ss_pred             EECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CC
Confidence            99999888875 666543321     12236788999998        5799999999999999999998654431  22


Q ss_pred             cccee------------eecCcccc--cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          324 NLVDW------------VLDSTILN--AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       324 ~~~~~------------v~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+.+|            +.++.+..  ....++..++.+++.+||+.||++||||+||+++|+++.+.
T Consensus       887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            22222            12333322  12345667788999999999999999999999999988653

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=367.82  Aligned_cols=227  Identities=41%  Similarity=0.711  Sum_probs=192.4

Q ss_pred             CCCcccHHHHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEE
Q 046461          150 SLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~  191 (383)
                      ..+.|++++|..||++|+..++||+|+||.||                                      ||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999                                      7999999999


Q ss_pred             EeCC-EEEEEEEeccCCCHHHHHhc-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          192 PVGE-KKLIVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       192 ~~~~-~~~lv~e~~~~gsL~~~l~~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                      .+.+ +.+||||||++|+|.++|+.       |..|++||.++|+||+|||+.+.++|+|||||++|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999874       567899999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee-------
Q 046461          264 FGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW-------  328 (383)
Q Consensus       264 fgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~-------  328 (383)
                      ||+|+..........+...||.+|++||        .|+|||||||+++|++||++|.+.... .....+++|       
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHHHHHC
Confidence            9999765531111111117999999998        589999999999999999998765331 122234444       


Q ss_pred             -----eecCccc-ccCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          329 -----VLDSTIL-NAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       329 -----v~~~~~~-~~~~~-~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                           ++|+.+. ..+.. ....++..++.+|++.+|++||+|.||+++|+.+...
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence                 4677765 44443 5788899999999999999999999999999776544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=315.49  Aligned_cols=187  Identities=32%  Similarity=0.454  Sum_probs=156.0

Q ss_pred             cccceeeeEEEeCC-EEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCC-eeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPH-IIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~-ivHrdlk~~NiL  252 (383)
                      ||||+++|+|.+.. ...+|||||++|+|.++++..       ..++.++.|||+||.|||++   . |||||||++|||
T Consensus        99 pNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiL  175 (362)
T KOG0192|consen   99 PNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNIL  175 (362)
T ss_pred             CCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEE
Confidence            79999999999887 799999999999999999762       24688999999999999998   6 999999999999


Q ss_pred             EcCCC-ceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          253 LNEDF-EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       253 l~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      ++.++ ++||+|||+++...... ...+...||+.|||||          .|+|||||||++|||+||+.||..    ..
T Consensus       176 v~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~----~~  250 (362)
T KOG0192|consen  176 VDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED----LA  250 (362)
T ss_pred             EcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC----CC
Confidence            99997 99999999998765432 3334478999999998          478999999999999999999643    23


Q ss_pred             CCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          322 GGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       322 ~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .......+.........+..+...+..++.+||..||+.||++.+++..|+.+..
T Consensus       251 ~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  251 PVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            3344444443444444455577789999999999999999999999999997654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-40  Score=312.98  Aligned_cols=200  Identities=32%  Similarity=0.521  Sum_probs=166.9

Q ss_pred             CeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccCCCHHHH
Q 046461          170 NVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDW  212 (383)
Q Consensus       170 ~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~  212 (383)
                      +.||+|-||.|+                                     +|||+++|+|..++.++||||||++|+|.++
T Consensus       212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence            679999999999                                     7999999999998999999999999999999


Q ss_pred             Hhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccccccc
Q 046461          213 LRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI  285 (383)
Q Consensus       213 l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~  285 (383)
                      |+..       .+.+.++.|||+|++||+++   ++|||||.++|||++++..+||+|||+||...++.........-..
T Consensus       292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPI  368 (468)
T KOG0197|consen  292 LRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPI  368 (468)
T ss_pred             hhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCc
Confidence            9862       23578999999999999999   9999999999999999999999999999965544333333333456


Q ss_pred             ccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHcccc
Q 046461          286 GYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFD  356 (383)
Q Consensus       286 ~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~  356 (383)
                      .|.|||        .|||||||||+|||++| |+.|+    ..+...+.++.+-.+.. -+.+..++..+.++|..||..
T Consensus       369 kWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py----~~msn~ev~~~le~GyR-lp~P~~CP~~vY~lM~~CW~~  443 (468)
T KOG0197|consen  369 KWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY----PGMSNEEVLELLERGYR-LPRPEGCPDEVYELMKSCWHE  443 (468)
T ss_pred             eecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC----CCCCHHHHHHHHhccCc-CCCCCCCCHHHHHHHHHHhhC
Confidence            788998        78999999999999999 67773    33344555555444332 234667888999999999999


Q ss_pred             CCCCCCCHHHHHHHHhccccC
Q 046461          357 NPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       357 ~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +|++|||++.+...|+.+...
T Consensus       444 ~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  444 DPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CcccCCCHHHHHHHHHHhhhc
Confidence            999999999999999988764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=299.66  Aligned_cols=205  Identities=28%  Similarity=0.411  Sum_probs=171.4

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc----------------------------------------cccceeeeEE
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~  191 (383)
                      ..++..|+...       +.||+|..|+||                                        |+||+++|.|
T Consensus        74 ~~i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF  146 (364)
T KOG0581|consen   74 NGISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF  146 (364)
T ss_pred             cccCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence            34666777765       889999999999                                        7999999999


Q ss_pred             EeCC-EEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCCceEEccc
Q 046461          192 PVGE-KKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDFEVKVSDF  264 (383)
Q Consensus       192 ~~~~-~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~~~kl~Df  264 (383)
                      .... ++.++||||.+|+|+++++.     +...-.++.++.+||.|||+ +   +|+||||||+|+|++..|++||+||
T Consensus       147 ~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  147 YSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             EeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccc
Confidence            9988 59999999999999999985     23356799999999999996 5   8999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCC-CCCCCccceeeecCccc
Q 046461          265 GLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFK-DKNGGNLVDWVLDSTIL  335 (383)
Q Consensus       265 gla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~-~~~~~~~~~~v~~~~~~  335 (383)
                      |+++.+...   ......||..||+||        .++||||||+.++|+++|+.|+.+... ..+..+++.++.+...+
T Consensus       224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP  300 (364)
T KOG0581|consen  224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP  300 (364)
T ss_pred             cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC
Confidence            999987653   345578999999999        579999999999999999999866411 12344566666664443


Q ss_pred             ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          336 NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       336 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .......++++.+++..|+++||.+|||+.|+++
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3222247888999999999999999999999986

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-38  Score=316.04  Aligned_cols=188  Identities=29%  Similarity=0.519  Sum_probs=160.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------------------hhhhHHHHhHHHHHHHHhhcCCCCee
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCIIACGTARGITFLHHRFQPHII  242 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~i~~~ia~gL~~LH~~~~~~iv  242 (383)
                      ||||+|+|+|.+++..++|+|||..|||.+||+..                   .+.+.||.|||.||+||-++   .+|
T Consensus       549 ~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FV  625 (774)
T KOG1026|consen  549 PNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFV  625 (774)
T ss_pred             CCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---ccc
Confidence            79999999999999999999999999999999721                   24578999999999999998   899


Q ss_pred             ecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc-ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCC
Q 046461          243 HRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST-DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQP  312 (383)
Q Consensus       243 Hrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p  312 (383)
                      ||||.++|+|+.++..+||+|||++|..-..+..... ...-..+||+||        ++||||||||+|||+++ |+.|
T Consensus       626 HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP  705 (774)
T KOG1026|consen  626 HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP  705 (774)
T ss_pred             ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc
Confidence            9999999999999999999999999876443322111 122357899998        78999999999999998 9999


Q ss_pred             CCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          313 TGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       313 ~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++.    ....+.++.+.++.+ -+.++.++.++++||..||+.+|++||+++||-.+|+.....
T Consensus       706 y~g----lSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  706 YYG----LSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ccc----cchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            643    355677777777777 455788999999999999999999999999999999987654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-36  Score=293.90  Aligned_cols=196  Identities=23%  Similarity=0.384  Sum_probs=165.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ..|...++||+|+|+.+|                                          ||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            357788999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+|++|+|..+++.     +.++..+..||+.||.|||+.   +|+|||||..|+++++++++||+|||+|..+..... 
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-  173 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc-
Confidence            99999999999984     345678999999999999999   999999999999999999999999999998765432 


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....+||+.|+|||        ..+||||+||++|-|++|++||.    ..+..+....+......  .+...+.+..+
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe----tk~vkety~~Ik~~~Y~--~P~~ls~~A~d  247 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE----TKTVKETYNKIKLNEYS--MPSHLSAEAKD  247 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc----cchHHHHHHHHHhcCcc--cccccCHHHHH
Confidence            334589999999999        56899999999999999999954    33334444444333321  23455667889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+.++.||.+|||+.+|+.
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-37  Score=283.54  Aligned_cols=180  Identities=24%  Similarity=0.374  Sum_probs=153.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ||||++++++...+..|+||||+++|+|.+++-..     ..-..++.|++.|+.|||++   +|+||||||+|||+..+
T Consensus       236 P~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  236 PNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSND  312 (475)
T ss_pred             CCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccC
Confidence            89999999999999999999999999999998643     22356889999999999999   99999999999999765


Q ss_pred             ---CceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          257 ---FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       257 ---~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                         ..+||+|||+|+....  .......+||+.|.|||           .+.|+||+||+||-+++|..||..++.   .
T Consensus       313 ~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~---~  387 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT---D  387 (475)
T ss_pred             CcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC---C
Confidence               7799999999998763  33455689999999999           478999999999999999999876654   2


Q ss_pred             CccceeeecCccc--ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTIL--NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+.+..+.+.  +..+....++.++++.+++..||+.|||+.|+++
T Consensus       388 ~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  388 PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            3355666666552  2345677889999999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=304.69  Aligned_cols=219  Identities=26%  Similarity=0.443  Sum_probs=181.0

Q ss_pred             CcccHHHHHHHhhCcc---------ccCeeecCCccccc-----------------------------------------
Q 046461          152 GKLTYDQIVAGTNKFY---------EKNVIRGDDFGIAF-----------------------------------------  181 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~---------~~~~lg~g~~g~v~-----------------------------------------  181 (383)
                      ..+||+|-..|-..|.         ..++||.|.||.|+                                         
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            3567887666666554         45789999999999                                         


Q ss_pred             --cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 --KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 --~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                        |||++|-|+......+++|+|||+||+|+.||+...      +...+.++||.|+.||-+.   +.|||||.++|||+
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILV  764 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILV  764 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheee
Confidence              899999999999999999999999999999998643      3466889999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCcccccccc--ccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAG--TIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNG  322 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~  322 (383)
                      +.+..+|++|||++|.+.++.....+...|  ...|.|||        .++|||||||++||.++ |.+|+    -++..
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY----WdmSN  840 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMSN  840 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc----cccch
Confidence            999999999999999886654333333333  36788888        67999999999999887 99994    44455


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+.++.+.++.- -+.+.+++..+.+||+.||++|-.+||++.||+..|.++...+
T Consensus       841 QdVIkaIe~gyR-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  841 QDVIKAIEQGYR-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHHHHHhccC-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            555555544432 3346788999999999999999999999999999999886553

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=287.66  Aligned_cols=206  Identities=27%  Similarity=0.414  Sum_probs=171.0

Q ss_pred             cccHHHHHHHhhCccccCeeecCCccccc------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          153 KLTYDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .+.|++|.+-       +-+|.|+-|.||                              +||+.+.|+|....-.++|||
T Consensus       120 eiPFe~IsEL-------eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  120 EIPFEEISEL-------EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             cCCHHHhhhh-------hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            3556666544       789999999999                              799999999999999999999


Q ss_pred             eccCCCHHHHHhcchh-----hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~~~-----~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ||+.|.|...|+....     ...+..+||.|+.|||.+   .|||||||+-||||..+..+||+|||.++...+.  .+
T Consensus       193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST  267 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST  267 (904)
T ss_pred             ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence            9999999999986543     357889999999999998   9999999999999999999999999999987654  45


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI  349 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  349 (383)
                      ...++||..|||||        .|.||||||||||||+||..|+    .+-+...++--|-...+.-..+..++.-+.-|
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPY----kdVdssAIIwGVGsNsL~LpvPstcP~GfklL  343 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPY----KDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL  343 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCc----cccchheeEEeccCCcccccCcccCchHHHHH
Confidence            56689999999998        7899999999999999999995    43333333322222223223355667778888


Q ss_pred             HHHccccCCCCCCCHHHHHHHHhcc
Q 046461          350 VVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +.+||+..|..||++.+++..|+=.
T Consensus       344 ~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  344 LKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHhcCCCCCccHHHHHHHHhhc
Confidence            9999999999999999999988743

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=311.41  Aligned_cols=187  Identities=28%  Similarity=0.437  Sum_probs=153.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------------AKHCIIACGTARGITFLHHRFQPHIIHRDINAS  249 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~  249 (383)
                      ||||+++|.|.+....++++|||++|+|..||++.            .+.+.++.|||+|+.||+++   ++|||||.++
T Consensus       755 pNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaR  831 (1025)
T KOG1095|consen  755 PNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAAR  831 (1025)
T ss_pred             cceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhh
Confidence            79999999999999999999999999999999864            24578999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEccccCccccCCCCCcccccc-ccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCC
Q 046461          250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDV-AGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKD  319 (383)
Q Consensus       250 NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~  319 (383)
                      |+|++....+||+|||+|+.+...+....... .-...|||||        .|+|||||||++||++| |..|    |.+
T Consensus       832 NCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P----Y~~  907 (1025)
T KOG1095|consen  832 NCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP----YPS  907 (1025)
T ss_pred             heeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC----CCC
Confidence            99999999999999999995543322221111 2246899998        79999999999999999 6666    444


Q ss_pred             CCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          320 KNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+..++...+..+. +-+.+..++..++++|.+||+.+|++||++..++++++.+..
T Consensus       908 ~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  908 RSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             cchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            45555555333333 223466788899999999999999999999999999887754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8e-36  Score=276.03  Aligned_cols=147  Identities=27%  Similarity=0.474  Sum_probs=130.9

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .+|.....||+|+|++||                                         +|||++++++.+++.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            466667779999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC------CceEEccccCccccC
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED------FEVKVSDFGLVRLIS  271 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~------~~~kl~Dfgla~~~~  271 (383)
                      ||.+|||.+|++..     .....++.|+|.||++||++   +|+||||||+|||++..      -.+||+|||+||.+.
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999864     34577899999999999999   99999999999999765      468999999999987


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ..  ......+|++-|||||        .|+|+||.|+|+|||++|+.||+.
T Consensus       167 ~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  167 PG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             ch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            53  2344579999999999        689999999999999999999763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-37  Score=270.46  Aligned_cols=185  Identities=23%  Similarity=0.310  Sum_probs=149.7

Q ss_pred             cccceeee-EEEeCCE-EEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCC
Q 046461          182 KNIVQLLG-YCPVGEK-KLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPH--IIHRDINA  248 (383)
Q Consensus       182 ~niv~l~g-~~~~~~~-~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~  248 (383)
                      ||||++++ .+.++.+ +++|||||..|+|.+.++..         +..+++..|++.||.++|... ++  |+||||||
T Consensus        78 pNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKP  156 (375)
T KOG0591|consen   78 PNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKP  156 (375)
T ss_pred             chHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcc
Confidence            79999998 4444444 89999999999999999742         346889999999999999842 24  99999999


Q ss_pred             CcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          249 SNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       249 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      .||+++.+|.+|++|||+++.+....+ ......||+.||+||        .|+||||+||++|||+.-..||..    .
T Consensus       157 aNIFl~~~gvvKLGDfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g----~  231 (375)
T KOG0591|consen  157 ANIFLTANGVVKLGDFGLGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG----D  231 (375)
T ss_pred             hheEEcCCCceeeccchhHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc----c
Confidence            999999999999999999999876433 344578999999998        799999999999999999999643    3


Q ss_pred             CCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          321 NGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       321 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      +-.++.+.+..+...+......+..+..++..|+..||+.||+...+++.++
T Consensus       232 n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  232 NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            4455666666665543333567889999999999999999999554444443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.7e-35  Score=278.27  Aligned_cols=189  Identities=28%  Similarity=0.425  Sum_probs=144.0

Q ss_pred             cccceeeeEEEeC-CEEEEEEEeccCCCHHHHHhcch-------------------------------------------
Q 046461          182 KNIVQLLGYCPVG-EKKLIVYEYMVKGSLNDWLRNQA-------------------------------------------  217 (383)
Q Consensus       182 ~niv~l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------  217 (383)
                      |||++++++|... +..++||||+++|+|.+++....                                           
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (338)
T cd05102          71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ  150 (338)
T ss_pred             cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence            7999999998764 46889999999999999986321                                           


Q ss_pred             ------------------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          218 ------------------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       218 ------------------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                                              ....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~  227 (338)
T cd05102         151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKD  227 (338)
T ss_pred             cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccC
Confidence                                    2245789999999999998   9999999999999999999999999999865432


Q ss_pred             CCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ... ......++..|+|||        .++|||||||++|||++ |..|+.....   .......+.+... ...+....
T Consensus       228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~-~~~~~~~~  303 (338)
T cd05102         228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFCQRLKDGTR-MRAPENAT  303 (338)
T ss_pred             cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHhcCCC-CCCCCCCC
Confidence            211 112234567899998        57899999999999997 8888643211   1111111122111 11233445


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            6788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=282.18  Aligned_cols=203  Identities=25%  Similarity=0.399  Sum_probs=163.5

Q ss_pred             ccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          166 FYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      +.....||+|.||+||                                      .||+-+.|||..... .+|+.+|++-
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs  472 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS  472 (678)
T ss_pred             hhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence            3344889999999999                                      499999999998776 9999999999


Q ss_pred             CHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Cccccc
Q 046461          208 SLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD  280 (383)
Q Consensus       208 sL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~~~~  280 (383)
                      +|+.+++...      +...||.|||+|+.|||.+   +|||||||+.||++++++++||+|||++..-+... ......
T Consensus       473 SLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q  549 (678)
T KOG0193|consen  473 SLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ  549 (678)
T ss_pred             hhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence            9999998543      4578999999999999999   99999999999999999999999999986533221 122223


Q ss_pred             cccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc---CChhHHHHH
Q 046461          281 VAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA---YSKPSMLKM  346 (383)
Q Consensus       281 ~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~---~~~~~~~~~  346 (383)
                      ..|+.-|||||           ..+||||||+++|||++|..|+.    ......++-.+-.+.+.+.   ....+..+|
T Consensus       550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys----i~~~dqIifmVGrG~l~pd~s~~~s~~pk~m  625 (678)
T KOG0193|consen  550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS----IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM  625 (678)
T ss_pred             CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC----CCChhheEEEecccccCccchhhhccCHHHH
Confidence            45888999998           67999999999999999999964    3233344433433333222   134566789


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+|+..||..++++||.+.+|+..|+.+..
T Consensus       626 k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  626 KRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             HHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            999999999999999999999998887765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=269.51  Aligned_cols=191  Identities=24%  Similarity=0.324  Sum_probs=158.6

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      -++|...++||+|+||.||                                          |.||++.-.|.+++.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4578888999999999999                                          7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      +||+.||+|..+|..+.     ....++..|+.||.|||+.   +|+|||+||+|||+|.+|.++++|||+++.......
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999998543     3567899999999999999   999999999999999999999999999986544332


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      . ....+||+.|||||        ..+|+||+||++|||++|.+||..    .+.....+.+....... .+.-......
T Consensus       181 ~-t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~----~~~~~~~~~I~~~k~~~-~p~~ls~~ar  254 (357)
T KOG0598|consen  181 A-TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA----EDVKKMYDKILKGKLPL-PPGYLSEEAR  254 (357)
T ss_pred             c-cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC----ccHHHHHHHHhcCcCCC-CCccCCHHHH
Confidence            2 23479999999999        678999999999999999999643    34455555555444221 1222455778


Q ss_pred             HHHHHccccCCCCCC
Q 046461          348 QIVVGCIFDNPTTRP  362 (383)
Q Consensus       348 ~l~~~C~~~~P~~RP  362 (383)
                      +++...++.||++|-
T Consensus       255 dll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  255 DLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHHHhccCHHHhc
Confidence            888999999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=277.70  Aligned_cols=201  Identities=20%  Similarity=0.348  Sum_probs=168.2

Q ss_pred             HHHhhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCE
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      .+.-++|...+.||+|+|++|+                                           |.||+|+--|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4455678888999999999998                                           789999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      +|+|+||++||+|.++++...     ....++.+|..||+|||++   +||||||||+|||+|.++.++|+|||-|+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999998543     3466899999999999999   99999999999999999999999999999885


Q ss_pred             CCCCc----------cc--cccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec
Q 046461          272 DCESH----------TS--TDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD  331 (383)
Q Consensus       272 ~~~~~----------~~--~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~  331 (383)
                      .....          ..  ....||..|.+||        ..+|+|+|||++|+|+.|.+||    .+.++..+.+.|++
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF----ra~NeyliFqkI~~  301 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF----RAANEYLIFQKIQA  301 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC----ccccHHHHHHHHHH
Confidence            42211          11  4478999999998        6799999999999999999995    44455555566654


Q ss_pred             CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      -.+  .+++...+.+.+|+.+.+..||.+|+|..+|.+
T Consensus       302 l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  302 LDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             hcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            433  334555567888999999999999999987765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=271.81  Aligned_cols=201  Identities=25%  Similarity=0.398  Sum_probs=158.6

Q ss_pred             CccccCeeecCCccccc---------------------------------------cccceeeeEEEeCC--EEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGE--KKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~--~~~lv~e~  203 (383)
                      ++...+.||+|.||.||                                       ||||+.+|.....+  ..++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            45566888888888888                                       79999999855544  68999999


Q ss_pred             ccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEccccCccccCC--CC
Q 046461          204 MVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRLISD--CE  274 (383)
Q Consensus       204 ~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfgla~~~~~--~~  274 (383)
                      +++|+|.+++.+..      ....+..|+++||+|||++   +++|||||++|||++. ++.+||+|||+++....  ..
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999998543      3578999999999999998   9999999999999999 79999999999987653  12


Q ss_pred             CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ........||+.|||||         .++||||+||++.||+||+.||...+   ...+..-++......+..+...+.+
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---~~~~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---EEAEALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---chHHHHHHHhccCCCCCCCcccCHH
Confidence            22334578999999998         27999999999999999999975421   1111111222222222445556678


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      ..+++..|+..||++|||+.++++.-
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            88999999999999999999999743

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.8e-34  Score=266.45  Aligned_cols=184  Identities=20%  Similarity=0.310  Sum_probs=146.0

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ||||+++|++.+    ....++||||+++|+|.+++...     .....++.+++.|+.|||+..  +++||||||+||+
T Consensus        78 ~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nil  155 (283)
T PHA02988         78 NNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFL  155 (283)
T ss_pred             CCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEE
Confidence            799999999977    34689999999999999999753     345789999999999999732  6779999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++.+|++|||+++......    ....|+..|+|||          .++|||||||++|||++|+.||...    +.
T Consensus       156 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~----~~  227 (283)
T PHA02988        156 VTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL----TT  227 (283)
T ss_pred             ECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC----CH
Confidence            9999999999999998654321    2245788899988          4789999999999999999996432    22


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .++...+.........+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       228 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            33333332222222223345678899999999999999999999999998764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=279.63  Aligned_cols=215  Identities=25%  Similarity=0.403  Sum_probs=169.8

Q ss_pred             HHHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEE
Q 046461          157 DQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++.+..-.+..-.+.||-|.||.||                                      ||+|+|+|+|..+...|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            3333333455667899999999999                                      79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcchh-------hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          199 IVYEYMVKGSLNDWLRNQAK-------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~~~-------~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      +|+|||.+|+|.++|+...+       .+.+|.||+.|++||..+   ++|||||..+|+|+.++..+|++|||++++++
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999986543       356899999999999998   99999999999999999999999999999987


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhH
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS  342 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  342 (383)
                      .+.........-...|.|||        .|+|||+|||+|||+.| |..|+.    +.+-.+ +-..+...+.-..++.+
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP----GidlSq-VY~LLEkgyRM~~PeGC  491 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP----GIDLSQ-VYGLLEKGYRMDGPEGC  491 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC----CccHHH-HHHHHhccccccCCCCC
Confidence            54322111111235677777        68999999999999998 788842    212111 11122333333446778


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      +++++++|+.||+.+|.+||+++|+-+.+|.+.....
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence            8899999999999999999999999999998866544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=280.78  Aligned_cols=188  Identities=26%  Similarity=0.393  Sum_probs=154.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ||||+++|++.....+++|||+|+||+|.++|+...      ++..++.++|.||+|||+.   .++||||-++|+|++.
T Consensus       221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~  297 (474)
T KOG0194|consen  221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSK  297 (474)
T ss_pred             CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecC
Confidence            799999999999999999999999999999998643      4678999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.+||+|||+++.-....... ....-...|+|||        .++|||||||++||+++ |..|+    .+....++.
T Consensus       298 ~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py----~g~~~~~v~  372 (474)
T KOG0194|consen  298 KGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY----PGMKNYEVK  372 (474)
T ss_pred             CCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC----CCCCHHHHH
Confidence            9999999999987643111111 0112356899998        78999999999999998 78884    444555666


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .++.........+...+..+..++.+||..+|++||||.++.+.|+.+...
T Consensus       373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            666444444444556677788889999999999999999999999987655

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=274.40  Aligned_cols=197  Identities=28%  Similarity=0.386  Sum_probs=164.2

Q ss_pred             CccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          165 KFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .|..-..||+|+.|.||                                       +|||++++.+..++++|.|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            46677889999999999                                       799999999999999999999999


Q ss_pred             CCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccc
Q 046461          206 KGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       206 ~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      +|+|.|.+..    +.+...|+.++++||+|||.+   +|+|||||.+|||++.++.+||+|||++..+..... .....
T Consensus       354 ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~Tm  429 (550)
T KOG0578|consen  354 GGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTM  429 (550)
T ss_pred             CCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccc
Confidence            9999999874    456778899999999999999   999999999999999999999999999988776544 33457


Q ss_pred             ccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc-ccCChhHHHHHHHHHHH
Q 046461          282 AGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL-NAYSKPSMLKMLQIVVG  352 (383)
Q Consensus       282 ~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~-~~~~~~~~~~~~~l~~~  352 (383)
                      .||+.|||||        +|.||||+|++.+||+.|++||-.+    +.......+.+..-+ -..++..+..+.++..+
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            8999999999        7899999999999999999997321    222222222222211 12244566788999999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 046461          353 CIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       353 C~~~~P~~RPs~~~v~~  369 (383)
                      |+..||++||++.|+++
T Consensus       506 cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLE  522 (550)
T ss_pred             HhhcchhcCCCHHHHhc
Confidence            99999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=253.12  Aligned_cols=184  Identities=21%  Similarity=0.348  Sum_probs=156.8

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|.....+|.|+||.|+                                          |.++++.+.|.+.+.+++|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            46666899999999998                                          799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+++|.|.++++..     +....+|.+|+.|++|||+.   .|++||+||+|||+|++|.+||+|||+|+.....    
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----  197 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence            99999999999863     34677999999999999999   9999999999999999999999999999987542    


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI  349 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  349 (383)
                      ....+||+.|+|||        .++|.|||||++|||+.|..||...    +...+.+.+....+  .++.-....+.++
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~----~~~~iY~KI~~~~v--~fP~~fs~~~kdL  271 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD----NPIQIYEKILEGKV--KFPSYFSSDAKDL  271 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC----ChHHHHHHHHhCcc--cCCcccCHHHHHH
Confidence            44589999999999        5789999999999999999997432    44666677766655  2344455567778


Q ss_pred             HHHccccCCCCC
Q 046461          350 VVGCIFDNPTTR  361 (383)
Q Consensus       350 ~~~C~~~~P~~R  361 (383)
                      +..-++.|-.+|
T Consensus       272 l~~LL~vD~t~R  283 (355)
T KOG0616|consen  272 LKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHhhhhHhh
Confidence            888888888877

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-33  Score=260.65  Aligned_cols=185  Identities=23%  Similarity=0.376  Sum_probs=144.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||++++|++..++..++||||+++|+|.+++...      .....++.|++.|++|||+.   +++|||+||+||+++.
T Consensus        66 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~  142 (266)
T cd05064          66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNS  142 (266)
T ss_pred             CCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcC
Confidence            79999999999999999999999999999998642      24578999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++++|||.+...............++..|+|||        .++|||||||++||+++ |+.|+...    ...+..
T Consensus       143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~----~~~~~~  218 (266)
T cd05064         143 DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM----SGQDVI  218 (266)
T ss_pred             CCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC----CHHHHH
Confidence            999999999987654322211112233567899998        57899999999999875 99886432    222233


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +.+.+... ...+...+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus       219 ~~~~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 KAVEDGFR-LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHCCCC-CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            32222211 122334556788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-33  Score=274.64  Aligned_cols=187  Identities=26%  Similarity=0.422  Sum_probs=143.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------------------------------------------
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------------------------------------------  217 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------  217 (383)
                      +|||+++++|...+..++||||+++|+|.++++...                                            
T Consensus       102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (374)
T cd05106         102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY  181 (374)
T ss_pred             CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence            699999999999999999999999999999985321                                            


Q ss_pred             -------------------------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccC
Q 046461          218 -------------------------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL  266 (383)
Q Consensus       218 -------------------------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgl  266 (383)
                                                     ....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGl  258 (374)
T cd05106         182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGL  258 (374)
T ss_pred             cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeecee
Confidence                                           2357889999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccc
Q 046461          267 VRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILN  336 (383)
Q Consensus       267 a~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~  336 (383)
                      ++......... .....++..|+|||        .++|||||||++|||++ |+.|+....    ...............
T Consensus       259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~----~~~~~~~~~~~~~~~  334 (374)
T cd05106         259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL----VNSKFYKMVKRGYQM  334 (374)
T ss_pred             eeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc----ccHHHHHHHHcccCc
Confidence            98654322111 11223556799998        57999999999999997 999964321    111111111111111


Q ss_pred             cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       337 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ..+...+.++.+++.+||+.||++|||+.+|+++|+++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            122233567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.4e-33  Score=272.61  Aligned_cols=186  Identities=26%  Similarity=0.440  Sum_probs=142.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------------------------------------------
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------------------------------------------  217 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------  217 (383)
                      |||++++++|.+++..++||||+++|+|.++++...                                            
T Consensus        99 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  178 (375)
T cd05104          99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV  178 (375)
T ss_pred             cceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence            799999999999999999999999999999986321                                            


Q ss_pred             ------------------------------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          218 ------------------------------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       218 ------------------------------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                                                          ....++.|++.||+|||+.   +++||||||+||+++.++.+|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl  255 (375)
T cd05104         179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKI  255 (375)
T ss_pred             cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEE
Confidence                                                1346788999999999998   9999999999999999999999


Q ss_pred             ccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeec
Q 046461          262 SDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLD  331 (383)
Q Consensus       262 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~  331 (383)
                      +|||+++......... .....++..|++||        .++|||||||++|||++ |..|+.....   .....+.+.+
T Consensus       256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~  332 (375)
T cd05104         256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMIKE  332 (375)
T ss_pred             ecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHHHh
Confidence            9999998664332211 11233456799998        57999999999999998 7777543211   1112222211


Q ss_pred             CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      . .....+.....++.+++.+||+.||++|||+.||++.|++.
T Consensus       333 ~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         333 G-YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C-ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1 11111223345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=264.00  Aligned_cols=212  Identities=26%  Similarity=0.417  Sum_probs=162.6

Q ss_pred             cccCeeecCCccccc------------------------------------cccceeeeEEEeCC----EEEEEEEeccC
Q 046461          167 YEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGE----KKLIVYEYMVK  206 (383)
Q Consensus       167 ~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~----~~~lv~e~~~~  206 (383)
                      ....++|+|+||.||                                    +||++++++-..+.    +.+||+||.++
T Consensus       213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k  292 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK  292 (534)
T ss_pred             hhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence            345789999999999                                    69999999887665    88999999999


Q ss_pred             CCHHHHHhc----chhhhHHHHhHHHHHHHHhhc------CCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          207 GSLNDWLRN----QAKHCIIACGTARGITFLHHR------FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       207 gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~------~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+|.+||+.    |....+++..+++||+|||+.      .+|+|+|||+|++|||+..|+++.|+|||+|..+......
T Consensus       293 GsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~  372 (534)
T KOG3653|consen  293 GSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ  372 (534)
T ss_pred             CcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC
Confidence            999999984    667889999999999999965      4678999999999999999999999999999888654433


Q ss_pred             c-ccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCC--------CCCCC-----CCCcccee
Q 046461          277 T-STDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGP--------EFKDK-----NGGNLVDW  328 (383)
Q Consensus       277 ~-~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~--------~~~~~-----~~~~~~~~  328 (383)
                      . .....||.+|||||              .+.||||+|.|+|||+++..-.++        .|...     ...++.+.
T Consensus       373 ~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~  452 (534)
T KOG3653|consen  373 GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQEL  452 (534)
T ss_pred             cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHH
Confidence            2 23468999999998              357999999999999987554321        11100     00111111


Q ss_pred             eec----CcccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          329 VLD----STILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       329 v~~----~~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ++.    |.++... .-..+..+.+.+..||..||+.|-|+.-|.+++.++....
T Consensus       453 VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  453 VVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            222    2222111 1133556788899999999999999999999888776543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=269.73  Aligned_cols=201  Identities=24%  Similarity=0.441  Sum_probs=160.5

Q ss_pred             cccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          167 YEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       167 ~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      .-.+.||+|.||.|+                                       ||||+|+|+|..++..++|+|||++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            345789999999998                                       89999999999999999999999999


Q ss_pred             CHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-cc
Q 046461          208 SLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-ST  279 (383)
Q Consensus       208 sL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~  279 (383)
                      +|.+|+...       ....+|+.|||.|++||.+.   +++|||+.++|+|+|.++++||+|||++|.+-..+... ..
T Consensus       621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg  697 (807)
T KOG1094|consen  621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG  697 (807)
T ss_pred             cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence            999999743       23477999999999999998   99999999999999999999999999999765444322 22


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHh--CCCCCCCCCCCCCCCcccee---eec-Ccc--cccCChhHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVI--RKQPTGPEFKDKNGGNLVDW---VLD-STI--LNAYSKPSM  343 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt--g~~p~~~~~~~~~~~~~~~~---v~~-~~~--~~~~~~~~~  343 (383)
                      ...-...|||+|        +++|||+||+++||+++  ..+|+....+    .+.++.   +.+ +..  ....+.-++
T Consensus       698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            233467899988        78999999999999864  7888654322    222221   111 111  112244567


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..+++++++||..+-++|||++++...|++.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            7899999999999999999999999988764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-33  Score=266.34  Aligned_cols=197  Identities=23%  Similarity=0.326  Sum_probs=159.1

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC--CEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG--EKKLIVY  201 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~--~~~~lv~  201 (383)
                      .|.....||+|.||.||                                         ||||+|.+...+.  ..+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            45555789999999999                                         7999999999886  6899999


Q ss_pred             EeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||++ ||..++..      ..+...++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus       198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            99977 89998875      346788999999999999999   999999999999999999999999999998877766


Q ss_pred             ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee------------cCcc
Q 046461          276 HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL------------DSTI  334 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~------------~~~~  334 (383)
                      ...+...-|.+|.+||         .+.|+||.|||+.||++|+..+..    ..+.+..+.|+            ...+
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G----~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG----RTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC----ccHHHHHHHHHHHhCCCChhccccccC
Confidence            6677778899999998         689999999999999999988542    22222222220            0000


Q ss_pred             c--------ccC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          335 L--------NAY-------SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       335 ~--------~~~-------~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +        ..+       ........++|+...+..||++|.|+.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0        011       1123456788999999999999999999886

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.7e-33  Score=257.66  Aligned_cols=185  Identities=26%  Similarity=0.479  Sum_probs=147.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||+++++++...+..+++|||+++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus        68 ~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~  144 (283)
T cd05048          68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---H  144 (283)
T ss_pred             cccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            79999999999999999999999999999999642                     12457899999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++|+||||+||+++.++.++|+|||+++....... .......++..|+|||        .++|||||||++|||++ |.
T Consensus       145 i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~  224 (283)
T cd05048         145 FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL  224 (283)
T ss_pred             eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999876533221 1222345678899998        46899999999999998 99


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      .|+...    ...++.+.+..... ...+...+.++.+++.+||+.||++||++.||+++|+++
T Consensus       225 ~p~~~~----~~~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         225 QPYYGF----SNQEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CCCCCC----CHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            896432    22333333332222 222345667899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.4e-33  Score=253.82  Aligned_cols=183  Identities=27%  Similarity=0.442  Sum_probs=143.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+.+..++||||+++|+|.++++..      .....++.|++.||+|||+.   +++|||+||+||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~  135 (256)
T cd05114          59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSS  135 (256)
T ss_pred             CCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcC
Confidence            79999999999999999999999999999998642      23577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.+|++|||.++..............++..|+|||        .++||||||+++|||++ |+.|+..    .+..+..
T Consensus       136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~----~~~~~~~  211 (256)
T cd05114         136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK----KSNYEVV  211 (256)
T ss_pred             CCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC----CCHHHHH
Confidence            999999999998865433222222334566799988        47899999999999999 8888542    2233333


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      +++...... ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus       212 ~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         212 EMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            333222111 112233457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=264.82  Aligned_cols=179  Identities=26%  Similarity=0.376  Sum_probs=148.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ||||++++.++......++||||+.+|+|.+++.+.     .....++.|++.|++|+|+.   +|+||||||+|+|+|.
T Consensus        79 HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   79 HPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG  155 (370)
T ss_pred             CCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence            379999999999999999999999999999999862     24577999999999999999   9999999999999999


Q ss_pred             C-CceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 D-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      + +++||+|||++.... .........+||+.|+|||          .++||||+||+||.|++|+.||+.    .+...
T Consensus       156 ~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d----~~~~~  230 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD----SNVPN  230 (370)
T ss_pred             CCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC----ccHHH
Confidence            9 999999999998764 2223445578999999998          568999999999999999999654    23334


Q ss_pred             cceeeecCcccccCChhH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPS-MLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~-~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +...+....+  .++... +.++..++.+|+..||.+|+|+.+|++
T Consensus       231 l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  231 LYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            4444433333  122333 778899999999999999999999993

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-33  Score=258.51  Aligned_cols=182  Identities=29%  Similarity=0.515  Sum_probs=137.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||++++|+|...+..++|+||+++|+|.++|...       ..+..++.|+++||+|||+.   +++|+||+++||+++
T Consensus        61 ~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~  137 (259)
T PF07714_consen   61 PNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLD  137 (259)
T ss_dssp             TTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc
Confidence            79999999999888899999999999999999864       24678999999999999998   899999999999999


Q ss_pred             CCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      .++.+||+|||+++....... ...........|++||        .++||||||+++||+++ |+.|+.    +.+..+
T Consensus       138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~----~~~~~~  213 (259)
T PF07714_consen  138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS----DYDNEE  213 (259)
T ss_dssp             TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT----TSCHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccc
Confidence            999999999999987632221 1122234667889987        58999999999999999 677743    223333


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      +.+.+.+... ...+......+.+++.+||+.||++||||.++++.|
T Consensus       214 ~~~~~~~~~~-~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  214 IIEKLKQGQR-LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHTTEE-TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccccccc-ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            3444433222 222344566788999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-32  Score=259.08  Aligned_cols=186  Identities=23%  Similarity=0.446  Sum_probs=140.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------------------------hhhhHHHHhHHHHHHHHhhc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------------------------AKHCIIACGTARGITFLHHR  236 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~~~i~~~ia~gL~~LH~~  236 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...                        .....++.|++.||+|||+.
T Consensus        78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  157 (304)
T cd05096          78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL  157 (304)
T ss_pred             CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            379999999999999999999999999999998632                        12467999999999999998


Q ss_pred             CCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHH
Q 046461          237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELV  307 (383)
Q Consensus       237 ~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ell  307 (383)
                         +++||||||+||+++.++.+||+|||+++........ ......++..|+|||        .++||||||+++|||+
T Consensus       158 ---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         158 ---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             ---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence               9999999999999999999999999999865433211 112234577899998        5789999999999998


Q ss_pred             hC--CCCCCCCCCCCCCCccceeee---cC---cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          308 IR--KQPTGPEFKDKNGGNLVDWVL---DS---TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       308 tg--~~p~~~~~~~~~~~~~~~~v~---~~---~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ++  ..|+...    ...+..+.+.   ..   ......+...+..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       235 ~~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         235 MLCKEQPYGEL----TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HccCCCCCCcC----CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            74  4554321    1112111110   00   00011123445678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-32  Score=257.05  Aligned_cols=188  Identities=26%  Similarity=0.494  Sum_probs=148.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||+++++++..++..++||||+++++|.+++...                     .....++.|++.|++|||++   +
T Consensus        67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  143 (291)
T cd05094          67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---H  143 (291)
T ss_pred             CCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            89999999999999999999999999999999632                     23577899999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++||||||+||+++.++.++++|||+++....... .......++..|++||        .++||||||+++|||++ |+
T Consensus       144 i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  223 (291)
T cd05094         144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK  223 (291)
T ss_pred             eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999976543221 1122345678899998        47999999999999999 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .|+...    ...+..+.+...... ......+..+.+++.+||+.+|++|||+.+|+++|+++.+.
T Consensus       224 ~p~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         224 QPWFQL----SNTEVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCCCC----CHHHHHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            886432    222222222222221 11233456788999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.98  E-value=2.3e-32  Score=254.80  Aligned_cols=188  Identities=23%  Similarity=0.384  Sum_probs=144.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.. ...++++||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        69 ~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~  144 (279)
T cd05111          69 AYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKS  144 (279)
T ss_pred             CCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcC
Confidence            799999998864 5578999999999999999642      24577999999999999998   8999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+|++|||+++....... .......++..|++||        .++||||||+++||+++ |+.|+...    .....
T Consensus       145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~  220 (279)
T cd05111         145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM----RPHEV  220 (279)
T ss_pred             CCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC----CHHHH
Confidence            99999999999987643321 2223345677899988        46899999999999998 88886432    11111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+.+..... ...+..+...+.+++.+||..||++|||+.|+++.|+.+....
T Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         221 PDLLEKGER-LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHHHCCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            111111111 1112233456788999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=1.6e-32  Score=256.83  Aligned_cols=181  Identities=22%  Similarity=0.293  Sum_probs=140.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++.+++.+++..++||||+++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++
T Consensus        60 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~  136 (285)
T cd05631          60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLD  136 (285)
T ss_pred             CcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEEC
Confidence            68999999999999999999999999999887532       24567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++|+|||+++......  ......|+..|+|||        .++|||||||++|||++|+.|+...........+.
T Consensus       137 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~  214 (285)
T cd05631         137 DRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD  214 (285)
T ss_pred             CCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence            99999999999998754322  223356899999998        57899999999999999999975321110001111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ..+...  ...++......+.+++.+||+.||++||+     ++++++
T Consensus       215 ~~~~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         215 RRVKED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHhhcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            111111  11223345567889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-33  Score=265.31  Aligned_cols=195  Identities=17%  Similarity=0.263  Sum_probs=155.4

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC-EEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE-KKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~-~~~lv~e  202 (383)
                      .|.-.+.||.|.||.||                                         +|||++.+++.+.+ .+++|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            34455789999999999                                         79999999999988 9999999


Q ss_pred             eccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+ -+|++.++.+.      ....|+.||.+||+|+|.+   ++.|||+||+|||+..+..+||+|||+||......  
T Consensus        91 ~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp--  164 (538)
T KOG0661|consen   91 FMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP--  164 (538)
T ss_pred             hhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC--
Confidence            995 59999998653      4578999999999999999   99999999999999999999999999999876533  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee------------------
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV------------------  329 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v------------------  329 (383)
                      ..|....|.+|+|||         .+.|+||+|||++|+.+-+.-|.    +.++.+...++                  
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP----G~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP----GASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC----CCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            345678899999999         67899999999999999887643    22222222111                  


Q ss_pred             ------ecCccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ------LDSTIL----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ------~~~~~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                            .-+...    ...-.....+..+++.+|++.||++|||++|.++
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                  000000    0111225567899999999999999999999987

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=2.5e-32  Score=252.17  Aligned_cols=185  Identities=26%  Similarity=0.411  Sum_probs=144.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++..++..+++|||+++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~  138 (263)
T cd05052          62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVG  138 (263)
T ss_pred             CChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEc
Confidence            79999999999999999999999999999998642       23567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.+|++|||+++..............++..|++||        .++|||||||++|||++ |..|+...    +..+.
T Consensus       139 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~----~~~~~  214 (263)
T cd05052         139 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQV  214 (263)
T ss_pred             CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHH
Confidence            9999999999999876543222222223456799988        47899999999999998 88885421    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      .+.+. .......+...+..+.+++.+||+.+|++|||+.++.++|+.+
T Consensus       215 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         215 YELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11111 1112222344556889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=2.3e-32  Score=251.82  Aligned_cols=185  Identities=26%  Similarity=0.442  Sum_probs=144.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+++..+++|||+++|+|.++++..       .....++.|++.|++|||+.   +++|||+||+||+++
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~  137 (261)
T cd05072          61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVS  137 (261)
T ss_pred             CCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEec
Confidence            79999999999999999999999999999998642       23567889999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++..............++..|++||        .++|||||||++|||++ |+.|+...    .....
T Consensus       138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~----~~~~~  213 (261)
T cd05072         138 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM----SNSDV  213 (261)
T ss_pred             CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC----CHHHH
Confidence            9999999999999876543222222334567899988        46899999999999998 88886432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..++... .........+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus       214 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         214 MSALQRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            2222111 11111223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.98  E-value=2.5e-32  Score=255.72  Aligned_cols=188  Identities=26%  Similarity=0.503  Sum_probs=147.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------------------hhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------------------AKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------------~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      +||+++++++..++..++||||+++|+|.+++...                  .....++.|++.||+|||+.   +++|
T Consensus        67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H  143 (288)
T cd05093          67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVH  143 (288)
T ss_pred             CCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            79999999999999999999999999999998632                  23567899999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      |||||+||+++.++.++++|||+++....... .......++..|+|||        .++|||||||+++||++ |..|+
T Consensus       144 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~  223 (288)
T cd05093         144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW  223 (288)
T ss_pred             cccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986533221 1112234567899988        47999999999999998 88886


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ...    ...+..+.+...... ..+...+..+.+++.+||+.||++|||+.++.+.|+++.+.
T Consensus       224 ~~~----~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         224 YQL----SNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCC----CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            432    122222222222211 11223456789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=3.8e-32  Score=251.17  Aligned_cols=185  Identities=28%  Similarity=0.450  Sum_probs=145.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+++..+++|||+++|+|.+++...      .....++.|++.|++|||+.   +++|+|+||+||+++.
T Consensus        65 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~  141 (266)
T cd05033          65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNS  141 (266)
T ss_pred             CCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            79999999999999999999999999999998642      34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.++++|||+++....... .......++..|++||        .++||||||+++||+++ |..|+...    ...+.
T Consensus       142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~----~~~~~  217 (266)
T cd05033         142 NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM----SNQDV  217 (266)
T ss_pred             CCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC----CHHHH
Confidence            99999999999987642211 1112233456799988        47899999999999998 88886322    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      .+.+.+... ...+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus       218 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         218 IKAVEDGYR-LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222222111 112234556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.98  E-value=2.8e-32  Score=266.81  Aligned_cols=188  Identities=26%  Similarity=0.416  Sum_probs=145.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------------------------------------------
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------------------------------------------  217 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------  217 (383)
                      ||||+++++|.+.+..++|||||++|+|.+++....                                            
T Consensus       101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (400)
T cd05105         101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM  180 (400)
T ss_pred             CCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence            799999999999999999999999999999886321                                            


Q ss_pred             ---------------------------------------------------------hhhHHHHhHHHHHHHHhhcCCCC
Q 046461          218 ---------------------------------------------------------KHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       218 ---------------------------------------------------------~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                                                                               ....++.|++.||+|||+.   +
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  257 (400)
T cd05105         181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---N  257 (400)
T ss_pred             ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                                                                     1245889999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++||||||+||+++.++.+|++|||+++........ ......++..|+|||        .++|||||||++|||++ |.
T Consensus       258 ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~  337 (400)
T cd05105         258 CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG  337 (400)
T ss_pred             eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence            999999999999999999999999999865432221 122234677899998        57999999999999997 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .|+.....+   ......+.. ......+......+.+++.+||+.||++|||+.+|.++|+++.+
T Consensus       338 ~P~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         338 TPYPGMIVD---STFYNKIKS-GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CCCcccchh---HHHHHHHhc-CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            886432211   111111111 11111223445678999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=2.4e-32  Score=254.14  Aligned_cols=184  Identities=27%  Similarity=0.487  Sum_probs=142.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +||+++++++.++...++||||+++|+|.+++...               .....++.|++.|++|||+.   +++|+||
T Consensus        69 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dl  145 (277)
T cd05062          69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDL  145 (277)
T ss_pred             CCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCc
Confidence            79999999999999999999999999999998642               13466889999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+||+++.++.++++|||+++......... .....++..|+|||        .++|||||||++|||++ |..|+...
T Consensus       146 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             chheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999987654322111 11234567899998        46899999999999999 67775322


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                          ......+.+...... ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       226 ----~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         226 ----SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             ----CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                222222222222221 1233445678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.98  E-value=2.7e-32  Score=259.02  Aligned_cols=188  Identities=22%  Similarity=0.380  Sum_probs=144.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||++++|+|... ..++++||+++|+|.++++..      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        69 ~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~  144 (316)
T cd05108          69 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKT  144 (316)
T ss_pred             CCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecC
Confidence            7999999999764 578999999999999999753      23567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+||+|||+++......... .....++..|++||        .++|||||||++||+++ |+.|+...    ...++
T Consensus       145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~----~~~~~  220 (316)
T cd05108         145 PQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEI  220 (316)
T ss_pred             CCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----CHHHH
Confidence            9999999999998765432211 12233466799988        47899999999999998 88886432    11122


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+.+... .....+..+...+.+++.+||+.+|++|||+.+++..+.++..+.
T Consensus       221 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         221 SSILEKG-ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHHHhCC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            2211111 111112334567889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=3.7e-32  Score=251.16  Aligned_cols=188  Identities=22%  Similarity=0.317  Sum_probs=147.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +|++++++++.+.+..++++||+++|+|.+++...         .....++.|++.||+|||+.   +++|+||||+||+
T Consensus        62 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil  138 (267)
T cd08228          62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVF  138 (267)
T ss_pred             cceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEE
Confidence            79999999999999999999999999999988521         23467899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++.++++|||+++....... ......++..|++||        .++|+||||+++|||++|+.|+.....  +..+
T Consensus       139 ~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~  215 (267)
T cd08228         139 ITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFS  215 (267)
T ss_pred             EcCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHH
Confidence            99999999999999887643221 122345788899998        468999999999999999999743211  1112


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ..+.+................+.+++.+||..+|++|||+.+|++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         216 LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            222222112222222344567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.98  E-value=1.6e-32  Score=262.27  Aligned_cols=183  Identities=20%  Similarity=0.263  Sum_probs=141.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        65 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~  141 (332)
T cd05614          65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE  141 (332)
T ss_pred             CCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC
Confidence            68999999999999999999999999999998642     34567889999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.+||+|||+++..............||..|+|||         .++|||||||++|||++|+.|+...........+..
T Consensus       142 ~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  221 (332)
T cd05614         142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR  221 (332)
T ss_pred             CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH
Confidence            99999999999865443333333467999999998         368999999999999999999753211111111111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+...  ....+......+.+++.+|++.||++||     +++++++
T Consensus       222 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         222 RILKC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHhcC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111  1122233456788999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2e-32  Score=266.18  Aligned_cols=177  Identities=23%  Similarity=0.318  Sum_probs=153.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ||++++++++.+..++|+|.||+++|.|++++...     .+..+++.||..|+.|+|+.   +|+|||+||+|+|+|.+
T Consensus        72 pnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~  148 (786)
T KOG0588|consen   72 PNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVK  148 (786)
T ss_pred             CCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcc
Confidence            89999999999999999999999999999999743     45788999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +++||+|||+|.....+.  .....+|+++|.+||         .++||||+||||+.|+||+.||+    +.+-..+..
T Consensus       149 ~nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----DdNir~LLl  222 (786)
T KOG0588|consen  149 NNIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLL  222 (786)
T ss_pred             cCEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----CccHHHHHH
Confidence            999999999998754432  334479999999999         68999999999999999999965    445556666


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +|..+.+  ..+...+.++.+|+.+++..||+.|.|++||++
T Consensus       223 KV~~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  223 KVQRGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHHcCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            6666554  223556678899999999999999999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.98  E-value=2.1e-32  Score=260.67  Aligned_cols=178  Identities=20%  Similarity=0.307  Sum_probs=141.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++.+++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        55 p~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~  131 (323)
T cd05571          55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKD  131 (323)
T ss_pred             CCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCC
Confidence            79999999999999999999999999999998642     34567889999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......||+.|+|||        .++||||+||++|||++|+.|+...    +.....+.
T Consensus       132 ~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~----~~~~~~~~  206 (323)
T cd05571         132 GHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFEL  206 (323)
T ss_pred             CCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC----CHHHHHHH
Confidence            999999999987542221 1223356899999998        4799999999999999999997432    22222222


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.....  ..+......+.+++.+|++.||++||     ++.++++
T Consensus       207 ~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         207 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            222211  12334556788999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.98  E-value=5.9e-32  Score=258.46  Aligned_cols=201  Identities=24%  Similarity=0.399  Sum_probs=153.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            467777888888888887                                        6999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      +++|+|.+++...     .....++.|++.||.|||+..  +++||||||+||+++.++.+||+|||+++.....   ..
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~  159 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  159 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---cc
Confidence            9999999999743     235678999999999999752  5999999999999999999999999998765432   12


Q ss_pred             cccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC----------CC-Ccc--------------
Q 046461          279 TDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK----------NG-GNL--------------  325 (383)
Q Consensus       279 ~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~----------~~-~~~--------------  325 (383)
                      ....|+..|+|||        .++|||||||++|||++|+.|+.......          +. ...              
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            2356899999998        57899999999999999999975321000          00 000              


Q ss_pred             -----------------ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 -----------------VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 -----------------~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                       ..++...............++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                             00000000000001123457889999999999999999999987

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.98  E-value=4.7e-33  Score=248.42  Aligned_cols=197  Identities=21%  Similarity=0.267  Sum_probs=152.1

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      .|..-.++|+|+||+||                                         +|+|.|+.+|......+||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            35556789999999999                                         6999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      |+..-|.+.=+..     .....+..|++.|+.|+|++   +++||||||+|||++.++.+|++|||+|+.+.. .....
T Consensus        83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y  158 (396)
T KOG0593|consen   83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY  158 (396)
T ss_pred             cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence            9874444433321     23577999999999999999   999999999999999999999999999998874 23445


Q ss_pred             cccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--------------------
Q 046461          279 TDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--------------------  329 (383)
Q Consensus       279 ~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--------------------  329 (383)
                      +....|.+|.|||         ...||||.||++.||++|..-|...    .+.+..-.+                    
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            6678899999998         6789999999999999999875432    222211111                    


Q ss_pred             ----ecCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ----LDSTILNAY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ----~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                          .-|......     .+....-+++++..|+..||++|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                001110000     1122345789999999999999999998874

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.98  E-value=5.4e-32  Score=259.45  Aligned_cols=188  Identities=29%  Similarity=0.448  Sum_probs=142.9

Q ss_pred             cccceeeeEEEe-CCEEEEEEEeccCCCHHHHHhcc--------------------------------------------
Q 046461          182 KNIVQLLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ--------------------------------------------  216 (383)
Q Consensus       182 ~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------  216 (383)
                      +||++++++|.. +...++++||+++|+|.+++...                                            
T Consensus        71 ~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (337)
T cd05054          71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIED  150 (337)
T ss_pred             cchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccC
Confidence            799999998875 45688999999999999998531                                            


Q ss_pred             ----------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          217 ----------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       217 ----------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                                            .....++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~  227 (337)
T cd05054         151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP  227 (337)
T ss_pred             cchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc
Confidence                                  12356889999999999998   99999999999999999999999999998764332


Q ss_pred             Ccc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          275 SHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       275 ~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      ... .....++..|+|||        .++|||||||++|||++ |..|+.....   ...+...+ ........+.....
T Consensus       228 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~  303 (337)
T cd05054         228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---DEEFCRRL-KEGTRMRAPEYATP  303 (337)
T ss_pred             chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---cHHHHHHH-hccCCCCCCccCCH
Confidence            221 22234567899998        57899999999999998 8888643111   11111111 11111112234456


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.6e-32  Score=247.82  Aligned_cols=185  Identities=27%  Similarity=0.422  Sum_probs=144.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++...+..+++|||+++++|.+++...       .....++.+++.|+.|||+.   +++|+||||+||+++
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~  137 (261)
T cd05068          61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVG  137 (261)
T ss_pred             CCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEc
Confidence            79999999999999999999999999999998643       24578899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++...............+..|++||        .++||||||++++||++ |+.|+...    .....
T Consensus       138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~  213 (261)
T cd05068         138 ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM----TNAEV  213 (261)
T ss_pred             CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC----CHHHH
Confidence            9999999999999876532222222222345799988        47999999999999999 88886432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...+. .......+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         214 LQQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            22211 1111122334556889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=5e-32  Score=271.35  Aligned_cols=196  Identities=23%  Similarity=0.351  Sum_probs=157.1

Q ss_pred             ccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          166 FYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      |...+.||+|+||.||                                        ||||++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            6677889999999888                                        699999999999999999999999


Q ss_pred             CCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-
Q 046461          206 KGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-  275 (383)
Q Consensus       206 ~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-  275 (383)
                      +|+|.++++..         .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988532         23466889999999999998   999999999999999999999999999987644321 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      .......||+.|+|||        .++|||||||++|||++|+.|+...    +..++.+.+...... ..+......+.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~----~~~~~~~~~~~~~~~-~~~~~~s~~~~  300 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP----SQREIMQQVLYGKYD-PFPCPVSSGMK  300 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC-CCCccCCHHHH
Confidence            1233456999999998        4689999999999999999996432    222333333222221 12233456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++||++.++++
T Consensus       301 ~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        301 ALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHhccChhhCcCHHHHHh
Confidence            9999999999999999999874

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=237.29  Aligned_cols=190  Identities=24%  Similarity=0.312  Sum_probs=155.9

Q ss_pred             cccceeeeEEEeC-----CEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPVG-----EKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      ||++++++++..+     .+.|+++.|...|+|.+.+..         +.+.+.++.++++||++||+. .++..|||+|
T Consensus        78 ~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiK  156 (302)
T KOG2345|consen   78 PNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIK  156 (302)
T ss_pred             cchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCC
Confidence            7999999988653     458999999999999999974         235688999999999999987 4579999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCC--------CccccccccccccccCC-----------CCCcchhHHHHHHHHHh
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCE--------SHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~--------~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Ellt  308 (383)
                      |.|||+.+.+.+++.|||-+......-        .+.......|..|.|||           +++|||||||++|+|+.
T Consensus       157 P~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf  236 (302)
T KOG2345|consen  157 PANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF  236 (302)
T ss_pred             cceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence            999999999999999999987653211        11122345788999998           68999999999999999


Q ss_pred             CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          309 RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       309 g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      |..||+..+.  .+.++.-.+..+.+..+.....++.+.+++..|++.||.+||++.+++..++.+
T Consensus       237 ~~sPfe~~~~--~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  237 GESPFERIYQ--QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             cCCcchHHhh--cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            9999988776  555665556665654444445778899999999999999999999999998765

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=268.95  Aligned_cols=193  Identities=22%  Similarity=0.381  Sum_probs=161.6

Q ss_pred             HhhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      .-++|.-..+||+|.||+|+                                           |.+++++.++...+.++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            34678888999999999998                                           78999999999999999


Q ss_pred             EEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          199 IVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      +||||+.||++..+.+.    ......+|..++.||+|||++   +||+||||.+|||+|.+|.+||+|||+++......
T Consensus       446 fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            99999999997666652    345677999999999999999   99999999999999999999999999999765333


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      . .....+||+.|||||        .+.|+|||||+||||+.|..||    .+.++.++.+.++....  .++...+.+.
T Consensus       523 ~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF----~gddEee~FdsI~~d~~--~yP~~ls~ea  595 (694)
T KOG0694|consen  523 D-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF----PGDDEEEVFDSIVNDEV--RYPRFLSKEA  595 (694)
T ss_pred             C-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC----CCCCHHHHHHHHhcCCC--CCCCcccHHH
Confidence            3 444589999999998        5789999999999999999995    44455555555443222  3456677788


Q ss_pred             HHHHHHccccCCCCCCCH
Q 046461          347 LQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~  364 (383)
                      ..|+.+.+..+|++|--+
T Consensus       596 ~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhccCcccccCC
Confidence            899999999999999765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=1.8e-32  Score=261.37  Aligned_cols=201  Identities=20%  Similarity=0.274  Sum_probs=157.6

Q ss_pred             HhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ..++|....+||+|+||.||                                          ++||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            44688999999999999999                                          799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC-
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~-  273 (383)
                      ||||+|||++..+|...     .....++.+++.|++-+|..   +++||||||+|+|||..|++||+|||++.-+... 
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            99999999999999753     34567888999999999999   9999999999999999999999999998543110 


Q ss_pred             ---------------------C-C----cc-------------------ccccccccccccCC--------CCCcchhHH
Q 046461          274 ---------------------E-S----HT-------------------STDVAGTIGYILLA--------CGGDIYSFS  300 (383)
Q Consensus       274 ---------------------~-~----~~-------------------~~~~~gt~~y~ape--------~~~Dv~SfG  300 (383)
                                           . .    ..                   .....||+-|||||        ..+|+||+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                 0 0    00                   01246999999999        568999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 046461          301 VVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT---MLRVQ  368 (383)
Q Consensus       301 vil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~  368 (383)
                      ||+|||+.|-+||..+-.......++.|...  +..+...+...+..+++.+|+. ||+.|--   +.||.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET--LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            9999999999997654333233334444321  2222223445788899999888 9999965   55554

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=5.4e-32  Score=255.51  Aligned_cols=187  Identities=25%  Similarity=0.401  Sum_probs=143.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||+++++++.+++..++|+||+++|+|.++++..                     .....++.|++.|++|||+.   +
T Consensus        68 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---g  144 (303)
T cd05088          68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---Q  144 (303)
T ss_pred             CCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            79999999999999999999999999999999632                     23567899999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQ  311 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~  311 (383)
                      ++||||||+||+++.++.+||+|||+++......  ......++..|++||        .++|||||||+++||+| |..
T Consensus       145 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  222 (303)
T cd05088         145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT  222 (303)
T ss_pred             ccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCC
Confidence            9999999999999999999999999986432111  111122356788887        57999999999999998 888


Q ss_pred             CCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          312 PTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       312 p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      |+...    +..+..+.+... .....+......+.+++.+||+.+|++||++.++++.|+++..++
T Consensus       223 p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         223 PYCGM----TCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             CcccC----ChHHHHHHHhcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            86422    222222222111 111122234567889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=3.9e-32  Score=261.99  Aligned_cols=182  Identities=26%  Similarity=0.412  Sum_probs=140.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHh-cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVK  260 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~k  260 (383)
                      +||+++++++.+++..++||||+++|+|.+... .......++.|++.||+|||+.   +++|||||++|||++.++.+|
T Consensus       132 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  208 (353)
T PLN00034        132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK  208 (353)
T ss_pred             CCcceeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence            699999999999999999999999999987543 2344567999999999999998   999999999999999999999


Q ss_pred             EccccCccccCCCCCccccccccccccccCCC-------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          261 VSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~gt~~y~ape~-------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      |+|||+++....... ......|+..|++||.             ++|||||||++|||++|+.||...-.. +......
T Consensus       209 L~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~  286 (353)
T PLN00034        209 IADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMC  286 (353)
T ss_pred             Ecccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHH
Confidence            999999987643221 1233568999999992             689999999999999999997521110 1011111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+... ...........++.+++.+||+.||++|||+.|+++
T Consensus       287 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        287 AICMS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100 111122344567899999999999999999999987

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=7.3e-32  Score=253.74  Aligned_cols=187  Identities=26%  Similarity=0.394  Sum_probs=143.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      +|||+++++++.+.+..++++||+++|+|.+++...                     .....++.|++.|++|||+.   
T Consensus        62 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---  138 (297)
T cd05089          62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---  138 (297)
T ss_pred             CCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            379999999999999999999999999999999642                     13467899999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      +++||||||+||+++.++.+||+|||++......  ........+..|++||        .++|||||||++|||++ |.
T Consensus       139 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~  216 (297)
T cd05089         139 QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG  216 (297)
T ss_pred             CcccCcCCcceEEECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999998643211  1111122345688887        57999999999999997 98


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .|+...    ...+..+.+.. ......+......+.+++.+||+.+|++|||++++++.|+.+..+
T Consensus       217 ~pf~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         217 TPYCGM----TCAELYEKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             CCCCCC----CHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            886432    22222222211 111112233456788999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=6.7e-32  Score=248.47  Aligned_cols=183  Identities=28%  Similarity=0.424  Sum_probs=142.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |||+++++++.+.+..+++|||+++|+|.+++...      .....++.|++.|++|||+.   +++|+||||+||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~  135 (256)
T cd05113          59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDD  135 (256)
T ss_pred             CCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcC
Confidence            89999999999999999999999999999998642      24578999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.+|++|||.++..............++..|++||        .++||||||+++|||++ |+.|+...    ...+..
T Consensus       136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~----~~~~~~  211 (256)
T cd05113         136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF----NNSETV  211 (256)
T ss_pred             CCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC----CHHHHH
Confidence            999999999998865433222222234566788887        56999999999999998 88886421    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ..+..... ...+......+.+++.+||+.+|++|||+.++++.|+
T Consensus       212 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         212 EKVSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            22222111 1112234568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=5.7e-32  Score=249.02  Aligned_cols=184  Identities=31%  Similarity=0.502  Sum_probs=145.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+.+..++||||+++|+|.+++...       .....++.+++.|++|||+.   +++|+|+||+||+++
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~  138 (261)
T cd05148          62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVG  138 (261)
T ss_pred             cchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEc
Confidence            79999999999999999999999999999999742       23577899999999999998   899999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.+|++|||.+......... .....++..|++||        .++||||||++++||++ |+.|+...    ...+.
T Consensus       139 ~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~----~~~~~  213 (261)
T cd05148         139 EDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM----NNHEV  213 (261)
T ss_pred             CCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC----CHHHH
Confidence            9999999999999776432211 22334567788887        47899999999999998 78886432    22223


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...+... .....+...+..+.+++.+||+.||++|||+.++.+.|+.+
T Consensus       214 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         214 YDQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHHhC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            3322221 11222344566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-32  Score=251.83  Aligned_cols=205  Identities=24%  Similarity=0.372  Sum_probs=158.3

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      +.|.-..+||.|..++||                                        |||++++..|..++++|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            345566788888888888                                        8999999999999999999999


Q ss_pred             ccCCCHHHHHhc-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          204 MVKGSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       204 ~~~gsL~~~l~~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |.+|++.+.++.       +.-...|..++++||.|||++   +.||||+|+.|||++.+|.+||+|||.+..+......
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            999999999974       233566889999999999999   9999999999999999999999999997665433222


Q ss_pred             cc---cccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--------cc
Q 046461          277 TS---TDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--------IL  335 (383)
Q Consensus       277 ~~---~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--------~~  335 (383)
                      ..   ....||+.|||||          .|+||||||++..|+.+|..||...    ......-.-+...        ..
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~----pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY----PPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC----ChHHHHHHHhcCCCCCcccccCC
Confidence            11   4468999999999          5899999999999999999997532    1111111101111        11


Q ss_pred             ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          336 NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       336 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                      .+........+.+++..|+..||++|||++++++  .+++.+
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            1111223446888999999999999999999986  444443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=3.8e-32  Score=259.58  Aligned_cols=193  Identities=21%  Similarity=0.314  Sum_probs=154.9

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            456677889999999888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---  171 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence            999999999999753     23456889999999999998   9999999999999999999999999999866432   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       .....|++.|+|||        .++|||||||++|||++|+.|+...    ......+.+.....  ..+......+.+
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~~~  244 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----TPFRIYEKILAGRL--KFPNWFDGRARD  244 (329)
T ss_pred             -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCc--CCCCCCCHHHHH
Confidence             12357899999998        5799999999999999999996432    22222232322222  112234457789


Q ss_pred             HHHHccccCCCCCCC-----HHHHHH
Q 046461          349 IVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ++.+||+.||++||+     ++++++
T Consensus       245 li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        245 LVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999999997     677764

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.1e-31  Score=248.15  Aligned_cols=185  Identities=27%  Similarity=0.450  Sum_probs=144.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++.+++.+.+..++||||+++++|.+++...      .....++.|++.|++|||+.   +++|+|+||+||+++.
T Consensus        66 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~  142 (268)
T cd05063          66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNS  142 (268)
T ss_pred             CCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcC
Confidence            79999999999999999999999999999998642      24577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCcccc--ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTST--DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~--~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||+++...........  ....+..|++||        .++|||||||++||+++ |+.|+...    ...+
T Consensus       143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~----~~~~  218 (268)
T cd05063         143 NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM----SNHE  218 (268)
T ss_pred             CCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC----CHHH
Confidence            999999999998866433221111  122345789988        46899999999999997 99996432    2222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ....+... .......+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus       219 ~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         219 VMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22222221 11122234556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=6.8e-32  Score=256.45  Aligned_cols=178  Identities=25%  Similarity=0.378  Sum_probs=140.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        55 hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~  131 (316)
T cd05592          55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDK  131 (316)
T ss_pred             CCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECC
Confidence            489999999999999999999999999999998643     34567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +..++..
T Consensus       132 ~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~----~~~~~~~  206 (316)
T cd05592         132 DGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----DEDELFD  206 (316)
T ss_pred             CCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC----CHHHHHH
Confidence            9999999999997643322 2233457899999998        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML-RVQ  368 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-~v~  368 (383)
                      .+...  ....+......+.+++.+||+.||++||++. ++.
T Consensus       207 ~i~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         207 SILND--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22111  1112233455678899999999999999975 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-32  Score=257.90  Aligned_cols=179  Identities=21%  Similarity=0.304  Sum_probs=140.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        52 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~  128 (312)
T cd05585          52 CPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDY  128 (312)
T ss_pred             CCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECC
Confidence            589999999999999999999999999999998643     34567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++|+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +.....+
T Consensus       129 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~----~~~~~~~  203 (312)
T cd05585         129 QGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE----NVNEMYR  203 (312)
T ss_pred             CCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC----CHHHHHH
Confidence            9999999999988643322 2223457899999998        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT---MLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~~  369 (383)
                      .+.....  ..+......+.+++.+||+.||++||+   +.|+++
T Consensus       204 ~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         204 KILQEPL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHcCCC--CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            2222211  123344567889999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=8.3e-32  Score=250.12  Aligned_cols=184  Identities=29%  Similarity=0.513  Sum_probs=145.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +||+++++++..+...++||||+++|+|.+++...               .....++.|++.|+.|||+.   +++||||
T Consensus        69 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di  145 (277)
T cd05032          69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDL  145 (277)
T ss_pred             CceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccccccc
Confidence            79999999999999999999999999999998632               23567889999999999988   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+||+++.++.+|++|||+++....... .......++..|++||        .++|||||||++||+++ |+.|+.. 
T Consensus       146 ~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-  224 (277)
T cd05032         146 AARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-  224 (277)
T ss_pred             ChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-
Confidence            99999999999999999999876543321 1122234677899988        56899999999999998 8888532 


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                         .+..+..+.+.+... ...+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       225 ---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         225 ---LSNEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ---CCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence               222333333332221 12233446788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=3.3e-32  Score=264.15  Aligned_cols=201  Identities=20%  Similarity=0.245  Sum_probs=159.3

Q ss_pred             HhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ..++|...+.||+|+||.||                                          +||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            45678888999999999998                                          699999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||||+++|+|.+++...    .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999998753    23566789999999999998   999999999999999999999999999987644332


Q ss_pred             ccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCC--hh
Q 046461          276 HTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS--KP  341 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~--~~  341 (383)
                      .......||+.|+|||            .++|||||||++|||++|+.||...    +.......+.+.......+  ..
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~  273 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMDHKNSLTFPDDIE  273 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC----CHHHHHHHHHcCCCcCCCCCcCC
Confidence            2233457999999998            3689999999999999999997432    2222222222211111111  13


Q ss_pred             HHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 046461          342 SMLKMLQIVVGCIFDNPTT--RPTMLRVQE  369 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~--RPs~~~v~~  369 (383)
                      .+..+.+++.+|++.+|++  |||+.|+++
T Consensus       274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         274 ISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            4567889999999999987  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=9.3e-32  Score=251.98  Aligned_cols=189  Identities=25%  Similarity=0.432  Sum_probs=146.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----------------------------hhhhHHHHhHHHHHH
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----------------------------AKHCIIACGTARGIT  231 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------------------~~~~~i~~~ia~gL~  231 (383)
                      ++||++++++|..++..++++||+++|+|.+++...                             .....++.|++.|++
T Consensus        62 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~  141 (290)
T cd05045          62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ  141 (290)
T ss_pred             CCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHH
Confidence            489999999999999999999999999999998631                             123678999999999


Q ss_pred             HHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHH
Q 046461          232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVV  302 (383)
Q Consensus       232 ~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvi  302 (383)
                      |||+.   +++||||||+||+++.++.+||+|||+++........ ......++..|++||        .++||||||++
T Consensus       142 ~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~  218 (290)
T cd05045         142 YLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL  218 (290)
T ss_pred             HHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHH
Confidence            99988   9999999999999999999999999999865332221 112234567799988        46899999999


Q ss_pred             HHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          303 LLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       303 l~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++||++ |+.|+...    ....+.+.+.. ......+......+.+++.+||+.+|++||++.++++.|+++..+
T Consensus       219 l~el~t~g~~p~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         219 LWEIVTLGGNPYPGI----APERLFNLLKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHHHhcCCCCCCCC----CHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            999998 88886432    22222222211 111122334456788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.1e-32  Score=259.04  Aligned_cols=178  Identities=20%  Similarity=0.256  Sum_probs=141.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||.|||+.   +++||||||+||+++.+
T Consensus        61 ~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~  137 (333)
T cd05600          61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDAS  137 (333)
T ss_pred             CCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC
Confidence            79999999999999999999999999999999642     34567889999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++....    ......|++.|+|||        .++|||||||++|||++|+.|+...    +..+....
T Consensus       138 ~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~  209 (333)
T cd05600         138 GHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS----TPNETWEN  209 (333)
T ss_pred             CCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC----CHHHHHHH
Confidence            9999999999976543    223457899999998        5799999999999999999997532    11111111


Q ss_pred             eec--Cccccc-C---ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          329 VLD--STILNA-Y---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       329 v~~--~~~~~~-~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      +..  ..+... .   .......+.+++.+|+..+|++||++.++++.
T Consensus       210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            100  001000 0   11335678899999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=248.51  Aligned_cols=212  Identities=26%  Similarity=0.396  Sum_probs=162.7

Q ss_pred             ccccCeeecCCccccc------------------------------------cccceeeeEEEeC----CEEEEEEEecc
Q 046461          166 FYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVG----EKKLIVYEYMV  205 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~----~~~~lv~e~~~  205 (383)
                      ..-.+.||+|+||.|+                                    +||..+++.=..+    .++|||++|.+
T Consensus       213 I~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             eEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            4456789999999998                                    6898887764432    26899999999


Q ss_pred             CCCHHHHHhcc----hhhhHHHHhHHHHHHHHhh-----cCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-
Q 046461          206 KGSLNDWLRNQ----AKHCIIACGTARGITFLHH-----RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-  275 (383)
Q Consensus       206 ~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~-----~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-  275 (383)
                      +|||+|||...    ...++++..+|.||+|||.     +.+|.|.|||||+.|||+..++.+.|+|+|+|-....... 
T Consensus       293 ~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~  372 (513)
T KOG2052|consen  293 HGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDT  372 (513)
T ss_pred             CCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCc
Confidence            99999999853    3468899999999999994     4588999999999999999999999999999976654321 


Q ss_pred             --ccccccccccccccCC--------------CCCcchhHHHHHHHHHhC----------CCCCCCCCCCCC-CCcccee
Q 046461          276 --HTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIR----------KQPTGPEFKDKN-GGNLVDW  328 (383)
Q Consensus       276 --~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg----------~~p~~~~~~~~~-~~~~~~~  328 (383)
                        .......||..|||||              ..+||||||.|+||++.+          +.||++..+... ..++.+-
T Consensus       373 idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkV  452 (513)
T KOG2052|consen  373 IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKV  452 (513)
T ss_pred             ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcc
Confidence              1223467999999999              358999999999999853          345543322211 1222222


Q ss_pred             e----ecCccccc-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          329 V----LDSTILNA-YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       329 v----~~~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +    ..|.++.. ...+.+..+.++|..||..+|..|-|+-.+.+.|.++.+.
T Consensus       453 VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  453 VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            2    22333222 2457788899999999999999999999999999888743

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-33  Score=257.71  Aligned_cols=196  Identities=25%  Similarity=0.395  Sum_probs=162.0

Q ss_pred             CccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          165 KFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .|....+||+|.||.||                                        +||.+++|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            46667899999999999                                        68999999999999999999999


Q ss_pred             cCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          205 VKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       205 ~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      .+|++.+.++..     .....+..++..|+.|||++   +.+|||||+.|||+..++.+|++|||++-.++...... .
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~  169 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K  169 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence            999999999743     23455788999999999999   99999999999999999999999999998877655444 5


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...||+.|||||        .|+||||+|++.+||++|.+|+...    ..+...- .....-++.........+.+++.
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~----hPmrvlf-lIpk~~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL----HPMRVLF-LIPKSAPPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc----CcceEEE-eccCCCCCccccccCHHHHHHHH
Confidence            578999999999        6899999999999999999996432    2222221 12222222223356667899999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 046461          352 GCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~  369 (383)
                      .|+..||+.|||+.++++
T Consensus       245 ~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             HHhhcCcccCcCHHHHhh
Confidence            999999999999999986

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=1.5e-31  Score=246.97  Aligned_cols=188  Identities=22%  Similarity=0.307  Sum_probs=146.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +||+++++++.+++..+++|||+++++|.+++..         +.....++.+++.|++|||+.   +++|+||||+||+
T Consensus        62 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nil  138 (267)
T cd08229          62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVF  138 (267)
T ss_pred             CchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            7999999999999999999999999999999863         123567899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++.++++|||++........ ......++..|++||        .++|+||||+++|||++|..|+...-.  +...
T Consensus       139 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~  215 (267)
T cd08229         139 ITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYS  215 (267)
T ss_pred             EcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHH
Confidence            99999999999999876643221 122345788899988        468999999999999999999743211  1112


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ..+.+................+.+++.+||..||++||||.+|.+.++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         216 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            222222211111122345567889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-32  Score=255.45  Aligned_cols=175  Identities=21%  Similarity=0.334  Sum_probs=141.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        61 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~  137 (291)
T cd05612          61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKE  137 (291)
T ss_pred             CcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCC
Confidence            79999999999999999999999999999998643     34567899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++.....    .....|+..|+|||        .++|||||||++|||++|+.|+...    ...++.+.
T Consensus       138 ~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~----~~~~~~~~  209 (291)
T cd05612         138 GHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD----NPFGIYEK  209 (291)
T ss_pred             CCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            99999999999865432    12356899999998        5789999999999999999996432    22233333


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      +.....  ..+......+.+++.+|++.||++||+     +.|+++
T Consensus       210 i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         210 ILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            322221  122334557889999999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.5e-31  Score=247.72  Aligned_cols=184  Identities=24%  Similarity=0.379  Sum_probs=138.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      ++||+++++++.+....++||||+++|+|.++++..          .....++.|++.|++|||+.   +++|||+||+|
T Consensus        54 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~n  130 (269)
T cd05087          54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRN  130 (269)
T ss_pred             CCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcce
Confidence            489999999999999999999999999999998642          12356889999999999998   99999999999


Q ss_pred             EEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC---------------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          251 ILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       251 iLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      |+++.++.++++|||+++....... .......++..|+|||               .++|+||||+++|||++ |+.|+
T Consensus       131 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  210 (269)
T cd05087         131 CLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY  210 (269)
T ss_pred             EEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999875433221 1122345677899988               26899999999999996 99897


Q ss_pred             CCCCCCCCCCccceeeec---Ccccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          314 GPEFKDKNGGNLVDWVLD---STILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~---~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ....    ..+.......   ..... .........+.+++..|| .+|++|||+.||+..|+
T Consensus       211 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         211 RHLS----DEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCC----hHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            4321    1111111111   11111 111223456778999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=245.45  Aligned_cols=182  Identities=23%  Similarity=0.293  Sum_probs=143.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++|+||+++++|.+++...     .....++.+++.|++|||+.   +++|+||+|+||+++.+
T Consensus        64 ~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~  140 (263)
T cd06625          64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSA  140 (263)
T ss_pred             CCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            79999999999999999999999999999998743     34577899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccc--cccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          257 FEVKVSDFGLVRLISDCESHTS--TDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~--~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      +.++|+|||+++..........  ....++..|++||        .++||||+|+++||+++|+.|+...    +.....
T Consensus       141 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~  216 (263)
T cd06625         141 GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAI  216 (263)
T ss_pred             CCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHH
Confidence            9999999999876543221111  2345778899998        5789999999999999999996432    121111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .+..........+......+.+++.+||..+|++|||+.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11111111222234455678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=3.3e-31  Score=247.23  Aligned_cols=190  Identities=26%  Similarity=0.437  Sum_probs=144.0

Q ss_pred             ccccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      |+||+++++++...  ...+++|||+++|+|.+++..    +.....++.|++.|++|||+.   +++||||||+||+++
T Consensus        65 h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~  141 (283)
T cd05080          65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLD  141 (283)
T ss_pred             CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEc
Confidence            38999999998763  468899999999999999874    345678999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++........  ......++..|++||        .++||||||++++||++|..|+......  ..+
T Consensus       142 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~  219 (283)
T cd05080         142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEE  219 (283)
T ss_pred             CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhh
Confidence            9999999999999876432211  112233556788887        5789999999999999999996432110  000


Q ss_pred             ccee------------eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDW------------VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~------------v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ....            ..+.......+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         220 MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000            01111111123344578999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.1e-31  Score=256.28  Aligned_cols=179  Identities=20%  Similarity=0.320  Sum_probs=142.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++.+++...+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.
T Consensus        54 hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~  130 (328)
T cd05593          54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDK  130 (328)
T ss_pred             CCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECC
Confidence            389999999999999999999999999999988643     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.||...    +..+..+
T Consensus       131 ~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~----~~~~~~~  205 (328)
T cd05593         131 DGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFE  205 (328)
T ss_pred             CCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC----CHHHHHH
Confidence            9999999999987543221 2223457899999998        5789999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+.....  ..+......+.+++.+|++.||++||     ++.|+++
T Consensus       206 ~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         206 LILMEDI--KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HhccCCc--cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            2221111  12334456788999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=266.04  Aligned_cols=193  Identities=23%  Similarity=0.373  Sum_probs=155.8

Q ss_pred             CeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEeccCCCHH
Q 046461          170 NVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLN  210 (383)
Q Consensus       170 ~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~  210 (383)
                      -++|+|.||+||                                       +|||+++|+|.+++..-+.||.+|||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999                                       69999999999999999999999999999


Q ss_pred             HHHhc-c-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCceEEccccCccccCCCCCcccccc
Q 046461          211 DWLRN-Q-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       211 ~~l~~-~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      +.|+. |       ...-.+..||.+||.|||.+   .|||||||-+|+|++ -.|.+||+|||.++.+..-+. .....
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence            99983 2       23455789999999999999   999999999999997 478999999999987754332 33447


Q ss_pred             ccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          282 AGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       282 ~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      .||..|||||          .++|||||||++.||.||++||......  ...+.+--+- ..-++.+++...+...+++
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmy-KvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMY-KVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcce-ecCCCCcHHHHHHHHHHHH
Confidence            8999999998          5789999999999999999997543211  0111100000 0112336677888999999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 046461          352 GCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~  369 (383)
                      +|..+||.+||++.++++
T Consensus       814 rcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHcCCCcccCccHHHhcc
Confidence            999999999999999986

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=9.2e-32  Score=256.32  Aligned_cols=178  Identities=21%  Similarity=0.323  Sum_probs=141.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++...+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        55 p~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  131 (323)
T cd05595          55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD  131 (323)
T ss_pred             CCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCC
Confidence            79999999999999999999999999999988643     34577899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +.....+.
T Consensus       132 ~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~  206 (323)
T cd05595         132 GHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFEL  206 (323)
T ss_pred             CCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            999999999987532221 1223356899999999        4689999999999999999996432    22222222


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.....  ..+......+.+++.+||+.||++||     ++.++++
T Consensus       207 ~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         207 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HhcCCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            222111  12334456788999999999999998     7888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=9.2e-32  Score=256.24  Aligned_cols=173  Identities=25%  Similarity=0.378  Sum_probs=138.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ++|+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+|||++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~  137 (323)
T cd05616          61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSE  137 (323)
T ss_pred             CeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCC
Confidence            57888999999999999999999999999998643     34677899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......||+.|+|||        .++|||||||++|||++|+.|+...    +..++.+.
T Consensus       138 ~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~  212 (323)
T cd05616         138 GHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE----DEDELFQS  212 (323)
T ss_pred             CcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            999999999987543221 1223457899999998        5789999999999999999996432    23333333


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      +.....  .++.....++.+++.+|++.||++|++.
T Consensus       213 i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            333222  2233455678899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=1.6e-31  Score=249.31  Aligned_cols=184  Identities=27%  Similarity=0.446  Sum_probs=143.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----------------------chhhhHHHHhHHHHHHHHhhcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----------------------QAKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----------------------~~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      +||+++++++..++..++||||+++|+|.+++..                      +.....++.|++.||+|||+.   
T Consensus        67 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  143 (283)
T cd05090          67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---  143 (283)
T ss_pred             CCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---
Confidence            7999999999999999999999999999999842                      122466899999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-C
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-R  309 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g  309 (383)
                      +++|||+||+||+++.++.+|++|||+++....... .......++..|++||        .++||||||+++|||++ |
T Consensus       144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g  223 (283)
T cd05090         144 FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG  223 (283)
T ss_pred             CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCC
Confidence            999999999999999999999999999986543221 1122234567799988        47899999999999998 8


Q ss_pred             CCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       310 ~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..|+...    ...++.+.+..... ...+......+.+++.+||+.||++||++.+|.++|..
T Consensus       224 ~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         224 LQPYYGF----SNQEVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCCC----CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            8886321    12222222222221 12233455678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.2e-31  Score=246.48  Aligned_cols=186  Identities=24%  Similarity=0.462  Sum_probs=143.1

Q ss_pred             ccccceeeeEEEeCCE------EEEEEEeccCCCHHHHHhcc-----------hhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          181 FKNIVQLLGYCPVGEK------KLIVYEYMVKGSLNDWLRNQ-----------AKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~------~~lv~e~~~~gsL~~~l~~~-----------~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      ++|++++++++...+.      .++++||+++|+|.+++...           .....++.|++.||+|||+.   +++|
T Consensus        60 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H  136 (273)
T cd05035          60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIH  136 (273)
T ss_pred             CCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            3799999999876554      79999999999999998532           23467899999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      ||+||+||++++++.+|++|||+++......... .....++..|++||        .++|||||||++|||++ |..|+
T Consensus       137 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~  216 (273)
T cd05035         137 RDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY  216 (273)
T ss_pred             cccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998664332211 11123456788887        57999999999999999 77775


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..    ....+..+++...... ..+...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       217 ~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         217 PG----VENHEIYDYLRHGNRL-KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC----CCHHHHHHHHHcCCCC-CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            32    2223333333332221 22345567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1e-31  Score=251.89  Aligned_cols=186  Identities=28%  Similarity=0.473  Sum_probs=144.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||+++++++..++..+++|||+++|+|.+++...                     .....++.|++.|++|||+.   +
T Consensus        76 ~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~  152 (293)
T cd05053          76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---K  152 (293)
T ss_pred             CCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            79999999999999999999999999999998631                     12467899999999999988   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++||||||+||+++.++.+|++|||+++......... .....++..|++||        .++|||||||++||+++ |.
T Consensus       153 ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence            9999999999999999999999999998764432111 12223456799998        46899999999999998 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .|+...    ...+..+.+... .....+......+.+++.+||..||++|||+.|+++.|+.+.
T Consensus       233 ~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         233 SPYPGI----PVEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCC----CHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            885321    111222221111 111223344567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-32  Score=259.67  Aligned_cols=188  Identities=21%  Similarity=0.385  Sum_probs=156.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchh------hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ||||+|+|.|.+ ...|+|||.++-|.|..+|...+.      ...++.|++.||+|||+.   +++||||..+|||+.+
T Consensus       451 phIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsS  526 (974)
T KOG4257|consen  451 PHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSS  526 (974)
T ss_pred             cchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecC
Confidence            799999999975 568999999999999999986543      356789999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      .-.+|++|||++|.+........+...-...||+||        .++|||-|||.+||++. |.+||...    ...+..
T Consensus       527 p~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv----kNsDVI  602 (974)
T KOG4257|consen  527 PQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV----KNSDVI  602 (974)
T ss_pred             cceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc----cccceE
Confidence            999999999999998876655555455567899998        68999999999999986 99996432    333444


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      -.+-.+. ..+.++.+++.+..++.+||+.+|.+||++.++...|+.+..++
T Consensus       603 ~~iEnGe-RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  603 GHIENGE-RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             EEecCCC-CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            3333333 23456788889999999999999999999999999998876643

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=2.1e-31  Score=251.42  Aligned_cols=186  Identities=26%  Similarity=0.443  Sum_probs=144.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++...+..+++|||+++|+|.++++..       .+...++.+++.|++|||+.   +++|+|+||+||+++
T Consensus        99 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~  175 (302)
T cd05055          99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLT  175 (302)
T ss_pred             CCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEc
Confidence            79999999999999999999999999999998642       34577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++........ ......++..|++||        .++|||||||++|||++ |..|+.....   ...
T Consensus       176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~~  252 (302)
T cd05055         176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DSK  252 (302)
T ss_pred             CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hHH
Confidence            9999999999999865433211 111234567899998        46899999999999998 8888643211   111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..+. .+.......+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       253 ~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         253 FYKL-IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHH-HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1111 111111112223456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.3e-32  Score=259.40  Aligned_cols=197  Identities=24%  Similarity=0.358  Sum_probs=167.6

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCE-EEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEK-KLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~-~~lv~e  202 (383)
                      +|...+.+|+|+||.++                                         ||||.+.+.+..++. .++||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            45556889999999887                                         899999999999888 999999


Q ss_pred             eccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          203 YMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||+||++.+.+...+       +.+.++.|++.|+.|||+.   .|+|||||++||++..+..+|++|||+|+.+.....
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999997543       4678999999999999988   999999999999999999999999999999876442


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                       ....+.||+.||.||        .|+||||+||++|||++-+++|    ...+...++..+....+ .+.+.....++.
T Consensus       162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF----~a~~m~~Li~ki~~~~~-~Plp~~ys~el~  235 (426)
T KOG0589|consen  162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF----KASNMSELILKINRGLY-SPLPSMYSSELR  235 (426)
T ss_pred             -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc----CccchHHHHHHHhhccC-CCCCccccHHHH
Confidence             334478999999998        7999999999999999999995    44455566666655443 333556677889


Q ss_pred             HHHHHccccCCCCCCCHHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .++..|+..+|+.||++.+++.+
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=1.8e-31  Score=249.45  Aligned_cols=185  Identities=22%  Similarity=0.218  Sum_probs=138.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++..++..++||||++++.+..+...     ......++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        60 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~  136 (287)
T cd07848          60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHN  136 (287)
T ss_pred             ccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC
Confidence            7999999999999999999999998877665432     224577899999999999988   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc--
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV--  326 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~--  326 (383)
                      +.+||+|||+++..............|+..|+|||        .++|||||||++|||++|+.|+...........+.  
T Consensus       137 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~  216 (287)
T cd07848         137 DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV  216 (287)
T ss_pred             CcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999876543333333456899999998        57899999999999999999975321100000000  


Q ss_pred             ---------e-eeecCcc-----c---c------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 ---------D-WVLDSTI-----L---N------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ---------~-~v~~~~~-----~---~------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                               . +..++..     .   .      ......+..+.+++.+|++.||++|||++|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         217 LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                     0 0000000     0   0      001123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=8.5e-32  Score=256.23  Aligned_cols=174  Identities=24%  Similarity=0.363  Sum_probs=139.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~  131 (320)
T cd05590          55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDH  131 (320)
T ss_pred             CCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECC
Confidence            489999999999999999999999999999988642     34567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||+.|+|||        .++|||||||++|||++|+.||...    +..++.+
T Consensus       132 ~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~~  206 (320)
T cd05590         132 EGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE----NEDDLFE  206 (320)
T ss_pred             CCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC----CHHHHHH
Confidence            9999999999987543221 2223457899999998        4789999999999999999996432    2223333


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      .+.....  ..+......+.+++.+|++.||++||++
T Consensus       207 ~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         207 AILNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            3332222  1123345578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=8e-32  Score=258.52  Aligned_cols=193  Identities=20%  Similarity=0.314  Sum_probs=155.8

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            356777889999999888                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....  
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            9999999999999743     24567899999999999998   9999999999999999999999999999865431  


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                        .....||+.|+|||        .++|||||||++|||++|+.|+...    +.....+.+.....  ..+......+.
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~~  256 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN----EPLLIYQKILEGII--YFPKFLDNNCK  256 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC----CHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence              22357899999998        4789999999999999999997432    22222222322221  12233445678


Q ss_pred             HHHHHccccCCCCCC-----CHHHHHH
Q 046461          348 QIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +++.+|++.||++|+     +++++++
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999999995     8888875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.7e-32  Score=241.61  Aligned_cols=180  Identities=22%  Similarity=0.355  Sum_probs=151.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ||+|+++.+++.++...++|+|.|+.|.|.|+|.+     +++..+|+.|+.+|++|||.+   .|+||||||+|||+|+
T Consensus        82 HP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   82 HPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             CCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            38999999999999999999999999999999974     456788999999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      +.++||+|||++..+..+.  .....+||++|.|||              ...|.||+|||+|-++.|..||...    .
T Consensus       159 n~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----k  232 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----K  232 (411)
T ss_pred             ccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----H
Confidence            9999999999998876543  334579999999998              3579999999999999999997421    1


Q ss_pred             CCccceeeecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 GGNLVDWVLDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 ~~~~~~~v~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..-+...+..+.+  ..+.+.+.+..+.+++.+|++.||++|.|++|+++
T Consensus       233 QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1222233344433  23335567778999999999999999999999986

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=2.3e-31  Score=254.64  Aligned_cols=201  Identities=25%  Similarity=0.405  Sum_probs=151.4

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||++++++|.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            567777888888888887                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      +++|+|.+++...     .....++.+++.|+.|||+..  +++||||||+||+++.++.+|++|||+++.....   ..
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~  159 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  159 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---cc
Confidence            9999999999743     234678899999999999742  6999999999999999999999999998765332   12


Q ss_pred             cccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC--------CCccc----------------
Q 046461          279 TDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN--------GGNLV----------------  326 (383)
Q Consensus       279 ~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~--------~~~~~----------------  326 (383)
                      ....|+..|+|||        .++|||||||++|||++|+.|+........        .....                
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            2346889999998        468999999999999999999753211000        00000                


Q ss_pred             ----------------eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 ----------------DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ----------------~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                      .++...............++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                            0000000000000112356789999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.1e-31  Score=250.46  Aligned_cols=185  Identities=23%  Similarity=0.412  Sum_probs=145.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      ++||+++++++.+.+..++++||+++++|.+++...                     .....++.|++.||+|+|+.   
T Consensus        67 h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---  143 (283)
T cd05091          67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---  143 (283)
T ss_pred             CCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---
Confidence            489999999999999999999999999999998521                     12467889999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-C
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-R  309 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g  309 (383)
                      +++||||||+||+++.++.+|++|||+++........ ......+++.|++||        .++||||||+++|||++ |
T Consensus       144 gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g  223 (283)
T cd05091         144 HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG  223 (283)
T ss_pred             CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999998865432211 112234567899998        47899999999999998 7


Q ss_pred             CCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       310 ~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..|+...    ...++.+.+.+.... ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       224 ~~p~~~~----~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         224 LQPYCGY----SNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCCCCCC----CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            7775321    223334443333321 2234566678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-31  Score=246.60  Aligned_cols=185  Identities=25%  Similarity=0.406  Sum_probs=142.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      ++||++++++|...+..++||||+++|+|.+++...                     .....++.|++.|++|||+.   
T Consensus        55 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---  131 (270)
T cd05047          55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---  131 (270)
T ss_pred             CCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            689999999999999999999999999999998632                     23467899999999999988   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      +++||||||+||+++.++.+|++|||+++.....  ........+..|++||        .++||||||++++||++ |.
T Consensus       132 ~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~  209 (270)
T cd05047         132 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG  209 (270)
T ss_pred             CEeecccccceEEEcCCCeEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999998632211  1111122356788888        47899999999999997 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .|+...    +..+..+.+... .....+......+.+++.+||..+|.+|||+.++++.|+++.
T Consensus       210 ~pf~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         210 TPYCGM----TCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCcccc----CHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            886432    222222222111 111122334457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.8e-31  Score=245.45  Aligned_cols=183  Identities=28%  Similarity=0.427  Sum_probs=142.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++...+..++||||+++++|.+++...      .....++.|++.|++|||+.   +++|||+||+||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~  135 (256)
T cd05059          59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGE  135 (256)
T ss_pred             CCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECC
Confidence            79999999999999999999999999999998642      24577899999999999998   8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.+|++|||+++..............++..|++||        .++||||||+++||+++ |+.|++..    ...+..
T Consensus       136 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~  211 (256)
T cd05059         136 DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF----SNSEVV  211 (256)
T ss_pred             CCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC----CHHHHH
Confidence            999999999998865432222222223445799988        47999999999999999 78886432    112222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ..+.. ......+...+..+.+++.+||..+|++|||+.|+++.|.
T Consensus       212 ~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         212 ESVSA-GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HHHHc-CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            22111 1111223345668999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.4e-31  Score=244.96  Aligned_cols=189  Identities=29%  Similarity=0.515  Sum_probs=142.6

Q ss_pred             ccccceeeeEEEe-CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|+++++++|.. ++..++++||+++|+|.+++...      .....++.|++.|++|||+.   +++||||||+||++
T Consensus        55 h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili  131 (262)
T cd05058          55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCML  131 (262)
T ss_pred             CCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEE
Confidence            5899999998764 55688999999999999998642      23467889999999999988   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCC---ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCES---HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +.++.+|++|||+++.......   .......++..|+|||        .++||||||+++|||++|..|+.   ...+.
T Consensus       132 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~---~~~~~  208 (262)
T cd05058         132 DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVDS  208 (262)
T ss_pred             cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC---CCCCH
Confidence            9999999999999876543221   1112234567899988        47899999999999999655532   22222


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+....+...... ..+...+..+.+++.+||..+|++||++.|+++.|+++..
T Consensus       209 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         209 FDITVYLLQGRRL-LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            2333322222111 1122334578899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=2.5e-31  Score=250.84  Aligned_cols=188  Identities=26%  Similarity=0.427  Sum_probs=146.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||+++++++...+..+++|||+++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus        81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---g  157 (304)
T cd05101          81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---K  157 (304)
T ss_pred             CCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            79999999999999999999999999999999642                     12456889999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++||||||+||+++.++.+|++|||+++......... .....++..|+|||        .++||||||+++||+++ |.
T Consensus       158 ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999998764332221 22234567899998        46999999999999998 67


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .|+..    ....++.+.+.... ....+...+..+.+++.+||..+|++|||+.|+++.|+++...
T Consensus       238 ~p~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         238 SPYPG----IPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CCccc----CCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            77532    12222222221111 1112334556788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=4.7e-31  Score=243.43  Aligned_cols=188  Identities=21%  Similarity=0.299  Sum_probs=146.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +|++++++++.+.+..++||||+++|+|.+++...         .....++.+++.|+.|||+.   +++|+|+||+||+
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil  138 (267)
T cd08224          62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVF  138 (267)
T ss_pred             CCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEE
Confidence            69999999999999999999999999999998531         23577899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++.++++|||+++....... ......++..|++||        .++|||||||++|||++|+.|+.....  +..+
T Consensus       139 ~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~  215 (267)
T cd08224         139 ITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYS  215 (267)
T ss_pred             ECCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHH
Confidence            99999999999999876543221 122345788899998        368999999999999999999643211  1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ..+.+................+.+++.+||..+|++|||+.+|+++|+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         216 LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            112111111111111244567889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.6e-31  Score=247.19  Aligned_cols=184  Identities=28%  Similarity=0.520  Sum_probs=145.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------------------hhhhHHHHhHHHHHHHHhhcCCCCee
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCIIACGTARGITFLHHRFQPHII  242 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~i~~~ia~gL~~LH~~~~~~iv  242 (383)
                      +|++++++++..++..++||||+++|+|.+++...                   .....++.|++.|++|||+.   +++
T Consensus        68 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~  144 (280)
T cd05049          68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFV  144 (280)
T ss_pred             CCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Cee
Confidence            79999999999999999999999999999999642                   12466899999999999998   999


Q ss_pred             ecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCC
Q 046461          243 HRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQP  312 (383)
Q Consensus       243 Hrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p  312 (383)
                      ||||||+||+++.++.++++|||+++....... .......++..|+|||        .++|||||||++|||++ |+.|
T Consensus       145 h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p  224 (280)
T cd05049         145 HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             ccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999876533221 1122334567899998        56999999999999998 9999


Q ss_pred             CCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          313 TGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       313 ~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      +...    +..+..+.+..... ...+...+..+.+++.+||+.||++|||+.||++.|++
T Consensus       225 ~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         225 WYGL----SNEEVIECITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CCCC----CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            6422    22233333332222 12233455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1e-31  Score=260.67  Aligned_cols=205  Identities=19%  Similarity=0.256  Sum_probs=158.0

Q ss_pred             HHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCE
Q 046461          159 IVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       159 l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      +....++|...+.||+|+||.||                                          |||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            33445678888999999999998                                          799999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      .++||||+++|+|.+++...    .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999999999999743    34567889999999999998   999999999999999999999999999987644


Q ss_pred             CCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC--
Q 046461          273 CESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--  338 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~--  338 (383)
                      ..........||+.|+|||            .++||||+||++|||++|+.||...    +.......+.+.......  
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~p~  270 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD----SLVGTYSKIMDHKNSLNFPE  270 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCcccCCCC
Confidence            3322233467999999998            3699999999999999999997432    222222222221111111  


Q ss_pred             ChhHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 046461          339 SKPSMLKMLQIVVGCIFDNPT--TRPTMLRVQEF  370 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~--~RPs~~~v~~~  370 (383)
                      .......+.+++..|+..+|.  .|||+.|+++.
T Consensus       271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            122345677788888875554  38899998873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.8e-31  Score=254.28  Aligned_cols=179  Identities=24%  Similarity=0.359  Sum_probs=141.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        59 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~  135 (323)
T cd05584          59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDA  135 (323)
T ss_pred             CCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC
Confidence            489999999999999999999999999999998643     23466889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +.....+
T Consensus       136 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~----~~~~~~~  210 (323)
T cd05584         136 QGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE----NRKKTID  210 (323)
T ss_pred             CCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC----CHHHHHH
Confidence            9999999999987543222 1223356899999999        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+.....  ..+......+.+++.+||+.||++||     ++.++++
T Consensus       211 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         211 KILKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             HHHcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            2222221  12233456788999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=1.7e-31  Score=247.32  Aligned_cols=184  Identities=26%  Similarity=0.384  Sum_probs=137.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch----------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA----------KHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      ++||++++++|.+.+..++||||+++|+|.+++....          ....++.|++.|++|||+.   +++||||||+|
T Consensus        54 h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~N  130 (269)
T cd05042          54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRN  130 (269)
T ss_pred             CCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhh
Confidence            5899999999999999999999999999999996421          2367899999999999998   99999999999


Q ss_pred             EEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC---------------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          251 ILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       251 iLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      |+++.++.+|++|||+++....... .......++..|++||               .++|||||||++|||++ |..|+
T Consensus       131 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  210 (269)
T cd05042         131 CQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY  210 (269)
T ss_pred             eEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999875432211 1112234566788887               26899999999999999 66675


Q ss_pred             CCCCCCCCCCccceeeec---Ccccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          314 GPEFKDKNGGNLVDWVLD---STILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~---~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ...    ...+.......   ..+.. .........+.+++..|| .||++|||+++|++.|.
T Consensus       211 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         211 PDL----SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CcC----CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            321    11111111111   11111 112234456677888899 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1.8e-31  Score=261.14  Aligned_cols=187  Identities=24%  Similarity=0.342  Sum_probs=143.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------------------------------------------
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------------------------------------------  217 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------  217 (383)
                      +|||+++++|...+..++|+||+++|+|.++++...                                            
T Consensus       101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (401)
T cd05107         101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD  180 (401)
T ss_pred             CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence            699999999999999999999999999999996321                                            


Q ss_pred             -----------------------------------------------------------hhhHHHHhHHHHHHHHhhcCC
Q 046461          218 -----------------------------------------------------------KHCIIACGTARGITFLHHRFQ  238 (383)
Q Consensus       218 -----------------------------------------------------------~~~~i~~~ia~gL~~LH~~~~  238 (383)
                                                                                 +...++.|++.||+|||+.  
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--  258 (401)
T cd05107         181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--  258 (401)
T ss_pred             cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence                                                                       1245778999999999988  


Q ss_pred             CCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-
Q 046461          239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-  308 (383)
Q Consensus       239 ~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-  308 (383)
                       +++|||+||+||+++.++.+|++|||+++....... .......++..|++||        .++|||||||++|||++ 
T Consensus       259 -~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~  337 (401)
T cd05107         259 -NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL  337 (401)
T ss_pred             -CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence             999999999999999999999999999986533221 1122235677899988        56899999999999998 


Q ss_pred             CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          309 RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       309 g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      |..|+...    ...+..............+......+.+++.+||..+|++||++.||++.|+++.
T Consensus       338 g~~P~~~~----~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         338 GGTPYPEL----PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCCCC----CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            78885421    1111111111111111223344568899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.3e-31  Score=254.99  Aligned_cols=179  Identities=22%  Similarity=0.323  Sum_probs=142.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||.|||+.   +++||||||+||+++.
T Consensus        55 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~  131 (321)
T cd05591          55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDA  131 (321)
T ss_pred             CCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC
Confidence            489999999999999999999999999999988643     34567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +..+..+
T Consensus       132 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~----~~~~~~~  206 (321)
T cd05591         132 EGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD----NEDDLFE  206 (321)
T ss_pred             CCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC----CHHHHHH
Confidence            9999999999987543222 2223456899999998        5789999999999999999996432    2233333


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-------TMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-------s~~~v~~  369 (383)
                      .+.....  ..+......+.+++.+|++.||++||       ++.++++
T Consensus       207 ~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         207 SILHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            3322221  11223445788999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=3.5e-31  Score=243.64  Aligned_cols=185  Identities=23%  Similarity=0.369  Sum_probs=143.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++. .+..++||||+++|+|.+++...     .....++.|++.|++|||..   +++|||+||+||+++.
T Consensus        55 h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~  130 (257)
T cd05116          55 NPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVT  130 (257)
T ss_pred             CCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcC
Confidence            589999999885 45678999999999999999643     34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCcc--ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+|++|||+++.........  .....++..|++||        .++|+|||||++|||++ |+.|+...    ...+
T Consensus       131 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~  206 (257)
T cd05116         131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM----KGNE  206 (257)
T ss_pred             CCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHH
Confidence            9999999999998764432211  12223457899998        47999999999999998 88886432    2222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +.+.+.... ....+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       207 ~~~~i~~~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         207 VTQMIESGE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHHCCC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            333222211 1222334566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=2e-31  Score=254.02  Aligned_cols=179  Identities=20%  Similarity=0.358  Sum_probs=140.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |+||+++++++.+++..++||||+++|+|..+++.    +.....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        61 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~  137 (324)
T cd05589          61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTE  137 (324)
T ss_pred             CCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCC
Confidence            48999999999999999999999999999998864    235677999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +..+..+.
T Consensus       138 ~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~----~~~~~~~~  212 (324)
T cd05589         138 GFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD----DEEEVFDS  212 (324)
T ss_pred             CcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            999999999987543221 1223457899999998        4789999999999999999996432    22222222


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.....  ..+......+.+++.+|++.||++||     ++.++++
T Consensus       213 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         213 IVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            222211  12233456788999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=2.2e-31  Score=249.24  Aligned_cols=186  Identities=27%  Similarity=0.486  Sum_probs=144.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +||+++++++.+++..++||||+++|+|.++++..               .....++.|++.||+|||+.   +++|||+
T Consensus        69 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~di  145 (288)
T cd05061          69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDL  145 (288)
T ss_pred             CCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCC
Confidence            79999999999999999999999999999999642               12456889999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+||+++.++.++++|||+++........ ......++..|++||        .++|||||||++|||++ |..|+.. 
T Consensus       146 kp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-  224 (288)
T cd05061         146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-  224 (288)
T ss_pred             ChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-
Confidence            999999999999999999998865432211 111223466799988        46899999999999998 6777532 


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                         ....+..+.+.+.... ..+......+.+++.+|++.||++|||+.++++.|++..
T Consensus       225 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         225 ---LSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ---CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence               1222333333322221 112334568899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=2e-31  Score=254.59  Aligned_cols=183  Identities=21%  Similarity=0.350  Sum_probs=140.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~  131 (329)
T cd05618          55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDS  131 (329)
T ss_pred             CCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECC
Confidence            389999999999999999999999999999988643     24567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC-CCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN-GGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~-~~~~~  326 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+........ .....
T Consensus       132 ~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  210 (329)
T cd05618         132 EGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  210 (329)
T ss_pred             CCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence            9999999999987542221 1223457899999998        479999999999999999999753211100 01111


Q ss_pred             ee----eecCcccccCChhHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 046461          327 DW----VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT------MLRVQE  369 (383)
Q Consensus       327 ~~----v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs------~~~v~~  369 (383)
                      .+    +.....  ..+......+.+++.+|++.||++||+      +.++++
T Consensus       211 ~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         211 DYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            11    111111  123345567889999999999999998      466653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=3.2e-31  Score=247.17  Aligned_cols=184  Identities=28%  Similarity=0.467  Sum_probs=142.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------------------hhhhHHHHhHHHHHHHHhhcCCCCe
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------------------AKHCIIACGTARGITFLHHRFQPHI  241 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------~~~~~i~~~ia~gL~~LH~~~~~~i  241 (383)
                      +||+++++++.+++..++++||+++|+|.+++...                    .....++.|++.|++|||+.   ++
T Consensus        67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i  143 (280)
T cd05092          67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HF  143 (280)
T ss_pred             CCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            79999999999999999999999999999998642                    23467889999999999988   99


Q ss_pred             eecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCC
Q 046461          242 IHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQ  311 (383)
Q Consensus       242 vHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~  311 (383)
                      +||||||+||+++.++.++++|||+++........ ......++..|++||        .++|||||||++|||++ |+.
T Consensus       144 ~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  223 (280)
T cd05092         144 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ  223 (280)
T ss_pred             ecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999998765432211 111233467899988        56899999999999998 888


Q ss_pred             CCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          312 PTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       312 p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      |+...    ...+..+.+..... ...+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus       224 p~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         224 PWYQL----SNTEAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             CCccC----CHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            85332    22222222222111 11123345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=3e-31  Score=245.74  Aligned_cols=186  Identities=24%  Similarity=0.435  Sum_probs=139.6

Q ss_pred             ccccceeeeEEEeC------CEEEEEEEeccCCCHHHHHhc-----------chhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          181 FKNIVQLLGYCPVG------EKKLIVYEYMVKGSLNDWLRN-----------QAKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       181 ~~niv~l~g~~~~~------~~~~lv~e~~~~gsL~~~l~~-----------~~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      ++||++++++|...      ...++++||+++|+|.+++..           +.....++.|++.||+|||+.   +++|
T Consensus        59 h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H  135 (272)
T cd05075          59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIH  135 (272)
T ss_pred             CCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence            37999999988542      246899999999999998742           123467889999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      ||+||+||+++.++.++++|||+++........ ......++..|++||        .++||||||+++|||++ |+.|+
T Consensus       136 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         136 RDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             cccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999999876432211 111223556788876        57999999999999999 77775


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...    ....+.+.+...... ..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       216 ~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         216 PGV----ENSEIYDYLRQGNRL-KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            321    222222222222111 11234456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=1.9e-31  Score=253.37  Aligned_cols=178  Identities=23%  Similarity=0.361  Sum_probs=140.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~  131 (316)
T cd05620          55 NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDR  131 (316)
T ss_pred             CCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC
Confidence            379999999999999999999999999999998643     24567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++|+|||+++...... .......||..|+|||        .++||||+||++|||++|+.|+...    +...+.+
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~----~~~~~~~  206 (316)
T cd05620         132 DGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD----DEDELFE  206 (316)
T ss_pred             CCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHH
Confidence            9999999999987532211 2233467899999998        4799999999999999999997432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML-RVQ  368 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-~v~  368 (383)
                      .+....  ...+.....++.+++.+|++.||++||++. ++.
T Consensus       207 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         207 SIRVDT--PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHhCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            221111  112233455788999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=4.5e-31  Score=244.31  Aligned_cols=204  Identities=23%  Similarity=0.349  Sum_probs=158.2

Q ss_pred             HHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEE
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      |++.+++++.....||+|+||.||                                       +||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            456678888888999999999988                                       79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEccccCccc
Q 046461          199 IVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRL  269 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfgla~~  269 (383)
                      +|+||+++++|.+++...        .....++.|++.|++|||+.   +++|||+||+||+++. ++.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999998742        22456788999999999998   9999999999999986 67899999999876


Q ss_pred             cCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee-cCcccccC
Q 046461          270 ISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL-DSTILNAY  338 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~-~~~~~~~~  338 (383)
                      ...... ......|+..|++||          .++||||||+++|||++|+.|+...    .......+.. ........
T Consensus       159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~  233 (268)
T cd06624         159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL----GEPQAAMFKVGMFKIHPEI  233 (268)
T ss_pred             cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc----cChhhhHhhhhhhccCCCC
Confidence            543221 122245788899988          3689999999999999999996431    1111110000 00111122


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.....++.+++.+||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            3345567889999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=2.1e-31  Score=253.03  Aligned_cols=179  Identities=23%  Similarity=0.354  Sum_probs=140.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~  131 (316)
T cd05619          55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDT  131 (316)
T ss_pred             CCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECC
Confidence            489999999999999999999999999999998642     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +..+..+
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~~~  206 (316)
T cd05619         132 DGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH----DEEELFQ  206 (316)
T ss_pred             CCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC----CHHHHHH
Confidence            9999999999987543221 1223456899999998        5789999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML-RVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~-~v~~  369 (383)
                      .+....  ...+......+.+++.+|++.||++||++. ++.+
T Consensus       207 ~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         207 SIRMDN--PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHhCC--CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            221111  112223445678999999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=3.7e-31  Score=246.41  Aligned_cols=188  Identities=22%  Similarity=0.388  Sum_probs=143.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||++++++|.. ...++++||+++|+|.++++..      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        69 ~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~  144 (279)
T cd05109          69 PYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKS  144 (279)
T ss_pred             CCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC
Confidence            799999999975 4578999999999999999742      24577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+||+|||+++........ ......++..|++||        .++|||||||++||+++ |..|+...    ....+
T Consensus       145 ~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~  220 (279)
T cd05109         145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREI  220 (279)
T ss_pred             CCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----CHHHH
Confidence            999999999999876432221 111223456799988        46899999999999998 88886432    11222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ..++..... ...+......+.+++.+||+.||++||++.++++.|+++....
T Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         221 PDLLEKGER-LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             HHHHHCCCc-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            222211111 1112345567889999999999999999999999999886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=4.3e-31  Score=244.42  Aligned_cols=186  Identities=25%  Similarity=0.420  Sum_probs=144.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|||+++++++..++..++||||+++|+|.+++...      .....++.|++.|++|||+.   +++|||+||+||+++
T Consensus        64 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~  140 (267)
T cd05066          64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVN  140 (267)
T ss_pred             CCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEEC
Confidence            389999999999999999999999999999999743      23577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccc--cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTS--TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGG  323 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~--~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~  323 (383)
                      .++.++++|||+++..........  ....++..|++||        .++|+||||++++|+++ |..|+...    ...
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~----~~~  216 (267)
T cd05066         141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM----SNQ  216 (267)
T ss_pred             CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC----CHH
Confidence            999999999999987654322111  1122346788888        46899999999999887 99996422    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +....+.+.. ....+...+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus       217 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         217 DVIKAIEEGY-RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            2222222221 1111233456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=2.1e-31  Score=253.92  Aligned_cols=173  Identities=24%  Similarity=0.391  Sum_probs=136.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ++|+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~  137 (324)
T cd05587          61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAE  137 (324)
T ss_pred             CceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCC
Confidence            35888899999999999999999999999998642     34577899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......||..|+|||        .++||||+||++|||++|+.|+...    +..+..+.
T Consensus       138 ~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~----~~~~~~~~  212 (324)
T cd05587         138 GHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE----DEDELFQS  212 (324)
T ss_pred             CCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            999999999987532211 1223456899999998        4789999999999999999997432    22223332


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      +.....  ..+......+.+++.+|+..||++||+.
T Consensus       213 i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         213 IMEHNV--SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            222211  2233455678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=2.9e-31  Score=250.85  Aligned_cols=189  Identities=27%  Similarity=0.426  Sum_probs=145.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +||++++++|...+..++||||+++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus        84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---g  160 (307)
T cd05098          84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---K  160 (307)
T ss_pred             CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            79999999999999999999999999999999642                     23467899999999999988   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      ++||||||+||+++.++.++++|||.++......... .....++..|++||        .++|||||||++|||++ |.
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999987654322111 11123456799998        46899999999999998 77


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .|+..    ....++.+.+.. ......+......+.+++.+||..+|++|||+.+|++.|+++....
T Consensus       241 ~p~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         241 SPYPG----VPVEELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             CCCCc----CCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            77532    122222221111 1111223345568889999999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=4.3e-31  Score=244.74  Aligned_cols=184  Identities=24%  Similarity=0.415  Sum_probs=136.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch---------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ||||++++++|.+....++||||+++|+|.++++...         ....++.|++.||+|||+.   +++||||||+||
T Consensus        54 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~ni  130 (268)
T cd05086          54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNC  130 (268)
T ss_pred             CcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceE
Confidence            4899999999999999999999999999999997431         2356889999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCC-CccccccccccccccCC---------------CCCcchhHHHHHHHHHhC-CCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCE-SHTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVIR-KQPTG  314 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Elltg-~~p~~  314 (383)
                      +++.++.++++|||++....... ........++..|++||               .++|||||||++|||+++ ..|+.
T Consensus       131 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         131 FLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             EEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999986432211 11122345778899987               268999999999999975 55643


Q ss_pred             CCCCCCCCCccceeeecC---cc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          315 PEFKDKNGGNLVDWVLDS---TI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v~~~---~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      . .   +..+....+...   .+ .+.........+.+++..|| .+|++||++++|++.|.
T Consensus       211 ~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         211 H-L---SDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C-C---CHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2 1   111211111111   00 11112234557788889999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=1.1e-31  Score=255.94  Aligned_cols=179  Identities=19%  Similarity=0.312  Sum_probs=140.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||+++.+++...+..++||||+++|+|.+++...     .....++.|++.||+|||+ .   +|+||||||+||+++
T Consensus        54 hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~  130 (325)
T cd05594          54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLD  130 (325)
T ss_pred             CCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEEC
Confidence            379999999999999999999999999999988642     3456789999999999997 5   899999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +.....
T Consensus       131 ~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~----~~~~~~  205 (325)
T cd05594         131 KDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLF  205 (325)
T ss_pred             CCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC----CHHHHH
Confidence            99999999999987543221 1222356899999998        5799999999999999999996432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.+.....  ..+......+.+++.+|++.||++|+     ++.++++
T Consensus       206 ~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         206 ELILMEEI--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHhcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            22221111  12233455788999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.9e-32  Score=258.50  Aligned_cols=197  Identities=22%  Similarity=0.330  Sum_probs=154.5

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|...+.||+|+||.||                                          +||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            56667788888888888                                          699999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC---
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE---  274 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~---  274 (383)
                      |+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......   
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999753     24567899999999999998   99999999999999999999999999998654332   


Q ss_pred             -------------------------CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          275 -------------------------SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       275 -------------------------~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                                               ........||..|+|||        .++|||||||++|||++|+.|+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~----  234 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT----  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC----
Confidence                                     11223356899999998        57999999999999999999975321    


Q ss_pred             CCccceeeec--CcccccCChhHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 046461          322 GGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-MLRVQE  369 (383)
Q Consensus       322 ~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-~~~v~~  369 (383)
                      .......+..  ..............+.+++.+|+. ||++||+ +.++++
T Consensus       235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            1111111111  111111112245678899999997 9999999 999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=8e-32  Score=257.29  Aligned_cols=197  Identities=19%  Similarity=0.223  Sum_probs=153.6

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|...+.||+|+||.||                                          +||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            56677888888888887                                          699999999999999999999


Q ss_pred             eccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999753      23466889999999999998   9999999999999999999999999999876543333


Q ss_pred             cccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--ccccCCh
Q 046461          277 TSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--ILNAYSK  340 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~~~~~~  340 (383)
                      ......||..|+|||              .++|||||||++|||++|+.|+...    ........+....  +.-....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~  234 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG----TSAKTYNNIMNFQRFLKFPEDP  234 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC----CHHHHHHHHHcCCCccCCCCCC
Confidence            333456899999998              3689999999999999999997432    1111111111111  1001112


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+.+++..|+. +|++|||+.++++
T Consensus       235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         235 KVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            245577888999997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=2.7e-31  Score=246.05  Aligned_cols=201  Identities=22%  Similarity=0.351  Sum_probs=152.6

Q ss_pred             HHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEeC------C
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVG------E  195 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~------~  195 (383)
                      .+++.|...+.||+|+||.||                                       +|++++++++...      +
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            356667777788888888887                                       7999999998753      4


Q ss_pred             EEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      ..+++|||+++|+|.+++...       .....++.|++.|++|||+.   +++|+|+||+||+++.++.++++|||+++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            689999999999999998742       22466889999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc
Q 046461          269 LISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL  335 (383)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~  335 (383)
                      ...... .......|+..|++||             .++|||||||++|||++|+.|+.....    .............
T Consensus       160 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~  234 (272)
T cd06637         160 QLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRALFLIPRNPAP  234 (272)
T ss_pred             eccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----HHHHHHHhcCCCC
Confidence            654322 1223456888999988             259999999999999999999743211    1111000111111


Q ss_pred             ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          336 NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       336 ~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .......+..+.+++.+||..+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1112234457889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=5.9e-31  Score=241.28  Aligned_cols=180  Identities=25%  Similarity=0.385  Sum_probs=143.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++.+++..++||||+++++|.+++...       .....++.+++.|+.|||+.   +++|+|+||+||+++
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~  135 (256)
T cd08529          59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLD  135 (256)
T ss_pred             CCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEe
Confidence            89999999999999999999999999999999753       23467899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||+++........ .....|+..|++||        .++|+||||++++||++|+.|+...    +.....
T Consensus       136 ~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~  210 (256)
T cd08529         136 AYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN----NQGALI  210 (256)
T ss_pred             CCCCEEEcccccceeccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHH
Confidence            9999999999998876543221 22346788899988        5799999999999999999997432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .++..... ...+......+.+++.+||+.+|++||++.++++.
T Consensus       211 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         211 LKIIRGVF-PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHcCCC-CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            22222221 11222445678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=3.8e-31  Score=256.10  Aligned_cols=198  Identities=22%  Similarity=0.305  Sum_probs=148.4

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            357777889999999988                                          69999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-  275 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999999643     34577899999999999998   999999999999999999999999999875432110 


Q ss_pred             ---------------------------------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          276 ---------------------------------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       276 ---------------------------------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                                                       .......||+.|+|||        .++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             0012357999999998        57899999999999999999975


Q ss_pred             CCCCCCCCCccceeeec----CcccccCChhHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 046461          315 PEFKDKNGGNLVDWVLD----STILNAYSKPSMLKMLQIVVG--CIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v~~----~~~~~~~~~~~~~~~~~l~~~--C~~~~P~~RPs~~~v~~~  370 (383)
                      ..    ...+..+.+..    ..+...  ......+.+++.+  |...++..||+++|+++.
T Consensus       238 ~~----~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SE----TPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CC----CHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            32    22222222211    111111  1223345555554  433445567999999873

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=4.3e-31  Score=246.46  Aligned_cols=183  Identities=23%  Similarity=0.359  Sum_probs=141.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++||+++.+++..++..++||||+++|+|.+++..         +.....++.|++.||+|||+.   +|+||||||+||
T Consensus        52 ~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  128 (280)
T cd05608          52 SRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENV  128 (280)
T ss_pred             CCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            48999999999999999999999999999988742         234567899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.++.++++|||+++....... ......|+..|+|||        .++|||||||++|||++|+.|+...-......
T Consensus       129 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  207 (280)
T cd05608         129 LLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK  207 (280)
T ss_pred             EECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH
Confidence            999999999999999976544322 223356899999998        47999999999999999999975321110111


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .....+.....  ..+...+..+.+++.+|++.||++||     +++++++
T Consensus       208 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         208 ELKQRILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHhhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11222222111  22334556788999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=6.9e-31  Score=241.97  Aligned_cols=185  Identities=21%  Similarity=0.397  Sum_probs=142.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||++++++|. .+..++||||+++|+|.+++...      .....++.|++.|++|||+.   +++||||||+||+++
T Consensus        54 h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~  129 (257)
T cd05115          54 NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLV  129 (257)
T ss_pred             CCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEc
Confidence            589999999885 45789999999999999998632      34578999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCcc--ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGG  323 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~  323 (383)
                      .++.+|++|||+++.........  .+...++..|++||        .++||||||+++||+++ |..|+...    ...
T Consensus       130 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~  205 (257)
T cd05115         130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM----KGP  205 (257)
T ss_pred             CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC----CHH
Confidence            99999999999998654332211  11122356799987        47899999999999996 89886432    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +....+.... ....+.....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       206 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         206 EVMSFIEQGK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            2222222211 1122344567888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=6.1e-31  Score=241.05  Aligned_cols=185  Identities=23%  Similarity=0.361  Sum_probs=141.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||++++++|...+..++||||+++++|.+++...      .....++.|++.||+|||+.   +++|+|+||+||+++
T Consensus        52 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~  128 (252)
T cd05084          52 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVT  128 (252)
T ss_pred             CCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEc
Confidence            589999999999999999999999999999998642      24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      .++.+|++|||+++......... ......+..|++||        .++||||||+++||+++ |..|+...    ....
T Consensus       129 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~----~~~~  204 (252)
T cd05084         129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL----SNQQ  204 (252)
T ss_pred             CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc----CHHH
Confidence            99999999999987654321111 11112345689998        36899999999999998 77775422    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ....+ ........+...+..+.+++.+||+.+|++|||+.++.++|++
T Consensus       205 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         205 TREAI-EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHH-HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11111 1111122233445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=3.8e-31  Score=247.59  Aligned_cols=179  Identities=24%  Similarity=0.356  Sum_probs=135.6

Q ss_pred             ccccceeeeEEEe-----CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          181 FKNIVQLLGYCPV-----GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       181 ~~niv~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      ||||++++++|..     ....++||||++ ++|.+++...       .....++.|++.||+|||+.   +++||||||
T Consensus        63 hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp  138 (290)
T cd07862          63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKP  138 (290)
T ss_pred             CCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCH
Confidence            4899999999863     456899999996 6999998632       24577999999999999998   999999999


Q ss_pred             CcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          249 SNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       249 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      +||+++.++.+|++|||+++.....  .......|+..|+|||        .++|||||||++|||++|+.|+...    
T Consensus       139 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~----  212 (290)
T cd07862         139 QNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS----  212 (290)
T ss_pred             HHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC----
Confidence            9999999999999999999865432  2223456899999998        5789999999999999999997532    


Q ss_pred             CCCccceeeec------------------Ccc----c---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 NGGNLVDWVLD------------------STI----L---NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 ~~~~~~~~v~~------------------~~~----~---~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+....+.+                  ...    .   ..........+.+++.+|++.||++|||+.|+++
T Consensus       213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         213 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11111111100                  000    0   0001123356779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=5.2e-31  Score=246.06  Aligned_cols=212  Identities=20%  Similarity=0.288  Sum_probs=161.6

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEE
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCP  192 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~  192 (383)
                      ..+.++.+..++++|.....||+|+||.||                                       +|++++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             ceEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            446677888888899999999999999888                                       69999999884


Q ss_pred             -----eCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 046461          193 -----VGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE  258 (383)
Q Consensus       193 -----~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~  258 (383)
                           .++..++||||+++|+|.+++...         .....++.|++.|+.|||+.   +++|||+||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence                 345789999999999999987532         12456889999999999998   9999999999999999999


Q ss_pred             eEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          259 VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      ++++|||+++....... ......|+..|+|||             .++|||||||++|||++|+.|+...-.   ....
T Consensus       163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~---~~~~  238 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---MRAL  238 (286)
T ss_pred             EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch---hHHH
Confidence            99999999886643221 222346889999997             268999999999999999999643211   1111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .+...........+......+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            111000000000112234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=233.38  Aligned_cols=197  Identities=21%  Similarity=0.283  Sum_probs=161.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|+-.++||+|.|+.|+                                         ||||+|.+...+....++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            345555789999999888                                         899999999999999999999


Q ss_pred             eccCCCHHHHHh-----cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCCC
Q 046461          203 YMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       203 ~~~~gsL~~~l~-----~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~~  274 (383)
                      +|.||+|..-+-     ++.....++.||+++|.|+|.+   +|+|||+||+|+++.+   ...+|++|||+|..+..  
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--  165 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--  165 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence            999999975543     3344567899999999999999   9999999999999954   35689999999998873  


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSML  344 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~  344 (383)
                      ........||++||+||        ..+|||+.||||+-++.|..||..    .+...+.+.+....+  ...+.....+
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~----~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD----EDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC----ccHHHHHHHHhccccCCCCcccCcCCH
Confidence            33445678999999998        568999999999999999999643    344556666654443  3334556677


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..+++.+|+..||.+|.|+.|.++
T Consensus       242 ~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  242 EAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHHHhccChhhhccHHHHhC
Confidence            8899999999999999999998865

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=4.8e-31  Score=246.79  Aligned_cols=185  Identities=30%  Similarity=0.551  Sum_probs=143.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------------hhhhHHHHhHHHHHHHH
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------------AKHCIIACGTARGITFL  233 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------------~~~~~i~~~ia~gL~~L  233 (383)
                      ++|+++++++|.+++..++++||+++|+|.+++...                           ...+.++.|++.||+||
T Consensus        67 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l  146 (288)
T cd05050          67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL  146 (288)
T ss_pred             CCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            379999999999999999999999999999999632                           12467999999999999


Q ss_pred             hhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHH
Q 046461          234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLL  304 (383)
Q Consensus       234 H~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~  304 (383)
                      |..   +++||||||+||+++.++.++++|||+++....... ........+..|++||        .++|||||||++|
T Consensus       147 H~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~  223 (288)
T cd05050         147 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  223 (288)
T ss_pred             HhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHH
Confidence            998   999999999999999999999999999876533221 1111223456799888        4689999999999


Q ss_pred             HHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          305 ELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       305 Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ||++ |..|+...    ...+....+.+.... ..+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       224 el~~~~~~p~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         224 EIFSYGMQPYYGM----AHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHhCCCCCCCCC----CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            9998 77775321    222333333333222 1223445688999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-31  Score=264.10  Aligned_cols=205  Identities=21%  Similarity=0.259  Sum_probs=164.1

Q ss_pred             ccccCeeecCCccccc----------------------------------------cccceeeeEE-Ee------CCEEE
Q 046461          166 FYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYC-PV------GEKKL  198 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~-~~------~~~~~  198 (383)
                      ..-.++|.+|||+.||                                        +|||.+++.. ..      .-+++
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl  118 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL  118 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence            3355889999999999                                        7999999943 21      24788


Q ss_pred             EEEEeccCCCHHHHHhc-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          199 IVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      |.||||++|.|-|++..       +.+.++|+.|+++|+++||.. +++|||||||.+||||+.++..||||||-+....
T Consensus       119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~  197 (738)
T KOG1989|consen  119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI  197 (738)
T ss_pred             eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence            99999999999999974       346799999999999999975 7899999999999999999999999999986432


Q ss_pred             CCCCcc--------ccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC
Q 046461          272 DCESHT--------STDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS  332 (383)
Q Consensus       272 ~~~~~~--------~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~  332 (383)
                      ......        .....-|+-|++||           +|+||||+||+||-|+....||+..    ...    .|+..
T Consensus       198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s----g~l----aIlng  269 (738)
T KOG1989|consen  198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES----GKL----AILNG  269 (738)
T ss_pred             CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC----cce----eEEec
Confidence            221110        11234689999999           7999999999999999999996432    111    24455


Q ss_pred             cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      .+.-+........+.+|+..|++.||++||++.+|+..+.++...+.
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            55333345778899999999999999999999999999988876654

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=7.6e-31  Score=246.83  Aligned_cols=181  Identities=25%  Similarity=0.336  Sum_probs=141.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++||||+++|+|.+++..    ..+...++.|++.|++|||+.   +++|+||||+||+++.++
T Consensus        77 ~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~  153 (296)
T cd06654          77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG  153 (296)
T ss_pred             CCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            7999999999999999999999999999999864    235678899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++|+|||+++....... ......++..|++||        .++|||||||++|||++|+.||.....   ........
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~~~~~  229 (296)
T cd06654         154 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIA  229 (296)
T ss_pred             CEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhHHHHh
Confidence            999999999876543221 122346788999988        579999999999999999999743211   11111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+......+......+.+++.+||..+|++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1111111112334456889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=2e-31  Score=254.07  Aligned_cols=178  Identities=21%  Similarity=0.288  Sum_probs=140.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        55 h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~  131 (325)
T cd05602          55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDS  131 (325)
T ss_pred             CCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC
Confidence            489999999999999999999999999999998643     23456889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++||||+||++|||++|+.|+...    +..+..+
T Consensus       132 ~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~  206 (325)
T cd05602         132 QGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----NTAEMYD  206 (325)
T ss_pred             CCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC----CHHHHHH
Confidence            9999999999987543221 1223457899999998        5799999999999999999996432    2222223


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~  368 (383)
                      .+.....  .........+.+++.+|++.||++||++.+.+
T Consensus       207 ~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         207 NILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            3222221  11234456788999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=5.9e-31  Score=245.07  Aligned_cols=188  Identities=26%  Similarity=0.460  Sum_probs=145.9

Q ss_pred             cccceeeeEEEe-CCEEEEEEEeccCCCHHHHHhcc-------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ-------------AKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      +|++++++++.. +...++++||+++|+|.+++...             .....++.+++.||+|||+.   +++|||+|
T Consensus        68 ~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~  144 (280)
T cd05043          68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIA  144 (280)
T ss_pred             CCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccC
Confidence            799999999876 57789999999999999998642             23467899999999999988   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEF  317 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~  317 (383)
                      |+||+++.++.+|++|||+++.+...... ......++..|++||        .++||||||+++||+++ |+.|+... 
T Consensus       145 p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-  223 (280)
T cd05043         145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-  223 (280)
T ss_pred             HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-
Confidence            99999999999999999999865433221 112234567799988        57999999999999999 99986432 


Q ss_pred             CCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          318 KDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                         +..++..++.+... .......+..+.+++.+||..||++|||+.++++.|+.+.++
T Consensus       224 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         224 ---DPFEMAAYLKDGYR-LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ---CHHHHHHHHHcCCC-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence               22233333222211 111223456788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=3.2e-31  Score=252.01  Aligned_cols=179  Identities=23%  Similarity=0.358  Sum_probs=141.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~  131 (318)
T cd05570          55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDS  131 (318)
T ss_pred             CCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECC
Confidence            589999999999999999999999999999988643     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +.....+
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~----~~~~~~~  206 (318)
T cd05570         132 EGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD----DEDELFQ  206 (318)
T ss_pred             CCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC----CHHHHHH
Confidence            9999999999987532221 1222356899999998        5789999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM-----LRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~-----~~v~~  369 (383)
                      .+.....  ..+......+.+++.+||..||++|||+     .++++
T Consensus       207 ~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         207 SILEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2222211  1223345678899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=4.3e-31  Score=257.38  Aligned_cols=200  Identities=20%  Similarity=0.263  Sum_probs=149.2

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .|...+.||+|+||.||                                          +||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            46677889999999998                                          699999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC--
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES--  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~--  275 (383)
                      |+++|+|.+++...     .....++.|++.||+|||..   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            99999999998643     23466788999999999998   999999999999999999999999999764311000  


Q ss_pred             --------------------------------------------ccccccccccccccCC--------CCCcchhHHHHH
Q 046461          276 --------------------------------------------HTSTDVAGTIGYILLA--------CGGDIYSFSVVL  303 (383)
Q Consensus       276 --------------------------------------------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil  303 (383)
                                                                  .......||..|+|||        .++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        0012346999999998        579999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHH--ccccCCCCCCCHHHHHH
Q 046461          304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVG--CIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       304 ~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~--C~~~~P~~RPs~~~v~~  369 (383)
                      |||++|+.||...........+..|........  ......++.+++.+  |+..+|..||++.|+++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999753211100011111111111111  11234456677765  67778888999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=7.4e-31  Score=248.92  Aligned_cols=188  Identities=27%  Similarity=0.456  Sum_probs=144.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      ++||++++++|.+.+..+++|||+++|+|.+++...                     .....++.|++.||+|||+.   
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---  153 (314)
T cd05099          77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---  153 (314)
T ss_pred             CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---
Confidence            489999999999999999999999999999999642                     12356889999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-C
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-R  309 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g  309 (383)
                      +++||||||+||+++.++.+|++|||+++......... .....++..|++||        .++||||||+++||+++ |
T Consensus       154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g  233 (314)
T cd05099         154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG  233 (314)
T ss_pred             CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence            99999999999999999999999999998664322111 11123446799988        47899999999999999 7


Q ss_pred             CCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       310 ~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..|+..    ....+..+.+..... ...+.....++.+++.+||+.+|++|||+.++++.|+++..
T Consensus       234 ~~p~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         234 GSPYPG----IPVEELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCCCC----CCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            877532    122222222222111 11223445578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=7.7e-31  Score=246.45  Aligned_cols=186  Identities=23%  Similarity=0.458  Sum_probs=140.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----------------hhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----------------AKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------------~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      ++|++++++++...+..++||||+++++|.+++...                 .....++.|++.|++|||+.   +++|
T Consensus        76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H  152 (295)
T cd05097          76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVH  152 (295)
T ss_pred             CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceec
Confidence            379999999999999999999999999999998532                 23467899999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh--CCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI--RKQP  312 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt--g~~p  312 (383)
                      +|+||+||+++.++.+|++|||+++........ ......++..|++||        .++|||||||+++||++  +..|
T Consensus       153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998765432211 112234567899988        57999999999999998  4555


Q ss_pred             CCCCCCCCCCCccceee---ec---CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          313 TGPEFKDKNGGNLVDWV---LD---STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       313 ~~~~~~~~~~~~~~~~v---~~---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      +...    ...+..+.+   .+   .......+...+..+.+++.+||+.||++||||.+|++.|++
T Consensus       233 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         233 YSLL----SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             Cccc----ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            4321    111111111   00   000011122344689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=3.7e-31  Score=256.90  Aligned_cols=208  Identities=18%  Similarity=0.234  Sum_probs=161.0

Q ss_pred             HHHHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEe
Q 046461          156 YDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       156 ~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~  193 (383)
                      ..++....++|...+.||+|+||.||                                          |||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            34555667889999999999999998                                          799999999999


Q ss_pred             CCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ++..++||||+++|+|.+++...    .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            99999999999999999998753    23566889999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--cc
Q 046461          270 ISDCESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--IL  335 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~  335 (383)
                      .............||+.|+|||            .++|||||||++|||++|+.|+...    +.....+.+....  +.
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~  267 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLT  267 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCccc
Confidence            6543333334467999999998            3689999999999999999997532    2212222222111  11


Q ss_pred             ccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 046461          336 NAYSKPSMLKMLQIVVGCIFDNPTT--RPTMLRVQEF  370 (383)
Q Consensus       336 ~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~~v~~~  370 (383)
                      .......+..+.+++..|+..++.+  ||++.|+++.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1112234567788899999844432  7899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1e-30  Score=239.19  Aligned_cols=184  Identities=24%  Similarity=0.348  Sum_probs=142.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||++++++|...+..++||||+++|+|.+++...      .....++.+++.|+.|+|..   +++|+|+||+||+++
T Consensus        51 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~  127 (250)
T cd05085          51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVG  127 (250)
T ss_pred             CCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEc
Confidence            589999999999999999999999999999998642      34577889999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||++...............++..|++||        .++||||||+++||+++ |..|+...    .....
T Consensus       128 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~----~~~~~  203 (250)
T cd05085         128 ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM----TNQQA  203 (250)
T ss_pred             CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC----CHHHH
Confidence            9999999999998764332222222233456799988        46899999999999998 88886432    11111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ...+.. ......+...+..+.+++.+||+.+|++|||+.|+.+.|.
T Consensus       204 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         204 REQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            111111 1111223345568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=6.3e-31  Score=244.71  Aligned_cols=184  Identities=26%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------------AKHCIIACGTARGITFLHHRFQPHIIHRDINAS  249 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~  249 (383)
                      +||+++++++.+.+..++||||+++|+|.+++...            .....++.|++.|++|||+.   +++||||||+
T Consensus        69 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~  145 (277)
T cd05036          69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAAR  145 (277)
T ss_pred             CCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchh
Confidence            79999999999999999999999999999998642            23467899999999999998   8999999999


Q ss_pred             cEEEcCCC---ceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          250 NILLNEDF---EVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       250 NiLl~~~~---~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+++.++   .+|++|||+++......... ......+..|++||        .++|||||||++|||++ |..|+...
T Consensus       146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99998654   59999999998763221111 11122346789988        57999999999999997 88886432


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                          ...+..+.+... .....+...+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       226 ----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         226 ----TNQEVMEFVTGG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             ----CHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                222222222111 1112233445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.2e-30  Score=245.21  Aligned_cols=185  Identities=21%  Similarity=0.441  Sum_probs=140.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +||+++++++..++..++||||+++|+|.+++...                .....++.|++.|++|||+.   +++|+|
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  155 (296)
T cd05095          79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD  155 (296)
T ss_pred             CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            79999999999999999999999999999998642                13577899999999999998   999999


Q ss_pred             CCCCcEEEcCCCceEEccccCccccCCCCCcc-ccccccccccccCC--------CCCcchhHHHHHHHHHh--CCCCCC
Q 046461          246 INASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI--RKQPTG  314 (383)
Q Consensus       246 lk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt--g~~p~~  314 (383)
                      |||+||+++.++.++++|||+++.+....... .....++..|++||        .++|||||||++|||++  |..|+.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999987653322111 11123356788886        57999999999999998  666753


Q ss_pred             CCCCCCCCCccceee---ecC---cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          315 PEFKDKNGGNLVDWV---LDS---TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v---~~~---~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..    ...+.....   ...   ......+......+.+++.+||+.||++|||+.+|.+.|++
T Consensus       236 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         236 QL----SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cc----ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            21    111111110   000   00011122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=7e-31  Score=252.31  Aligned_cols=189  Identities=27%  Similarity=0.414  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeC-CEEEEEEEeccCCCHHHHHhcc--------------------------------------------
Q 046461          182 KNIVQLLGYCPVG-EKKLIVYEYMVKGSLNDWLRNQ--------------------------------------------  216 (383)
Q Consensus       182 ~niv~l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------  216 (383)
                      +||++++++|... ...+++|||+++|+|.+++...                                            
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (343)
T cd05103          71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASS  150 (343)
T ss_pred             ccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccc
Confidence            6999999988654 5678999999999999998631                                            


Q ss_pred             ----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          217 ----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       217 ----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                                                  .....++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~  227 (343)
T cd05103         151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR  227 (343)
T ss_pred             cccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccc
Confidence                                        11245789999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccC
Q 046461          269 LISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAY  338 (383)
Q Consensus       269 ~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~  338 (383)
                      ........ ......++..|++||        .++||||||+++|||++ |..|+.....   .......+.. ......
T Consensus       228 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~  303 (343)
T cd05103         228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRLKE-GTRMRA  303 (343)
T ss_pred             ccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---cHHHHHHHhc-cCCCCC
Confidence            65332211 111233566799988        47899999999999997 8888643211   1111111111 111111


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +......+.+++..||+.+|++|||+.||++.|+.+.+.
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            222345788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=8.2e-31  Score=245.94  Aligned_cols=185  Identities=24%  Similarity=0.473  Sum_probs=141.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch----------------hhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA----------------KHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +|++++++++..++..++++||+++++|.+++....                ....++.|++.||+|||+.   +++|||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            799999999999999999999999999999986432                3467899999999999998   999999


Q ss_pred             CCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh--CCCCCC
Q 046461          246 INASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI--RKQPTG  314 (383)
Q Consensus       246 lk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt--g~~p~~  314 (383)
                      |||+||+++.++.++++|||+++....... .......++..|++||        .++|||||||++|||++  +..|+.
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999876543221 1122344577899998        57999999999999998  556643


Q ss_pred             CCCCCCCCCccceeeec------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          315 PEFKDKNGGNLVDWVLD------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v~~------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..    ...+..+....      .......+...+.++.+++.+||+.||++|||+.||++.|++
T Consensus       236 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         236 HL----TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             Cc----ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            21    11111111110      001111122344689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=6.2e-31  Score=251.27  Aligned_cols=183  Identities=21%  Similarity=0.341  Sum_probs=140.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~  131 (329)
T cd05588          55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDA  131 (329)
T ss_pred             CCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECC
Confidence            489999999999999999999999999999988532     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC-CCCc--
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK-NGGN--  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~-~~~~--  324 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|++..-... ....  
T Consensus       132 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~  210 (329)
T cd05588         132 EGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE  210 (329)
T ss_pred             CCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccch
Confidence            9999999999987532211 1223457899999998        57999999999999999999975321100 0111  


Q ss_pred             --cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 046461          325 --LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT------MLRVQE  369 (383)
Q Consensus       325 --~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs------~~~v~~  369 (383)
                        ..+.+.....  ..+......+.+++.+|++.||++||+      +.++++
T Consensus       211 ~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         211 DYLFQVILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              1111111111  123344567889999999999999997      667754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.3e-31  Score=267.15  Aligned_cols=204  Identities=23%  Similarity=0.358  Sum_probs=156.5

Q ss_pred             HHHHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC-
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE-  195 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~-  195 (383)
                      +.....++|...+.||+|+||.||                                         +|++++.+.+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            334445688889999999999998                                         46677666554322 


Q ss_pred             -------EEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          196 -------KKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       196 -------~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                             ..++||||+++|+|.++++..         .....++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence                   368999999999999998642         23467889999999999998   99999999999999999999


Q ss_pred             EEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          260 KVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      ||+|||+++....... .......||+.|+|||        .++|||||||++|||++|+.|+...    +..++.+.+.
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~  258 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTL  258 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHh
Confidence            9999999987643221 2223457899999998        5789999999999999999996432    2222222222


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .... ...+......+.+++.+||+.||++||++.++++
T Consensus       259 ~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 AGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             cCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            2221 1223445567889999999999999999999976

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.4e-31  Score=253.31  Aligned_cols=175  Identities=22%  Similarity=0.306  Sum_probs=138.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+|||++.
T Consensus        55 hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~  131 (323)
T cd05575          55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDS  131 (323)
T ss_pred             CCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECC
Confidence            489999999999999999999999999999998643     24567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +..++.+
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~  206 (323)
T cd05575         132 QGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DTAEMYD  206 (323)
T ss_pred             CCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC----CHHHHHH
Confidence            9999999999987543221 2233457899999998        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML  365 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~  365 (383)
                      .+.....  .........+.+++.+|++.||++||++.
T Consensus       207 ~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         207 NILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            2222211  11223456788999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.8e-31  Score=240.51  Aligned_cols=186  Identities=24%  Similarity=0.424  Sum_probs=144.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++++. .+..++||||+++|+|.+++...     .....++.|++.|++|||..   +++|+||||+||+++.
T Consensus        55 h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~  130 (257)
T cd05060          55 HPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVN  130 (257)
T ss_pred             CCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcC
Confidence            489999999876 45689999999999999999643     34678999999999999998   8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccc--cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTS--TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~--~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+|++|||+++..........  ....++..|++||        .++||||||+++||+++ |..|+...    +..+
T Consensus       131 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~----~~~~  206 (257)
T cd05060         131 RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM----KGAE  206 (257)
T ss_pred             CCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC----CHHH
Confidence            99999999999987643322211  1122346799988        47999999999999998 88886432    2233


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      +.+++.... ....+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       207 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         207 VIAMLESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHHcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            333322211 11223345568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.4e-31  Score=259.55  Aligned_cols=180  Identities=23%  Similarity=0.374  Sum_probs=149.4

Q ss_pred             cccceeeeEEEeCCE--EEEEEEeccCCCHHHHHhcchh-----hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEK--KLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~-----~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|||+++.++.+...  .-+|+|.+..|+|..|++..++     ...+++||++||.|||++ .|+|+|||||.+||+++
T Consensus       101 ~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFin  179 (632)
T KOG0584|consen  101 PNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVN  179 (632)
T ss_pred             CceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEc
Confidence            799999999998665  7799999999999999986543     467999999999999997 78999999999999998


Q ss_pred             CC-CceEEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 ED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .+ |.+||+|.|+|.....   .....+.||+.+||||       ...||||||+.++||+|+..|+..   ..+...+.
T Consensus       180 G~~G~VKIGDLGLAtl~r~---s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsE---C~n~AQIY  253 (632)
T KOG0584|consen  180 GNLGEVKIGDLGLATLLRK---SHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSE---CTNPAQIY  253 (632)
T ss_pred             CCcCceeecchhHHHHhhc---cccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhh---hCCHHHHH
Confidence            64 8999999999987654   2334489999999998       679999999999999999999642   22445566


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++|..+.-+..+.+-..+++.+++.+|+.. .++|||+.|+++
T Consensus       254 KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  254 KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            666555444444444456889999999999 899999999986

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=4.6e-31  Score=251.52  Aligned_cols=173  Identities=24%  Similarity=0.399  Sum_probs=137.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ++|+++.+++.+.+..++||||+++|+|.+++..     +.....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~  137 (323)
T cd05615          61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSE  137 (323)
T ss_pred             CchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC
Confidence            4678889999999999999999999999999864     245678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|+...    +.....+.
T Consensus       138 ~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~----~~~~~~~~  212 (323)
T cd05615         138 GHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE----DEDELFQS  212 (323)
T ss_pred             CCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            999999999987543222 1223356899999998        5789999999999999999996432    22233333


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      +.....  ..+......+.+++.+|++.+|++|++.
T Consensus       213 i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            332222  1233445678899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.1e-30  Score=240.54  Aligned_cols=183  Identities=30%  Similarity=0.490  Sum_probs=142.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++. .+..+++|||+++++|.+++...       .....++.+++.|++|||+.   +++|||+||+||+++
T Consensus        61 ~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~  136 (260)
T cd05070          61 DKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVG  136 (260)
T ss_pred             CceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEe
Confidence            69999999875 45689999999999999998642       24578999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++..............++..|+|||        .++|+||||+++||+++ |..|+...    +..+.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~----~~~~~  212 (260)
T cd05070         137 DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREV  212 (260)
T ss_pred             CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC----CHHHH
Confidence            9999999999999876433222222233556799998        47999999999999999 78886432    22233


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+++... .....+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         213 LEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            3322221 1122234456688999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1e-31  Score=255.39  Aligned_cols=176  Identities=22%  Similarity=0.314  Sum_probs=140.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        57 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  133 (318)
T cd05582          57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDE  133 (318)
T ss_pred             CCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECC
Confidence            489999999999999999999999999999998642     34677899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......|+..|++||        .++|||||||++|||++|+.|+...    +..+...
T Consensus       134 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~----~~~~~~~  208 (318)
T cd05582         134 EGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK----DRKETMT  208 (318)
T ss_pred             CCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC----CHHHHHH
Confidence            9999999999987654322 1223457899999998        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      .+.....  ..+......+.+++.+||+.||++||++.+
T Consensus       209 ~i~~~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         209 MILKAKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2222211  122334567889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=1.5e-30  Score=240.51  Aligned_cols=182  Identities=26%  Similarity=0.310  Sum_probs=140.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++..++..++|+||+++|+|.++++..     .....++.|++.|++|||+.   +++|||+||+||+++.+
T Consensus        66 ~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~  142 (267)
T cd06646          66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDN  142 (267)
T ss_pred             CCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC
Confidence            69999999999999999999999999999998632     34577899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      +.++++|||+++...... .......|+..|++||           .++|||||||+++||++|+.|+.....    ...
T Consensus       143 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~----~~~  217 (267)
T cd06646         143 GDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP----MRA  217 (267)
T ss_pred             CCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch----hhh
Confidence            999999999998654321 1122345788899988           258999999999999999999643211    111


Q ss_pred             ceeeecCcccccC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          326 VDWVLDSTILNAY---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       326 ~~~v~~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      ...+.........   ....+..+.+++.+||+.+|++|||++++++.|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         218 LFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             heeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1111111111110   122346788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=5.8e-31  Score=245.23  Aligned_cols=183  Identities=21%  Similarity=0.233  Sum_probs=140.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++||+++.+++.++...++||||+++|+|.+++...       .....++.|++.|++|||+.   +++||||||+||++
T Consensus        52 hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili  128 (277)
T cd05607          52 SPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLL  128 (277)
T ss_pred             CCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEE
Confidence            589999999999999999999999999999888532       23467889999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      +.++.++|+|||++.......  ......|+..|++||        .++||||+||++|||++|+.|+...-......+.
T Consensus       129 ~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~  206 (277)
T cd05607         129 DDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL  206 (277)
T ss_pred             cCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence            999999999999987664322  223346888999998        5789999999999999999997532111011111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ........... .......++.+++..||+.||++||+++|+++
T Consensus       207 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         207 KRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            11111111111 11234557889999999999999999977664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=3.1e-31  Score=233.01  Aligned_cols=196  Identities=21%  Similarity=0.346  Sum_probs=153.7

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      .|...+++|+|.||.||                                         +||+.+++.+...+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            35566889999999999                                         7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+. +|+..+++.      .+...++.++.+|++|||.+   .|+|||+||.|+|+++++.+|++|||+++.........
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            975 999999864      35678999999999999999   89999999999999999999999999999887544332


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee----------------e--
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV----------------L--  330 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v----------------~--  330 (383)
                       +...-|.+|.|||         ...|+||.|||+.||+-|.+-+.    +..+.+....+                .  
T Consensus       159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHHHHHcCCCCcccCccccccc
Confidence             2336788999999         56899999999999998765532    21221111111                0  


Q ss_pred             -------cCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 -------DSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 -------~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                             -+.. ............++++..++..||.+|+|+.|+++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence                   0000 00011223456799999999999999999999986

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.2e-30  Score=240.38  Aligned_cols=183  Identities=29%  Similarity=0.447  Sum_probs=141.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++. .+..+++|||+++|+|.++++..       .....++.+++.||+|||+.   +++|+||||+||+++
T Consensus        61 ~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~  136 (260)
T cd05069          61 DKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVG  136 (260)
T ss_pred             CCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEc
Confidence            79999998875 45688999999999999999642       23567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++..............++..|++||        .++||||||+++|||++ |+.|+...    ...+.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~~  212 (260)
T cd05069         137 DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----VNREV  212 (260)
T ss_pred             CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHH
Confidence            9999999999999765433222222234567799988        46899999999999999 88886432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+++... .....+...+..+.+++.+||..||++||++.+|++.|++
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         213 LEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHcC-CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2222211 1112233456678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-31  Score=230.18  Aligned_cols=194  Identities=21%  Similarity=0.370  Sum_probs=163.0

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|.||.||                                          |||.++++|+.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            456777999999999999                                          89999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          202 EYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||.++|++...|...       .....++.|+|.|+.|+|..   +|+|||+||+|+|++..+..|++|||-+....   
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  175 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence            999999999999832       23577999999999999998   99999999999999999999999999986543   


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      .......+||.-|.+||        .+.|+|++|++.+|++.|.+||..    +...+..+.+....+  .++......+
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes----~~~~etYkrI~k~~~--~~p~~is~~a  249 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES----QSHSETYKRIRKVDL--KFPSTISGGA  249 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh----hhhHHHHHHHHHccc--cCCcccChhH
Confidence            22334578999999998        568999999999999999999643    334455554443333  2234556678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+|+..+|.+|.+..||++
T Consensus       250 ~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHHHHHhccCccccccHHHHhh
Confidence            89999999999999999999986

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=9.8e-31  Score=243.36  Aligned_cols=177  Identities=23%  Similarity=0.355  Sum_probs=135.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      |+||++++++|.++...++||||+++|+|.+++...      ..+..++.|+++||+|||+.   +++||||||+||+++
T Consensus        75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~  151 (274)
T cd05076          75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLA  151 (274)
T ss_pred             CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEe
Confidence            589999999999999999999999999999998642      34578999999999999998   999999999999997


Q ss_pred             CCC-------ceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHH-hCCCCCCCCC
Q 046461          255 EDF-------EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELV-IRKQPTGPEF  317 (383)
Q Consensus       255 ~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Ell-tg~~p~~~~~  317 (383)
                      ..+       .++++|||.+......     ....++..|++||         .++||||||+++||++ +|+.|+... 
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-  225 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-  225 (274)
T ss_pred             ccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-
Confidence            643       3799999997643221     1234667789887         3689999999999995 688886432 


Q ss_pred             CCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          318 KDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                         ...+.. .......  ..+.+....+.+++.+||+.+|++||||.+|++.|.
T Consensus       226 ---~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         226 ---TPSEKE-RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---ChHHHH-HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               111111 1111111  112223346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.2e-30  Score=241.62  Aligned_cols=189  Identities=21%  Similarity=0.358  Sum_probs=145.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++.+ +..++||||+++|+|.+++...      .....++.+++.|++|||+.   +++|+||||+||+++
T Consensus        66 h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~  141 (270)
T cd05056          66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVS  141 (270)
T ss_pred             CCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEe
Confidence            3899999999875 4578999999999999999642      23567889999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++..............++..|++||        .++||||||++++|+++ |..|+...    ...+.
T Consensus       142 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~----~~~~~  217 (270)
T cd05056         142 SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV----KNNDV  217 (270)
T ss_pred             cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC----CHHHH
Confidence            9999999999999876543222222233456799988        46899999999999986 99996432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ..++..... ...+...+..+.+++.+||..+|++|||+.++++.|+++..++
T Consensus       218 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         218 IGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             HHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            222211111 1122344567889999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.3e-30  Score=239.67  Aligned_cols=181  Identities=28%  Similarity=0.392  Sum_probs=140.2

Q ss_pred             cccceeeeEEE-eCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCP-VGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +|++++++++. .++..++++||+++|+|.++++..       .....++.+++.||+|||+.   +++||||||+||++
T Consensus        59 ~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~  135 (256)
T cd05082          59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLV  135 (256)
T ss_pred             CCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEE
Confidence            79999999865 456789999999999999998743       23477899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      +.++.+|++|||+++......    ....++..|++||        .++|||||||++|||++ |+.|+...    +..+
T Consensus       136 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~  207 (256)
T cd05082         136 SEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKD  207 (256)
T ss_pred             cCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHH
Confidence            999999999999987653321    1233456799987        47999999999999998 88885321    2222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...++.. ..........+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       208 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         208 VVPRVEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            2222211 111122334456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.2e-30  Score=242.14  Aligned_cols=185  Identities=23%  Similarity=0.387  Sum_probs=143.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------------KHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      +||+++++++.+.+..++||||+++|+|.+++....              .+..++.|++.||+|||+.   +++|||||
T Consensus        68 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlk  144 (275)
T cd05046          68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLA  144 (275)
T ss_pred             cceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCc
Confidence            799999999999899999999999999999986422              3567899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFK  318 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~  318 (383)
                      |+||+++.++.++++|||+++..............++..|++||        .++||||||++++|+++ |..|+..   
T Consensus       145 p~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~---  221 (275)
T cd05046         145 ARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---  221 (275)
T ss_pred             cceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc---
Confidence            99999999999999999998754332222222334567799988        45899999999999999 6777532   


Q ss_pred             CCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          319 DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       319 ~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                       .........+.........+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         222 -LSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -cchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             122222322222222222233455688899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.2e-30  Score=241.44  Aligned_cols=185  Identities=21%  Similarity=0.355  Sum_probs=144.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++|++++++++.+++..+++|||+++++|.+++..         ....+.++.|++.|+.|||+..  +++|+|++|+||
T Consensus        68 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~ni  145 (269)
T cd08528          68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNI  145 (269)
T ss_pred             CCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHE
Confidence            68999999999999999999999999999998742         1235778999999999999631  799999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.++.++++|||.+.......  ......|+..|++||        .++||||||+++|||++|+.|+...    +..
T Consensus       146 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~----~~~  219 (269)
T cd08528         146 MLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----NML  219 (269)
T ss_pred             EECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc----CHH
Confidence            99999999999999998754432  233456788899988        5789999999999999999996422    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .....+.+..............+.+++.+||+.||++||++.||.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         220 SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            22222222222111122345678899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=4.2e-31  Score=251.42  Aligned_cols=175  Identities=24%  Similarity=0.322  Sum_probs=138.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        55 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~  131 (321)
T cd05603          55 HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDS  131 (321)
T ss_pred             CCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECC
Confidence            489999999999999999999999999999888642     23566889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++...... .......|+..|+|||        .++|||||||++|||++|+.|+...    +.....+
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~  206 (321)
T cd05603         132 QGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DVSQMYD  206 (321)
T ss_pred             CCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC----CHHHHHH
Confidence            9999999999987532221 2223456899999998        4799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML  365 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~  365 (383)
                      .+.....  ..+......+.+++.+|++.||++||+..
T Consensus       207 ~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         207 NILHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHhcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2222221  12334456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.1e-30  Score=241.90  Aligned_cols=191  Identities=25%  Similarity=0.405  Sum_probs=139.3

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +||+++++++..  ....++|+||+++|+|.+++...      .....++.|++.||+|||..   +++||||||+||++
T Consensus        65 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili  141 (284)
T cd05081          65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILV  141 (284)
T ss_pred             CCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEE
Confidence            799999998754  34689999999999999998632      34577899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCcc--ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC---
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK---  320 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~---  320 (383)
                      +.++.++++|||+++.........  .....++..|++||        .++|||||||+++||++|..++.......   
T Consensus       142 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~  221 (284)
T cd05081         142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM  221 (284)
T ss_pred             CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence            999999999999998764332211  11122345688887        56899999999999999877643211000   


Q ss_pred             CCCc-----ccee---eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          321 NGGN-----LVDW---VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       321 ~~~~-----~~~~---v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      ...+     ....   ..............+..+.+++.+||+.+|++|||+.||++.|+.++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0000     0000   00001111112334567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=9.7e-31  Score=240.91  Aligned_cols=178  Identities=21%  Similarity=0.363  Sum_probs=136.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++..++..++||||+++|+|.++++..      .....++.|++.|++|||+.   +++|||+||+||+++
T Consensus        58 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~  134 (258)
T cd05078          58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLI  134 (258)
T ss_pred             CCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEe
Confidence            589999999999999999999999999999999643      23467899999999999998   999999999999998


Q ss_pred             CCCc--------eEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          255 EDFE--------VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       255 ~~~~--------~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      .++.        ++++|||++......     ....++..|++||         .++||||||+++||+++|..++....
T Consensus       135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~  209 (258)
T cd05078         135 REEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL  209 (258)
T ss_pred             cccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence            7765        589999988654321     2245778899998         35899999999999999964432111


Q ss_pred             CCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          318 KDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                         +...... +....  ...+.....++.+++.+||+.||++|||++++++.|+
T Consensus       210 ---~~~~~~~-~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         210 ---DSQKKLQ-FYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---cHHHHHH-HHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               1111111 11111  1122334467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.5e-30  Score=240.95  Aligned_cols=186  Identities=25%  Similarity=0.434  Sum_probs=143.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|||+++++++.+++..++||||+++|+|.+++...      .+...++.|++.|++|||+.   +++|+|+||+||+++
T Consensus        64 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~  140 (269)
T cd05065          64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVN  140 (269)
T ss_pred             CcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEc
Confidence            389999999999999999999999999999998742      24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc-cccc-cc--cccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESH-TSTD-VA--GTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKN  321 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~-~~~~-~~--gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~  321 (383)
                      .++.++++|||+++........ .... ..  .+..|++||        .++|||||||++||+++ |..|+...    +
T Consensus       141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~----~  216 (269)
T cd05065         141 SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM----S  216 (269)
T ss_pred             CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC----C
Confidence            9999999999998765432211 1111 11  235788888        46899999999999886 88886432    2


Q ss_pred             CCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          322 GGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       322 ~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..+..+++... .....+.+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       217 ~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         217 NQDVINAIEQD-YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHHHcC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            22333333211 11112234456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.1e-31  Score=255.13  Aligned_cols=198  Identities=21%  Similarity=0.274  Sum_probs=151.7

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            357777889999999888                                          69999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.++++|||+++.+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            999999999998743     34567899999999999998   9999999999999999999999999998754321100


Q ss_pred             -------------------------------------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCC
Q 046461          277 -------------------------------------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQ  311 (383)
Q Consensus       277 -------------------------------------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~  311 (383)
                                                           ......||+.|+|||        .++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 011246899999998        57999999999999999999


Q ss_pred             CCCCCCCCCCCCccceeeecC--cccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046461          312 PTGPEFKDKNGGNLVDWVLDS--TILNAYSKPSMLKMLQIVVGCIFDNPTTRPT---MLRVQE  369 (383)
Q Consensus       312 p~~~~~~~~~~~~~~~~v~~~--~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~~  369 (383)
                      ||...    +..+....+...  .+...........+.+++.+|+. +|.+|++   +.|+++
T Consensus       238 Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSD----NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCC----CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            97432    212211111111  11111111234567788888886 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=3e-31  Score=252.92  Aligned_cols=178  Identities=22%  Similarity=0.258  Sum_probs=139.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        55 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~  131 (325)
T cd05604          55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDS  131 (325)
T ss_pred             CCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECC
Confidence            489999999999999999999999999999988643     34567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.+||+|||+++..... ........|+..|+|||        .++|||||||++|||++|+.|+...    +..++.+
T Consensus       132 ~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~~~  206 (325)
T cd05604         132 QGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR----DVAEMYD  206 (325)
T ss_pred             CCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC----CHHHHHH
Confidence            999999999998754221 12233457899999998        5799999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~  368 (383)
                      .+.....  .........+.+++.+|++.+|++||++.+.+
T Consensus       207 ~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         207 NILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             HHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            2222221  11223455778899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=241.13  Aligned_cols=187  Identities=23%  Similarity=0.400  Sum_probs=145.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|+++++++|.. +..++|+||+++|+|.+++...      .....++.|++.|++|||+.   +++|||+||+||+++.
T Consensus        69 ~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~  144 (279)
T cd05057          69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKT  144 (279)
T ss_pred             CCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcC
Confidence            799999999987 7889999999999999999752      34578899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccc-cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTS-TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+|++|||+++.......... ....++..|++||        .++|+||||++++|+++ |+.|+...    ...++
T Consensus       145 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~  220 (279)
T cd05057         145 PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI----PAVEI  220 (279)
T ss_pred             CCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC----CHHHH
Confidence            99999999999987653322111 1122356799887        46899999999999998 99996432    22233


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+.+..... ...+......+.+++.+||..+|++|||+.++++.|+++.++
T Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         221 PDLLEKGER-LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             HHHHhCCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            333322211 111233456788999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2.3e-30  Score=239.09  Aligned_cols=184  Identities=31%  Similarity=0.476  Sum_probs=141.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++. .+..++||||+++|+|.+++...       .....++.|++.||+|+|+.   +++|||+||+||+++
T Consensus        61 ~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~  136 (262)
T cd05071          61 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVG  136 (262)
T ss_pred             CCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEc
Confidence            79999999875 45679999999999999999742       24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++|+|||.++..............++..|++||        .++||||||+++||+++ |+.|+...    ...+.
T Consensus       137 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~----~~~~~  212 (262)
T cd05071         137 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREV  212 (262)
T ss_pred             CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----ChHHH
Confidence            9999999999999866443322222334567899998        46899999999999999 77775432    11122


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      .+.+... .......+.+..+.+++.+||+.+|++|||+.++.+.|++.
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         213 LDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHHhcC-CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2111111 11122334566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=1.9e-30  Score=248.23  Aligned_cols=189  Identities=28%  Similarity=0.436  Sum_probs=145.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQP  239 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~  239 (383)
                      ++||++++++|..++..++++||+++|+|.+++...                     .....++.|++.||+|||+.   
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---  153 (334)
T cd05100          77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---  153 (334)
T ss_pred             CCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---
Confidence            489999999999999999999999999999998632                     12356889999999999998   


Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-C
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-R  309 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g  309 (383)
                      +++||||||+||+++.++.+||+|||+++........ ......++..|++||        .++||||||+++|||++ |
T Consensus       154 givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g  233 (334)
T cd05100         154 KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG  233 (334)
T ss_pred             CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcC
Confidence            9999999999999999999999999999865432211 112223456799998        47899999999999998 7


Q ss_pred             CCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       310 ~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..|+..    ....+..+.+.... ....+......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus       234 ~~p~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         234 GSPYPG----IPVEELFKLLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CCCCCC----CCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            777532    12222222222211 1122234456788999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=1.3e-30  Score=244.16  Aligned_cols=210  Identities=20%  Similarity=0.302  Sum_probs=160.5

Q ss_pred             cccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEe
Q 046461          153 KLTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~  193 (383)
                      -+++.++..++++|...+.||+|+||.||                                       +|++++++++..
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            35667777888999999999999999888                                       689999999875


Q ss_pred             C-----CEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          194 G-----EKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       194 ~-----~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      .     +..++|+||+++|+|.++++.         +.....++.|++.||+|||+.   +++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998853         123467899999999999988   99999999999999999999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      |++|||+++....... ......|+..|++||             .++|||||||++|||++|+.|+.....   ...+.
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLF  243 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHH
Confidence            9999999886543221 122345788899988             368999999999999999999643211   11111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +........-..+......+.+++.+||+.+|++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111100000112233456889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=2e-30  Score=238.18  Aligned_cols=199  Identities=29%  Similarity=0.432  Sum_probs=156.1

Q ss_pred             hCccccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      ++|...+.||+|+||.||                                    +|++++++++.+.+..++||||++++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            355666788888888887                                    69999999999999999999999999


Q ss_pred             CHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          208 SLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       208 sL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      +|.+++...       .....++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||.++.......    .
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~  158 (256)
T cd05039          86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----S  158 (256)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc----c
Confidence            999998643       24578899999999999998   999999999999999999999999999987633221    2


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...+..|++||        .++||||||++++|+++ |..|+...    ...++.+.+... .....+...+..+.+++.
T Consensus       159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPHVEKG-YRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHhcC-CCCCCccCCCHHHHHHHH
Confidence            23456788888        36899999999999997 88886432    112222211111 111223344568899999


Q ss_pred             HccccCCCCCCCHHHHHHHHhcc
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +||..+|++|||+.|++++|+++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         234 DCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHhccChhhCcCHHHHHHHHhcC
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.2e-30  Score=239.35  Aligned_cols=177  Identities=20%  Similarity=0.352  Sum_probs=135.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|||+++++++......++||||+++|+|..++...      .....++.|++.|++|||+.   +++||||||+||+++
T Consensus        63 hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~  139 (262)
T cd05077          63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLA  139 (262)
T ss_pred             CCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEe
Confidence            699999999999999999999999999999988642      23577999999999999998   999999999999998


Q ss_pred             CCCc-------eEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHH-hCCCCCCCCC
Q 046461          255 EDFE-------VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELV-IRKQPTGPEF  317 (383)
Q Consensus       255 ~~~~-------~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Ell-tg~~p~~~~~  317 (383)
                      .++.       ++++|||++......     ....++..|+|||         .++|||||||++|||+ .|..|+... 
T Consensus       140 ~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-  213 (262)
T cd05077         140 REGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-  213 (262)
T ss_pred             cCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-
Confidence            7654       899999998654321     2235678899998         3579999999999998 477775321 


Q ss_pred             CCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          318 KDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                         ...+.. ........  ...+....+.+++.+||+.||++||++.++++.++
T Consensus       214 ---~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         214 ---TLAEKE-RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ---chhHHH-HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence               111111 11111111  11223457889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=267.64  Aligned_cols=186  Identities=25%  Similarity=0.453  Sum_probs=150.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch---------------------hhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------------------KHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      +|++.++|+|...+..++|.||+..|+|.++|+...                     +.+.++.|||.|++||++.   +
T Consensus       362 ~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~  438 (609)
T KOG0200|consen  362 PNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---P  438 (609)
T ss_pred             cchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---C
Confidence            799999999999999999999999999999998544                     2467999999999999999   8


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccccc--ccccccCC--------CCCcchhHHHHHHHHHh-C
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--TIGYILLA--------CGGDIYSFSVVLLELVI-R  309 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~ape--------~~~Dv~SfGvil~Ellt-g  309 (383)
                      ++|||+.++|||+..+..+||+|||+++..............+  ...|||||        .|+|||||||+|||++| |
T Consensus       439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG  518 (609)
T KOG0200|consen  439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG  518 (609)
T ss_pred             ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence            9999999999999999999999999999765544333222222  34599998        68999999999999999 6


Q ss_pred             CCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       310 ~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..|+.. ..  ...++.+++.++.. ...+..+..++.++|..||+.+|++||++.++++.++..
T Consensus       519 ~~PYp~-~~--~~~~l~~~l~~G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  519 GTPYPG-IP--PTEELLEFLKEGNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCCCC-CC--cHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            666432 11  13344444444433 233566788999999999999999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.1e-30  Score=246.34  Aligned_cols=198  Identities=18%  Similarity=0.277  Sum_probs=148.8

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            566777888888888887                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++ ++|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  159 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT  159 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence            95 6888887642      24567899999999999998   99999999999999999999999999987543221 22


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee-------------------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV-------------------  329 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v-------------------  329 (383)
                      .....++..|+|||         .++||||+||++|||++|+.||.....   ..+..+.+                   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchhhcc
Confidence            23356789999998         357999999999999999999753211   00000000                   


Q ss_pred             -ecC-cccccCCh---------hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 -LDS-TILNAYSK---------PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 -~~~-~~~~~~~~---------~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       .++ ......+.         .....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             000 00000000         11245778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=2.9e-30  Score=238.76  Aligned_cols=185  Identities=30%  Similarity=0.479  Sum_probs=143.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      ++||++++++|...+..++||||+++|+|.+++...            .+...++.|++.|++|||+.   +++|+|+||
T Consensus        58 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p  134 (269)
T cd05044          58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAA  134 (269)
T ss_pred             CCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence            699999999999999999999999999999999642            23567899999999999988   899999999


Q ss_pred             CcEEEcCCC-----ceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          249 SNILLNEDF-----EVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       249 ~NiLl~~~~-----~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      +||+++.+.     .++++|||+++........ ......++..|++||        .++|||||||++|||++ |+.|+
T Consensus       135 ~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~  214 (269)
T cd05044         135 RNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY  214 (269)
T ss_pred             heEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCC
Confidence            999999877     8999999998765432211 111234567899988        57899999999999998 88886


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ...    +..+....+..... ...+...+..+.+++.+||+.+|++||++.++.+.|++
T Consensus       215 ~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         215 PAL----NNQEVLQHVTAGGR-LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ccc----CHHHHHHHHhcCCc-cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            422    22222222211111 11123445678899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=263.32  Aligned_cols=203  Identities=24%  Similarity=0.436  Sum_probs=164.3

Q ss_pred             ccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          166 FYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +....+||+|+||+||                                            +|+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            4566899999999999                                            79999999998765 88999


Q ss_pred             EeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      +|||.|+|.++++..+      ..+.+..|||+||.|||.+   +++||||.++|+|+..-..+|++|||+++.+.....
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999999998643      3578999999999999998   999999999999999999999999999998865443


Q ss_pred             cccc-ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          276 HTST-DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       276 ~~~~-~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      .-.. ...-.+.|||.|        .++|||||||++||++| |.+|++.    ....++.+.+.++.- -..++.+..+
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g----i~~~eI~dlle~geR-LsqPpiCtiD  928 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG----IPAEEIPDLLEKGER-LSQPPICTID  928 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC----CCHHHhhHHHhcccc-CCCCCCccHH
Confidence            2222 222345677654        78999999999999998 9999543    233344433333332 2346678889


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++.++.+||..|++.||+++++...+.++...
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            99999999999999999999999988877654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.4e-30  Score=248.59  Aligned_cols=177  Identities=23%  Similarity=0.358  Sum_probs=136.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        56 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~  132 (327)
T cd05617          56 PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDAD  132 (327)
T ss_pred             CCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCC
Confidence            79999999999999999999999999999888642     34677999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC--CCc-c
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN--GGN-L  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~--~~~-~  325 (383)
                      +.+||+|||+++...... .......||..|+|||        .++|||||||++|||++|+.|++.......  ..+ .
T Consensus       133 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~  211 (327)
T cd05617         133 GHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL  211 (327)
T ss_pred             CCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence            999999999987532211 1223457899999998        579999999999999999999753211100  001 1


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      .+.+.....  ..+......+.+++.+|++.||++||++
T Consensus       212 ~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         212 FQVILEKPI--RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            111111111  1233345678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.2e-30  Score=246.18  Aligned_cols=187  Identities=22%  Similarity=0.399  Sum_probs=142.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||++++|+|... ..++++||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        69 ~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~  144 (303)
T cd05110          69 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKS  144 (303)
T ss_pred             CCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecC
Confidence            7999999999754 467999999999999998643      24578899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+|++|||+++........ ......++..|++||        .++||||||+++||+++ |+.|+...    ...+.
T Consensus       145 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~----~~~~~  220 (303)
T cd05110         145 PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREI  220 (303)
T ss_pred             CCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHH
Confidence            999999999999876432221 122234567899887        46899999999999997 88886432    11122


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+.+..... ...+......+.+++..||..+|++||+++++++.|+++...
T Consensus       221 ~~~~~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         221 PDLLEKGER-LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HHHHHCCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            222211111 111223456788999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=243.79  Aligned_cols=181  Identities=22%  Similarity=0.286  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+++..++||||+++|+|.+++...       .....++.|++.|++|||+.   +++||||||+||+++
T Consensus        60 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~  136 (285)
T cd05605          60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLD  136 (285)
T ss_pred             CCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEEC
Confidence            79999999999999999999999999999988532       23567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||+++......  ......|+..|++||        .++||||+||++||+++|+.|+...-.......+.
T Consensus       137 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~  214 (285)
T cd05605         137 DYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE  214 (285)
T ss_pred             CCCCEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH
Confidence            99999999999988754322  122346889999998        46899999999999999999975321100000111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      ..+..  .....+......+.+++.+||..||++||     +++++++
T Consensus       215 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         215 RRVKE--DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHhhh--cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            11111  11122334556788999999999999999     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.3e-30  Score=252.91  Aligned_cols=202  Identities=21%  Similarity=0.244  Sum_probs=153.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------cccceeeeEEEeCCEEEEEEEeccCCCHH
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLN  210 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~  210 (383)
                      ++|...+.||+|+||.||                                 ||||++++++..++..++|+|++. ++|.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~  170 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY  170 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence            468888999999999998                                 799999999999999999999995 7898


Q ss_pred             HHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccccccc
Q 046461          211 DWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI  285 (383)
Q Consensus       211 ~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~  285 (383)
                      +++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..............||+
T Consensus       171 ~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~  247 (391)
T PHA03212        171 CYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI  247 (391)
T ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence            888642     34678999999999999998   9999999999999999999999999999764332222333467999


Q ss_pred             ccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC---CCccceee----------------------e--
Q 046461          286 GYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN---GGNLVDWV----------------------L--  330 (383)
Q Consensus       286 ~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~---~~~~~~~v----------------------~--  330 (383)
                      .|+|||        .++|||||||++|||++|+.|+........   .......+                      .  
T Consensus       248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~  327 (391)
T PHA03212        248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG  327 (391)
T ss_pred             CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence            999998        478999999999999999988632110000   00000000                      0  


Q ss_pred             --cCccccc----C---ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 --DSTILNA----Y---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 --~~~~~~~----~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        .......    .   .......+.+++.+|++.||++|||+.|+++
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0000000    0   0122456888999999999999999999985

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=2.2e-30  Score=242.66  Aligned_cols=196  Identities=20%  Similarity=0.281  Sum_probs=149.1

Q ss_pred             CccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          165 KFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      +|...+.||+|+||.||                                        +||+++++++.+++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            46667788888888887                                        79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      + |+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~  160 (288)
T cd07871          86 D-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY  160 (288)
T ss_pred             C-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence            7 5999988642      23567889999999999998   99999999999999999999999999987653322 122


Q ss_pred             cccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--------------------
Q 046461          279 TDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--------------------  329 (383)
Q Consensus       279 ~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--------------------  329 (383)
                      ....++..|+|||         .++||||+||++|||++|+.|+.....    .+....+                    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV----KEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChHHhhccccchh
Confidence            3346788999998         358999999999999999999743211    0000000                    


Q ss_pred             ----ecCcccc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ----LDSTILN----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ----~~~~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                          ..+....    ........+..+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0000000    001122456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=2.7e-30  Score=238.00  Aligned_cols=183  Identities=28%  Similarity=0.442  Sum_probs=141.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++. .+..+++|||+++|+|.+++...       .....++.|++.||+|||+.   +++|||+||+||+++
T Consensus        61 ~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~  136 (260)
T cd05067          61 PRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVS  136 (260)
T ss_pred             cCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEc
Confidence            79999999874 45789999999999999998632       23567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||+++..............++..|++||        .++||||||++++|+++ |+.|+...    +..+.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~  212 (260)
T cd05067         137 ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM----TNPEV  212 (260)
T ss_pred             CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC----ChHHH
Confidence            9999999999999776532222222334567898888        47899999999999999 89886432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+.+.+. .....+.....++.+++.+||..+|++|||++++++.|+.
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         213 IQNLERG-YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            2222111 1112223345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.3e-30  Score=240.78  Aligned_cols=190  Identities=24%  Similarity=0.398  Sum_probs=141.6

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +|++++.+++.+.  ...++||||+++++|.+++...      ..+..++.|++.||+|||+.   +++|||+||+||++
T Consensus        66 ~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~  142 (284)
T cd05079          66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV  142 (284)
T ss_pred             CCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEE
Confidence            7999999999875  5689999999999999998532      34578899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC---
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK---  320 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~---  320 (383)
                      +.++.++++|||+++........  ......++..|++||        .++||||||+++||+++++.|........   
T Consensus       143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~  222 (284)
T cd05079         143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM  222 (284)
T ss_pred             cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh
Confidence            99999999999999866432211  112244667788888        57999999999999999877643221100   


Q ss_pred             ----CCC-ccceee--ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          321 ----NGG-NLVDWV--LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       321 ----~~~-~~~~~v--~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                          ... .....+  .........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         223 IGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                000 000000  000001111234566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.1e-30  Score=241.56  Aligned_cols=209  Identities=22%  Similarity=0.356  Sum_probs=160.5

Q ss_pred             cccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEe
Q 046461          153 KLTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~  193 (383)
                      ..++.++..+.+.|.....+|+|+||.||                                       +|++++++++..
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            35677777788889988999999999988                                       699999999853


Q ss_pred             ------CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceE
Q 046461          194 ------GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVK  260 (383)
Q Consensus       194 ------~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~k  260 (383)
                            .+..+++|||+++|+|.+++...       .....++.|++.|++|||+.   +++|+|+||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence                  46789999999999999998642       22466888999999999998   999999999999999999999


Q ss_pred             EccccCccccCCCCCccccccccccccccCCC-------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          261 VSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~gt~~y~ape~-------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++|||+++....... ......|+..|+|||.             ++|||||||++|||++|+.|+.....    .....
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----~~~~~  236 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----MRALF  236 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----Hhhhh
Confidence            999999876532211 1223567888999872             58999999999999999999753211    11111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.............+..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            111111111112234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=4.7e-30  Score=239.19  Aligned_cols=183  Identities=23%  Similarity=0.383  Sum_probs=140.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHh-cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVK  260 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~k  260 (383)
                      +|++++++++...+..++||||+++|+|..+.. .......++.|++.|++|||+.   +++|+||||+||+++.++.++
T Consensus        59 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~  135 (279)
T cd06619          59 PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVK  135 (279)
T ss_pred             CCeeeEEEEEEECCEEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEE
Confidence            799999999999999999999999999987654 3344577999999999999998   999999999999999999999


Q ss_pred             EccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC---ccceee
Q 046461          261 VSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG---NLVDWV  329 (383)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~---~~~~~v  329 (383)
                      ++|||++......   ......|+..|++||        .++||||||+++|||++|+.|+..........   ...+.+
T Consensus       136 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  212 (279)
T cd06619         136 LCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI  212 (279)
T ss_pred             EeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence            9999998765432   223356888999998        56899999999999999999976433211111   111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .+..............+.+++.+||+.+|++||+++|+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11111111112234578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.3e-30  Score=254.07  Aligned_cols=199  Identities=19%  Similarity=0.261  Sum_probs=145.7

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .|...+.||+|+||.||                                          +|||++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            46677889999999888                                          699999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC---
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE---  274 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~---  274 (383)
                      |+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            99999999998643     23456788999999999998   99999999999999999999999999975321000   


Q ss_pred             -------------------------------------------CccccccccccccccCC--------CCCcchhHHHHH
Q 046461          275 -------------------------------------------SHTSTDVAGTIGYILLA--------CGGDIYSFSVVL  303 (383)
Q Consensus       275 -------------------------------------------~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil  303 (383)
                                                                 ........||+.|+|||        .++||||+||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       00012246899999998        578999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046461          304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT---MLRVQE  369 (383)
Q Consensus       304 ~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~~  369 (383)
                      |||++|+.||...-.......+..+......  ........+..+++.+++ .+|++|++   +.++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHI--PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCC--CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            9999999997532110000111111111111  111223445566666554 49999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=4.8e-30  Score=235.68  Aligned_cols=184  Identities=28%  Similarity=0.473  Sum_probs=143.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++||+++++++.+ ...++|+||+++|+|.+++.+..       ....++.|++.||+|||+.   +++|+|+||+||++
T Consensus        55 h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~  130 (257)
T cd05040          55 HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILL  130 (257)
T ss_pred             CCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEE
Confidence            5899999999988 88999999999999999986532       3467889999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNG  322 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~  322 (383)
                      +.++.+|++|||+++........  ......++..|++||        .++||||||+++|||++ |+.|+...    ..
T Consensus       131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~  206 (257)
T cd05040         131 ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL----SG  206 (257)
T ss_pred             ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC----CH
Confidence            99999999999999876442211  112245677899988        46899999999999998 99996422    22


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      .+..+.+.........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         207 SQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            22222221111111112334567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.2e-30  Score=236.23  Aligned_cols=183  Identities=27%  Similarity=0.459  Sum_probs=141.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++.+++.+ ...+++|||+++|+|.+++...       .....++.+++.||+|||+.   +++|+||||+||+++
T Consensus        61 ~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~  136 (260)
T cd05073          61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVS  136 (260)
T ss_pred             CCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEc
Confidence            799999999887 7789999999999999999642       24567889999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||.++..............++..|++||        .++|+|||||+++|+++ |+.|+...    +..+.
T Consensus       137 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~----~~~~~  212 (260)
T cd05073         137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----SNPEV  212 (260)
T ss_pred             CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC----CHHHH
Confidence            9999999999998765433222222234556788887        47899999999999999 88885421    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+++... .........+..+.+++.+||..+|++||++.++.+.|+.
T Consensus       213 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         213 IRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHhCC-CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2222111 1111123345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=247.34  Aligned_cols=183  Identities=23%  Similarity=0.305  Sum_probs=145.5

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|||+|+.+..+  .+.+|||+|||..|.+...-.+     ..+...+..++..||+|||.+   +|+||||||+|+|++
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS  244 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence            799999999876  4689999999999987643221     235678999999999999999   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCC----ccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCES----HTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFK  318 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~  318 (383)
                      +++++||+|||.+........    .......||+.++|||            .+.||||+||+||.++.|+.||-.   
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---  321 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---  321 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---
Confidence            999999999999876633211    1122367999999998            467999999999999999999643   


Q ss_pred             CCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          319 DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       319 ~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                       ....++.+.++...+.-+..++..+.+.+++.+++.+||+.|.+..+|....
T Consensus       322 -~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  322 -DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             3445566666555553332335567888999999999999999999987543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=2.4e-30  Score=247.41  Aligned_cols=199  Identities=20%  Similarity=0.211  Sum_probs=150.3

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|...+.||+|+||.||                                          +||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            56667888888888887                                          689999999999999999999


Q ss_pred             eccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+++|+|.+++...      .....++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            99999999999752      23466889999999999998   9999999999999999999999999998765433332


Q ss_pred             cccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc---ccCCh
Q 046461          277 TSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL---NAYSK  340 (383)
Q Consensus       277 ~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~---~~~~~  340 (383)
                      ......||+.|+|||             .++|||||||++|||++|+.|+...    +..+....+......   +....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~~p~~~~  234 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQFPAQVT  234 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC----CHHHHHHHHhCCCccccCCCccc
Confidence            333457899999998             2689999999999999999997432    222222222211110   11112


Q ss_pred             hHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 046461          341 PSMLKMLQIVVGCIFD--NPTTRPTMLRVQEF  370 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~--~P~~RPs~~~v~~~  370 (383)
                      .....+.+++.+|+..  ++..||++.|+++.
T Consensus       235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            3455677788876654  44447899988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=5.7e-30  Score=234.83  Aligned_cols=184  Identities=29%  Similarity=0.470  Sum_probs=147.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      ++|++++++++.++...++||||+++|+|.+++...              .....++.|++.|++|||+.   +++|+||
T Consensus        55 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di  131 (262)
T cd00192          55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDL  131 (262)
T ss_pred             CCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCcc
Confidence            689999999999999999999999999999999753              23578999999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+||+++.++.++++|||.++....... .......++..|++||        .++||||+|++++||++ |..|+...
T Consensus       132 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         132 AARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             CcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999987654321 1223345678899998        46899999999999999 58886432


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                          ...++.+.+.+.. ....+...+.++.+++.+||..+|++|||+.|+++.|+
T Consensus       212 ----~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         212 ----SNEEVLEYLRKGY-RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CHHHHHHHHHcCC-CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                2223333332221 11223444678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=2.8e-30  Score=237.09  Aligned_cols=180  Identities=24%  Similarity=0.342  Sum_probs=141.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++.+++.+++..+++|||+++|+|.+++...       .....++.+++.|+.|||+.   +++|+||||+||+++
T Consensus        58 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~  134 (255)
T cd08219          58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLT  134 (255)
T ss_pred             CCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEC
Confidence            89999999999999999999999999999988632       23567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||.++....... ......|+..|+|||        .++|+||||+++|||++|+.|+...    +.....
T Consensus       135 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~----~~~~~~  209 (255)
T cd08219         135 QNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNLI  209 (255)
T ss_pred             CCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC----CHHHHH
Confidence            999999999999876643221 122356788899988        5789999999999999999997432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      ..+..... ...+......+.+++.+||+.||++|||+.+++..
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         210 LKVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhcCCC-CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            21111111 11223344568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=3.8e-30  Score=236.20  Aligned_cols=183  Identities=26%  Similarity=0.445  Sum_probs=141.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++......++|+||+++|+|.+++...      .....++.+++.|++|||+.   +++|+|+||+||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~  135 (256)
T cd05112          59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGE  135 (256)
T ss_pred             CCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcC
Confidence            79999999999999999999999999999998642      23567889999999999998   8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++++|||+++..............++.+|++||        .++||||||+++||+++ |+.|+...    ......
T Consensus       136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~~  211 (256)
T cd05112         136 NQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR----SNSEVV  211 (256)
T ss_pred             CCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC----CHHHHH
Confidence            999999999998765433222222233567899988        46899999999999998 88886432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      +.+... .....+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       212 ~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         212 ETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            221111 111112224567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=5.7e-30  Score=235.02  Aligned_cols=181  Identities=25%  Similarity=0.328  Sum_probs=144.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+.+..+++|||+++|+|.+++...       .....++.|++.|++|||+.   +++|+|++|+||+++
T Consensus        59 ~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~  135 (256)
T cd08221          59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLT  135 (256)
T ss_pred             CCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEe
Confidence            79999999999999999999999999999999753       23567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.+|++|||.++....... ......++..|++||        .++||||||+++|||++|+.|+...    ...+..
T Consensus       136 ~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~  210 (256)
T cd08221         136 KAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLV  210 (256)
T ss_pred             CCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CHHHHH
Confidence            999999999999987644332 223356788999988        4689999999999999999996432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      ..+...... ........++.+++.+||..+|++||++.++++.+
T Consensus       211 ~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         211 VKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            222222221 11234456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=3.6e-31  Score=253.08  Aligned_cols=195  Identities=25%  Similarity=0.405  Sum_probs=163.8

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|.-.+.||+|.||.||                                         ||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            355666789999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+.+ +|..+|...     .....++.++..||.|||+.   +|+|||+||+|||++..+.+|++|||+||.++. ++..
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v  156 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV  156 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence            9976 999999743     35678999999999999999   999999999999999999999999999998765 3455


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI  349 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  349 (383)
                      .+.+.||+-|||||        ..+|.||+||++||+++|++||...    ...++++.|.......  +......+..+
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~--p~~~S~~f~nf  230 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKP--PSTASSSFVNF  230 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCC--cccccHHHHHH
Confidence            66788999999998        5689999999999999999997432    3445555554433322  23556677888


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 046461          350 VVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..-+.+||.+|.|..+++.
T Consensus       231 l~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHhhcChhhcccHHHHhc
Confidence            88999999999999999875

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-31  Score=250.61  Aligned_cols=180  Identities=22%  Similarity=0.250  Sum_probs=139.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        55 ~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~  131 (330)
T cd05586          55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDA  131 (330)
T ss_pred             CCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECC
Confidence            589999999999999999999999999999998643     34567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++|+|||+++...... .......||..|+|||         .++||||+||++|||++|+.|+...    +..+..
T Consensus       132 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~----~~~~~~  206 (330)
T cd05586         132 TGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE----DTQQMY  206 (330)
T ss_pred             CCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC----CHHHHH
Confidence            9999999999987543222 2223457899999998         4589999999999999999997432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP----TMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP----s~~~v~~  369 (383)
                      +.+......-. .......+.+++.+|++.||++||    ++.++++
T Consensus       207 ~~i~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         207 RNIAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            22221111100 112345678899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=7.2e-30  Score=240.31  Aligned_cols=204  Identities=25%  Similarity=0.345  Sum_probs=157.7

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .+|...+.||+|+||.||                                       +|++++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            456677788888888887                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          205 VKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       205 ~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      ++++|.+++.+.    .....++.+++.||.|||+.   +++||||||+||+++.++.++++|||++........ ....
T Consensus        99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~  174 (297)
T cd06656          99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (297)
T ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence            999999998642    35678899999999999998   999999999999999999999999999876543322 2223


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc-cccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~-~~~~~~~~~~~~~~l~~  351 (383)
                      ..++..|++||        .++|+|||||++||+++|+.|+...    +.......+..... ....+......+.+++.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            46788899988        5689999999999999999997432    11111111111111 11112334456788999


Q ss_pred             HccccCCCCCCCHHHHHH--HHhccc
Q 046461          352 GCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                      +||..+|++||+++++++  .++..+
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcccc
Confidence            999999999999999997  555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.4e-30  Score=236.43  Aligned_cols=184  Identities=32%  Similarity=0.495  Sum_probs=142.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++......++||||+++++|.+++...       .....++.+++.|++|||+.   +++|+|+||+||+++
T Consensus        61 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~  137 (261)
T cd05034          61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVG  137 (261)
T ss_pred             CCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEc
Confidence            79999999999888999999999999999999642       24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||.++..............++..|++||        .++|+||||++++|+++ |+.|+...    .....
T Consensus       138 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~~~  213 (261)
T cd05034         138 ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREV  213 (261)
T ss_pred             CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHHH
Confidence            9999999999998866432211112223456788887        47899999999999999 88886321    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+.+... .....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       214 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         214 LEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            2222211 1111123345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=252.34  Aligned_cols=180  Identities=21%  Similarity=0.250  Sum_probs=134.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        61 p~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~  137 (377)
T cd05629          61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRG  137 (377)
T ss_pred             CCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCC
Confidence            79999999999999999999999999999998643     23456889999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCC------------c----------------------------------cccccccccccccC
Q 046461          257 FEVKVSDFGLVRLISDCES------------H----------------------------------TSTDVAGTIGYILL  290 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~------------~----------------------------------~~~~~~gt~~y~ap  290 (383)
                      +.+|++|||+++.......            .                                  ......||+.|+||
T Consensus       138 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  217 (377)
T cd05629         138 GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAP  217 (377)
T ss_pred             CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCH
Confidence            9999999999863311000            0                                  00124689999999


Q ss_pred             C--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec--CcccccCChhHHHHHHHHHHHccccCCCC
Q 046461          291 A--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTT  360 (383)
Q Consensus       291 e--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~  360 (383)
                      |        .++|||||||++|||++|+.||...    +..+....+..  ..+.-.........+.+++.+|+. +|.+
T Consensus       218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~  292 (377)
T cd05629         218 EIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE----NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             HHHccCCCCCceeeEecchhhhhhhcCCCCCCCC----CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence            8        5799999999999999999997432    11121111111  111101111234567788888987 6776


Q ss_pred             C---CCHHHHHH
Q 046461          361 R---PTMLRVQE  369 (383)
Q Consensus       361 R---Ps~~~v~~  369 (383)
                      |   ||+.|+++
T Consensus       293 r~~r~~~~~~l~  304 (377)
T cd05629         293 RLGRGGAHEIKS  304 (377)
T ss_pred             cCCCCCHHHHhc
Confidence            5   59999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.6e-30  Score=252.44  Aligned_cols=180  Identities=22%  Similarity=0.302  Sum_probs=136.8

Q ss_pred             cccceeeeEEEeCC-----EEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVGE-----KKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +||+++++++...+     ..++|+||+. ++|.+++...     .....++.|++.||+|||+.   +++||||||+||
T Consensus        59 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Ni  134 (372)
T cd07853          59 DNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNL  134 (372)
T ss_pred             CCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHE
Confidence            79999999998776     7899999996 6888887532     34577899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +++.++.+||+|||+++..............++..|+|||         .++||||+||++|||++|+.||...    +.
T Consensus       135 li~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~  210 (372)
T cd07853         135 LVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ----SP  210 (372)
T ss_pred             EECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC----CH
Confidence            9999999999999999875443333333456788899987         3579999999999999999997532    11


Q ss_pred             Cccceee-----------------------ecCcccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWV-----------------------LDSTILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v-----------------------~~~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+..+.+                       .......       .........+.+++.+|++.||++|||+.|+++
T Consensus       211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            1111100                       0000000       011223457889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=1.7e-30  Score=257.53  Aligned_cols=202  Identities=15%  Similarity=0.303  Sum_probs=149.4

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------cccceeeeEEEeC--------CEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVG--------EKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~--------~~~~l  199 (383)
                      +.+|...++||+|+||.||                                   +|||++++++...        ...++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            3568888999999999999                                   7999999887432        24679


Q ss_pred             EEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccc
Q 046461          200 VYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRL  269 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~  269 (383)
                      ||||+++ +|.+++...         .....++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus       145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            9999974 787776521         23467889999999999998   999999999999998664 799999999987


Q ss_pred             cCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee----------
Q 046461          270 ISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL----------  330 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~----------  330 (383)
                      .....  ......||..|+|||         .++|||||||++|||++|..||....    ..+....+.          
T Consensus       221 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        221 LLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS----SVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             ccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCCHHH
Confidence            64322  222356789999998         35799999999999999999975321    111000000          


Q ss_pred             ----c-------------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          331 ----D-------------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       331 ----~-------------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                          .             ..+...++...+.++.+++.+||..||++|||+.|+++  .++.+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                0             00001112223457889999999999999999999985  44443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.4e-30  Score=247.42  Aligned_cols=184  Identities=21%  Similarity=0.254  Sum_probs=133.8

Q ss_pred             cccceeeeEEEeC-----CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVG-----EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      |||+++++++...     ...++||||++ ++|.+++...     .....++.|++.||+|||+.   +|+||||||+||
T Consensus        59 pniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  134 (338)
T cd07859          59 PDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNI  134 (338)
T ss_pred             CCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            7999999988643     24799999995 6899988642     34577899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCC--ccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      +++.++.+||+|||+++.......  .......|+..|+|||          .++|||||||++|||++|+.|+......
T Consensus       135 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~  214 (338)
T cd07859         135 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV  214 (338)
T ss_pred             EECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence            999999999999999986532211  1123456899999998          3689999999999999999997432100


Q ss_pred             -----------CCCCccceeeec-----------Cccccc---CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 -----------KNGGNLVDWVLD-----------STILNA---YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 -----------~~~~~~~~~v~~-----------~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                 ....+....+..           ......   ........+.+++.+||+.||++|||++|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                       000000000000           000000   00122356789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=6e-30  Score=239.44  Aligned_cols=181  Identities=21%  Similarity=0.327  Sum_probs=139.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++.+.+.+..++||||+++|+|.+++...       .....++.|++.||.|||+.   +++||||||+||+++
T Consensus        60 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~  136 (285)
T cd05630          60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLD  136 (285)
T ss_pred             CCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEEC
Confidence            68999999999999999999999999999988532       24567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||++.......  ......|+..|+|||        .++|||||||++|||++|+.|+........ ....
T Consensus       137 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~  213 (285)
T cd05630         137 DHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV  213 (285)
T ss_pred             CCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH
Confidence            99999999999987654322  122346889999998        468999999999999999999754221100 0111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ....+ ......+......+.+++.+||+.||++|||     +.|+++
T Consensus       214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         214 ERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             Hhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            11111 1111223334557889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=1e-29  Score=240.50  Aligned_cols=180  Identities=27%  Similarity=0.384  Sum_probs=138.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++||||+++|+|.++++..     .....++.|++.||.|||+.+  +++|+|+||+||+++.+
T Consensus        59 ~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~  136 (308)
T cd06615          59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSR  136 (308)
T ss_pred             CCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecC
Confidence            79999999999999999999999999999999743     235678999999999999732  79999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.++++|||++.......   .....|+..|++||        .++||||||+++|||++|+.|+.....    ......
T Consensus       137 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~  209 (308)
T cd06615         137 GEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAM  209 (308)
T ss_pred             CcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHh
Confidence            999999999987653321   22346788899988        468999999999999999999743210    000000


Q ss_pred             e------------------------------------ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          329 V------------------------------------LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       329 v------------------------------------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .                                    ................+.+++.+||..+|++|||++||++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0                                    00000000001134568899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=5.7e-30  Score=238.36  Aligned_cols=191  Identities=24%  Similarity=0.412  Sum_probs=143.0

Q ss_pred             ccccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++||+++++++..  +...+++|||+++++|.+++...      .....++.|++.||+|||+.   +++|+|+||+||+
T Consensus        65 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil  141 (284)
T cd05038          65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNIL  141 (284)
T ss_pred             CCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEE
Confidence            4899999999987  56789999999999999999643      24577899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++.++++|||.+.........  ......++..|++||        .++||||||++++||++|+.|+.........
T Consensus       142 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~  221 (284)
T cd05038         142 VESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR  221 (284)
T ss_pred             EcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc
Confidence            999999999999999876532211  111223455688877        4689999999999999999986532211000


Q ss_pred             -----------CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          323 -----------GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       323 -----------~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                                 ..+.++ .........+.....++.+++.+||+.+|++||||.||+++|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         222 MIGIAQGQMIVTRLLEL-LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             ccccccccccHHHHHHH-HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence                       000000 1111111112334467899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=1.7e-30  Score=252.74  Aligned_cols=180  Identities=19%  Similarity=0.233  Sum_probs=133.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++.+.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        61 ~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~  137 (376)
T cd05598          61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRD  137 (376)
T ss_pred             CCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCC
Confidence            68999999999999999999999999999998753     23456788999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCC------------------------------------------CCccccccccccccccCC---
Q 046461          257 FEVKVSDFGLVRLISDC------------------------------------------ESHTSTDVAGTIGYILLA---  291 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~------------------------------------------~~~~~~~~~gt~~y~ape---  291 (383)
                      +.+||+|||++..+...                                          .........||+.|+|||   
T Consensus       138 ~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  217 (376)
T cd05598         138 GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL  217 (376)
T ss_pred             CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc
Confidence            99999999997532100                                          000112346899999998   


Q ss_pred             -----CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec--CcccccCChhHHHHHHHHHHHccccCCCCCC--
Q 046461          292 -----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTTRP--  362 (383)
Q Consensus       292 -----~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP--  362 (383)
                           .++|||||||++|||++|+.||...    +..+....+..  ..............+.+++.+|+ .+|++|+  
T Consensus       218 ~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         218 RTGYTQLCDWWSVGVILYEMLVGQPPFLAD----TPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             CCCCCcceeeeeccceeeehhhCCCCCCCC----CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence                 5789999999999999999997532    11111111111  11111111223445667777765 4999999  


Q ss_pred             -CHHHHHH
Q 046461          363 -TMLRVQE  369 (383)
Q Consensus       363 -s~~~v~~  369 (383)
                       |+.++++
T Consensus       293 ~t~~ell~  300 (376)
T cd05598         293 NGADEIKA  300 (376)
T ss_pred             CCHHHHhC
Confidence             8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-31  Score=255.25  Aligned_cols=180  Identities=25%  Similarity=0.417  Sum_probs=146.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|+++|+|...+ ....+|+|+++.|+|.+.|++..       ..+.++.|||.||.||..+   ++|||||..+|+|+-
T Consensus       171 ~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNllla  246 (1039)
T KOG0199|consen  171 PHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLA  246 (1039)
T ss_pred             cceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheec
Confidence            799999999987 67889999999999999998732       2467999999999999999   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCcc-cc-ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESHT-ST-DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGG  323 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~-~~-~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~  323 (383)
                      ....+||+|||+.|-+...+..- .. ...-.+.|.|||        .++|||+|||++|||+| |+.||.    +..+.
T Consensus       247 sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~----G~~g~  322 (1039)
T KOG0199|consen  247 SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV----GCRGI  322 (1039)
T ss_pred             ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC----CCCHH
Confidence            99999999999999886544322 11 122345678887        68999999999999998 778853    33455


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .+.+.+-++... .-++.+++.+++++..||..+|++|||+.++.+.
T Consensus       323 qIL~~iD~~erL-pRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  323 QILKNIDAGERL-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHhccccccC-CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            666655544332 3367889999999999999999999999999853

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=9.1e-30  Score=233.66  Aligned_cols=179  Identities=28%  Similarity=0.417  Sum_probs=137.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++++... ..+++|||+++|+|.+++...       .....++.|++.|+.|||+.   +++|||+||+||+++
T Consensus        59 ~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~  134 (254)
T cd05083          59 KNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVS  134 (254)
T ss_pred             CCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEc
Confidence            7999999998764 479999999999999999743       23467899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||.++......    .....+..|++||        .++|+||||+++|||++ |+.|+...    ...+.
T Consensus       135 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~----~~~~~  206 (254)
T cd05083         135 EDGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM----SLKEV  206 (254)
T ss_pred             CCCcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC----CHHHH
Confidence            99999999999987643211    1123346788887        46899999999999998 88886432    11122


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+.+.. ..........+..+.+++.+||+.+|++||+++++++.|++
T Consensus       207 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         207 KECVEK-GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHhC-CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            221111 11111223445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=8.5e-31  Score=240.10  Aligned_cols=195  Identities=23%  Similarity=0.314  Sum_probs=151.3

Q ss_pred             CccccCeeecCCccccc-----------------------------------cccceeeeEEEeCC---EE--EEEEEec
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVGE---KK--LIVYEYM  204 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~~---~~--~lv~e~~  204 (383)
                      .+...+++|.|+||.||                                   ||||+|.-++....   +.  .+|||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            45677999999999999                                   79999999887532   23  4899999


Q ss_pred             cCCCHHHHHhcc---h------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CceEEccccCccccCCCC
Q 046461          205 VKGSLNDWLRNQ---A------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       205 ~~gsL~~~l~~~---~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-~~~kl~Dfgla~~~~~~~  274 (383)
                      |. +|.+.++..   +      ...-+..|+.+||+|||+.   +|+||||||+|+|+|.+ +.+||||||-|+.+..+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            87 999999842   1      2456899999999999997   99999999999999976 999999999999887654


Q ss_pred             CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee----------------
Q 046461          275 SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV----------------  329 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v----------------  329 (383)
                      ..  .....|..|+|||         .+.||||.|||+.||+-|+.-|..    ++..+....+                
T Consensus       181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            33  3356788899998         688999999999999999987543    2222222221                


Q ss_pred             ------ecCcccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ------LDSTILN-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ------~~~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                            ..+.+..     -.......+..+++.+++..+|++|.++.|++.
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  0111111     122344567899999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.9e-30  Score=234.59  Aligned_cols=197  Identities=23%  Similarity=0.306  Sum_probs=153.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--CCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--GEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--~~~~~lv  200 (383)
                      ++|...|.|++|.||.||                                         ||||.+-.+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            345666999999999999                                         799999888765  4679999


Q ss_pred             EEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||||++ +|...+...+      +...++.|+++|++|||++   .|+|||||++|+|+...|.+||+|||+||.+... 
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            999976 9999998654      4567899999999999999   8999999999999999999999999999988764 


Q ss_pred             CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec--------------
Q 046461          275 SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--------------  331 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~--------------  331 (383)
                      ....+...-|.+|.|||         ++.|+||+|||+.|++++++-+..    ....+..+.+++              
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G----~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG----KSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC----CchHHHHHHHHHHhCCCccccCCCcc
Confidence            23445567799999988         678999999999999999877432    222222222200              


Q ss_pred             ----------Cc-----ccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ----------ST-----ILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ----------~~-----~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                +.     +...+... ....-.+++...+..||.+|-|+.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                      00     00111111 2356678899999999999999999875

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=3.8e-30  Score=246.00  Aligned_cols=198  Identities=19%  Similarity=0.217  Sum_probs=149.9

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|...+.||+|+||.||                                          +||+++++++.+++..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            56667788888888887                                          689999999999999999999


Q ss_pred             eccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999999999752      23466889999999999998   9999999999999999999999999999876543332


Q ss_pred             cccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--cc-ccCCh
Q 046461          277 TSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--IL-NAYSK  340 (383)
Q Consensus       277 ~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~-~~~~~  340 (383)
                      ......|+..|+|||             .++|||||||++|||++|+.|+...    +..+....+....  .. +....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~~p~~~~  234 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHEERFQFPSHIT  234 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC----CHHHHHHHHHcCCCcccCCCccc
Confidence            333356899999998             2579999999999999999997432    1112222221111  10 11112


Q ss_pred             hHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 046461          341 PSMLKMLQIVVGCIFDNPTT--RPTMLRVQE  369 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~--RPs~~~v~~  369 (383)
                      ..+..+.+++.+|+..++++  |++++++.+
T Consensus       235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            33567788888888765543  467888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7e-30  Score=244.17  Aligned_cols=182  Identities=18%  Similarity=0.208  Sum_probs=134.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+++..++||||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~  137 (331)
T cd05597          61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDK  137 (331)
T ss_pred             CCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECC
Confidence            68999999999999999999999999999999642      23567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.+||+|||+++..............||+.|+|||             .++|||||||++|||++|+.|+...    ..
T Consensus       138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~----~~  213 (331)
T cd05597         138 NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SL  213 (331)
T ss_pred             CCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC----CH
Confidence            999999999998765443332233356899999997             2589999999999999999997432    11


Q ss_pred             CccceeeecCc--cc-ccCChhHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 046461          323 GNLVDWVLDST--IL-NAYSKPSMLKMLQIVVGCIF--DNPTTRPTMLRVQEF  370 (383)
Q Consensus       323 ~~~~~~v~~~~--~~-~~~~~~~~~~~~~l~~~C~~--~~P~~RPs~~~v~~~  370 (383)
                      .+....+....  .. .......+..+.+++.+|+.  .++..||++.++++.
T Consensus       214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11111111100  00 01111234566677776554  444458899988863

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=9.7e-30  Score=264.45  Aligned_cols=205  Identities=20%  Similarity=0.305  Sum_probs=155.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...++||+|+||.||                                          |||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            356667788888888887                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc----------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          202 EYMVKGSLNDWLRNQ----------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       202 e~~~~gsL~~~l~~~----------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      ||+++|+|.+++...                .....++.|+++||+|||+.   +|+||||||+||+++.++.++++|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998631                12367889999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCC-----------------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          266 LVRLISDCES-----------------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       266 la~~~~~~~~-----------------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      +++.......                 .......||+.|+|||        .++|||||||+++||++|+.|+...    
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~----  234 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK----  234 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc----
Confidence            9986521100                 0111246899999998        5789999999999999999997432    


Q ss_pred             CCCccc--eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccc
Q 046461          321 NGGNLV--DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-TMLRVQEFLEKYHT  376 (383)
Q Consensus       321 ~~~~~~--~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-s~~~v~~~L~~~~~  376 (383)
                      +.....  ..+.++.-.. ...+.+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus       235 ~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        235 KGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             chhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            111111  1111111000 1123445688999999999999995 67778788876643

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.5e-29  Score=232.36  Aligned_cols=176  Identities=22%  Similarity=0.374  Sum_probs=135.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||+++++++.. +..++||||+++|+|.+++...      ..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus        60 h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~  135 (259)
T cd05037          60 HKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVA  135 (259)
T ss_pred             CcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEe
Confidence            5899999999988 7789999999999999999743      23577889999999999988   999999999999999


Q ss_pred             CCC-------ceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhC-CCCCCCC
Q 046461          255 EDF-------EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIR-KQPTGPE  316 (383)
Q Consensus       255 ~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg-~~p~~~~  316 (383)
                      .++       .+|++|||+++.....     ....++..|++||          .++||||||+++||+++| ..|+...
T Consensus       136 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         136 RYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             cCccccCCceeEEeCCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            887       7999999998765431     1234556788887          358999999999999995 5554321


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                          ...+...+......   .+......+.+++.+||..+|++|||+.+|++.|+
T Consensus       211 ----~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         211 ----SSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----CchhHHHHHhcCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                11111111111111   11222368889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=4.9e-30  Score=238.63  Aligned_cols=179  Identities=25%  Similarity=0.373  Sum_probs=141.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +||+++++++..++..++||||+++++|.+++...    .....++.|++.|+.|||+.   +++|+|++|+||+++.++
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~  138 (277)
T cd06642          62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQG  138 (277)
T ss_pred             CccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCC
Confidence            89999999999999999999999999999998642    34567899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||+++....... ......++..|++||        .++|||||||+++||++|+.|+....    .......+
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~  213 (277)
T cd06642         139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH----PMRVLFLI  213 (277)
T ss_pred             CEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc----hhhHHhhh
Confidence            999999999876643221 122245788899987        47999999999999999999964321    11111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ... .........+..+.+++.+||+.+|++||||.++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         214 PKN-SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             hcC-CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111 111122334567889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.8e-29  Score=234.49  Aligned_cols=181  Identities=21%  Similarity=0.328  Sum_probs=141.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ++|++++++++.++...++||||+++++|.+++...    .....++.+++.|+.|||+.   +++|+|++|+||+++.+
T Consensus        61 ~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~  137 (277)
T cd06917          61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNT  137 (277)
T ss_pred             CCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCC
Confidence            489999999999999999999999999999998643    34577899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.++++|||++....... .......|+..|++||         .++|||||||++|||++|+.|+...    +......
T Consensus       138 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~----~~~~~~~  212 (277)
T cd06917         138 GNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV----DAFRAMM  212 (277)
T ss_pred             CCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC----Chhhhhh
Confidence            999999999988765433 2223346888899988         4689999999999999999997532    1111111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+................+.+++.+||+.||++||++.|+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         213 LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111111111111124567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=7.8e-30  Score=235.71  Aligned_cols=180  Identities=24%  Similarity=0.305  Sum_probs=138.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++..++..++|+||+++++|.+++...     .....++.|++.|+.|||+.   +++|+||||+||+++.+
T Consensus        66 ~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  142 (267)
T cd06645          66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDN  142 (267)
T ss_pred             CCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence            79999999999999999999999999999998643     34677899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      +.++++|||++....... .......|+..|+|||           .++|||||||++|||++|+.|+.....   ....
T Consensus       143 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~---~~~~  218 (267)
T cd06645         143 GHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP---MRAL  218 (267)
T ss_pred             CCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc---hhhH
Confidence            999999999987654321 1223356888999998           258999999999999999999643211   1111


Q ss_pred             ceeeecCcccccC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVLDSTILNAY---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .. ..........   .......+.+++.+|++.+|++|||++++++
T Consensus       219 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         219 FL-MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Hh-hhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            10 0001110000   1123346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=2.8e-30  Score=249.72  Aligned_cols=197  Identities=22%  Similarity=0.297  Sum_probs=147.5

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +|...+.||+|+||.||                                          +||+++++++.+++..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            56677888999999888                                          689999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC--
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES--  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~--  275 (383)
                      |+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.......  
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            99999999998643     23567899999999999998   999999999999999999999999999875432110  


Q ss_pred             --------------------------------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          276 --------------------------------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       276 --------------------------------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                                                      .......||..|+|||        .++|||||||++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            0012346899999998        578999999999999999999743


Q ss_pred             CCCCCCCCccceeeec--CcccccCChhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046461          316 EFKDKNGGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTTRPT---MLRVQE  369 (383)
Q Consensus       316 ~~~~~~~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~~  369 (383)
                      .    ........+..  ..+.-........++.+++.+++ .||.+|++   +.|+.+
T Consensus       239 ~----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 E----TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             C----CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            2    22222221211  11100101123456677777765 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=1.3e-29  Score=236.30  Aligned_cols=180  Identities=22%  Similarity=0.305  Sum_probs=139.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++..++..++|+||+++|+|.+++..      +.....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        62 ~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~  138 (282)
T cd06643          62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTL  138 (282)
T ss_pred             CCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcc
Confidence            7999999999999999999999999999998753      234577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++++|||+++...... .......++..|++||             .++|||||||++|||++|+.|+...    +.
T Consensus       139 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~  213 (282)
T cd06643         139 DGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL----NP  213 (282)
T ss_pred             CCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc----CH
Confidence            9999999999987653321 1223356888999998             2699999999999999999996432    11


Q ss_pred             CccceeeecCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ............ ....+......+.+++.+||+.||++|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         214 MRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111100 00112234457889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=1.1e-29  Score=238.97  Aligned_cols=180  Identities=24%  Similarity=0.344  Sum_probs=141.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++|+||+++++|.+++...    .+...++.+++.|++|||+.   +++|+||||+||+++.++
T Consensus        76 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~  152 (296)
T cd06655          76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDG  152 (296)
T ss_pred             CceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            79999999999999999999999999999998742    45678899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||+++....... ......++..|++||        .++|||||||++||+++|+.|+....    .......+
T Consensus       153 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~----~~~~~~~~  227 (296)
T cd06655         153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLI  227 (296)
T ss_pred             CEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH
Confidence            999999999876543322 122346788999998        46899999999999999999974321    11111111


Q ss_pred             ecCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..... ....+......+.+++.+||..||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11110 01112334557888999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=2e-29  Score=233.14  Aligned_cols=180  Identities=23%  Similarity=0.330  Sum_probs=133.4

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+  ++..++++||+++++|.+++...     .....++.|++.||+|||+.   +++|+|+||+||+++
T Consensus        64 ~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~  140 (266)
T cd06651          64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRD  140 (266)
T ss_pred             CCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEC
Confidence            799999998875  36788999999999999998643     34567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCC--CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCE--SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~--~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++......  ........++..|+|||        .++|||||||++||+++|+.|+...    +...
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~----~~~~  216 (266)
T cd06651         141 SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY----EAMA  216 (266)
T ss_pred             CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc----chHH
Confidence            99999999999987653211  11112345788999998        4689999999999999999996432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..............+......+.+++ +||..+|++||+++||++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11111111111112222334455555 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=2.8e-29  Score=233.60  Aligned_cols=180  Identities=24%  Similarity=0.375  Sum_probs=142.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++.+++..++||||+++|+|.+++...    .....++.+++.|++|||+.   +++|+||+|+||+++.++
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~  138 (277)
T cd06640          62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQG  138 (277)
T ss_pred             CCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCC
Confidence            79999999999999999999999999999998742    34567889999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||++........ ......++..|++||        .++|+|||||++|||++|+.|+....    .......+
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~----~~~~~~~~  213 (277)
T cd06640         139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH----PMRVLFLI  213 (277)
T ss_pred             CEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC----hHhHhhhh
Confidence            999999999976644321 222345778899988        47899999999999999999965321    11111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                       .....+.........+.+++.+||+.+|++||++.++++.
T Consensus       214 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             1111222234566788999999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=1.3e-29  Score=237.14  Aligned_cols=181  Identities=21%  Similarity=0.282  Sum_probs=138.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++.+++..++..+++|||+++|+|.+++...       .....++.|++.||.|||+.   +|+|||+||+||+++
T Consensus        60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~  136 (285)
T cd05632          60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLD  136 (285)
T ss_pred             cCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEC
Confidence            68999999999999999999999999999888632       24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||++.......  ......|+..|++||        .++|+|||||++||+++|+.|+...-.......+.
T Consensus       137 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~  214 (285)
T cd05632         137 DYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD  214 (285)
T ss_pred             CCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999987654322  123356899999998        46899999999999999999975321100000111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ..+...  ...........+.+++..||+.||++||+     +.++++
T Consensus       215 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         215 RRVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             Hhhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            111111  11222334557789999999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=2e-29  Score=233.60  Aligned_cols=182  Identities=27%  Similarity=0.398  Sum_probs=139.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++++...+..++||||+++|+|.++++..     .....++.|++.|+.|||+.   +++|+|++|+||+++.
T Consensus        67 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~  143 (272)
T cd06629          67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDA  143 (272)
T ss_pred             CCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcC
Confidence            589999999999999999999999999999998753     23466889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-ccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||+++....... .......++..|++||          .++|+||||++++|+++|..|+...    +...
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~  219 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIA  219 (272)
T ss_pred             CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chHH
Confidence            99999999999876543211 1123345788898887          3589999999999999999996421    1111


Q ss_pred             -ccee---eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 -LVDW---VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 -~~~~---v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       ..+.   .................+.+++.+||..+|++|||+.+|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             1100   01111111112234567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=3.3e-29  Score=232.19  Aligned_cols=203  Identities=20%  Similarity=0.248  Sum_probs=154.2

Q ss_pred             HHHHHHhhCccccCee--ecCCccccc-----------------------------------cccceeeeEEEeCCEEEE
Q 046461          157 DQIVAGTNKFYEKNVI--RGDDFGIAF-----------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~l--g~g~~g~v~-----------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++....++|...+.+  |+|+||.||                                   +|++++++++...+..++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            3444444555555554  888888887                                   799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~~~~~  273 (383)
                      ||||+++|+|.+++...     .....++.|+++|+.|||+.   +++||||||+||+++.++ .++++|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            99999999999998753     34577899999999999998   899999999999999988 9999999998765432


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                           ....++..|+|||        .++||||||++++||++|+.|+.....  .......+.................
T Consensus       164 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T PHA03390        164 -----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQQKKLPFIKNVSKN  236 (267)
T ss_pred             -----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhhcccCCcccccCHH
Confidence                 1235788899998        468999999999999999999753221  1111111110001111122345667


Q ss_pred             HHHHHHHccccCCCCCCC-HHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPT-MLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs-~~~v~~  369 (383)
                      +.+++.+|++.+|++||+ ++|+++
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhc
Confidence            889999999999999996 688874

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=1.4e-29  Score=239.15  Aligned_cols=185  Identities=20%  Similarity=0.254  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++.+..++..++||||+++|+|.+++...     .....++.+++.|++|||+.   +++|||+||+||+++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~  137 (305)
T cd05609          61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSM  137 (305)
T ss_pred             CCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCC
Confidence            79999999999999999999999999999999643     23466788999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCC--------------CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          257 FEVKVSDFGLVRLISDCE--------------SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~--------------~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      +.++++|||+++......              ........++..|++||        .++|+||||+++||+++|+.|+.
T Consensus       138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999987421100              00111245778899998        47999999999999999999964


Q ss_pred             CCCCCCCCCccceeeecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          315 PEFKDKNGGNLVDWVLDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..    ...++.+......... ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       218 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         218 GD----TPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             CC----CHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            21    2222222222211111 1111345678899999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=2e-29  Score=231.06  Aligned_cols=180  Identities=26%  Similarity=0.381  Sum_probs=140.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++.+++..++++||+++++|.+++..      +.....++.|++.|+.|||+.   +++|+|++|+||+++.
T Consensus        58 ~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~  134 (256)
T cd06612          58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNE  134 (256)
T ss_pred             CcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECC
Confidence            7999999999999999999999999999999863      234577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||++........ ......++..|++||        .++||||||+++|||++|+.|+.....    .....
T Consensus       135 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~----~~~~~  209 (256)
T cd06612         135 EGQAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP----MRAIF  209 (256)
T ss_pred             CCcEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch----hhhhh
Confidence            99999999999887654321 222345788899998        479999999999999999999753211    11111


Q ss_pred             eeecCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTIL-NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+...... ...+......+.+++.+||+.||++|||+.||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11100000 0112233457889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.7e-29  Score=229.89  Aligned_cols=185  Identities=24%  Similarity=0.349  Sum_probs=141.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||+++++++.+.+..++||||+++++|.+++...      .....++.+++.|++|||++   +++|||+||+||+++
T Consensus        51 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~  127 (251)
T cd05041          51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVG  127 (251)
T ss_pred             CCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEc
Confidence            589999999999999999999999999999998642      23467889999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccc-cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTS-TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++.......... ....++..|++||        .++|+||||++++||++ |..|+...    ....
T Consensus       128 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~----~~~~  203 (251)
T cd05041         128 ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM----SNQQ  203 (251)
T ss_pred             CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC----CHHH
Confidence            999999999999876542211111 1122355688887        57899999999999999 77775322    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      ..+.+.. ......+...+..+.+++.+||..+|++|||+.|+++.|+.
T Consensus       204 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         204 TRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            1111111 11112233455689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2e-29  Score=233.98  Aligned_cols=180  Identities=24%  Similarity=0.326  Sum_probs=142.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ++|++++++++.++...++|+||+++++|.+++...    .....++.|++.|+.|||+.   +++|+|++|+||+++.+
T Consensus        58 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~  134 (274)
T cd06609          58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEE  134 (274)
T ss_pred             CCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC
Confidence            389999999999999999999999999999998753    34677899999999999998   89999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.++++|||+++...... .......++..|++||        .++||||||+++|||++|+.|+...    +.......
T Consensus       135 ~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~----~~~~~~~~  209 (274)
T cd06609         135 GDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL----HPMRVLFL  209 (274)
T ss_pred             CCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC----chHHHHHH
Confidence            999999999998765432 1223346788899998        5799999999999999999996432    11111111


Q ss_pred             eecCcccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          329 VLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +... ........ ....+.+++.+||..+|++|||++++++
T Consensus       210 ~~~~-~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         210 IPKN-NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             hhhc-CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111 11111111 4557889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=1.5e-29  Score=235.63  Aligned_cols=180  Identities=22%  Similarity=0.320  Sum_probs=136.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +|++++++++..++..+++|||++ |+|.+++...         .....++.|++.|++|||+++  +++|||+||+||+
T Consensus        60 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil  136 (283)
T cd06617          60 PYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVL  136 (283)
T ss_pred             CCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEE
Confidence            799999999999999999999996 7888887532         235688999999999999753  7999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      ++.++.+||+|||+++......  ..+...++..|++||            .++|+||||+++|||++|+.|+....   
T Consensus       137 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---  211 (283)
T cd06617         137 INRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK---  211 (283)
T ss_pred             ECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc---
Confidence            9999999999999988654321  122245778899887            35899999999999999999964311   


Q ss_pred             CCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 NGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+....+.............+..+.+++.+||+.+|++|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         212 TPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111111111111111223467889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5e-30  Score=244.90  Aligned_cols=197  Identities=20%  Similarity=0.296  Sum_probs=156.1

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      .|.....||+||.+.||                                         .+||+|++|-..++.+|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            35566789999999999                                         5999999999999999999997


Q ss_pred             ccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-c
Q 046461          204 MVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-H  276 (383)
Q Consensus       204 ~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~  276 (383)
                      = .-+|.++|+...      ....+..|++.++.++|.+   +|||.||||.|.|+- .|.+||+|||+|..+....+ -
T Consensus       442 G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             c-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence            6 569999998532      2456889999999999999   999999999999985 68899999999987765432 2


Q ss_pred             cccccccccccccCC-------------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc
Q 046461          277 TSTDVAGTIGYILLA-------------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA  337 (383)
Q Consensus       277 ~~~~~~gt~~y~ape-------------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~  337 (383)
                      .....+||+.||+||                   .++||||+|||||+|+.|+.||.. +.  +...-...+.++...-+
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-~~--n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-II--NQIAKLHAITDPNHEIE  593 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-HH--HHHHHHHhhcCCCcccc
Confidence            334578999999998                   578999999999999999999743 21  11222233455533223


Q ss_pred             CCh-hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          338 YSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       338 ~~~-~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++. ....++.++|..|++.||.+|||..++++
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            322 12233899999999999999999999986

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=4.4e-30  Score=235.83  Aligned_cols=183  Identities=27%  Similarity=0.431  Sum_probs=141.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+.+..++||||+++++|.+++..     ......++.|+++||++||+.   +++|+||||+||+++.+
T Consensus        58 ~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~  134 (260)
T PF00069_consen   58 PNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDEN  134 (260)
T ss_dssp             TTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence            7999999999999999999999999999999972     234678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.++++|||.+..... .........++..|+|||         .++||||+|++++||++|..|+..... .+......
T Consensus       135 ~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~  212 (260)
T PF00069_consen  135 GEVKLIDFGSSVKLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIE  212 (260)
T ss_dssp             SEEEESSGTTTEESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHH
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhh
Confidence            9999999999876422 222334456788899887         468999999999999999999754300 01111111


Q ss_pred             eeecCcccccCC--hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYS--KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ............  ......+.+++..|++.||++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111111111  112368999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=2.6e-29  Score=232.00  Aligned_cols=181  Identities=23%  Similarity=0.378  Sum_probs=140.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||++++++|.+.+..++++||+++++|.+++...     .....++.|++.|++|||+.   +++|+||+|+||+++.+
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~  138 (265)
T cd06631          62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPN  138 (265)
T ss_pred             CCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCC
Confidence            79999999999999999999999999999998642     23567889999999999988   89999999999999999


Q ss_pred             CceEEccccCccccCCCC-----CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          257 FEVKVSDFGLVRLISDCE-----SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~-----~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +.++++|||+++......     ........|+..|++||        .++||||||++++|+++|+.|+...    +..
T Consensus       139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~  214 (265)
T cd06631         139 GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----DRL  214 (265)
T ss_pred             CeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC----ChH
Confidence            999999999987653211     11122345788999998        5699999999999999999997432    111


Q ss_pred             ccceeeecC-cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDS-TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~-~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+... ......+......+.+++.+||+.+|++||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         215 AAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111111111 1111223345567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=3.2e-29  Score=231.47  Aligned_cols=181  Identities=23%  Similarity=0.324  Sum_probs=141.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+.+..++++||+++++|.+++...     .....++.|++.|++|||+.   +++||||+|+||+++.
T Consensus        65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~  141 (267)
T cd06628          65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDN  141 (267)
T ss_pred             CCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcC
Confidence            589999999999999999999999999999999643     23567899999999999988   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-----ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCES-----HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-----~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++++|||.++.......     .......|+..|++||        .++|+||+|+++|||++|+.|+...    +.
T Consensus       142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~  217 (267)
T cd06628         142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC----TQ  217 (267)
T ss_pred             CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc----cH
Confidence            99999999999887642211     1112245788899998        4689999999999999999997532    11


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+.. ......+......+.+++.+||+.||++||++.|+++
T Consensus       218 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         218 LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111111111 1111223344567889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=2.8e-29  Score=230.27  Aligned_cols=179  Identities=26%  Similarity=0.369  Sum_probs=139.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +|++++.+++.+++..++++||+++++|.+++...     .....++.|++.|++|||+.   +++|+||+|+||+++.+
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~  138 (258)
T cd06632          62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTN  138 (258)
T ss_pred             CCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            79999999999999999999999999999998643     34567899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.+||+|||++.......  ......++..|++||         .++|+||||+++||+++|+.|+....    ......
T Consensus       139 ~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~  212 (258)
T cd06632         139 GVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVF  212 (258)
T ss_pred             CCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHH
Confidence            999999999987654332  123345778888877         35899999999999999999965321    111111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.........+......+.+++.+||+.+|++||++.+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         213 KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            111101111222334567888999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=4.9e-30  Score=236.86  Aligned_cols=176  Identities=23%  Similarity=0.352  Sum_probs=150.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||++++.+|...+...+||||..+|+|+|++...     .+...++.||..|+.|+|.+   +++|||||.+|||+|.+
T Consensus       113 PhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N  189 (668)
T KOG0611|consen  113 PHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQN  189 (668)
T ss_pred             CceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCC
Confidence            89999999999999999999999999999999754     34678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +++||+|||++-.+....  ..+.++|++-|.+||         +..|.||+||+||-++.|..||+    +.+...++.
T Consensus       190 ~NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD----G~Dhk~lvr  263 (668)
T KOG0611|consen  190 NNIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD----GRDHKRLVR  263 (668)
T ss_pred             CCeeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC----CchHHHHHH
Confidence            999999999998775432  344589999999998         56899999999999999999954    446666777


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+-.+.+..+   +.+....-++.+++..||+.|.|+.+|..
T Consensus       264 QIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  264 QISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             HhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            7666655432   23334556888899999999999999976

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=2.9e-29  Score=232.50  Aligned_cols=186  Identities=21%  Similarity=0.435  Sum_probs=139.1

Q ss_pred             ccccceeeeEEEeCC------EEEEEEEeccCCCHHHHHhcc-----------hhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          181 FKNIVQLLGYCPVGE------KKLIVYEYMVKGSLNDWLRNQ-----------AKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       181 ~~niv~l~g~~~~~~------~~~lv~e~~~~gsL~~~l~~~-----------~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      ++|++++++++...+      ..++++||+++|+|.+++...           .....++.|++.|++|||+.   +++|
T Consensus        60 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H  136 (273)
T cd05074          60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIH  136 (273)
T ss_pred             CCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEee
Confidence            489999999886532      247889999999999887421           23477899999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPT  313 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~  313 (383)
                      ||+||+||+++.++.+|++|||.++....... .......++..|++||        .++||||||+++|||++ |+.|+
T Consensus       137 ~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~  216 (273)
T cd05074         137 RDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY  216 (273)
T ss_pred             cccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCC
Confidence            99999999999999999999999886543221 1112233456788877        46899999999999999 77775


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...    +..+...++...... .........+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 ~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         217 AGV----ENSEIYNYLIKGNRL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCC----CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            321    222222222221111 11233456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-29  Score=233.66  Aligned_cols=180  Identities=24%  Similarity=0.329  Sum_probs=136.6

Q ss_pred             cccceeeeEEEeCC------EEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          182 KNIVQLLGYCPVGE------KKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       182 ~niv~l~g~~~~~~------~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +||+++++++....      ..++||||+++++|.+++...         .....++.|++.||+|||+.   +++|+|+
T Consensus        63 ~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l  139 (275)
T cd06608          63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDI  139 (275)
T ss_pred             CChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCC
Confidence            79999999997644      589999999999999988642         23466899999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      +|+||+++.++.++++|||.+....... .......|+..|+|||             .++||||||++++|+++|+.|+
T Consensus       140 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  218 (275)
T cd06608         140 KGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL  218 (275)
T ss_pred             CHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCc
Confidence            9999999999999999999987654322 1222345788899987             2589999999999999999997


Q ss_pred             CCCCCCCCCCccceeeecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...    ........+....... ..+......+.+++.+||..||++|||+.|+++
T Consensus       219 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         219 CDM----HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccc----chHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            432    1111111111111111 111224557889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=1.9e-29  Score=231.59  Aligned_cols=179  Identities=26%  Similarity=0.345  Sum_probs=141.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+.+..++|+||+++++|.+++...       .....++.|++.|++|||+.   +++|+|++|+||+++
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~  135 (256)
T cd08218          59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLT  135 (256)
T ss_pred             CCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence            79999999999999999999999999999998642       23577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||++........ ......|+..|++||        .++|+|||||+++|+++|+.|+...    +..+..
T Consensus       136 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~  210 (256)
T cd08218         136 KDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----NMKNLV  210 (256)
T ss_pred             CCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----CHHHHH
Confidence            999999999999876543221 112345778899988        4789999999999999999996432    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+..... ...+......+.+++.+||+.+|++||++.+|++
T Consensus       211 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         211 LKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            22222221 1123344567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=4e-29  Score=234.31  Aligned_cols=180  Identities=23%  Similarity=0.324  Sum_probs=138.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++..++..++||||+++++|..++..      +.....++.|++.|++|||+.   +++|||+||+||+++.
T Consensus        69 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~  145 (292)
T cd06644          69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTL  145 (292)
T ss_pred             CcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcC
Confidence            7999999999999999999999999999988753      234577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++|+|||++...... ........++..|++||             .++|||||||++|||++|+.|+...    +.
T Consensus       146 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~  220 (292)
T cd06644         146 DGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL----NP  220 (292)
T ss_pred             CCCEEEccCccceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc----cH
Confidence            999999999998754322 11222345778899987             2589999999999999999996431    11


Q ss_pred             CccceeeecCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ............ ....+......+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         221 MRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111111111110 00112234457889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.9e-29  Score=235.52  Aligned_cols=185  Identities=25%  Similarity=0.375  Sum_probs=141.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++...+..++||||+++|+|.+++...     .....++.+++.|+.|||+..  +++|||+||+||+++.+
T Consensus        63 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~  140 (284)
T cd06620          63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSR  140 (284)
T ss_pred             CCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCC
Confidence            79999999999999999999999999999988653     245678999999999999732  79999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC----Cc
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG----GN  324 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~----~~  324 (383)
                      +.++++|||++.......   .....|+..|++||        .++|+|||||++||+++|+.|++......+.    ..
T Consensus       141 ~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~  217 (284)
T cd06620         141 GQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG  217 (284)
T ss_pred             CcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH
Confidence            999999999986543221   12346888999988        4799999999999999999997643221110    01


Q ss_pred             ---cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          325 ---LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       325 ---~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                         ..+.+................+.+++.+||+.||++|||+.|++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         218 ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence               11111111111111122456788999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=2e-29  Score=236.98  Aligned_cols=183  Identities=16%  Similarity=0.180  Sum_probs=128.8

Q ss_pred             ccceeeeEEEeCC----EEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          183 NIVQLLGYCPVGE----KKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       183 niv~l~g~~~~~~----~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      |++++++++....    ..++++|++.. ++.+.+..     ......++.|++.||+|||+.   +++||||||+|||+
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            4566666554432    34677777643 56555542     233567999999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCC------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCES------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      +.++.++++|||+++.......      .......||+.|++||        .++|||||||+++||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            9999999999999986642211      1112246899999987        5789999999999999999997542111


Q ss_pred             CCC-----CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          320 KNG-----GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       320 ~~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ...     .+....+..+..   ........+.+++..||+.+|++||++.++.+.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            000     001111111111   12234567889999999999999999999998763

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.2e-29  Score=242.08  Aligned_cols=147  Identities=21%  Similarity=0.330  Sum_probs=125.5

Q ss_pred             HHhhCccccCeeecCCccccc---------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF---------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~---------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      ....+|...+.||+|+||.||                                 +||+++++++..++..++|+||+ .|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~  141 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS  141 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence            344678899999999999998                                 69999999999999999999999 56


Q ss_pred             CHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccc
Q 046461          208 SLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       208 sL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      +|.+++...      .....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus       142 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~  216 (357)
T PHA03209        142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGL  216 (357)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccccc
Confidence            899988642      34678999999999999998   9999999999999999999999999998754322  122345


Q ss_pred             ccccccccCC--------CCCcchhHHHHHHHHHhCCCCC
Q 046461          282 AGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       282 ~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      .||..|+|||        .++|||||||++|||+++..|+
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            6899999998        5789999999999999976654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=5.1e-29  Score=229.65  Aligned_cols=181  Identities=27%  Similarity=0.411  Sum_probs=140.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +|++++++.+..++..++|+||+++++|.++++..        .....++.|++.|++|||+.   +++|+|+||+||++
T Consensus        59 ~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~  135 (267)
T cd06610          59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILL  135 (267)
T ss_pred             CCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEE
Confidence            79999999999999999999999999999998642        23467889999999999988   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc---cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      +.++.++++|||++.........   ......|+..|++||         .++|+|||||+++||++|+.|+....    
T Consensus       136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~----  211 (267)
T cd06610         136 GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP----  211 (267)
T ss_pred             cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC----
Confidence            99999999999998776543222   123345788899987         36899999999999999999975321    


Q ss_pred             CCccceeeecC---cccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 GGNLVDWVLDS---TILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 ~~~~~~~v~~~---~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...........   .+.... ....+..+.+++.+||..||++|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         212 PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             hhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111111111   111110 1234567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=2.8e-29  Score=234.22  Aligned_cols=180  Identities=22%  Similarity=0.299  Sum_probs=139.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++.+++..++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~  132 (279)
T cd05633          56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDE  132 (279)
T ss_pred             CCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECC
Confidence            478999999999999999999999999999998643     34677899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++++|||++.......   .....|+..|++||         .++|||||||+++||++|..|+...... ....+.
T Consensus       133 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~  208 (279)
T cd05633         133 HGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEID  208 (279)
T ss_pred             CCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-CHHHHH
Confidence            9999999999987553322   22346888999988         3579999999999999999997532111 111111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +...  ......+......+.+++.+|+..||++||     |++++++
T Consensus       209 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         209 RMTL--TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             HHhh--cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            1110  111122334456788999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=1.7e-29  Score=238.93  Aligned_cols=184  Identities=19%  Similarity=0.284  Sum_probs=137.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++..++..++||||+++ +|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        64 ~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~  139 (309)
T cd07872          64 ANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINE  139 (309)
T ss_pred             CCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence            7999999999999999999999975 888887642      23566889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      ++.+||+|||+++...... .......++..|++||         .++|||||||++|||++|+.|+....    ..+..
T Consensus       140 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~----~~~~~  214 (309)
T cd07872         140 RGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST----VEDEL  214 (309)
T ss_pred             CCCEEECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHH
Confidence            9999999999987643322 1222345788899998         35899999999999999999974321    11100


Q ss_pred             eee---------------------ecCccccc-------CChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          327 DWV---------------------LDSTILNA-------YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       327 ~~v---------------------~~~~~~~~-------~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ..+                     .+......       ........+.+++.+|++.||++|||+.|+++  .++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            000                     00000000       00123456789999999999999999999987  44443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=3.6e-29  Score=229.71  Aligned_cols=180  Identities=20%  Similarity=0.339  Sum_probs=140.0

Q ss_pred             ccccceeeeEEEe-CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++|++++++.+.. ....+++|||+++++|.+++...       .+...++.+++.|++|||+.   +++|+||||+||+
T Consensus        58 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil  134 (257)
T cd08223          58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVF  134 (257)
T ss_pred             CCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEE
Confidence            3799999988764 44689999999999999998642       24578999999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++.++++|||+++....... ......++..|+|||        .++||||||++++|+++|+.|++..    +...
T Consensus       135 ~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~----~~~~  209 (257)
T cd08223         135 LTRTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----DMNS  209 (257)
T ss_pred             EecCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHH
Confidence            99999999999999987643222 223346788999998        4789999999999999999996432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+..... ...+......+.+++.+||+.+|++|||+.++++
T Consensus       210 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         210 LVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHHHHHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111111 1223345568899999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.5e-29  Score=249.37  Aligned_cols=204  Identities=20%  Similarity=0.262  Sum_probs=152.9

Q ss_pred             hhCccccCeeecCCccccc---------------------------------cccceeeeEEEeCCEEEEEEEeccCCCH
Q 046461          163 TNKFYEKNVIRGDDFGIAF---------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSL  209 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~---------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL  209 (383)
                      ..+|.....||+|+||.||                                 +|||++++++..++..++|||++ .++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L  246 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL  246 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence            3468888999999999998                                 79999999999999999999999 4799


Q ss_pred             HHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccc
Q 046461          210 NDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVA  282 (383)
Q Consensus       210 ~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~  282 (383)
                      .+++..      +.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       247 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        247 YTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            988853      234678999999999999998   999999999999999999999999999987643221 1223456


Q ss_pred             cccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC----CCccceeeecC-----ccc----------
Q 046461          283 GTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN----GGNLVDWVLDS-----TIL----------  335 (383)
Q Consensus       283 gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~----~~~~~~~v~~~-----~~~----------  335 (383)
                      ||..|++||        .++|||||||++|||++|..|+........    ...+.+.+...     ...          
T Consensus       324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~  403 (461)
T PHA03211        324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ  403 (461)
T ss_pred             CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence            999999998        578999999999999998876432111000    00011100000     000          


Q ss_pred             ----------ccC----Ch---hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          336 ----------NAY----SK---PSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       336 ----------~~~----~~---~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                                ...    ..   .....+.+++.+|++.||++|||+.|+++.
T Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      000    00   112357889999999999999999999863

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.96  E-value=6e-29  Score=227.86  Aligned_cols=183  Identities=31%  Similarity=0.513  Sum_probs=142.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++++.+.+..+++|||+++++|.+++...       .....++.|++.|++|||+.   +++|+|+||+||++
T Consensus        60 ~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~  136 (258)
T smart00219       60 HPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLV  136 (258)
T ss_pred             CCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEE
Confidence            489999999999999999999999999999998642       23577899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      +.++.++++|||+++..............++..|++||        .++||||+|++++||++ |..|+..    .+...
T Consensus       137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~----~~~~~  212 (258)
T smart00219      137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG----MSNEE  212 (258)
T ss_pred             ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCHHH
Confidence            99999999999999876543222221233677899887        57999999999999998 6677532    12223


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      ..+.+...... ..+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       213 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      213 VLEYLKKGYRL-PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHhcCCCC-CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            33322222211 12233556788999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-31  Score=270.82  Aligned_cols=200  Identities=27%  Similarity=0.360  Sum_probs=162.2

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +-++...+.||.|.||.||                                         ||+|+++|.-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456788999999999999                                         89999999999999999999


Q ss_pred             EeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-
Q 046461          202 EYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-  275 (383)
                      |||++|+|.+.+....     -...+..|++.|++|||+.   +|||||+||.||+++.++.+|.+|||.|..+..... 
T Consensus      1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            9999999999986431     2345778999999999998   999999999999999999999999999988754321 


Q ss_pred             --ccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhH
Q 046461          276 --HTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS  342 (383)
Q Consensus       276 --~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  342 (383)
                        .......||+.|||||           .++||||+|||++||+||++||.. ++  +.-.++-+|..+.. +..++..
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~-~d--ne~aIMy~V~~gh~-Pq~P~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE-LD--NEWAIMYHVAAGHK-PQIPERL 1466 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh-cc--chhHHHhHHhccCC-CCCchhh
Confidence              1122457999999999           357999999999999999999853 22  23334434433332 2334556


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+-.+++.+|++.||+.|+++.|+++
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            677789999999999999999988876

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=1.7e-29  Score=243.73  Aligned_cols=202  Identities=23%  Similarity=0.262  Sum_probs=149.2

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC------
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG------  194 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~------  194 (383)
                      ..++|...+.||+|+||.||                                         +||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            44678888899999999998                                         7999999988643      


Q ss_pred             CEEEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      ...++||||+++ ++.+.+..   ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            357999999965 67776653   334567899999999999998   99999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC-----------CCcc-------
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN-----------GGNL-------  325 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~-----------~~~~-------  325 (383)
                      ..  .......||..|+|||        .++|||||||++|||++|+.||........           ..+.       
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            32  2223356889999998        578999999999999999999743210000           0000       


Q ss_pred             -ceee----------e-----cCccc--ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 -VDWV----------L-----DSTIL--NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 -~~~v----------~-----~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       ..++          .     +....  ..........+.+++.+|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence             0000          0     00000  0001112356789999999999999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=5.9e-29  Score=229.74  Aligned_cols=180  Identities=21%  Similarity=0.239  Sum_probs=136.0

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+.  ...+++|||+++|+|.+++...     .....++.+++.||+|||+.   +++|+||||+||+++
T Consensus        64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~  140 (265)
T cd06652          64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRD  140 (265)
T ss_pred             CCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEec
Confidence            7999999988763  4678999999999999998643     24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCC--ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++.......  .......++..|++||        .++|||||||++|||++|+.|+...    +...
T Consensus       141 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~  216 (265)
T cd06652         141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMA  216 (265)
T ss_pred             CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc----chHH
Confidence            999999999999876542211  1122345888999998        4689999999999999999996421    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..............+......+.+++.+||. +|++||+++||++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         217 AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111111111122233445677888889985 9999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=2.8e-29  Score=234.63  Aligned_cols=183  Identities=26%  Similarity=0.355  Sum_probs=134.6

Q ss_pred             ccccceeeeEEEe-----CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          181 FKNIVQLLGYCPV-----GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       181 ~~niv~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      |+||+++++++..     ....+++|||++ ++|.+++...       .....++.|++.||+|||+.   +++||||||
T Consensus        61 h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp  136 (288)
T cd07863          61 HPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKP  136 (288)
T ss_pred             CCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            4899999998864     345799999997 5898888642       24577899999999999998   999999999


Q ss_pred             CcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          249 SNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       249 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      +||+++.++.+||+|||+++......  ......|+..|+|||        .++||||+||++|||++|+.|+.......
T Consensus       137 ~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~  214 (288)
T cd07863         137 ENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD  214 (288)
T ss_pred             HHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence            99999999999999999998664321  223356788999998        57899999999999999999864321100


Q ss_pred             CCCccc---------eeeecC-----ccc-------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 NGGNLV---------DWVLDS-----TIL-------NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 ~~~~~~---------~~v~~~-----~~~-------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+.         .|-.+.     ...       ..........+.+++.+|++.||++|||+.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         215 QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000         000000     000       0011223456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-29  Score=233.83  Aligned_cols=180  Identities=24%  Similarity=0.329  Sum_probs=139.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++..++..++||||+++|+|.+++...      .....++.|++.|+.|||+.   +++|+|+||+||+++.
T Consensus        62 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~  138 (280)
T cd06611          62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTL  138 (280)
T ss_pred             CceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECC
Confidence            79999999999999999999999999999998642      34578999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      ++.++++|||++........ ......++..|++||             .++|+||||+++|||++|+.|+...    +.
T Consensus       139 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~----~~  213 (280)
T cd06611         139 DGDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL----NP  213 (280)
T ss_pred             CCCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC----CH
Confidence            99999999999876533221 122345788899887             2689999999999999999996432    11


Q ss_pred             CccceeeecCccc-ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTIL-NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+...... ...+......+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1111111111110 0112234457889999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=5.6e-29  Score=228.16  Aligned_cols=178  Identities=25%  Similarity=0.393  Sum_probs=140.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +|++++++.+..++..++||||+++++|.+++...       .....++.+++.|++|||+.   +++|+|+||+||+++
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~  135 (256)
T cd08220          59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLD  135 (256)
T ss_pred             CchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            79999999999999999999999999999999642       23567889999999999998   999999999999998


Q ss_pred             CC-CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 ED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .+ ..++++|||.++......  ......++..|++||        .++||||||+++|||++|+.|+...    +....
T Consensus       136 ~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~----~~~~~  209 (256)
T cd08220         136 KHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA----NLPAL  209 (256)
T ss_pred             CCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC----chHHH
Confidence            54 568999999998765432  122345788999998        4799999999999999999996432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..++..... ...+......+.+++.+||+.+|++|||+.|+++
T Consensus       210 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         210 VLKIMSGTF-APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHHHhcCC-CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            222222211 1122335567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=4.3e-29  Score=238.21  Aligned_cols=186  Identities=21%  Similarity=0.289  Sum_probs=135.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ||||++++++|..++..++||||+++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||++
T Consensus        58 hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~  134 (327)
T cd08227          58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILI  134 (327)
T ss_pred             CCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEE
Confidence            489999999999999999999999999999998532       24577899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc------cccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH------TSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      +.++.++++||+...........      ......++..|++||          .++|||||||++|||++|+.|+....
T Consensus       135 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            99999999999875433211100      011234567799987          46899999999999999999975321


Q ss_pred             CCCCC-----Cc---cce-------e-e-------ecCcc-----------------cccCChhHHHHHHHHHHHccccC
Q 046461          318 KDKNG-----GN---LVD-------W-V-------LDSTI-----------------LNAYSKPSMLKMLQIVVGCIFDN  357 (383)
Q Consensus       318 ~~~~~-----~~---~~~-------~-v-------~~~~~-----------------~~~~~~~~~~~~~~l~~~C~~~~  357 (383)
                      .....     ..   ..+       . .       .+...                 ...........+.+++.+||+.|
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  294 (327)
T cd08227         215 ATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN  294 (327)
T ss_pred             hhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence            10000     00   000       0 0       00000                 00011223457889999999999


Q ss_pred             CCCCCCHHHHHH
Q 046461          358 PTTRPTMLRVQE  369 (383)
Q Consensus       358 P~~RPs~~~v~~  369 (383)
                      |++|||++|+++
T Consensus       295 P~~Rpt~~ell~  306 (327)
T cd08227         295 PDARPSASTLLN  306 (327)
T ss_pred             chhcCCHHHHhc
Confidence            999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=6.4e-29  Score=235.70  Aligned_cols=129  Identities=22%  Similarity=0.320  Sum_probs=105.0

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc--------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ--------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +||+++++++..  +...+++|||++ ++|.+++...              .....++.|++.||+|||+.   +|+|||
T Consensus        58 ~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrD  133 (317)
T cd07868          58 PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRD  133 (317)
T ss_pred             CCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCC
Confidence            799999998864  456889999995 5888887521              12467899999999999998   999999


Q ss_pred             CCCCcEEE----cCCCceEEccccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCC
Q 046461          246 INASNILL----NEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRK  310 (383)
Q Consensus       246 lk~~NiLl----~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~  310 (383)
                      |||+|||+    +.++.+||+|||+++.......  .......||..|+|||         .++||||+||++|||++|+
T Consensus       134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  213 (317)
T cd07868         134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  213 (317)
T ss_pred             CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            99999999    4567899999999987643221  1223457899999998         3589999999999999999


Q ss_pred             CCCC
Q 046461          311 QPTG  314 (383)
Q Consensus       311 ~p~~  314 (383)
                      .|+.
T Consensus       214 ~~f~  217 (317)
T cd07868         214 PIFH  217 (317)
T ss_pred             CCcc
Confidence            9975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.96  E-value=7.4e-29  Score=232.98  Aligned_cols=181  Identities=25%  Similarity=0.353  Sum_probs=141.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++|+||+++|+|.+++...    .....++.+++.|+.|||+.   +++|+|+||+||+++.++
T Consensus        76 p~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~  152 (293)
T cd06647          76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG  152 (293)
T ss_pred             CCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCC
Confidence            79999999999999999999999999999998742    34677899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++|+|||++........ ......++..|++||        .++||||||+++||+++|+.|+...    +.......+
T Consensus       153 ~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~----~~~~~~~~~  227 (293)
T cd06647         153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYLI  227 (293)
T ss_pred             CEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----Chhhheeeh
Confidence            999999999876543322 222346788899998        4689999999999999999997532    111111111


Q ss_pred             e-cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          330 L-DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       330 ~-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      . .+.............+.+++.+||..+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1 1111111122334568899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=3.2e-29  Score=242.19  Aligned_cols=201  Identities=22%  Similarity=0.242  Sum_probs=148.0

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC------
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE------  195 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~------  195 (383)
                      .++|...+.||+|+||.||                                         +||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            3677888899999999888                                         79999999986543      


Q ss_pred             EEEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          196 KKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ..++||||+++ +|.+.+..   ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            57999999965 67666642   334567899999999999998   999999999999999999999999999976432


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC-----------CCCcccee-----
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK-----------NGGNLVDW-----  328 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~-----------~~~~~~~~-----  328 (383)
                      .  .......||..|+|||        .++||||+||++|||++|+.||...-...           ...+....     
T Consensus       176 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         176 N--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             C--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            2  2223356889999998        57899999999999999999975321000           00000000     


Q ss_pred             ---ee-cCcccc----------------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          329 ---VL-DSTILN----------------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       329 ---v~-~~~~~~----------------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                         .. .+....                .........+.+++.+|+..||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence               00 000000                000112356789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.6e-29  Score=228.91  Aligned_cols=183  Identities=25%  Similarity=0.322  Sum_probs=138.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++.+++..+++|||+++++|.+++...      .....++.|++.|++|||+.   +++|+|+||+||+++.
T Consensus        60 ~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~  136 (262)
T cd06613          60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTE  136 (262)
T ss_pred             CChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECC
Confidence            89999999999999999999999999999988643      24567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||.+....... .......++..|++||           .++||||||+++|||++|+.|+...........
T Consensus       137 ~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~  215 (262)
T cd06613         137 DGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL  215 (262)
T ss_pred             CCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999987654321 1122345777888888           247999999999999999999743211000000


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .......+.. ..........+.+++.+||..+|++|||+.+|+.
T Consensus       216 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         216 ISKSNFPPPK-LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHhccCCCcc-ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000001100 0112234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=5.2e-29  Score=236.07  Aligned_cols=129  Identities=22%  Similarity=0.321  Sum_probs=104.5

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc--------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ--------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +||+++++++..  +...++|+||++ ++|.+++...              .....++.|++.||+|||+.   +++|||
T Consensus        58 ~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~D  133 (317)
T cd07867          58 PNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRD  133 (317)
T ss_pred             CCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCC
Confidence            799999999854  567899999986 4788776421              12457899999999999998   999999


Q ss_pred             CCCCcEEE----cCCCceEEccccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCC
Q 046461          246 INASNILL----NEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRK  310 (383)
Q Consensus       246 lk~~NiLl----~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~  310 (383)
                      |||+||++    +.++.+||+|||+++.......  .......||..|+|||         .++|||||||++|||++|+
T Consensus       134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~  213 (317)
T cd07867         134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  213 (317)
T ss_pred             CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence            99999999    5667899999999987643221  1223356789999998         3579999999999999999


Q ss_pred             CCCC
Q 046461          311 QPTG  314 (383)
Q Consensus       311 ~p~~  314 (383)
                      .|+.
T Consensus       214 ~~f~  217 (317)
T cd07867         214 PIFH  217 (317)
T ss_pred             CCcc
Confidence            9975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=3e-29  Score=242.87  Aligned_cols=198  Identities=21%  Similarity=0.234  Sum_probs=149.1

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC------
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG------  194 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~------  194 (383)
                      ..++|...+.||+|+||.||                                         +||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            34678888999999999987                                         6999999987543      


Q ss_pred             CEEEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      ...++||||+++ +|.+++..   ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            357999999965 77777653   334567899999999999998   99999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee-------------
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL-------------  330 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~-------------  330 (383)
                      ..  .......||..|+|||        .++|||||||++|||++|+.||...    +..+....+.             
T Consensus       178 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         178 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT----DHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCHHHHHh
Confidence            32  1223356889999998        5799999999999999999997432    1100000000             


Q ss_pred             -----------cCcc---------c-------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 -----------DSTI---------L-------NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 -----------~~~~---------~-------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                 .+..         .       ..........+.+++.+|++.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       0000         0       0001112346789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=6.9e-29  Score=231.65  Aligned_cols=186  Identities=20%  Similarity=0.238  Sum_probs=139.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..+++|||++++.+..+...     ......++.+++.|++|||..   +++|+|++|+||+++.
T Consensus        59 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~  135 (288)
T cd07833          59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSE  135 (288)
T ss_pred             CCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC
Confidence            37999999999999999999999998777766653     234577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCC------
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDK------  320 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~------  320 (383)
                      ++.+|++|||++...............++..|++||         .++||||||+++|||++|+.|+...-...      
T Consensus       136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  215 (288)
T cd07833         136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ  215 (288)
T ss_pred             CCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999999876554332333456788899988         46899999999999999998864321000      


Q ss_pred             ------CCCccceeeecCc-----c---------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 ------NGGNLVDWVLDST-----I---------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 ------~~~~~~~~v~~~~-----~---------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                            .......+..++.     .         ...++.....++.+++.+||..+|++|||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         216 KCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  0000000000000     0         00112223577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=7.7e-29  Score=234.26  Aligned_cols=175  Identities=27%  Similarity=0.377  Sum_probs=135.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++.++|.+++..++|+||++ |++.+++..      +.....++.|++.||.|||+.   +++|+|++|+||+++.
T Consensus        75 ~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~  150 (307)
T cd06607          75 PNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTE  150 (307)
T ss_pred             CCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECC
Confidence            799999999999999999999996 677777642      234567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||++......     ....++..|++||           .++||||||+++|||++|+.|+...    +...
T Consensus       151 ~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~----~~~~  221 (307)
T cd06607         151 PGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMS  221 (307)
T ss_pred             CCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc----cHHH
Confidence            999999999998765432     2245777899987           3689999999999999999996421    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+................+.+++.+||+.+|++||++.+|+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            111111111111112234557889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=4e-29  Score=229.11  Aligned_cols=206  Identities=20%  Similarity=0.284  Sum_probs=153.9

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cc-cceeeeEEEeCC------
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KN-IVQLLGYCPVGE------  195 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~n-iv~l~g~~~~~~------  195 (383)
                      ..|...+.+|+|+||+||                                         +| ||++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            345555779999999999                                         46 999999998877      


Q ss_pred             EEEEEEEeccCCCHHHHHhcch---------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccC
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL  266 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgl  266 (383)
                      ..++|+||+. -+|.+++....         ....++.|+..|++|||++   +|+||||||+|||++.++..|++|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            7899999995 59999997543         2577999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC---------CCCCcccee
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD---------KNGGNLVDW  328 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~---------~~~~~~~~~  328 (383)
                      |+...... ...+...+|..|.|||         +..||||+|||+.||++++.-|....+.         ........|
T Consensus       167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            99665322 2345567899999998         5689999999999999988765432110         000000111


Q ss_pred             e-------ecCcccccC-C-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 046461          329 V-------LDSTILNAY-S-------KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF--LEKY  374 (383)
Q Consensus       329 v-------~~~~~~~~~-~-------~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~--L~~~  374 (383)
                      -       .+....... +       +.......+++.+|++.+|.+|.|++.++++  +...
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            1       000110000 0       1112467899999999999999999999874  5544

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=5.2e-29  Score=232.29  Aligned_cols=184  Identities=21%  Similarity=0.265  Sum_probs=134.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++|++++++++.+++..++||||++ ++|.+++...        .....++.|++.||+|||+.   +++|+|+||+||+
T Consensus        58 h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil  133 (285)
T cd07861          58 HPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLL  133 (285)
T ss_pred             CCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEE
Confidence            4899999999999999999999997 6898888532        23467899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC--
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN--  321 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~--  321 (383)
                      ++.++.++|+|||+++...... .......++..|+|||         .++|||||||+++||++|+.|+........  
T Consensus       134 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~  212 (285)
T cd07861         134 IDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF  212 (285)
T ss_pred             EcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999987653221 1122235678899988         357999999999999999998743211000  


Q ss_pred             ---------CCccceee-----ecCcc-------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 ---------GGNLVDWV-----LDSTI-------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 ---------~~~~~~~v-----~~~~~-------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                               ........     .....       ..........++.+++.+||..||++|||+.+|++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         213 RIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     00000000     00000       00001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=3.9e-29  Score=233.24  Aligned_cols=184  Identities=21%  Similarity=0.284  Sum_probs=137.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++|+||+++++|.++...     +.....++.|++.|++|||+.   +++|+|++|+||+++.+
T Consensus        60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~  136 (286)
T cd07846          60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQS  136 (286)
T ss_pred             cchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCC
Confidence            7999999999999999999999999999888753     345678899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc-
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV-  326 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~-  326 (383)
                      +.++++|||+++...... .......++..|++||         .++||||||+++|||++|+.|+...-.......+. 
T Consensus       137 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  215 (286)
T cd07846         137 GVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK  215 (286)
T ss_pred             CcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence            999999999988654432 2223345788899988         45899999999999999998864221000000000 


Q ss_pred             ------e---e----------eecCcccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 ------D---W----------VLDSTILN-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ------~---~----------v~~~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                            +   .          ...+....     .........+.+++.+||+.+|++||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                  0   0          00000000     001123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.4e-28  Score=226.48  Aligned_cols=181  Identities=25%  Similarity=0.355  Sum_probs=139.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+.+..++|+||+++++|.+++...     .....++.+++.|++|||+.   +++|+||+|+||+++.+
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~  135 (264)
T cd06626          59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHN  135 (264)
T ss_pred             CChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            79999999999999999999999999999998653     34567899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCcccc---ccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          257 FEVKVSDFGLVRLISDCESHTST---DVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~---~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +.+|++|||.+............   ...++..|++||           .++||||||++++|+++|+.|+...-   ..
T Consensus       136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~---~~  212 (264)
T cd06626         136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---NE  212 (264)
T ss_pred             CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc---ch
Confidence            99999999998876543322211   345778898887           35799999999999999999974321   11


Q ss_pred             CccceeeecCcccccCCh--hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTILNAYSK--PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~--~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+.. ......+.  .....+.+++.+||+.+|++|||+.|++.
T Consensus       213 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         213 FQIMFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111111 11111111  22567789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.5e-29  Score=235.56  Aligned_cols=181  Identities=20%  Similarity=0.270  Sum_probs=138.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+++..++||||+.+++|.+++...       .....++.|++.||+|||..   +++|+||||+||+++
T Consensus        61 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~  137 (316)
T cd05574          61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLH  137 (316)
T ss_pred             CCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEc
Confidence            79999999999999999999999999999998642       23466889999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc----------------------------cccccccccccccCC--------CCCcchh
Q 046461          255 EDFEVKVSDFGLVRLISDCESH----------------------------TSTDVAGTIGYILLA--------CGGDIYS  298 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~----------------------------~~~~~~gt~~y~ape--------~~~Dv~S  298 (383)
                      .++.++++|||++.........                            ......|+..|++||        .++||||
T Consensus       138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s  217 (316)
T cd05574         138 ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT  217 (316)
T ss_pred             CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence            9999999999998754322110                            111235788899998        4789999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 046461          299 FSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT----MLRVQE  369 (383)
Q Consensus       299 fGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs----~~~v~~  369 (383)
                      ||+++|||++|+.|+...    +.......+.+..............+.+++.+||..||++|||    +.|+++
T Consensus       218 lG~ll~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         218 LGILLYEMLYGTTPFKGS----NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHHHhhCCCCCCCC----chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            999999999999996432    2222122122222111111224668899999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=2.6e-29  Score=236.02  Aligned_cols=179  Identities=22%  Similarity=0.382  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++||||+++++|.+++..    ......++.+++.|++|||+.   +++||||||+||+++.++
T Consensus        79 ~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~  155 (292)
T cd06658          79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDG  155 (292)
T ss_pred             CcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCC
Confidence            7999999999999999999999999999999854    234678899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||++....... .......|+..|+|||        .++||||||+++||+++|+.|+...    +.......+
T Consensus       156 ~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~~~~~~  230 (292)
T cd06658         156 RIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE----PPLQAMRRI  230 (292)
T ss_pred             CEEEccCcchhhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence            99999999987653322 1222346788999998        5699999999999999999996432    111111111


Q ss_pred             ---ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          330 ---LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       330 ---~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                         ..+....  .......+.+++.+||..||++|||++|+++.
T Consensus       231 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         231 RDNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HhcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               1111111  11234567889999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=5.1e-29  Score=243.68  Aligned_cols=203  Identities=17%  Similarity=0.227  Sum_probs=151.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      ..|.....||+|+||.||                                    +|||++++++...+..++||||+. +
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  170 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C  170 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence            357777788888888887                                    799999999999999999999995 6


Q ss_pred             CHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-cccccc
Q 046461          208 SLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDV  281 (383)
Q Consensus       208 sL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~  281 (383)
                      +|.+++..     ......++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||+++....... ......
T Consensus       171 ~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~  247 (392)
T PHA03207        171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW  247 (392)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccccccc
Confidence            89988853     235678999999999999998   999999999999999999999999999976543322 222345


Q ss_pred             ccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc----------------------ceee--
Q 046461          282 AGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL----------------------VDWV--  329 (383)
Q Consensus       282 ~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~----------------------~~~v--  329 (383)
                      .||..|+|||        .++|||||||++|||++|+.|+...........+                      .+..  
T Consensus       248 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  327 (392)
T PHA03207        248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQ  327 (392)
T ss_pred             ccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHh
Confidence            7899999998        5789999999999999999997432111000000                      0000  


Q ss_pred             ecCcccccCC-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          330 LDSTILNAYS-------KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       330 ~~~~~~~~~~-------~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      ........+.       ......+.+++.+|+..||++|||+.|++..
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        328 YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000       1123457788999999999999999999873

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.2e-28  Score=229.38  Aligned_cols=179  Identities=25%  Similarity=0.371  Sum_probs=141.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +||+++++++..++..++||||+++|+|.+++..    ......++.+++.|+.|||+.   +++|+|+||+||+++.++
T Consensus        62 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~  138 (277)
T cd06641          62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHG  138 (277)
T ss_pred             CCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCC
Confidence            7999999999999999999999999999999864    334677899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||+++....... ......++..|++||        .++|+|||||++|||++|..|+...    ........+
T Consensus       139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~~~~~~  213 (277)
T cd06641         139 EVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL----HPMKVLFLI  213 (277)
T ss_pred             CEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc----chHHHHHHH
Confidence            999999999876543221 122345778899987        4689999999999999999996432    111111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ... ............+.+++.+||+.+|++||++.++++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         214 PKN-NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             hcC-CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111 111122334567889999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=1.1e-28  Score=227.19  Aligned_cols=182  Identities=29%  Similarity=0.454  Sum_probs=144.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++..++..++|+||+++++|.+++...     .....++.|+++|++|||+ .   +++|+|++|+||+++.
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~  135 (264)
T cd06623          59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINS  135 (264)
T ss_pred             CCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECC
Confidence            79999999999999999999999999999999742     3457899999999999999 7   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||.+......... .....++..|++||        .++|+||||+++|||++|+.|+..... ....+..+
T Consensus       136 ~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~  213 (264)
T cd06623         136 KGEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQ  213 (264)
T ss_pred             CCCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHH
Confidence            999999999998876543322 12345778899988        478999999999999999999754321 01122233


Q ss_pred             eeecCcccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++...... ..... .+..+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         214 AICDGPPP-SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHhcCCCC-CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            33322221 11223 5568899999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=3.2e-29  Score=250.55  Aligned_cols=210  Identities=18%  Similarity=0.267  Sum_probs=152.1

Q ss_pred             HHHHHHhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEE
Q 046461          157 DQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCP  192 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~  192 (383)
                      +++...+++|...++||+|+||.||                                            .+++++++++.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445567889999999999999999                                            14778888887


Q ss_pred             eC-CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---------
Q 046461          193 VG-EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---------  257 (383)
Q Consensus       193 ~~-~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---------  257 (383)
                      .. ...++|||++ +++|.+++...     .....++.|++.||+|||+++  +|+||||||+|||++.++         
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence            64 5788999988 77899988642     345779999999999999732  899999999999998765         


Q ss_pred             -------ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          258 -------EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       258 -------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                             .+||+|||.+....    ...+...||..|+|||        .++|||||||++|||++|+.||+..-.. +.
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~  353 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EH  353 (467)
T ss_pred             ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence                   49999999875432    2233467999999999        4689999999999999999997532110 00


Q ss_pred             Cccceee--------------------ec--CcccccCC---------------hhHHHHHHHHHHHccccCCCCCCCHH
Q 046461          323 GNLVDWV--------------------LD--STILNAYS---------------KPSMLKMLQIVVGCIFDNPTTRPTML  365 (383)
Q Consensus       323 ~~~~~~v--------------------~~--~~~~~~~~---------------~~~~~~~~~l~~~C~~~~P~~RPs~~  365 (383)
                      ...+...                    .+  ..+.....               ......+.+++.+|+..||++|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            0000000                    00  00000000               00124567999999999999999999


Q ss_pred             HHHH--HHhcc
Q 046461          366 RVQE--FLEKY  374 (383)
Q Consensus       366 ~v~~--~L~~~  374 (383)
                      |+++  .+.+.
T Consensus       434 e~L~Hp~~~~~  444 (467)
T PTZ00284        434 QMTTHPYVLKY  444 (467)
T ss_pred             HHhcCcccccc
Confidence            9997  55553

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=8e-29  Score=231.38  Aligned_cols=181  Identities=24%  Similarity=0.378  Sum_probs=139.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +||+++++++..++..++||||+++++|.+++...        .....++.+++.|+.|||+.+  +++|+||||+||++
T Consensus        59 ~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~  136 (286)
T cd06622          59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLV  136 (286)
T ss_pred             CcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEE
Confidence            79999999999999999999999999999988652        235778999999999999632  89999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      +.++.++++|||+++......   .....++..|++||              .++|+|||||++|||++|+.|+...-. 
T Consensus       137 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-  212 (286)
T cd06622         137 NGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-  212 (286)
T ss_pred             CCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-
Confidence            999999999999987653321   12245778899987              258999999999999999999743211 


Q ss_pred             CCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 KNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .........+.+.. ....+......+.+++.+||+.+|++||++.++++
T Consensus       213 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         213 ANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00001111111111 11223345667889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=8.3e-29  Score=227.65  Aligned_cols=183  Identities=21%  Similarity=0.303  Sum_probs=141.4

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcC--CCCeeecCCCC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRF--QPHIIHRDINA  248 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~  248 (383)
                      +|++++++++..  +...+++|||+++++|.+++...         .....++.+++.|++|||..+  ..+++|+|+||
T Consensus        59 ~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p  138 (265)
T cd08217          59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKP  138 (265)
T ss_pred             CccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCH
Confidence            799999998764  45679999999999999998642         235778999999999999332  33999999999


Q ss_pred             CcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          249 SNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       249 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      +||+++.++.+|++|||++......... .....++..|++||        .++|+||||++++||++|+.|+...    
T Consensus       139 ~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----  213 (265)
T cd08217         139 ANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR----  213 (265)
T ss_pred             HHEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc----
Confidence            9999999999999999999876543321 22346788899998        4589999999999999999996532    


Q ss_pred             CCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          321 NGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       321 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      +.....+.+..... ...+......+.+++.+|++.+|++|||+.+|++.
T Consensus       214 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         214 NQLQLASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CHHHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            22222333222222 22233455688999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=4.1e-29  Score=235.19  Aligned_cols=180  Identities=23%  Similarity=0.347  Sum_probs=140.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++|+||+++++|.+++..    +.....++.|++.||+|||+.   +++|+|+||+||+++.++
T Consensus        78 p~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~  154 (297)
T cd06659          78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDG  154 (297)
T ss_pred             CchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCC
Confidence            7999999999999999999999999999998864    234677899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++|+|||+++...... .......|+..|++||        .++|||||||+++||++|+.|+...    +..+....+
T Consensus       155 ~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~~~~~~~  229 (297)
T cd06659         155 RVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRL  229 (297)
T ss_pred             cEEEeechhHhhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence            99999999987654322 1223356888999988        4689999999999999999997422    111111111


Q ss_pred             ecCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..... ...........+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         230 RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             hccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            11100 00111223456788999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=1e-28  Score=232.62  Aligned_cols=183  Identities=19%  Similarity=0.234  Sum_probs=135.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++..++..++||||++ ++|.+++...      .....++.|++.||+|||+.   +++|+||||+||+++.
T Consensus        64 ~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~  139 (301)
T cd07873          64 ANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINE  139 (301)
T ss_pred             CCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECC
Confidence            799999999999999999999997 6999888643      23567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCC------
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDK------  320 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~------  320 (383)
                      ++.++++|||+++...... .......++..|++||         .++|||||||++|||++|+.|+.......      
T Consensus       140 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~  218 (301)
T cd07873         140 RGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF  218 (301)
T ss_pred             CCcEEECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999987653322 1122345678899998         35899999999999999999975321000      


Q ss_pred             -----CCCccceeee------c---Cccccc----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 -----NGGNLVDWVL------D---STILNA----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 -----~~~~~~~~v~------~---~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                           ........+.      .   +.....    ........+.+++.+|+..||.+|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 0000000000      0   000000    01123456789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=4.2e-29  Score=230.29  Aligned_cols=183  Identities=28%  Similarity=0.410  Sum_probs=140.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl  253 (383)
                      ++||+++++++..++..++++||+++++|.+++...      .....++.|++.|++|||+ .   +++|+||||+||++
T Consensus        58 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~  134 (265)
T cd06605          58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILV  134 (265)
T ss_pred             CCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEE
Confidence            489999999999999999999999999999999743      2346789999999999998 6   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC-CCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK-NGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~-~~~~  324 (383)
                      +.++.++++|||.+.........   ...++..|++||        .++||||||++++|+++|+.|+....... ...+
T Consensus       135 ~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  211 (265)
T cd06605         135 NSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE  211 (265)
T ss_pred             CCCCCEEEeecccchhhHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH
Confidence            99999999999998765332111   156778899988        47899999999999999999975432100 0111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+................+.+++.+||..+|++|||+.+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         212 LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111111111111111114567889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=1.4e-28  Score=227.17  Aligned_cols=184  Identities=22%  Similarity=0.354  Sum_probs=140.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +|++++++++.+++..++|+||+++++|.+++...     .....++.|++.||+|||+.   +++|+||||+||+++.+
T Consensus        63 ~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~  139 (268)
T cd06630          63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDST  139 (268)
T ss_pred             CceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            79999999999999999999999999999998643     34577899999999999998   99999999999999877


Q ss_pred             C-ceEEccccCccccCCCCCc---cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          257 F-EVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       257 ~-~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      + .++++|||.+.........   ......++..|++||        .++||||+|++++|+++|+.|+...-. .....
T Consensus       140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~  218 (268)
T cd06630         140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLA  218 (268)
T ss_pred             CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHH
Confidence            5 5999999998776532111   112245788999988        568999999999999999999642110 01111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+.........+......+.+++.+|+..+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         219 LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111111111112223345567889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=5.3e-29  Score=260.07  Aligned_cols=206  Identities=20%  Similarity=0.270  Sum_probs=153.9

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--CCEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--GEKKL  198 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--~~~~~  198 (383)
                      ..++|.....||+|+||.||                                         ||||++++++.+  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            34567788899999999998                                         799999998865  45789


Q ss_pred             EEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCC----CCeeecCCCCCcEEEcC----------
Q 046461          199 IVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQ----PHIIHRDINASNILLNE----------  255 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~----~~ivHrdlk~~NiLl~~----------  255 (383)
                      +||||+++|+|.++|...         ...+.++.||+.||+|||....    .+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998642         2357789999999999998521    25999999999999964          


Q ss_pred             -------CCceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCC
Q 046461          256 -------DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFK  318 (383)
Q Consensus       256 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~  318 (383)
                             ...+||+|||+++......  ......||+.|+|||          .++|||||||++|||++|+.||...- 
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence                   2348999999998654322  223356899999998          36899999999999999999974311 


Q ss_pred             CCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          319 DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       319 ~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                        ....+...+....  ..........+.+++..||+.+|++||++.|+++  .+..+
T Consensus       248 --~~~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        248 --NFSQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             --cHHHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence              1111111111111  1111223567889999999999999999999984  45433

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=9.6e-29  Score=248.77  Aligned_cols=184  Identities=17%  Similarity=0.192  Sum_probs=133.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +|||++++++.+.+..++|+|++. ++|.+++...          .....++.|++.||+|||+.   +|+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            699999999999999999999984 6788776432          12456899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      |++.++.+||+|||+++.+............||..|++||        .++|||||||++|||++|..++..........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9999999999999999876543333333467899999998        46899999999999999876532211100000


Q ss_pred             ccce---------------------eeecCcccc---cC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVD---------------------WVLDSTILN---AY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~---------------------~v~~~~~~~---~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.+                     ++....+..   ..     .......+.+++.+|++.||++|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0100                     000000000   00     0011234567788999999999999999986

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.3e-28  Score=230.35  Aligned_cols=180  Identities=23%  Similarity=0.364  Sum_probs=140.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++++||+++++|.+++...    .....++.|++.|++|||+.   +++||||+|+||+++.++
T Consensus        76 ~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~  152 (285)
T cd06648          76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDG  152 (285)
T ss_pred             CChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCC
Confidence            79999999999999999999999999999998752    34567899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||.+....... .......|+..|++||        .++||||||++++||++|+.|+...    +.....+.+
T Consensus       153 ~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~----~~~~~~~~~  227 (285)
T cd06648         153 RVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE----PPLQAMKRI  227 (285)
T ss_pred             cEEEcccccchhhccCC-cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC----CHHHHHHHH
Confidence            99999999987554322 1222345788999988        5689999999999999999996431    111111111


Q ss_pred             ecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....... .........+.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         228 RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1110000 011124467899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.5e-28  Score=229.93  Aligned_cols=187  Identities=27%  Similarity=0.389  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      +||++++++|.+.  +..++||||+++++|.+++...         .....++.|++.||+|||+.   +++|+|++|+|
T Consensus        59 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~n  135 (287)
T cd06621          59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSN  135 (287)
T ss_pred             CCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence            7999999998653  4689999999999999887531         23467899999999999998   99999999999


Q ss_pred             EEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC-CC
Q 046461          251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD-KN  321 (383)
Q Consensus       251 iLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~-~~  321 (383)
                      |+++.++.++++|||++.......   .....++..|++||        .++||||+|+++|||++|+.|++..... ..
T Consensus       136 il~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  212 (287)
T cd06621         136 ILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG  212 (287)
T ss_pred             EEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC
Confidence            999999999999999987654321   12345677899887        4789999999999999999997643210 01


Q ss_pred             CCccceeeecCc---ccccCC--hhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          322 GGNLVDWVLDST---ILNAYS--KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       322 ~~~~~~~v~~~~---~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ..+..+++.+..   +.....  ......+.+++.+||+.+|++|||+.|+++  .+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             hHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            122222222211   111101  123567889999999999999999999997  44443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-28  Score=226.38  Aligned_cols=211  Identities=21%  Similarity=0.366  Sum_probs=170.2

Q ss_pred             HHHHHhhCccccCeeecCCccccc---------------------------------------------cccceeeeEEE
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCP  192 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~  192 (383)
                      ++......+....++-+|.||.||                                             ||+.++.+.+.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            444444567778889999999998                                             79999999987


Q ss_pred             e-CCEEEEEEEeccCCCHHHHHhcc-------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 046461          193 V-GEKKLIVYEYMVKGSLNDWLRNQ-------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE  258 (383)
Q Consensus       193 ~-~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~  258 (383)
                      + .+..+.+|.++.-|+|..||.-.             .+...++.|++.|++|||.+   +++|.||.++|+++|+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhee
Confidence            6 56789999999999999999721             13466899999999999999   9999999999999999999


Q ss_pred             eEEccccCccccCCCCCccc-cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcccee
Q 046461          259 VKVSDFGLVRLISDCESHTS-TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~  328 (383)
                      +|++|=.++|.+-..+.+.. ........||++|        .++|||||||++|||+| |+.|+    .+-+..+....
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py----aeIDPfEm~~y  510 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY----AEIDPFEMEHY  510 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc----cccCHHHHHHH
Confidence            99999999987755443222 1233467899887        68999999999999998 88884    33345555555


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +.|+... ..+.++++++..+|..||...|++||+++|++.-|.+...
T Consensus       511 lkdGyRl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  511 LKDGYRL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             Hhcccee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            5555432 3356788899999999999999999999999999987654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=235.96  Aligned_cols=194  Identities=24%  Similarity=0.337  Sum_probs=156.3

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .+.|..-.+||+|+||.|+                                          +.||.+--.+.+.+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            3678888999999999999                                          6889998899999999999


Q ss_pred             EEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      +..|.||+|.-+|.+.       .+...++.+|+.||++||.+   +||.||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999999998753       34678999999999999999   9999999999999999999999999999888765


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ...  ....||.+|||||        ...|.||+||++|||+.|+.||...-......++-+.+...  ...+++..+++
T Consensus       341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--~~ey~~kFS~e  416 (591)
T KOG0986|consen  341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--PEEYSDKFSEE  416 (591)
T ss_pred             Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--hhhcccccCHH
Confidence            433  3348999999998        56899999999999999999964321111111111111111  12345566778


Q ss_pred             HHHHHHHccccCCCCCCC
Q 046461          346 MLQIVVGCIFDNPTTRPT  363 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs  363 (383)
                      ..++...-++.||++|--
T Consensus       417 akslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HHHHHHHHHccCHHHhcc
Confidence            888888899999999863

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=1.1e-28  Score=230.07  Aligned_cols=185  Identities=23%  Similarity=0.284  Sum_probs=137.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++++..++..++||||+++++|..+...     +.....++.|++.||+|||+.   +++|+||||+||+++.
T Consensus        59 h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~  135 (286)
T cd07847          59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITK  135 (286)
T ss_pred             CCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcC
Confidence            38999999999999999999999999999888753     234678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++++|||++........ ......++..|++||         .++||||||+++|||++|+.|+...........+.
T Consensus       136 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~  214 (286)
T cd07847         136 QGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR  214 (286)
T ss_pred             CCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999999987654321 122345677888877         46899999999999999999974321100000000


Q ss_pred             -----------------eeeecCccccc--------CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 -----------------DWVLDSTILNA--------YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 -----------------~~v~~~~~~~~--------~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                       .+.........        ........+.+++.+||+.+|++|||+.|++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                             00000000000        00122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=2e-28  Score=228.23  Aligned_cols=180  Identities=22%  Similarity=0.303  Sum_probs=140.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++.+++.+.+..++||||+++|+|.+++...     ..+..++.|++.|++|||+.   +++|||+||+||+++.
T Consensus        56 ~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~  132 (278)
T cd05606          56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE  132 (278)
T ss_pred             CCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECC
Confidence            589999999999999999999999999999988642     35678999999999999998   8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      ++.++++|||+++......   .....|+..|++||         .++||||+||++|||++|+.|+...... ......
T Consensus       133 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-~~~~~~  208 (278)
T cd05606         133 HGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEID  208 (278)
T ss_pred             CCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-chHHHH
Confidence            9999999999987654322   12346888999987         3579999999999999999997543110 111111


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +...  ......+...+..+.+++.+|+..+|++||     ++.++++
T Consensus       209 ~~~~--~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         209 RMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHhh--ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1010  011112233456788999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=2.8e-28  Score=231.59  Aligned_cols=178  Identities=27%  Similarity=0.375  Sum_probs=137.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++.+++..++||||++ |+|.+.+..      +.+...++.+++.|+.|||+.   +++||||+|+||+++.
T Consensus        85 ~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~  160 (317)
T cd06635          85 PNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE  160 (317)
T ss_pred             CCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECC
Confidence            799999999999999999999996 588877743      234567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||++......     ....|+..|++||           .++|||||||++|||++|+.|+...    +...
T Consensus       161 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~----~~~~  231 (317)
T cd06635         161 PGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMS  231 (317)
T ss_pred             CCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc----cHHH
Confidence            999999999998754321     2245778899887           3579999999999999999996432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ....+................+.+++.+||+.+|++||++.++++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             HHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            111111111111112234557889999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=227.08  Aligned_cols=179  Identities=22%  Similarity=0.292  Sum_probs=139.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++++..++..++|+||+++++|.+++...     .....++.|++.||.|||+.   +++|+||+|+||+++.
T Consensus        56 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~  132 (260)
T cd05611          56 SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQ  132 (260)
T ss_pred             CCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC
Confidence            589999999999999999999999999999999642     34677899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||+++....     .....++..|++||        .++||||||+++||+++|..|+...    +.....+
T Consensus       133 ~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~  203 (260)
T cd05611         133 TGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE----TPDAVFD  203 (260)
T ss_pred             CCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC----CHHHHHH
Confidence            99999999999876433     12345778899887        4789999999999999999997432    2222211


Q ss_pred             eeecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 046461          328 WVLDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL  371 (383)
Q Consensus       328 ~v~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L  371 (383)
                      .+.....  ...........+.+++.+||+.+|++||++.++.+.|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         204 NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            1111111  1111123456789999999999999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-29  Score=230.56  Aligned_cols=194  Identities=24%  Similarity=0.386  Sum_probs=161.5

Q ss_pred             HHHHHhhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeC
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~  194 (383)
                      +..++| +|....+||+|+||.|.                                           |.++++..++..-
T Consensus       344 d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  344 DRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             cceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            344444 58888999999999997                                           6888999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +.+|+||||+.+|+|--++..     +.....+|..||-||-|||++   +|+.||||.+||++|.++.+||+|||+++.
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999988874     334677899999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChh
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP  341 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~  341 (383)
                      ---. ..+....+||+.|+|||        ..+|.|||||+||||+.|+.||+    +.++.++.+.+.+...  .+++.
T Consensus       500 ni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd----GeDE~elF~aI~ehnv--syPKs  572 (683)
T KOG0696|consen  500 NIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD----GEDEDELFQAIMEHNV--SYPKS  572 (683)
T ss_pred             cccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC----CCCHHHHHHHHHHccC--cCccc
Confidence            3222 23344589999999999        56899999999999999999954    4466666666665544  45666


Q ss_pred             HHHHHHHHHHHccccCCCCCC
Q 046461          342 SMLKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RP  362 (383)
                      .+.+..++...-+...|.+|-
T Consensus       573 lSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  573 LSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ccHHHHHHHHHHhhcCCcccc
Confidence            777888888888999999984

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.95  E-value=7e-30  Score=227.92  Aligned_cols=195  Identities=25%  Similarity=0.380  Sum_probs=157.0

Q ss_pred             ccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccCCC
Q 046461          166 FYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGS  208 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gs  208 (383)
                      |+-...+|+|+||.||                                     |++|+++|.+.....+|+|||||.-|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            4445789999999999                                     799999999999999999999999999


Q ss_pred             HHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccc
Q 046461          209 LNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA  282 (383)
Q Consensus       209 L~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  282 (383)
                      ..+.++-+.      +...+..+.++||+|||..   .-+|||+|+-|||++.+|.+|++|||+|..+++.- .....+.
T Consensus       115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVI  190 (502)
T KOG0574|consen  115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVI  190 (502)
T ss_pred             HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccc
Confidence            999997443      3456788899999999988   78999999999999999999999999998776532 2234578


Q ss_pred             cccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC--ChhHHHHHHHHHHH
Q 046461          283 GTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--SKPSMLKMLQIVVG  352 (383)
Q Consensus       283 gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~--~~~~~~~~~~l~~~  352 (383)
                      ||+.|||||        +++||||+|++..||..|++|+.+..    .....- ......++.+  ++.-+.++.+++.+
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH----PMRAIF-MIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH----PMRAIF-MIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc----ccceeE-eccCCCCCCCCChHhhhhHHHHHHHH
Confidence            999999998        78999999999999999999964321    111111 1111122333  33446678999999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 046461          353 CIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       353 C~~~~P~~RPs~~~v~~  369 (383)
                      |+-++|++|-|+.++++
T Consensus       266 CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhcCCHHHHHHHHHHhh
Confidence            99999999999988876

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=2e-28  Score=229.53  Aligned_cols=175  Identities=19%  Similarity=0.315  Sum_probs=139.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||.|||+.   +++|+||+|+||+++.+
T Consensus        61 ~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~  137 (290)
T cd05580          61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSD  137 (290)
T ss_pred             CCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCC
Confidence            79999999999999999999999999999998643     24567889999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +.+|++|||+++.....    .....++..|++||        .++||||||++++||++|+.|+...    +.....+.
T Consensus       138 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~  209 (290)
T cd05580         138 GYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD----NPIQIYEK  209 (290)
T ss_pred             CCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHH
Confidence            99999999998876443    23346888999998        4689999999999999999996432    22222222


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.....  ..+......+.+++.+||+.||++||     +++|+++
T Consensus       210 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         210 ILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             HhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            222211  12233456788999999999999999     6677653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=2.3e-28  Score=228.42  Aligned_cols=184  Identities=27%  Similarity=0.418  Sum_probs=142.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++...+..++++||+++++|.+++....      ....++.+++.||+|||..   +++|+|++|+||+++.
T Consensus        75 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~  151 (286)
T cd06614          75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSK  151 (286)
T ss_pred             CCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcC
Confidence            799999999999999999999999999999997542      4577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++|+|||++........ ......++..|++||        .++|||||||++|||++|+.|+...    +......
T Consensus       152 ~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~----~~~~~~~  226 (286)
T cd06614         152 DGSVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE----PPLRALF  226 (286)
T ss_pred             CCCEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC----CHHHHHH
Confidence            99999999999876543221 122345778899987        5799999999999999999996421    1111111


Q ss_pred             eeecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 046461          328 WVLDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       328 ~v~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                      .+....... .........+.+++.+||+.+|.+|||+.++++  .+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            111111111 111224567889999999999999999999985  4444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=1.4e-28  Score=229.37  Aligned_cols=181  Identities=21%  Similarity=0.272  Sum_probs=135.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++.+.+..++|+||++ ++|.+++..      ......++.|+++||.|||+.   +++||||||+||+++
T Consensus        58 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~  133 (284)
T cd07839          58 HKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLIN  133 (284)
T ss_pred             CCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEc
Confidence            3799999999999999999999996 588888753      224578899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++|+|||+++...... .......++..|+|||         .++|||||||++|||++|..|+.....   ..+.
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~  209 (284)
T cd07839         134 KNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQ  209 (284)
T ss_pred             CCCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHH
Confidence            99999999999987654322 1122345678899988         358999999999999999998643211   0000


Q ss_pred             ceee------------------ec----Ccccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWV------------------LD----STILN-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v------------------~~----~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.+                  .+    +....     .........+.+++.+||+.||++|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         210 LKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000                  00    00000     001123457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.95  E-value=1.2e-28  Score=230.54  Aligned_cols=188  Identities=21%  Similarity=0.281  Sum_probs=142.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++.+..++..++||||+++|+|.+++...     .....++.|+++||+|||+.   +++|+|+||+||+++.
T Consensus        64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~  140 (288)
T cd05583          64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDS  140 (288)
T ss_pred             CcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC
Confidence            489999999999999999999999999999998642     24566888999999999988   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      ++.++++|||+++..............|+..|++||          .++||||||++++||++|..|+...-......++
T Consensus       141 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~  220 (288)
T cd05583         141 EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI  220 (288)
T ss_pred             CCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH
Confidence            999999999998775443322223345788899887          3689999999999999999996421110001111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK  373 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~  373 (383)
                      .+.+....  ...+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       221 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         221 SRRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11111111  11222344577899999999999999999988877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=1.4e-28  Score=225.70  Aligned_cols=180  Identities=26%  Similarity=0.347  Sum_probs=139.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++.+.+++..++|+||+++++|.+++...       .....++.+++.|++|||+.   +++|+|+||+||++
T Consensus        58 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~  134 (257)
T cd08225          58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFL  134 (257)
T ss_pred             CCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEE
Confidence            379999999999999999999999999999998642       34577899999999999998   99999999999999


Q ss_pred             cCCC-ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDF-EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++ .++++|||.+........ ......|+..|++||        .++|+||||++++|+++|+.|+...    +..+
T Consensus       135 ~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~  209 (257)
T cd08225         135 SKNGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN----NLHQ  209 (257)
T ss_pred             cCCCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHH
Confidence            8875 469999999876643221 122245788899988        5789999999999999999996432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ........... .........+.+++.+||..+|++|||+.|+++
T Consensus       210 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         210 LVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11111111111 112234457889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5e-29  Score=240.75  Aligned_cols=178  Identities=22%  Similarity=0.373  Sum_probs=140.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |+||+|++.++..+.+|+..|||+||-.+..+-.      ..+..-++.+++.||.|||++   .|+|||||+-|||+..
T Consensus        89 P~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~Tl  165 (1187)
T KOG0579|consen   89 PVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTL  165 (1187)
T ss_pred             hHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEe
Confidence            8999999999999999999999999999887753      234556789999999999999   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +|.++++|||++...... ......+.||+.|||||             .++||||||++|.||..+.+|...    .+.
T Consensus       166 dGdirLADFGVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe----lnp  240 (1187)
T KOG0579|consen  166 DGDIRLADFGVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE----LNP  240 (1187)
T ss_pred             cCcEeeecccccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc----cch
Confidence            999999999997543221 12233478999999998             579999999999999999999432    122


Q ss_pred             Cccceeeec---CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLD---STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +...-.+..   +.+..  +..-...+.++...|+..||..||+++++++
T Consensus       241 MRVllKiaKSePPTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  241 MRVLLKIAKSEPPTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHhhcCCCcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            222222211   11211  2334567889999999999999999999975

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=2.6e-28  Score=228.47  Aligned_cols=184  Identities=22%  Similarity=0.301  Sum_probs=139.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++..+...++||||+++++|.+++...     .....++.|++.||.|||+.   +++||||||+||+++.
T Consensus        64 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~  140 (290)
T cd05613          64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDS  140 (290)
T ss_pred             CCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECC
Confidence            489999999999999999999999999999998643     23456778999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      ++.++++|||+++..............|+..|++||          .++||||||+++|||++|+.|+...-......++
T Consensus       141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~  220 (290)
T cd05613         141 NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI  220 (290)
T ss_pred             CCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH
Confidence            999999999999876443322333456888999998          3589999999999999999997421110011111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+.+...  ....+......+.+++.+||+.||++||     +..++..
T Consensus       221 ~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 SRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1111111  1122334456788999999999999997     6677665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-28  Score=234.68  Aligned_cols=197  Identities=21%  Similarity=0.273  Sum_probs=163.1

Q ss_pred             CccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      .|.-.+.||+|.||.||                                           ||||++.+.+.+.+..++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            45555889999999998                                           79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CceEEccccCccccCCC
Q 046461          202 EYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED----FEVKVSDFGLVRLISDC  273 (383)
Q Consensus       202 e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~----~~~kl~Dfgla~~~~~~  273 (383)
                      |++.+|+|.+.+...    .+...++.|++.++.|||+.   +++|||+||+|+|+...    +.+|++|||++..... 
T Consensus       116 EL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            999999999998753    34577899999999999998   99999999999999643    4799999999998765 


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--ccccCChhHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--ILNAYSKPSM  343 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~~~~~~~~~  343 (383)
                       .......+||+.|+|||        ..+||||.||++|.|++|..||...    ........+....  +..+.+....
T Consensus       192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~----~~~~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  192 -GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE----TEFEIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             -CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC----ChhHHHHHHHcCCCCCCCCCccccC
Confidence             33455689999999999        5789999999999999999997543    2222222333332  2344456667


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      ..+.+++..++..||..|+|+.++++.
T Consensus       267 ~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  267 ESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            889999999999999999999999983

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=2.1e-28  Score=225.59  Aligned_cols=182  Identities=21%  Similarity=0.303  Sum_probs=142.6

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..++++||+++++|.+++...     .....++.|++.||+|||+.   +++|+|++|+||+++.
T Consensus        52 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~  128 (262)
T cd05572          52 HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDS  128 (262)
T ss_pred             CCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcC
Confidence            589999999999999999999999999999999743     23567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||+++......  ......++..|++||        .++|+||||+++||+++|..|+...-.  +.....+
T Consensus       129 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~  204 (262)
T cd05572         129 NGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYN  204 (262)
T ss_pred             CCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHH
Confidence            9999999999998765432  222346788899988        468999999999999999999753311  1222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      .+.+.......+......+.+++.+||+.+|++||+     ++|+++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222211122223334568899999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-29  Score=227.67  Aligned_cols=187  Identities=25%  Similarity=0.376  Sum_probs=142.2

Q ss_pred             cccceeeeEEEe-----CCEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPV-----GEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +||+.+.+.+..     -+.+|+|+|+| .-+|.+.++...     ...-+..|+.+||.|+|+.   +|+|||+||+|+
T Consensus        81 eNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNl  156 (359)
T KOG0660|consen   81 ENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNL  156 (359)
T ss_pred             CCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhhe
Confidence            799999998865     35789999999 569999998654     2355789999999999999   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCC-CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      +++.+...||+|||+||..... .....+....|.+|.|||         .+.||||.|||+.||++|+.-|    .+.+
T Consensus       157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF----pG~d  232 (359)
T KOG0660|consen  157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF----PGKD  232 (359)
T ss_pred             eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC----CCCc
Confidence            9999999999999999987543 122345677899999998         5789999999999999999874    3323


Q ss_pred             CCccceee---------------e----c------Ccccc-cC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHH--H
Q 046461          322 GGNLVDWV---------------L----D------STILN-AY---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--F  370 (383)
Q Consensus       322 ~~~~~~~v---------------~----~------~~~~~-~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~  370 (383)
                      ..+..+.+               .    .      +..++ .+   .+...+..+++..+++..||.+|+|++|.++  .
T Consensus       233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence            32222222               0    0      00000 00   1123456889999999999999999999986  5


Q ss_pred             Hhcccc
Q 046461          371 LEKYHT  376 (383)
Q Consensus       371 L~~~~~  376 (383)
                      |+....
T Consensus       313 l~~~hd  318 (359)
T KOG0660|consen  313 LAPYHD  318 (359)
T ss_pred             hhhhcC
Confidence            555443

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.95  E-value=1.4e-28  Score=230.03  Aligned_cols=180  Identities=24%  Similarity=0.347  Sum_probs=133.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHh---c-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR---N-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~---~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +||+++++++..++..+++|||++ +++.++..   .       ......++.+++.||+|||+..  +++||||||+||
T Consensus        63 ~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Ni  139 (288)
T cd06616          63 PYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNI  139 (288)
T ss_pred             CCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHE
Confidence            799999999999999999999986 45554432   1       1235678999999999999742  799999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      +++.++.++++|||+++......  ......|+..|++||           .++|||||||++|||++|+.|+....   
T Consensus       140 l~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---  214 (288)
T cd06616         140 LLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---  214 (288)
T ss_pred             EEccCCcEEEeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---
Confidence            99999999999999987654322  122345778898887           26899999999999999999964321   


Q ss_pred             CCCccceeeec---CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          321 NGGNLVDWVLD---STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       321 ~~~~~~~~v~~---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+....+..   +.+........+..+.+++.+||+.+|++|||+.+|++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         215 SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             hHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00011111111   11111112235667899999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=4.6e-28  Score=226.93  Aligned_cols=203  Identities=19%  Similarity=0.224  Sum_probs=147.1

Q ss_pred             HhhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++++|...+.||+|+||.||                                        +||+++.+++.+++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            34567777778888887777                                        79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||++ +++.+++...      .....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6887776532      24567889999999999998   999999999999999999999999999876433221


Q ss_pred             ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC------------CC----------c
Q 046461          276 HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN------------GG----------N  324 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~------------~~----------~  324 (383)
                       ......++..|++||         .++|||||||++|||++|+.|+.......+            ..          .
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             122234678899998         247999999999999999999753211000            00          0


Q ss_pred             cceeeecCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..............     .......+.+++.+|+..||++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000     0012356788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=4.2e-28  Score=226.14  Aligned_cols=181  Identities=24%  Similarity=0.359  Sum_probs=138.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++..++..++|+||+ +++|.+++..      ......++.|++.||+|||+.   +++|+|+||+||+++
T Consensus        58 ~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~  133 (286)
T cd07832          58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLIS  133 (286)
T ss_pred             CCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEc
Confidence            489999999999999999999999 9999999864      234678899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||.+...............++..|++||         .++||||+|++++||++|..|+....    ....
T Consensus       134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~----~~~~  209 (286)
T cd07832         134 ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN----DIEQ  209 (286)
T ss_pred             CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC----HHHH
Confidence            9999999999999876543322233456888999988         46899999999999999976653211    1000


Q ss_pred             ceeee---------------------------cCc-ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVL---------------------------DST-ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~---------------------------~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..++.                           ... .......+....+.+++.+|+..+|++|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000                           000 000001123467889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=2.6e-28  Score=227.07  Aligned_cols=178  Identities=19%  Similarity=0.207  Sum_probs=135.8

Q ss_pred             ccccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++|++++++++.++  +..++|+||++ |+|.+++...      .....++.|++.||+|||+.   +++||||||+||+
T Consensus        57 h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~  132 (282)
T cd07831          57 HPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENIL  132 (282)
T ss_pred             CCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEE
Confidence            58999999999987  88999999996 6888888642      24577899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      ++. +.+||+|||+++.......  .....++..|++||         .++|||||||++|||++|+.|+...    +..
T Consensus       133 l~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~----~~~  205 (282)
T cd07831         133 IKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT----NEL  205 (282)
T ss_pred             EcC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC----CHH
Confidence            999 9999999999987643221  12245778899988         4689999999999999999987432    111


Q ss_pred             ccceeee--------------------cCcccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVL--------------------DSTILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~--------------------~~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +...+..                    +.....       ......+..+.+++.+||+.+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         206 DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111000                    000000       001133578899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.6e-28  Score=235.74  Aligned_cols=197  Identities=19%  Similarity=0.278  Sum_probs=149.0

Q ss_pred             HHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC-----
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG-----  194 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~-----  194 (383)
                      +..++|...+.||+|+||.||                                         +||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            345677888899999999998                                         6999999887543     


Q ss_pred             -CEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 -EKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 -~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                       ...++++|++ +++|.+++..    ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence             3578999988 7899988863    234677899999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee-----------
Q 046461          270 ISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV-----------  329 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v-----------  329 (383)
                      ....    .....|+..|+|||         .++|||||||++|||++|+.|+...    +..+....+           
T Consensus       168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN----DYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHhCCCCHHH
Confidence            5432    23356889999998         3689999999999999999996432    111100000           


Q ss_pred             ----ec-------CcccccC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ----LD-------STILNAY-------SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ----~~-------~~~~~~~-------~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                          ..       ..+....       .......+.+++.+|+..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00       0000000       0112235679999999999999999999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-28  Score=227.96  Aligned_cols=183  Identities=19%  Similarity=0.283  Sum_probs=132.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+++..++||||++ ++|.+++...      .....++.|++.||.|||+.   +++||||||+||+++.
T Consensus        63 ~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~  138 (291)
T cd07844          63 ANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISE  138 (291)
T ss_pred             cceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcC
Confidence            799999999999999999999997 5999988642      23567888999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC----
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG----  322 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~----  322 (383)
                      ++.+|++|||+++...... .......++..|++||         .++||||+|+++|||++|+.|+.......+.    
T Consensus       139 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~  217 (291)
T cd07844         139 RGELKLADFGLARAKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI  217 (291)
T ss_pred             CCCEEECccccccccCCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence            9999999999987543221 1112234577888887         3579999999999999999997432100000    


Q ss_pred             --------Cccceee----------e----cCcccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 --------GNLVDWV----------L----DSTILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 --------~~~~~~v----------~----~~~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                              .+....+          .    ...+.... .......+.+++.+|++.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    0000000          0    00000000 0011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=242.36  Aligned_cols=191  Identities=27%  Similarity=0.383  Sum_probs=153.7

Q ss_pred             ccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          166 FYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      |.+...||.|+||.||                                          ||+|.+.|++..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5666789999999999                                          8999999999999999999999


Q ss_pred             ccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      | -|+-.|.+.-.      .....|..+.+.||+|||+.   +.||||||+-|||+.+.+.+|++|||-|....+.    
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            9 56777777532      23456788999999999999   9999999999999999999999999999876543    


Q ss_pred             ccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          278 STDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       278 ~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       ..+.||+.|||||           -|+||||+||++.|+..+++|..    +++.+...-.|....-+.....+-+..+
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF----nMNAMSALYHIAQNesPtLqs~eWS~~F  254 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----NMNAMSALYHIAQNESPTLQSNEWSDYF  254 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc----CchHHHHHHHHHhcCCCCCCCchhHHHH
Confidence             3478999999998           58999999999999999999952    2233333333322221111133445677


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..++-.|+++-|.+|||.++++.
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhh
Confidence            88888999999999999998875

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=2.7e-28  Score=228.72  Aligned_cols=183  Identities=19%  Similarity=0.221  Sum_probs=132.1

Q ss_pred             cccceeeeEEEeCCE-----EEEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          182 KNIVQLLGYCPVGEK-----KLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       182 ~niv~l~g~~~~~~~-----~~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +|++++++++...+.     .++||||+++ +|.+++...          .....++.|++.||+|||+.   +++|||+
T Consensus        61 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl  136 (295)
T cd07837          61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDL  136 (295)
T ss_pred             CCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCC
Confidence            699999999987665     8999999985 898887531          23567899999999999998   9999999


Q ss_pred             CCCcEEEcC-CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCC
Q 046461          247 NASNILLNE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~  316 (383)
                      ||+||+++. ++.+|++|||+++...... .......+++.|+|||         .++||||||+++|||++|..|+...
T Consensus       137 ~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         137 KPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ChHHEEEecCCCeEEEeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999998 8899999999987653321 1122234677888887         4689999999999999999986431


Q ss_pred             CCCCCCCccce---------e---------eecCcccc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          317 FKDKNGGNLVD---------W---------VLDSTILN----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       317 ~~~~~~~~~~~---------~---------v~~~~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      -.......+.+         |         ...+....    ...+....++.+++.+||..||++|||+.|++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            10000000000         0         00000000    001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=7.3e-28  Score=226.22  Aligned_cols=181  Identities=23%  Similarity=0.309  Sum_probs=136.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||+++++++.+++..++||||+ +|+|.+++....      ....++.|+++||+|||+.   +++|+||||+||+++
T Consensus        61 h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~  136 (298)
T cd07841          61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIA  136 (298)
T ss_pred             CCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEc
Confidence            489999999999999999999999 999999996432      3577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++|+|||+++....... ......++..|++||         .++|||||||+++||++|..|+...    ...+.
T Consensus       137 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~----~~~~~  211 (298)
T cd07841         137 SDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD----SDIDQ  211 (298)
T ss_pred             CCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC----ccHHH
Confidence            999999999999987644321 112234567788887         3589999999999999997664321    11110


Q ss_pred             ceee---------------------ecCcccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          326 VDWV---------------------LDSTILN-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       326 ~~~v---------------------~~~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .+.+                     .......     .........+.+++.+||+.+|++|||++|+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000                     0000000     0012234678899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=6.3e-28  Score=226.24  Aligned_cols=179  Identities=20%  Similarity=0.244  Sum_probs=135.8

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +||+++++++...  +..++||||++ ++|.+++...      .....++.|++.||+|||+.   +++|+||||+||++
T Consensus        64 ~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili  139 (293)
T cd07843          64 PNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLL  139 (293)
T ss_pred             CCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEE
Confidence            8999999999887  88999999997 5999888632      34578999999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++.++++|||+++...... .......++..|++||         .++|+||+|++++||++|+.|+.....    .+
T Consensus       140 ~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~  214 (293)
T cd07843         140 NNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----ID  214 (293)
T ss_pred             CCCCcEEEeecCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HH
Confidence            999999999999988765432 1122345678899988         458999999999999999998753211    00


Q ss_pred             ccee-----------------------------eecCcccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDW-----------------------------VLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~-----------------------------v~~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....                             .....+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000                             0000011111111 3556789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=2.4e-28  Score=227.87  Aligned_cols=184  Identities=20%  Similarity=0.268  Sum_probs=134.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++||+++++++.+++..++||||++ ++|.+++...       .....++.|++.|++|||+.   +++|+|++|+||++
T Consensus        58 h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill  133 (284)
T cd07860          58 HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLI  133 (284)
T ss_pred             CCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            3899999999999999999999995 6899888532       23567899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++.+|++|||+++...... .......++..|++||         .++||||||+++|||+||+.|+...-.......
T Consensus       134 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~  212 (284)
T cd07860         134 NTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR  212 (284)
T ss_pred             CCCCCEEEeeccchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999999987654322 1122334677899988         358999999999999999999643210000000


Q ss_pred             cceeeecC----------------cc---cc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDS----------------TI---LN----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~----------------~~---~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+....+                ..   ..    .........+.+++.+||+.||++|||++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000                00   00    001122346778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=2.3e-28  Score=224.73  Aligned_cols=185  Identities=22%  Similarity=0.311  Sum_probs=141.9

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++.+..++..++++||+++++|.+++...     .....++.|++.||+|||+.   +++|+||+|+||+++.
T Consensus        52 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~  128 (265)
T cd05579          52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDS  128 (265)
T ss_pred             CcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcC
Confidence            689999999999999999999999999999998753     24577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCES-------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~  320 (383)
                      ++.++++|||++........       .......++..|++||        .++||||||++++|+++|+.|+...    
T Consensus       129 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----  204 (265)
T cd05579         129 NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE----  204 (265)
T ss_pred             CCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----
Confidence            99999999999876533211       1223345778899987        4799999999999999999996432    


Q ss_pred             CCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          321 NGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       321 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ......+.+................+.+++.+||+.+|++|||+.++.+.|+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         205 TPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            2222222222211111111112567889999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=6.3e-28  Score=228.27  Aligned_cols=176  Identities=26%  Similarity=0.369  Sum_probs=135.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++.+++...+..++||||+. |++.+++..      ......++.+++.|+.|||+.   +++||||||+||+++.
T Consensus        75 ~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~  150 (308)
T cd06634          75 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE  150 (308)
T ss_pred             CCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECC
Confidence            799999999999999999999996 688887742      234567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||++......     ....++..|++||           .++|||||||++|||++|+.|+...    +..+
T Consensus       151 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~  221 (308)
T cd06634         151 PGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMS  221 (308)
T ss_pred             CCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc----cHHH
Confidence            999999999998765432     2345777898887           2689999999999999999996431    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      ....+................+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            1111111111111122345678899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=1e-27  Score=218.30  Aligned_cols=178  Identities=29%  Similarity=0.425  Sum_probs=139.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++..++..++++||+++++|.+++...      .....++.+++.|+.|||..   +++|+|++|+||+++.
T Consensus        57 ~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~  133 (253)
T cd05122          57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTS  133 (253)
T ss_pred             CCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEcc
Confidence            79999999999999999999999999999998653      24567899999999999997   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++|+|||.+........  .....++..|++||        .++||||||++++||++|+.|+...    +......
T Consensus       134 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~~~  207 (253)
T cd05122         134 DGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL----PPMKALF  207 (253)
T ss_pred             CCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----chHHHHH
Confidence            99999999999887654322  23356778899888        5799999999999999999996432    1111111


Q ss_pred             eeecCcccccCChh--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKP--SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~--~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...... .......  ....+.+++.+||+.||++|||+.|+++
T Consensus       208 ~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         208 KIATNG-PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHhcC-CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111100 1111111  1457889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=1.8e-27  Score=217.61  Aligned_cols=182  Identities=25%  Similarity=0.323  Sum_probs=142.9

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++.+.+.  +..++++||+++++|.+++...     .....++.+++.|++|||+.   +++|+|++|+||+++
T Consensus        59 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~  135 (260)
T cd06606          59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVD  135 (260)
T ss_pred             CCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEc
Confidence            8999999999988  8999999999999999998743     34578899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++|+|||.+......... ......++..|++||        .++||||||++++|+++|..|+....   +....
T Consensus       136 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~  212 (260)
T cd06606         136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAA  212 (260)
T ss_pred             CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHH
Confidence            9999999999998876543321 123356788899988        56899999999999999999975421   11111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+.........+......+.+++.+|++.+|++||++.|+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11111111112223344568899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-29  Score=219.66  Aligned_cols=180  Identities=24%  Similarity=0.361  Sum_probs=137.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch----h--hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA----K--HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~--~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |.||+-+|||..+..+++.||.|. -.++.+++...    +  .-++...+..||.||...+  +|+|||+||+|||+|.
T Consensus       151 pyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe  227 (391)
T KOG0983|consen  151 PYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDE  227 (391)
T ss_pred             CeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEcc
Confidence            789999999999999999999984 34555554322    1  2346677889999998764  8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      .|++|++|||++-.+.+..  ..+..+|.+.|||||           .++||||||+.++|+.||..|+..   ...+.+
T Consensus       228 ~GniKlCDFGIsGrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~---c~tdFe  302 (391)
T KOG0983|consen  228 RGNIKLCDFGISGRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG---CKTDFE  302 (391)
T ss_pred             CCCEEeecccccceeeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC---CCccHH
Confidence            9999999999998776533  344568999999998           358999999999999999999642   112233


Q ss_pred             cceeeecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+.+...+. ......+..+.++...|+..|+.+||...++++
T Consensus       303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            344444422111 112336778899999999999999999888875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=7.7e-28  Score=223.30  Aligned_cols=181  Identities=19%  Similarity=0.266  Sum_probs=141.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchh-------hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      |-+..|+..+..++..+++||||+||+|....+.+..       ...++.++..||+|||-.   +||.|||||+|||+.
T Consensus       137 PFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvr  213 (459)
T KOG0610|consen  137 PFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVR  213 (459)
T ss_pred             CccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEe
Confidence            7899999999999999999999999999999876532       456899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCC---------------------------------CCC----------------------cccc
Q 046461          255 EDFEVKVSDFGLVRLISD---------------------------------CES----------------------HTST  279 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~---------------------------------~~~----------------------~~~~  279 (383)
                      ++|.+.++||.++.....                                 ...                      ..+.
T Consensus       214 edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSn  293 (459)
T KOG0610|consen  214 EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSN  293 (459)
T ss_pred             cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccc
Confidence            999999999987643210                                 000                      0011


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...||-.|.|||        .++|+|+|||++|||+.|+.||.    +.+..+....|+...+.-......+..+.+|+.
T Consensus       294 SFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK----G~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  294 SFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK----GSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             ccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC----CCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence            245889999999        67899999999999999999954    334444333343333322222356678899999


Q ss_pred             HccccCCCCCCC----HHHHHH
Q 046461          352 GCIFDNPTTRPT----MLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs----~~~v~~  369 (383)
                      +-+.+||++|--    ++||-+
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHhccChhhhhccccchHHhhc
Confidence            999999999987    666654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=8e-28  Score=226.06  Aligned_cols=180  Identities=22%  Similarity=0.348  Sum_probs=135.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||++++++|.++...+++|||++ +++.++...      +.....++.+++.|++|||+.+  +++||||+|+||+++.
T Consensus        74 ~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~  150 (296)
T cd06618          74 PYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDA  150 (296)
T ss_pred             CchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcC
Confidence            799999999999999999999985 477776653      2235679999999999999732  8999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      ++.++|+|||++........  .....++..|++||            .++||||||+++|||++|+.|+...-   ...
T Consensus       151 ~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~  225 (296)
T cd06618         151 SGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---TEF  225 (296)
T ss_pred             CCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch---hHH
Confidence            99999999999876543222  12235677888887            25899999999999999999974311   111


Q ss_pred             ccceeeecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +...++....... ........++.+++.+||..||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1222222221111 111124567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=4.8e-28  Score=222.59  Aligned_cols=180  Identities=21%  Similarity=0.282  Sum_probs=140.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++++.+++..++|+||+++++|.+++...     .....++.|+++||.|||+.   +++|+||+|+||+++.
T Consensus        59 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~  135 (258)
T cd05578          59 HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDE  135 (258)
T ss_pred             CCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcC
Confidence            389999999999999999999999999999998643     24577899999999999988   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||.+.......  ......|+..|++||        .++|+||||+++|||++|+.|+...-.. ....+.+
T Consensus       136 ~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~  212 (258)
T cd05578         136 QGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRA  212 (258)
T ss_pred             CCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHH
Confidence            9999999999987654332  223356778899888        5799999999999999999997543210 0111111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM--LRVQ  368 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~--~~v~  368 (383)
                      ....  .....+......+.+++.+||+.||++||++  +|+.
T Consensus       213 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 KQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             Hhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1111  1122233445788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=1.2e-27  Score=222.58  Aligned_cols=182  Identities=22%  Similarity=0.307  Sum_probs=138.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++++...+..++||||+++++|.+++....       ....++.|++.|+.|||+.   +++|+||+|+||++
T Consensus        52 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~  128 (277)
T cd05577          52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLL  128 (277)
T ss_pred             CCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            5899999999999999999999999999999986432       3466889999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      +.++.++++|||.+.......  ......++..|++||        .++||||||++++||++|+.|+...........+
T Consensus       129 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  206 (277)
T cd05577         129 DDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL  206 (277)
T ss_pred             CCCCCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence            999999999999987654321  122345677899988        3689999999999999999997532111111111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+.+...  ....+......+.+++.+||+.||++||     ++.++++
T Consensus       207 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         207 KRRTLEM--AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             Hhccccc--cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1111111  1112233456788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=3.7e-28  Score=246.63  Aligned_cols=205  Identities=16%  Similarity=0.241  Sum_probs=142.7

Q ss_pred             HhhCccccCeeecCCccccccc-------------ccee--------------------------e-eE-----EEeCCE
Q 046461          162 GTNKFYEKNVIRGDDFGIAFKN-------------IVQL--------------------------L-GY-----CPVGEK  196 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~~n-------------iv~l--------------------------~-g~-----~~~~~~  196 (383)
                      ..++|...+.||+|+||.||.-             .++-                          . ++     +..++.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            5678999999999999999931             0110                          0 00     134567


Q ss_pred             EEEEEEeccCCCHHHHHhcch-------------------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          197 KLIVYEYMVKGSLNDWLRNQA-------------------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~~-------------------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      .++||||+++++|.+++....                         ....++.|++.||+|||+.   +|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence            899999999999999886321                         1235889999999999998   999999999999


Q ss_pred             EEcC-CCceEEccccCccccCCCCCccccccccccccccCCC------------------------------CCcchhHH
Q 046461          252 LLNE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC------------------------------GGDIYSFS  300 (383)
Q Consensus       252 Ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape~------------------------------~~Dv~SfG  300 (383)
                      |++. ++.+||+|||+++.+............+++.|+|||.                              ++||||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 5789999999998764433333445678899999981                              34999999


Q ss_pred             HHHHHHHhCCCCCCCCCC------CCCCCccceee--ecCccccc----C--ChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          301 VVLLELVIRKQPTGPEFK------DKNGGNLVDWV--LDSTILNA----Y--SKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       301 vil~Elltg~~p~~~~~~------~~~~~~~~~~v--~~~~~~~~----~--~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      |++|||+++..+.+....      .....+...|.  ..+.....    +  .........+++.+|++.||++|||+.|
T Consensus       367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            999999997766432110      00011111111  01100000    0  0011223458999999999999999999


Q ss_pred             HHH
Q 046461          367 VQE  369 (383)
Q Consensus       367 v~~  369 (383)
                      +++
T Consensus       447 ~L~  449 (566)
T PLN03225        447 ALA  449 (566)
T ss_pred             HhC
Confidence            987

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=6.3e-28  Score=224.73  Aligned_cols=181  Identities=24%  Similarity=0.287  Sum_probs=137.4

Q ss_pred             ccccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++|++++++++.+.  +..++|+||+++ +|.+++...      .....++.|++.|++|||+.   +++|+|+||+||+
T Consensus        57 ~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil  132 (287)
T cd07840          57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNIL  132 (287)
T ss_pred             CCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeE
Confidence            48999999999988  899999999974 899888643      24578999999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      ++.++.++++|||++...........+...++..|++||         .++||||||+++|||++|+.|+...-    ..
T Consensus       133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~----~~  208 (287)
T cd07840         133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST----EL  208 (287)
T ss_pred             EcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC----hH
Confidence            999999999999999876544322233345677899988         36899999999999999999964321    11


Q ss_pred             ccceeee-------------------------cC----cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVL-------------------------DS----TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~-------------------------~~----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+.                         ..    .+...........+.+++.+||+.+|++||+++++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000                         00    0000001112567889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.2e-27  Score=219.20  Aligned_cols=180  Identities=23%  Similarity=0.271  Sum_probs=137.5

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +||+++++++.+.  +..++++||+++++|.+++...     .....++.|++.|+.|||+.   +++|+|+||+||+++
T Consensus        64 ~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~  140 (264)
T cd06653          64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRD  140 (264)
T ss_pred             CCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence            7999999998764  4688999999999999998643     34567899999999999988   999999999999999


Q ss_pred             CCCceEEccccCccccCCCC--CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCE--SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~--~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      .++.++++|||+++......  ........++..|++||        .++|+|||||+++|+++|+.|+...    ....
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~  216 (264)
T cd06653         141 SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAMA  216 (264)
T ss_pred             CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHHH
Confidence            99999999999998653211  11122346788999998        4689999999999999999996432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..............+......+.+++.+||. +|..||+..+++.
T Consensus       217 ~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         217 AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111111111222344556778899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=1.6e-27  Score=217.95  Aligned_cols=180  Identities=27%  Similarity=0.372  Sum_probs=142.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++|++++.+.+..++..++|+||+++++|.+++...         .....++.+++.|++|||+.   +++|+|++|+||
T Consensus        58 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~ni  134 (258)
T cd08215          58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNI  134 (258)
T ss_pred             CCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHe
Confidence            379999999999999999999999999999998753         24578899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.++.++++|||.+....... .......|+..|++||        .++|+||+|++++||++|+.|+...    +..
T Consensus       135 l~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~~  209 (258)
T cd08215         135 FLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE----NLL  209 (258)
T ss_pred             EEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC----cHH
Confidence            99999999999999998765432 1222346788899988        5799999999999999999996432    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+......... ...+......+.+++.+||..+|++|||+.++++
T Consensus       210 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         210 ELALKILKGQY-PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22222222211 1223345567889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=2.5e-27  Score=228.50  Aligned_cols=182  Identities=21%  Similarity=0.270  Sum_probs=132.9

Q ss_pred             cccceeeeEEEeC------CEEEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVG------EKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~------~~~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +||+++++++...      ...++||||+. ++|.+.+..   ......++.|++.||+|||+.   +++||||||+||+
T Consensus        75 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil  150 (353)
T cd07850          75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV  150 (353)
T ss_pred             CCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEE
Confidence            7999999988643      35799999995 588888753   344567899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC-----
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD-----  319 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~-----  319 (383)
                      ++.++.+|++|||+++......  ......++..|++||        .++|||||||+++||++|+.|+...-..     
T Consensus       151 ~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  228 (353)
T cd07850         151 VKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK  228 (353)
T ss_pred             ECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999998754322  122345788899998        5789999999999999999997421000     


Q ss_pred             ------CCCCccc--------eee--------------ecCccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          320 ------KNGGNLV--------DWV--------------LDSTIL----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       320 ------~~~~~~~--------~~v--------------~~~~~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                            ....++.        .+.              ......    ..........+.+++.+|++.||++|||+.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence                  0000000        000              000000    00011234567899999999999999999999


Q ss_pred             HH
Q 046461          368 QE  369 (383)
Q Consensus       368 ~~  369 (383)
                      ++
T Consensus       309 L~  310 (353)
T cd07850         309 LQ  310 (353)
T ss_pred             hc
Confidence            86

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=9.4e-28  Score=219.84  Aligned_cols=178  Identities=23%  Similarity=0.309  Sum_probs=141.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++||+++.+++.+....++|+||+++++|.+++...         .....++.+++.|++|||+.   +++|+|++|+||
T Consensus        58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni  134 (256)
T cd08530          58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANI  134 (256)
T ss_pred             CCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceE
Confidence            489999999999999999999999999999998641         23467899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.++.+|++|||+++.....   ......++..|++||        .++|+||+|++++|+++|+.|+...    +..
T Consensus       135 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~----~~~  207 (256)
T cd08530         135 LLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR----SMQ  207 (256)
T ss_pred             EEecCCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHH
Confidence            9999999999999999876543   122245778888887        4799999999999999999996432    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+...+..... ...+......+.+++.+|++.+|++|||+.++++
T Consensus       208 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         208 DLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHHHhcCCC-CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            22222222222 1222345567899999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=2.4e-27  Score=224.85  Aligned_cols=175  Identities=27%  Similarity=0.368  Sum_probs=134.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|++++++++.+++..++||||++ |++.+++...      .....++.|++.|+.|||+.   +++|+|++|+||+++.
T Consensus        81 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~  156 (313)
T cd06633          81 PNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE  156 (313)
T ss_pred             CCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECC
Confidence            799999999999999999999995 6888877532      24567889999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.++++|||++.....     .....|+..|++||           .++|||||||++|||++|..|+...    +...
T Consensus       157 ~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~----~~~~  227 (313)
T cd06633         157 PGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMS  227 (313)
T ss_pred             CCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHH
Confidence            99999999999864322     12345788899987           2479999999999999999996432    1112


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+.................+.+++.+||+.+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         228 ALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111111111223346788999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=226.94  Aligned_cols=184  Identities=20%  Similarity=0.316  Sum_probs=155.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-  254 (383)
                      ||||+|+.+...+..+|||+|.-.+|+|++|+-...      -..+++.||..|+.|+|..   .+|||||||+|+.+- 
T Consensus        77 pNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFE  153 (864)
T KOG4717|consen   77 PNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFE  153 (864)
T ss_pred             cCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEee
Confidence            899999999999999999999999999999996432      2467999999999999998   899999999999875 


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .-|-+|+.|||++-.+..+.  ..+..+|+..|-|||         ++.||||+|||||-+++|+.||..    .+..+.
T Consensus       154 KlGlVKLTDFGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe----ANDSET  227 (864)
T KOG4717|consen  154 KLGLVKLTDFGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE----ANDSET  227 (864)
T ss_pred             ecCceEeeeccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc----ccchhh
Confidence            45889999999987665543  344578999999998         789999999999999999999643    355566


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                      ...++|..+.  .+.....++.+++..|+..||.+|.+.+||+.  +|+.+..
T Consensus       228 LTmImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  228 LTMIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hhhhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            6677777663  35677889999999999999999999999985  6665543

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=1.4e-27  Score=228.78  Aligned_cols=188  Identities=29%  Similarity=0.412  Sum_probs=139.2

Q ss_pred             ccccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||++++++|...  ...++||||++ ++|.+++..    +.....++.|++.||+|||+.   +++|||+||+||+++
T Consensus        66 h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~  141 (337)
T cd07852          66 HPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLN  141 (337)
T ss_pred             CCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence            48999999998653  46899999997 599998864    234567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCC----ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCES----HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      .++.+|++|||+++.......    .......|+..|++||         .++||||||+++|||++|+.|+.....   
T Consensus       142 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~---  218 (337)
T cd07852         142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST---  218 (337)
T ss_pred             CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh---
Confidence            999999999999986643321    1223356788999998         368999999999999999999643211   


Q ss_pred             CCcccee-----------------------eec----Ccc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--H
Q 046461          322 GGNLVDW-----------------------VLD----STI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--F  370 (383)
Q Consensus       322 ~~~~~~~-----------------------v~~----~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~  370 (383)
                       .+....                       ..+    ...  ...........+.+++.+||+.||++|||+.++++  .
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~  297 (337)
T cd07852         219 -LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY  297 (337)
T ss_pred             -HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence             000000                       000    000  00001123457889999999999999999999997  3


Q ss_pred             Hhcccc
Q 046461          371 LEKYHT  376 (383)
Q Consensus       371 L~~~~~  376 (383)
                      ++++..
T Consensus       298 ~~~~~~  303 (337)
T cd07852         298 VAQFHN  303 (337)
T ss_pred             hhhhcc
Confidence            555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=9.5e-28  Score=225.78  Aligned_cols=179  Identities=25%  Similarity=0.296  Sum_probs=133.2

Q ss_pred             cccceeeeEEEeCC----------EEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPVGE----------KKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~~~----------~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +|++++++++.+.+          ..++|+||+++ ++.+.+...      .....++.|++.||+|||+.   +++|+|
T Consensus        66 ~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~d  141 (302)
T cd07864          66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRD  141 (302)
T ss_pred             CCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            79999999987654          78999999976 777777532      34678999999999999998   999999


Q ss_pred             CCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCC
Q 046461          246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPE  316 (383)
Q Consensus       246 lk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~  316 (383)
                      +||+||+++.++.+|++|||+++..............++..|++||         .++|||||||+++||++|+.|+...
T Consensus       142 l~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             CCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322222234567788887         4589999999999999999887532


Q ss_pred             CCCCCCCccceee-----------------------ecC------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          317 FKDKNGGNLVDWV-----------------------LDS------TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       317 ~~~~~~~~~~~~v-----------------------~~~------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                      -    ..+....+                       .+.      ..... ....+..+.+++.+||+.+|++|||+.++
T Consensus       222 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         222 Q----ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             C----hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            1    10000000                       000      00000 11234678999999999999999999998


Q ss_pred             HH
Q 046461          368 QE  369 (383)
Q Consensus       368 ~~  369 (383)
                      ++
T Consensus       297 l~  298 (302)
T cd07864         297 LN  298 (302)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=8.7e-28  Score=221.15  Aligned_cols=179  Identities=22%  Similarity=0.338  Sum_probs=138.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      |||++++++++.+.+..++||||+++++|.+++..         +.....++.|++.|+.|||+.   +++|+|+||+||
T Consensus        61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~ni  137 (260)
T cd08222          61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNI  137 (260)
T ss_pred             CCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhhe
Confidence            48999999999999999999999999999998863         234577899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++. +.++++|||+++....... ......|+..|++||        .++|+||||+++|||++|..|+...    ...
T Consensus       138 li~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~  211 (260)
T cd08222         138 FLKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFL  211 (260)
T ss_pred             Eeec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHH
Confidence            9975 5699999999877643221 122345778898887        4789999999999999999996421    111


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+.... ....+......+.+++.+||..+|++||++.|+++
T Consensus       212 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         212 SVVLRIVEGP-TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHHHcCC-CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            2222222111 11223445568889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=1.6e-27  Score=227.42  Aligned_cols=192  Identities=21%  Similarity=0.296  Sum_probs=138.5

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      |+||+++++++..++..++|+||+++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||++
T Consensus        58 h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill  134 (328)
T cd08226          58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILI  134 (328)
T ss_pred             CCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            689999999999999999999999999999998742       23457899999999999988   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCcc------ccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHT------STDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      +.++.++++||+.+..........      .....++..|++||          .++|||||||++|||++|+.|+....
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999998654332111000      01123456789987          35799999999999999999975421


Q ss_pred             CCCCCCccc--------------------------------e---------eeecCcccccCChhHHHHHHHHHHHcccc
Q 046461          318 KDKNGGNLV--------------------------------D---------WVLDSTILNAYSKPSMLKMLQIVVGCIFD  356 (383)
Q Consensus       318 ~~~~~~~~~--------------------------------~---------~v~~~~~~~~~~~~~~~~~~~l~~~C~~~  356 (383)
                      .........                                +         .+.+..............+.+++.+||+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  294 (328)
T cd08226         215 RTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ  294 (328)
T ss_pred             hHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccC
Confidence            100000000                                0         00000111111233556789999999999


Q ss_pred             CCCCCCCHHHHHH--HHhccc
Q 046461          357 NPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       357 ~P~~RPs~~~v~~--~L~~~~  375 (383)
                      ||++|||+.|+++  .++.++
T Consensus       295 dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         295 DPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             CcccCCCHHHHhhCHHHHHHH
Confidence            9999999999985  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.95  E-value=1.8e-27  Score=223.46  Aligned_cols=178  Identities=23%  Similarity=0.369  Sum_probs=138.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      +|++++++++..++..++||||+++++|.+++...    .....++.|++.|++|||+.   +++|+|++|+||+++.++
T Consensus        77 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~  153 (292)
T cd06657          77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDG  153 (292)
T ss_pred             cchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence            79999999999999999999999999999988532    34567899999999999998   999999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .++++|||++....... .......|+..|++||        .++|+||||+++|||++|..|+...    ........+
T Consensus       154 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~----~~~~~~~~~  228 (292)
T cd06657         154 RVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE----PPLKAMKMI  228 (292)
T ss_pred             CEEEcccccceeccccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Confidence            99999999987654322 1223346788899988        4689999999999999999996432    111111111


Q ss_pred             ---ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ---LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ---~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                         .......  .......+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         229 RDNLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HhhCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence               1111111  1223456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=9.4e-30  Score=223.66  Aligned_cols=203  Identities=25%  Similarity=0.349  Sum_probs=150.8

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeE
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGY  190 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~  190 (383)
                      ..|+-+++..-       ..||.|.||+|+                                         ||||+++|.
T Consensus        59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            34555555544       679999999998                                         799999999


Q ss_pred             EEeCCEEEEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceE
Q 046461          191 CPVGEKKLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVK  260 (383)
Q Consensus       191 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~k  260 (383)
                      +..++..|+.||.| .-||+.+-+.-          .-.-.|..-...||.||-...  .|+|||+||+|||+|..|.+|
T Consensus       132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence            99999999999999 45776554321          111235556678999998764  799999999999999999999


Q ss_pred             EccccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          261 VSDFGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      ++|||++-.+.+  +...+.-+|...|||||          .++||||+|++|+|+.||+.|+.. +.  +..+.+..++
T Consensus       209 LCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-w~--svfeql~~Vv  283 (361)
T KOG1006|consen  209 LCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-WD--SVFEQLCQVV  283 (361)
T ss_pred             eecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-HH--HHHHHHHHHH
Confidence            999999976643  23344467889999998          468999999999999999999532 11  1112222222


Q ss_pred             --cCccc-ccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 --DSTIL-NAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 --~~~~~-~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        |+.+. ... ..+....+..++..|+.+|-++||...++.+
T Consensus       284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              22221 111 1235667889999999999999999988765

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1e-27  Score=223.51  Aligned_cols=184  Identities=20%  Similarity=0.253  Sum_probs=135.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++++.+++..+++|||++ ++|.+++...       .....++.|+++||+|||+.   +++|+|++|+||++
T Consensus        57 ~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~  132 (283)
T cd07835          57 HPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLI  132 (283)
T ss_pred             CCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEE
Confidence            5899999999999999999999995 6999998643       23577899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++.++++|||+++...... .......++..|++||         .++||||||+++|||++|+.|+...-.......
T Consensus       133 ~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  211 (283)
T cd07835         133 DREGALKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR  211 (283)
T ss_pred             cCCCcEEEeecccccccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999997654322 1122234678899998         358999999999999999998643210000000


Q ss_pred             cceee------------ecCc----c-------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWV------------LDST----I-------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v------------~~~~----~-------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.++.            ..+.    .       ...........+.+++.+||+.+|++|||++|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000            0000    0       00111223357889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=232.45  Aligned_cols=193  Identities=18%  Similarity=0.248  Sum_probs=156.5

Q ss_pred             hhCccccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      +..|.....+|.|+|+.|.                                    +|++++.+.+.++.+.|+|||++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            4455555668999998776                                    7999999999999999999999999


Q ss_pred             CCHHHHHhcch----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE-cCCCceEEccccCccccCCCCCcccccc
Q 046461          207 GSLNDWLRNQA----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILL-NEDFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       207 gsL~~~l~~~~----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl-~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      |.+.+.+....    .+..|+.+++.++.|||.+   +++|||+||+|||+ +..++++++|||.++.....    ....
T Consensus       401 ~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp  473 (612)
T KOG0603|consen  401 GELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTP  473 (612)
T ss_pred             cHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hccc
Confidence            99888876432    3456999999999999998   99999999999999 58899999999999876543    2234


Q ss_pred             ccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHc
Q 046461          282 AGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGC  353 (383)
Q Consensus       282 ~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C  353 (383)
                      +-|..|.|||        .++|+||+|++||||++|+.|+...-   .+.++...+..+..    ....+....+++.+|
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P---~~~ei~~~i~~~~~----s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP---AGIEIHTRIQMPKF----SECVSDEAKDLLQQL  546 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC---chHHHHHhhcCCcc----ccccCHHHHHHHHHh
Confidence            5677888988        68999999999999999999964321   22344444443332    355667888999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 046461          354 IFDNPTTRPTMLRVQE  369 (383)
Q Consensus       354 ~~~~P~~RPs~~~v~~  369 (383)
                      ++.||.+||+|.++..
T Consensus       547 L~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGA  562 (612)
T ss_pred             ccCChhhCcChhhhcc
Confidence            9999999999999875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-27  Score=228.92  Aligned_cols=190  Identities=24%  Similarity=0.322  Sum_probs=135.9

Q ss_pred             cccceeeeEEEeC-----CEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVG-----EKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +||+++++++...     ...++++||++ ++|.+++...    .....++.|++.||+|||+.   +++||||||+||+
T Consensus        63 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nil  138 (336)
T cd07849          63 ENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLL  138 (336)
T ss_pred             CCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEE
Confidence            7999999887654     35799999996 5888887642    34577899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCc--cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC--
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD--  319 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~--  319 (383)
                      ++.++.++++|||+++........  ......|+..|+|||         .++||||+||++|||++|+.|+...-..  
T Consensus       139 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~  218 (336)
T cd07849         139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ  218 (336)
T ss_pred             ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999998765432211  122356788999998         3579999999999999999997421000  


Q ss_pred             ---------CCCCccceeeecCc-------cc--cc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 046461          320 ---------KNGGNLVDWVLDST-------IL--NA-----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF--LEKY  374 (383)
Q Consensus       320 ---------~~~~~~~~~v~~~~-------~~--~~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~--L~~~  374 (383)
                               ....+....+.+..       ..  ..     ........+.+++.+||+.+|++|||+.|+++.  +++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                     00000000000000       00  00     001224568899999999999999999999974  5554


Q ss_pred             c
Q 046461          375 H  375 (383)
Q Consensus       375 ~  375 (383)
                      .
T Consensus       299 ~  299 (336)
T cd07849         299 H  299 (336)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=2.2e-27  Score=222.63  Aligned_cols=184  Identities=21%  Similarity=0.229  Sum_probs=132.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++++.+++..++||||++ ++|.+++...       .....++.|++.||+|||+.   +++|+||+|+||++
T Consensus        60 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill  135 (294)
T PLN00009         60 HGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLI  135 (294)
T ss_pred             CCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEE
Confidence            3899999999999999999999995 5888887532       22456889999999999998   99999999999999


Q ss_pred             cC-CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          254 NE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       254 ~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +. ++.+|++|||+++...... .......++..|++||         .++||||||+++|||++|+.|+...-......
T Consensus       136 ~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~  214 (294)
T PLN00009        136 DRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF  214 (294)
T ss_pred             ECCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            85 5678999999997653321 1222345678898887         36899999999999999999964321000000


Q ss_pred             cc------------------ceee-ecCcccc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NL------------------VDWV-LDSTILN----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~------------------~~~v-~~~~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..                  ..+. ..+....    .........+.+++.+|++.+|++||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00                  0000 0000000    001223456789999999999999999999986

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=4.5e-27  Score=219.17  Aligned_cols=180  Identities=26%  Similarity=0.337  Sum_probs=135.8

Q ss_pred             cccccceeeeEEEeCCE-----EEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          180 AFKNIVQLLGYCPVGEK-----KLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       180 v~~niv~l~g~~~~~~~-----~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      .++|++++++++.+.+.     .+++|||++ ++|.+++...       .....++.|++.||+|||+.   +++|+|++
T Consensus        59 ~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~  134 (287)
T cd07838          59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLK  134 (287)
T ss_pred             CCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCC
Confidence            36899999999988776     899999997 5899888642       24577899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      |+||+++.++.++++|||.+........  .....++..|++||        .++|+|||||++|||++|+.|+....  
T Consensus       135 ~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--  210 (287)
T cd07838         135 PQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--  210 (287)
T ss_pred             hhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--
Confidence            9999999999999999999887643321  12234678899987        57999999999999999988864321  


Q ss_pred             CCCCccceeee-------------c---------Cccc---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 KNGGNLVDWVL-------------D---------STIL---NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 ~~~~~~~~~v~-------------~---------~~~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        ..+..+.+.             .         ....   ..........+.+++.+||+.||++||++.|+++
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         211 --EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             --hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              111100000             0         0000   0001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=4.6e-27  Score=221.68  Aligned_cols=183  Identities=20%  Similarity=0.285  Sum_probs=131.6

Q ss_pred             cccceeeeEEEeCC--------EEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPVGE--------KKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~~~--------~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      +||++++++|...+        ..++||||++ ++|.+++...      .....++.|++.||+|||+.   +++|+|||
T Consensus        71 ~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~  146 (310)
T cd07865          71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMK  146 (310)
T ss_pred             CCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            79999999987654        3599999996 5888887642      34578899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCc---cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      |+||+++.++.+|++|||++.........   ......++..|+|||         .++||||||++++||++|..|+..
T Consensus       147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999866432211   112345678899998         368999999999999999988643


Q ss_pred             CCCCCCCCccceee-----------------ec-CcccccC---------ChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046461          316 EFKDKNGGNLVDWV-----------------LD-STILNAY---------SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       316 ~~~~~~~~~~~~~v-----------------~~-~~~~~~~---------~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~  368 (383)
                      .... ........+                 .+ -......         .......+.+++.+||..||++|||++|++
T Consensus       227 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l  305 (310)
T cd07865         227 NTEQ-HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL  305 (310)
T ss_pred             CCHH-HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence            2110 000000000                 00 0000000         001134567899999999999999999997


Q ss_pred             H
Q 046461          369 E  369 (383)
Q Consensus       369 ~  369 (383)
                      +
T Consensus       306 ~  306 (310)
T cd07865         306 N  306 (310)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.9e-27  Score=214.66  Aligned_cols=180  Identities=24%  Similarity=0.410  Sum_probs=141.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++++.+++..++++||+++++|.+++...     .....++.|++.|+.|||+.   +++|+|+||+||+++.
T Consensus        58 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~  134 (254)
T cd06627          58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTK  134 (254)
T ss_pred             CCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECC
Confidence            379999999999999999999999999999998643     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||.+......... .....++..|++||        .++||||+|++++||++|+.|+...    .......
T Consensus       135 ~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~----~~~~~~~  209 (254)
T cd06627         135 DGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL----NPMAALF  209 (254)
T ss_pred             CCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc----cHHHHHH
Confidence            999999999999876543321 22346788899988        5699999999999999999996432    1111111


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..... .....+......+.+++.+|+..+|++|||+.+++.
T Consensus       210 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         210 RIVQD-DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHhcc-CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11111 111223344567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=3.4e-27  Score=219.79  Aligned_cols=183  Identities=21%  Similarity=0.307  Sum_probs=136.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++|++++++++.+++..++||||+ +|+|.+++...       .....++.|++.+|.|||+.   +++|+||+|+||++
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i  132 (283)
T cd07830          57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLV  132 (283)
T ss_pred             CCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEE
Confidence            589999999999999999999999 88999988643       23577899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC---
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN---  321 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~---  321 (383)
                      +.++.++++|||+++.......  .....++..|++||         .++|+||||++++||++|+.|+........   
T Consensus       133 ~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~  210 (283)
T cd07830         133 SGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK  210 (283)
T ss_pred             cCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence            9999999999999986643221  22345778899988         468999999999999999988642210000   


Q ss_pred             ---------C------Cc---cceeeecCcc---cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 ---------G------GN---LVDWVLDSTI---LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 ---------~------~~---~~~~v~~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                               .      ..   ..++......   ...........+.+++.+||+.+|++|||++|++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         211 ICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                     0      00   0000000000   00001112457889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=3.7e-27  Score=222.86  Aligned_cols=179  Identities=25%  Similarity=0.307  Sum_probs=132.7

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +|++++++++.+.  +..++||||++ ++|.+++..      +.....++.|++.|++|||+.   +++||||||+||++
T Consensus        66 ~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~  141 (309)
T cd07845          66 PNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLL  141 (309)
T ss_pred             CCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            6999999998764  56899999996 588888763      234577999999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++.+||+|||+++...... .......++..|++||         .++||||+||++|||++|+.|+...    +..+
T Consensus       142 ~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~----~~~~  216 (309)
T cd07845         142 TDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK----SEIE  216 (309)
T ss_pred             CCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC----CHHH
Confidence            999999999999998764322 1122234567899988         4689999999999999999986432    1111


Q ss_pred             cceeeec-------------------Cc--cccc-C------ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLD-------------------ST--ILNA-Y------SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~-------------------~~--~~~~-~------~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+.+                   ..  .... .      .......+.+++.+|++.||++|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1100000                   00  0000 0      0112456788999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=8.7e-27  Score=220.52  Aligned_cols=185  Identities=19%  Similarity=0.245  Sum_probs=134.8

Q ss_pred             ccccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          181 FKNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       181 ~~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      +|||+++++++.+.  +..++||||+++ +|.+++...          .....++.|++.|++|||+.   +++||||||
T Consensus        61 h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp  136 (316)
T cd07842          61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKP  136 (316)
T ss_pred             CCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCH
Confidence            48999999999988  889999999974 777766421          23467899999999999998   899999999


Q ss_pred             CcEEEcC----CCceEEccccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCC
Q 046461          249 SNILLNE----DFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       249 ~NiLl~~----~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      +||+++.    ++.+|++|||+++.......  .......++..|+|||         .++|||||||+++||++|+.|+
T Consensus       137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~  216 (316)
T cd07842         137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF  216 (316)
T ss_pred             HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence            9999999    89999999999887643222  1222346788899998         3589999999999999999997


Q ss_pred             CCCCCCCCCC------c---------------------cceeee--cCcccccCC---------h--hHHHHHHHHHHHc
Q 046461          314 GPEFKDKNGG------N---------------------LVDWVL--DSTILNAYS---------K--PSMLKMLQIVVGC  353 (383)
Q Consensus       314 ~~~~~~~~~~------~---------------------~~~~v~--~~~~~~~~~---------~--~~~~~~~~l~~~C  353 (383)
                      ..........      .                     ..++..  +......++         .  .....+.+++.+|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  296 (316)
T cd07842         217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL  296 (316)
T ss_pred             cCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHH
Confidence            5322111000      0                     000000  000000001         0  2345688999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 046461          354 IFDNPTTRPTMLRVQE  369 (383)
Q Consensus       354 ~~~~P~~RPs~~~v~~  369 (383)
                      ++.||++|||+.|+++
T Consensus       297 l~~~P~~Rps~~eil~  312 (316)
T cd07842         297 LEYDPTKRITAEEALE  312 (316)
T ss_pred             hcCCcccCcCHHHHhc
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=211.22  Aligned_cols=183  Identities=19%  Similarity=0.219  Sum_probs=141.1

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      +|||++++++..    ..-+.+|||.|+||+|.+.+.+..       +...|+.||+.|+.|||+.   .|.|||+||+|
T Consensus       115 ~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpEN  191 (400)
T KOG0604|consen  115 PHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPEN  191 (400)
T ss_pred             CceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhh
Confidence            799999998865    345679999999999999997543       4578999999999999999   99999999999


Q ss_pred             EEEcC---CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          251 ILLNE---DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       251 iLl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      +|...   |...|++|||+|+.....  ......+-|+.|.|||        ..+|+||+||++|-|++|-+||+..-.-
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~  269 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_pred             eeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence            99964   567999999999875432  2333457789999998        4579999999999999999998643211


Q ss_pred             CCCCccceeeecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 KNGGNLVDWVLDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .-.......+..+.+  +.+.+...++...++++..+..+|++|-|+.++++
T Consensus       270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            111112222322222  23334556777889999999999999999999975

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.9e-27  Score=228.37  Aligned_cols=210  Identities=19%  Similarity=0.272  Sum_probs=153.1

Q ss_pred             HHHHHHHh----hCccccCeeecCCccccc-----------------------------------------cccceeeeE
Q 046461          156 YDQIVAGT----NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGY  190 (383)
Q Consensus       156 ~~~l~~~t----~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~  190 (383)
                      .+|+..++    ++|...+.||+|+||.||                                         +||++++++
T Consensus         3 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~   82 (342)
T cd07879           3 REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV   82 (342)
T ss_pred             hhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhe
Confidence            34555443    677778888888888887                                         799999999


Q ss_pred             EEeC------CEEEEEEEeccCCCHHHHHh---cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          191 CPVG------EKKLIVYEYMVKGSLNDWLR---NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       191 ~~~~------~~~~lv~e~~~~gsL~~~l~---~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                      +...      ...++|+||+.. +|.++..   .......++.|++.||+|||+.   +++||||||+||+++.++.+++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             ecccccCCCCceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            8654      346899999964 7877654   2334567899999999999998   9999999999999999999999


Q ss_pred             ccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee---
Q 046461          262 SDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV---  329 (383)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v---  329 (383)
                      +|||+++.....    .....++..|++||         .++|||||||++|||++|+.|+...    +.......+   
T Consensus       159 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~----~~~~~~~~~~~~  230 (342)
T cd07879         159 LDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKV  230 (342)
T ss_pred             eeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHh
Confidence            999998764321    22345677899988         3689999999999999999997532    111100000   


Q ss_pred             ------------ec----------CcccccC----ChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccccC
Q 046461          330 ------------LD----------STILNAY----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHTG  377 (383)
Q Consensus       330 ------------~~----------~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~~  377 (383)
                                  .+          +......    .......+.+++.+||+.||++||++++++.  .++..++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                        00          0000000    0122346789999999999999999999995  46666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-28  Score=246.96  Aligned_cols=205  Identities=19%  Similarity=0.215  Sum_probs=158.3

Q ss_pred             HHHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeC
Q 046461          157 DQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~  194 (383)
                      .++....++|....+||+|+||.|+                                          +-||+++-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3455556788889999999999887                                          5789999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +.+|+|||||+||+|-..+.+..     -...++..|..||.-+|+.   +.|||||||+|||+|..|++|++|||.+-.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence            99999999999999999997543     2456788899999999999   999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc
Q 046461          270 ISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN  336 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~  336 (383)
                      +...+.-.+....|||-|++||             ..+|+||+||++|||+.|..||+.+.    -.+....|++..-.-
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~~l  300 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKESL  300 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhhhc
Confidence            7765555555568999999998             56899999999999999999986431    111112222211111


Q ss_pred             cCC--hhHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 046461          337 AYS--KPSMLKMLQIVVGCIFDNPTTRPT---MLRVQE  369 (383)
Q Consensus       337 ~~~--~~~~~~~~~l~~~C~~~~P~~RPs---~~~v~~  369 (383)
                      .+|  .+.+.+..+++.+-+. +|+.|-.   ++++..
T Consensus       301 ~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  301 SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            122  2355666777766443 7777876   766654

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=1.5e-27  Score=233.23  Aligned_cols=141  Identities=27%  Similarity=0.339  Sum_probs=120.5

Q ss_pred             CccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .|.-.++||+|.||.|-                                            -|+|++++|+...++.+||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            56677999999999987                                            3999999999999999999


Q ss_pred             EEeccCCCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCceEEccccCccccC
Q 046461          201 YEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE--DFEVKVSDFGLVRLIS  271 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~~~  271 (383)
                      +|.+. -+|+++++..+       ....++.||+.||.+||..   +|||+||||+||||..  ...+||+|||.+....
T Consensus       267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            99994 59999998543       3467899999999999988   9999999999999964  3479999999998764


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCC
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      ..-    ....-+..|+|||        .+.||||||||+.||++|.+-|
T Consensus       343 q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  343 QRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             Ccc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            321    1356678899999        7899999999999999996553

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=4.4e-27  Score=219.15  Aligned_cols=180  Identities=22%  Similarity=0.297  Sum_probs=135.1

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ++|++++++++.+.+..++||||+++ +|.+++...        .....++.|++.||+|||+.   +++|+|+||+||+
T Consensus        57 h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~  132 (284)
T cd07836          57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLL  132 (284)
T ss_pred             CCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEE
Confidence            38999999999999999999999984 898887532        23567899999999999988   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      ++.++.++++|||+++...... .......++..|++||         .++||||||+++||+++|+.|+....    ..
T Consensus       133 ~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~----~~  207 (284)
T cd07836         133 INKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN----NE  207 (284)
T ss_pred             ECCCCcEEEeecchhhhhcCCc-cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----cH
Confidence            9999999999999987653321 1122345677899887         35899999999999999999965321    11


Q ss_pred             ccceeee--------------------cCcccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVL--------------------DSTILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~--------------------~~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +....+.                    ......       ...+.....+.+++.+|++.||++||++.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1100000                    000000       001122456789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=2.3e-27  Score=220.15  Aligned_cols=180  Identities=21%  Similarity=0.342  Sum_probs=140.0

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++.+++..++||||+++++|.+++...     .....++.|++.||.|||+.   +++|+|++|+||+++.
T Consensus        61 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~  137 (280)
T cd05581          61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDK  137 (280)
T ss_pred             CCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECC
Confidence            489999999999999999999999999999999743     34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-------------------ccccccccccccccCC--------CCCcchhHHHHHHHHHh
Q 046461          256 DFEVKVSDFGLVRLISDCES-------------------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-------------------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt  308 (383)
                      ++.++++|||++........                   .......++..|++||        .++|+||+|++++|+++
T Consensus       138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~  217 (280)
T cd05581         138 DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT  217 (280)
T ss_pred             CCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence            99999999999886543221                   1112235678899887        46899999999999999


Q ss_pred             CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 046461          309 RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM----LRVQE  369 (383)
Q Consensus       309 g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~----~~v~~  369 (383)
                      |+.|+...    ......+.+.+.  ....+......+.+++.+||+.+|++|||+    +++++
T Consensus       218 g~~p~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         218 GKPPFRGS----NEYLTFQKILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCCCCc----cHHHHHHHHHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            99996432    111111111111  112233345678899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=3.4e-27  Score=225.79  Aligned_cols=190  Identities=21%  Similarity=0.332  Sum_probs=137.6

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +||+++++++..    ....++|+||+. |+|.+++...     .....++.|++.||+|||+.   +++|||+||+||+
T Consensus        64 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil  139 (334)
T cd07855          64 DNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLL  139 (334)
T ss_pred             CCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            799999988753    356899999995 6999998632     34677899999999999998   9999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCc---cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC-
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD-  319 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~-  319 (383)
                      ++.++.+||+|||+++........   ......++..|++||         .++|||||||++|||++|+.|+...... 
T Consensus       140 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~  219 (334)
T cd07855         140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH  219 (334)
T ss_pred             EcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence            999999999999999765432211   112346788899988         4699999999999999999997432100 


Q ss_pred             ----------CCCCccceeeecCc-------c--ccc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 046461          320 ----------KNGGNLVDWVLDST-------I--LNA-----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       320 ----------~~~~~~~~~v~~~~-------~--~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                                .......+.+.+..       .  ...     ........+.+++.+||+.+|++|||++++++  .+++
T Consensus       220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence                      00000111000000       0  000     01223567899999999999999999999987  4444


Q ss_pred             cc
Q 046461          374 YH  375 (383)
Q Consensus       374 ~~  375 (383)
                      ..
T Consensus       300 ~~  301 (334)
T cd07855         300 YH  301 (334)
T ss_pred             cc
Confidence            43

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=2.8e-27  Score=226.66  Aligned_cols=189  Identities=22%  Similarity=0.309  Sum_probs=137.4

Q ss_pred             cccceeeeEEEeC-----CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVG-----EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +||+++++++...     ...++|+||+. ++|.+++...     .....++.|++.||.|||+.   +++||||||+||
T Consensus        64 ~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Ni  139 (337)
T cd07858          64 ENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNL  139 (337)
T ss_pred             CCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            7999999988654     34799999995 7899888643     34577899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC---
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD---  319 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~---  319 (383)
                      +++.++.+||+|||+++...... .......++..|++||         .++|||||||++|||++|+.|+...-..   
T Consensus       140 l~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  218 (337)
T cd07858         140 LLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL  218 (337)
T ss_pred             EEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence            99999999999999998654322 1222345778899988         4699999999999999999997421000   


Q ss_pred             --------CCCCccceeeecCcc----------c----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhccc
Q 046461          320 --------KNGGNLVDWVLDSTI----------L----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF--LEKYH  375 (383)
Q Consensus       320 --------~~~~~~~~~v~~~~~----------~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~--L~~~~  375 (383)
                              ....+...++.+...          .    .......+..+.+++.+||+.+|++|||++++++.  ++.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         219 KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence                    000000001100000          0    00012345678899999999999999999999974  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=4.8e-27  Score=227.74  Aligned_cols=197  Identities=23%  Similarity=0.316  Sum_probs=162.1

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .++.|.-...||+|.|+.|.                                         ||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            34566777888888888876                                         8999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||+.+|.+++++.+.     .....+..|+.+|++|||++   .|+|||||++|+||+.++++||+|||++..+...  
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--  208 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--
Confidence            9999999999999753     33566789999999999999   8999999999999999999999999999887642  


Q ss_pred             ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          276 HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      ......+|++.|.|||         +.+|+||+|+++|-|+.|..||+.    ..-.++.+.++...+.-.+  ....++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG----~~lk~Lr~rvl~gk~rIp~--~ms~dc  282 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG----QNLKELRPRVLRGKYRIPF--YMSCDC  282 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC----cccccccchheeeeecccc--eeechh
Confidence            2334578999999998         679999999999999999999653    3344444455544443322  233467


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+.+-.+|.+|+++.++.+
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhh
Confidence            78888899999999999999875

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.94  E-value=6.4e-27  Score=217.66  Aligned_cols=180  Identities=21%  Similarity=0.256  Sum_probs=136.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++.+++..++|+||+++ +|.+++...      .....++.+++.|+.|||+.   +++|+|+||+||+++
T Consensus        57 ~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~  132 (283)
T cd05118          57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLIN  132 (283)
T ss_pred             CCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEEC
Confidence            48999999999999999999999975 888888643      24577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++++|||.+....... .......++..|++||         .++|+||+|++++||++|+.|+...    +..+.
T Consensus       133 ~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~~~~~  207 (283)
T cd05118         133 TEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----SEIDQ  207 (283)
T ss_pred             CCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CHHHH
Confidence            99999999999988765433 1222345677888887         4689999999999999999886421    11000


Q ss_pred             cee---------------eec----C--ccc-------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDW---------------VLD----S--TIL-------NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~---------------v~~----~--~~~-------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...               ..+    .  ...       .........++.+++.+||+.||++||++.+++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000               000    0  000       0011234567899999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.94  E-value=4e-26  Score=216.14  Aligned_cols=189  Identities=20%  Similarity=0.277  Sum_probs=141.4

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ++||+++++++.+.+..+++|||+++|+|.+++...       .....++.|++.||+|||+.   +|+||||||+||++
T Consensus        58 h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili  134 (314)
T cd08216          58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILL  134 (314)
T ss_pred             CcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEE
Confidence            699999999999999999999999999999998742       23467889999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCC------ccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCES------HTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      +.++.++++|||.+........      .......++..|++||          .++|||||||++|||++|+.|+...-
T Consensus       135 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999875532211      1112244677898887          46899999999999999999975321


Q ss_pred             CCCCCCcccee--------e-------------------ecCcc----cccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          318 KDKNGGNLVDW--------V-------------------LDSTI----LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       318 ~~~~~~~~~~~--------v-------------------~~~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      .   .....+.        +                   .++..    ...........+.+++.+||..||++|||+.+
T Consensus       215 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         215 A---TQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             H---HHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence            0   0000000        0                   00000    00112233457889999999999999999999


Q ss_pred             HHH--HHhccc
Q 046461          367 VQE--FLEKYH  375 (383)
Q Consensus       367 v~~--~L~~~~  375 (383)
                      +++  .+++++
T Consensus       292 ll~~p~~~~~~  302 (314)
T cd08216         292 LLNHSFFKQCK  302 (314)
T ss_pred             HhcCchHhhhc
Confidence            987  555554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=215.44  Aligned_cols=189  Identities=22%  Similarity=0.351  Sum_probs=152.0

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+++|+|.||.|-                                          |.+..|--.+...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            578888999999999886                                          45566666778899999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||..||.|.-+|...     .+...+...|..||.|||++   +|+.||+|.+|.|+|.+|.+||+|||+++.--.. ..
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~  323 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GD  323 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc-cc
Confidence            999999999888643     23456788999999999998   9999999999999999999999999999863222 23


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....+||+.|.|||        .+.|.|..||++|||++|+.||+    +++...+.+.+.-..+  .++.....+...
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy----n~dh~kLFeLIl~ed~--kFPr~ls~eAkt  397 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY----NKDHEKLFELILMEDL--KFPRTLSPEAKT  397 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc----ccchhHHHHHHHhhhc--cCCccCCHHHHH
Confidence            445589999999998        67899999999999999999964    3355556555544443  233444556667


Q ss_pred             HHHHccccCCCCCC
Q 046461          349 IVVGCIFDNPTTRP  362 (383)
Q Consensus       349 l~~~C~~~~P~~RP  362 (383)
                      +....+..||.+|-
T Consensus       398 LLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHHhhcChHhhc
Confidence            77788899999994

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=1.5e-26  Score=210.49  Aligned_cols=170  Identities=19%  Similarity=0.151  Sum_probs=132.9

Q ss_pred             cccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          180 AFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       180 v~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      .+||++++++++.+.+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++|||+||+||+++
T Consensus        43 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~  119 (237)
T cd05576          43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLD  119 (237)
T ss_pred             CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence            4699999999999999999999999999999998642     34577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||.+......    .....++..|++||        .++||||+|++++||++|+.|+...-.     . .
T Consensus       120 ~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~-----~-~  189 (237)
T cd05576         120 DRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS-----G-I  189 (237)
T ss_pred             CCCCEEEecccchhccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch-----h-c
Confidence            9999999999987655432    12234566788888        368999999999999999987542111     0 0


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      ......    ..+......+.+++.+|++.||++||++.+
T Consensus       190 ~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         190 NTHTTL----NIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             cccccc----CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            000000    112234457888999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-26  Score=211.52  Aligned_cols=176  Identities=26%  Similarity=0.357  Sum_probs=139.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++|++++++.+..++..++||||+++++|.+++...     .....++.|++.|+.|+|+.   +++|+|++|+||+++.
T Consensus        52 h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~  128 (250)
T cd05123          52 HPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDA  128 (250)
T ss_pred             CCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcC
Confidence            689999999999999999999999999999998643     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      ++.++++|||.+....... .......++..|++||        .++|+||||+++||+++|+.|+...    +.....+
T Consensus       129 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~----~~~~~~~  203 (250)
T cd05123         129 DGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE----DRKEIYE  203 (250)
T ss_pred             CCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHH
Confidence            9999999999987764432 1223456788899988        4699999999999999999996432    2222222


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      .+.....  ..+......+.+++.+||..||++||++++
T Consensus       204 ~~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         204 KILKDPL--RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHhcCCC--CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2222111  122333567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=3.2e-26  Score=212.82  Aligned_cols=180  Identities=24%  Similarity=0.274  Sum_probs=136.2

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++.+.+..++|+||++ ++|.+++...      .....++.+++.|++|||+.   +++|+|++|+||+++
T Consensus        57 ~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~  132 (282)
T cd07829          57 HPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILIN  132 (282)
T ss_pred             CCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEc
Confidence            4899999999999999999999997 5999999653      34678899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.++|+|||.++....... ......++..|++||         .++||||||++++|+++|+.|+...-    ..+.
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~----~~~~  207 (282)
T cd07829         133 RDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS----EIDQ  207 (282)
T ss_pred             CCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc----HHHH
Confidence            999999999999887643321 122234567788887         46899999999999999988864321    0000


Q ss_pred             ceee--------------------ecCccc---c----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWV--------------------LDSTIL---N----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v--------------------~~~~~~---~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..++                    .+....   .    .........+.+++.+||+.+|++||++.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000                    000000   0    001112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=1.6e-26  Score=218.09  Aligned_cols=184  Identities=23%  Similarity=0.274  Sum_probs=129.9

Q ss_pred             cccceeeeEEEeCC--------EEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPVGE--------KKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~~~--------~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      +||+++++++.+..        ..++|+||+.+ ++.+.+..      ......++.|+++||+|||+.   +++|+|+|
T Consensus        67 ~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~  142 (311)
T cd07866          67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIK  142 (311)
T ss_pred             CCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            79999998875433        46999999964 77777653      234577899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCc----------cccccccccccccCC---------CCCcchhHHHHHHHHHh
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESH----------TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Ellt  308 (383)
                      |+||+++.++.++++|||+++........          ..+...++..|+|||         .++|||||||+++||++
T Consensus       143 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~  222 (311)
T cd07866         143 AANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT  222 (311)
T ss_pred             HHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh
Confidence            99999999999999999999765432211          112345677899988         35899999999999999


Q ss_pred             CCCCCCCCCCCCC------------CCcccee---------eecCccccc---CChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          309 RKQPTGPEFKDKN------------GGNLVDW---------VLDSTILNA---YSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       309 g~~p~~~~~~~~~------------~~~~~~~---------v~~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      |+.|+........            ......|         .........   ........+.+++.+|++.||++|||+
T Consensus       223 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence            9988643211000            0000000         000000000   001122567899999999999999999


Q ss_pred             HHHHH
Q 046461          365 LRVQE  369 (383)
Q Consensus       365 ~~v~~  369 (383)
                      .|+++
T Consensus       303 ~ell~  307 (311)
T cd07866         303 SDALE  307 (311)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-26  Score=206.73  Aligned_cols=210  Identities=19%  Similarity=0.266  Sum_probs=159.6

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc----------------------------------------cccceeeeEE
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~  191 (383)
                      ..-+++|+.+-|+     ++||+|+|+.|-                                        +||++|++||
T Consensus        71 ~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   71 LSGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             ccchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            4456888888886     889999998775                                        7999999999


Q ss_pred             EeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEcc
Q 046461          192 PVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSD  263 (383)
Q Consensus       192 ~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~D  263 (383)
                      .++...|||||-|.+|.|.+++...     .+..++..+||.||.|||.+   +|.|||+||+|||-...   -.+||+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence            9999999999999999999999753     35678999999999999999   99999999999998643   3489999


Q ss_pred             ccCccccCCCC------CccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC--
Q 046461          264 FGLVRLISDCE------SHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG--  322 (383)
Q Consensus       264 fgla~~~~~~~------~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~--  322 (383)
                      |.+..-.....      +......+|+..|||||             .++|.||+|||+|-|++|..||...-...-+  
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            98865432211      22233467899999998             5799999999999999999997543321110  


Q ss_pred             -Cc--------cceeeecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 -GN--------LVDWVLDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 -~~--------~~~~v~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       .+        +.+.+.++.+  +...+...+.+..+++..-+..|+.+|-++.++++
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             00        1111223322  11112234556677888888899999999999987

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=220.52  Aligned_cols=181  Identities=19%  Similarity=0.215  Sum_probs=135.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++||+++++++..++..++||||++ |+|.+++...     .....++.|++.||+|||+.   +++|+||||+||+++.
T Consensus        79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~  154 (335)
T PTZ00024         79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINS  154 (335)
T ss_pred             CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECC
Confidence            4899999999999999999999996 6999998642     34577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCC-------------CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCC
Q 046461          256 DFEVKVSDFGLVRLISDCE-------------SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      ++.++++|||+++......             ........++..|++||         .++||||+||++|||++|+.|+
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999987654111             11112234677899988         3579999999999999999986


Q ss_pred             CCCCCCCCCCccceee-------------ec---C-------cccc---cCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          314 GPEFKDKNGGNLVDWV-------------LD---S-------TILN---AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v-------------~~---~-------~~~~---~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                      ...-    ..+....+             ..   +       ....   .........+.+++.+|++.+|++|||++|+
T Consensus       235 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        235 PGEN----EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCC----HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            4321    11100000             00   0       0000   0011234568899999999999999999999


Q ss_pred             HH
Q 046461          368 QE  369 (383)
Q Consensus       368 ~~  369 (383)
                      +.
T Consensus       311 l~  312 (335)
T PTZ00024        311 LK  312 (335)
T ss_pred             hc
Confidence            86

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.4e-26  Score=220.78  Aligned_cols=189  Identities=23%  Similarity=0.297  Sum_probs=140.7

Q ss_pred             ccccceeeeEEEeCC-----EEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          181 FKNIVQLLGYCPVGE-----KKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       181 ~~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      ++||+++.+++...+     ..+++|||++ ++|.+++...     .....++.+++.||+|||+.   +++|+||||+|
T Consensus        58 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~n  133 (330)
T cd07834          58 HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSN  133 (330)
T ss_pred             CcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            379999999988765     7899999997 5899888643     34577999999999999998   99999999999


Q ss_pred             EEEcCCCceEEccccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          251 ILLNEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       251 iLl~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      |+++.++.++++|||++........  .......++..|++||         .++|+||||++++||++|+.|+...-  
T Consensus       134 ili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~--  211 (330)
T cd07834         134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD--  211 (330)
T ss_pred             EEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC--
Confidence            9999999999999999987654321  1123345778899988         46899999999999999999974321  


Q ss_pred             CCCCccceeeec---------------Cc---------cc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH-
Q 046461          320 KNGGNLVDWVLD---------------ST---------IL-----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE-  369 (383)
Q Consensus       320 ~~~~~~~~~v~~---------------~~---------~~-----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~-  369 (383)
                        ..+..+.+.+               ..         ..     ..........+.+++.+||+.+|++|||+.++++ 
T Consensus       212 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         212 --YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             --HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              1110000000               00         00     0001123456889999999999999999999997 


Q ss_pred             -HHhccccC
Q 046461          370 -FLEKYHTG  377 (383)
Q Consensus       370 -~L~~~~~~  377 (383)
                       .++++...
T Consensus       290 ~~~~~~~~~  298 (330)
T cd07834         290 PYLAQLHDP  298 (330)
T ss_pred             ccHHhhccc
Confidence             46665543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=1.4e-26  Score=221.20  Aligned_cols=205  Identities=20%  Similarity=0.280  Sum_probs=150.4

Q ss_pred             HHHHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe-CC
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV-GE  195 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~-~~  195 (383)
                      ++...+++|...+.||+|+||.||                                         ||++++++++.. .+
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            445567778888888888888877                                         799999999876 56


Q ss_pred             EEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      ..++++||+ +++|.++++..    .....++.|++.||+|||+.   +++|||++|+||+++.++.++++|||.++...
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            789999999 56999888642    23456889999999999998   99999999999999999999999999987543


Q ss_pred             CCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCC-----------CCCccceeeec
Q 046461          272 DCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDK-----------NGGNLVDWVLD  331 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~-----------~~~~~~~~v~~  331 (383)
                      ..    .....++..|++||         .++||||||++++||++|+.|+.......           ...+..+.+.+
T Consensus       160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            21    12235677788887         35899999999999999999864321100           00000000000


Q ss_pred             Cc-------c--cccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          332 ST-------I--LNAY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       332 ~~-------~--~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      ..       .  ....     .......+.+++.+|++.+|++|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00       0  0000     11234678899999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.3e-26  Score=220.10  Aligned_cols=205  Identities=20%  Similarity=0.274  Sum_probs=153.8

Q ss_pred             cccHHHHHHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEE
Q 046461          153 KLTYDQIVAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~  191 (383)
                      +....++...+++|...+.||+|+||.||                                         +||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            34556777788899999999999999888                                         6999999988


Q ss_pred             EeC------CEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          192 PVG------EKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       192 ~~~------~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                      ...      ...+++++++ +++|.+++..    +.....++.|+++|++|||+.   +++|||+||+||+++.++.+|+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence            643      3467888877 7899988764    234577899999999999998   9999999999999999999999


Q ss_pred             ccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee---
Q 046461          262 SDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV---  329 (383)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v---  329 (383)
                      +|||+++....    ......++..|++||         .++|||||||++|||++|+.|+...    +.......+   
T Consensus       162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~  233 (345)
T cd07877         162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRL  233 (345)
T ss_pred             ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHH
Confidence            99999876432    122345778899988         3689999999999999999996421    111100000   


Q ss_pred             ------------ec----------Cccccc----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ------------LD----------STILNA----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ------------~~----------~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                  .+          +.....    ........+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                        00          000000    00112456789999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.93  E-value=6.7e-27  Score=224.65  Aligned_cols=176  Identities=23%  Similarity=0.321  Sum_probs=132.4

Q ss_pred             cccceeeeEEEeCCE------EEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVGEK------KLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~~~------~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +|++++++++...+.      .++|+||+ +++|.+++..    ......++.|++.|++|||+.   +++|||+||+||
T Consensus        74 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Ni  149 (343)
T cd07851          74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNI  149 (343)
T ss_pred             CCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            688888887766554      89999999 6799998864    235677899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +++.++.++++|||++......    .....++..|++||         .++|||||||+++|+++|+.|+...    +.
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~----~~  221 (343)
T cd07851         150 AVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS----DH  221 (343)
T ss_pred             EECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----Ch
Confidence            9999999999999998765432    22345677888887         4689999999999999999996422    11


Q ss_pred             Cccceeeec---------------C---------ccc--cc---CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLD---------------S---------TIL--NA---YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~---------------~---------~~~--~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+....+.+               .         ...  ..   ........+.+++.+|++.+|++|||+.+|++
T Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         222 IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            111110000               0         000  00   00122567889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=3.4e-26  Score=218.68  Aligned_cols=191  Identities=24%  Similarity=0.283  Sum_probs=135.6

Q ss_pred             ccccceeeeEEEeC----CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVG----EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++||+++++++...    ...++++||+. ++|.+++...     .....++.|++.||+|||+.   +++||||||+||
T Consensus        61 h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Ni  136 (332)
T cd07857          61 HKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNL  136 (332)
T ss_pred             CCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHe
Confidence            58999999876432    45788899885 6899988642     34577899999999999998   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCc---cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      +++.++.++|+|||+++........   ......|+..|++||         .++|+||+||+++|+++|+.|+...-..
T Consensus       137 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~  216 (332)
T cd07857         137 LVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV  216 (332)
T ss_pred             EEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence            9999999999999999865432211   122346888999998         3579999999999999999886431100


Q ss_pred             -----------CCCCccceeeecCc----------cc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHh
Q 046461          320 -----------KNGGNLVDWVLDST----------IL----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLE  372 (383)
Q Consensus       320 -----------~~~~~~~~~v~~~~----------~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~  372 (383)
                                 ....+....+.++.          ..    ..........+.+++.+|++.||++|||+.++++  .+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence                       00000000000000          00    0001112457889999999999999999999985  454


Q ss_pred             ccc
Q 046461          373 KYH  375 (383)
Q Consensus       373 ~~~  375 (383)
                      +.+
T Consensus       297 ~~~  299 (332)
T cd07857         297 IWH  299 (332)
T ss_pred             hhc
Confidence            443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=3.2e-26  Score=219.88  Aligned_cols=202  Identities=20%  Similarity=0.298  Sum_probs=142.6

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeC----------
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVG----------  194 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~----------  194 (383)
                      ++|...+.||.|+||.||                                       +||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            456667778888888777                                       6888888766543          


Q ss_pred             ----CEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEcccc
Q 046461          195 ----EKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFG  265 (383)
Q Consensus       195 ----~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfg  265 (383)
                          ...++|+||++ ++|.+++..    ......++.|++.||.|||+.   +++||||||+||+++. +..++++|||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence                35789999997 599888853    235677899999999999998   9999999999999974 5678999999


Q ss_pred             CccccCCCCCc--cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC-------------
Q 046461          266 LVRLISDCESH--TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN-------------  321 (383)
Q Consensus       266 la~~~~~~~~~--~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~-------------  321 (383)
                      .++........  ......++..|+|||         .++|||||||++|||++|+.|+........             
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98765322111  112235677899988         368999999999999999999753210000             


Q ss_pred             --CCccc----eeeecCcccc-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 --GGNLV----DWVLDSTILN-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 --~~~~~----~~v~~~~~~~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        .....    ..........     ........++.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              00000    0000000000     001123456789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=213.68  Aligned_cols=184  Identities=22%  Similarity=0.335  Sum_probs=139.6

Q ss_pred             cccceeeeEEE-eCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCP-VGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +.||++++|+. +.+..+-|+|||++.+|+-+|+.     +++...|+.||..||.||... +++|+|-||||.|||+-.
T Consensus       527 pRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  527 PRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             ceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence            68999999986 56788999999999999999974     356788999999999999976 789999999999999943


Q ss_pred             ---CCceEEccccCccccCCCCCc------cccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          256 ---DFEVKVSDFGLVRLISDCESH------TSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       256 ---~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                         .|.+||+|||+++.+......      .....+||++|++||            .|.||||.|||+|.++.|++||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence               478999999999998654321      122357999999988            57999999999999999999975


Q ss_pred             CCCCCCCCCcccee--eecCc-ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          315 PEFKDKNGGNLVDW--VLDST-ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       315 ~~~~~~~~~~~~~~--v~~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....   ..++.+.  ++... +.-+..+....+..+++.+|++..-++|....++..
T Consensus       686 hnqs---QQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  686 HNQS---QQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             Cchh---HHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            4321   2222221  11111 111111234456788999999999899988777653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=222.88  Aligned_cols=147  Identities=28%  Similarity=0.397  Sum_probs=124.5

Q ss_pred             CccccCeeecCCccccc----------------------------------------cccceeeeEEEeC------CEEE
Q 046461          165 KFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVG------EKKL  198 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~------~~~~  198 (383)
                      .+...+.||+|+||.||                                        +|||++++.-.+.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            34566889999999999                                        6999999987553      3678


Q ss_pred             EEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCC--ceEEccccC
Q 046461          199 IVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN--EDF--EVKVSDFGL  266 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~--~~~--~~kl~Dfgl  266 (383)
                      +|||||++|||+..|...        ...+.+..+++.||.|||.+   +|+||||||.||++-  .++  --||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999999853        34678899999999999988   999999999999983  223  479999999


Q ss_pred             ccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCC
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPE  316 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~  316 (383)
                      ||.+.+..  ..+.+.||..|.+|+         ..+|.|||||++||++||..||-+.
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99887654  455689999999997         2479999999999999999998764

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.4e-26  Score=219.00  Aligned_cols=205  Identities=18%  Similarity=0.288  Sum_probs=149.6

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC-----
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE-----  195 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~-----  195 (383)
                      ..++|...+.||+|+||.||                                         +||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45667777888888888887                                         69999999887543     


Q ss_pred             -EEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          196 -KKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       196 -~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                       ..++||||+ +++|.+++..    ......++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence             458999999 7799988864    234677899999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC-----------CCccceeee
Q 046461          271 SDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN-----------GGNLVDWVL  330 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~-----------~~~~~~~v~  330 (383)
                      ...    .....++..|++||         .++|+||+|++++|+++|+.|+...-....           ..+..+.+.
T Consensus       169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            322    12345677888887         358999999999999999999753210000           000000000


Q ss_pred             cC----------ccc----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          331 DS----------TIL----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       331 ~~----------~~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ..          ...    ..........+.+++.+|+..||++|||+.++++  .++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            00          000    0001223456789999999999999999999984  45444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=1.2e-25  Score=233.48  Aligned_cols=102  Identities=26%  Similarity=0.460  Sum_probs=91.3

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            456667788888888887                                          69999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||..   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998642     34678999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=4.8e-26  Score=234.32  Aligned_cols=165  Identities=24%  Similarity=0.396  Sum_probs=128.3

Q ss_pred             EEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      .+|+-||||+.-.+.++++..      ...++++.+|++||.|+|+.   ++|||||||.||++|++..+||+|||+|..
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchh
Confidence            458999999998888887642      23578999999999999999   999999999999999999999999999987


Q ss_pred             cC-----------------CCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC
Q 046461          270 IS-----------------DCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN  321 (383)
Q Consensus       270 ~~-----------------~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~  321 (383)
                      ..                 .......+...||.-|+|||           .|+|+||+|||++||+.-   |+..   ++
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts---ME  820 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS---ME  820 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch---HH
Confidence            21                 01122455678999999998           578999999999999853   3221   23


Q ss_pred             CCccceeeecCccccc--CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          322 GGNLVDWVLDSTILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       322 ~~~~~~~v~~~~~~~~--~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .........++.++..  +..+.+..-.+++.++++.||++|||+.|+++
T Consensus       821 Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  821 RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            3344444455555433  24455666678999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.1e-25  Score=221.78  Aligned_cols=172  Identities=18%  Similarity=0.198  Sum_probs=119.5

Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +..++||||+++|+|.++++..                             .....++.|++.||.|||+.   +|+|||
T Consensus       258 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrD  334 (507)
T PLN03224        258 GSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRD  334 (507)
T ss_pred             CceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            4679999999999999998631                             11345788999999999998   899999


Q ss_pred             CCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCCC------------------------------CCc
Q 046461          246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC------------------------------GGD  295 (383)
Q Consensus       246 lk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape~------------------------------~~D  295 (383)
                      |||+||+++.++.+|++|||+++..............+++.|++||.                              +.|
T Consensus       335 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~D  414 (507)
T PLN03224        335 IKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFD  414 (507)
T ss_pred             CchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccc
Confidence            99999999999999999999997654322222222334788999881                              259


Q ss_pred             chhHHHHHHHHHhCCC-CCCCC--CCCC---CCCccceeeec--CcccccCChhHHHHHHHHHHHccccCC---CCCCCH
Q 046461          296 IYSFSVVLLELVIRKQ-PTGPE--FKDK---NGGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNP---TTRPTM  364 (383)
Q Consensus       296 v~SfGvil~Elltg~~-p~~~~--~~~~---~~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P---~~RPs~  364 (383)
                      |||+||+++||+++.. |+...  +...   ...+...|...  ....-...........+++.+++..+|   .+|+|+
T Consensus       415 vwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa  494 (507)
T PLN03224        415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV  494 (507)
T ss_pred             hhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence            9999999999999875 43211  1100   01111112110  111001122345677889999998765   689999


Q ss_pred             HHHHH
Q 046461          365 LRVQE  369 (383)
Q Consensus       365 ~~v~~  369 (383)
                      +|+++
T Consensus       495 ~eaL~  499 (507)
T PLN03224        495 GQALS  499 (507)
T ss_pred             HHHhC
Confidence            99986

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-26  Score=219.21  Aligned_cols=173  Identities=20%  Similarity=0.290  Sum_probs=143.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +.||+++.-+.+...+|+.||-|-||.|...|++..     ....++..+.+|++|||+.   +|+.|||||+|.++|.+
T Consensus       480 ~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~  556 (732)
T KOG0614|consen  480 DFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNR  556 (732)
T ss_pred             hHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccC
Confidence            688999999999999999999999999999998653     3456777899999999999   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      |.+|+.|||+|+.+..+  ......+||+.|.|||        .++|.||+|++++|+++|++||.    ..+.+...+.
T Consensus       557 Gy~KLVDFGFAKki~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs----~~dpmktYn~  630 (732)
T KOG0614|consen  557 GYLKLVDFGFAKKIGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS----GVDPMKTYNL  630 (732)
T ss_pred             CceEEeehhhHHHhccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC----CCchHHHHHH
Confidence            99999999999988653  3445689999999999        57899999999999999999954    3344444444


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCC
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT  363 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs  363 (383)
                      ++.+.-.-.++........+++.+-+..+|.+|--
T Consensus       631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            44433333445556667788888888899999965

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-25  Score=222.43  Aligned_cols=209  Identities=22%  Similarity=0.336  Sum_probs=163.3

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEe-
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPV-  193 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~-  193 (383)
                      +.++.+..-++.|....+||.|.+|.||                                       ||++.++|++.. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            4455566667778888999999999999                                       799999999864 


Q ss_pred             ----CCEEEEEEEeccCCCHHHHHhcchh-------hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEc
Q 046461          194 ----GEKKLIVYEYMVKGSLNDWLRNQAK-------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVS  262 (383)
Q Consensus       194 ----~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~  262 (383)
                          ++++|||||||.+|+..|++++...       ..-|...++.|+.+||..   .++|||+|-.|||++.++.+|+.
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence                6899999999999999999986432       244778899999999998   99999999999999999999999


Q ss_pred             cccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          263 DFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      |||++..++..... .....||+.|||||             ..+|+||+|++-.||.-|.+|.-+..+.   ..+..-.
T Consensus       166 DFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~Ip  241 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIP  241 (953)
T ss_pred             eeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCC
Confidence            99999887654332 23367999999998             4689999999999999999995432211   1111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..|...-..++.-..++.+++..|+.+|-+.||++.++++
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1111111113444678999999999999999999998875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.2e-24  Score=210.79  Aligned_cols=170  Identities=22%  Similarity=0.345  Sum_probs=133.2

Q ss_pred             HHHHHHHh---hCccccCeeecCCccccc------------------------------------------cccceeeeE
Q 046461          156 YDQIVAGT---NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGY  190 (383)
Q Consensus       156 ~~~l~~~t---~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~  190 (383)
                      |-.|++|.   .-|....-||-|+||.|-                                          +-||+|+-.
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            44444443   347777889999999886                                          578999999


Q ss_pred             EEeCCEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          191 CPVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       191 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      |.+.+.+|+||||++||++-.+|....     -...++.++..|+++.|..   ++|||||||+|||||.+|.+||+|||
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            999999999999999999999986432     2345777899999999998   99999999999999999999999999


Q ss_pred             CccccC---------CCCC--------------------------------ccccccccccccccCC--------CCCcc
Q 046461          266 LVRLIS---------DCES--------------------------------HTSTDVAGTIGYILLA--------CGGDI  296 (383)
Q Consensus       266 la~~~~---------~~~~--------------------------------~~~~~~~gt~~y~ape--------~~~Dv  296 (383)
                      ++.-+.         .++.                                .......||..|+|||        ..+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            986431         1000                                0112245899999998        45899


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          297 YSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       297 ~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      ||.||||+||+.|+.||-..........+..|
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence            99999999999999998655443333344444

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=2.4e-25  Score=199.83  Aligned_cols=146  Identities=22%  Similarity=0.345  Sum_probs=122.6

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEe-CCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPV-GEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~-~~~~  197 (383)
                      ..|.....||+|.||.||                                             +|++.|..++.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            456667789999999999                                             799999999877 7789


Q ss_pred             EEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CceEEcc
Q 046461          198 LIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED----FEVKVSD  263 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~----~~~kl~D  263 (383)
                      ++++||.+. +|.+.++-.          .....|..||..|+.|||++   -|+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 899988632          12467899999999999999   89999999999999877    8999999


Q ss_pred             ccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCC
Q 046461          264 FGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       264 fgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      +|++|.+.+.-.  .....+.-|..|.|||         .+.||||.|||..||++-++-|
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            999998754322  2334567799999998         6789999999999999877664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.91  E-value=2.8e-24  Score=194.12  Aligned_cols=182  Identities=27%  Similarity=0.335  Sum_probs=143.0

Q ss_pred             cccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          180 AFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       180 v~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      -++|++++++++......++++||+++++|.+++...     .....++.+++.++.|||..   +++|+|++|+||+++
T Consensus        45 ~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~  121 (244)
T smart00220       45 KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLD  121 (244)
T ss_pred             CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEEC
Confidence            3589999999999999999999999999999998643     34577899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.++++|||.+.......  ......++..|++||        .++||||||++++|+++|..|+...   .+.....
T Consensus       122 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~---~~~~~~~  196 (244)
T smart00220      122 EDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD---DQLLELF  196 (244)
T ss_pred             CCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHH
Confidence            99999999999998765432  223355778888887        5799999999999999999996431   1222222


Q ss_pred             eeeecCcccccCChh-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNAYSKP-SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~-~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.............. ....+.+++.+||..+|++||++.++++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      197 KKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            222222221111111 4567889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=7.1e-25  Score=218.51  Aligned_cols=196  Identities=22%  Similarity=0.334  Sum_probs=150.5

Q ss_pred             CccccCeeecCCcccc-c-----------------------------------cccceeeeEEEeCCEEEEEEEeccCCC
Q 046461          165 KFYEKNVIRGDDFGIA-F-----------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGS  208 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v-~-----------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gs  208 (383)
                      -|+..+++|.|.-|++ |                                   +|||++++.-.+..+.|+..|.| .-+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s  588 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS  588 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence            4667788888888764 3                                   79999999999999999999999 569


Q ss_pred             HHHHHhcc-h--------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCceEEccccCccccCCCC
Q 046461          209 LNDWLRNQ-A--------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-----DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       209 L~~~l~~~-~--------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-----~~~~kl~Dfgla~~~~~~~  274 (383)
                      |.+++... .        .......|++.||++||+.   +|+||||||.||||+.     ...++|+|||+++.+..+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999863 1        1356789999999999997   9999999999999976     2579999999999886554


Q ss_pred             Cc--cccccccccccccCC--------CCCcchhHHHHHHHHHhC-CCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          275 SH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       275 ~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg-~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      +.  ......||.||+|||        .++|++|+||++|..++| +.||...+..  ..++..-..+-...... .++ 
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~-~d~-  741 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPL-PDC-  741 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccC-chH-
Confidence            32  234567999999999        568999999999999986 8897654431  12222211110111111 112 


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       ...+++.+++.++|..||++.+|+.
T Consensus       742 -eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  742 -EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             6778999999999999999999974

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-24  Score=195.81  Aligned_cols=193  Identities=22%  Similarity=0.351  Sum_probs=149.8

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|.-..+||+|+|..|.                                           |.+|-+..++..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            578888999999999876                                           6788888889999999999


Q ss_pred             EEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      .||+++|+|--++..+.     ....+...|..||.|||++   +|+.||+|.+|+|+|..+.+|++|+|+++.--... 
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g-  405 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-  405 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence            99999999976665332     2455778899999999999   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC---CCCc-cceeeecCcccccCChhHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK---NGGN-LVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~---~~~~-~~~~v~~~~~~~~~~~~~~  343 (383)
                      ......+||+.|+|||        ...|.|++||+++||+.|+.||+..-.+.   +..+ +.+-++...+.  .+...+
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--iprsls  483 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IPRSLS  483 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--ccceee
Confidence            3344589999999998        57899999999999999999987533221   1122 11222333221  133445


Q ss_pred             HHHHHHHHHccccCCCCCC
Q 046461          344 LKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RP  362 (383)
                      .+...+...-+.+||.+|-
T Consensus       484 vkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhc
Confidence            5667788888999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=185.53  Aligned_cols=129  Identities=29%  Similarity=0.440  Sum_probs=107.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      |.+|.++|........++.||.|. -||+.+-+.-         .-.-+||..+.+||.|||++.  .++|||+||+|||
T Consensus       105 Pf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiL  181 (282)
T KOG0984|consen  105 PFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNIL  181 (282)
T ss_pred             CeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEE
Confidence            789999999988899999999994 5787765531         113568999999999999874  7999999999999


Q ss_pred             EcCCCceEEccccCccccCCCCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       253 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ++.+|.+|++|||++-.+.+.-  ..+.-.|...|||||            .|+||||+|+++.||.+++.|++.
T Consensus       182 In~~GqVKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  182 INYDGQVKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             EccCCcEEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            9999999999999998775422  222346888999998            479999999999999999999653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.1e-24  Score=231.07  Aligned_cols=177  Identities=16%  Similarity=0.194  Sum_probs=122.9

Q ss_pred             cccceeeeEE-------EeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          182 KNIVQLLGYC-------PVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       182 ~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      +||.+++++|       ...+..+.++||+ +++|.+++...      .+...++.||++||+|||++   +|+||||||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP  108 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRP  108 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCc
Confidence            5788888877       2234567888988 66999999642      34678999999999999998   999999999


Q ss_pred             CcEEEcC-------------------CCceEEccccCccccCCCCC---------------ccccccccccccccCC---
Q 046461          249 SNILLNE-------------------DFEVKVSDFGLVRLISDCES---------------HTSTDVAGTIGYILLA---  291 (383)
Q Consensus       249 ~NiLl~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~ape---  291 (383)
                      +|||++.                   ++.+|++|||+++.......               .......||+.|||||   
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            9999954                   45567777777764211000               0011235788899998   


Q ss_pred             -----CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          292 -----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       292 -----~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                           .++|||||||++|||++|..|+....      .....+..... +............++.+||..+|.+||+|.|
T Consensus       189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             cCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence                 67899999999999999887743210      01110100011 1111112345567888999999999999999


Q ss_pred             HHH
Q 046461          367 VQE  369 (383)
Q Consensus       367 v~~  369 (383)
                      +++
T Consensus       262 il~  264 (793)
T PLN00181        262 LLQ  264 (793)
T ss_pred             Hhh
Confidence            986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.6e-24  Score=189.41  Aligned_cols=184  Identities=21%  Similarity=0.303  Sum_probs=131.8

Q ss_pred             cccceeeeEEEe--------CCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPV--------GEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      +|++.++..|..        ....++|+++|+. +|...|.+..      ....++.++..||.|+|..   .|+|||+|
T Consensus        76 env~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmK  151 (376)
T KOG0669|consen   76 ENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMK  151 (376)
T ss_pred             hhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhccc
Confidence            588888887754        2357999999976 8999987653      3467899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCC---ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCES---HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ++|+|++.++..|++|||+++.++....   ...+...-|..|.+||         ++.|||+-|||+.||.||.+-+..
T Consensus       152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence            9999999999999999999987653321   1233345588999887         688999999999999999876432


Q ss_pred             C--------------------CCCCCCCccceeeecCccccc-C--ChhH------HHHHHHHHHHccccCCCCCCCHHH
Q 046461          316 E--------------------FKDKNGGNLVDWVLDSTILNA-Y--SKPS------MLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       316 ~--------------------~~~~~~~~~~~~v~~~~~~~~-~--~~~~------~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                      .                    .++.+...+.+.+-.+.+... +  -++.      .....+++...+..||.+|+++.+
T Consensus       232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence            1                    111111111111111111100 0  0111      125678888999999999999999


Q ss_pred             HHH
Q 046461          367 VQE  369 (383)
Q Consensus       367 v~~  369 (383)
                      +++
T Consensus       312 aln  314 (376)
T KOG0669|consen  312 ALN  314 (376)
T ss_pred             hhc
Confidence            875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-24  Score=197.35  Aligned_cols=198  Identities=18%  Similarity=0.271  Sum_probs=149.6

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++.|.....+|+|.||.|-                                            --+|++.+++.-.+..+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            6677788889999999876                                            13678888888889999


Q ss_pred             EEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----------------
Q 046461          199 IVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE----------------  255 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~----------------  255 (383)
                      +|+|.+ |-|+++++++.       .....++.|++++++|||+.   .++|-||||+|||+-+                
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999998 56999999863       24567999999999999999   9999999999999832                


Q ss_pred             ----CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          256 ----DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       256 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                          +..+++.|||-|+.-..    ..+.+..|..|.|||        .++||||+||||.|+.+|..-|...- +.+..
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n~EHL  318 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-NLEHL  318 (415)
T ss_pred             ccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-cHHHH
Confidence                23478999999986433    224577899999999        78999999999999999987654211 11111


Q ss_pred             ccceeeecC------------------cc--------------c---------ccCChhHHHHHHHHHHHccccCCCCCC
Q 046461          324 NLVDWVLDS------------------TI--------------L---------NAYSKPSMLKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       324 ~~~~~v~~~------------------~~--------------~---------~~~~~~~~~~~~~l~~~C~~~~P~~RP  362 (383)
                      .+++.++-+                  .+              .         ......+..++++++..++..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            122222000                  00              0         011234556799999999999999999


Q ss_pred             CHHHHHH
Q 046461          363 TMLRVQE  369 (383)
Q Consensus       363 s~~~v~~  369 (383)
                      |+.|++.
T Consensus       399 Tl~EAL~  405 (415)
T KOG0671|consen  399 TLREALS  405 (415)
T ss_pred             cHHHHhc
Confidence            9999885

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=4.2e-23  Score=178.92  Aligned_cols=150  Identities=18%  Similarity=0.170  Sum_probs=110.5

Q ss_pred             CCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.++++.      +.....++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            688888874      234678999999999999988   3      999999999999999  99988754321      


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc-----cCChhHHH--H
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN-----AYSKPSML--K  345 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~-----~~~~~~~~--~  345 (383)
                      ..|+..|+|||        .++|||||||++|||++|+.|+.....   .....+.+.......     ........  .
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPADDPRDRSNLESVSAARS  140 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence            25789999999        579999999999999999999743211   111111111110000     01112222  5


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +.+++.+||+.+|++|||+.|+++.+..+..
T Consensus       141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      141 FADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            8999999999999999999999998876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=175.14  Aligned_cols=144  Identities=26%  Similarity=0.385  Sum_probs=119.5

Q ss_pred             CccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      +|...+.||+|.||+||                                         +|||++++...++...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45556789999999999                                         6999999999999999999999


Q ss_pred             ccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |. .+|..+..+..      ....++.|+.+|+.|+|++   .+.|||+||+|.|++.+++.|++|||+++-+...-. .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-c  157 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C  157 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence            94 47877765432      2456889999999999999   999999999999999999999999999997754322 2


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCC
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      .....-|..|.+|.         +..|+||-|||+.|+.....|.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence            22334578888876         6789999999999999866664

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=4.6e-24  Score=202.96  Aligned_cols=190  Identities=18%  Similarity=0.316  Sum_probs=149.5

Q ss_pred             ccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          168 EKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       168 ~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      .++++|+|.||+||                                         |.||.+--.|+..+.+++|||-+ +
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            45899999999999                                         78999999999999999999999 5


Q ss_pred             CCHHHHH-hcchh------hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEccccCccccCCCCCc
Q 046461          207 GSLNDWL-RNQAK------HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       207 gsL~~~l-~~~~~------~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |++.+.+ ..++.      ...++.||+.||.|||..   +|+|+||||+|||+...   -.+|++|||+||+..+..  
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            5665555 43332      245788999999999999   99999999999999654   468999999999987643  


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      ....+.||+.|.|||        ..-|+||.|||+|--++|..||.+      +.++-+.+....+  +...+.+.....
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE------dEdIndQIQNAaFMyPp~PW~eis~~A  795 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE------DEDINDQIQNAAFMYPPNPWSEISPEA  795 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC------ccchhHHhhccccccCCCchhhcCHHH
Confidence            344588999999999        346999999999999999999643      3334444433332  233355666778


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++++..-++..-.+|-|..+.+.
T Consensus       796 idlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  796 IDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHHHHHHHHhcchHhhcc
Confidence            88888888888888988776543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.85  E-value=1.1e-20  Score=166.23  Aligned_cols=148  Identities=32%  Similarity=0.526  Sum_probs=125.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ++++++++++......++++||+++++|.+++...      .....++.++++++++||+.   +++|+|++|.||+++.
T Consensus        51 ~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~  127 (215)
T cd00180          51 PNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDS  127 (215)
T ss_pred             CCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeC
Confidence            79999999999989999999999999999998643      24577899999999999998   9999999999999999


Q ss_pred             -CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          256 -DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 -~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                       +..++++|||.+........ ......+...|++||         .+.|+|++|++++|+                   
T Consensus       128 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------  187 (215)
T cd00180         128 DNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------  187 (215)
T ss_pred             CCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------
Confidence             89999999999986644321 122234566677765         458999999999999                   


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                                        ..+.+++..|++.+|++||++.++++.
T Consensus       188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                              577889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.6e-22  Score=177.32  Aligned_cols=179  Identities=20%  Similarity=0.305  Sum_probs=125.0

Q ss_pred             cccceeeeE-EEeCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-C
Q 046461          182 KNIVQLLGY-CPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-E  255 (383)
Q Consensus       182 ~niv~l~g~-~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~  255 (383)
                      +||+.-++. +...+..++++||+|.|+|.+-+...    .....++.|++.|+.|||+.   .+||||||.+|||+- .
T Consensus        81 ~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~  157 (378)
T KOG1345|consen   81 QHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDA  157 (378)
T ss_pred             hhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecC
Confidence            577776654 45567888999999999999988642    34577999999999999999   999999999999993 3


Q ss_pred             -CCceEEccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCC-CC
Q 046461          256 -DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFK-DK  320 (383)
Q Consensus       256 -~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~-~~  320 (383)
                       ...+|++|||..+.....    -.....+..|-+||             +.+|+|.||++++.++||+.||..... +.
T Consensus       158 df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~  233 (378)
T KOG1345|consen  158 DFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK  233 (378)
T ss_pred             CccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence             357999999998754321    11122334455655             568999999999999999999864322 11


Q ss_pred             CCCccceeeec--CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046461          321 NGGNLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       321 ~~~~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~  368 (383)
                      .-.+..+|...  +..+.. .....++++++-.+-++++|++|=-..++.
T Consensus       234 ~Y~~~~~w~~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  234 PYWEWEQWLKRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             hHHHHHHHhcccCccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            11223333222  222222 234556777888888999999994444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.85  E-value=8.3e-22  Score=177.86  Aligned_cols=177  Identities=26%  Similarity=0.298  Sum_probs=133.9

Q ss_pred             ccccceeeeEEEeC------CEEEEEEEeccCCCHHHHHhcc---hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVG------EKKLIVYEYMVKGSLNDWLRNQ---AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~------~~~~lv~e~~~~gsL~~~l~~~---~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      ++|+++++.++.-.      .+.|+||||| .++|.+.+..+   .....+..|++.|+.|||+.   +|+||||||+||
T Consensus        74 ~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsni  149 (369)
T KOG0665|consen   74 HKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNI  149 (369)
T ss_pred             ccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccc
Confidence            58999999998653      3579999999 56898887632   34567889999999999999   999999999999


Q ss_pred             EEcCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      ++..+...||.|||+++....  ....+....|..|.|||        ..+||||.||++.||++|+.-|..    .+  
T Consensus       150 vv~~~~~lKi~dfg~ar~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d--  221 (369)
T KOG0665|consen  150 VVNSDCTLKILDFGLARTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KD--  221 (369)
T ss_pred             eecchhheeeccchhhcccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----ch--
Confidence            999999999999999986433  23455677888999998        568999999999999999876431    11  


Q ss_pred             ccceee----------------------------------------ecCcccc--cCChhHHHHHHHHHHHccccCCCCC
Q 046461          324 NLVDWV----------------------------------------LDSTILN--AYSKPSMLKMLQIVVGCIFDNPTTR  361 (383)
Q Consensus       324 ~~~~~v----------------------------------------~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~R  361 (383)
                      .+-+|.                                        -|...+.  +.+.-......+++.+++..||++|
T Consensus       222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R  301 (369)
T KOG0665|consen  222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR  301 (369)
T ss_pred             HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence            111111                                        0000000  0111223456788999999999999


Q ss_pred             CCHHHHHH
Q 046461          362 PTMLRVQE  369 (383)
Q Consensus       362 Ps~~~v~~  369 (383)
                      -|+.++++
T Consensus       302 isv~daL~  309 (369)
T KOG0665|consen  302 ISVDDALR  309 (369)
T ss_pred             ccHHHHhc
Confidence            99999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.9e-21  Score=172.06  Aligned_cols=184  Identities=23%  Similarity=0.335  Sum_probs=143.3

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      ||||..++|.|.......++..|||.|+|+..|+..       .+..+++.++|+|++|||+. .+-|..-.+.+..+++
T Consensus       246 hpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmi  324 (448)
T KOG0195|consen  246 HPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMI  324 (448)
T ss_pred             CCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEe
Confidence            499999999999999999999999999999999853       46789999999999999986 4445555789999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      |++.+++|+- +-+++-     .......-++.||+||           .++|+|||.+++||+.|++.||.+    ...
T Consensus       325 dedltarism-ad~kfs-----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad----lsp  394 (448)
T KOG0195|consen  325 DEDLTARISM-ADTKFS-----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD----LSP  394 (448)
T ss_pred             cchhhhheec-ccceee-----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc----CCc
Confidence            9999998752 112211     1112234467899887           468999999999999999999643    233


Q ss_pred             CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       323 ~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .+.-.++.-..+....++..+..+.+++.-|+..||.+||.+..|+-.||++.
T Consensus       395 mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  395 MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            34333333334434445666778889999999999999999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=8.9e-22  Score=170.16  Aligned_cols=198  Identities=15%  Similarity=0.254  Sum_probs=141.7

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCC--EEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGE--KKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~--~~~lv~e~~  204 (383)
                      ++|.-.+.+|+|.|+.||                                     +||+++++...+..  ...||+||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            345555778999999888                                     79999999998754  567999999


Q ss_pred             cCCCHHHHHhc--chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEccccCccccCCCCCcccccc
Q 046461          205 VKGSLNDWLRN--QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       205 ~~gsL~~~l~~--~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      .+-+....-..  ..+..-+..+++.||.|+|+.   +|+|||+||.|+++|. ....+++|+|+|.+...+....  ..
T Consensus       118 ~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn--VR  192 (338)
T KOG0668|consen  118 NNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--VR  192 (338)
T ss_pred             ccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee--ee
Confidence            99887765432  234556789999999999999   9999999999999986 4679999999998876543221  11


Q ss_pred             ccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc-ccee--e----------------ecCc
Q 046461          282 AGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN-LVDW--V----------------LDST  333 (383)
Q Consensus       282 ~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~-~~~~--v----------------~~~~  333 (383)
                      ..+..|.-||         ..-|+|||||.+.+|+..+.||...   .+..+ +++-  +                +++.
T Consensus       193 VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG---~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~  269 (338)
T KOG0668|consen  193 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG---HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ  269 (338)
T ss_pred             eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC---CCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence            2233344455         5679999999999999999998432   22221 2111  0                2221


Q ss_pred             ccc---c--------C----Ch-hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          334 ILN---A--------Y----SK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       334 ~~~---~--------~----~~-~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..   .        +    .. -..++.++++-..+..|-++|||+.|...
T Consensus       270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            100   0        0    00 11356788888999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.84  E-value=1.2e-21  Score=191.31  Aligned_cols=183  Identities=25%  Similarity=0.312  Sum_probs=133.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +|||.++|.+...+..|+.||||.+|+|.+.-+.     +.+..-..+...+|+.|||+.   +-+|||+|-.|||+...
T Consensus        72 ~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~  148 (829)
T KOG0576|consen   72 PNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDE  148 (829)
T ss_pred             cChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccceeeccc
Confidence            7999999999999999999999999999987653     223444567888999999998   88999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      +.+|++|||.+..++..- .......||+.|||||           .++|||+.|+.-.|+-.-..|.........-.-.
T Consensus       149 gDvklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm  227 (829)
T KOG0576|consen  149 GDVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM  227 (829)
T ss_pred             CceeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh
Confidence            999999999987654321 2233478999999998           5689999999999997776663211100000000


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.-.++.-... ...-...+-+++..|+.++|.+|||++.+++
T Consensus       228 TkS~~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  228 TKSGFQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             hccCCCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            000011111111 1122446778999999999999999887653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-22  Score=178.89  Aligned_cols=115  Identities=27%  Similarity=0.388  Sum_probs=91.2

Q ss_pred             EEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      +.|+++|.|.. +|...+-+.     .....+..||.+||.|||+.   +|.||||||-|.|++++...||+|||+++..
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence            34566666633 566555432     12455789999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          271 SDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      ...+....+...-|..|.|||         .+.||||.|||..|++.++.-|.
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ  259 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence            665555555556678899988         57899999999999997776543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.84  E-value=5.5e-21  Score=178.35  Aligned_cols=153  Identities=27%  Similarity=0.361  Sum_probs=126.6

Q ss_pred             HHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEE
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ..-.+.|...+.||+|.|++||                                         .||+++.+++..++.+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3344678889999999999999                                         49999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc--hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEccccCccccC----
Q 046461          199 IVYEYMVKGSLNDWLRNQ--AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRLIS----  271 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~--~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfgla~~~~----  271 (383)
                      +|+||+++-+..++...-  .+...+...+..||+++|+.   +|+|||+||+|+|.+. .+.-.|.|||+|....    
T Consensus       112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            999999999999998754  45677889999999999999   9999999999999975 4677899999987210    


Q ss_pred             -------------C-CC-------------------------CccccccccccccccCC---------CCCcchhHHHHH
Q 046461          272 -------------D-CE-------------------------SHTSTDVAGTIGYILLA---------CGGDIYSFSVVL  303 (383)
Q Consensus       272 -------------~-~~-------------------------~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil  303 (383)
                                   . ..                         .......+||+||.|||         +++||||.|||+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0 00                         00011245899999998         678999999999


Q ss_pred             HHHHhCCCCCCC
Q 046461          304 LELVIRKQPTGP  315 (383)
Q Consensus       304 ~Elltg~~p~~~  315 (383)
                      +-+++++.||..
T Consensus       269 Lslls~~~PFf~  280 (418)
T KOG1167|consen  269 LSLLSRRYPFFK  280 (418)
T ss_pred             ehhhcccccccc
Confidence            999999999853

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=1.8e-20  Score=182.76  Aligned_cols=197  Identities=22%  Similarity=0.422  Sum_probs=148.6

Q ss_pred             ccccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchh------hhHHHHhHHHHHHHHhhcCCCCe-eecCCCCCcE
Q 046461          179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------HCIIACGTARGITFLHHRFQPHI-IHRDINASNI  251 (383)
Q Consensus       179 ~v~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~i~~~ia~gL~~LH~~~~~~i-vHrdlk~~Ni  251 (383)
                      ..|.|+.+++|.+.++...+.|.+||+.|+|.|.+.....      ...+..+++.||+|+|+.   +| .|+.++++|+
T Consensus         4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSSNC   80 (484)
T ss_pred             cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccccc
Confidence            3578999999999999999999999999999999986432      356789999999999986   44 9999999999


Q ss_pred             EEcCCCceEEccccCccccCCC-CCccccccccccccccCC---------------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          252 LLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       252 Ll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ++|..+.+|++|||+....... .....+...-..-|.+||               .++||||||++++|+++.+.||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421 001111111223344554               568999999999999999999876


Q ss_pred             CCCCCCCCccceeeec-Cc--ccccCC--hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          316 EFKDKNGGNLVDWVLD-ST--ILNAYS--KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       316 ~~~~~~~~~~~~~v~~-~~--~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .....+..+++.++.+ ..  +.+...  .+..+.+..++.+||..+|++||++++|...++.+....
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            5554444445544433 11  111111  133446889999999999999999999999998887653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.82  E-value=4.4e-21  Score=184.63  Aligned_cols=145  Identities=22%  Similarity=0.341  Sum_probs=126.0

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------------cccceeeeEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------------~niv~l~g~~~~  193 (383)
                      .+|..-..+|+|+||.|.                                                  +||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            357788899999999887                                                  699999999999


Q ss_pred             CCEEEEEEEec-cCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCc
Q 046461          194 GEKKLIVYEYM-VKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV  267 (383)
Q Consensus       194 ~~~~~lv~e~~-~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla  267 (383)
                      ++..||+||-. ++-+|.+++.-     +....-|..|++.|+++||+.   +|+|||||-+|+.+|.+|-+|++|||-+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence            99999999975 45699999973     345677999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          268 RLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       268 ~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      .....+.   .....||.+|.|||         ...|||++|++||-++....|++
T Consensus       718 a~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            7765432   22367999999998         45799999999999999988864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.8e-20  Score=175.22  Aligned_cols=70  Identities=29%  Similarity=0.429  Sum_probs=61.0

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCc
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASN  250 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N  250 (383)
                      ++||+|+++|..    +.++++|+|++ |-+|..++...       ..+..|+.|++.||.|||..|  +|+|-||||+|
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN  218 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN  218 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence            589999999965    56899999999 66899998743       235789999999999999998  99999999999


Q ss_pred             EEEc
Q 046461          251 ILLN  254 (383)
Q Consensus       251 iLl~  254 (383)
                      ||+.
T Consensus       219 vLl~  222 (590)
T KOG1290|consen  219 VLLC  222 (590)
T ss_pred             eeee
Confidence            9994

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.80  E-value=1.9e-19  Score=160.98  Aligned_cols=131  Identities=34%  Similarity=0.467  Sum_probs=110.8

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|++++++++......++++||+++++|.+++....      ....++.+++.++.+||..   +++|+|++++||+++
T Consensus        56 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~  132 (225)
T smart00221       56 HPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLG  132 (225)
T ss_pred             CCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            5899999999999899999999999999999986532      2567889999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      .++.++++|||.+...............++..|++||         .++|||+||++++||++|+.||+
T Consensus       133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      133 MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            9999999999998876543211222345667788877         36899999999999999999974

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.76  E-value=3.1e-19  Score=170.10  Aligned_cols=126  Identities=23%  Similarity=0.208  Sum_probs=104.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      .|+++|+-.|...++++||+|-+ .-+|.+.|+...        .+..++.|+..||..|-..   +|+|.||||.|||+
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV  569 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence            38899999999999999999987 458999998643        2456899999999999987   99999999999999


Q ss_pred             cCC-CceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          254 NED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       254 ~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      ++. ...||||||-|.......   .+...-+..|.|||        ...|+||.||.|||+.||+.-|.
T Consensus       570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            875 568999999998765432   23344566788988        67899999999999999987754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=8.1e-19  Score=178.38  Aligned_cols=176  Identities=20%  Similarity=0.233  Sum_probs=130.8

Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ....-.||||++ +|..++...     .++..+..|+..|+.|+|+.   ++.|||+|++|+++..++.+||+|||.+..
T Consensus       394 ~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  394 DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence            334445999999 999998763     24567899999999999999   999999999999999999999999999876


Q ss_pred             cCCCC---CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC---CccceeeecCcc
Q 046461          270 ISDCE---SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG---GNLVDWVLDSTI  334 (383)
Q Consensus       270 ~~~~~---~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~---~~~~~~v~~~~~  334 (383)
                      .....   ........|+.+|+|||         ...||||.|+++..|++|+.||...-..++.   .....|.....-
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~  549 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG  549 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence            54322   24556678999999999         4579999999999999999998654332111   011111111000


Q ss_pred             cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       335 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ..............++.++++.||.+|-|+++|++  +++.+
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            11112234556788999999999999999999986  55544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=6.6e-17  Score=150.20  Aligned_cols=183  Identities=20%  Similarity=0.236  Sum_probs=125.7

Q ss_pred             cccceeeeEEEe---------------------------CCEEEEEEEeccCCCHHHHHhcch----hhhHHHHhHHHHH
Q 046461          182 KNIVQLLGYCPV---------------------------GEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGI  230 (383)
Q Consensus       182 ~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~----~~~~i~~~ia~gL  230 (383)
                      ||||++.++|.+                           +...|+||.-.+. +|.+++....    ...-+..|+.+|+
T Consensus       276 PNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav  354 (598)
T KOG4158|consen  276 PNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAV  354 (598)
T ss_pred             CCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHH
Confidence            799999988754                           1256888877644 8998886432    2345778999999


Q ss_pred             HHHhhcCCCCeeecCCCCCcEEEc--CCC--ceEEccccCccccCCC-----CCccccccccccccccCC----------
Q 046461          231 TFLHHRFQPHIIHRDINASNILLN--EDF--EVKVSDFGLVRLISDC-----ESHTSTDVAGTIGYILLA----------  291 (383)
Q Consensus       231 ~~LH~~~~~~ivHrdlk~~NiLl~--~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~ape----------  291 (383)
                      .|||.+   +|.|||+|++|||+.  .+.  ...++|||.+---..-     -........|...-||||          
T Consensus       355 ~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  355 THLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999998   999999999999993  333  4678999987421110     011112234556677887          


Q ss_pred             ----CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          292 ----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       292 ----~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                          .|+|.|+.|.+-||++....||+..    ....+...-+...-.+..++.+...+.+++...++.||++||+..-.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~r----Gem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKR----GEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCccccc----chheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence                5899999999999999999998642    11111111122222233345566678888999999999999986655


Q ss_pred             HHHHh
Q 046461          368 QEFLE  372 (383)
Q Consensus       368 ~~~L~  372 (383)
                      .+.|+
T Consensus       508 ANvl~  512 (598)
T KOG4158|consen  508 ANVLN  512 (598)
T ss_pred             HhHHH
Confidence            54443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.68  E-value=4.4e-16  Score=148.31  Aligned_cols=208  Identities=19%  Similarity=0.219  Sum_probs=145.2

Q ss_pred             CccccCeeecCCccccc--------------------------------------------cccceeeeEE-EeCCEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYC-PVGEKKLI  199 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~-~~~~~~~l  199 (383)
                      .|.....||+|+||.||                                            +++.++++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            67888999999999999                                            1555566666 35667899


Q ss_pred             EEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CceEEccccCc
Q 046461          200 VYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-----FEVKVSDFGLV  267 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-----~~~kl~Dfgla  267 (383)
                      ||+.+ +.+|.++.+..       ...+.++.|+..+|+++|+.   +++||||||+|+.+...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 78999987532       24578999999999999998   99999999999999764     46899999999


Q ss_pred             c--ccCCCCC----c--c-ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          268 R--LISDCES----H--T-STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       268 ~--~~~~~~~----~--~-~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      +  .......    .  . .....||..|.++.        .+.|+||++.++.|+..|..||...-.........+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  3221111    0  1 12345999998754        678999999999999999999743211101111111001


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +. ............+.++...+-+.+..++|....+...+++....
T Consensus       255 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  255 KL-LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hh-ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            10 11101122334555666666668999999999999988776554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=2.2e-16  Score=151.20  Aligned_cols=124  Identities=23%  Similarity=0.196  Sum_probs=93.0

Q ss_pred             HHHHhhCccccCeeecCCccccc---------------------------------------------cccce-eeeEEE
Q 046461          159 IVAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQ-LLGYCP  192 (383)
Q Consensus       159 l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~-l~g~~~  192 (383)
                      .....++|...+.||+|+||.||                                             +|++. +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            33445678888999999999998                                             24442 222   


Q ss_pred             eCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCceEEccccCccccC
Q 046461          193 VGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDI-NASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       193 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl-k~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                       .+..++||||+++++|... .. .....++.++++||.|||+.   +|+|||| ||+|||++.++.++|+|||+++...
T Consensus        90 -~~~~~LVmE~~~G~~L~~~-~~-~~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA-RP-HGDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh-Cc-cchHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence             2457999999999999743 21 12356788999999999998   9999999 9999999999999999999999765


Q ss_pred             CCCCc-------cccccccccccccCC
Q 046461          272 DCESH-------TSTDVAGTIGYILLA  291 (383)
Q Consensus       272 ~~~~~-------~~~~~~gt~~y~ape  291 (383)
                      .....       ..+...+++.|++||
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcc
Confidence            43211       112355677788877

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.62  E-value=4.5e-15  Score=138.53  Aligned_cols=185  Identities=28%  Similarity=0.403  Sum_probs=135.1

Q ss_pred             ccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       183 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      +++++.+++......++++||+.++++.+++....        ....+..+++.++.|+|..   +++|||+||+||+++
T Consensus        59 ~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~  135 (384)
T COG0515          59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLD  135 (384)
T ss_pred             ceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeec
Confidence            79999999977777899999999999998776432        3467889999999999998   899999999999999


Q ss_pred             CCC-ceEEccccCccccCCCCCc-----cccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          255 EDF-EVKVSDFGLVRLISDCESH-----TSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       255 ~~~-~~kl~Dfgla~~~~~~~~~-----~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      ... .++++|||.++........     ......|+..|++||           ...|+||+|++++++++|..|+....
T Consensus       136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            988 7999999999865543322     234567899999887           24699999999999999999954321


Q ss_pred             CCCCCCccceeeecCc---ccccCCh----hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 046461          318 KDKNGGNLVDWVLDST---ILNAYSK----PSMLKMLQIVVGCIFDNPTTRPTMLRVQEF  370 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~---~~~~~~~----~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~  370 (383)
                      .........+.+....   .......    .....+.+++..|+..+|..|.++.+....
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1000111111111111   1111111    112467788999999999999998877653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2e-16  Score=154.98  Aligned_cols=165  Identities=21%  Similarity=0.286  Sum_probs=128.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchh-----hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +.+|++...+..+...+++.+|..+|+|...+.....     ...+...++-+++++|..   +++|||+|++||+++.+
T Consensus        57 ~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~  133 (612)
T KOG0603|consen   57 PFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLE  133 (612)
T ss_pred             CceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeeccc
Confidence            6788888888889999999999999999998875432     344566788899999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      |.+++.|||+++..-....     .+||.-|||||      ..+|.||||++++||+||..|+..        +....+.
T Consensus       134 Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il  200 (612)
T KOG0603|consen  134 GHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRIL  200 (612)
T ss_pred             CccccCCchhhhHhHhhhh-----cccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHh
Confidence            9999999999987644322     28999999999      578999999999999999999643        3333332


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCH
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM  364 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~  364 (383)
                      ...+  ..+........++.......+|..|--.
T Consensus       201 ~~~~--~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  201 KAEL--EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhcc--CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2221  2234444555566666777777777543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=8.1e-15  Score=128.68  Aligned_cols=124  Identities=15%  Similarity=0.106  Sum_probs=93.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCceE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDI-NASNILLNEDFEVK  260 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl-k~~NiLl~~~~~~k  260 (383)
                      +++.+++++    +..+++|||+.+.+|.+.+..  ....+..+++.++.++|..   +|+|||| ||+|||++.++.++
T Consensus        62 ~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~  132 (218)
T PRK12274         62 PRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPA  132 (218)
T ss_pred             CCCCEEEEE----cCEEEEEeeecCccHHhhhhh--hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEE
Confidence            467777775    346999999999999876532  2345778999999999999   9999999 79999999999999


Q ss_pred             EccccCccccCCCCCc----c--------ccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          261 VSDFGLVRLISDCESH----T--------STDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       261 l~Dfgla~~~~~~~~~----~--------~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      |+|||++.........    .        ......++.|+.|+          ...+.++-|.-+|.++|+..+..
T Consensus       133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            9999999854432210    0        00012455666665          23477899999999999999853

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.53  E-value=3.2e-14  Score=129.69  Aligned_cols=147  Identities=21%  Similarity=0.372  Sum_probs=120.1

Q ss_pred             CccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          165 KFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      +|.-...||+|.||..+                                      ++|-.++-|-.++-.-.||+|.+ +
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            56777899999999888                                      47777777767777788999998 7


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CceEEccccCccccCCCCC
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-----FEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-----~~~kl~Dfgla~~~~~~~~  275 (383)
                      .+|+|+..-.      +....+|.|+..-++|+|++   .+|.|||||+|.||..-     ..+.+.|||+|+...+..+
T Consensus       108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            8998887522      34577999999999999999   99999999999999753     3478999999998866543


Q ss_pred             cc------ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          276 HT------STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       276 ~~------~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ..      .....||..||+..        .+.|.=|+|-++...+.|..||..
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            32      23467999999854        567999999999999999999865

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.52  E-value=1.4e-14  Score=126.68  Aligned_cols=212  Identities=18%  Similarity=0.268  Sum_probs=146.4

Q ss_pred             cHHHHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCE
Q 046461          155 TYDQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       155 ~~~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~  196 (383)
                      +..++..+ ++|.-.+.||.|+||.+|                                      ..|..+..|..+.+.
T Consensus         7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen    7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            33444444 467778899999999998                                      355566677778888


Q ss_pred             EEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEccccCc
Q 046461          197 KLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSDFGLV  267 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~Dfgla  267 (383)
                      -.+|||.. +.+|.+...-      .+..+-++-|+..-++|+|.+   +.+||||||+|.|..-+   ..+.++|||++
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            89999998 8899998752      234577889999999999999   89999999999998643   56889999999


Q ss_pred             cccCCCCCc------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc
Q 046461          268 RLISDCESH------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST  333 (383)
Q Consensus       268 ~~~~~~~~~------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~  333 (383)
                      +...+..+.      ......||..|.+..        .+.|+=|.|.+|...-.|..||...... ....-.+.+....
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQKYEKISEKK  240 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHHHHHHHHhh
Confidence            977543322      223456888887632        5679999999999999999998653221 1111122222211


Q ss_pred             cc---ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          334 IL---NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       334 ~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      +.   .......+.++.-.+.-|-..--++-|.-.-+.+...
T Consensus       241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            11   1112233445555566677777777777666655444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.52  E-value=2.5e-15  Score=144.66  Aligned_cols=158  Identities=26%  Similarity=0.379  Sum_probs=115.3

Q ss_pred             EEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV  267 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla  267 (383)
                      ..++.|++|...+|.+|+...        .....++.|++.|++|   +   +.+|||+||.||....+...||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999632        2346788999999999   4   8999999999999998999999999998


Q ss_pred             cccCCCC-----CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCc
Q 046461          268 RLISDCE-----SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDST  333 (383)
Q Consensus       268 ~~~~~~~-----~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~  333 (383)
                      .......     ....+...||..||+||        .|+||||+|++++|+++ =..++.       .......+.++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~  476 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGI  476 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCC
Confidence            7765544     23445678999999998        68999999999999987 222211       111111223333


Q ss_pred             ccccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                      +++.+..+.+ .-..+..+.+.+.|.+||++.++
T Consensus       477 ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  477 IPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             CChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence            3322222222 33467788999999999955443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.51  E-value=1.3e-14  Score=129.77  Aligned_cols=133  Identities=14%  Similarity=0.162  Sum_probs=97.4

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeC--
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVG--  194 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~--  194 (383)
                      .++|...+++|.|+||.||                                              ++|.....++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            4678888888888888887                                              4666666664432  


Q ss_pred             ------CEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          195 ------EKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       195 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                            ...+++|||++|.+|.++....   .....+++.++..+|..   +++|||+||+|++++.++ ++++|||..+
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~~~---~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~  182 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPEIS---EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKR  182 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhhcc---HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence                  3578999999999999885322   23456899999999999   999999999999999888 9999999987


Q ss_pred             ccCCCCCccccccccccccccCCCCCcchhHHHHHHHHH
Q 046461          269 LISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELV  307 (383)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~ape~~~Dv~SfGvil~Ell  307 (383)
                      ..........  ..-..   +...++|+||||+++.-..
T Consensus       183 ~~~e~~a~d~--~vler---~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        183 CTAQRKAKDR--IDLER---HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccchhhHHH--HHHHh---HhcccccccceeEeehHHH
Confidence            5533221111  00001   1225799999999876553

>PLN03150 hypothetical protein; Provisional

Probab=99.50  E-value=3.6e-14  Score=146.15  Aligned_cols=98  Identities=28%  Similarity=0.336  Sum_probs=86.8

Q ss_pred             ccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCccccccc
Q 046461            4 TQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         4 ~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~~s~   77 (383)
                      ++.|+|++|++ |.+|..++++++|+.|+|++|+|+|.+|++++++.+|+.|+|     +|.+|.+++++++|+.|++++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            56789999999 888888899999999999999999999999999999999998     568999999999999999999


Q ss_pred             ccccccCCCC---------------CcCCccccCCCCCc
Q 046461           78 NMLGGHIPEK---------------NIDLCGKIMGLDYQ  101 (383)
Q Consensus        78 N~l~g~ip~~---------------n~~lcg~~~~~~~~  101 (383)
                      |+|+|.+|..               |..+|+.+....|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            9999999963               66788865433564

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=1.7e-14  Score=148.27  Aligned_cols=182  Identities=20%  Similarity=0.329  Sum_probs=121.7

Q ss_pred             hCccccCeeecCCccccc-----------------cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhH
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT  226 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~i  226 (383)
                      .+|...++|..|+||.||                 +|+| +.+.-...+..+.|      |+-...+++....   -.++
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-lRnilt~a~npfvv------gDc~tllk~~g~l---Pvdm  152 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-LRNILTFAGNPFVV------GDCATLLKNIGPL---PVDM  152 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccchh-hhccccccCCccee------chhhhhcccCCCC---cchh
Confidence            578888999999999999                 1111 00011111222232      4445555432211   1234


Q ss_pred             HHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC--------------CccccccccccccccCC-
Q 046461          227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE--------------SHTSTDVAGTIGYILLA-  291 (383)
Q Consensus       227 a~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~--------------~~~~~~~~gt~~y~ape-  291 (383)
                      +.+++|+|+.   +|+|||+||+|.++..-|.+|++|||+.+......              ......++||+.|+||| 
T Consensus       153 vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            7899999998   99999999999999999999999999987532110              01123468999999998 


Q ss_pred             -------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc-cccCChhHHHHHHHHHHHccccCCCCCC
Q 046461          292 -------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       292 -------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RP  362 (383)
                             ..+|+|++|+|+||.+.|+.||+.+    ...++...++...+ ..+..+....++.+++.+-+..+|.+|-
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGd----tpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD----TPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCC----CHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                   5689999999999999999997543    23333333322222 1222334455777888888999999993

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.46  E-value=6.6e-15  Score=151.59  Aligned_cols=178  Identities=18%  Similarity=0.221  Sum_probs=118.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ||.+.+...-....-.|||-+|..+ +|+|.+.-+.     +...|+.|+..|+.-+|..   +|+|+|||.+|||++.-
T Consensus        81 pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSW  156 (1431)
T KOG1240|consen   81 PNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSW  156 (1431)
T ss_pred             CcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeee
Confidence            5666555554445555677777754 7777776432     3466899999999999999   99999999999999999


Q ss_pred             CceEEccccCccc--cCCCCCccccccc----cccccccCC-------------------CCCcchhHHHHHHHHHhC-C
Q 046461          257 FEVKVSDFGLVRL--ISDCESHTSTDVA----GTIGYILLA-------------------CGGDIYSFSVVLLELVIR-K  310 (383)
Q Consensus       257 ~~~kl~Dfgla~~--~~~~~~~~~~~~~----gt~~y~ape-------------------~~~Dv~SfGvil~Elltg-~  310 (383)
                      ..+.++||.-.+.  +++++....+-..    .-..|+|||                   ++-||||.||++.|+++- +
T Consensus       157 NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~  236 (1431)
T KOG1240|consen  157 NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR  236 (1431)
T ss_pred             chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence            9999999987653  3333322222111    223577777                   356999999999999985 5


Q ss_pred             CCCCCC----CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          311 QPTGPE----FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       311 ~p~~~~----~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      ++|.-.    |+..+ ....+.++     .   .-+...+..++..|++.||++|-++++.++.-.
T Consensus       237 PlF~LSQL~aYr~~~-~~~~e~~L-----e---~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  237 PLFTLSQLLAYRSGN-ADDPEQLL-----E---KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             CcccHHHHHhHhccC-ccCHHHHH-----H---hCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            554310    11100 11111100     0   011124677889999999999999999987643

>PRK10345 hypothetical protein; Provisional

Probab=99.45  E-value=2.7e-13  Score=120.64  Aligned_cols=84  Identities=12%  Similarity=0.151  Sum_probs=66.3

Q ss_pred             ccccceeeeEEEeCC---EEE-EEEEe--ccCCCHHHHHhcch--hhhHHHHhHHHHH-HHHhhcCCCCeeecCCCCCcE
Q 046461          181 FKNIVQLLGYCPVGE---KKL-IVYEY--MVKGSLNDWLRNQA--KHCIIACGTARGI-TFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       181 ~~niv~l~g~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~--~~~~i~~~ia~gL-~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      |+||++++|++.++.   ..+ +|+||  +++|+|.+++....  ....++.++..++ +|||++   +|+||||||+||
T Consensus        60 h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NI  136 (210)
T PRK10345         60 WSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN---RIVTMELKPQNI  136 (210)
T ss_pred             CcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC---CEeecCCCHHHE
Confidence            489999999998863   433 78999  66899999997531  2234567888777 999999   999999999999


Q ss_pred             EEcC----CCceEEccccCc
Q 046461          252 LLNE----DFEVKVSDFGLV  267 (383)
Q Consensus       252 Ll~~----~~~~kl~Dfgla  267 (383)
                      |++.    +..++|+||+-+
T Consensus       137 Ll~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        137 LCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEeccCCCCCcEEEEECCCC
Confidence            9974    347999994443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.45  E-value=2.1e-13  Score=125.75  Aligned_cols=146  Identities=18%  Similarity=0.291  Sum_probs=93.5

Q ss_pred             EEEEEeccCCCHHHHHhc---ch---------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          198 LIVYEYMVKGSLNDWLRN---QA---------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~---~~---------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      +++|+-+ .+||.+++.-   ..         -+..+..|+.+.+++||+.   +++|+|+|++|++++.+|.+.++||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChH
Confidence            5677777 5689888652   11         1355668999999999999   99999999999999999999999998


Q ss_pred             CccccCCCCCccccccccccccccCC----------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          266 LVRLISDCESHTSTDVAGTIGYILLA----------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       266 la~~~~~~~~~~~~~~~gt~~y~ape----------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      ...........    ...+..|.+||                .+.|.|++|+++|.|.++..|++.......    ..| 
T Consensus       191 ~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----~~~-  261 (288)
T PF14531_consen  191 SLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD----PEW-  261 (288)
T ss_dssp             GEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST----SGG-
T ss_pred             HHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc----ccc-
Confidence            87654321111    11123344443                456999999999999999999764322111    111 


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCC
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR  361 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R  361 (383)
                         .+ ..+. +.++.+..++...++.||++|
T Consensus       262 ---~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 ---DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence               12 2333 677788899999999999988

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.44  E-value=3.4e-13  Score=137.11  Aligned_cols=109  Identities=22%  Similarity=0.215  Sum_probs=88.7

Q ss_pred             cHHHHHHHhhCccccCeeecCCccccc---------------------------------------------cccceeee
Q 046461          155 TYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLG  189 (383)
Q Consensus       155 ~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g  189 (383)
                      ++......+..|...+.||+|+||.||                                             ++++....
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333334444556678999999999999                                             24455555


Q ss_pred             EEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          190 YCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       190 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ++.+.+..++||||+++++|.+++.   ....++.++++++.|||+.   +++|||+||+||++ .++.++++|||+++.
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~---~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE---GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH---HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            6666667899999999999999986   3467889999999999998   99999999999999 578899999999976


Q ss_pred             c
Q 046461          270 I  270 (383)
Q Consensus       270 ~  270 (383)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.35  E-value=3.6e-12  Score=112.07  Aligned_cols=72  Identities=15%  Similarity=0.195  Sum_probs=59.7

Q ss_pred             EEEEEEeccCCCHHHH-Hhc----chhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          197 KLIVYEYMVKGSLNDW-LRN----QAKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~-l~~----~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .++||||++++++... +..    ......++.+++.++.++|+ .   +++|||+||+||+++ ++.++++|||+++..
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence            4899999998855433 332    23457899999999999999 7   999999999999999 889999999999875


Q ss_pred             CC
Q 046461          271 SD  272 (383)
Q Consensus       271 ~~  272 (383)
                      ..
T Consensus       168 ~~  169 (190)
T cd05145         168 DH  169 (190)
T ss_pred             CC
Confidence            43

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.1e-12  Score=119.73  Aligned_cols=182  Identities=18%  Similarity=0.281  Sum_probs=119.6

Q ss_pred             ccccccceeeeEEEeC-----CEEEEEEEeccCCCHHHHHhcchh---------hhHHHHhHHHHHHHHhhcCCCCeeec
Q 046461          179 IAFKNIVQLLGYCPVG-----EKKLIVYEYMVKGSLNDWLRNQAK---------HCIIACGTARGITFLHHRFQPHIIHR  244 (383)
Q Consensus       179 ~v~~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~---------~~~i~~~ia~gL~~LH~~~~~~ivHr  244 (383)
                      .||.|||+++.|+.+.     .+..++.|||+.|++.++|+..+.         -.++..||..||.|||+ |.|+|+|+
T Consensus       124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppiihg  202 (458)
T KOG1266|consen  124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccC
Confidence            3568999999998663     357899999999999999985432         25688999999999998 58999999


Q ss_pred             CCCCCcEEEcCCCceEEccccCccccC---CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCC
Q 046461          245 DINASNILLNEDFEVKVSDFGLVRLIS---DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       245 dlk~~NiLl~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      ++..+.|.+..++-+|+.--.-.....   ...........+.++|.+|+        .++|||+||...+||..+..-.
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~  282 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS  282 (458)
T ss_pred             CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence            999999999999888875322111110   00011111123456677766        4689999999999998876542


Q ss_pred             CCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          314 GPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       314 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...-    ..-..+.-....+... ..   ..-...+..|++..|+.||+|.+++-
T Consensus       283 tnse----S~~~~ee~ia~~i~~l-en---~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  283 TNSE----SKVEVEENIANVIIGL-EN---GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             CCCc----ceeehhhhhhhheeec-cC---ccccCcCcccccCCCCCCcchhhhhc
Confidence            2110    0001110001111000 00   01124567899999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.33  E-value=4.7e-12  Score=111.89  Aligned_cols=74  Identities=30%  Similarity=0.420  Sum_probs=64.4

Q ss_pred             EEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          190 YCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       190 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ++...+..++||||+++++|.+++.....  .++.+++.++.++|..   +++|+|++|.||+++ ++.+++.|||.++.
T Consensus        65 ~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        65 YDVDPDNKTIVMEYIEGKPLKDVIEEGND--ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCCCEEEEEEECCccHHHHHhhcHH--HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            34455667899999999999998865332  7889999999999998   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.32  E-value=6.1e-12  Score=112.17  Aligned_cols=83  Identities=27%  Similarity=0.379  Sum_probs=70.4

Q ss_pred             ccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch-hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       183 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                      |+.....++.+.+..+++|||+++++|.+++.... ....++.+++.++.++|+.   +++|+|++|.||+++ ++.+++
T Consensus        60 ~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~l  135 (211)
T PRK14879         60 GVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYL  135 (211)
T ss_pred             CCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEE
Confidence            45555556666777899999999999999986432 4567899999999999998   999999999999999 788999


Q ss_pred             ccccCccc
Q 046461          262 SDFGLVRL  269 (383)
Q Consensus       262 ~Dfgla~~  269 (383)
                      +|||.++.
T Consensus       136 iDf~~a~~  143 (211)
T PRK14879        136 IDFGLAEF  143 (211)
T ss_pred             EECCcccC
Confidence            99999864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2.9e-12  Score=134.03  Aligned_cols=203  Identities=19%  Similarity=0.282  Sum_probs=134.2

Q ss_pred             HHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEE
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      +.......|.-...+|+|+||.||                                      +-|+.+.......+.-++
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            344455678888999999999999                                      233444444445677799


Q ss_pred             EEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-------CCCceEEccccCc
Q 046461          200 VYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-------EDFEVKVSDFGLV  267 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-------~~~~~kl~Dfgla  267 (383)
                      |+||.+-|+|.+++...+     -...++.++++-++.||..   +|||+||||+|.+|.       .+..++|+|||.+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            999999999999997432     2567889999999999998   999999999999993       2356899999998


Q ss_pred             cccCCCC-CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC
Q 046461          268 RLISDCE-SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY  338 (383)
Q Consensus       268 ~~~~~~~-~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~  338 (383)
                      --+..-. .......++|-.+-.+|        ..+|-|.+..+++-|+.|+..-   ..     .-..|.++..++.-.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---~~-----~g~~~~~~~~~~Ry~  920 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---VK-----NGSSWMVKTNFPRYW  920 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH---hc-----CCcceeccccchhhh
Confidence            6543211 11222233444443333        5689999999999999998652   11     111233333332222


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ..+.-.+++++++.   .|-..=|...++...++++
T Consensus       921 ~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  921 KRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             hHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHH
Confidence            23333445554443   3333337777777776654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.28  E-value=7.7e-13  Score=134.88  Aligned_cols=184  Identities=20%  Similarity=0.286  Sum_probs=142.7

Q ss_pred             ccccceeeeEEEeCCEEEEEEEeccCCCHHHHH-hcc------hhhhHHHHhHHHHHHHHh-hcCCCCeeecCCCCCcEE
Q 046461          181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-RNQ------AKHCIIACGTARGITFLH-HRFQPHIIHRDINASNIL  252 (383)
Q Consensus       181 ~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l-~~~------~~~~~i~~~ia~gL~~LH-~~~~~~ivHrdlk~~NiL  252 (383)
                      |+|++++++...+.+..++..||..+|++.+.+ +..      ...-.+..|+..++.|+| +.   ++.|||+||+|.+
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~  156 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSL  156 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccch
Confidence            689999999999999999999999999999988 432      134567889999999999 66   8999999999999


Q ss_pred             EcCCC-ceEEccccCccccCC--CCCcccccccc-ccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          253 LNEDF-EVKVSDFGLVRLISD--CESHTSTDVAG-TIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       253 l~~~~-~~kl~Dfgla~~~~~--~~~~~~~~~~g-t~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      ++..+ ..+++|||+|.....  +........+| ++.|++||         ...|+||.|+++.-+++|..|++.... 
T Consensus       157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~-  235 (601)
T KOG0590|consen  157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR-  235 (601)
T ss_pred             hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc-
Confidence            99999 999999999987765  23333445677 99999998         457999999999999999999864433 


Q ss_pred             CCCCccceeeecCcc-cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 KNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       .......|.-.... .............++...++..+|+.|.+.+++..
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  236 -KDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -ccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence             22333344433211 11223344456677888888899999999887653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.25  E-value=1.3e-11  Score=109.27  Aligned_cols=74  Identities=19%  Similarity=0.179  Sum_probs=63.2

Q ss_pred             CEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ...++||||+++++|.+.... .....++.+++.++.++|+.   +++|+|+||+||+++.++.++++|||.+.....
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~-~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL-EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc-ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            345899999999999876541 34567889999999999998   999999999999999999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.18  E-value=3.1e-11  Score=106.03  Aligned_cols=70  Identities=16%  Similarity=0.234  Sum_probs=57.8

Q ss_pred             EEEEEEeccCCCHHHH-Hhc----chhhhHHHHhHHHHHHHH-hhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          197 KLIVYEYMVKGSLNDW-LRN----QAKHCIIACGTARGITFL-HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~-l~~----~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .++||||++++++... +..    ......++.|++.+|.|+ |+.   +|+|||+||+||+++ ++.++++|||++...
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            3899999998877654 322    234678899999999999 566   899999999999998 578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.14  E-value=2e-10  Score=104.66  Aligned_cols=83  Identities=23%  Similarity=0.168  Sum_probs=65.8

Q ss_pred             ceeeeEEEeC-C---EEEEEEEeccC-CCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          185 VQLLGYCPVG-E---KKLIVYEYMVK-GSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       185 v~l~g~~~~~-~---~~~lv~e~~~~-gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      ++.+++.... .   ..++|+||+++ .+|.+++.........+.+++.++.+||..   +|+|||+||.|||++.++.+
T Consensus       105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence            4555554332 1   23599999997 699998875432344577899999999999   99999999999999998899


Q ss_pred             EEccccCcccc
Q 046461          260 KVSDFGLVRLI  270 (383)
Q Consensus       260 kl~Dfgla~~~  270 (383)
                      +++|||.++..
T Consensus       182 ~LIDfg~~~~~  192 (239)
T PRK01723        182 WLIDFDRGELR  192 (239)
T ss_pred             EEEECCCcccC
Confidence            99999998764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.07  E-value=4e-10  Score=98.42  Aligned_cols=71  Identities=20%  Similarity=0.184  Sum_probs=58.7

Q ss_pred             EEEEEEEeccCC-----CHHHHHhcchhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          196 KKLIVYEYMVKG-----SLNDWLRNQAKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       196 ~~~lv~e~~~~g-----sL~~~l~~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..++||||++++     .|.+.... .+...++.+++.++.++|. .   +++|+|+||+||+++ ++.++++|||.+..
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~  163 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence            457999999994     44444322 4567789999999999998 6   999999999999999 89999999999976


Q ss_pred             cC
Q 046461          270 IS  271 (383)
Q Consensus       270 ~~  271 (383)
                      ..
T Consensus       164 ~~  165 (187)
T cd05119         164 ID  165 (187)
T ss_pred             cc
Confidence            54

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.04  E-value=6.3e-10  Score=92.62  Aligned_cols=86  Identities=16%  Similarity=0.192  Sum_probs=71.7

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                      .++.+++++...++..++++||++++.+..+  .......++.+++++++++|.....+++|+|++++||+++..+.+++
T Consensus        53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l  130 (155)
T cd05120          53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI  130 (155)
T ss_pred             CCCCeEEEEcCCCCccEEEEEecCCeecccC--CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEE
Confidence            4667777877777889999999999888765  33345667889999999999864457999999999999999899999


Q ss_pred             ccccCccc
Q 046461          262 SDFGLVRL  269 (383)
Q Consensus       262 ~Dfgla~~  269 (383)
                      .|||.++.
T Consensus       131 ~Df~~~~~  138 (155)
T cd05120         131 IDWEYAGY  138 (155)
T ss_pred             EecccccC
Confidence            99999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN03150 hypothetical protein; Provisional

Probab=98.98  E-value=1.1e-09  Score=112.98  Aligned_cols=92  Identities=27%  Similarity=0.372  Sum_probs=80.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCC-CCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNL-VQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~-~~L~~l   73 (383)
                      |++|+.|+|+.|++ |.+|..++++++|+.|||++|+|+|.+|.+++++.+|+.|+|     +|.+|.+++.+ .++..+
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l  520 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF  520 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence            57899999999999 888888899999999999999999999999999999999988     56899998874 567889


Q ss_pred             ccccccccccCCCCCcCCccc
Q 046461           74 DFSMNMLGGHIPEKNIDLCGK   94 (383)
Q Consensus        74 ~~s~N~l~g~ip~~n~~lcg~   94 (383)
                      ++++|...+.+|.  ...|..
T Consensus       521 ~~~~N~~lc~~p~--l~~C~~  539 (623)
T PLN03150        521 NFTDNAGLCGIPG--LRACGP  539 (623)
T ss_pred             EecCCccccCCCC--CCCCcc
Confidence            9999988777774  345754

>smart00090 RIO RIO-like kinase

Probab=98.93  E-value=1.3e-09  Score=99.19  Aligned_cols=71  Identities=17%  Similarity=0.187  Sum_probs=59.8

Q ss_pred             EEEEEEeccCCCHHHHHhc-c----hhhhHHHHhHHHHHHHHhhcCCCC-eeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          197 KLIVYEYMVKGSLNDWLRN-Q----AKHCIIACGTARGITFLHHRFQPH-IIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~-~----~~~~~i~~~ia~gL~~LH~~~~~~-ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .++||||+++++|..+... .    .....++.|++.++++||..   + ++|||+||+||+++ ++.++++|||.+...
T Consensus       123 ~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      123 NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            4899999999888765422 1    12457899999999999998   8 99999999999999 889999999998754


Q ss_pred             C
Q 046461          271 S  271 (383)
Q Consensus       271 ~  271 (383)
                      .
T Consensus       199 ~  199 (237)
T smart00090      199 D  199 (237)
T ss_pred             C
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.84  E-value=5.5e-09  Score=102.92  Aligned_cols=179  Identities=21%  Similarity=0.212  Sum_probs=128.8

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHH----HHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTAR----GITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~----gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +|.|+....+.+.+..++-+|++. .+|.++.+...      ..+....+...    |+.++|..   .++|-|+|+.||
T Consensus       178 ~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i  253 (524)
T KOG0601|consen  178 ENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANI  253 (524)
T ss_pred             ccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhhe
Confidence            588888888888899999999984 78888877432      34556666666    99999998   999999999999


Q ss_pred             EEcCC-CceEEccccCccccCCCCCcc----ccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCC
Q 046461          252 LLNED-FEVKVSDFGLVRLISDCESHT----STDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKD  319 (383)
Q Consensus       252 Ll~~~-~~~kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~  319 (383)
                      .+..+ ...+++|||+...+.......    .....|...|++||       .++|+||+|.+.+|..++.......+..
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            99999 889999999998876544211    11224667799887       5689999999999999987765432211


Q ss_pred             CCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          320 KNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       ....+.++    .++.++...-..++.....++++.+|-.|++.+.+.+
T Consensus       334 -~W~~~r~~----~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 -SWSQLRQG----YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -Cccccccc----cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             11111111    1233333334445555788899999999999776653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=98.73  E-value=8.7e-09  Score=112.37  Aligned_cols=86  Identities=34%  Similarity=0.446  Sum_probs=75.9

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ +..|..+.++++|+.|+|++|+++|.+|..++++.+|+.|++     +|.+|.++.++++|+.|++
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            4678888888888 788888888999999999999999999999999999999988     4578999999999999999


Q ss_pred             ccccccccCCCC
Q 046461           76 SMNMLGGHIPEK   87 (383)
Q Consensus        76 s~N~l~g~ip~~   87 (383)
                      ++|+++|.+|..
T Consensus       555 s~N~l~~~~p~~  566 (968)
T PLN00113        555 SQNQLSGEIPKN  566 (968)
T ss_pred             CCCcccccCChh
Confidence            999999999964

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.65  E-value=3.3e-08  Score=97.84  Aligned_cols=74  Identities=22%  Similarity=0.310  Sum_probs=59.7

Q ss_pred             EEEEEEEeccCCCHHHHHhcc---hhhhHHHHhHHH-HHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ---AKHCIIACGTAR-GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~---~~~~~i~~~ia~-gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      ..+|||||++|++|.++....   .....++..++. .+..+|..   +++|+|+||.||+++.++.+++.|||++..++
T Consensus       232 ~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       232 ERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            468999999999999876532   134456666665 46778877   99999999999999999999999999998765


Q ss_pred             C
Q 046461          272 D  272 (383)
Q Consensus       272 ~  272 (383)
                      .
T Consensus       309 ~  309 (437)
T TIGR01982       309 E  309 (437)
T ss_pred             H
Confidence            3

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.57  E-value=5.4e-08  Score=95.99  Aligned_cols=177  Identities=18%  Similarity=0.179  Sum_probs=118.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHh-----cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      .+++.....+...+..++--|||.++++.....     +....+++..+++.++.++|+.   .++|+|+||+||++..+
T Consensus       326 ~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~  402 (524)
T KOG0601|consen  326 LPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISND  402 (524)
T ss_pred             cccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccc
Confidence            366666666666677789999999998876653     2345677889999999999987   99999999999999876


Q ss_pred             -CceEEccccCccccCCCCCccccccccccccc--c---CC-----CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          257 -FEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--L---LA-----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 -~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~--a---pe-----~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                       +..++.|||.+..+.-..   .. ....-++.  +   .|     .+.|++|||.-+.|.+++..-..       ....
T Consensus       403 ~~~~~~~~~~~~t~~~~~~---~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-------~~~~  471 (524)
T KOG0601|consen  403 GFFSKLGDFGCWTRLAFSS---GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-------SGVQ  471 (524)
T ss_pred             hhhhhccccccccccceec---cc-ccccccccccchhhccccccccccccccccccccccccCcccCc-------cccc
Confidence             888999999986432111   00 11111222  1   11     67899999999999988765421       1111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...+..+..... + ........+.......++..||.+.+.....+..
T Consensus       472 ~~~i~~~~~p~~-~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  472 SLTIRSGDTPNL-P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ceeeecccccCC-C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            122233322221 1 1225566667778889999999998887655443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.55  E-value=4.3e-07  Score=90.88  Aligned_cols=189  Identities=16%  Similarity=0.198  Sum_probs=122.2

Q ss_pred             cccccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchh--hhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 046461          180 AFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF  257 (383)
Q Consensus       180 v~~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~  257 (383)
                      .||||++++......+..|+|+|-+.  -|..+++...+  ..-.+.||+.||.|||+.|  +++|+++.-+.|+++..|
T Consensus        67 RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~G  142 (690)
T KOG1243|consen   67 RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESG  142 (690)
T ss_pred             cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCC
Confidence            47999999999999999999999873  46666665432  3446789999999999876  899999999999999999


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--  329 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--  329 (383)
                      .-||++|.++...+.... ......---.|..|+      ...|.|-||++++|++.|..+.......  ...+-+..  
T Consensus       143 eWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng~~~~~~~~~~--~~~ipk~~~~  219 (690)
T KOG1243|consen  143 EWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNGSLLTKTDLSN--TGKIPKALIE  219 (690)
T ss_pred             cEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccccchhhhhHHHHHHHHhCcccCcchhhhc--cCccchhHHH
Confidence            999999988754432211 000000111233343      2359999999999999984332111111  01110000  


Q ss_pred             -ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          330 -LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       330 -~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                       ....+... +.... ...+++..|....+-.|=.+-++...|+++.-+
T Consensus       220 ~~~k~~~~~-~~~r~-n~~~~~~~~~~~~gff~n~fvd~~~fLeel~lk  266 (690)
T KOG1243|consen  220 LYCKKLGAT-ELKRP-NKLRFILECRLLGGFFRNDFVDTLLFLEELRLK  266 (690)
T ss_pred             HHHHHhccc-ccccc-chhhHHHHHHhccccccchHHHHHHHHHhcccC
Confidence             00000000 00011 155677778888888888888888888877544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.52  E-value=6.4e-08  Score=100.73  Aligned_cols=167  Identities=20%  Similarity=0.267  Sum_probs=117.3

Q ss_pred             EeCCEEEEEEEeccCCCHHHHHhcch-----hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccC
Q 046461          192 PVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL  266 (383)
Q Consensus       192 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgl  266 (383)
                      ......+|+++|..+++|...|++..     -.......+..+.+|||..   .+.|||++|.|.+...++..+++|||.
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence            34567899999999999999998543     1233445567889999987   689999999999999999999999985


Q ss_pred             ccccCCC---------------------C---------CccccccccccccccCC--------CCCcchhHHHHHHHHHh
Q 046461          267 VRLISDC---------------------E---------SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       267 a~~~~~~---------------------~---------~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt  308 (383)
                      ......-                     .         ........||+.|.+||        ..+|+|+.|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            4322100                     0         00122346889999998        56899999999999999


Q ss_pred             CCCCCCCCCCCCCCCccceeeecCccccc-CChhHHHHHHHHHHHccccCCCCCCCHH
Q 046461          309 RKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSKPSMLKMLQIVVGCIFDNPTTRPTML  365 (383)
Q Consensus       309 g~~p~~~~~~~~~~~~~~~~v~~~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPs~~  365 (383)
                      |..|+.....    ..+.+.+....+... .+......+.++...-+..+|.+|-.|.
T Consensus      1031 g~pp~na~tp----q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETP----QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcch----hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999765433    333333333333221 1334445666777777788888886654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.50  E-value=5.9e-08  Score=68.52  Aligned_cols=60  Identities=40%  Similarity=0.558  Sum_probs=49.3

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccccChhhhCCCCCcccccccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNML   80 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~~~~~~~L~~l~~s~N~l   80 (383)
                      ++|+.++|+.|++ .+++..+..+++|++|++++|+++. ||                  |..|.++++|+++++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~-i~------------------~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTS-IP------------------PDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESE-EE------------------TTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCc-cC------------------HHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999 7888889999999999999999974 33                  34567778888888888865

...

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=6.4e-07  Score=76.64  Aligned_cols=73  Identities=30%  Similarity=0.361  Sum_probs=61.6

Q ss_pred             EEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          191 CPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       191 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..+.+...++|||+++-.|.+.+...  ...++..+-.-+.-||..   +|+|+|+.++||.+..+. +.++|||++..
T Consensus        68 dvD~~~~~I~me~I~G~~lkd~l~~~--~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          68 DVDPDNGLIVMEYIEGELLKDALEEA--RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEcCCCCEEEEEEeCChhHHHHHHhc--chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            45667788999999999999888755  356677777788899998   999999999999997654 89999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.39  E-value=6.6e-07  Score=76.55  Aligned_cols=70  Identities=17%  Similarity=0.135  Sum_probs=55.0

Q ss_pred             EEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcC--CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRF--QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..++||||+++.++.+.   .......+.+++++++.||...  ...++|+|+++.||+++ ++.+++.||+.+..
T Consensus        65 ~~~lv~e~i~G~~l~~~---~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          65 TGVLITEFIEGSELLTE---DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCeEEEEecCCCccccc---cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            45799999999988754   1122345678999999999873  22369999999999999 67899999999754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.32  E-value=1e-06  Score=77.25  Aligned_cols=73  Identities=16%  Similarity=0.163  Sum_probs=54.5

Q ss_pred             CEEEEEEEeccCCCH-----HHHHhcchhhhHHHHhHHHHHHHH-hhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          195 EKKLIVYEYMVKGSL-----NDWLRNQAKHCIIACGTARGITFL-HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL-----~~~l~~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      ...++||||+.++.+     .+......+...+..++..++..+ |..   +++|+|+++.||+++ ++.+.++|||-+.
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav  172 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSV  172 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEE-CCcEEEEECCCce
Confidence            456899999976533     222212223455678999999998 666   999999999999997 4679999999886


Q ss_pred             ccC
Q 046461          269 LIS  271 (383)
Q Consensus       269 ~~~  271 (383)
                      ...
T Consensus       173 ~~~  175 (197)
T cd05146         173 EPT  175 (197)
T ss_pred             eCC
Confidence            554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.29  E-value=8.6e-07  Score=89.29  Aligned_cols=74  Identities=22%  Similarity=0.285  Sum_probs=51.3

Q ss_pred             EEEEEEEeccCCCHHHHH--hcch-hhhHHHHhHHHH-HHHHhhcCCCCeeecCCCCCcEEEcCCC----ceEEccccCc
Q 046461          196 KKLIVYEYMVKGSLNDWL--RNQA-KHCIIACGTARG-ITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLV  267 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l--~~~~-~~~~i~~~ia~g-L~~LH~~~~~~ivHrdlk~~NiLl~~~~----~~kl~Dfgla  267 (383)
                      ..+|||||++|+.+.+.-  .... +...++...+.. +.-+...   +++|+|+||.||+++.++    .+++.|||++
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGiv  311 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIV  311 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence            346999999999998752  2221 222333322222 1223334   999999999999999887    8999999999


Q ss_pred             cccCC
Q 046461          268 RLISD  272 (383)
Q Consensus       268 ~~~~~  272 (383)
                      ..++.
T Consensus       312 g~l~~  316 (537)
T PRK04750        312 GSLNK  316 (537)
T ss_pred             EECCH
Confidence            87754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.18  E-value=1.1e-06  Score=83.01  Aligned_cols=47  Identities=26%  Similarity=0.428  Sum_probs=21.0

Q ss_pred             cccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee
Q 046461            9 LIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV   56 (383)
Q Consensus         9 l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l   56 (383)
                      |++|.++.+|.++..+++|..|+|++|-+. .+|.+++.+..|+.+|+
T Consensus       419 lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl  465 (565)
T KOG0472|consen  419 LSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL  465 (565)
T ss_pred             hhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence            333333444444444444444444444333 34444444444444443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.16  E-value=8.2e-06  Score=75.40  Aligned_cols=72  Identities=22%  Similarity=0.295  Sum_probs=60.0

Q ss_pred             CEEEEEEEeccCC-CHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------CCce
Q 046461          195 EKKLIVYEYMVKG-SLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-------DFEV  259 (383)
Q Consensus       195 ~~~~lv~e~~~~g-sL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-------~~~~  259 (383)
                      ...++|+|++++- +|.+++..+       .....++.+++..+.-||..   +|+|+|++++|||++.       +..+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence            3578999999876 899988632       13456888999999999999   9999999999999975       4678


Q ss_pred             EEccccCccc
Q 046461          260 KVSDFGLVRL  269 (383)
Q Consensus       260 kl~Dfgla~~  269 (383)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998864

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.14  E-value=3.4e-07  Score=76.92  Aligned_cols=81  Identities=26%  Similarity=0.348  Sum_probs=67.7

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      |++.+.|-|+-|-+...|.-+.++.+|+.|++++|++. ++|.+++++..|+.|+++-    .+|..||.++.|+.||++
T Consensus        32 ~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcc
Confidence            34566788888888655555588999999999999987 8999999999999998843    578889999999999999


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|+|+-
T Consensus       111 ynnl~e  116 (264)
T KOG0617|consen  111 YNNLNE  116 (264)
T ss_pred             cccccc
Confidence            999976

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=1.6e-06  Score=87.24  Aligned_cols=143  Identities=14%  Similarity=0.199  Sum_probs=91.3

Q ss_pred             HHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc--------cccccccccccccCC---
Q 046461          223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--------TSTDVAGTIGYILLA---  291 (383)
Q Consensus       223 ~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~ape---  291 (383)
                      +.+++.|+.|+|..  ..+||+++.|++|.++.++.-|++.|+.+.........        ...-..-...|.+||   
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            35566899999975  48999999999999999999999999987654331110        000011234566776   


Q ss_pred             -----CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 046461          292 -----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR  366 (383)
Q Consensus       292 -----~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~  366 (383)
                           .++|+||+||+++-+..|.++.-................+.. ...+....+.++.+=+.+.+..++..||++.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-AFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-cccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence                 689999999999999866655322211111111111111111 11223444556777777788999999998776


Q ss_pred             HH
Q 046461          367 VQ  368 (383)
Q Consensus       367 v~  368 (383)
                      +.
T Consensus       262 l~  263 (700)
T KOG2137|consen  262 LL  263 (700)
T ss_pred             hh
Confidence            64

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.08  E-value=1e-05  Score=71.98  Aligned_cols=72  Identities=28%  Similarity=0.368  Sum_probs=62.3

Q ss_pred             EEEEEEEeccCC-CHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---ceEEccccC
Q 046461          196 KKLIVYEYMVKG-SLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---EVKVSDFGL  266 (383)
Q Consensus       196 ~~~lv~e~~~~g-sL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---~~kl~Dfgl  266 (383)
                      ..++|+|++++- +|.+++..     ......++.+++..++-||..   +|+|+|+++.|||++.+.   .+.++||+.
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~  167 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDR  167 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence            458999999874 89999986     345667889999999999999   999999999999999876   789999998


Q ss_pred             cccc
Q 046461          267 VRLI  270 (383)
Q Consensus       267 a~~~  270 (383)
                      ++..
T Consensus       168 ~~~~  171 (206)
T PF06293_consen  168 MRFR  171 (206)
T ss_pred             ceeC
Confidence            8754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.00  E-value=1.7e-06  Score=85.77  Aligned_cols=82  Identities=29%  Similarity=0.346  Sum_probs=64.5

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----------------------
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----------------------   58 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----------------------   58 (383)
                      ++-.|.|+.|++ .||-..+.+|+.|-+||||+|+|. .+|+.+-++..|+.|+|++                       
T Consensus       127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms  205 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS  205 (1255)
T ss_pred             CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence            344678899999 566667789999999999999987 7888888877777776633                       


Q ss_pred             -------ccChhhhCCCCCcccccccccccccCCC
Q 046461           59 -------KIPPDLCNLVQLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        59 -------~ip~~~~~~~~L~~l~~s~N~l~g~ip~   86 (383)
                             ++|+++..+.+|..+|+|.|+|.- +|+
T Consensus       206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPe  239 (1255)
T KOG0444|consen  206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPE  239 (1255)
T ss_pred             cccchhhcCCCchhhhhhhhhccccccCCCc-chH
Confidence                   388888888899989999888843 553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.96  E-value=9.6e-05  Score=70.76  Aligned_cols=154  Identities=13%  Similarity=0.132  Sum_probs=98.6

Q ss_pred             hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC------
Q 046461          218 KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------  291 (383)
Q Consensus       218 ~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------  291 (383)
                      -.++.+..+|.+.+-||..   +.+-+|+.++|+|+.+++.+.+.|-.--....+  ........|...|.+||      
T Consensus       118 fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n--g~~~~cpVg~~eftPPElQ~~~s  192 (637)
T COG4248         118 FLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN--GTLHLCPVGVSEFTPPELQTLPS  192 (637)
T ss_pred             HHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeeccC--CceEecccCccccCCHHHhcccc
Confidence            3467889999999999998   888899999999999999998876322221111  11222345677788887      


Q ss_pred             -------CCCcchhHHHHHHHHHhC-CCCCCCCCCCCCCC-----cccee--eec----Cccccc---C-ChhHHHHHHH
Q 046461          292 -------CGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGG-----NLVDW--VLD----STILNA---Y-SKPSMLKMLQ  348 (383)
Q Consensus       292 -------~~~Dv~SfGvil~Elltg-~~p~~~~~~~~~~~-----~~~~~--v~~----~~~~~~---~-~~~~~~~~~~  348 (383)
                             ...|-|.+||++++++.| +.|+.......+..     ++..-  ...    ..+...   . ..-....+..
T Consensus       193 f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA  272 (637)
T COG4248         193 FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA  272 (637)
T ss_pred             ccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHH
Confidence                   346999999999999886 88876433211111     11111  111    111111   0 1112356677


Q ss_pred             HHHHcccc--CCCCCCCHHHHHHHHhcccc
Q 046461          349 IVVGCIFD--NPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       349 l~~~C~~~--~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +-.+|...  ++.-|||++.-+..|..++.
T Consensus       273 lF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         273 LFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             HHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            77788764  46789999887777665543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.96  E-value=3.2e-05  Score=66.22  Aligned_cols=76  Identities=28%  Similarity=0.315  Sum_probs=58.9

Q ss_pred             EEeCCEEEEEEEeccC-CCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---ce
Q 046461          191 CPVGEKKLIVYEYMVK-GSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---EV  259 (383)
Q Consensus       191 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---~~  259 (383)
                      +.+...-.++|||.++ -++.+++....       .....+..+-+.+.-||..   .++|+||.++||++..++   .+
T Consensus        79 ~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~  155 (229)
T KOG3087|consen   79 FIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITP  155 (229)
T ss_pred             EEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCce
Confidence            4455666899999966 37888876321       1246788888999999998   999999999999996543   46


Q ss_pred             EEccccCccc
Q 046461          260 KVSDFGLVRL  269 (383)
Q Consensus       260 kl~Dfgla~~  269 (383)
                      .+.|||++..
T Consensus       156 ~lIdfgls~~  165 (229)
T KOG3087|consen  156 ILIDFGLSSV  165 (229)
T ss_pred             EEEeecchhc
Confidence            8999999753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.85  E-value=3.9e-05  Score=67.00  Aligned_cols=71  Identities=25%  Similarity=0.305  Sum_probs=47.7

Q ss_pred             EEEEEEecc--CCCHHHHHhcc---hhhhHHHHhHHHHHHHH-hhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          197 KLIVYEYMV--KGSLNDWLRNQ---AKHCIIACGTARGITFL-HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       197 ~~lv~e~~~--~gsL~~~l~~~---~~~~~i~~~ia~gL~~L-H~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      ..+||||++  +..+..+....   .....+..++...+..+ |..   +++|+|+.+.||+++.+ .+.++|||-+...
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence            479999998  54444433322   34556777777766664 566   99999999999999877 9999999988654


Q ss_pred             C
Q 046461          271 S  271 (383)
Q Consensus       271 ~  271 (383)
                      .
T Consensus       157 ~  157 (188)
T PF01163_consen  157 S  157 (188)
T ss_dssp             T
T ss_pred             C
Confidence            3

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.84  E-value=2.8e-06  Score=87.65  Aligned_cols=79  Identities=29%  Similarity=0.388  Sum_probs=69.2

Q ss_pred             CCccEeecccCCCC-CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLG-MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~-~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      .||+.|.|+.|.++ +|.....++..|+.|+||+|.|+ .||+++.+|..|+.|...+    ..| ++..+++|+.+|+|
T Consensus       383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS  460 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLS  460 (1081)
T ss_pred             cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecc
Confidence            68999999999995 77777888999999999999998 8999999999998887744    356 79999999999999


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      .|+|+-
T Consensus       461 ~N~L~~  466 (1081)
T KOG0618|consen  461 CNNLSE  466 (1081)
T ss_pred             cchhhh
Confidence            999965

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.83  E-value=1.4e-05  Score=83.63  Aligned_cols=78  Identities=24%  Similarity=0.326  Sum_probs=50.7

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      .|+.|+|+.|.+...|..   .++|+.|++++|+|++ ||....   +|..|++++    .+|.+++++++|+.+++++|
T Consensus       383 ~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Lss-IP~l~~---~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N  455 (788)
T PRK15387        383 GLKELIVSGNRLTSLPVL---PSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLTRLPESLIHLSSETTVNLEGN  455 (788)
T ss_pred             ccceEEecCCcccCCCCc---ccCCCEEEccCCcCCC-CCcchh---hhhhhhhccCcccccChHHhhccCCCeEECCCC
Confidence            344455555555322222   2456667777777664 665433   344555533    58999999999999999999


Q ss_pred             cccccCCCC
Q 046461           79 MLGGHIPEK   87 (383)
Q Consensus        79 ~l~g~ip~~   87 (383)
                      +|+|.+|..
T Consensus       456 ~Ls~~~~~~  464 (788)
T PRK15387        456 PLSERTLQA  464 (788)
T ss_pred             CCCchHHHH
Confidence            999988764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=97.81  E-value=5.4e-06  Score=69.80  Aligned_cols=77  Identities=21%  Similarity=0.246  Sum_probs=41.3

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-------------------------c
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-------------------------Q   57 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-------------------------~   57 (383)
                      +|+.|.+.+|+++-.|..+..+++|+.|+++-|+++ ..|..||+++.|+.|||                         +
T Consensus        57 nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~  135 (264)
T KOG0617|consen   57 NLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLG  135 (264)
T ss_pred             hhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhc
Confidence            455555666666433333355555555555555554 34555555544444444                         1


Q ss_pred             c----ccChhhhCCCCCcccccccccc
Q 046461           58 F----KIPPDLCNLVQLEYFDFSMNML   80 (383)
Q Consensus        58 g----~ip~~~~~~~~L~~l~~s~N~l   80 (383)
                      .    -+|..++++++|+.|.+.+|.|
T Consensus       136 dndfe~lp~dvg~lt~lqil~lrdndl  162 (264)
T KOG0617|consen  136 DNDFEILPPDVGKLTNLQILSLRDNDL  162 (264)
T ss_pred             CCCcccCChhhhhhcceeEEeeccCch
Confidence            1    1566666666666666666665

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.76  E-value=8.4e-06  Score=81.01  Aligned_cols=78  Identities=37%  Similarity=0.540  Sum_probs=47.1

Q ss_pred             CCCccEeecccCCC---CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhh-hCCCCCcc
Q 046461            1 MPHTQKKILIRDNL---GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDL-CNLVQLEY   72 (383)
Q Consensus         1 ~~~~~~~~l~~~~~---~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~-~~~~~L~~   72 (383)
                      |+.|+-+++..|++   |+|++++ .+..|..||||+|+|. +.|..+-+-.++-.|+|+.    +||.++ .+++.|-+
T Consensus        77 Lp~LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLf  154 (1255)
T KOG0444|consen   77 LPRLRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLF  154 (1255)
T ss_pred             chhhHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhh
Confidence            46677788888887   7777775 4788888888888876 5555555444444444432    244332 24444444


Q ss_pred             cccccccc
Q 046461           73 FDFSMNML   80 (383)
Q Consensus        73 l~~s~N~l   80 (383)
                      ||+|+|.|
T Consensus       155 LDLS~NrL  162 (1255)
T KOG0444|consen  155 LDLSNNRL  162 (1255)
T ss_pred             hccccchh
Confidence            44444444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.71  E-value=0.00024  Score=69.69  Aligned_cols=120  Identities=13%  Similarity=0.254  Sum_probs=91.6

Q ss_pred             cccccceeeeEEEe----CCEEEEEEEeccC-CCHHHHHhc--------------------chhhhHHHHhHHHHHHHHh
Q 046461          180 AFKNIVQLLGYCPV----GEKKLIVYEYMVK-GSLNDWLRN--------------------QAKHCIIACGTARGITFLH  234 (383)
Q Consensus       180 v~~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~l~~--------------------~~~~~~i~~~ia~gL~~LH  234 (383)
                      ++.|+|++..++..    +..+++||+|.|+ ++|.+.-..                    +...+.++.|+..||.++|
T Consensus       331 ~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH  410 (655)
T KOG3741|consen  331 CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH  410 (655)
T ss_pred             ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH
Confidence            34799999988763    4578999999886 577765431                    0124778999999999999


Q ss_pred             hcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCCCCCcchhHHHHHHHHHhCCCC
Q 046461          235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQP  312 (383)
Q Consensus       235 ~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape~~~Dv~SfGvil~Elltg~~p  312 (383)
                      +.   ++.-+-|.+++|+++.+.+++|+..|+...+..+......   +       ..+-|.-.+|.+++-|.||..-
T Consensus       411 ss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~le---~-------~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  411 SS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEPLE---S-------QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             hc---CceeecccHhHeEeeCcceEEEecccceeeecCCCCcchh---H-------HhhhhHHHHHHHHHHHhhcccc
Confidence            98   8888999999999999999999988887665443211000   0       1456999999999999998644

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.69  E-value=6.8e-05  Score=66.74  Aligned_cols=86  Identities=24%  Similarity=0.326  Sum_probs=60.7

Q ss_pred             cceeeeEEEeC---CEEEEEEEeccCCCHHHHHh----cchhhhHHHHhHHHHHHHHhhc--------------------
Q 046461          184 IVQLLGYCPVG---EKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHR--------------------  236 (383)
Q Consensus       184 iv~l~g~~~~~---~~~~lv~e~~~~gsL~~~l~----~~~~~~~i~~~ia~gL~~LH~~--------------------  236 (383)
                      +.+++.+....   +..++||||+++.++.+.+.    +..+...++.++++.+..||+.                    
T Consensus        59 vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~  138 (223)
T cd05154          59 VPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQ  138 (223)
T ss_pred             CCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHH
Confidence            44455555543   25689999999998877652    2223445666777777777642                    


Q ss_pred             ---------------------------------CCCCeeecCCCCCcEEEcC--CCceEEccccCccc
Q 046461          237 ---------------------------------FQPHIIHRDINASNILLNE--DFEVKVSDFGLVRL  269 (383)
Q Consensus       237 ---------------------------------~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~  269 (383)
                                                       ....++|+|+++.||+++.  ++.+.+.||+.+..
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         139 VARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                             1246799999999999998  56689999988754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.64  E-value=1.3e-05  Score=79.10  Aligned_cols=87  Identities=17%  Similarity=0.126  Sum_probs=72.1

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-ccC----hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-KIP----PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-~ip----~~~~~~~~L~~l~   74 (383)
                      |+.|+.|+|++|.+ -+-++...-+++|+.||||.|+++---|.+|.-|..|+.|+|+. +|.    ..|..+.+|+.||
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld  371 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD  371 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence            67899999999999 56677777899999999999999988888888899999999854 221    2467788999999


Q ss_pred             cccccccccCCCC
Q 046461           75 FSMNMLGGHIPEK   87 (383)
Q Consensus        75 ~s~N~l~g~ip~~   87 (383)
                      ++.|.|++.|-+.
T Consensus       372 Lr~N~ls~~IEDa  384 (873)
T KOG4194|consen  372 LRSNELSWCIEDA  384 (873)
T ss_pred             CcCCeEEEEEecc
Confidence            9999999988653

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.61  E-value=4.3e-05  Score=49.91  Aligned_cols=37  Identities=24%  Similarity=0.242  Sum_probs=29.0

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLN   38 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~   38 (383)
                      ++|+.|+|+.|++...|..+++|++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence            4788999999999555555688999999999999988

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.56  E-value=5.4e-05  Score=49.42  Aligned_cols=37  Identities=38%  Similarity=0.638  Sum_probs=26.7

Q ss_pred             CCCCEEECcCCccccccchhHHhhhccceeeeccccChhhhCCCCCccccccccccc
Q 046461           25 NELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLG   81 (383)
Q Consensus        25 ~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~~~~~~~L~~l~~s~N~l~   81 (383)
                      ++|++|++++|+++ .||                   .+++++++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~-~l~-------------------~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLP-------------------PELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHG-------------------GHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccC-------------------chHhCCCCCCEEEecCCCCC
Confidence            47899999999998 454                   44667777777888877776

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.43  E-value=0.00032  Score=61.40  Aligned_cols=84  Identities=26%  Similarity=0.328  Sum_probs=69.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCH-------HHHHh-cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSL-------NDWLR-NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL-------~~~l~-~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +++.+++|+|-    .++|.||.+.+++       .++.. .|..+.++|.++.+.+.++++.....+.-.|++++|+.+
T Consensus        20 ~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv   95 (188)
T PF12260_consen   20 EPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGV   95 (188)
T ss_pred             CCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEE
Confidence            37889999993    3689999987754       45544 577899999999999999998655467889999999999


Q ss_pred             cCCCceEEccccCccc
Q 046461          254 NEDFEVKVSDFGLVRL  269 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~  269 (383)
                      ++++++|+.|...+..
T Consensus        96 ~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   96 NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             eCCCcEEEEechhcch
Confidence            9999999999877644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.39  E-value=0.0001  Score=63.48  Aligned_cols=78  Identities=22%  Similarity=0.214  Sum_probs=25.6

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhh-CCCCCccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLC-NLVQLEYFDFSM   77 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~-~~~~L~~l~~s~   77 (383)
                      +++.|+|++|.+..+...-..+.+|+.||||+|.++. |+ .+..+..|+.|+++.    .++..+. .+++|+.|++++
T Consensus        20 ~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~   97 (175)
T PF14580_consen   20 KLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSN   97 (175)
T ss_dssp             ----------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TT
T ss_pred             ccccccccccccccccchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcC
Confidence            4677888888886665543357888888888888873 44 366778888888854    3554453 578888888888


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |++..
T Consensus        98 N~I~~  102 (175)
T PF14580_consen   98 NKISD  102 (175)
T ss_dssp             S---S
T ss_pred             CcCCC
Confidence            88865

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.39  E-value=0.00025  Score=61.10  Aligned_cols=79  Identities=24%  Similarity=0.278  Sum_probs=37.4

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhH-Hhhhccceeeecc-ccC-----hhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFL-SHILGILGLYVQF-KIP-----PDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~-~~~~~l~~l~l~g-~ip-----~~~~~~~~L~~l   73 (383)
                      |++|+.|+|+.|++.....+ ..+++|+.|++++|+++ .|++.+ ..+++|+.|++++ .|.     ..+..+++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~~l~~l-~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKLEGL-PGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S--TT-----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCccccCc-cChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            46889999999999655554 46999999999999998 466555 4689999999965 232     346788999999


Q ss_pred             cccccccc
Q 046461           74 DFSMNMLG   81 (383)
Q Consensus        74 ~~s~N~l~   81 (383)
                      ++.+|-++
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            99998775

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.36  E-value=0.00041  Score=61.65  Aligned_cols=68  Identities=22%  Similarity=0.296  Sum_probs=52.9

Q ss_pred             CEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ...+++|||++|-.|.+...-..   .++..+.+++.-+|..   ++.|+|..|.|++++.+ .+++.||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~i~e---~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIEDIDE---DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchhcCH---HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            45579999999988876543111   2445677889999998   99999999999999854 589999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN03210 Resistant to P

Probab=97.35  E-value=0.00027  Score=78.59  Aligned_cols=82  Identities=23%  Similarity=0.137  Sum_probs=37.2

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s~   77 (383)
                      +|+.|.|..|.+...+.....+++|+.|+|++|+..+.+|. ++++++|+.|+|++     .+|.+++++++|+.|++++
T Consensus       612 ~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~  690 (1153)
T PLN03210        612 NLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR  690 (1153)
T ss_pred             CCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence            34445555544433333334445555555554444444442 44444444444432     3444444444444444444


Q ss_pred             ccccccCC
Q 046461           78 NMLGGHIP   85 (383)
Q Consensus        78 N~l~g~ip   85 (383)
                      |+.-+.+|
T Consensus       691 c~~L~~Lp  698 (1153)
T PLN03210        691 CENLEILP  698 (1153)
T ss_pred             CCCcCccC
Confidence            43333344

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=97.28  E-value=0.00035  Score=77.71  Aligned_cols=84  Identities=17%  Similarity=0.070  Sum_probs=70.8

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.++|+.++. +.+|. +.++++|+.|+|++|.....+|.+++++.+|+.|++++     .+|..+ ++++|+.|+
T Consensus       633 l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~  710 (1153)
T PLN03210        633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLN  710 (1153)
T ss_pred             CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEe
Confidence            57899999998765 66665 57899999999999888889999999999999999965     577755 789999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|...+.+|.
T Consensus       711 Lsgc~~L~~~p~  722 (1153)
T PLN03210        711 LSGCSRLKSFPD  722 (1153)
T ss_pred             CCCCCCcccccc
Confidence            999887777775

syringae 6; Provisional

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.27  E-value=9.2e-05  Score=70.24  Aligned_cols=84  Identities=25%  Similarity=0.293  Sum_probs=67.8

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCcc----------------------ccccchh-HHhhhccceeeec
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKL----------------------NGEISTF-LSHILGILGLYVQ   57 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l----------------------~G~iP~~-~~~~~~l~~l~l~   57 (383)
                      +++|.-|.|++|-+.-.|...+.+..|+.||+|.|+|                      -|++|++ +.++.+|..|||.
T Consensus       434 l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~  513 (565)
T KOG0472|consen  434 LQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQ  513 (565)
T ss_pred             hhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccC
Confidence            4677889999998888888889999999999999999                      3556665 6777778888874


Q ss_pred             c----ccChhhhCCCCCcccccccccccccCCC
Q 046461           58 F----KIPPDLCNLVQLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        58 g----~ip~~~~~~~~L~~l~~s~N~l~g~ip~   86 (383)
                      .    .||+.++++++|++|++++|.|.  .|.
T Consensus       514 nNdlq~IPp~LgnmtnL~hLeL~gNpfr--~Pr  544 (565)
T KOG0472|consen  514 NNDLQQIPPILGNMTNLRHLELDGNPFR--QPR  544 (565)
T ss_pred             CCchhhCChhhccccceeEEEecCCccC--CCH
Confidence            4    57888888888888888888886  554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.25  E-value=0.00041  Score=73.05  Aligned_cols=76  Identities=22%  Similarity=0.340  Sum_probs=48.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|++ ++|...+   .+|+.|+|++|+|+ .||..+.  .+|+.|+|++    .+|.++.  .+|+.|+++
T Consensus       199 ~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        199 EQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPERLP--SALQSLDLF  270 (754)
T ss_pred             cCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECc
Confidence            3567777777777 4444332   46777888888877 5676554  3566666644    3565543  467777777


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|+|+. +|.
T Consensus       271 ~N~L~~-LP~  279 (754)
T PRK15370        271 HNKISC-LPE  279 (754)
T ss_pred             CCccCc-ccc
Confidence            777763 554

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=97.25  E-value=0.00015  Score=77.47  Aligned_cols=84  Identities=24%  Similarity=0.317  Sum_probs=73.0

Q ss_pred             CCccEeecccCC--C-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDN--L-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~--~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~   74 (383)
                      +.|+.|.+..|.  + .+++..+..++.|..||||+|.=-|.+|.++++|.+|++|++++    .+|..+.++..|.+||
T Consensus       545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISHLPSGLGNLKKLIYLN  624 (889)
T ss_pred             CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccccchHHHHHHhhheec
Confidence            457888888886  5 66676788899999999999998899999999999999999966    5899999999999999


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +..+.-...+|
T Consensus       625 l~~~~~l~~~~  635 (889)
T KOG4658|consen  625 LEVTGRLESIP  635 (889)
T ss_pred             ccccccccccc
Confidence            99887666554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.24  E-value=9e-05  Score=73.14  Aligned_cols=80  Identities=28%  Similarity=0.406  Sum_probs=64.9

Q ss_pred             ccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccccc
Q 046461            4 TQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMNM   79 (383)
Q Consensus         4 ~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N~   79 (383)
                      |+.|++++|.++..|..++-+..|..||.|.|.+. .+|+.++.+.+|+.+++.-    .+|.++.. -.|..||+|+|+
T Consensus       145 Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~-LpLi~lDfScNk  222 (722)
T KOG0532|consen  145 LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCS-LPLIRLDFSCNK  222 (722)
T ss_pred             ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhC-CceeeeecccCc
Confidence            78899999999888887788889999999999987 7899999998888887733    47777773 367778888888


Q ss_pred             ccccCCC
Q 046461           80 LGGHIPE   86 (383)
Q Consensus        80 l~g~ip~   86 (383)
                      ++- ||.
T Consensus       223 is~-iPv  228 (722)
T KOG0532|consen  223 ISY-LPV  228 (722)
T ss_pred             eee-cch
Confidence            765 664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.14  E-value=0.00048  Score=72.55  Aligned_cols=75  Identities=20%  Similarity=0.393  Sum_probs=50.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|++ ++|...+   .+|+.|+|++|++. .||..+.  .+|+.|++++    .+|..+.  ++|+.|+++
T Consensus       220 ~nL~~L~Ls~N~LtsLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls  291 (754)
T PRK15370        220 GNIKTLYANSNQLTSIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVY  291 (754)
T ss_pred             cCCCEEECCCCccccCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECC
Confidence            4688889998888 4544332   46778888888877 7777664  4677777744    3555443  467777777


Q ss_pred             cccccccCC
Q 046461           77 MNMLGGHIP   85 (383)
Q Consensus        77 ~N~l~g~ip   85 (383)
                      +|+|++ +|
T Consensus       292 ~N~Lt~-LP  299 (754)
T PRK15370        292 DNSIRT-LP  299 (754)
T ss_pred             CCcccc-Cc
Confidence            777764 44

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.06  E-value=0.0002  Score=74.44  Aligned_cols=82  Identities=26%  Similarity=0.388  Sum_probs=67.9

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      +|+.|+|++|..+-.|.-+..+..|+.|++|+|.+. +.|.+.++..+|+.+.|.+    ..|.++..+.+|+++|+|+|
T Consensus        46 ~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~N  124 (1081)
T KOG0618|consen   46 KLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSFN  124 (1081)
T ss_pred             eeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccchh
Confidence            478889999988777766677888888899988876 6788888888888888865    47989999999999999999


Q ss_pred             cccccCCC
Q 046461           79 MLGGHIPE   86 (383)
Q Consensus        79 ~l~g~ip~   86 (383)
                      +| +.+|.
T Consensus       125 ~f-~~~Pl  131 (1081)
T KOG0618|consen  125 HF-GPIPL  131 (1081)
T ss_pred             cc-CCCch
Confidence            98 45663

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=97.01  E-value=0.0002  Score=67.66  Aligned_cols=83  Identities=25%  Similarity=0.231  Sum_probs=63.3

Q ss_pred             CCccEeecccCCCCC-C------CCcCCCCCCCCEEECcCCccccccchhHHhhhc---cceeeeccc---------cCh
Q 046461            2 PHTQKKILIRDNLGM-P------PIIPKNLNELPHLDLSCNKLNGEISTFLSHILG---ILGLYVQFK---------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~-~------~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~---l~~l~l~g~---------ip~   62 (383)
                      +.++.+.+..+..+. +      +..++++++|+.|+|++|.+.+..+..+..+..   |+.|++++.         +..
T Consensus        51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~  130 (319)
T cd00116          51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK  130 (319)
T ss_pred             CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence            457888888887752 2      233456889999999999999888888888877   999998541         334


Q ss_pred             hhhCC-CCCcccccccccccccC
Q 046461           63 DLCNL-VQLEYFDFSMNMLGGHI   84 (383)
Q Consensus        63 ~~~~~-~~L~~l~~s~N~l~g~i   84 (383)
                      .+..+ ++|+.+++++|++++..
T Consensus       131 ~l~~~~~~L~~L~L~~n~l~~~~  153 (319)
T cd00116         131 GLKDLPPALEKLVLGRNRLEGAS  153 (319)
T ss_pred             HHHhCCCCceEEEcCCCcCCchH
Confidence            56666 89999999999998643

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK09902 hypothetical protein; Provisional

Probab=96.99  E-value=0.0024  Score=56.56  Aligned_cols=71  Identities=20%  Similarity=0.200  Sum_probs=58.0

Q ss_pred             EEEEEEEeccC-CCHHHHHhcch-------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--eEEcccc
Q 046461          196 KKLIVYEYMVK-GSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE--VKVSDFG  265 (383)
Q Consensus       196 ~~~lv~e~~~~-gsL~~~l~~~~-------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~--~kl~Dfg  265 (383)
                      ..+||+|-+++ -+|.+++.++.       .+..+..+++..++-||..   ++.|+|+-+.||+++.++.  +++.||.
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            46799997753 58999986532       2357889999999999999   9999999999999986666  8999997


Q ss_pred             Cccc
Q 046461          266 LVRL  269 (383)
Q Consensus       266 la~~  269 (383)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            7654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=96.92  E-value=0.00037  Score=48.84  Aligned_cols=37  Identities=41%  Similarity=0.531  Sum_probs=34.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCcc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKL   37 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l   37 (383)
                      |++|++++|+.|.+ .++|..+.++++|+.|++++|++
T Consensus        24 l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen   24 LPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             GTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57899999999999 78888999999999999999985

...

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=96.92  E-value=0.00097  Score=70.16  Aligned_cols=73  Identities=23%  Similarity=0.320  Sum_probs=41.1

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhh-----------------hccceeeeccc----cC
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHI-----------------LGILGLYVQFK----IP   61 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~-----------------~~l~~l~l~g~----ip   61 (383)
                      +|+.|+|..|+++..|..   +++|+.|+|++|+|+ .+|....++                 .+|..|+++++    +|
T Consensus       223 ~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~Lt-sLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt~LP  298 (788)
T PRK15387        223 HITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLP  298 (788)
T ss_pred             CCCEEEccCCcCCCCCCC---CCCCcEEEecCCccC-cccCcccccceeeccCCchhhhhhchhhcCEEECcCCcccccc
Confidence            466677777776444432   467777888888777 455432211                 12233333331    23


Q ss_pred             hhhhCCCCCcccccccccccc
Q 046461           62 PDLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        62 ~~~~~~~~L~~l~~s~N~l~g   82 (383)
                      .   .+++|+.|++++|+|++
T Consensus       299 ~---~p~~L~~LdLS~N~L~~  316 (788)
T PRK15387        299 V---LPPGLQELSVSDNQLAS  316 (788)
T ss_pred             c---cccccceeECCCCcccc
Confidence            2   23567778888887776

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.87  E-value=0.00029  Score=38.54  Aligned_cols=22  Identities=41%  Similarity=0.542  Sum_probs=17.9

Q ss_pred             CCCEEECcCCccccccchhHHhh
Q 046461           26 ELPHLDLSCNKLNGEISTFLSHI   48 (383)
Q Consensus        26 ~L~~l~ls~N~l~G~iP~~~~~~   48 (383)
                      +|++|||++|+|+ .||+++++|
T Consensus         1 ~L~~Ldls~n~l~-~ip~~~~~l   22 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSSFSNL   22 (22)
T ss_dssp             TESEEEETSSEES-EEGTTTTT-
T ss_pred             CccEEECCCCcCE-eCChhhcCC
Confidence            5789999999999 899876653

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=96.87  E-value=0.00081  Score=66.83  Aligned_cols=78  Identities=26%  Similarity=0.256  Sum_probs=42.7

Q ss_pred             ccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-ccC----hhhhCCCCCccccccc
Q 046461            4 TQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-KIP----PDLCNLVQLEYFDFSM   77 (383)
Q Consensus         4 ~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-~ip----~~~~~~~~L~~l~~s~   77 (383)
                      +|.|+|++|-+ .+-+..+-++++|+.+++..|.|+ .||...+....|+.|+|.. .|+    +++.-++.|+.+|+|.
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr  158 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR  158 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence            45566666666 444555566666666666666665 5665444444455555522 222    2345555566666666


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |.++-
T Consensus       159 N~is~  163 (873)
T KOG4194|consen  159 NLISE  163 (873)
T ss_pred             chhhc
Confidence            65543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=96.80  E-value=0.00057  Score=64.52  Aligned_cols=81  Identities=25%  Similarity=0.222  Sum_probs=55.0

Q ss_pred             CccEeecccCCCC-----CCCCcCCCC-CCCCEEECcCCccccccch----hHHhhhccceeeeccc---------cChh
Q 046461            3 HTQKKILIRDNLG-----MPPIIPKNL-NELPHLDLSCNKLNGEIST----FLSHILGILGLYVQFK---------IPPD   63 (383)
Q Consensus         3 ~~~~~~l~~~~~~-----~~~~~~~~l-~~L~~l~ls~N~l~G~iP~----~~~~~~~l~~l~l~g~---------ip~~   63 (383)
                      +|+.++|+.|.++     .....+..+ ++|+.|++++|.+++..+.    .+..+..|+.+++++.         ++..
T Consensus       109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~  188 (319)
T cd00116         109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG  188 (319)
T ss_pred             cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence            4888888888874     122233455 7888999999998865443    3444567888887442         3444


Q ss_pred             hhCCCCCccccccccccccc
Q 046461           64 LCNLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        64 ~~~~~~L~~l~~s~N~l~g~   83 (383)
                      +...++|+.|++++|.+++.
T Consensus       189 l~~~~~L~~L~L~~n~i~~~  208 (319)
T cd00116         189 LKANCNLEVLDLNNNGLTDE  208 (319)
T ss_pred             HHhCCCCCEEeccCCccChH
Confidence            55667888999998888653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=96.67  E-value=0.00035  Score=56.94  Aligned_cols=77  Identities=18%  Similarity=0.129  Sum_probs=41.7

Q ss_pred             cEeecccCCCCCCCCcCCCC---CCCCEEECcCCccccccchhHHhh-hccceeeecc----ccChhhhCCCCCcccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNL---NELPHLDLSCNKLNGEISTFLSHI-LGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l---~~L~~l~ls~N~l~G~iP~~~~~~-~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      +.++|+...++-++..+..+   ..|...+||+|.|. .+|..|... +.++.++++.    .+|.++..++.|+.+|++
T Consensus        30 h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~  108 (177)
T KOG4579|consen   30 HFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLR  108 (177)
T ss_pred             hhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccc
Confidence            34555555555444433332   33444566666665 445555443 2455555532    466666677777777777


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|.|+-
T Consensus       109 ~N~l~~  114 (177)
T KOG4579|consen  109 FNPLNA  114 (177)
T ss_pred             cCcccc
Confidence            776655

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=96.65  E-value=0.00061  Score=64.63  Aligned_cols=80  Identities=23%  Similarity=0.278  Sum_probs=67.9

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccCh-hhhCCCCCccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~-~~~~~~~L~~l~~   75 (383)
                      .+..+.|..|++ .+||..++.+.+|+.||||+|+++---|..|..+.+|..|-+.|     .+|. .|+++.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            356788999999 78899999999999999999999988899999998888877755     3664 4788888888888


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      .-|++.-
T Consensus       148 Nan~i~C  154 (498)
T KOG4237|consen  148 NANHINC  154 (498)
T ss_pred             Chhhhcc
Confidence            8888865

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.35  E-value=0.0049  Score=56.28  Aligned_cols=72  Identities=22%  Similarity=0.210  Sum_probs=49.6

Q ss_pred             CCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      .+...+||||+++-.|...--.....-.+...|.+-+.-.-..   +++|+|+..=||+++.++.+.+.||--+.
T Consensus       179 ~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         179 WNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             cccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCcccc
Confidence            3566899999988766654312222233344444444444445   89999999999999999999999995543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.34  E-value=0.019  Score=52.10  Aligned_cols=31  Identities=19%  Similarity=0.232  Sum_probs=26.9

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          239 PHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       239 ~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +.++|+|+.+.||+++.+....|.||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            4689999999999999887788999988753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=96.34  E-value=0.0023  Score=62.65  Aligned_cols=83  Identities=28%  Similarity=0.373  Sum_probs=54.9

Q ss_pred             CCccEeecccCCCCCCCCcCCCCC-CCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLN-ELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~-~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      +.++.+.+..|+..-++..++.+. +|+.|++++|++. .+|..+.++++|+.|+++.    .+|...+.++.|+.++++
T Consensus       116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls  194 (394)
T COG4886         116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLS  194 (394)
T ss_pred             cceeEEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheecc
Confidence            356677777777755555555553 7777777777765 5666677777777777754    466655577777777777


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|+++- +|.
T Consensus       195 ~N~i~~-l~~  203 (394)
T COG4886         195 GNKISD-LPP  203 (394)
T ss_pred             CCcccc-Cch
Confidence            777744 443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=96.34  E-value=0.0013  Score=60.39  Aligned_cols=75  Identities=15%  Similarity=0.019  Sum_probs=45.3

Q ss_pred             ccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----cChhhhCCCCCccccccccc
Q 046461            4 TQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----IPPDLCNLVQLEYFDFSMNM   79 (383)
Q Consensus         4 ~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----ip~~~~~~~~L~~l~~s~N~   79 (383)
                      |..++|+.|.+.-+.+...-++.++.|++|+|++. .+- ++..+.+|+.|||+++    +-.|=.++.+.+.|+++.|.
T Consensus       286 LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~  363 (490)
T KOG1259|consen  286 LTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNK  363 (490)
T ss_pred             hhhccccccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhh
Confidence            56677788877777776667777778888888765 232 2566667777777653    22222334444444444444


Q ss_pred             c
Q 046461           80 L   80 (383)
Q Consensus        80 l   80 (383)
                      +
T Consensus       364 i  364 (490)
T KOG1259|consen  364 I  364 (490)
T ss_pred             H
Confidence            3

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=96.29  E-value=0.0024  Score=68.42  Aligned_cols=78  Identities=21%  Similarity=0.217  Sum_probs=66.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.- +-.|..+++|-+|++|||++...+ .+|..+.++..|.+|++..     .+|.-+..+++|++|.
T Consensus       570 m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~  648 (889)
T KOG4658|consen  570 LPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLR  648 (889)
T ss_pred             CcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEE
Confidence            67899999997766 788888899999999999999988 9999999999999999943     3455566699999988


Q ss_pred             ccccc
Q 046461           75 FSMNM   79 (383)
Q Consensus        75 ~s~N~   79 (383)
                      +-.-.
T Consensus       649 l~~s~  653 (889)
T KOG4658|consen  649 LPRSA  653 (889)
T ss_pred             eeccc
Confidence            76543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.27  E-value=0.032  Score=50.32  Aligned_cols=30  Identities=17%  Similarity=0.204  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          239 PHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       239 ~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +.++|+|+.|.||+++.++ +.+.||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            3578999999999999877 99999988753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=96.24  E-value=0.00066  Score=55.36  Aligned_cols=83  Identities=18%  Similarity=0.281  Sum_probs=68.0

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      .+|....|++|.+ .+|+..-...+.++.|+|++|.++ .+|.++..++.|++++++.    ..|.-+..+.+|..||.-
T Consensus        53 ~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~  131 (177)
T KOG4579|consen   53 YELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSP  131 (177)
T ss_pred             ceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCC
Confidence            3677789999999 577666666778999999999998 7999999999999999955    357777888889999988


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|... +||.
T Consensus       132 ~na~~-eid~  140 (177)
T KOG4579|consen  132 ENARA-EIDV  140 (177)
T ss_pred             CCccc-cCcH
Confidence            88763 4554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=96.18  E-value=0.00066  Score=62.20  Aligned_cols=80  Identities=21%  Similarity=0.234  Sum_probs=62.1

Q ss_pred             CCccEeecccCCC---CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc------cChhhhCCCCCcc
Q 046461            2 PHTQKKILIRDNL---GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK------IPPDLCNLVQLEY   72 (383)
Q Consensus         2 ~~~~~~~l~~~~~---~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~------ip~~~~~~~~L~~   72 (383)
                      ++.+.++|..|.+   .-+..++.+++.|++|+||+|.|+..|-..=..+.+|..+-|.|+      ....+.++|.++.
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte  150 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE  150 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence            5677889999988   466778889999999999999998776432234567777777663      3456788899999


Q ss_pred             ccccccccc
Q 046461           73 FDFSMNMLG   81 (383)
Q Consensus        73 l~~s~N~l~   81 (383)
                      |.+|.|++.
T Consensus       151 lHmS~N~~r  159 (418)
T KOG2982|consen  151 LHMSDNSLR  159 (418)
T ss_pred             hhhccchhh
Confidence            999999663

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=96.11  E-value=0.0026  Score=58.48  Aligned_cols=78  Identities=26%  Similarity=0.242  Sum_probs=50.1

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccccChh---hhCCCCCcccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPD---LCNLVQLEYFDFSMN   78 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~---~~~~~~L~~l~~s~N   78 (383)
                      +.++.|+|+.|++..... +..+++|+.||||+|.++ ++-..-..+-++..|.|+++.=.+   ++++-+|.+||+++|
T Consensus       307 Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~LSGL~KLYSLvnLDl~~N  384 (490)
T KOG1259|consen  307 PKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETLSGLRKLYSLVNLDLSSN  384 (490)
T ss_pred             cceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhhhhhhHhhhhheecccccc
Confidence            567889999999966655 578999999999999986 222222233445555554432222   334445666666666


Q ss_pred             ccc
Q 046461           79 MLG   81 (383)
Q Consensus        79 ~l~   81 (383)
                      ++.
T Consensus       385 ~Ie  387 (490)
T KOG1259|consen  385 QIE  387 (490)
T ss_pred             chh
Confidence            653

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=96.09  E-value=0.0025  Score=62.43  Aligned_cols=76  Identities=29%  Similarity=0.399  Sum_probs=66.6

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      +|+.++++.|++...|...+++++|+.|+++.|+++ .+|...+.+..|..+++++    .+|..+..+..|+.+.+++|
T Consensus       141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N  219 (394)
T COG4886         141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNN  219 (394)
T ss_pred             hcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCC
Confidence            789999999999776666789999999999999988 7888888899999999977    57877777777999999999


Q ss_pred             c
Q 046461           79 M   79 (383)
Q Consensus        79 ~   79 (383)
                      +
T Consensus       220 ~  220 (394)
T COG4886         220 S  220 (394)
T ss_pred             c
Confidence            6

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=95.56  E-value=0.0064  Score=60.04  Aligned_cols=83  Identities=23%  Similarity=0.171  Sum_probs=60.9

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-c--ChhhhCCCCCccccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-I--PPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-i--p~~~~~~~~L~~l~~s~   77 (383)
                      +++|..++|..|++.-+...+..+.+|++||||.|+++.-.+  +..+..|+.|+++|+ |  -..+..+.+|+.+++++
T Consensus        94 ~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~~~~~l~~L~~l~l~~  171 (414)
T KOG0531|consen   94 LKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDISGLESLKSLKLLDLSY  171 (414)
T ss_pred             ccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheeccCcchhccCCccchhhhcccCCc
Confidence            357888899999986666545778999999999999876554  556667888888663 2  22355578888899999


Q ss_pred             ccccccCC
Q 046461           78 NMLGGHIP   85 (383)
Q Consensus        78 N~l~g~ip   85 (383)
                      |.+...-+
T Consensus       172 n~i~~ie~  179 (414)
T KOG0531|consen  172 NRIVDIEN  179 (414)
T ss_pred             chhhhhhh
Confidence            88876443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=95.36  E-value=0.0023  Score=65.28  Aligned_cols=80  Identities=25%  Similarity=0.274  Sum_probs=51.6

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccceeeeccccCh---hhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYVQFKIPP---DLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l~g~ip~---~~~~~~~L~~l~~s   76 (383)
                      +++|+.|.|+-|.+..-. .+..|+.|++||||.|.|. .+|- +...|. |..|.+.|+-=.   .+.++.+|..||+|
T Consensus       186 l~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL~gie~LksL~~LDls  262 (1096)
T KOG1859|consen  186 LPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTLRGIENLKSLYGLDLS  262 (1096)
T ss_pred             HHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhhhhHHhhhhhhccchh
Confidence            356777777777775444 4467788888888888876 3443 233344 666777553222   25667778888888


Q ss_pred             ccccccc
Q 046461           77 MNMLGGH   83 (383)
Q Consensus        77 ~N~l~g~   83 (383)
                      +|-|++.
T Consensus       263 yNll~~h  269 (1096)
T KOG1859|consen  263 YNLLSEH  269 (1096)
T ss_pred             Hhhhhcc
Confidence            8887773

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.94  E-value=0.049  Score=55.00  Aligned_cols=76  Identities=26%  Similarity=0.375  Sum_probs=50.8

Q ss_pred             CEEEEEEEeccCCCHHHHH--hcch-hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----CCceEEccccCc
Q 046461          195 EKKLIVYEYMVKGSLNDWL--RNQA-KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE----DFEVKVSDFGLV  267 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l--~~~~-~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~----~~~~kl~Dfgla  267 (383)
                      ....|+||||+|..+.|.-  .+.+ ....++..+.++  |++.-...+++|+|-.|-||++..    +..+.+-|||+.
T Consensus       275 t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~  352 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY  352 (538)
T ss_pred             cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence            4679999999998776553  2221 222333333322  222222338999999999999983    678999999998


Q ss_pred             cccCC
Q 046461          268 RLISD  272 (383)
Q Consensus       268 ~~~~~  272 (383)
                      ..++.
T Consensus       353 ~~is~  357 (538)
T KOG1235|consen  353 AVISH  357 (538)
T ss_pred             ccccH
Confidence            77654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	383
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-05
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-04
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-04
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-04
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-04
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-04
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-04
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-04
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-04
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 113/221 (51%), Gaps = 30/221 (13%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITF 232
           +N+++L G+C    ++L+VY YM  GS+   LR +          K   IA G+ARG+ +
Sbjct: 95  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           LH    P IIHRD+ A+NILL+E+FE  V DFGL +L+   + H    V GTIG+I    
Sbjct: 155 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEY 214
Query: 290 LACGG-----DIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDWV------------LD 331
           L+ G      D++ + V+LLEL+  ++        + +   L+DWV            +D
Sbjct: 215 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 274
Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             +   Y    + +++Q+ + C   +P  RP M  V   LE
Sbjct: 275 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 115/232 (49%), Gaps = 30/232 (12%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA---------KHCIIACGTARGITF 232
           +N+++L G+C    ++L+VY YM  GS+   LR +          K   IA G+ARG+ +
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           LH    P IIHRD+ A+NILL+E+FE  V DFGL +L+   + H    V G IG+I    
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEY 206
Query: 290 LACGG-----DIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDWV------------LD 331
           L+ G      D++ + V+LLEL+  ++        + +   L+DWV            +D
Sbjct: 207 LSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD 266
Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY 383
             +   Y    + +++Q+ + C   +P  RP M  V   LE     E +  +
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEW 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFL 233
           +N+V+LLG+   G+   +VY YM  GSL D L         +    C IA G A GI FL
Sbjct: 90  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGYIL--- 289
           H   + H IHRDI ++NILL+E F  K+SDFGL R      ++   + + GT  Y+    
Sbjct: 150 H---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA 206
Query: 290 ----LACGGDIYSFSVVLLELVIRKQPTGPEFKDKN------------GGNLVDWVLDST 333
               +    DIYSF VVLLE +I   P   E ++                 + D++    
Sbjct: 207 LRGEITPKSDIYSFGVVLLE-IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DK 263
Query: 334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +N     S+  M  +   C+ +    RP + +VQ+ L++
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFL 233
           +N+V+LLG+   G+   +VY YM  GSL D L         +    C IA G A GI FL
Sbjct: 90  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGYIL--- 289
           H   + H IHRDI ++NILL+E F  K+SDFGL R      ++     + GT  Y+    
Sbjct: 150 H---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA 206
Query: 290 ----LACGGDIYSFSVVLLELVIRKQPTGPEFKDKN------------GGNLVDWVLDST 333
               +    DIYSF VVLLE +I   P   E ++                 + D++    
Sbjct: 207 LRGEITPKSDIYSFGVVLLE-IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DK 263
Query: 334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +N     S+  M  +   C+ +    RP + +VQ+ L++
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFL 233
           +N+V+LLG+   G+   +VY YM  GSL D L         +    C IA G A GI FL
Sbjct: 84  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGYIL--- 289
           H   + H IHRDI ++NILL+E F  K+SDFGL R      +      + GT  Y+    
Sbjct: 144 H---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA 200
Query: 290 ----LACGGDIYSFSVVLLELVIRKQPTGPEFKDKN------------GGNLVDWVLDST 333
               +    DIYSF VVLLE +I   P   E ++                 + D++    
Sbjct: 201 LRGEITPKSDIYSFGVVLLE-IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DK 257
Query: 334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +N     S+  M  +   C+ +    RP + +VQ+ L++
Sbjct: 258 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFL 233
           +N+V+LLG+   G+   +VY Y   GSL D L         +    C IA G A GI FL
Sbjct: 81  ENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFL 140
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGYIL--- 289
           H   + H IHRDI ++NILL+E F  K+SDFGL R      +    + + GT  Y     
Sbjct: 141 H---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEA 197
Query: 290 ----LACGGDIYSFSVVLLELVIRKQPTGPEFKDKN------------GGNLVDWVLDST 333
               +    DIYSF VVLLE +I   P   E ++                 + D++    
Sbjct: 198 LRGEITPKSDIYSFGVVLLE-IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI--DK 254
Query: 334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             N     S+     +   C+ +    RP + +VQ+ L++
Sbjct: 255 KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFL 233
           ++V L+G+C    + +++Y+YM  G+L   L             +   I  G ARG+ +L
Sbjct: 96  HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYI---- 288
           H R    IIHRD+ + NILL+E+F  K++DFG+ +  ++  ++H    V GT+GYI    
Sbjct: 156 HTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEY 212
Query: 289 ----LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDS 332
                L    D+YSF VVL E++  +         +   NL +W            ++D 
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQLEQIVDP 271
Query: 333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM----------LRVQE 369
            + +     S+ K     V C+  +   RP+M          LR+QE
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFL 233
           ++V L+G+C    + +++Y+YM  G+L   L             +   I  G ARG+ +L
Sbjct: 96  HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYI---- 288
           H R    IIHRD+ + NILL+E+F  K++DFG+ +  ++  ++H    V GT+GYI    
Sbjct: 156 HTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEY 212
Query: 289 ----LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW------------VLDS 332
                L    D+YSF VVL E++  +         +   NL +W            ++D 
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQLEQIVDP 271
Query: 333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM----------LRVQE 369
            + +     S+ K     V C+  +   RP+M          LR+QE
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 179 IAFKNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGI 230
           I  + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+
Sbjct: 70  IRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILL 290
            ++      + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +   
Sbjct: 128 AYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184
Query: 291 ACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
                       D++SF ++L EL  + +   P   ++        VLD  +   Y  P 
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPC 236
Query: 343 MLKMLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +  +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 237 PPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 63  EKLVQL--YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 120
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 121 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 177
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 229
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C    P  RPT   +Q FLE Y T
Sbjct: 230 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 62  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 119
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 120 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 176
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 228
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
             +    ++  C   +P  RPT   +Q FLE Y T 
Sbjct: 229 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 264

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 66  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 123
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 124 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 180
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 232
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
             +    ++  C    P  RPT   +Q FLE Y T 
Sbjct: 233 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 268

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 64  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 121
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 122 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 178
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 230
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
             +    ++  C   +P  RPT   +Q FLE Y T 
Sbjct: 231 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTS 266

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 183 NIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            +VQL  Y  V E+ + IV EYM KGSL D+L++     +       +A   A G+ ++ 
Sbjct: 65  KLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG- 293
                + IHRD+ ++NIL+      K++DFGL RLI D E          I +       
Sbjct: 123 RM---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 179
Query: 294 -------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP----S 342
                   D++SF ++L ELV + +   P   ++        VL+  +   Y  P     
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQ-VERGYRMPCPQDC 231
Query: 343 MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
            + + ++++ C   +P  RPT   +Q FLE Y T 
Sbjct: 232 PISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTA 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 239 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 297 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 405
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
               +  ++  C    P  RPT   +Q FLE Y T 
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 239 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 297 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 405
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
               +  ++  C    P  RPT   +Q FLE Y T 
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 322 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 380 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 488
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C    P  RPT   +Q FLE Y T
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 239 EKLVQL--YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 297 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 405
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C    P  RPT   +Q FLE Y T
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFLH 234
           NIV  +G         IV EY+ +GSL   L         ++ +   +A   A+G+ +LH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-- 292
           +R  P I+HRD+ + N+L+++ + VKV DFGL RL +      S   AGT  ++      
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-SXFLXSKXAAGTPEWMAPEVLR 212
Query: 293 ------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D+YSF V+L EL   +QP G    + N   +V  V          +    ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG----NLNPAQVVAAVGFKCKRLEIPRNLNPQV 268
Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLE 372
             I+ GC  + P  RP+   + + L 
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       ++   A G+ ++
Sbjct: 70  EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 128 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 184
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 236
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C    P  RPT   +Q FLE Y T
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 271

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       ++   A G+ ++
Sbjct: 70  EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 128 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAA 184
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 236
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C    P  RPT   +Q FLE Y T
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 271

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KG L D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KG L D+L+ +    +       +A   A G+ ++
Sbjct: 73  EKLVQL--YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 131 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 187
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 239
Query: 346 MLQ----IVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             +    ++  C   +P  RPT   +Q FLE Y T
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
           + +VQL  Y  V E+ + IV EYM KGSL D+L+ +    +       +A   A G+ ++
Sbjct: 240 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 297
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A+NIL+ E+   KV+DFGL RLI D E          I +      
Sbjct: 298 ERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAA 354
Query: 294 --------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++SF ++L EL  + +   P   ++        VLD  +   Y  P   +
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ-VERGYRMPCPPE 406
Query: 346 ----MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +  ++  C   +P  RPT   +Q FLE Y T
Sbjct: 407 CPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 441

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFLH 234
           NIV  +G         IV EY+ +GSL   L         ++ +   +A   A+G+ +LH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-- 292
           +R  P I+HR++ + N+L+++ + VKV DFGL RL +     +S   AGT  ++      
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLR 212
Query: 293 ------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D+YSF V+L EL   +QP G    + N   +V  V          +    ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG----NLNPAQVVAAVGFKCKRLEIPRNLNPQV 268
Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLE 372
             I+ GC  + P  RP+   + + L 
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 77  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 133
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 134 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 190
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 191 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 245

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 131 IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 73  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 129
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 186
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 72  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 72  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 70  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 126
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 127 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 183
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 184 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 71  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 127
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 128 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 184
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 185 KEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 73  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 129
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ FL  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLD 186
Query: 273 CE---SHTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 91  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 147
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 148 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 204
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 205 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 259

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 90  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 146
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 147 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 203
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 204 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 69  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 126 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 183 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 64  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 120
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 121 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 177
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 178 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 232

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 72  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 72  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 71  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 127
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 128 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 184
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 185 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 67  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 160 VAGTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAK 218
           +   ++F  + +I  D    +  N++ LLG C   E   L+V  YM  G L +++RN+  
Sbjct: 70  IGEVSQFLTEGIIMKD---FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 126
Query: 219 HCII------ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           +  +          A+G+ +L  +     +HRD+ A N +L+E F VKV+DFGL R + D
Sbjct: 127 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 183
Query: 273 CES---HTSTDVAGTIGYILL--------ACGGDIYSFSVVLLELVIRKQPTGPE 316
            E    H  T     + ++ L            D++SF V+L EL+ R  P  P+
Sbjct: 184 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIA--CGTARGI-TFLHHRFQP 239
           NI++L G    G   +IV EYM  GSL+ +LR       I    G  RG+   + +    
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A N+L++ +   KVSDFGL R++ D      T   G           I +  
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
            +   D++SF VV+ E++         + ++   N+ +  + S++   Y  P+ +     
Sbjct: 231 FSSASDVWSFGVVMWEVLA--------YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           + Q+++ C   +   RP   ++   L+
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIA--CGTARGI-TFLHHRFQP 239
           NI++L G    G   +IV EYM  GSL+ +LR       I    G  RG+   + +    
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A N+L++ +   KVSDFGL R++ D      T   G           I +  
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
            +   D++SF VV+ E++         + ++   N+ +  + S++   Y  P+ +     
Sbjct: 231 FSSASDVWSFGVVMWEVLA--------YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           + Q+++ C   +   RP   ++   L+
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RPT
Sbjct: 201 TEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRPT 256
Query: 364 MLRVQEFLEKYHTGENFGRY 383
              ++  LE + T    G+Y
Sbjct: 257 FDYLRSVLEDFFTATE-GQY 275

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 25/201 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 94  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 150
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 151 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 209
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RP
Sbjct: 210 LTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRP 265
Query: 363 TMLRVQEFLEKYHTGENFGRY 383
           T   ++  LE + T    G+Y
Sbjct: 266 TFDYLRSVLEDFFTATE-GQY 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 47/230 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------------------- 221
           NIV+LLG C VG+   +++EYM  G LN++LR+ + H +                     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 222 --------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
                   IA   A G+ +L  R     +HRD+   N L+ E+  VK++DFGL R I   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 274 ESHTSTD---------VAGTIGYILLACGGDIYSFSVVLLELVIRK-QPTGPEFKDKNGG 323
           + + +              +I Y       D++++ VVL E+     QP    +      
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----YYGMAHE 283
Query: 324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            ++ +V D  IL A  +   L++  ++  C    P  RP+   +   L++
Sbjct: 284 EVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 79  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 135
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 136 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 194
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RP
Sbjct: 195 LTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRP 250
Query: 363 TMLRVQEFLEKYHTG 377
           T   ++  LE + T 
Sbjct: 251 TFDYLRSVLEDFFTA 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 146
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 205
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RP
Sbjct: 206 LTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRP 261
Query: 363 TMLRVQEFLEKYHTG 377
           T   ++  LE + T 
Sbjct: 262 TFDYLRSVLEDFFTA 276

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 89  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 145
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 146 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 204
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RP
Sbjct: 205 LTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRP 260
Query: 363 TMLRVQEFLEKYHTG 377
           T   ++  LE + T 
Sbjct: 261 TFDYLRSVLEDFFTA 275

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 38/202 (18%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK-------MLQIVVGCIF 355
           L E+V   +   P   +              I N      M++       + Q++  C  
Sbjct: 200 LTEIVTHGRIPYPGMTNP-----------EVIQNLERGYRMVRPDNCPEELYQLMRLCWK 248
Query: 356 DNPTTRPTMLRVQEFLEKYHTG 377
           + P  RPT   ++  LE + T 
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFTA 270

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 24/195 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ E+M KGSL D+L++         K    +   A G+ F+  R   + IHRD+ A+NI
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI 315
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L++     K++DFGL R+I D E +T+ + A           I +       D++SF ++
Sbjct: 316 LVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L+E+V   +   P   +      V   L+        +    ++  I++ C  + P  RP
Sbjct: 375 LMEIVTYGRIPYPGMSNPE----VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERP 430
Query: 363 TMLRVQEFLEKYHTG 377
           T   +Q  L+ ++T 
Sbjct: 431 TFEYIQSVLDDFYTA 445

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 266
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 267 LYQLMLDCWQKDRNNRPKFEQIVSILDK 294

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 164
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 276
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 277 LYQLMLDCWQKDRNNRPKFEQIVSILDK 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-AKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR   A+  +I   G  RGI + + +    
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 249
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDK 277

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 183 NIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH-----CII--ACGTARGITFL 233
           N+VQLLG   V EK    IV EYM KGSL D+LR++ +      C++  +      + +L
Sbjct: 247 NLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL---- 289
                 + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L    
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 362
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS--KPSMLKML 347
            +   D++SF ++L E+    +   P    K   ++V  V     ++A     P++  ++
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMDAPDGCPPAVYDVM 419
Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           +    C   +  TRPT L+++E LE   T E
Sbjct: 420 K---NCWHLDAATRPTFLQLREQLEHIRTHE 447

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 92  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 148
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 208
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RPT
Sbjct: 209 TEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRPT 264
Query: 364 MLRVQEFLEKYHTGENFGRY 383
              ++  LE + T    G+Y
Sbjct: 265 FDYLRSVLEDFFTATE-GQY 283

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P   +      V   L+             ++ Q++  C  + P  RPT
Sbjct: 201 TEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 364 MLRVQEFLEKYHTGENFGRY 383
              ++  LE + T    G+Y
Sbjct: 257 FDYLRSVLEDFFTATE-GQY 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 90  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 146
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 206
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RPT
Sbjct: 207 TEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRPT 262
Query: 364 MLRVQEFLEKYHTGENFGRY 383
              ++  LE + T    G+Y
Sbjct: 263 FDYLRSVLEDFFTATE-GQY 281

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 93  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 149
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 209
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RPT
Sbjct: 210 TEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRPT 265
Query: 364 MLRVQEFLEKYHTG 377
              ++  LE + T 
Sbjct: 266 FDYLRSVLEDFFTA 279

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWT 177
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDYRMERPEGC 235
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 236 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWT 177
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDYRMERPEGC 235
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 236 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V+E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 118
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI------- 285
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     +       
Sbjct: 119 LE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 175
Query: 286 -GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
             +   +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 176 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 228
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 229 ASTHVYQIMNHCWKERPEDRPAFSRL 254

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 22/194 (11%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 86  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 142
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 202
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            E+V   +   P     N   + +      ++   + P   ++ Q++  C  + P  RPT
Sbjct: 203 TEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCPE--ELYQLMRLCWKERPEDRPT 258
Query: 364 MLRVQEFLEKYHTG 377
              ++  LE + T 
Sbjct: 259 FDYLRSVLEDFFTA 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 36/201 (17%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 84  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK-------MLQIVVGCIFD 356
            E+V   +   P   +              I N      M++       + Q++  C  +
Sbjct: 201 TEIVTHGRIPYPGMTNP-----------EVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 357 NPTTRPTMLRVQEFLEKYHTG 377
            P  RPT   ++  LE + T 
Sbjct: 250 RPEDRPTFDYLRSVLEDFFTA 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 36/201 (17%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHRD+ A+NI
Sbjct: 85  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 141
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGTIGYILLACGGDIYSFSVVL 303
           L+++    K++DFGL RLI D E                  I Y       D++SF ++L
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 201
Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK-------MLQIVVGCIFD 356
            E+V   +   P   +              I N      M++       + Q++  C  +
Sbjct: 202 TEIVTHGRIPYPGMTNP-----------EVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 250
Query: 357 NPTTRPTMLRVQEFLEKYHTG 377
            P  RPT   ++  LE + T 
Sbjct: 251 RPEDRPTFDYLRSVLEDFFTA 271

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV EYM  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 123
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 124 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTFTAHAGAKFPIKWT 177
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDYRMERPEGC 235
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 236 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V+E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 62  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 121
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---- 288
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     + +     
Sbjct: 122 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 178
Query: 289 ----LLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
                 +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 179 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 231
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 232 ASTHVYQIMNHCWRERPEDRPAFSRL 257

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAPAGAKFPIKWT 180
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 238
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 239 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWT 184
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 242
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 243 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V+E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI------- 285
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     +       
Sbjct: 117 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 286 -GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
             +   +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 226
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRL 252

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 128 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAPAGAKFPIKWT 181
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 239
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 240 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V+E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 118
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI------- 285
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     +       
Sbjct: 119 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 175
Query: 286 -GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
             +   +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 176 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 228
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 229 ASTHVYQIMNHCWKERPEDRPAFSRL 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V+E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 79  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 138
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI------- 285
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     +       
Sbjct: 139 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 195
Query: 286 -GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
             +   +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 196 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 248
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 249 ASTHVYQIMNHCWKERPEDRPAFSRL 274

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGIT-FLH 234
           I   N+VQLLG C       I+ E+M  G+L D+LR    Q  + ++    A  I+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------- 283
           +  + + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG           
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPE 182
Query: 284 TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           ++ Y   +   D+++F V+L E+        P         L++   D  +      P  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCPE- 239
Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            K+ +++  C   NP+ RP+   + +  E
Sbjct: 240 -KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-------ACGTARGITFLHH 235
            +V+L       E   I+ EYM KGSL D+L++     ++       +   A G+ ++  
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 128
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIG 286
           +   + IHRD+ A+N+L++E    K++DFGL R+I D E +T+ + A           I 
Sbjct: 129 K---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN 184
Query: 287 YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML-- 344
           +       D++SF ++L E+V   +   P      G    D  + + +   Y  P +   
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYP------GRTNAD--VMTALSQGYRMPRVENC 236
Query: 345 --KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY 383
             ++  I+  C  +    RPT   +Q  L+ ++T    G+Y
Sbjct: 237 PDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATE-GQY 276

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWT 180
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 238
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 239 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I +    T     G  G 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE----TDXXRKGGKGL 186
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 187 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 242
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML  L+++  C   NP  RP+ L +
Sbjct: 243 LLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEI 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGIT-FLH 234
           I   N+VQLLG C       I+ E+M  G+L D+LR    Q  + ++    A  I+  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------- 283
           +  + + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG           
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPE 182
Query: 284 TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           ++ Y   +   D+++F V+L E+        P         L++   D  +      P  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCPE- 239
Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            K+ +++  C   NP+ RP+   + +  E
Sbjct: 240 -KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 129
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 183
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 241
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 242 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 184
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 242
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 243 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ EYM  GSL D+L+  +       K   +A   A G+ F+  R   + IHR++ A+NI
Sbjct: 80  IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANI 136
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L+++    K++DFGL RLI D E +T+ + A           I Y       D++SF ++
Sbjct: 137 LVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 195
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L E+V   +   P   +      V   L+             ++ Q++  C  + P  RP
Sbjct: 196 LTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 251
Query: 363 TMLRVQEFLEKYHTG 377
           T   ++  LE + T 
Sbjct: 252 TFDYLRSVLEDFFTA 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 184
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 242
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 243 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGIT-FLH 234
           I   N+VQLLG C       I+ E+M  G+L D+LR    Q  + ++    A  I+  + 
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 138
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------- 283
           +  + + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG           
Sbjct: 139 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPE 195
Query: 284 TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           ++ Y   +   D+++F V+L E+        P         L++   D  +      P  
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCPE- 252
Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            K+ +++  C   NP+ RP+   + +  E
Sbjct: 253 -KVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGIT-FLH 234
           I   N+VQLLG C       I+ E+M  G+L D+LR    Q  + ++    A  I+  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------- 283
           +  + + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG           
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPE 184
Query: 284 TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           ++ Y   +   D+++F V+L E+        P         L++   D  +      P  
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCPE- 241
Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            K+ +++  C   NP+ RP+   + +  E
Sbjct: 242 -KVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 184
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 242
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 243 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 179
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 237
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 238 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-------ACGTARGITFLHH 235
            +V+L       E   I+ E+M KGSL D+L++     ++       +   A G+ ++  
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIG 286
           +   + IHRD+ A+N+L++E    K++DFGL R+I D E +T+ + A           I 
Sbjct: 128 K---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAIN 183
Query: 287 YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML-- 344
           +       +++SF ++L E+V   +   P      G    D  + S +   Y  P M   
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYP------GRTNAD--VMSALSQGYRMPRMENC 235
Query: 345 --KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY 383
             ++  I+  C  +    RPT   +Q  L+ ++T    G+Y
Sbjct: 236 PDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATE-GQY 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 179
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 237
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 238 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGIT-FLH 234
           I   N+VQLLG C       I+ E+M  G+L D+LR    Q  + ++    A  I+  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------- 283
           +  + + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG           
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPE 184
Query: 284 TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           ++ Y   +   D+++F V+L E+        P         L++   D  +      P  
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGCPE- 241
Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
            K+ +++  C   NP+ RP+   + +  E
Sbjct: 242 -KVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 179
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 237
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 238 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 184
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 242
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 243 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 179
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 237
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 238 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGITF-LHHRFQP 239
           NI+ L G     +  +IV EYM  GSL+ +L+ N  +  +I   G  RGI+  + +    
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I +  
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +V+ E+V         + ++    + +  +   +   Y  PS +     
Sbjct: 204 FTSASDVWSYGIVMWEVV--------SYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAA 255
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C      +RP    +   L+K
Sbjct: 256 LYQLMLDCWQKERNSRPKFDEIVNMLDK 283

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIA--CGTARGITF-LHHRFQP 239
           NI++L G     +  +I+ EYM  G+L+ +LR +     +    G  RGI   + +    
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
           + +HRD+ A NIL+N +   KVSDFGL R++ D    T T   G           I Y  
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 290 LACGGDIYSFSVVLLELV 307
                D++SF +V+ E++
Sbjct: 227 FTSASDVWSFGIVMWEVM 244

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 24/193 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ E+M KGSL D+L++         K    +   A G+ F+  R   + IHRD+ A+NI
Sbjct: 86  IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI 142
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TIGYILLACGGDIYSFSVV 302
           L++     K++DFGL R+I D E +T+ + A           I +       D++SF ++
Sbjct: 143 LVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 201
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L+E+V   +   P   +      V   L+        +    ++  I++ C  + P  RP
Sbjct: 202 LMEIVTYGRIPYPGMSNPE----VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERP 257
Query: 363 TMLRVQEFLEKYH 375
           T   +Q  L+ + 
Sbjct: 258 TFEYIQSVLDDFE 270

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 183 NIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH-----CII--ACGTARGITFL 233
           N+VQLLG   V EK    IV EYM KGSL D+LR++ +      C++  +      + +L
Sbjct: 66  NLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 124
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL---- 289
                 + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L    
Sbjct: 125 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAA 181
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS--KPSMLKML 347
            +   D++SF ++L E+    +   P    K   ++V  V     ++A     P++ +++
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMDAPDGCPPAVYEVM 238
Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           +    C   +   RP+ L+++E LE   T E
Sbjct: 239 K---NCWHLDAAMRPSFLQLREQLEHIKTHE 266

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 183 NIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH-----CII--ACGTARGITFL 233
           N+VQLLG   V EK    IV EYM KGSL D+LR++ +      C++  +      + +L
Sbjct: 60  NLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL---- 289
                 + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L    
Sbjct: 119 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 175
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS--KPSMLKML 347
            +   D++SF ++L E+    +   P    K   ++V  V     ++A     P++ +++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMDAPDGCPPAVYEVM 232
Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           +    C   +   RP+ L+++E LE   T E
Sbjct: 233 K---NCWHLDAAMRPSFLQLREQLEHIKTHE 260

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I +    T     G  G 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE----TDXXRKGGKGL 195
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 251
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 252 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 284

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITF 232
           ++   +VQL G C       +V E+M  G L+D+LR Q     A+  +  C     G+ +
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---- 288
           L    +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     + +     
Sbjct: 120 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 289 ----LLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
                 +   D++SF V++ E+    K P    +++++   +V+ +  ST    Y KP +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP----YENRSNSEVVEDI--STGFRLY-KPRL 229
Query: 344 LK--MLQIVVGCIFDNPTTRPTMLRV 367
               + QI+  C  + P  RP   R+
Sbjct: 230 ASTHVYQIMNHCWRERPEDRPAFSRL 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 183 NIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH-----CII--ACGTARGITFL 233
           N+VQLLG   V EK    IV EYM KGSL D+LR++ +      C++  +      + +L
Sbjct: 75  NLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL---- 289
                 + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L    
Sbjct: 134 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 190
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS--KPSMLKML 347
            +   D++SF ++L E+    +   P    K   ++V  V     ++A     P++ +++
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMDAPDGCPPAVYEVM 247
Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           +    C   +   RP+ L+++E LE   T E
Sbjct: 248 K---NCWHLDAAMRPSFLQLREQLEHIKTHE 275

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 201
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 257
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 258 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 201
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 257
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 258 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 290

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N  + EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 188
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 244
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML  L+++  C   NP  RP+ L +
Sbjct: 245 LLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEI 277

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 195
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 251
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 252 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 284

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV E M  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 140 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 192
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 193 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 248
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 249 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 194
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 250
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 251 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 188
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 244
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 245 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 277

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 171 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 223
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 224 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 279
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 280 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 312

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV E M  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 249
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 250 LYQLMLDCWQKDRNNRPKFEQIVSILDK 277

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 191
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 192 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 247
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 248 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 280

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 43/215 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTA 227
           ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +      G  G 
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGL 194
Query: 288 I-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDST 333
           +             +     D++SF VVL E+  + +QP    ++  +   ++ +V++  
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGG 250
Query: 334 ILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRV 367
           +L+     P ML   +++  C   NP  RP+ L +
Sbjct: 251 LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEI 283

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C +     IV EYM  G+L D+LR   +  +       +A   +  + 
Sbjct: 85  IKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAME 144
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHRD+ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 145 YLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 198
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P        +L    L+        +
Sbjct: 199 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDL----LEKGYRMEQPE 254
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
               K+ +++  C   +P  RP+     +  E
Sbjct: 255 GCPPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G     +  +IV E M  GSL+ +LR + A+  +I   G  RGI + + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I Y  
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML----K 345
                D++S+ +VL E++   +    E  +++    VD          Y  P  +     
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRLPPPMDCPAA 278
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C   +   RP   ++   L+K
Sbjct: 279 LYQLMLDCWQKDRNNRPKFEQIVSILDK 306

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH--CIIACGTARGITF-LHHRFQP 239
           N+V L G    G+  +IV E+M  G+L+ +LR        I   G  RGI   + +    
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFGL R+I D      T   G           I Y  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK---- 345
                D++S+ +V+ E++         + ++   ++ +  +   I   Y  P+ +     
Sbjct: 225 FTSASDVWSYGIVMWEVM--------SYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAG 276
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + Q+++ C       RP   ++   L+K
Sbjct: 277 LHQLMLDCWQKERAERPKFEQIVGILDK 304

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI+ L G     +  +I+ EYM  GSL+ +LR N  +  +I   G  RGI + + +    
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFG+ R++ D      T   G           I Y  
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 290 LACGGDIYSFSVVLLELV 307
                D++S+ +V+ E++
Sbjct: 211 FTSASDVWSYGIVMWEVM 228

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 371
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHR++ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 372 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 425
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 483
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 484 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGIT 231
           I   N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------- 283
           +L  +   + IHR++ A N L+ E+  VKV+DFGL RL++     T T  AG        
Sbjct: 333 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWT 386
Query: 284 ---TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK 340
              ++ Y   +   D+++F V+L E+        P         L++   D  +      
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KDYRMERPEGC 444
Query: 341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           P   K+ +++  C   NP+ RP+   + +  E
Sbjct: 445 PE--KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI+ L G     +  +I+ EYM  GSL+ +LR N  +  +I   G  RGI + + +    
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFG+ R++ D      T   G           I Y  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 290 LACGGDIYSFSVVLLELV 307
                D++S+ +V+ E++
Sbjct: 196 FTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI+ L G     +  +I+ EYM  GSL+ +LR N  +  +I   G  RGI + + +    
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGYIL 289
             +HRD+ A NIL+N +   KVSDFG+ R++ D      T   G           I Y  
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 290 LACGGDIYSFSVVLLELV 307
                D++S+ +V+ E++
Sbjct: 190 FTSASDVWSYGIVMWEVM 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 16/186 (8%)
Query: 199 IVYEYMVKGSLNDWLRNQA-------KHCIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I+ E+M KGSL D+L++         K    +   A G+ F+  R   + IHRD+ A+NI
Sbjct: 253 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI 309
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQ 311
           L++     K++DFGL R+ +      +   A   G   +    D++SF ++L+E+V   +
Sbjct: 310 LVSASLVCKIADFGLARVGAKFPIKWTAPEAINFGSFTIKS--DVWSFGILLMEIVTYGR 367
Query: 312 PTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
              P   +      V   L+        +    ++  I++ C  + P  RPT   +Q  L
Sbjct: 368 IPYPGMSNPE----VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423
Query: 372 EKYHTG 377
           + ++T 
Sbjct: 424 DDFYTA 429

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I +    T     
Sbjct: 136 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRK 188
Query: 283 GTIGYI-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDW 328
           G  G +             +     D++SF VVL E+  + +QP    ++  +   ++ +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKF 244
Query: 329 VLDSTILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           V+D   L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 245 VMDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 75  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 134
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-- 280
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I + + +      
Sbjct: 135 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 191
Query: 281 -------VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDS 332
                     ++   +     D++SF VVL E+  + +QP    ++  +   ++ +V+D 
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDG 247
Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 248 GYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 73  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 132
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I +    T     
Sbjct: 133 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRK 185
Query: 283 GTIGYI-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDW 328
           G  G +             +     D++SF VVL E+  + +QP    ++  +   ++ +
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKF 241
Query: 329 VLDSTILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           V+D   L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 242 VMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I +    T     
Sbjct: 136 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRK 188
Query: 283 GTIGYI-------------LLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDW 328
           G  G +             +     D++SF VVL E+  + +QP    ++  +   ++ +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKF 244
Query: 329 VLDSTILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           V+D   L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 245 VMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC---------------II 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+                     +
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-- 280
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I + + +      
Sbjct: 136 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 192
Query: 281 -------VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDS 332
                     ++   +     D++SF VVL E+  + +QP    ++  +   ++ +V+D 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDG 248
Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 249 GYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 178 GIAFKNIVQLLG-YCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGI 230
           G+   N++ L+G   P      ++  YM  G L  ++R+  ++  +          ARG+
Sbjct: 78  GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-------SHTSTDVAG 283
            +L  +     +HRD+ A N +L+E F VKV+DFGL R I D E        H    V  
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 284 T----IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NA 337
           T    +         D++SF V+L EL+ R     P ++  +  +L  ++     L    
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTR---GAPPYRHIDPFDLTHFLAQGRRLPQPE 251
Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPT 363
           Y   S+ +++Q    C   +P  RPT
Sbjct: 252 YCPDSLYQVMQ---QCWEADPAVRPT 274

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 15/140 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGITF-LHHRFQP 239
           N++ L G        +I+ E+M  GSL+ +LR N  +  +I   G  RGI   + +    
Sbjct: 95  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAG-----------TIGY 287
           + +HRD+ A NIL+N +   KVSDFGL R + D  S  T T   G            I Y
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 288 ILLACGGDIYSFSVVLLELV 307
                  D++S+ +V+ E++
Sbjct: 215 RKFTSASDVWSYGIVMWEVM 234

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC---------------II 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+                     +
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-- 280
           A   A G+ +L+ +     +HRD+ A N ++  DF VK+ DFG+ R I +   +      
Sbjct: 136 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKG 192
Query: 281 -------VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDS 332
                     ++   +     D++SF VVL E+  + +QP    ++  +   ++ +V+D 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDG 248
Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 249 GYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 199 IVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           I+ EY+  GS  D L     ++ +   I     +G+ +LH   +   IHRDI A+N+LL+
Sbjct: 82  IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLS 138
Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVVLLELV 307
           E  EVK++DFG+   ++D +   +T V          I         DI+S  +  +EL 
Sbjct: 139 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 198
Query: 308 IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            R +P   E        L+      T+   YSKP    + + V  C+   P+ RPT
Sbjct: 199 -RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPT 249

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 199 IVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           I+ EY+  GS  D L     ++ +   I     +G+ +LH   +   IHRDI A+N+LL+
Sbjct: 102 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLS 158
Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVVLLELV 307
           E  EVK++DFG+   ++D +   +T V          I         DI+S  +  +EL 
Sbjct: 159 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 218
Query: 308 IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            R +P   E        L+      T+   YSKP    + + V  C+   P+ RPT
Sbjct: 219 -RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPT 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 76  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 135
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-- 280
           A   A G+ +L+ +     +HR++ A N ++  DF VK+ DFG+ R I + + +      
Sbjct: 136 AAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 192
Query: 281 -------VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDS 332
                     ++   +     D++SF VVL E+  + +QP    ++  +   ++ +V+D 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDG 248
Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 249 GYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN---QAKH------------CII 222
           G    ++V+LLG    G+  L+V E M  G L  +LR+   +A++              +
Sbjct: 77  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 136
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-- 280
           A   A G+ +L+ +     +HR++ A N ++  DF VK+ DFG+ R I + + +      
Sbjct: 137 AAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 193
Query: 281 -------VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDS 332
                     ++   +     D++SF VVL E+  + +QP    ++  +   ++ +V+D 
Sbjct: 194 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----YQGLSNEQVLKFVMDG 249
Query: 333 TILNAYSK-PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
             L+     P   ++  ++  C   NP  RPT L +   L+
Sbjct: 250 GYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------------------NQAKHC 220
           +  ++IV+  G C  G+  ++V+EYM  G LN +LR                   Q++  
Sbjct: 72  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 221 IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-----S 275
            IA   A G+ +L  +   H +HRD+   N L+ E+  VK+ DFG+ R +   +      
Sbjct: 132 HIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 276 HTSTDV----AGTIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVL 330
           HT   +      +I Y       D++S  VVL E+    KQP    +   +   +++ + 
Sbjct: 189 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP----WYQLSNNEVIECIT 244
Query: 331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
              +L    +    ++ ++++GC    P  R  +  +   L+
Sbjct: 245 QGRVLQR-PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TARG+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 113 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ 169
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
           ++G+I ++             +   D+Y+F +VL EL+  + P        N   +++ V
Sbjct: 170 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMV 226
Query: 330 LDSTILNAYSKPSM---LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              ++    SK       +M +++  C+      RP+  R+   +E+
Sbjct: 227 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 273

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 136 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV 192
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 246
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 247 SEKVYTIMYSCWHEKADERPT 267

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 120 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 230
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 231 SEKVYTIMYSCWHEKADERPT 251

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 121 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 177
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 231
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 232 SEKVYTIMYSCWHEKADERPT 252

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 199 IVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           I+ EY+  GS  D L     ++ +   I     +G+ +LH   +   IHRDI A+N+LL+
Sbjct: 82  IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLS 138
Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVVLLELV 307
           E  EVK++DFG+   ++D +   +  V          I         DI+S  +  +EL 
Sbjct: 139 EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 198
Query: 308 IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            R +P   E        L+      T+   YSKP    + + V  C+   P+ RPT
Sbjct: 199 -RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPT 249

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 199 IVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           I+ EY+  GS  D L     ++ +   I     +G+ +LH   +   IHRDI A+N+LL+
Sbjct: 97  IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLS 153
Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVVLLELV 307
           E  EVK++DFG+   ++D +   +  V          I         DI+S  +  +EL 
Sbjct: 154 EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213
Query: 308 IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
            R +P   E        L+      T+   YSKP    + + V  C+   P+ RPT
Sbjct: 214 -RGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP----LKEFVEACLNKEPSFRPT 264

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 27/152 (17%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII----ACGTARGITFLHHRFQ 238
           NI+ L G C       +V E+   G LN  L  +     I    A   ARG+ +LH    
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 239 PHIIHRDINASNILLNEDFE--------VKVSDFGLVRLISDCESHTSTDVAGTIGYILL 290
             IIHRD+ +SNIL+ +  E        +K++DFGL R     E H +T ++    Y  +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWM 181
Query: 291 AC----------GGDIYSFSVVLLELVIRKQP 312
           A           G D++S+ V+L EL+  + P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 116 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 226
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 227 SEKVYTIMYSCWHEKADERPT 247

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 127 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 183
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 237
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 238 SEKVYTIMYSCWHEKADERPT 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 121 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV 177
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 231
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 232 SEKVYTIMYSCWHEKADERPT 252

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 25/201 (12%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIAC-GTARGITF 232
           ++ + +VQL G C       I+ EYM  G L ++LR      Q +  +  C      + +
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST--------DVAGT 284
           L  +     +HRD+ A N L+N+   VKVSDFGL R + D E  +S              
Sbjct: 136 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192
Query: 285 IGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML 344
           + Y   +   DI++F V++ E+    +     F +      +     +  L  Y +P + 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY-RPHLA 246
Query: 345 --KMLQIVVGCIFDNPTTRPT 363
             K+  I+  C  +    RPT
Sbjct: 247 SEKVYTIMYSCWHEKADERPT 267

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGITF-LHHRFQP 239
           N++ L G        +I+ E+M  GSL+ +LR N  +  +I   G  RGI   + +    
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAG-----------TIGY 287
           + +HR + A NIL+N +   KVSDFGL R + D  S  T T   G            I Y
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 288 ILLACGGDIYSFSVVLLELV 307
                  D++S+ +V+ E++
Sbjct: 189 RKFTSASDVWSYGIVMWEVM 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TARG+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    
Sbjct: 125 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
           ++G+I ++             +   D+Y+F +VL EL+  + P        N   +++ V
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMV 238
Query: 330 LDSTILNAYSKPSM---LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              ++    SK       +M +++  C+      RP+  R+   +E+
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TARG+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    
Sbjct: 125 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
           ++G+I ++             +   D+Y+F +VL EL+  + P        N   +++ V
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMV 238
Query: 330 LDSTILNAYSKPSM---LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              ++    SK       +M +++  C+      RP+  R+   +E+
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------------IACGT 226
           +NIV LLG C  G   L++ EY   G L ++LR +A+  +                +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I +  ++     A    
Sbjct: 170 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 +I   +     D++S+ ++L E+        P       G LV+      + + 
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFYKLVKDG 279
Query: 338 Y--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 280 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 319

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 114 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------------IACGT 226
           +NIV LLG C  G   L++ EY   G L ++LR +A+  +                +   
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I +  ++     A    
Sbjct: 162 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 +I   +     D++S+ ++L E+        P       G LV+      + + 
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFYKLVKDG 271
Query: 338 Y--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 272 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 311

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 111 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 167
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 168 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 136 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 137 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    
Sbjct: 114 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 171 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 55/231 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA----KHC---------------II 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +     ++C               ++
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLELVI------RKQPTGPEFKDKNGGN 324
             G +    +A             D++SF V+L E+           P    FK    G+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 325 LVDWVLDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +D            KPS    ++  ++  C    P+ RPT  ++ E L++
Sbjct: 270 RMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 55/231 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA----KHC---------------II 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +     ++C               ++
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 194
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLELVI------RKQPTGPEFKDKNGGN 324
             G +    +A             D++SF V+L E+           P    FK    G+
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254
Query: 325 LVDWVLDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +D            KPS    ++  ++  C    P+ RPT  ++ E L++
Sbjct: 255 RMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 100 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 157
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 158 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 214
Query: 306 LVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM- 364
           + + + P G          L+D++++       S    L+    V  C+  NP  R  + 
Sbjct: 215 MAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 274
Query: 365 -LRVQEFLEKYHTGE 378
            L V  F+++    E
Sbjct: 275 QLMVHAFIKRSDAEE 289

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 15/140 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G        +I+ E+M  G+L+ +LR N  +  +I   G  RGI + + +  + 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAG-----------TIGY 287
             +HRD+ A NIL+N +   KVSDFGL R + +  S  T T   G            I +
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 288 ILLACGGDIYSFSVVLLELV 307
                  D +S+ +V+ E++
Sbjct: 198 RKFTSASDAWSYGIVMWEVM 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 182 KNIVQLLGYCP-VGEKKL-IVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHH 235
           ++I++  G C   GEK L +V EY+  GSL D+L       A+  + A     G+ +LH 
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLAC- 292
           +   H IHR++ A N+LL+ D  VK+ DFGL + + +   +     D    + +    C 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 293 -------GGDIYSFSVVLLELV 307
                    D++SF V L EL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 51/228 (22%)
Query: 183 NIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIAC-GTARGITF 232
           NIV+L G C  PV     +V EY   GSL + L          A H +  C   ++G+ +
Sbjct: 62  NIVKLYGACLNPV----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTIGYIL-- 289
           LH      +IHRD+   N+LL     V K+ DFG      D ++H  T+  G+  ++   
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHM-TNNKGSAAWMAPE 173
Query: 290 ------LACGGDIYSFSVVLLELVIRKQP----TGPEFKDKNGGNLVDWVLDSTILNAYS 339
                  +   D++S+ ++L E++ R++P     GP F+       + W + +      +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-------IMWAVHNG-----T 221
Query: 340 KPSMLKML-----QIVVGCIFDNPTTRPTM---LRVQEFLEKYHTGEN 379
           +P ++K L      ++  C   +P+ RP+M   +++   L +Y  G +
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 182 KNIVQLLGYCP-VGEKKL-IVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHH 235
           ++I++  G C   GEK L +V EY+  GSL D+L       A+  + A     G+ +LH 
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLAC- 292
           +   H IHR++ A N+LL+ D  VK+ DFGL + + +   +     D    + +    C 
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 293 -------GGDIYSFSVVLLELV 307
                    D++SF V L EL+
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 51/228 (22%)
Query: 183 NIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIAC-GTARGITF 232
           NIV+L G C  PV     +V EY   GSL + L          A H +  C   ++G+ +
Sbjct: 63  NIVKLYGACLNPV----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTIGYIL-- 289
           LH      +IHRD+   N+LL     V K+ DFG      D ++H  T+  G+  ++   
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHM-TNNKGSAAWMAPE 174
Query: 290 ------LACGGDIYSFSVVLLELVIRKQP----TGPEFKDKNGGNLVDWVLDSTILNAYS 339
                  +   D++S+ ++L E++ R++P     GP F+       + W + +      +
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-------IMWAVHNG-----T 222
Query: 340 KPSMLKML-----QIVVGCIFDNPTTRPTM---LRVQEFLEKYHTGEN 379
           +P ++K L      ++  C   +P+ RP+M   +++   L +Y  G +
Sbjct: 223 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 270

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------HCIIACGTARGITFLHH 235
           +NIV LLG C  G   L++ EY   G L ++LR +++         IA  TA     LH 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 236 RFQ----------PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--- 282
             Q           + IHRD+ A N+LL      K+ DFGL R I +  ++     A   
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 283 ------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN 336
                  +I   +     D++S+ ++L E+        P       G LV+      + +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFYKLVKD 282
Query: 337 AY--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-NQAKHCIIA-CGTARGI-TFLHHRFQP 239
           NI++L G        +I+ E+M  G+L+ +LR N  +  +I   G  RGI + + +  + 
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEM 135
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES---HTST---------DVAGTIGY 287
             +HRD+ A NIL+N +   KVSDFGL R + +  S   +TS+              I +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
                  D +S+ +V+ E++
Sbjct: 196 RKFTSASDAWSYGIVMWEVM 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA----------------KHCII-AC 224
           N+V LLG C   G   +++ E+   G+L+ +LR++                 +H I  + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA-- 282
             A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A  
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 283 -------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL 335
                   TI   +     D++SF V+L E+        P  K          + + T +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFXRRLKEGTRM 266
Query: 336 NA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 267 RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    
Sbjct: 109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK---------HCIIACGTARG 229
           ++   +V+  G C       IV EY+  G L ++LR+  K          C   C    G
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC---EG 116
Query: 230 ITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST--------D 280
           + FL  H+F    IHRD+ A N L++ D  VKVSDFG+ R + D +  +S          
Sbjct: 117 MAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 281 VAGTIGYILLACGGDIYSFSVVLLELV-IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS 339
                 Y   +   D+++F +++ E+  + K P      D    + V  VL  +  +   
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY-----DLYTNSEV--VLKVSQGHRLY 225
Query: 340 KPSMLK--MLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           +P +    + QI+  C  + P  RPT  ++   +E
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 250
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 25/145 (17%)
Query: 182 KNIVQLLGYCP-VGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITF 232
           ++IV+  G C   GEK + +V EY+  GSL D+L    +HC+        A     G+ +
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAY 126
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILL 290
           LH +   H IHR + A N+LL+ D  VK+ DFGL + + +   +     D    + +   
Sbjct: 127 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 291 AC--------GGDIYSFSVVLLELV 307
            C          D++SF V L EL+
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 25/145 (17%)
Query: 182 KNIVQLLGYCP-VGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITF 232
           ++IV+  G C   GEK + +V EY+  GSL D+L    +HC+        A     G+ +
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAY 127
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILL 290
           LH +   H IHR + A N+LL+ D  VK+ DFGL + + +   +     D    + +   
Sbjct: 128 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 291 AC--------GGDIYSFSVVLLELV 307
            C          D++SF V L EL+
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELL 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 42/197 (21%)
Query: 155 TYDQIVAGTNKFYEKNVIRGDDF--------GIAFKNIVQLLGYCPVGEKKLIVYEYMVK 206
           T D+++       +  +    DF         +  ++IV+  G C  G+  ++V+EYM  
Sbjct: 42  TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 101
Query: 207 GSLNDWLR--------------NQAKHCI-------IACGTARGITFLHHRFQPHIIHRD 245
           G LN +LR               QAK  +       IA   A G+ +L  +   H +HRD
Sbjct: 102 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRD 158
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCE-----SHTSTDV----AGTIGYILLACGGDI 296
           +   N L+  +  VK+ DFG+ R +   +      HT   +      +I Y       D+
Sbjct: 159 LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 218
Query: 297 YSFSVVLLELVIR-KQP 312
           +SF V+L E+    KQP
Sbjct: 219 WSFGVILWEIFTYGKQP 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    
Sbjct: 129 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 55/231 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLELVI------RKQPTGPEFKDKNGGN 324
             G +    +A             D++SF V+L E+           P    FK    G+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 325 LVDWVLDSTILNAYSKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +D            KPS    ++  ++  C    P+ RPT  ++ E L++
Sbjct: 270 RMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 209
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 143 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 198
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 146 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 201
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 15/103 (14%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTD 280
           IA  TA+G+ +LH +    IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    
Sbjct: 137 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 281 VAGTIGYIL-----------LACGGDIYSFSVVLLELVIRKQP 312
           ++G+I ++             +   D+Y+F +VL EL+  + P
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 147 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 202
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCII 222
           KNI+ LLG C       ++ EY  KG+L ++L+ +                   +   ++
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I   +    T 
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT- 209
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V+L E+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA----------------KHCII-AC 224
           N+V LLG C   G   +++ E+   G+L+ +LR++                 +H I  + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA-- 282
             A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A  
Sbjct: 152 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 283 -------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL 335
                   TI   +     D++SF V+L E+        P  K          + + T +
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRM 266
Query: 336 NA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 267 RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 138
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 306 LVIRKQPTGPEFKDKNGG------NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPT 359
           + + + P  P    ++         L+D++++       S    L+    V  C+  NP 
Sbjct: 196 MAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 255
Query: 360 TRPTM--LRVQEFLEKYHTGE 378
            R  +  L V  F+++    E
Sbjct: 256 ERADLKQLMVHAFIKRSDAEE 276

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 28/197 (14%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 84  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 141
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D     + +  GT  Y+          +   DI+S  + L+E
Sbjct: 142 NSRGEIKLCDFGVSGQLID---EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 198
Query: 306 LVIRKQPTGPE--FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
           + + + P  P   F+      L+D++++       S    L+    V  C+  NP  R  
Sbjct: 199 MAVGRYPRPPMAIFE------LLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERAD 252
Query: 364 M--LRVQEFLEKYHTGE 378
           +  L V  F+++    E
Sbjct: 253 LKQLMVHAFIKRSDAEE 269

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG C +G   L++ EY   G L ++LR +    I +  +                
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 227 -------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
                  A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++   
Sbjct: 171 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 280 DVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
             A          +I   +     D++S+ + L EL        P       G  VD   
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 280
Query: 331 DSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              I   +     + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA------------------KHCII- 222
           N+V LLG C   G   +++ E+   G+L+ +LR++                   +H I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDV 281
           +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     D 
Sbjct: 154 SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 282 AGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST 333
              + ++        +     D++SF V+L E+        P  K          + + T
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGT 268
Query: 334 ILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 269 RMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG C +G   L++ EY   G L ++LR +    I +  +                
Sbjct: 106 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 165
Query: 227 -------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
                  A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++   
Sbjct: 166 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 280 DVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
             A          +I   +     D++S+ + L EL        P       G  VD   
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 275
Query: 331 DSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              I   +     + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG C +G   L++ EY   G L ++LR +    I +  +                
Sbjct: 111 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 170
Query: 227 -------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
                  A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++   
Sbjct: 171 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 280 DVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
             A          +I   +     D++S+ + L EL        P       G  VD   
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 280
Query: 331 DSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              I   +     + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG C +G   L++ EY   G L ++LR +    I +  +                
Sbjct: 104 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 163
Query: 227 -------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
                  A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++   
Sbjct: 164 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 280 DVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
             A          +I   +     D++S+ + L EL        P       G  VD   
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 273
Query: 331 DSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              I   +     + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------HCIIACGT--------- 226
           +NIV LLG C  G   L++ EY   G L ++LR +++         IA  T         
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 227 ----ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
               A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I +  ++     A
Sbjct: 170 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 283 ---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST 333
                     +I   +     D++S+ ++L E+        P       G LV+      
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFYKL 279
Query: 334 ILNAY--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           + + Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT---------------- 226
           NIV LLG C +G   L++ EY   G L ++LR +    I +  +                
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 227 -------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
                  A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++   
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 280 DVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
             A          +I   +     D++S+ + L EL        P       G  VD   
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPVDSKF 257
Query: 331 DSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              I   +     + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 19/142 (13%)
Query: 182 KNIVQLLGYCP-VGEKKL-IVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHH 235
           ++I++  G C   G   L +V EY+  GSL D+L       A+  + A     G+ +LH 
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLAC- 292
           +   H IHRD+ A N+LL+ D  VK+ DFGL + + +         D    + +    C 
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 293 -------GGDIYSFSVVLLELV 307
                    D++SF V L EL+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 148 SCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT- 203
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 39/164 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------------------I 221
           ++IV+  G C  G   L+V+EYM  G LN +LR+                          
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +A   A G+ +L      H +HRD+   N L+ +   VK+ DFG+ R   D  S     V
Sbjct: 163 VASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRV 216
Query: 282 AG------------TIGYILLACGGDIYSFSVVLLEL-VIRKQP 312
            G            +I Y       D++SF VVL E+    KQP
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + + +T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 39/164 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------------------I 221
           ++IV+  G C  G   L+V+EYM  G LN +LR+                          
Sbjct: 80  QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +A   A G+ +L      H +HRD+   N L+ +   VK+ DFG+ R   D  S     V
Sbjct: 140 VASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRV 193
Query: 282 AG------------TIGYILLACGGDIYSFSVVLLELVIR-KQP 312
            G            +I Y       D++SF VVL E+    KQP
Sbjct: 194 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 39/164 (23%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------------------I 221
           ++IV+  G C  G   L+V+EYM  G LN +LR+                          
Sbjct: 74  QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +A   A G+ +L      H +HRD+   N L+ +   VK+ DFG+ R   D  S     V
Sbjct: 134 VASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRV 187
Query: 282 AG------------TIGYILLACGGDIYSFSVVLLELVIR-KQP 312
            G            +I Y       D++SF VVL E+    KQP
Sbjct: 188 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 262
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA-------------------KHCII 222
           N+V LLG C   G   +++ E+   G+L+ +LR++                    +H I 
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 223 -ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTD 280
            +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     D
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 281 VAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS 332
               + ++        +     D++SF V+L E+        P  K          + + 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEG 267
Query: 333 TILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
           T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 268 TRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTST 279
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 280 DVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           D    + ++        +     D++SF V+L E+        P  K          + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 257
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 258 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 153 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 208
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 150 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 205
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 154 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          TI   +     D++SF V+L E+        P  K          + +
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 268
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 269 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTST 279
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 280 DVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           D    + ++        +     D++SF V+L E+        P  K          + +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 266
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 267 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 189 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          TI   +     D++SF V+L E+        P  K          + +
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 303
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 304 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTST 279
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 280 DVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           D    + ++        +     D++SF V+L E+        P  K          + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 257
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 258 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ +    T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTST 279
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I  D +     
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 280 DVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           D    + ++        +     D++SF V+L E+        P  K          + +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 266
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 267 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          TI   +     D++SF V+L E+        P  K          + +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 266
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 267 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ +    T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          TI   +     D++SF V+L E+        P  K          + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 257
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 258 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQA--------------------KHCI 221
           N+V LLG C   G   +++ E+   G+L+ +LR++                     +H I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 222 I-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 143 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          TI   +     D++SF V+L E+        P  K          + +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE 257
Query: 332 STILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
            T + A  Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 258 GTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 36/206 (17%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE 258
           I+   + KG     + +++    I      G+ +LH   Q   IHRD+ A NILL ED  
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 259 VKVSDFGLVRLISDCESHTSTDVAGTI----------------GYILLACGGDIYSFSVV 302
           V+++DFG+   ++     T   V  T                 GY   A   DI+SF + 
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA---DIWSFGIT 216
Query: 303 LLELVIRKQP--TGPEFK------DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCI 354
            +EL     P    P  K        +  +L   V D  +L  Y K S  KM+ +   C+
Sbjct: 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK-SFRKMISL---CL 272
Query: 355 FDNPTTRPTMLRV--QEFLEKYHTGE 378
             +P  RPT   +   +F +K    E
Sbjct: 273 QKDPEKRPTAAELLRHKFFQKAKNKE 298

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  ST V GT  ++        A 
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++ EY  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  ++++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 29/187 (15%)
Query: 199 IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           IV EY   GS++D +R + K         I   T +G+ +LH   +   IHRDI A NIL
Sbjct: 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNIL 157
Query: 253 LNEDFEVKVSDFGLVRLISDCESHT----------STDVAGTIGYILLACGGDIYSFSVV 302
           LN +   K++DFG+   ++D  +            + +V   IGY    C  DI+S  + 
Sbjct: 158 LNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY---NCVADIWSLGIT 214
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK--MLQIVVGCIFDNPTT 360
            +E+   K    P + D +    + +++ +     + KP +        V  C+  +P  
Sbjct: 215 AIEMAEGK----PPYADIHPMRAI-FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQ 269
Query: 361 RPTMLRV 367
           R T  ++
Sbjct: 270 RATATQL 276

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 51/233 (21%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           +NIV LLG C  G   L++ EY   G L ++LR +A+  +                    
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 222 --------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
                    +   A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I + 
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 274 ESHTSTDVA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN 324
            ++     A          +I   +     D++S+ ++L E+        P       G 
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GI 264
Query: 325 LVDWVLDSTILNAY--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           LV+      + + Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 265 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 317

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQP 239
           I +  G      K  I+ EY+  GS  D L+     +     I     +G+ +LH   + 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK- 137
Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLAC 292
             IHRDI A+N+LL+E  +VK++DFG+   ++D +   +  V          I       
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 293 GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVG 352
             DI+S  +  +EL  + +P   +        L+      T+   +SKP      + V  
Sbjct: 196 KADIWSLGITAIELA-KGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKP----FKEFVEA 250
Query: 353 CIFDNPTTRPTM--LRVQEFLEKYHTGENF 380
           C+  +P  RPT   L   +F+ +Y    +F
Sbjct: 251 CLNKDPRFRPTAKELLKHKFITRYTKKTSF 280

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 36/201 (17%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE 258
           I+   + KG     + +++    I      G+ +LH   Q   IHRD+ A NILL ED  
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 259 VKVSDFGLVRLISDCESHTSTDVAGTI----------------GYILLACGGDIYSFSVV 302
           V+++DFG+   ++     T   V  T                 GY   A   DI+SF + 
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA---DIWSFGIT 211
Query: 303 LLELVIRKQP--TGPEFK------DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCI 354
            +EL     P    P  K        +  +L   V D  +L  Y K S  KM+ +   C+
Sbjct: 212 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK-SFRKMISL---CL 267
Query: 355 FDNPTTRPTMLRV--QEFLEK 373
             +P  RPT   +   +F +K
Sbjct: 268 QKDPEKRPTAAELLRHKFFQK 288

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 19/181 (10%)
Query: 194 GEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINAS 249
           G K  I+ EY+  GS  D LR    ++ +   +     +G+ +LH   +   IHRDI A+
Sbjct: 93  GSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAA 149
Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-------TIGYILLACGGDIYSFSVV 302
           N+LL+E  +VK++DFG+   ++D +   +T V          I         DI+S  + 
Sbjct: 150 NVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 209
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
            +EL  + +P   +        L+      T++  ++K       + +  C+  +P+ RP
Sbjct: 210 AIELA-KGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTK----SFKEFIDACLNKDPSFRP 264
Query: 363 T 363
           T
Sbjct: 265 T 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHR 236
           N+++ +G     ++   + EY+  G+L   +++       ++    A   A G+ +LH  
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS--------------TDVA 282
              +IIHRD+N+ N L+ E+  V V+DFGL RL+ D ++                 T V 
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 283 GTIGYILLACGG-------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD-STI 334
                      G       D++SF +VL E++ R     P++  +     +D+ L+    
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN-ADPDYLPRT----MDFGLNVRGF 239
Query: 335 LNAYSKPSM-LKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           L+ Y  P+       I V C   +P  RP+ ++++ +LE
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+  A+   H  +   T++    + +  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 46/219 (21%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCI----IACGTARGITFLH-----HRFQPHIIHRDINAS 249
           ++  Y   GSL D+L+      +    I    A G+  LH      + +P I HRD+ + 
Sbjct: 83  LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDVA-----GTIGY---------ILLACGG- 294
           NIL+ ++ +  ++D GL  + S  +S    DV      GT  Y         I + C   
Sbjct: 143 NILVKKNGQCCIADLGLAVMHS--QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 295 ----DIYSFSVVLLELVIRKQ----------------PTGPEFKDKNGGNLVDWVLDSTI 334
               DI++F +VL E+  R                  P  P F+D      VD    +  
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              +S P++  + +++  C + NP+ R T LR+++ L K
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 46/219 (21%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCI----IACGTARGITFLH-----HRFQPHIIHRDINAS 249
           ++  Y   GSL D+L+      +    I    A G+  LH      + +P I HRD+ + 
Sbjct: 83  LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDVA-----GTIGY---------ILLACGG- 294
           NIL+ ++ +  ++D GL  + S  +S    DV      GT  Y         I + C   
Sbjct: 143 NILVKKNGQCCIADLGLAVMHS--QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 295 ----DIYSFSVVLLELVIRKQ----------------PTGPEFKDKNGGNLVDWVLDSTI 334
               DI++F +VL E+  R                  P  P F+D      VD    +  
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260
Query: 335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              +S P++  + +++  C + NP+ R T LR+++ L K
Sbjct: 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 71/142 (50%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  S ++ GT  ++        A 
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-EMVGTPYWMAPEVVTRKAY 193
Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           +NIV LLG C  G   L++ EY   G L ++LR +    +                    
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             +   A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I +  ++    
Sbjct: 170 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 281 VA---------GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
            A          +I   +     D++S+ ++L E+        P       G LV+    
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP-------GILVNSKFY 279
Query: 332 STILNAY--SKPSML--KMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             + + Y  ++P+     +  I+  C    PT RPT  ++  FL++
Sbjct: 280 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 46/219 (21%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCI----IACGTARGITFLH-----HRFQPHIIHRDINAS 249
           ++  Y   GSL D+L+      +    I    A G+  LH      + +P I HRD+ + 
Sbjct: 112 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 171
Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHTSTDVA-----GTIGY---------ILLACGG- 294
           NIL+ ++ +  ++D GL  + S  +S    DV      GT  Y         I + C   
Sbjct: 172 NILVKKNGQCCIADLGLAVMHS--QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 229
Query: 295 ----DIYSFSVVLLELVIRKQ----------------PTGPEFKDKNGGNLVDWVLDSTI 334
               DI++F +VL E+  R                  P  P F+D      VD    +  
Sbjct: 230 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 289
Query: 335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              +S P++  + +++  C + NP+ R T LR+++ L K
Sbjct: 290 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 328

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 27/147 (18%)
Query: 182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWL---------RNQAKHCIIACGTARGI 230
           +NIV+  G C    G    ++ E++  GSL ++L         + Q K+ +  C   +G+
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC---KGM 139
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHT-STDVAGTIGYI 288
            +L  R     +HRD+ A N+L+  + +VK+ DFGL + I +D E  T   D    + + 
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 196
Query: 289 LLAC--------GGDIYSFSVVLLELV 307
              C          D++SF V L EL+
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++  Y  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 27/147 (18%)
Query: 182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWL---------RNQAKHCIIACGTARGI 230
           +NIV+  G C    G    ++ E++  GSL ++L         + Q K+ +  C   +G+
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC---KGM 127
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHT-STDVAGTIGYI 288
            +L  R     +HRD+ A N+L+  + +VK+ DFGL + I +D E  T   D    + + 
Sbjct: 128 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 289 LLAC--------GGDIYSFSVVLLELV 307
              C          D++SF V L EL+
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           N+V +     VG++  +V E++  G+L D +     N+ +   +     R +++LH++  
Sbjct: 103 NVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ-- 160
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYILL 290
             +IHRDI + +ILL  D  +K+SDFG    +S  E      + GT        I  +  
Sbjct: 161 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKXLVGTPYWMAPEVISRLPY 218
Query: 291 ACGGDIYSFSVVLLELVIRKQP 312
               DI+S  ++++E++  + P
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 71/142 (50%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHR+I + NILL  D  VK++DFG    I+  +S  ST V GT  ++        A 
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAY 194
Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 106/251 (42%), Gaps = 41/251 (16%)
Query: 152 GKLTYDQIVAGTNKFYEKNVIRGDDFG--------IAFKNIVQLLGYC--PVGEKKLIVY 201
           G+   + IV    K  + +  +  DF          +  N++ +LG C  P      ++ 
Sbjct: 29  GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88
Query: 202 EYMVKGSL-------NDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
            +M  GSL        +++ +Q++    A   ARG+ FLH   +P I    +N+ +++++
Sbjct: 89  HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMID 147
Query: 255 EDFEVKVSDFGLVRLISDCE-SHTSTDVAGTIGYILLAC-----------GGDIYSFSVV 302
           ED   ++S       ++D + S  S        ++                 D++SF+V+
Sbjct: 148 EDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 303 LLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRP 362
           L ELV R+ P       + G  +    L  TI    S P + K+++I   C+ ++P  RP
Sbjct: 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS-PHVSKLMKI---CMNEDPAKRP 256
Query: 363 TMLRVQEFLEK 373
               +   LEK
Sbjct: 257 KFDMIVPILEK 267

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 19/105 (18%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           IA  TA+G+ +LH +   +IIHRD+ ++NI L+E   VK+ DFGL  + S      S  V
Sbjct: 137 IARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG--SQQV 191
Query: 282 AGTIGYIL--------------LACGGDIYSFSVVLLELVIRKQP 312
               G +L               +   D+YS+ +VL EL+  + P
Sbjct: 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  S  V GT  ++        A 
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAY 193
Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 242

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           NIV  L    VG++  +V EY+  GSL D +     ++ +   +     + + FLH    
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------LAC 292
             +IHRDI + NILL  D  VK++DFG    I+  +S  S  V GT  ++        A 
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAY 194
Query: 293 GG--DIYSFSVVLLELVIRKQP 312
           G   DI+S  ++ +E++  + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------------HCII 222
           KNI+ LLG C       ++  Y  KG+L ++LR +                       ++
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 223 ACG--TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
           +C    ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT- 216
Query: 281 VAGTIGYILLACGG----------DIYSFSVVLLEL 306
             G +    +A             D++SF V++ E+
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 237

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 244

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 42/217 (19%)
Query: 199 IVYEYMVKGSLNDWLRNQA--KHCII--ACGTARGITFLH-----HRFQPHIIHRDINAS 249
           ++  Y   GSL D+L+ Q    H  +  A   A G+  LH      + +P I HRD  + 
Sbjct: 83  LITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSR 142
Query: 250 NILLNEDFEVKVSDFGLVRLISDCESHT---STDVAGTIGY---------ILLAC----- 292
           N+L+  + +  ++D GL  + S    +    +    GT  Y         I   C     
Sbjct: 143 NVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYK 202
Query: 293 GGDIYSFSVVLLELVIRK----------------QPTGPEFKDKNGGNLVDWVLDSTILN 336
             DI++F +VL E+  R                  P  P F+D      VD    +    
Sbjct: 203 WTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNR 262
Query: 337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             + P +  + Q++  C + NP+ R T LR+++ L+K
Sbjct: 263 LAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQK 299

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 256

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 236

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLVDWVLDSTILNAY- 338
              +   D++SF VVL EL   I K  + P EF      DK G  +V  +++    N   
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 269
Query: 339 SKPSML--KMLQIVVGCIFDNPTTRPT 363
            +P     ++  I+  C  +N   RP+
Sbjct: 270 PRPDGCPDEIYMIMTECWNNNVNQRPS 296

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 245

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 20/131 (15%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRFQPHIIHRDINASNIL 252
           I  E+M  GSL+  L+ +AK         ++    RG+ +L  + Q  I+HRD+  SNIL
Sbjct: 91  ICMEHMDGGSLDQVLK-EAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNIL 147
Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLL 304
           +N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+
Sbjct: 148 VNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLV 204
Query: 305 ELVIRKQPTGP 315
           EL + + P  P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITF-----L 233
           ++ +NIV ++      +   +V EY+   +L++++ +   H  ++  TA   T      +
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGI 124
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--LA 291
            H     I+HRDI   NIL++ +  +K+ DFG+ + +S+     +  V GT+ Y     A
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 292 CG------GDIYSFSVVLLELVIRKQP 312
            G       DIYS  +VL E+++ + P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRFQ 238
           N+V++     VGE+  ++ E++  G+L D +     N+ +   +     + + +LH +  
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYILL 290
             +IHRDI + +ILL  D  VK+SDFG    IS  +      + GT        I   L 
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKXLVGTPYWMAPEVISRSLY 218
Query: 291 ACGGDIYSFSVVLLELVIRKQP 312
           A   DI+S  ++++E+V  + P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 30/152 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------------NQAKHCI------- 221
           NI+ LLG C       +  EY   G+L D+LR              N     +       
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
            A   ARG+ +L    Q   IHRD+ A NIL+ E++  K++DFGL R        T   +
Sbjct: 147 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 282 A------GTIGYILLACGGDIYSFSVVLLELV 307
                   ++ Y +     D++S+ V+L E+V
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 30/152 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------------NQAKHCI------- 221
           NI+ LLG C       +  EY   G+L D+LR              N     +       
Sbjct: 77  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
            A   ARG+ +L    Q   IHRD+ A NIL+ E++  K++DFGL R        T   +
Sbjct: 137 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 282 A------GTIGYILLACGGDIYSFSVVLLELV 307
                   ++ Y +     D++S+ V+L E+V
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T +G+ +LH+     +IHRD+   N+ LN+D +VK+ DFGL   I + +     D+ GT 
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTP 190
Query: 286 GYI---LLACGG-----DIYSFSVVLLELVIRKQP 312
            YI   +L   G     DI+S   +L  L++ K P
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 81  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 12/95 (12%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T +G+ +LH+     +IHRD+   N+ LN+D +VK+ DFGL   I + +     D+ GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTP 206
Query: 286 GYI---LLACGG-----DIYSFSVVLLELVIRKQP 312
            YI   +L   G     DI+S   +L  L++ K P
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 141
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NI+++    VKV DFG+ R I+D  +  +   A  GT  Y+         +    D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 296 IYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIF 355
           +YS   VL E++  + P   +  D      V    D    +A  +     +  +V+  + 
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVRE--DPIPPSARHEGLSADLDAVVLKALA 259
Query: 356 DNPTTR-PTMLRVQEFLEKYHTGE 378
            NP  R  T   ++  L + H GE
Sbjct: 260 KNPENRYQTAAEMRADLVRVHNGE 283

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 71  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 17/108 (15%)
Query: 198 LIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLH------HRFQPHIIHRDIN 247
           L+V EY   GSL  +L     +    C +A    RG+ +LH        ++P I HRD+N
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147
Query: 248 ASNILLNEDFEVKVSDFGL-VRLISDC------ESHTSTDVAGTIGYI 288
           + N+L+  D    +SDFGL +RL  +       E + +    GTI Y+
Sbjct: 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ EY+  GSL D+L+   +   H  +   T++    + +  
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHR++   NIL+  +  VK+ DFGL +++   + +      G          ++  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 193 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 239

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 18/137 (13%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 102 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 158
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NI+++    VKV DFG+ R I+D  +  +   A  GT  Y+         +    D
Sbjct: 159 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 218
Query: 296 IYSFSVVLLELVIRKQP 312
           +YS   VL E++  + P
Sbjct: 219 VYSLGCVLYEVLTGEPP 235

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 71  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 183 NIVQLLGYCPVGE-----KKLIVYEYMVKGSLNDWL-----RNQAKHCIIAC------GT 226
           N+++LLG C         K +++  +M  G L+ +L         KH  +          
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A G+ +L +R   + +HRD+ A N +L +D  V V+DFGL + I   + +    +A    
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 284 ------TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 ++   +     D+++F V + E+  R     P  ++     + D++L    L  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLLHGHRLKQ 270
Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPT--MLRVQEFLEK 373
             +  + ++ +I+  C   +P  RPT  +LR+Q  LEK
Sbjct: 271 -PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ--LEK 305

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 71  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 18/137 (13%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 141
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NI+++    VKV DFG+ R I+D  +  +   A  GT  Y+         +    D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 296 IYSFSVVLLELVIRKQP 312
           +YS   VL E++  + P
Sbjct: 202 VYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 18/137 (13%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 141
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NI+++    VKV DFG+ R I+D  +  +   A  GT  Y+         +    D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 296 IYSFSVVLLELVIRKQP 312
           +YS   VL E++  + P
Sbjct: 202 VYSLGCVLYEVLTGEPP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 81  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 253
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 18/137 (13%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 141
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NI+++    VKV DFG+ R I+D  +  +   A  GT  Y+         +    D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 296 IYSFSVVLLELVIRKQP 312
           +YS   VL E++  + P
Sbjct: 202 VYSLGCVLYEVLTGEPP 218

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 131 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 189
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 190 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 246
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 23/147 (15%)
Query: 176 DFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKHCIIACGTARG 229
           DF + ++ +     Y P  +   +V EY+  G L D+L+      + ++  + +    +G
Sbjct: 71  DFIVKYRGV----SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG------ 283
           + +L  R     +HRD+ A NIL+  +  VK++DFGL +L+   + +      G      
Sbjct: 127 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 284 ----TIGYILLACGGDIYSFSVVLLEL 306
               ++   + +   D++SF VVL EL
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 81  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 139
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 140 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 196
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 88  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 146
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 147 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 203
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 86  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 144
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 145 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 201
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 77  ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 135
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 192
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTA-RGITFLHHRFQPHIIHRD 245
            P G    IV EY+   +L D +  +     K  I     A + + F H   Q  IIHRD
Sbjct: 85  TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRD 141
Query: 246 INASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--GTIGYI--------LLACGGD 295
           +  +NIL++    VKV DFG+ R I+D  +      A  GT  Y+         +    D
Sbjct: 142 VKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 296 IYSFSVVLLELVIRKQP 312
           +YS   VL E++  + P
Sbjct: 202 VYSLGCVLYEVLTGEPP 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 23/147 (15%)
Query: 176 DFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKHCIIACGTARG 229
           DF + ++ +     Y P  +   +V EY+  G L D+L+      + ++  + +    +G
Sbjct: 72  DFIVKYRGV----SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG------ 283
           + +L  R     +HRD+ A NIL+  +  VK++DFGL +L+   + +      G      
Sbjct: 128 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 284 ----TIGYILLACGGDIYSFSVVLLEL 306
               ++   + +   D++SF VVL EL
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 23/147 (15%)
Query: 176 DFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKHCIIACGTARG 229
           DF + ++ +     Y P  +   +V EY+  G L D+L+      + ++  + +    +G
Sbjct: 84  DFIVKYRGV----SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG------ 283
           + +L  R     +HRD+ A NIL+  +  VK++DFGL +L+   + +      G      
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 284 ----TIGYILLACGGDIYSFSVVLLEL 306
               ++   + +   D++SF VVL EL
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 75  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
           +N+V++     VG++  +V E++  G+L D +     N+ +   +     + ++ LH + 
Sbjct: 208 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 266
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
              +IHRDI + +ILL  D  VK+SDFG    +S  E      + GT        I  + 
Sbjct: 267 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPYWMAPELISRLP 323
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                DI+S  ++++E+V  + P
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 178 GIAFKNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQA----KHCIIACGTARG 229
           G+  +NI+Q +G    G        ++  +  KGSL+D+L+       + C IA   ARG
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARG 133
Query: 230 ITFLHHRF-------QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           + +LH          +P I HRDI + N+LL  +    ++DFGL       +S  + D  
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS--AGDTH 191
Query: 283 GTIG 286
           G +G
Sbjct: 192 GQVG 195

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           ++V+LLG C +     +V + M  G L +++     +         C+     A+G+ +L
Sbjct: 101 HLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV---QIAKGMMYL 156
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-TIGYILLAC 292
             R    ++HRD+ A N+L+     VK++DFGL RL+   E   + D     I ++ L C
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 293 --------GGDIYSFSVVLLELV 307
                     D++S+ V + EL+
Sbjct: 214 IHYRKFTHQSDVWSYGVTIWELM 236

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII------ACGTARGITFLHH 235
           +N+++L G       K++  E    GSL D LR    H ++      A   A G+ +L  
Sbjct: 75  RNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC--- 292
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H        + +   A    
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 247
Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFL 371
           +  ++V C    P  RPT + +++FL
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           ++V+LLG C +     +V + M  G L +++     +         C+     A+G+ +L
Sbjct: 78  HLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV---QIAKGMMYL 133
Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-TIGYILLAC 292
             R    ++HRD+ A N+L+     VK++DFGL RL+   E   + D     I ++ L C
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 293 --------GGDIYSFSVVLLELV 307
                     D++S+ V + EL+
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELM 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 19/156 (12%)
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A    
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 TI   +     D++SF V+L E+        P  K          + + T + A
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA 317
Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
             Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 318 PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 19/156 (12%)
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A    
Sbjct: 208 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 TI   +     D++SF V+L E+        P  K          + + T + A
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA 322
Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
             Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 323 PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 19/156 (12%)
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A    
Sbjct: 201 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 TI   +     D++SF V+L E+        P  K          + + T + A
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA 315
Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
             Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 316 PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 19/156 (12%)
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
           A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A    
Sbjct: 210 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 283 -----GTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 TI   +     D++SF V+L E+        P  K          + + T + A
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRA 324
Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFL 371
             Y+ P   +M Q ++ C    P+ RPT   + E L
Sbjct: 325 PDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 143 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 200
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 201 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 257
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 258 MAVGRYPIPP 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 23/147 (15%)
Query: 176 DFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR------NQAKHCIIACGTARG 229
           DF + ++ +     Y P   +  +V EY+  G L D+L+      + ++  + +    +G
Sbjct: 68  DFIVKYRGV----SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG------ 283
           + +L  R     +HRD+ A NIL+  +  VK++DFGL +L+   +        G      
Sbjct: 124 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 284 ----TIGYILLACGGDIYSFSVVLLEL 306
               ++   + +   D++SF VVL EL
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 30/152 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------------NQAKHCI------- 221
           NI+ LLG C       +  EY   G+L D+LR              N     +       
Sbjct: 84  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
            A   ARG+ +L    Q   IHR++ A NIL+ E++  K++DFGL R        T   +
Sbjct: 144 FAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 282 A------GTIGYILLACGGDIYSFSVVLLELV 307
                   ++ Y +     D++S+ V+L E+V
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 165
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 166 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 223 MAVGRYPIPP 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 90  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 144
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 205 YKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 90  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 144
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 204
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 205 YKFSSKSDVWSFGVLMWE 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 70  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 185 YKFSSKSDVWSFGVLMWE 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 74  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 188
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 189 YKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 88  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 142
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 143 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 202
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 203 YKFSSKSDVWSFGVLMWE 220

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 80  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 134
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 195 YKFSSKSDVWSFGVLMWE 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 138
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 196 MAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 138
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 196 MAVGRYPIPP 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 138
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 196 MAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 18/130 (13%)
Query: 199 IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQPHIIHRDINASNILL 253
           I  E+M  GSL+  L+   +        ++    +G+T+L  + +  I+HRD+  SNIL+
Sbjct: 81  ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV 138
Query: 254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLE 305
           N   E+K+ DFG+   + D  +++     GT  Y+          +   DI+S  + L+E
Sbjct: 139 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 306 LVIRKQPTGP 315
           + + + P  P
Sbjct: 196 MAVGRYPIPP 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 68  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 122
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 123 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 183 YKFSSKSDVWSFGVLMWE 200

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 433 IVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 487
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 488 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 547
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 548 YKFSSKSDVWSFGVLMWE 565

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 432 IVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 486
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E++      G           I Y
Sbjct: 487 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 547 YKFSSKSDVWSFGVLMWE 564

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGT--ARGITFLHHR 236
           +IV+LLG CP G    +V +Y+  GSL D +R          ++  G   A+G+ +L   
Sbjct: 94  HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTIGYILLAC--- 292
               ++HR++ A N+LL    +V+V+DFG+  L+  D +    ++    I ++ L     
Sbjct: 153 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 293 -----GGDIYSFSVVLLELV 307
                  D++S+ V + EL+
Sbjct: 210 GKYTHQSDVWSYGVTVWELM 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGT--ARGITFLHHR 236
           +IV+LLG CP G    +V +Y+  GSL D +R          ++  G   A+G+ +L   
Sbjct: 76  HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTIGYILLAC--- 292
               ++HR++ A N+LL    +V+V+DFG+  L+  D +    ++    I ++ L     
Sbjct: 135 ---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 293 -----GGDIYSFSVVLLELV 307
                  D++S+ V + EL+
Sbjct: 192 GKYTHQSDVWSYGVTVWELM 211

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 183 NIVQLLGYC-PVGEKKL-IVYEYMVKGSLNDWLRNQAK---HCIIACGTARGITFLHHRF 237
           NIV+  G C   G + L ++ E++  GSL ++L+   +   H  +   T++    + +  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIGY 287
               IHRD+   NIL+  +  VK+ DFGL +++   +        G          ++  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 288 ILLACGGDIYSFSVVLLELV--IRKQPTGP-EF-----KDKNGGNLV 326
              +   D++SF VVL EL   I K  + P EF      DK G  +V
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYI 184
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 185 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 232
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 233 EYSIPKHINPVAASLIQKMLQTDPTARPTI 262

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYI 184
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 185 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 232
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 233 EYSIPKHINPVAASLIQKMLQTDPTARPTI 262

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 133 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYI 188
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 189 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 236
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 237 EYSIPKHINPVAASLIQKMLQTDPTARPTI 266

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           N +Q  G         +V EY + GS +D L    K         +  G  +G+ +LH  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG-- 294
              ++IHRD+ A NILL+E   VK+ DFG   +++       T        IL    G  
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQY 230
Query: 295 ----DIYSFSVVLLELVIRKQP 312
               D++S  +  +EL  RK P
Sbjct: 231 DGKVDVWSLGITCIELAERKPP 252

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 63/238 (26%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK------------------H----- 219
           ++++L G C      L++ EY   GSL  +LR   K                  H     
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 220 ------CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
                    A   ++G+ +L    +  ++HRD+ A NIL+ E  ++K+SDFGL R + + 
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 274 ESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG 323
           +S+      G I    +A             D++SF V+L E+V              GG
Sbjct: 204 DSYVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL------------GG 250
Query: 324 NLVDWVLDSTILN------AYSKPS--MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           N    +    + N         +P     +M ++++ C    P  RP    + + LEK
Sbjct: 251 NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 31/169 (18%)
Query: 178 GIAFKNIVQLLGYCPVGE----KKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARG 229
           G+  +N++Q +     G     +  ++  +  KGSL D+L+       + C +A   +RG
Sbjct: 65  GMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRG 124
Query: 230 ITFLHHRF--------QPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTD 280
           +++LH           +P I HRD  + N+LL  D    ++DFGL VR         +  
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHG 184
Query: 281 VAGTIGYILLAC--GG-----------DIYSFSVVLLELVIR-KQPTGP 315
             GT  Y+      G            D+Y+  +VL ELV R K   GP
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGP 233

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 50/227 (22%)
Query: 199 IVYEYMVKGSLNDWLRN---QAKHCI-IACGTARGITFLHHRF-----QPHIIHRDINAS 249
           ++ +Y   GSL D+L++    AK  + +A  +  G+  LH        +P I HRD+ + 
Sbjct: 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 250 NILLNEDFEVKVSDFGL-VRLISDCESHTSTDV-----AGTIGYILLAC----------- 292
           NIL+ ++    ++D GL V+ ISD       D+      GT  Y+               
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDT---NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228
Query: 293 ---GGDIYSFSVVLLELVIR----------------KQPTGPEFKDKNGGNLVDWVLDST 333
                D+YSF ++L E+  R                  P+ P ++D      +   L  +
Sbjct: 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK-KLRPS 287
Query: 334 ILNAYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
             N +S    L+ + +++  C   NP +R T LRV++ L K    ++
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T +G+ +LH+     +IHRD+   N+ LN+D +VK+ DFGL   I + +      + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKTLCGTP 206
Query: 286 GYI---LLACGG-----DIYSFSVVLLELVIRKQP 312
            YI   +L   G     DI+S   +L  L++ K P
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 21/138 (15%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHRF 237
           IV+++G C   E  ++V E    G LN +L+ Q +H        +    + G+ +L    
Sbjct: 74  IVRMIGICE-AESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE--- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------IGY 287
           + + +HRD+ A N+LL      K+SDFGL + +   E+       G           I Y
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINY 188
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF V++ E
Sbjct: 189 YKFSSKSDVWSFGVLMWE 206

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 12/95 (12%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T +G+ +LH+     +IHRD+   N+ LN+D +VK+ DFGL   I + +      + GT 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTP 206
Query: 286 GYI---LLACGG-----DIYSFSVVLLELVIRKQP 312
            YI   +L   G     DI+S   +L  L++ K P
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 22/158 (13%)
Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI---------SDCESHT 277
           ARG+ FL  R     IHRD+ A NILL+E+  VK+ DFGL R I          D     
Sbjct: 209 ARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 278 STDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
                 +I   + +   D++S+ V+L E+        P  +     +    + +   + A
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDE--DFCSRLREGMRMRA 323
Query: 338 --YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             YS P   ++ QI++ C   +P  RP   R  E +EK
Sbjct: 324 PEYSTP---EIYQIMLDCWHRDPKERP---RFAELVEK 355

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 127 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF 183
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYI 208
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 256
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 257 EYSIPKHINPVAASLIQKMLQTDPTARPTI 286

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 61/142 (42%), Gaps = 16/142 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           N +Q  G         +V EY + GS +D L    K         +  G  +G+ +LH  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG-- 294
              ++IHRD+ A NILL+E   VK+ DFG   +++       T        IL    G  
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 295 ----DIYSFSVVLLELVIRKQP 312
               D++S  +  +EL  RK P
Sbjct: 192 DGKVDVWSLGITCIELAERKPP 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 151 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYI 206
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 207 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 254
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 255 EYSIPKHINPVAASLIQKMLQTDPTARPTI 284

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 57/235 (24%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------HCIIACGTARG 229
           ++++L G C      L++ EY   GSL  +LR   K                +     R 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 230 ITF-------------LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH 276
           +T              + +  +  ++HRD+ A NIL+ E  ++K+SDFGL R + + +S 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 277 TSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV 326
                 G I    +A             D++SF V+L E+V              GGN  
Sbjct: 207 VKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL------------GGNPY 253
Query: 327 DWVLDSTILN------AYSKPS--MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             +    + N         +P     +M ++++ C    P  RP    + + LEK
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 127 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 30/150 (20%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G  +LH      +IHRD+   N+ LNED EVK+ DFGL   + + +      + GT  YI
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYI 182
Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL----N 336
              +L+  G     D++S   ++  L++ K P                 L  T L    N
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------------FETSCLKETYLRIKKN 230
Query: 337 AYSKPSMLKML--QIVVGCIFDNPTTRPTM 364
            YS P  +  +   ++   +  +PT RPT+
Sbjct: 231 EYSIPKHINPVAASLIQKMLQTDPTARPTI 260

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 79  HVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 138 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 195 RIYTHQSDVWSYGVTVWELM 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 57/235 (24%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-------------HCIIACGTARG 229
           ++++L G C      L++ EY   GSL  +LR   K                +     R 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 230 ITF-------------LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH 276
           +T              + +  +  ++HRD+ A NIL+ E  ++K+SDFGL R + + +S 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 277 TSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV 326
                 G I    +A             D++SF V+L E+V              GGN  
Sbjct: 207 VKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL------------GGNPY 253
Query: 327 DWVLDSTILN------AYSKPS--MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             +    + N         +P     +M ++++ C    P  RP    + + LEK
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 112 HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 171 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 227
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 228 RIYTHQSDVWSYGVTVWELM 247

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 18/138 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIAC------GTARGITFLHHR 236
           NIV+L+G C   +   IV E +  G    +LR +     +          A G+ +L  +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST---------DVAGTIGY 287
                IHRD+ A N L+ E   +K+SDFG+ R  +D     S               + Y
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF ++L E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 147 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 127 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 81  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 140 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 197 RIYTHQSDVWSYGVTVWELM 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 85  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 144 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 201 RIYTHQSDVWSYGVTVWELM 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 79  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 138 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 194
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 195 RIYTHQSDVWSYGVTVWELM 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 88  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 147 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 203
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 204 RIYTHQSDVWSYGVTVWELM 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 82  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 141 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 198 RIYTHQSDVWSYGVTVWELM 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 80  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 196 RIYTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 103 HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 162 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 218
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 219 RIYTHQSDVWSYGVTVWELM 238

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   TD+ GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 81  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 140 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 197 RIYTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 81  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 140 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 197 RIYTHQSDVWSYGVTVWELM 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 81  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 140 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 196
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 197 RIYTHQSDVWSYGVTVWELM 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 129 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGF 185
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   TD+ GT+ Y+        +
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 85  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 144 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 201 RIYTHQSDVWSYGVTVWELM 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   TD+ GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 72  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 131 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 188 RIYTHQSDVWSYGVTVWELM 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 80  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 196 RIYTHQSDVWSYGVTVWELM 215

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   TD+ GT+ Y+        +
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 225

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 84  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 143 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 199
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 200 RIYTHQSDVWSYGVTVWELM 219

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 129 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 125 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 132 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 85  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 144 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 201 RIYTHQSDVWSYGVTVWELM 220

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 133 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 124 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 18/138 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIAC------GTARGITFLHHR 236
           NIV+L+G C   +   IV E +  G    +LR +     +          A G+ +L  +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST---------DVAGTIGY 287
                IHRD+ A N L+ E   +K+SDFG+ R  +D     S               + Y
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 288 ILLACGGDIYSFSVVLLE 305
              +   D++SF ++L E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 147 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 203
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 125 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 135 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 191
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 192 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 127 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 127 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 129 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 115 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 205

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 116 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 206

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 40/207 (19%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----------HCIIACGTARGIT 231
           +I++L  Y        +V E    G +N +L+N+ K           H II      G+ 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-----GML 126
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLV-RLISDCESHTSTDVAGTIGYILL 290
           +LH      I+HRD+  SN+LL  +  +K++DFGL  +L    E H +  + GT  YI  
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISP 181
Query: 291 ACG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
                       D++S   +   L+I + P   +         V   L+  +L  Y  PS
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD--------TVKNTLNKVVLADYEMPS 233
Query: 343 MLKM--LQIVVGCIFDNPTTRPTMLRV 367
            L +    ++   +  NP  R ++  V
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSV 260

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 113 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 203

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 204

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 228

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++AG + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 228

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++AG + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 184

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 225

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 141 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 143 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++AG + 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVA 180

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTA-------RGITFLHHRFQPHIIHRDINASNI 251
           +V E+   GS+ D ++N   + +     A       RG++ LH   Q  +IHRDI   N+
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 160
Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACG----------GDIYS 298
           LL E+ EVK+ DFG+   +       +T + GT  ++   ++AC            D++S
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 299 FSVVLLELVIRKQP----------------TGPEFKDKNGGNLVDWVLDSTILNAYS-KP 341
             +  +E+     P                  P  K K         ++S ++  +S +P
Sbjct: 220 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 279
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           +  ++++     I D P  R   +++++ +++
Sbjct: 280 ATEQLMKHPF--IRDQPNERQVRIQLKDHIDR 309

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY  +G +   L+  +K       T     A  +++ H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 285 IGYI---LL----AC-GGDIYSFSVVLLELV 307
             Y+   LL    AC   D+++   ++ +LV
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLV 210

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A G+ +L  R
Sbjct: 75  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFGL +L+   E     +            +I +
Sbjct: 134 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 190
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 191 RIYTHQSDVWSYGVTVWELM 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 21/103 (20%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS------- 278
           T R +  LH     ++IHRD+  SN+L+N + ++KV DFGL R+I +  +  S       
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 279 --TDVAGTIGY----ILLACGG-----DIYSFSVVLLELVIRK 310
             T+   T  Y    ++L         D++S   +L EL +R+
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+L+N   ++K+ DFGL R+      HT  
Sbjct: 147 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGF 203
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
            T+   T  Y    I+L   G     DI+S   +L E++
Sbjct: 204 LTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           TA+ ++ L H  Q +II+RD+   N+LL++D  V++SD GL   +   ++ T    AGT 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 286 GY----ILLACGGDIYSFS-------VVLLELVIRKQP 312
           G+    +LL   G+ Y FS       V L E++  + P
Sbjct: 354 GFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 132 QRGNRQQHLSINLAMFEPSLGKLTYDQIVAG----TNKFY-----EKNVIRGDD------ 176
           +R + Q  L I   +    LGK ++ ++       TN+F+     +K+V+  DD      
Sbjct: 6   ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 177 -----FGIAFKNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLR-----NQAKHCIIAC 224
                  +A+++      +C    K+    V EY+  G L   ++     + ++    A 
Sbjct: 66  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR--LISDCESHTSTDVA 282
               G+ FLH +    I++RD+   NILL++D  +K++DFG+ +  ++ D +++      
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNX---FC 179
Query: 283 GTIGYILLAC--------GGDIYSFSVVLLELVIRKQP 312
           GT  YI              D +SF V+L E++I + P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 21/103 (20%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS------- 278
           T R +  LH     ++IHRD+  SN+L+N + ++KV DFGL R+I +  +  S       
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 279 --TDVAGTIGY----ILLACGG-----DIYSFSVVLLELVIRK 310
             T+   T  Y    ++L         D++S   +L EL +R+
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           TA+ ++ L H  Q +II+RD+   N+LL++D  V++SD GL   +   ++ T    AGT 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 286 GY----ILLACGGDIYSFS-------VVLLELVIRKQP 312
           G+    +LL   G+ Y FS       V L E++  + P
Sbjct: 354 GFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           TA+ ++ L H  Q +II+RD+   N+LL++D  V++SD GL   +   ++ T    AGT 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 286 GY----ILLACGGDIYSFS-------VVLLELVIRKQP 312
           G+    +LL   G+ Y FS       V L E++  + P
Sbjct: 354 GFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 15/98 (15%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           TA+ ++ L H  Q +II+RD+   N+LL++D  V++SD GL   +   ++ T    AGT 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTP 353
Query: 286 GY----ILLACGGDIYSFS-------VVLLELVIRKQP 312
           G+    +LL   G+ Y FS       V L E++  + P
Sbjct: 354 GFMAPELLL---GEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G++F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 114 QGLSFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 23/145 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS--TDVAGTIGYI------- 288
              +IHRDI   N+LL    E+K++DFG       C + +S  T ++GT+ Y+       
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGW-----SCHAPSSRRTTLSGTLDYLPPEMIEG 181
Query: 289 -LLACGGDIYSFSVVLLELVIRKQP 312
            +     D++S  V+  E ++ K P
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT+ ++ G + 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT+ ++ G + 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT+ ++ G + 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 27/244 (11%)
Query: 152 GKLTYDQIVAGTNKFYEKNVIRGDDFG--------IAFKNIVQLLGYC--PVGEKKLIVY 201
           G+   + IV    K  + +  +  DF          +  N++ +LG C  P      ++ 
Sbjct: 29  GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88
Query: 202 EYMVKGSL-------NDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
            +   GSL        +++ +Q++    A   ARG  FLH   +P I    +N+ ++ ++
Sbjct: 89  HWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXID 147
Query: 255 EDFEVKVSDFGL-VRLISDCESHTSTDVAGTI----GYILLACGGDIYSFSVVLLELVIR 309
           ED   ++S   +     S    +    VA                D +SF+V+L ELV R
Sbjct: 148 EDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTR 207
Query: 310 KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
           + P       + G  +    L  TI    S P + K+ +I   C  ++P  RP    +  
Sbjct: 208 EVPFADLSNXEIGXKVALEGLRPTIPPGIS-PHVSKLXKI---CXNEDPAKRPKFDXIVP 263
Query: 370 FLEK 373
            LEK
Sbjct: 264 ILEK 267

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVA 195

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVA 189

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 43/218 (19%)
Query: 132 QRGNRQQHLSINLAMFEPSLGKLTYDQIVAG----TNKFY-----EKNVIRGDD------ 176
           +R + Q  L I        LGK ++ ++       TN+F+     +K+V+  DD      
Sbjct: 7   ERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 66
Query: 177 -----FGIAFKNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLR-----NQAKHCIIAC 224
                  +A+++      +C    K+    V EY+  G L   ++     + ++    A 
Sbjct: 67  VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 126
Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR--LISDCESHTSTDVA 282
               G+ FLH +    I++RD+   NILL++D  +K++DFG+ +  ++ D +   + +  
Sbjct: 127 EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFC 180
Query: 283 GTIGYILLAC--------GGDIYSFSVVLLELVIRKQP 312
           GT  YI              D +SF V+L E++I + P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVA 189

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 121 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 175
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 22/64 (34%), Positives = 37/64 (57%), Gaps = 1/64 (1%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 285 IGYI 288
             Y+
Sbjct: 198 AQYV 201

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T++ GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVA 184

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVA 186

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 115 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 169
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVA 190

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 82  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 141 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 197
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 198 RIYTHQSDVWSYGVTVWELM 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 118 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 172
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 21/103 (20%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           T R +  LH     ++IHRD+  SN+L+N + ++KV DFGL R+I +  +  S       
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 286 GYILLAC------------------GGDIYSFSVVLLELVIRK 310
           G +                        D++S   +L EL +R+
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 80  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 196 RIYTHQSDVWSYGVTVWELM 215

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 165 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 198 LIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
            +V++ M KG L D+L      ++ +   I       ++FLH     +I+HRD+   NIL
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232
Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGGD 295
           L+++ ++++SDFG    +   E     ++ GT GY+   +L C  D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMD 276

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S    D+ GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVA 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 195

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 196

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 191

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 23/145 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH- 234
           NIV+LL       K  +V+E++ +  L D++   A   I             +G+ F H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILL 290
           HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ Y    ILL
Sbjct: 122 HR----VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILL 176
Query: 291 AC-----GGDIYSFSVVLLELVIRK 310
            C       DI+S   +  E+V R+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 68/140 (48%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI+ + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 80  HVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 196 RIYTHQSDVWSYGVTVWELM 215

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 196

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 186

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG-----ITFLHHRF 237
           NIV+L       +   +V EY   G + D+L     H  +    AR      ++ + +  
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGL 266
           Q +I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 132 QKYIVHRDLKAENLLLDGDMNIKIADFGF 160

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 196

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 189

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 135 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 183

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 186

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 207

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 189

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 22/64 (34%), Positives = 37/64 (57%), Gaps = 1/64 (1%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGT 284
           TA  ++ L +     IIHRD+   NILLNED  ++++DFG  +++S + +   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 285 IGYI 288
             Y+
Sbjct: 198 AQYV 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 23/145 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH- 234
           NIV+LL       K  +V+E++    L D++   A   I             +G+ F H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILL 290
           HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ Y    ILL
Sbjct: 125 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILL 179
Query: 291 AC-----GGDIYSFSVVLLELVIRK 310
            C       DI+S   +  E+V R+
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 190

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 181

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 184

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 180

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 181

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 146 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 194

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 134 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 182

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 78  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 194 RIYTHQSDVWSYGVTVWELM 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 68/146 (46%), Gaps = 21/146 (14%)
Query: 178 GIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGIT 231
           G+    + +LLG C     +L+  + M  G L D +R       ++  +  C   A+G++
Sbjct: 75  GVGSPYVSRLLGICLTSTVQLVT-QLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA 291
           +L       ++HRD+ A N+L+     VK++DFGL RL+   E+    D  G +    +A
Sbjct: 134 YLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-GGKVPIKWMA 189
Query: 292 C----------GGDIYSFSVVLLELV 307
                        D++S+ V + EL+
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELM 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 186

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 80  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 139 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 195
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 196 RIYTHQSDVWSYGVTVWELM 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 204

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S    D+ GT+ Y+        +
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRM 208
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 180

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 180

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG--------ITFLH 234
           NIV+L       +   +V EY   G + D+L     H  +    AR         + + H
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
            +F   I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGF 152

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
             +   T  Y    I+L   G     DI+S   +L E++
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 14/99 (14%)
Query: 220 CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS- 278
           C       RG+ ++H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT  
Sbjct: 132 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 279 -TDVAGTIGY----ILLACGG-----DIYSFSVVLLELV 307
             +   T  Y    I+L   G     DI+S   +L E++
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVA 207

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 23/145 (15%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH- 234
           NIV+LL       K  +V+E++    L D++   A   I             +G+ F H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILL 290
           HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ Y    ILL
Sbjct: 124 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILL 178
Query: 291 AC-----GGDIYSFSVVLLELVIRK 310
            C       DI+S   +  E+V R+
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIAC-GTARGITFLHHR 236
           ++ +LLG C     +LI  + M  G L D++R       +++ +  C   A+G+ +L  R
Sbjct: 85  HVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD---------VAGTIGY 287
               ++HRD+ A N+L+     VK++DFG  +L+   E     +            +I +
Sbjct: 144 ---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILH 200
Query: 288 ILLACGGDIYSFSVVLLELV 307
            +     D++S+ V + EL+
Sbjct: 201 RIYTHQSDVWSYGVTVWELM 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 190

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 27/178 (15%)
Query: 162 GTNKFYEKNVIRGDDFGIAFKN--IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH 219
           GT K   + ++R         N  IV+L+G C   E  ++V E    G L+ +L  + + 
Sbjct: 48  GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE 106
Query: 220 CIIAC------GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
             ++         + G+ +L  +   + +HRD+ A N+LL      K+SDFGL + +   
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163
Query: 274 ESHTSTDVAGT----------IGYILLACGGDIYSFSVVLLELVI-----RKQPTGPE 316
           +S+ +   AG           I +   +   D++S+ V + E +       K+  GPE
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 190

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DFGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVA 184

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 72/164 (43%), Gaps = 24/164 (14%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----IIACGTARGITFLHHRFQ 238
           I+++ G     ++  ++ +Y+  G L   LR   +         A      + +LH +  
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-- 125
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG---- 294
             II+RD+   NILL+++  +K++DFG  + + D     +  + GT  YI          
Sbjct: 126 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYXLCGTPDYIAPEVVSTKPY 180
Query: 295 ----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
               D +SF +++ E++    P    F D N     + +L++ +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAEL 220

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 8/89 (8%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG-----ITFLHHRF 237
           NIV+L       +   ++ EY   G + D+L     H  +    AR      ++ + +  
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGL 266
           Q  I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGF 157

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 16/104 (15%)
Query: 183 NIVQLLGYCPVGEKK-------LIVYEYMVKGSLNDWLRNQAKHCIIACGT--------A 227
           NIVQ      +G+++        ++   + KG L ++L+       ++C T         
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
           R +  +H R +P IIHRD+   N+LL+    +K+ DFG    IS
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/162 (22%), Positives = 68/162 (41%), Gaps = 40/162 (24%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------------------- 219
           +NIV LLG C +     +++EY   G L ++LR++ +                       
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 220 ------CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISD 272
                    A   A+G+ FL  +     +HRD+ A N+L+     VK+ DFGL R ++SD
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 273 CESHTSTDVAGTIGYI--------LLACGGDIYSFSVVLLEL 306
                  +    + ++        +     D++S+ ++L E+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 126
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 127 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 15/96 (15%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISDCESHT--STDVAGT 284
           RG+ ++H      +IHRD+  SN+L+NE+ E+K+ DFG+ R L +    H    T+   T
Sbjct: 170 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 285 IGY----ILLAC-----GGDIYSFSVVLLELVIRKQ 311
             Y    ++L+        D++S   +  E++ R+Q
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 23/200 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL-----RNQAKHCIIACGTARGITFLHHRF 237
           +I++L           +V EY+  G L D++      ++ +   +      G+ + H   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE----SHTSTDVAGT---IGYILL 290
              ++HRD+   N+LL+     K++DFGL  ++SD E    S  S + A      G +  
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 291 ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSKPSMLKMLQI 349
               DI+S  V+L  L+    P    F D +   L   + D       Y  PS++ +L+ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLP----FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249
Query: 350 VVGCIFDNPTTRPTMLRVQE 369
           ++     +P  R T+  ++E
Sbjct: 250 MLQV---DPMKRATIKDIRE 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 132 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 8/89 (8%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARG-----ITFLHHRF 237
           NIV+L       +   ++ EY   G + D+L     H  +    AR      ++ + +  
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGL 266
           Q  I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGF 160

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 208
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 209 HDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 124
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 125 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY  +G +   L+  +K       T     A  +++ H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 22/158 (13%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-------SDCE 274
           IACG    + +L  R   + IHRD+ A N +L ED  V V+DFGL R I         C 
Sbjct: 146 IACG----MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 275 SHTSTD--VAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS 332
           S          ++   L     D+++F V + E++ R Q     +       + ++++  
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---YAGIENAEIYNYLIGG 255
Query: 333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRP--TMLRVQ 368
             L    +  M ++  ++  C   +P  RP  T LR++
Sbjct: 256 NRLKQPPE-CMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 19/113 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ FLH HR    ++HRD+   NIL+    ++K++DFGL R+ S   + TS  V  T+ 
Sbjct: 131 RGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLW 184
Query: 287 Y----ILL----ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           Y    +LL    A   D++S   +  E+  RK    P F+  +  + +  +LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILD 233

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 15/96 (15%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR-LISDCESHT--STDVAGT 284
           RG+ ++H      +IHRD+  SN+L+NE+ E+K+ DFG+ R L +    H    T+   T
Sbjct: 169 RGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 285 IGY----ILLAC-----GGDIYSFSVVLLELVIRKQ 311
             Y    ++L+        D++S   +  E++ R+Q
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 19/113 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ FLH HR    ++HRD+   NIL+    ++K++DFGL R+ S   + TS  V  T+ 
Sbjct: 131 RGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLW 184
Query: 287 Y----ILL----ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           Y    +LL    A   D++S   +  E+  RK    P F+  +  + +  +LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILD 233

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSXQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 19/113 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ FLH HR    ++HRD+   NIL+    ++K++DFGL R+ S   + TS  V  T+ 
Sbjct: 131 RGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLW 184
Query: 287 Y----ILL----ACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           Y    +LL    A   D++S   +  E+  RK    P F+  +  + +  +LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILD 233

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ D+GL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEMTGYVA 184

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 28/160 (17%)
Query: 215 NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
            + +    A   + G+ FLH R    II+RD+   N++L+ +  +K++DFG+      C+
Sbjct: 118 KEPQAVFYAAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGM------CK 168
Query: 275 SH-----TSTDVAGTIGYIL--------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKN 321
            H     T+ +  GT  YI              D +++ V+L E++  +    P F  ++
Sbjct: 169 EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ----PPFDGED 224
Query: 322 GGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
              L   +++  +  +Y K    + + I  G +  +P  R
Sbjct: 225 EDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPAKR 262

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 20/125 (16%)
Query: 198 LIVYEYMVKGSLNDWL---RNQAKHCIIAC----GTARGITFLHHRFQPHIIHRDINASN 250
            I  E+  KG+L  W+   R +    ++A        +G+ ++H +    +IHRD+  SN
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSN 166
Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--------LACGGDIYSFSVV 302
           I L +  +VK+ DFGLV  + +    T +   GT+ Y+              D+Y+  ++
Sbjct: 167 IFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLI 224
Query: 303 LLELV 307
           L EL+
Sbjct: 225 LAELL 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 144
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+        +
Sbjct: 145 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 199
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 200 HDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 8/89 (8%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWL----RNQAKHCIIACGT-ARGITFLHHRF 237
           NIV+L       +   +V EY   G + D+L    R + K            + + H +F
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGL 266
              I+HRD+ A N+LL+ D  +K++DFG 
Sbjct: 134 ---IVHRDLKAENLLLDADXNIKIADFGF 159

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    G +   
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360
Query: 289 LLACG------GDIYSFSVVLLELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
           +L  G       D +S   +L +L+    P    + KDK+  + +   +   + +++S P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS-P 419
Query: 342 SMLKMLQ 348
            +  +L+
Sbjct: 420 ELRSLLE 426

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    G +   
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360
Query: 289 LLACG------GDIYSFSVVLLELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
           +L  G       D +S   +L +L+    P    + KDK+  + +   +   + +++S P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS-P 419
Query: 342 SMLKMLQ 348
            +  +L+
Sbjct: 420 ELRSLLE 426

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    G +   
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360
Query: 289 LLACG------GDIYSFSVVLLELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
           +L  G       D +S   +L +L+    P    + KDK+  + +   +   + +++S P
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS-P 419
Query: 342 SMLKMLQ 348
            +  +L+
Sbjct: 420 ELRSLLE 426

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 11/127 (8%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           G+  +H+RF   +++RD+  +NILL+E   V++SD GL    S  + H S    G +   
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 359
Query: 289 LLACG------GDIYSFSVVLLELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
           +L  G       D +S   +L +L+    P    + KDK+  + +   +   + +++S P
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS-P 418
Query: 342 SMLKMLQ 348
            +  +L+
Sbjct: 419 ELRSLLE 425

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 23/150 (15%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGITFL 233
           KNIVQ LG         I  E +  GSL+  LR        N+            G+ +L
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 234 HHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTIGYIL--- 289
           H      I+HRDI   N+L+N    V K+SDFG  + ++     T T   GT+ Y+    
Sbjct: 125 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEI 180
Query: 290 -------LACGGDIYSFSVVLLELVIRKQP 312
                       DI+S    ++E+   K P
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 78/192 (40%), Gaps = 37/192 (19%)
Query: 198 LIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFLHHRFQPHIIHRDINAS 249
            +V EY+  G L D++    KH  +    AR         + + H      ++HRD+   
Sbjct: 87  FMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPE 140
Query: 250 NILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGYILLACGGDIYSFSVV 302
           N+LL+     K++DFGL  ++SD       C S          G +      DI+S  V+
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
Query: 303 LLELVIRKQPTGPE-----FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDN 357
           L  L+    P   E     FK   GG  V ++     LN      ++ MLQ+       +
Sbjct: 201 LYALLCGTLPFDDEHVPTLFKKIRGG--VFYI--PEYLNRSVATLLMHMLQV-------D 249
Query: 358 PTTRPTMLRVQE 369
           P  R T+  ++E
Sbjct: 250 PLKRATIKDIRE 261

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 62/153 (40%), Gaps = 23/153 (15%)
Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR--------NQAKHCIIACGTARGI 230
           +  KNIVQ LG         I  E +  GSL+  LR        N+            G+
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTIGYIL 289
            +LH      I+HRDI   N+L+N    V K+SDFG  + ++     T T   GT+ Y+ 
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMA 191
Query: 290 ----------LACGGDIYSFSVVLLELVIRKQP 312
                          DI+S    ++E+   K P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 78/192 (40%), Gaps = 37/192 (19%)
Query: 198 LIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFLHHRFQPHIIHRDINAS 249
            +V EY+  G L D++    KH  +    AR         + + H      ++HRD+   
Sbjct: 87  FMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPE 140
Query: 250 NILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGYILLACGGDIYSFSVV 302
           N+LL+     K++DFGL  ++SD       C S          G +      DI+S  V+
Sbjct: 141 NVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200
Query: 303 LLELVIRKQPTGPE-----FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDN 357
           L  L+    P   E     FK   GG  V ++     LN      ++ MLQ+       +
Sbjct: 201 LYALLCGTLPFDDEHVPTLFKKIRGG--VFYI--PEYLNRSVATLLMHMLQV-------D 249
Query: 358 PTTRPTMLRVQE 369
           P  R T+  ++E
Sbjct: 250 PLKRATIKDIRE 261

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 34/157 (21%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           IA    + +  LH +    +IHRD+  SN+L+N   +VK+ DFG+   + D  S   T  
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--SVAKTID 213
Query: 282 AGTIGYIL------------LACGGDIYSFSVVLLELVIRKQPT---GPEFK-------- 318
           AG   Y+              +   DI+S  + ++EL I + P    G  F+        
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 273
Query: 319 -------DKNGGNLVDWVLDSTILNAYSKPSMLKMLQ 348
                  DK     VD+       N+  +P+  +++Q
Sbjct: 274 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 118
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 119 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 234 DSAP-LALLHKILVENPSARITIPDIKK 260

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 117
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 118 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 233 DSAP-LALLHKILVENPSARITIPDIKK 259

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----------NQAKHCIIACGTARGIT 231
           +N+V+  G+   G  + +  EY   G L D +            +  H ++A     G+ 
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVV 119
Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS-DCESHTSTDVAGTIGYI-- 288
           +LH      I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+  
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 289 -------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
                    A   D++S  +VL  ++  + P   +    +     DW    T LN + K 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
                L ++   + +NP+ R T+  +++
Sbjct: 235 DSAP-LALLHKILVENPSARITIPDIKK 261

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 116 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 170
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 116 QGLAFCHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 170
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 117 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 171
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 116 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 170
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 117 QGLAFCHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 171
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 117 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 171
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 113 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 167
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 118 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 172
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 115 QGLAFCHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 169
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 115 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 169
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 117 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 171
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 115 QGLAFCHSHR----VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 169
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 115 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 169
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 117 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 171
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+ ++H      IIHRD+  SN+ +NED E+++ DFGL R
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T      T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTLW 168
Query: 287 Y----ILLAC-----GGDIYSFSVVLLELVIRK 310
           Y    ILL C       DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC----- 292
              +IHRDI   N+LL    E+K++DFG         S   T + GT+ Y+         
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 293 ---GGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+ ++H      IIHRD+  SN+ +NED E+++ DFGL R
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/111 (26%), Positives = 53/111 (47%), Gaps = 11/111 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+     ++ +        A  +++ H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK- 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
              +IHRDI   N+LL  + E+K++DFG         S   T + GT+ Y+
Sbjct: 132 --RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYL 177

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/54 (46%), Positives = 33/54 (61%), Gaps = 4/54 (7%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDV 281
           G  F+H   +  IIHRD+  +N LLN+D  VK+ DFGL R I SD + H   D+
Sbjct: 143 GEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 72/162 (44%), Gaps = 22/162 (13%)
Query: 162 GTNKFYEKNVIRGDDFGIAFKN--IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH 219
           GT K   + ++R         N  IV+L+G C   E  ++V E    G L+ +L  + + 
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 220 CIIAC------GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
             ++         + G+ +L  +   + +HR++ A N+LL      K+SDFGL + +   
Sbjct: 433 IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 274 ESHTSTDVAGT----------IGYILLACGGDIYSFSVVLLE 305
           +S+ +   AG           I +   +   D++S+ V + E
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           RG+ ++H      IIHRD+  SN+ +NED E+++ DFGL R
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------- 292
           II+RD+   NILL+E+  +K++DFGL +   D E    +   GT+ Y+            
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQ 205
Query: 293 GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVV 351
             D +SF V++ E++    P    F+ K+    +  +L + + +  +  P    +L+++ 
Sbjct: 206 SADWWSFGVLMFEMLTGTLP----FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261
Query: 352 GCIFDNPTTR 361
                NP  R
Sbjct: 262 KR---NPANR 268

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 19/39 (48%), Positives = 29/39 (74%), Gaps = 3/39 (7%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           +GI +LH++    IIHRDI  SN+L+ ED  +K++DFG+
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGY 287
           HR +  I+HRD+   N+LL+E   VK++DFGL  +++D       C S          G 
Sbjct: 124 HRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 181
Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPE 316
           +      D++S  V+L  ++ R+ P   E
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGY 287
           HR +  I+HRD+   N+LL+E   VK++DFGL  +++D       C S          G 
Sbjct: 120 HRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPE 316
           +      D++S  V+L  ++ R+ P   E
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K+++FG         S   T + GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------- 292
           II+RD+   NILL+E+  +K++DFGL +   D E   +    GT+ Y+            
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQ 206
Query: 293 GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVV 351
             D +SF V++ E++    P    F+ K+    +  +L + + +  +  P    +L+++ 
Sbjct: 207 SADWWSFGVLMFEMLTGTLP----FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 262
Query: 352 GCIFDNPTTR 361
                NP  R
Sbjct: 263 K---RNPANR 269

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGY 287
           HR +  I+HRD+   N+LL+E   VK++DFGL  +++D       C S          G 
Sbjct: 129 HRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 186
Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPE 316
           +      D++S  V+L  ++ R+ P   E
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGY 287
           HR +  I+HRD+   N+LL+E   VK++DFGL  +++D       C S          G 
Sbjct: 130 HRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGK 187
Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPE 316
           +      D++S  V+L  ++ R+ P   E
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------- 292
           II+RD+   NILL+E+  +K++DFGL +   D E    +   GT+ Y+            
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQ 205
Query: 293 GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIVV 351
             D +SF V++ E++    P    F+ K+    +  +L + + +  +  P    +L+++ 
Sbjct: 206 SADWWSFGVLMFEMLTGTLP----FQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLF 261
Query: 352 GCIFDNPTTR 361
                NP  R
Sbjct: 262 K---RNPANR 268

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 121 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 175
Query: 287 Y----ILL-----ACGGDIYSFSVVLLELVIRK 310
           Y    ILL     +   DI+S   +  E+V R+
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 18/108 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---- 283
           +G+ F H R   +++HRD+   N+L+N + E+K++DFGL R         S +V      
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 284 ----TIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD 327
                 G  L +   D++S   +  EL    +P  P       GN VD
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP-------GNDVD 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K+++FG         S   T + GT+ Y+        +
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 30/155 (19%)
Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD--------- 272
           IA    + +  LH +    +IHRD+  SN+L+N   +VK+ DFG+   + D         
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG 171
Query: 273 CESHTSTD-VAGTIGYILLACGGDIYSFSVVLLELVIRKQPT---GPEFK---------- 318
           C+ + + + +   +     +   DI+S  + ++EL I + P    G  F+          
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
Query: 319 -----DKNGGNLVDWVLDSTILNAYSKPSMLKMLQ 348
                DK     VD+       N+  +P+  +++Q
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 15/93 (16%)
Query: 228 RGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ F H HR    ++HRD+   N+L+N +  +K++DFGL R        T T    T+ 
Sbjct: 114 QGLAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 168
Query: 287 Y----ILL-----ACGGDIYSFSVVLLELVIRK 310
           Y    ILL     +   DI+S   +  E+V R+
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 16/138 (11%)
Query: 183 NIVQLLGYCPVGEKKLIVYEY---MVKGSLNDWLRNQAKHCI--IACGTARGITFLHHRF 237
           N+V LL       +  +V+EY    V   L+ + R   +H +  I   T + + F H   
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH--- 119
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT--------IGYIL 289
           + + IHRD+   NIL+ +   +K+ DFG  RL++    +   +VA          +G   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 290 LACGGDIYSFSVVLLELV 307
                D+++   V  EL+
Sbjct: 180 YGPPVDVWAIGCVFAELL 197

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ D GL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEMTGYVA 184

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL--L 290
           L H  +  II+RDI   NILL+ +  V ++DFGL +     E+  + D  GTI Y+   +
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 291 ACGGDI--------YSFSVVLLELVIRKQP 312
             GGD         +S  V++ EL+    P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+  FGL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEMTGYVA 184

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 128 --KVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT- 284
           T +G+ +LH  +   I+HRD+  +N+LL+E+  +K++DFGL +            V    
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW 177
Query: 285 -------IGYILLACGGDIYSFSVVLLELVIR 309
                   G  +   G D+++   +L EL++R
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-------CESHTSTDVAGTIGY 287
           HR +  I+HRD+   N+LL+++  VK++DFGL  +++D       C S          G 
Sbjct: 125 HRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 288 ILLACGGDIYSFSVVLLELVIRKQPTGPEF 317
           +      D++S  +VL  +++ + P   EF
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT-----ARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K       T     A  +++ H + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI   N+LL    E+K++DFG         S     + GT+ Y+        +
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRM 183
Query: 290 LACGGDIYSFSVVLLELVIRKQP 312
                D++S  V+  E ++ K P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 215 NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
           ++A+    A      + FLH +    II+RD+   N+LL+ +   K++DFG+ +    C 
Sbjct: 122 DEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICN 177
Query: 275 SHTSTDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV 326
             T+    GT  YI        L     D ++  V+L E++    P    F+ +N  +L 
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP----FEAENEDDLF 233
Query: 327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           + +L+  ++  Y          I+   +  NPT R
Sbjct: 234 EAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ D GL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEMTGYVA 184

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ DF L R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEMTGYVA 184

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 59/142 (41%), Gaps = 15/142 (10%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           +G+ FLH R  P IIHRD+   NI +      VK+ D GL  L     +  +  V GT  
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPE 195
Query: 287 YILLAC-------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS 339
           +              D+Y+F    LE    + P     + +N   +   V       ++ 
Sbjct: 196 FXAPEXYEEKYDESVDVYAFGXCXLEXATSEYPYS---ECQNAAQIYRRVTSGVKPASFD 252
Query: 340 KPSMLKMLQIVVGCIFDNPTTR 361
           K ++ ++ +I+ GCI  N   R
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDER 274

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQ 238
           IV L+     G K  ++ EY+  G L   L  +        C      +  +  LH   Q
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---Q 139
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG 294
             II+RD+   NI+LN    VK++DFGL +  S  +   +    GTI Y    IL+  G 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 295 ----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
               D +S   ++ +++       P F  +N    +D +L
Sbjct: 199 NRAVDWWSLGALMYDMLT----GAPPFTGENRKKTIDKIL 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-----KHCIIACGTARGITFLHHRFQ 238
           IV L+     G K  ++ EY+  G L   L  +        C      +  +  LH   Q
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---Q 139
Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG 294
             II+RD+   NI+LN    VK++DFGL +  S  +   +    GTI Y    IL+  G 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 295 ----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL 330
               D +S   ++ +++       P F  +N    +D +L
Sbjct: 199 NRAVDWWSLGALMYDMLT----GAPPFTGENRKKTIDKIL 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NI+QL           +V++ M KG L D+L      ++ +   I       I  LH   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 141
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           + +I+HRD+   NILL++D  +K++DFG    +   E   S  V GT  Y+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYL 190

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 19/157 (12%)
Query: 214 RNQAKHCII-ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD 272
           R +  H +  A   A G+ FL  +    II+RD+   N++L+ +  +K++DFG+ +  + 
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NI 172
Query: 273 CESHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN 324
            +  T+    GT  YI              D ++F V+L E++  + P    F+ ++   
Sbjct: 173 WDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGEDEDE 228
Query: 325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR 361
           L   +++  +  AY K    + + I  G +  +P  R
Sbjct: 229 LFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 33/57 (57%), Gaps = 6/57 (10%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           G  F+H   +  IIHRD+  +N LLN+D  VKV DFGL R I+   S   T++   +
Sbjct: 141 GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN---SEKDTNIVNDL 191

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 10/59 (16%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           RG+ ++H      IIHRD+  SN+ +NED E+K+ D GL R       HT  ++ G + 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEMTGYVA 184

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NI+QL           +V++ M KG L D+L      ++ +   I       I  LH   
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 128
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           + +I+HRD+   NILL++D  +K++DFG    +   E     +V GT  Y+
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 177

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 13/91 (14%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           RG+ FLH      I+HRD+   NIL+     VK++DFGL R+ S       T V  T+ Y
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWY 185
Query: 288 ----ILL----ACGGDIYSFSVVLLELVIRK 310
               +LL    A   D++S   +  E+  RK
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           GI + H R    ++HRD+   N+L+N + E+K++DFGL R
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           GI + H R    ++HRD+   N+L+N + E+K++DFGL R
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
           GI + H R    ++HRD+   N+L+N + E+K++DFGL R
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NI+QL           +V++ M KG L D+L      ++ +   I       I  LH   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 141
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           + +I+HRD+   NILL++D  +K++DFG    +   E     +V GT  Y+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 190

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 18/44 (40%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
           RG+ + H +    ++HRD+   N+L+NE  E+K++DFGL R  S
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/111 (25%), Positives = 52/111 (46%), Gaps = 11/111 (9%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-----NQAKHCIIACGTARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+     ++ +        A  +++ H + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK- 131
Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
              +IHRDI   N+LL  + E+K++DFG         S     + GT+ Y+
Sbjct: 132 --RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYL 177

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 150 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEILM 235

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 124 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEILM 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 33/154 (21%)
Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIA------------------- 223
           N+V LLG     +   +++ Y   G L+++L  ++ H  +                    
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 224 --CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT---- 277
                A G+ +L      H++H+D+   N+L+ +   VK+SD GL R +   + +     
Sbjct: 150 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 278 -----STDVAGTIGYILLACGGDIYSFSVVLLEL 306
                       I Y   +   DI+S+ VVL E+
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILM 204

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 9/80 (11%)
Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC-------- 292
           II+RD+   NILL+E+  +K++DFGL +   D E    +   GT+ Y+            
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEVVNRQGHSH 209
Query: 293 GGDIYSFSVVLLELVIRKQP 312
             D +S+ V++ E++    P
Sbjct: 210 SADWWSYGVLMFEMLTGSLP 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 125 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEILM 210

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 8/86 (9%)
Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD--------VA 282
           T L +      +HRDI A N+L++ +  VK+ DFGL R + D   + ++           
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 283 GTIGYILLACGGDIYSFSVVLLELVI 308
            +I +       D++ F V + E+++
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILM 207

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	383
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-67
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-57
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-57
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-46
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-36
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-31
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-20
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-19
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-17
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-15
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-14
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-14
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-14
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-13
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-12
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-12
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-12
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-12
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-11
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-11
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-10
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-10
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-08
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-06
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-05
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-09
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-09
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-09
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-09
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-09
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-08
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-07
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-09
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-05
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-07
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-07
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-06
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-06
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-06
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  215 bits (549), Expect = 2e-67
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 71/293 (24%)

Query: 150 SLGKLTYDQIVAGTNKFYEKNVI-RGDDFGIAFK-------------------------- 182
            L + +  ++   ++ F  KN++ RG  FG  +K                          
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGG-FGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74

Query: 183 -------------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------- 221
                        N+++L G+C    ++L+VY YM  GS+   LR + +           
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
            IA G+ARG+ +LH    P IIHRD+ A+NILL+E+FE  V DFGL +L+   ++H +T 
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 281 VAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGP-EFKDKNGGNLVDWV-- 329
           V GTIG+I          +   D++ + V+LLEL+  ++        + +   L+DWV  
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 330 ----------LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
                     +D  +   Y    + +++Q+ + C   +P  RP M  V   LE
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  189 bits (482), Expect = 2e-57
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 72/286 (25%)

Query: 155 TYDQIVAGTNKFYEKNVI---------RG---DDFGIAFK-------------------- 182
               +   TN F  K +I         +G   D   +A K                    
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89

Query: 183 ------NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------IACGTA 227
                 ++V L+G+C    + +++Y+YM  G+L   L       +         I  G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-ESHTSTDVAGTIG 286
           RG+ +LH      IIHRD+ + NILL+E+F  K++DFG+ +  ++  ++H ST V GT+G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206

Query: 287 YI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL-------- 330
           YI         L    D+YSF VVL E++  +         +   NL +W +        
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNLAEWAVESHNNGQL 265

Query: 331 ----DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
               D  + +     S+ K     V C+  +   RP+M  V   LE
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  188 bits (480), Expect = 3e-57
 Identities = 72/224 (32%), Positives = 106/224 (47%), Gaps = 40/224 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH--------CIIACGTARGITFL 233
           +N+V+LLG+   G+   +VY YM  GSL D L              C IA G A GI FL
Sbjct: 90  ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTIGYI---- 288
           H   + H IHRDI ++NILL+E F  K+SDFGL R      ++  ++ + GT  Y+    
Sbjct: 150 H---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206

Query: 289 ---LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG--NLVDWV-------------L 330
               +    DIYSF VVLLE++     TG    D++     L+D               +
Sbjct: 207 LRGEITPKSDIYSFGVVLLEII-----TGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI 261

Query: 331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
           D   +N     S+  M  +   C+ +    RP + +VQ+ L++ 
Sbjct: 262 DKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  159 bits (404), Expect = 5e-46
 Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 48/239 (20%)

Query: 182 KNIVQLLGYCPVGEK----KLIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGITFL 233
           +NI+Q +G    G        ++  +  KGSL+D+L+       + C IA   ARG+ +L
Sbjct: 78  ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYL 137

Query: 234 HH-------RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTI 285
           H          +P I HRDI + N+LL  +    ++DFGL       +S   T    GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 286 GYI---LLACG----------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--- 329
            Y+   +L              D+Y+  +VL EL  R         +       + +   
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE-YMLPFEEEIGQH 256

Query: 330 --------------LDSTILNAYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEK 373
                             + + + K + + ML + +  C   +   R +   V E + +
Sbjct: 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  132 bits (335), Expect = 4e-36
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------IIACGTARGITFL 233
            NIV  +G         IV EY+ +GSL   L                +A   A+G+ +L
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LL 290
           H+R  P I+HR++ + N+L+++ + VKV DFGL RL +     +S   AGT  ++   +L
Sbjct: 154 HNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVL 211

Query: 291 ACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
                    D+YSF V+L EL   +QP    + + N   +V  V          +  +  
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP----WGNLNPAQVVAAV-----GFKCKRLEIPR 262

Query: 344 ---LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
               ++  I+ GC  + P  RP+   + + L   
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  133 bits (336), Expect = 4e-36
 Identities = 50/249 (20%), Positives = 90/249 (36%), Gaps = 57/249 (22%)

Query: 182 KNIVQLLGYC-----PVGEKKLIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGITF 232
            NI + +            + L+V EY   GSL  +L          C +A    RG+ +
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAY 126

Query: 233 LH------HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC-------ESHTST 279
           LH        ++P I HRD+N+ N+L+  D    +SDFGL   ++         E + + 
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 280 DVAGTIGY---------ILLACGG------DIYSFSVVLLELVIRKQPTGPE-------- 316
              GTI Y         + L          D+Y+  ++  E+ +R     P         
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

Query: 317 -FKDKNGGN-----LVDWVLDS----TILNAYSKPS--MLKMLQIVVGCIFDNPTTRPTM 364
            F+ + G +     +   V           A+ + S  +  + + +  C   +   R T 
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306

Query: 365 LRVQEFLEK 373
              +E + +
Sbjct: 307 QXAEERMAE 315

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 2e-34
 Identities = 51/238 (21%), Positives = 92/238 (38%), Gaps = 46/238 (19%)

Query: 182 KNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGITFL 233
           +NI+  +     G        ++ +Y   GSL D+L++          +A  +  G+  L
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150

Query: 234 H-----HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT---STDVAGTI 285
           H      + +P I HRD+ + NIL+ ++    ++D GL        +          GT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 286 GY----ILLACGG----------DIYSFSVVLLELVIRKQPTGPE------FKDKNG--- 322
            Y    +L               D+YSF ++L E+  R    G        + D      
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270

Query: 323 --GNLVDWVLDS----TILNAYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEK 373
              ++ + V       +  N +S    L+ + +++  C   NP +R T LRV++ L K
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  126 bits (318), Expect = 7e-34
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 38/218 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            NI+  +GY     +  IV ++    SL   L              IA  TARG+ +LH 
Sbjct: 80  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH- 137

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTDVAGTIGY-----IL 289
                IIHRD+ ++NI L+ED  VK+ DFGL    S    SH    ++G+I +     I 
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 290 LACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           +          D+Y+F +VL EL+  + P    + + N  + +  ++          P +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIEMVG----RGSLSPDL 247

Query: 344 LK--------MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            K        M +++  C+      RP+  R+   +E+
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (317), Expect = 1e-33
 Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 46/238 (19%)

Query: 182 KNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGITFL 233
           +NI+  +              ++  Y   GSL D+L+           I    A G+  L
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121

Query: 234 H-----HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH---TSTDVAGTI 285
           H      + +P I HRD+ + NIL+ ++ +  ++D GL  + S   +     +    GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 286 GY---------ILLACGG-----DIYSFSVVLLELVIRKQPTGPE------FKDKNGGN- 324
            Y         I + C       DI++F +VL E+  R    G        F D    + 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 325 ----LVDWVLDS----TILNAYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEK 373
               +   V        I N +     L  L +++  C + NP+ R T LR+++ L K
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  124 bits (314), Expect = 2e-33
 Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 39/216 (18%)

Query: 182 KNIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITF 232
            N++ +LG C  P      ++  +M  GSL + L       +        A   ARG+ F
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG------ 286
           LH   +P I    +N+ +++++ED   ++S   +        S  S              
Sbjct: 127 LHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEA 179

Query: 287 -----YILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS----TILNA 337
                        D++SF+V+L ELV R+ P    F D +   +   V       TI   
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADLSNMEIGMKVALEGLRPTIPPG 235

Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            S      + +++  C+ ++P  RP    +   LEK
Sbjct: 236 ISPH----VSKLMKICMNEDPAKRPKFDMIVPILEK 267

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  123 bits (311), Expect = 2e-32
 Identities = 49/238 (20%), Positives = 84/238 (35%), Gaps = 46/238 (19%)

Query: 182 KNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQA----KHCIIACGTARGITFL 233
           +NI+  +              +V +Y   GSL D+L            +A  TA G+  L
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 155

Query: 234 H-----HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT---STDVAGTI 285
           H      + +P I HRD+ + NIL+ ++    ++D GL                   GT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 286 GY----ILLACGG----------DIYSFSVVLLELVIRKQPTGPE------FKDKNGGN- 324
            Y    +L               DIY+  +V  E+  R    G        + D    + 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 325 ----LVDWVLDSTI-----LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
               +   V +  +         S  ++  M +I+  C + N   R T LR+++ L +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  121 bits (307), Expect = 2e-32
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 35/216 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRF 237
            NI+ L G C       +V E+   G LN  L  +          A   ARG+ +LH   
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEA 125

Query: 238 QPHIIHRDINASNILLNEDFE--------VKVSDFGLVRLISDCESHTSTDVAGTIGYI- 288
              IIHRD+ +SNIL+ +  E        +K++DFGL R        T    AG   ++ 
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMA 182

Query: 289 --LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS----TILNA 337
             ++         D++S+ V+L EL+  + P    F+  +G  +   V  +     I + 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAVAYGVAMNKLALPIPST 238

Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             +P      +++  C   +P +RP+   + + L  
Sbjct: 239 CPEP----FAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  121 bits (305), Expect = 7e-32
 Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 36/214 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------IIACGTARGITFL 233
            NIV+L G C       +V EY   GSL + L                     ++G+ +L
Sbjct: 61  PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 234 HHRFQPHIIHRDINASNILLNEDFEV-KVSDFGLVRLISDCESHTSTDVAGTIGYI---L 289
           H      +IHRD+   N+LL     V K+ DFG    I        T+  G+  ++   +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEV 174

Query: 290 LACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNL-VDWVLDS----TILNAYS 339
                     D++S+ ++L E++ R++P    F +  G    + W + +     ++    
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPLIKNLP 230

Query: 340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           KP    +  ++  C   +P+ RP+M  + + +  
Sbjct: 231 KP----IESLMTRCWSKDPSQRPSMEEIVKIMTH 260

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (302), Expect = 2e-31
 Identities = 46/226 (20%), Positives = 89/226 (39%), Gaps = 41/226 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
            N+++ +G     ++   + EY+  G+L   +++             A   A G+ +LH 
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI---GYILLAC 292
               +IIHRD+N+ N L+ E+  V V+DFGL RL+ D ++      +             
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 293 GG------------------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
           G                   D++SF +VL E++ R     P++  +     ++      +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-PDYLPRTMDFGLN------V 236

Query: 335 LNAYSKPSM----LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
                +            I V C   +P  RP+ ++++ +LE    
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  119 bits (300), Expect = 3e-31
 Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            NIV+L G         +V E++  G L   L ++A          +    A GI ++ +
Sbjct: 83  PNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 236 RFQPHIIHRDINASNILL-----NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY--- 287
           +  P I+HRD+ + NI L     N     KV+DFGL +       H+ + + G   +   
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAP 195

Query: 288 -ILLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGG--NLVDWVLDS----TI 334
             + A         D YSF+++L  ++  + P    F + + G    ++ + +     TI
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRPTI 251

Query: 335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                 P  L+   ++  C   +P  RP    + + L +
Sbjct: 252 PEDC--PPRLR--NVIELCWSGDPKKRPHFSYIVKELSE 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (291), Expect = 9e-30
 Identities = 42/220 (19%), Positives = 84/220 (38%), Gaps = 37/220 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
           +N+V  +G C       I+       +L   +R+            IA    +G+ +LH 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH- 147

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE----SHTSTDVAGTIGY---- 287
                I+H+D+ + N+  +   +V ++DFGL  +    +            G + +    
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 288 ILLACGG-------------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
           I+                  D+++   +  EL  R+ P    FK +    ++ W + + +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKTQPAEAII-WQMGTGM 259

Query: 335 LNAYSKPSMLKML-QIVVGCIFDNPTTRPTMLRVQEFLEK 373
               S+  M K +  I++ C       RPT  ++ + LEK
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (263), Expect = 2e-25
 Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 28/212 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHH 235
            NIV+L+G C   +   IV E +  G    +LR +           +    A G+ +L  
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TI 285
           +     IHRD+ A N L+ E   +K+SDFG+ R  +D   + ++               +
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEAL 287

Query: 286 GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSM 343
            Y   +   D++SF ++L E       P    + + +     ++V     L      P  
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP----YPNLSNQQTREFVEKGGRLPCPELCPDA 343

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH 375
           +   +++  C    P  RP+   + + L+   
Sbjct: 344 VF--RLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  106 bits (266), Expect = 2e-25
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + +L 
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TI 285
            +   + IHR++ A N L+ E+  VKV+DFGL RL++  +++T+   A          ++
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESL 391

Query: 286 GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSM 343
            Y   +   D+++F V+L E+      P    +   +   + + +     +      P  
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRMERPEGCPEK 447

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF 380
           +   +++  C   NP+ RP+   + +  E      + 
Sbjct: 448 VY--ELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  100 bits (251), Expect = 2e-23
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 31/217 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
           + +VQL       E   IV EYM KGSL D+L+ +    +       +A   A G+ ++ 
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GTIG 286
                + +HRD+ A+NIL+ E+   KV+DFGL RLI D E                    
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSML 344
           Y       D++SF ++L EL  + + P    +       ++D V     +    + P  L
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQVERGYRMPCPPECPESL 493

Query: 345 K--MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
              M Q    C    P  RPT   +Q FLE Y T   
Sbjct: 494 HDLMCQ----CWRKEPEERPTFEYLQAFLEDYFTSTE 526

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 31/217 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
           + +VQL       E   IV EYM KGSL D+L+ +    +       +A   A G+ ++ 
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA--------GTIG 286
                + +HRD+ A+NIL+ E+   KV+DFGL RLI D E                    
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSK-PSML 344
           Y       D++SF ++L EL  + + P    +       ++D V     +    + P  L
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQVERGYRMPCPPECPESL 410

Query: 345 K--MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
              M Q    C    P  RPT   +Q FLE Y T   
Sbjct: 411 HDLMCQ----CWRKEPEERPTFEYLQAFLEDYFTSTE 443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + +L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------TI 285
            +   + IHRD+ A N L+ E+  VKV+DFGL RL++  +++T+   A          ++
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESL 184

Query: 286 GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM- 343
            Y   +   D+++F V+L E+      P    +   +   + + +     +    +P   
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLEKDYRM---ERPEGC 237

Query: 344 -LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF 380
             K+ +++  C   NP+ RP+   + +  E      + 
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.0 bits (232), Expect = 7e-22
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 33/217 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHH 235
             +V+  G C       IV EY+  G L ++LR+  K         +      G+ FL  
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------- 284
                 IHRD+ A N L++ D  VKVSDFG+ R + D +  +S    GT           
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV---GTKFPVKWSAPEV 176

Query: 285 IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
             Y   +   D+++F +++ E+    K P    +       +V  V     L    +P +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMP----YDLYTNSEVVLKVSQGHRL---YRPHL 229

Query: 344 --LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
               + QI+  C  + P  RPT  ++   +E     +
Sbjct: 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 29/213 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHR 236
           NI++L G     +  +I+ EYM  G+L+ +LR +           +  G A G+ +L + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
              + +HRD+ A NIL+N +   KVSDFGL R++ D    T T   G           I 
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
           Y       D++SF +V+ E++   ++P    + + +   ++  + D   L     P    
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP----YWELSNHEVMKAINDGFRL---PTPMDCP 276

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             + Q+++ C       RP    +   L+K   
Sbjct: 277 SAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 31/216 (14%)

Query: 182 KNIVQLLGYCPVGE-KKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLH 234
            N++ L+G     E    ++  YM  G L  ++R+  ++             ARG+ +L 
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT---------- 284
            +     +HRD+ A N +L+E F VKV+DFGL R I D E ++                 
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 285 -IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
            +         D++SF V+L EL+ R   P    ++  +  +L  ++     L    +P 
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP----YRHIDPFDLTHFLAQGRRL---PQPE 251

Query: 343 M--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
                + Q++  C   +P  RPT   +   +E+  +
Sbjct: 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 92.3 bits (230), Expect = 1e-21
 Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 9/99 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHH 235
           + +VQL G C       I+ EYM  G L ++LR             +       + +L  
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
           +     +HRD+ A N L+N+   VKVSDFGL R + D E
Sbjct: 139 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 9/99 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHH 235
             +VQL G C       +V E+M  G L+D+LR Q           +      G+ +L  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
                +IHRD+ A N L+ E+  +KVSDFG+ R + D +
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 29/213 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLHHR 236
           NI++L G    G   +IV EYM  GSL+ +LR             +  G   G+ +L   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
                +HRD+ A N+L++ +   KVSDFGL R++ D      T   G           I 
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
           +   +   D++SF VV+ E++   ++P    + +    +++  V +   L     P    
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP----YWNMTNRDVISSVEEGYRL---PAPMGCP 280

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
             + Q+++ C   +   RP   ++   L+    
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 182 KNIVQLLGYCPVGEKK-LIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLH 234
            N++ LLG C   E   L+V  YM  G L +++RN+  +             A+G+ +L 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT---------- 284
            +     +HRD+ A N +L+E F VKV+DFGL R + D E ++  +  G           
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

Query: 285 -IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
            +         D++SF V+L EL+ R   P    + D N  ++  ++L    L    +P 
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRRL---LQPE 255

Query: 343 M--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
                + ++++ C       RP+   +   +    +
Sbjct: 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 19/141 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           NI++L G     +  +IV EYM  GSL+ +LR             +  G A G+ +L   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
                +HRD+ A NIL+N +   KVSDFGL R++ D      T   G           I 
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 287 YILLACGGDIYSFSVVLLELV 307
           Y       D++S+ +VL E++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVM 244

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 35/226 (15%)

Query: 182 KNIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKH----CIIACGTARGITFLHH 235
           ++I++  G C         +V EY+  GSL D+L   +       + A     G+ +LH 
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TI 285
           +   H IHRD+ A N+LL+ D  VK+ DFGL + + +   +      G           +
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 286 GYILLACGGDIYSFSVVLLELV-----------IRKQPTGPEFKDKNGGNLVDWVLDSTI 334
                    D++SF V L EL+              +  G          L + +     
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269

Query: 335 LNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           L    +P     ++  ++  C     + RPT   +   L+  H   
Sbjct: 270 L---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.4 bits (225), Expect = 9e-21
 Identities = 45/213 (21%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-----IACGTARGITFLHHR 236
             IV+++G C   E  ++V E    G LN +L+            +    + G+ +L   
Sbjct: 78  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
              + +HRD+ A N+LL      K+SDFGL + +   E++      G           I 
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
           Y   +   D++SF V++ E     ++P    ++   G  +   +     +     P+   
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKGERM---GCPAGCP 246

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
            +M  ++  C   +   RP    V+  L  Y+ 
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 10/107 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            ++ +LLG C       ++ + M  G L D++R    +             A+G+ +L  
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA 282
           R    ++HRD+ A N+L+     VK++DFGL +L+   E     +  
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 9e-21
 Identities = 45/223 (20%), Positives = 89/223 (39%), Gaps = 32/223 (14%)

Query: 183 NIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLH 234
           NIV+  G C    ++   ++ EY+  GSL D+L+   +               +G+ +L 
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------T 284
            +     IHRD+   NIL+  +  VK+ DFGL +++   + +      G          +
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 285 IGYILLACGGDIYSFSVVLLELV---IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS-- 339
           +     +   D++SF VVL EL     + +    EF    G +    ++   ++      
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279

Query: 340 ----KPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +P     ++  I+  C  +N   RP+   +   +++   
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 11/100 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
           + +V+L       E   I+ EYM  GSL D+L+  +   +       +A   A G+ F+ 
Sbjct: 68  QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
            R   + IHRD+ A+NIL+++    K++DFGL RLI D E
Sbjct: 127 ER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 183 NIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLH 234
           NIV+  G C         ++ EY+  GSL D+L+   +               +G+ +L 
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------T 284
            +     IHRD+   NIL+  +  VK+ DFGL +++   +        G          +
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 285 IGYILLACGGDIYSFSVVLLELV---IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS-- 339
           +     +   D++SF VVL EL     + +    EF    G +    ++   ++      
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248

Query: 340 ----KPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +P     ++  I+  C  +N   RP+   +   +++   
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 37/220 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---------------IACGT 226
            ++V+LLG    G+  L++ E M +G L  +LR+                     +A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + + +          
Sbjct: 148 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204

Query: 284 ------TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILN 336
                 ++   +     D++SF VVL E+    +QP    ++  +   ++ +V++  +L 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQVLRFVMEGGLL- 259

Query: 337 AYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
              KP      + +++  C   NP  RP+ L +   +++ 
Sbjct: 260 --DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 182 KNIVQLLGYCPVGEKK-LIVYEYMVKGSLNDWLRNQAKHCI------IACGTARGITFLH 234
            N++ LLG C   E   L+V  YM  G L +++RN+  +             A+G+ FL 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT---------- 284
            +     +HRD+ A N +L+E F VKV+DFGL R + D E  +  +  G           
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 285 -IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
            +         D++SF V+L EL+ R   P    + D N  ++  ++L    L    +P 
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRRL---LQPE 319

Query: 343 M--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
                + ++++ C       RP+   +   +    +
Sbjct: 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 47/225 (20%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
             +V+L       E   I+ E+M KGSL D+L++              +   A G+ F+ 
Sbjct: 243 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT---------- 284
            R   + IHRD+ A+NIL++     K++DFGL R+I D E        G           
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE---GAKFPIKWTAPE 355

Query: 285 -IGYILLACGGDIYSFSVVLLELVIR-KQP----TGPEFKDKNGGNLVDWVLDSTILNAY 338
            I +       D++SF ++L+E+V   + P    + PE            V+ + +   Y
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------------VIRA-LERGY 402

Query: 339 SKPSML----KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
             P       ++  I++ C  + P  RPT   +Q  L+ ++T   
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 37/223 (16%)

Query: 182 KNIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFL 233
           +NIV+  G C    G    ++ E++  GSL ++L               A    +G+ +L
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------- 283
             R     +HRD+ A N+L+  + +VK+ DFGL + I   + + +               
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 284 TIGYILLACGGDIYSFSVVLLELV-----------IRKQPTGPEFKDKNGGNLVDWVLDS 332
            +         D++SF V L EL+           +  +  GP         LV+ + + 
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259

Query: 333 TILNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             L     P     ++ Q++  C    P+ R +   + E  E 
Sbjct: 260 KRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 43/229 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           ++IV+  G C  G+  ++V+EYM  G LN +LR      +                    
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
            IA   A G+ +L  +   H +HRD+   N L+  +  VK+ DFG+ R +   + +    
Sbjct: 137 HIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193

Query: 281 VAG---------TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVL 330
                       +I Y       D++SF V+L E+    KQP    +   +   +++ + 
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSNTEVIECIT 249

Query: 331 DSTILNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG 377
              +L    +P +   ++  +++GC    P  R  +  + + L      
Sbjct: 250 QGRVL---ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 10/110 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
             IV+L+G C   E  ++V E    G L+ +L  + +         +    + G+ +L  
Sbjct: 70  PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
           +   + +HRD+ A N+LL      K+SDFGL + +   +S+ +   AG  
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
            N+VQLLG     +  L IV EYM KGSL D+LR++ +  +        +      + +L
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
                 + +HRD+ A N+L++ED   KVSDFGL +
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
            N+VQLLG     +  L IV EYM KGSL D+LR++ +  +        +      + +L
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
                 + +HRD+ A N+L++ED   KVSDFGL +
Sbjct: 134 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 31/226 (13%)

Query: 182 KNIVQLLGYCPVGEKK--LIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFL 233
             IV+  G      ++   +V EY+  G L D+L+            + +    +G+ +L
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG---------- 283
             R     +HRD+ A NIL+  +  VK++DFGL +L+   + +      G          
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 284 TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAY---- 338
           ++   + +   D++SF VVL EL     +   P  +          V   + L       
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 339 ---SKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
                P     ++ +++  C   +P  RP+   +   L+   +G  
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 10/108 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
           +N+++L G         +V E    GSL D LR    H         A   A G+ +L  
Sbjct: 81  RNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG 283
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H       
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.0 bits (219), Expect = 5e-20
 Identities = 46/216 (21%), Positives = 83/216 (38%), Gaps = 34/216 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           +IV+L+G     E   I+ E    G L  +L             + +    + + +L   
Sbjct: 74  HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-----------I 285
              + +HRDI   NIL+     VK+ DFGL R I D + + ++    T           I
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---VTRLPIKWMSPESI 186

Query: 286 GYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM- 343
            +       D++ F+V + E++   KQP    F      +++  +     L    KP + 
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLENKDVIGVLEKGDRL---PKPDLC 239

Query: 344 -LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
              +  ++  C   +P+ RP    +   L   +  E
Sbjct: 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 29/213 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            ++ +LLG C       ++ + M  G L D++R    +             A+G+ +L  
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT---------IG 286
           R    ++HRD+ A N+L+     VK++DFGL +L+   E     +             I 
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
           + +     D++S+ V + EL+    +P    +       +   +     L    +P +  
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGERL---PQPPICT 245

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
           + +  I+V C   +  +RP    +     K   
Sbjct: 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 34/218 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            +IV+L+G         I+ E    G L  +L+ +          + A   +  + +L  
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT----------- 284
           +     +HRDI A N+L++ +  VK+ DFGL R + D   + ++                
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS---KGKLPIKWMAPES 188

Query: 285 IGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
           I +       D++ F V + E+++   +P    F+     +++  + +   L     P  
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERL---PMPPN 241

Query: 344 --LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN 379
               +  ++  C   +P+ RP    ++  L      E 
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 10/105 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            +IV+LLG CP G    +V +Y+  GSL D +R                  A+G+ +L  
Sbjct: 75  AHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
                ++HR++ A N+LL    +V+V+DFG+  L+   +      
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 22/108 (20%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------I 222
           +NIV LLG C  G   L++ EY   G L ++LR +++                       
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 223 ACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
           +   A+G+ FL  +   + IHRD+ A N+LL      K+ DFGL R I
Sbjct: 170 SSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/225 (24%), Positives = 87/225 (38%), Gaps = 42/225 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           ++IV+  G C  G   L+V+EYM  G LN +LR+                          
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +A   A G+ +L      H +HRD+   N L+ +   VK+ DFG+ R I   + +     
Sbjct: 163 VASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219

Query: 282 AG---------TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLD 331
                      +I Y       D++SF VVL E+    KQP    +   +    +D +  
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WYQLSNTEAIDCITQ 275

Query: 332 STILNAYSKPS--MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
              L    +P     ++  I+ GC    P  R ++  V   L+  
Sbjct: 276 GREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 24/110 (21%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           KNI+ LLG C       ++ EY  KG+L ++LR +    +                    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                 ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 41/216 (18%), Positives = 85/216 (39%), Gaps = 28/216 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            +IV+L+G         I+ E    G L  +L+ +          + A   +  + +L  
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD----VAGT----IGY 287
           +     +HRDI A N+L++ +  VK+ DFGL R + D   + ++     +       I +
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566

Query: 288 ILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM--L 344
                  D++ F V + E+++   +P    F+     +++  + +   L     P     
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENGERL---PMPPNCPP 619

Query: 345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF 380
            +  ++  C   +P+ RP    ++  L      E  
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKL 655

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 26/112 (23%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT--------------- 226
            NIV LLG C +G   L++ EY   G L ++LR +    I +  +               
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 227 --------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                   A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 38/223 (17%)

Query: 182 KNIVQLLGYC----PVGEKK-LIVYEYMVKGSLNDWLRNQAKHC-----------IIACG 225
            N+++LLG C      G  K +++  +M  G L+ +L                       
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG-- 283
            A G+ +L +R   + +HRD+ A N +L +D  V V+DFGL + I   + +    +A   
Sbjct: 156 IALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 284 -------TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTIL 335
                  ++   +     D+++F V + E+  R   P    +       + D++L    L
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPGVQNHEMYDYLLHGHRL 268

Query: 336 NAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
               +P     ++ +I+  C   +P  RPT   ++  LEK   
Sbjct: 269 ---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 63/238 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           KNI+ LLG C       ++ EY  KG+L ++LR +    +                    
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
                 ARG+ +L  +     IHRD+ A N+L+ E+  +K++DFGL R I++ + +    
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 260

Query: 281 VAGTIGYI--------LLACG-----GDIYSFSVVLLELVIR-KQP----TGPEFKD--K 320
              T G +         L         D++SF V++ E+      P       E     K
Sbjct: 261 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

Query: 321 NGGNLVDWVLDSTILNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
            G  +              KP+    ++  ++  C    P+ RPT  ++ E L++  T
Sbjct: 320 EGHRM-------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 24/114 (21%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
            N+V LLG     +   +++ Y   G L+++L  ++ H                      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE 274
            +    A G+ +L      H++H+D+   N+L+ +   VK+SD GL R +   +
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 33/108 (30%), Positives = 46/108 (42%), Gaps = 24/108 (22%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
            NI+ LLG C       +  EY   G+L D+LR                           
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR 268
             A   ARG+ +L  +     IHRD+ A NIL+ E++  K++DFGL R
Sbjct: 146 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 87.3 bits (216), Expect = 7e-19
 Identities = 42/213 (19%), Positives = 89/213 (41%), Gaps = 30/213 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
            IV+L+G C   E  ++V E    G L+ +L  + +         +    + G+ +L  +
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG----------TIG 286
              + +HR++ A N+LL      K+SDFGL + +   +S+ +   AG           I 
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

Query: 287 YILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM-- 343
           +   +   D++S+ V + E +   ++P    +K   G  ++ ++     +     P    
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGKRM---ECPPECP 565

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
            ++  ++  C       RP  L V++ +   + 
Sbjct: 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 31/108 (28%), Positives = 41/108 (37%), Gaps = 18/108 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------------IACGTARG 229
           +NIV+ +G       + I+ E M  G L  +LR                   +A   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 230 ITFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLISDCE 274
             +L      H IHRDI A N LL         K+ DFG+ R I    
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 42/224 (18%), Positives = 85/224 (37%), Gaps = 39/224 (17%)

Query: 182 KNIVQLLGYC------PVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----------IIAC 224
            ++ +L+G              +++  +M  G L+ +L                      
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 225 GTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG- 283
             A G+ +L  R   + IHRD+ A N +L ED  V V+DFGL R I   + +     +  
Sbjct: 145 DIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 284 --------TIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLVDWVLDSTI 334
                   ++   L     D+++F V + E++ R + P    +       + ++++    
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAGIENAEIYNYLIGGNR 257

Query: 335 LNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
           L    +P     ++  ++  C   +P  RP+   ++  LE    
Sbjct: 258 L---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 8e-19
 Identities = 41/232 (17%), Positives = 80/232 (34%), Gaps = 61/232 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
           K++V   G C  G++ ++V E++  GSL+ +L+             +A   A  + FL  
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 236 RFQPHIIHRDINASNILLNEDFE--------VKVSDFGLVRLISDCE------------- 274
                +IH ++ A NILL  + +        +K+SD G+   +   +             
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188

Query: 275 -------SHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIR-KQPTGPEFKDKNGGNLV 326
                  +  +                D +SF   L E+     +P        +    +
Sbjct: 189 IENPKNLNLAT----------------DKWSFGTTLWEICSGGDKP----LSALDSQRKL 228

Query: 327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
            +  D   L     P   ++  ++  C+   P  RP+   +   L    T +
Sbjct: 229 QFYEDRHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 24/110 (21%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT--------------- 226
           KNI+ LLG C       ++ EY  KG+L ++L+ +    +                    
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 227 ------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                 ARG+ +L  +     IHRD+ A N+L+ ED  +K++DFGL R I
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 31/108 (28%), Positives = 41/108 (37%), Gaps = 18/108 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------------IACGTARG 229
           +NIV+ +G       + I+ E M  G L  +LR                   +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 230 ITFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLISDCE 274
             +L      H IHRDI A N LL         K+ DFG+ R I    
Sbjct: 194 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 31/117 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT--------------- 226
           +NIV LLG C +     +++EY   G L ++LR++ +                       
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 227 -------------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                        A+G+ FL  +     +HRD+ A N+L+     VK+ DFGL R I
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 36/205 (17%)

Query: 182 KNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQAKH--------CIIACGTARG 229
            NIV+         K     ++V E M  G+L  +L+   +                 +G
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKG 141

Query: 230 ITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTI--- 285
           + FLH R  P IIHRD+   NI +      VK+ D GL  L     +     V GT    
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFM 197

Query: 286 -------GYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY 338
                   Y       D+Y+F + +LE+   + P       +N   +   V       ++
Sbjct: 198 APEMYEEKYDESV---DVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGVKPASF 251

Query: 339 SKPSMLKMLQIVVGCIFDNPTTRPT 363
            K ++ ++ +I+ GCI  N   R +
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYS 276

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 30/118 (25%), Positives = 50/118 (42%), Gaps = 32/118 (27%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGT--------------- 226
            ++++L G C      L++ EY   GSL  +LR   K      G+               
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 227 --------------ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                         ++G+ +L       ++HRD+ A NIL+ E  ++K+SDFGL R +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 25/111 (22%)

Query: 182 KNIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQAKHCI------------------- 221
            N+V LLG C   G   +++ E+   G+L+ +LR++    +                   
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 222 --IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
              +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I
Sbjct: 151 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 47/199 (23%), Positives = 73/199 (36%), Gaps = 30/199 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHH 235
           NIVQ            IV +Y   G L   +  Q                    +  +H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLAC 292
           R    I+HRDI + NI L +D  V++ DFG+ R+++           GT  Y+   +   
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICEN 199

Query: 293 GG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSML 344
                  DI++   VL EL   K      F+  +  NLV  ++  +   +   YS     
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVLKIISGSFPPVSLHYSYD--- 252

Query: 345 KMLQIVVGCIFDNPTTRPT 363
            +  +V      NP  RP+
Sbjct: 253 -LRSLVSQLFKRNPRDRPS 270

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 20/145 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKG-SLNDWLRNQAKHCI-----IACGTARGITFLHHR 236
           NIV ++      +   +V EY ++G +L++++ +     +            GI   H  
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEY-IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGYIL--LACG 293
               I+HRDI   NIL++ +  +K+ DFG+ + +S+  S T T+ V GT+ Y     A G
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQAKG 186

Query: 294 G------DIYSFSVVLLELVIRKQP 312
                  DIYS  +VL E+++ + P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 33/148 (22%), Positives = 55/148 (37%), Gaps = 29/148 (19%)

Query: 176 DFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKG-SLNDWLRNQ---AKHCIIACGTARGIT 231
           +F          +GY        IV EY V G SL      +   A+           ++
Sbjct: 146 NFVEHTDRHGDPVGY--------IVMEY-VGGQSLKRSKGQKLPVAEAIAYLLEILPALS 196

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL-- 289
           +LH      +++ D+   NI+L E+ ++K+ D G V  I+         + GT G+    
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS----FGY-LYGTPGFQAPE 247

Query: 290 LACGG-----DIYSFSVVLLELVIRKQP 312
           +   G     DIY+    L  L +    
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 32/118 (27%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
            NIV+LLG C VG+   +++EYM  G LN++LR+ + H +                    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 222 ---------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI 270
                    IA   A G+ +L  R     +HRD+   N L+ E+  VK++DFGL R I
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 224

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 199 IVYEYMVKGSLNDWLRNQAKH-------CIIACGTARGITFLHHRFQPHIIHRDINASNI 251
           I  E+  KG+L  W+  +            +     +G+ ++H +    +I+RD+  SNI
Sbjct: 97  IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153

Query: 252 LLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG-----DIYSFSVVL 303
            L +  +VK+ DFGLV  + +    T +   GT+ Y+    ++        D+Y+  ++L
Sbjct: 154 FLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLIL 211

Query: 304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS---MLKMLQIVVGCIFDNPTT 360
            EL+                     + D  I + + K     + K+L          P  
Sbjct: 212 AELL------HVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSK-------KPED 258

Query: 361 RPTM 364
           RP  
Sbjct: 259 RPNT 262

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 20/130 (15%)

Query: 199 IVYEYMVKG-SLNDWLRNQAKHCI-----IACGTARGITFLHHRFQPHIIHRDINASNIL 252
           IV EY V G +L D +  +          +     + + F H      IIHRD+  +NI+
Sbjct: 93  IVMEY-VDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIM 148

Query: 253 LNEDFEVKVSDFGLVRLISDCESH-TSTD-VAGTIGYIL--LACGG------DIYSFSVV 302
           ++    VKV DFG+ R I+D  +  T T  V GT  Y+    A G       D+YS   V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208

Query: 303 LLELVIRKQP 312
           L E++  + P
Sbjct: 209 LYEVLTGEPP 218

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 48/223 (21%), Positives = 78/223 (34%), Gaps = 39/223 (17%)

Query: 183 NIVQLLG--YCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGIT 231
           NIV+              IV EY   G L   +    K            +       + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 232 FLHHR--FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI- 288
             H R      ++HRD+  +N+ L+    VK+ DFGL R+++   S   T V GT  Y+ 
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184

Query: 289 --LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAY 338
              +         DI+S   +L EL     P    F   +   L   + +     I   Y
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRRIPYRY 240

Query: 339 SKPSMLKMLQIVVGCIFDNPTTRPTM---LR---VQEFLEKYH 375
           S     ++ +I+   +      RP++   L    + E    +H
Sbjct: 241 SD----ELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 35/194 (18%), Positives = 60/194 (30%), Gaps = 26/194 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
             V+L      G    +  E     SL                      T   +  LH +
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACG 293
               ++H D+  +NI L      K+ DFGL+  +    +       G   Y+   LL   
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQGS 231

Query: 294 ----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI 349
                D++S  + +LE+    +   P    +    L    L        S      +  +
Sbjct: 232 YGTAADVFSLGLTILEVACNMEL--P-HGGEGWQQLRQGYLPPEFTAGLSSE----LRSV 284

Query: 350 VVGCIFDNPTTRPT 363
           +V  +  +P  R T
Sbjct: 285 LVMMLEPDPKLRAT 298

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 49/251 (19%), Positives = 88/251 (35%), Gaps = 62/251 (24%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRF 237
            IV   G      +  I  E+M  GSL+  L+   +        ++    +G+T+L  + 
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------ 291
              I+HRD+  SNIL+N   E+K+ DFG+   + D  +++     GT  Y  ++      
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSY--MSPERLQG 204

Query: 292 ----CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP------ 341
                  DI+S  + L+E+ + + P  P    +        V                  
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 342 -----------SMLKMLQIVV---------------------GCIFDNPTTRPT--MLRV 367
                      ++ ++L  +V                      C+  NP  R     L V
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 368 QEFLEKYHTGE 378
             F+++    E
Sbjct: 325 HAFIKRSDAEE 335

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 40/172 (23%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA-KHCIIAC---GTARGITFLHHRF 237
            NIV  L    VG++  +V EY+  GSL D +         IA       + + FLH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-----------IG 286
              +IHRDI + NILL  D  VK++DFG    I+  +S  ST + GT             
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 192

Query: 287 YILLACGGDIYSFSVVLLELV-----------------IRKQPTGPEFKDKN 321
           Y       DI+S  ++ +E++                 I    T PE ++  
Sbjct: 193 YGPKV---DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPE 240

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 23/150 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----IIACGTA---RGITFL 233
           KNIVQ LG         I  E +  GSL+  LR++          I   T     G+ +L
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 234 HHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----- 287
           H      I+HRDI   N+L+N     +K+SDFG  + ++     T T   GT+ Y     
Sbjct: 139 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEI 194

Query: 288 ILLACGG-----DIYSFSVVLLELVIRKQP 312
           I     G     DI+S    ++E+   K P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 40/172 (23%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
            N+V++     VGE+  ++ E++  G+L D +     N+ +   +     + + +LH + 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ- 160

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-----------IG 286
              +IHRDI + +ILL  D  VK+SDFG    IS       + + GT             
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSL 217

Query: 287 YILLACGGDIYSFSVVLLELV-----------------IRKQPTGPEFKDKN 321
           Y       DI+S  ++++E+V                 +R  P  P+ K+ +
Sbjct: 218 YATEV---DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSH 265

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 30/129 (23%), Positives = 45/129 (34%), Gaps = 20/129 (15%)

Query: 199 IVYEYMVKG-SLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL 252
           +     + G  L   LR Q      +   I       +   H        HRD+   NIL
Sbjct: 111 VDMRL-INGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENIL 166

Query: 253 LNEDFEVKVSDFGLVRLISDCESHTSTDVA-GTIGYIL--LACGG------DIYSFSVVL 303
           ++ D    + DFG+    +D E  T      GT+ Y+              DIY+ + VL
Sbjct: 167 VSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225

Query: 304 LELVIRKQP 312
            E +    P
Sbjct: 226 YECLTGSPP 234

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 43/202 (21%), Positives = 75/202 (37%), Gaps = 31/202 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           N+++         +  IV E    G L+  +++  K                    +  +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LL 290
           H R    ++HRDI  +N+ +     VK+ D GL R  S   +   + + GT  Y+    +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208

Query: 291 ACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI----LNAYSKP 341
              G     DI+S   +L E+   + P        N  +L   +          + YS+ 
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266

Query: 342 SMLKMLQIVVGCIFDNPTTRPT 363
             L+  Q+V  CI  +P  RP 
Sbjct: 267 --LR--QLVNMCINPDPEKRPD 284

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 17/116 (14%)

Query: 182 KNIVQLLG-----YCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI----IAC---GTAR 228
           +NI    G       P  + +L +V E+   GS+ D ++N   + +    IA       R
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
           G++ LH   Q  +IHRDI   N+LL E+ EVK+ DFG+   +       +T   GT
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGT 192

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 31/157 (19%), Positives = 50/157 (31%), Gaps = 32/157 (20%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI----IAC---GTARGITFLH 234
            NIV          +  +V  +M  GS  D +       +    IA    G  + + ++H
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST------DVAGT---- 284
           H      +HR + AS+IL++ D +V +S       +                        
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 285 ---------IGYILLACGGDIYSFSVVLLELVIRKQP 312
                     GY   +   DIYS  +   EL     P
Sbjct: 203 SPEVLQQNLQGYDAKS---DIYSVGITACELANGHVP 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 73.1 bits (180), Expect = 9e-15
 Identities = 23/90 (25%), Positives = 44/90 (48%), Gaps = 9/90 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
             IV+LLG      K  I+ E+   G+++  +    +        ++       + FLH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFG 265
           +    IIHRD+ A N+L+  + +++++DFG
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFG 162

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 41/194 (21%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFLHHRFQPHIIHRDINASN 250
           I  +   K +L DW+  +        G            + FLH +    ++HRD+  SN
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSN 194

Query: 251 ILLNEDFEVKVSDFGLVR-LISDCESHTS----------TDVAGTIGYI---LLACGG-- 294
           I    D  VKV DFGLV  +  D E  T           T   GT  Y+    +      
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254

Query: 295 ---DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--KMLQI 349
              DI+S  ++L EL+     T  E + +   ++ +          Y +  M+   ML  
Sbjct: 255 HKVDIFSLGLILFELLYSF-STQME-RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSP 312

Query: 350 VVGCIFDNPTTRPT 363
                  +PT RP 
Sbjct: 313 -------SPTERPE 319

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 58/219 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITFL 233
            +I++L  Y        +V E    G +N +L+N+ K    +   AR        G+ +L
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYL 128

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCES-HTSTDVAGTIGYI--- 288
           H      I+HRD+  SN+LL  +  +K++DFGL  +L    E  +T     GT  YI   
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTPNYISPE 182

Query: 289 LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNA-YS 339
           +          D++S   +   L+I + P    F            + +T   ++ A Y 
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDT--------VKNTLNKVVLADYE 230

Query: 340 KPSML---------KMLQIVVGCIFDNPTTRPTMLRVQE 369
            PS L         ++L+        NP  R ++  V +
Sbjct: 231 MPSFLSIEAKDLIHQLLRR-------NPADRLSLSSVLD 262

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 10/109 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            ++V+  G         IV EY   GS++D +R + K         I   T +G+ +LH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
                 IHRDI A NILLN +   K++DFG+   ++D  +  +T + GT
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GT 188

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 33/152 (21%), Positives = 50/152 (32%), Gaps = 27/152 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTA---RGITFLHHR 236
             IV L G    G    I  E +  GSL   ++                   G+ +LH R
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169

Query: 237 FQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTST----DVAGTI------ 285
               I+H D+ A N+LL+ D     + DFG    +       S      + GT       
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 286 -----GYILLACGGDIYSFSVVLLELVIRKQP 312
                         DI+S   ++L ++    P
Sbjct: 227 VVMGKPCDAKV---DIWSSCCMMLHMLNGCHP 255

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 42/210 (20%), Positives = 64/210 (30%), Gaps = 45/210 (21%)

Query: 199 IVYEYMVKGSLNDWLRNQAKHCI--------IACGTARGITFLHHRFQPHIIHRDINASN 250
           I  +   K +L DW+  +             I    A  + FLH +    ++HRD+  SN
Sbjct: 92  IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSN 148

Query: 251 ILLNEDFEVKVSDFGLVR-LISDCESHTSTDVAGTIGYILLACG---------------- 293
           I    D  VKV DFGLV  +  D E  T               G                
Sbjct: 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208

Query: 294 --GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSMLKMLQ 348
              DI+S  ++L EL+       P          +  V +     +              
Sbjct: 209 HKVDIFSLGLILFELLY------PFSTQMERVRTLTDVRNLKFPPLFTQKYP----CEYV 258

Query: 349 IVVGCIFDNPTTRPTMLRV--QEFLEKYHT 376
           +V   +  +P  RP  + +      E    
Sbjct: 259 MVQDMLSPSPMERPEAINIIENAVFEDLDF 288

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 22/140 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR----NQAKHCIIACGTARGITFLHHRF 237
             + +  G      K  I+ EY+  GS  D L     ++ +   I     +G+ +LH   
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT-----------IG 286
               IHRDI A+N+LL+E  EVK++DFG+   ++D +   +T   GT             
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSA 195

Query: 287 YILLACGGDIYSFSVVLLEL 306
           Y   A   DI+S  +  +EL
Sbjct: 196 YDSKA---DIWSLGITAIEL 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 53/221 (23%), Positives = 83/221 (37%), Gaps = 63/221 (28%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARGIT 231
           +++V   G+    +   +V E   + SL +  + +              I+      G  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 155

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYI- 288
           +LH      +IHRD+   N+ LNED EVK+ DFGL   +              GT  YI 
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIA 209

Query: 289 --LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNA- 337
             +L+  G     D++S   ++  L++ K P    F+           L  T   I    
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSC--------LKETYLRIKKNE 257

Query: 338 YSKPSML---------KMLQIVVGCIFDNPTTRPTMLRVQE 369
           YS P  +         KMLQ        +PT RPT+  +  
Sbjct: 258 YSIPKHINPVAASLIQKMLQT-------DPTARPTINELLN 291

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 44/228 (19%), Positives = 78/228 (34%), Gaps = 47/228 (20%)

Query: 170 NVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIA 223
            V+R     +  +N V+ +          I  EY   G+L D + ++  +        + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA- 282
                 ++++H +    IIHRD+   NI ++E   VK+ DFGL + +         D   
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 283 ------------GTIGY----ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
                       GT  Y    +L   G      D+YS  ++  E++       P      
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGME 233

Query: 322 GGNLV------DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
             N++               +   K    K  +I+   I  +P  RP 
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKV--EK--KIIRLLIDHDPNKRPG 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 38/228 (16%), Positives = 80/228 (35%), Gaps = 46/228 (20%)

Query: 182 KNIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWL--RNQAKHCI-------IACGTAR 228
            NI++L+ YC           ++  +  +G+L + +       + +       +  G  R
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA------ 282
           G+  +H        HRD+  +NILL ++ +  + D G +         +   +       
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 283 --GTIGYI---LLACGG--------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
              TI Y    L +           D++S   VL  ++  + P    +   +        
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----Y---DMVFQKGDS 255

Query: 330 LDSTILNAYSKPSMLK----MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           +   + N  S P   +    + Q++   +  +P  RP +  +   LE 
Sbjct: 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 26/151 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
             V   G         I  E M   SL+ + +                IA    + +  L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-----I 288
           H +    +IHRD+  SN+L+N   +VK+ DFG+   + D         AG   Y     I
Sbjct: 126 HSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERI 181

Query: 289 LLACGG-------DIYSFSVVLLELVIRKQP 312
                        DI+S  + ++EL I + P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 51/234 (21%), Positives = 86/234 (36%), Gaps = 56/234 (23%)

Query: 182 KNIVQLLGYCPVGEKKLI--VYEYMV-----KGSLNDWLRNQAKH--------CIIACGT 226
            NIVQ      +G+++      E+++     KG L ++L+               I   T
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVA---- 282
            R +  +H + +P IIHRD+   N+LL+    +K+ DFG    IS    ++ +       
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 283 -------GTIGY-----ILLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGN 324
                   T  Y     I L          DI++   +L  L  R+ P    F+D     
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

Query: 325 LVDWVLDSTILNA-YSKPSMLK----MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                    I+N  YS P           ++   +  NP  R ++  V   L++
Sbjct: 261 ---------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 69.1 bits (170), Expect = 2e-13
 Identities = 53/221 (23%), Positives = 83/221 (37%), Gaps = 63/221 (28%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARGIT 231
           +++V   G+    +   +V E   + SL +  + +              I+      G  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-----GCQ 129

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYI- 288
           +LH      +IHRD+   N+ LNED EVK+ DFGL   +              GT  YI 
Sbjct: 130 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTPNYIA 183

Query: 289 --LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNA- 337
             +L+  G     D++S   ++  L++ K P    F+           L  T   I    
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSC--------LKETYLRIKKNE 231

Query: 338 YSKPSML---------KMLQIVVGCIFDNPTTRPTMLRVQE 369
           YS P  +         KMLQ        +PT RPT+  +  
Sbjct: 232 YSIPKHINPVAASLIQKMLQT-------DPTARPTINELLN 265

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 40/156 (25%), Positives = 53/156 (33%), Gaps = 35/156 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC----------IIACGTARGITF 232
            IVQ  G         I  E M   S + + +                 I   T + +  
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFG----LVRLISDCESHTSTDVAGTIGY- 287
           L       IIHRDI  SNILL+    +K+ DFG    LV       S   T  AG   Y 
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDAGCRPYM 192

Query: 288 ----ILLACGG-------DIYSFSVVLLELVIRKQP 312
               I  +          D++S  + L EL   + P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 35/148 (23%), Positives = 54/148 (36%), Gaps = 22/148 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRF 237
            IVQ  G         I  E M   +     R Q          +     + + +L  + 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY-----ILLAC 292
              +IHRD+  SNILL+E  ++K+ DFG+   + D         AG   Y     I    
Sbjct: 145 --GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPD 200

Query: 293 GG--------DIYSFSVVLLELVIRKQP 312
                     D++S  + L+EL   + P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 43/212 (20%), Positives = 78/212 (36%), Gaps = 49/212 (23%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NI++L GY     +  ++ EY   G++   L+                   A  +++ H 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--YITELANALSYCHS 127

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLAC 292
           +    +IHRDI   N+LL    E+K++DFG                 GT+ Y+   ++  
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL---CGTLDYLPPEMIEG 181

Query: 293 GG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSKPSML-- 344
                  D++S  V+  E ++ K P    F+               I    ++ P  +  
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYK-----RISRVEFTFPDFVTE 232

Query: 345 -------KMLQIVVGCIFDNPTTRPTMLRVQE 369
                  ++L+        NP+ RP +  V E
Sbjct: 233 GARDLISRLLKH-------NPSQRPMLREVLE 257

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 21/161 (13%), Positives = 48/161 (29%), Gaps = 26/161 (16%)

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +     R +  LHH     ++H  +   +I+L++   V ++ F  +              
Sbjct: 216 LTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRG 272

Query: 282 AGTIGYI---LLACGG----------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW 328
                     +L  G           D ++  + +  +     P      D       +W
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEW 328

Query: 329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
           +  S      + P  ++   ++ G +      R   L+  E
Sbjct: 329 IFRSC----KNIPQPVR--ALLEGFLRYPKEDRLLPLQAME 363

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 30/90 (33%), Positives = 42/90 (46%), Gaps = 10/90 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
            N +Q  G         +V EY   GS +D L    K         +  G  +G+ +LH 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFG 265
               ++IHRD+ A NILL+E   VK+ DFG
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFG 199

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 36/218 (16%), Positives = 71/218 (32%), Gaps = 53/218 (24%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITFL 233
           ++V+        +  LI  EY   GSL D +    +            +     RG+ ++
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 234 HHRFQPHIIHRDINASNILLNED-------------------FEVKVSDFGLVRLISDCE 274
           H      ++H DI  SNI ++                        K+ D G V  IS  +
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 275 SHTST-------DVAGTIGYILLACGGDIYSFSVVLLELVIRKQP--TGPEFKDKNGGNL 325
                        +     ++  A   DI++ ++ ++     +     G ++ +   G L
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKA---DIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245

Query: 326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPT 363
                   I    S+       +++   I  +P  RP+
Sbjct: 246 ------PRIPQVLSQE----FTELLKVMIHPDPERRPS 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 31/263 (11%), Positives = 61/263 (23%), Gaps = 47/263 (17%)

Query: 131 IQRGNRQQHLSINLAMFEPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAFKNIVQLLGY 190
                R    S   A     L   +    V     F + +  + D       N + L+  
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA---VANYLLLMPA 169

Query: 191 CPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASN 250
             V  + L     +    +           I+     R    L  +    ++H      N
Sbjct: 170 ASVDLELLF--STLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDN 224

Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG-------DIYSFS 300
           + +  D  + + D   +  +           +  + Y     L           + +   
Sbjct: 225 LFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 301 VVLLELVIRKQPTGPEFKDKNGGNLVDW------VLDSTILNAYSKPSM--------LKM 346
           + +  +     P    F     G    W      V  +  L   S   +         + 
Sbjct: 281 LSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336

Query: 347 LQIVVGCIFDNPTTRPTMLRVQE 369
           L         +   R   L   E
Sbjct: 337 LNF-------DRRRRLLPLEAME 352

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 26/119 (21%), Positives = 48/119 (40%), Gaps = 18/119 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACG-----TAR--------G 229
             +   G     ++  I+YEYM   S+  +                    +         
Sbjct: 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNS 163

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
            +++H+    +I HRD+  SNIL++++  VK+SDFG    + D +   S    GT  ++
Sbjct: 164 FSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFM 217

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 22/167 (13%), Positives = 51/167 (30%), Gaps = 37/167 (22%)

Query: 222 IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV 281
           +     R +  LHH     ++H  +   +I+L++   V ++ F  +              
Sbjct: 211 LTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVS 262

Query: 282 AGTIGYI---LLACGG----------------DIYSFSVVLLELVIRKQPTGPEFKDKNG 322
           + + G+    L A                   D ++  +V+  +     P          
Sbjct: 263 SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAA 318

Query: 323 GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
               +W+  S      + P  ++   ++ G +      R   L+  E
Sbjct: 319 LGGSEWIFRSC----KNIPQPVR--ALLEGFLRYPKEDRLLPLQAME 359

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 41/212 (19%), Positives = 76/212 (35%), Gaps = 49/212 (23%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NI+++  Y    ++  ++ E+  +G L   L+         +   +     A  + + H 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--LADALHYCHE 132

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLAC 292
           R    +IHRDI   N+L+    E+K++DFG           T     GT+ Y+   ++  
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMIEG 186

Query: 293 GG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSKPSML-- 344
                  D++   V+  E ++   P    F   +            I+N     P  L  
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP----FDSPSHTETHR-----RIVNVDLKFPPFLSD 237

Query: 345 -------KMLQIVVGCIFDNPTTRPTMLRVQE 369
                  K+L+        +P  R  +  V E
Sbjct: 238 GSKDLISKLLRY-------HPPQRLPLKGVME 262

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 51/230 (22%), Positives = 79/230 (34%), Gaps = 69/230 (30%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACG-------------TAR 228
            NIV       V ++  +V + +  GS+ D +++         G                
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI--- 285
           G+ +LH       IHRD+ A NILL ED  V+++DFG+   ++     T   V  T    
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 286 -------------GYILLACGGDIYSFSVVLLELV-----------------IRKQPTGP 315
                        GY   A   DI+SF +  +EL                    +    P
Sbjct: 190 PCWMAPEVMEQVRGYDFKA---DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-P 245

Query: 316 EFKDKNGGNLVDWVLDSTILNAYSKP--SMLKMLQIVVGCIFDNPTTRPT 363
             +          V D  +L  Y K    M+ +      C+  +P  RPT
Sbjct: 246 SLETG--------VQDKEMLKKYGKSFRKMISL------CLQKDPEKRPT 281

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 38/213 (17%), Positives = 77/213 (36%), Gaps = 44/213 (20%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN--------QAKHCIIACGTARGITFLH 234
           N+++        + + I  E     +L +++          +    +    T  G+  LH
Sbjct: 79  NVIRYFCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQ--QTTSGLAHLH 135

Query: 235 HRFQPHIIHRDINASNILLNEDFE-----VKVSDFGLVRLISDCESHTS--TDVAGTIGY 287
                +I+HRD+   NIL++           +SDFGL + ++      S  + V GT G+
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 288 I---LLACGG--------DIYSFSVVLLELVIRKQP-----TGPEFKDKNGGNLVDWVLD 331
           I   +L+           DI+S   V   ++             +     G   +D +  
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252

Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTM 364
               +  ++  + KM+ +       +P  RP+ 
Sbjct: 253 EKHEDVIARELIEKMIAM-------DPQKRPSA 278

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 24/146 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLHH 235
            NIV L+          +V+E+M   +K  L++  +   +   I        RG+   H 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
                I+HRD+   N+L+N D  +K++DFGL R        + T    T+ Y    +L+ 
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLM- 192

Query: 292 CGGDIYSFSV-------VLLELVIRK 310
            G   YS SV       +  E++  K
Sbjct: 193 -GSKKYSTSVDIWSIGCIFAEMITGK 217

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 24/148 (16%)

Query: 182 KNIVQLL----GYCPVGEKKL-IVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGI 230
            N+V+L           E KL +V+E++   +   L+           I        RG+
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY--- 287
            FLH      ++HRD+   NIL+    ++K++DFGL R+ S   + TS  V  T+ Y   
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188

Query: 288 -ILL----ACGGDIYSFSVVLLELVIRK 310
            +LL    A   D++S   +  E+  RK
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 43/236 (18%), Positives = 63/236 (26%), Gaps = 60/236 (25%)

Query: 183 NIVQLL------GYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR-------- 228
           N+V               +  L+  EY   G L  +L      C +  G  R        
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 229 GITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTS------- 278
            + +LH      IIHRD+   NI+L    +    K+ D G  + +   E  T        
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY 189

Query: 279 --------------TDV--AGTIGYILLACG---GDIYSFSVVLLELVIRKQPTGPEFKD 319
                          D    GT+ +  +  G          V     V  K        D
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECI-TGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 320 KNGGN------LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE 369
              G       L      S IL    +  +  ML         +   R T  +   
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-------HQRQRGTDPQNPN 297

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 62.2 bits (152), Expect = 4e-11
 Identities = 36/148 (24%), Positives = 64/148 (43%), Gaps = 24/148 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLHH 235
           KNIV+L       +K  +V+E+    +K   +          I+        +G+ F H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
           R   +++HRD+   N+L+N + E+K+++FGL R          +    T+ Y    +L  
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF- 174

Query: 292 CGGDIYSFSV-------VLLELVIRKQP 312
            G  +YS S+       +  EL    +P
Sbjct: 175 -GAKLYSTSIDMWSAGCIFAELANAGRP 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 24/146 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLHH 235
            NIV+L       ++ ++V+E++   +K  L+       +             GI + H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
           R    ++HRD+   N+L+N + E+K++DFGL R          T    T+ Y    +L+ 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLM- 173

Query: 292 CGGDIYSFSV-------VLLELVIRK 310
            G   YS ++       +  E+V   
Sbjct: 174 -GSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 27/150 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKH----CIIACGTA---RGIT 231
           +NIV+L        K  +V+E+M   +K  ++              ++        +G+ 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY---- 287
           F H      I+HRD+   N+L+N+  ++K+ DFGL R       +T +    T+ Y    
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPD 178

Query: 288 ILLACGGDIYSFSV-------VLLELVIRK 310
           +L+  G   YS S+       +L E++  K
Sbjct: 179 VLM--GSRTYSTSIDIWSCGCILAEMITGK 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.1 bits (149), Expect = 9e-11
 Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 71/222 (31%)

Query: 183 NIVQLLGYC---PVGEKKL-IVYEYMVKGSLNDWLRNQAKHCIIACG-----TAR----- 228
           N+V+L          E  L +V+E + +G + +         +          AR     
Sbjct: 97  NVVKL--VEVLDDPNEDHLYMVFELVNQGPVME---------VPTLKPLSEDQARFYFQD 145

Query: 229 ---GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI 285
              GI +LH++    IIHRDI  SN+L+ ED  +K++DFG+       ++  S    GT 
Sbjct: 146 LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-TVGTP 201

Query: 286 GYI---LLACGG--------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
            ++    L+           D+++  V L   V  + P    F D+    L        I
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FMDERIMCLHS-----KI 252

Query: 335 LNA-YSKPS-----------MLKMLQIVVGCIFDNPTTRPTM 364
            +     P            + +ML         NP +R  +
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDK-------NPESRIVV 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 28/158 (17%), Positives = 52/158 (32%), Gaps = 34/158 (21%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLH 234
             I++L  Y    +   +V E      LN WL+        + K           +  +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIH 172

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGY----IL 289
                 I+H D+  +N L+ +   +K+ DFG+   +    +    D   G + Y     +
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 290 LACGG---------------DIYSFSVVLLELVIRKQP 312
                               D++S   +L  +   K P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 24/146 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLHH 235
            NIV L       +   +V+EY+   +K  L+D   N      +        RG+ + H 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
           +    ++HRD+   N+L+NE  E+K++DFGL R  S   + T  +   T+ Y    ILL 
Sbjct: 119 Q---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPDILL- 173

Query: 292 CGGDIYSFSV-------VLLELVIRK 310
            G   YS  +       +  E+   +
Sbjct: 174 -GSTDYSTQIDMWGVGCIFYEMATGR 198

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 28/160 (17%)

Query: 182 KNIVQLLG-YCPVGEKKL----IVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITF 232
           +NI+ +         +++    IV + M +  L   L+ Q       C       RG+ +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKY 143

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS--TDVAGTIGY--- 287
           +H     +++HRD+  SN+LLN   ++K+ DFGL R+      HT   T+   T  Y   
Sbjct: 144 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 288 -ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
            I+L   G     DI+S   +L E++  +    P F  K+
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKH 236

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 31/102 (30%), Positives = 44/102 (43%), Gaps = 17/102 (16%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            GI  LH      IIHRD+  SNI++  D  +K+ DFGL R      S   T    T  Y
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYY 229

Query: 288 ----ILLAC----GGDIYSFSVVLLELVIRKQPTGPEFKDKN 321
               ++L        DI+S   ++ E+V  K      F  ++
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRD 267

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 34/151 (22%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTA----------RGIT 231
            NI+ LL          +V+++M      D L    K   +    +          +G+ 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD-CESHTSTDVAGTIGY--- 287
           +LH  +   I+HRD+  +N+LL+E+  +K++DFGL +       ++T   V  T  Y   
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAP 181

Query: 288 -ILLACGGDIYSFSV-------VLLELVIRK 310
            +L   G  +Y   V       +L EL++R 
Sbjct: 182 ELLF--GARMYGVGVDMWAVGCILAELLLRV 210

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 32/113 (28%), Positives = 51/113 (45%), Gaps = 14/113 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NI+QL           +V++ M KG L D+L  +        +  + A      I  LH 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA--LLEVICALHK 142

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
               +I+HRD+   NILL++D  +K++DFG    +         +V GT  Y+
Sbjct: 143 L---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYL 190

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 15/115 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLH 234
             I++L  Y    +   +V E      LN WL+        + K           +  +H
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIH 125

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGYI 288
                 I+H D+  +N L+ +   +K+ DFG+   +    +    D   GT+ Y+
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 24/148 (16%)

Query: 182 KNIVQLL----GYCPVGEKKL-IVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGI 230
            N+V+L+          E K+ +V+E++   ++  L+           I        RG+
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY--- 287
            FLH      I+HRD+   NIL+     VK++DFGL R+ S   + T   V  T+ Y   
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAP 188

Query: 288 -ILL----ACGGDIYSFSVVLLELVIRK 310
            +LL    A   D++S   +  E+  RK
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 59.5 bits (145), Expect = 4e-10
 Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 24/146 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLHH 235
           +N+V LL  C   ++  +V+E++   +   L     N   + ++         GI F H 
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
               +IIHRDI   NIL+++   VK+ DFG  R ++        D   T  Y    +L+ 
Sbjct: 143 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVATRWYRAPELLV- 197

Query: 292 CGGDIYSFSV-------VLLELVIRK 310
            G   Y  +V       ++ E+ + +
Sbjct: 198 -GDVKYGKAVDVWAIGCLVTEMFMGE 222

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 15/115 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLH 234
             I++L  Y    +   +V E      LN WL+        + K           +  +H
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS--YWKNMLEAVHTIH 144

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGYI 288
                 I+H D+  +N L+ +   +K+ DFG+   +    +    D   GT+ Y+
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.6 bits (146), Expect = 4e-10
 Identities = 61/419 (14%), Positives = 119/419 (28%), Gaps = 120/419 (28%)

Query: 20  IPKNLNELPH----LDLSCNKLNGEISTFLS-----HILGILGLYVQFKIPPDLCNLVQL 70
           I  N          + L  + +  E+   L      + L +L          ++ N    
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL---------NVQNAKAW 259

Query: 71  EYFDFS------------MNMLGG----HI----------PEKNIDLCGKIMGLDYQVLT 104
             F+ S             + L      HI          P++   L  K +    Q L 
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL- 318

Query: 105 FSKLALFGTVVGSVLAIAIIVSMLW-WIQRGNRQQHLSIN--LAMFEPSLGKLTYDQIVA 161
             +  L      +   ++II   +   +   +  +H++ +    + E SL  L   +   
Sbjct: 319 -PREVL----TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY-- 371

Query: 162 GTNKFYEKNVIRGDDFGIAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI 221
              K +++  +      I    +  +       +  ++V + + K SL            
Sbjct: 372 --RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK-LHKYSL------------ 416

Query: 222 IACGTARGITFLHH---RFQPHI-----IHRD-INASNILLNEDFEVKVSDFGLVRLISD 272
           +          +       +  +     +HR  ++  NI    D +    D     L   
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD----DLIPPYLDQY 472

Query: 273 CESHTSTDVAGTIGYILLAC--GGDIYSFSVVLLELV-----IRKQPTGPEFKDKNGGNL 325
             SH        IG+ L        +  F +V L+       IR   T         G++
Sbjct: 473 FYSH--------IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNAS----GSI 520

Query: 326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLR-VQEFLEKYHTGENFGRY 383
           ++ +     L  Y               I DN      ++  + +FL K    EN    
Sbjct: 521 LNTLQQ---LKFYKP------------YICDNDPKYERLVNAILDFLPKI--EENLICS 562

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 29/102 (28%), Positives = 42/102 (41%), Gaps = 17/102 (16%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            GI  LH      IIHRD+  SNI++  D  +K+ DFGL R      S   T    T  Y
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYY 192

Query: 288 ----ILLAC----GGDIYSFSVVLLELVIRKQPTGPEFKDKN 321
               ++L        DI+S   ++ E++         F   +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTD 230

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 28/114 (24%), Positives = 55/114 (48%), Gaps = 14/114 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLH 234
            +I+ L+          +V++ M KG L D+L  +        +  + +      ++FLH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS--LLEAVSFLH 217

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
                +I+HRD+   NILL+++ ++++SDFG    +         ++ GT GY+
Sbjct: 218 AN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTPGYL 266

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 39/144 (27%), Positives = 60/144 (41%), Gaps = 22/144 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYM---VKGSLNDWLRNQAKHCI--IACGTARGITFLHHRF 237
           N+V LL       +  +V+EY    V   L+ + R   +H +  I   T + + F H   
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG 293
             + IHRD+   NIL+ +   +K+ DFG  RL++   S    D   T  Y    +L+  G
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVATRWYRSPELLV--G 176

Query: 294 GDIYSFSV-------VLLELVIRK 310
              Y   V       V  EL+   
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGV 200

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 59.9 bits (146), Expect = 6e-10
 Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 5/77 (6%)

Query: 15  GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQ 69
           G       N   +  LD+S N L+G I   +  +  +  L +        IP ++ +L  
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681

Query: 70  LEYFDFSMNMLGGHIPE 86
           L   D S N L G IP+
Sbjct: 682 LNILDLSSNKLDGRIPQ 698

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 27/87 (31%), Positives = 35/87 (40%), Gaps = 7/87 (8%)

Query: 20  IPK-NLNELPHLDLSCNKLNGEISTFLSHILGIL-GLYVQF-----KIPPDLCNLVQLEY 72
           IP   L  L +L L+ NK  GEI  FLS     L GL +        +PP   +   LE 
Sbjct: 263 IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322

Query: 73  FDFSMNMLGGHIPEKNIDLCGKIMGLD 99
              S N   G +P   +     +  LD
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLD 349

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 6/89 (6%)

Query: 17  PPIIPKNLNELPHLDLSCNKLNGEISTFLSHI--LGILGLYV-QF--KIPPD-LCNLVQL 70
           P  +    + L  LDLS N   G +  F      L  L L    F  ++P D L  +  L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 71  EYFDFSMNMLGGHIPEKNIDLCGKIMGLD 99
           +  D S N   G +PE   +L   ++ LD
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLD 374

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 27/77 (35%), Positives = 30/77 (38%), Gaps = 7/77 (9%)

Query: 17  PPIIPKNLNELPHLDLSCNKLNGEISTFLSHI----LGILGLYV-QF--KIPPDLCNLVQ 69
           P  +      L  LDLS N  +G I   L       L  L L    F  KIPP L N  +
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419

Query: 70  LEYFDFSMNMLGGHIPE 86
           L     S N L G IP 
Sbjct: 420 LVSLHLSFNYLSGTIPS 436

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 27/95 (28%), Positives = 38/95 (40%), Gaps = 21/95 (22%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLE 71
           IPK   ++  L  L+L  N ++G I   +  + G+  L +       +IP  +  L  L 
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707

Query: 72  YFDFSMNMLGGHIPEK-------------NIDLCG 93
             D S N L G IPE              N  LCG
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 23/75 (30%), Positives = 34/75 (45%), Gaps = 5/75 (6%)

Query: 17  PPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLE 71
           P +     N L  L L  N   G+I   LS+   ++ L++ F      IP  L +L +L 
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445

Query: 72  YFDFSMNMLGGHIPE 86
                +NML G IP+
Sbjct: 446 DLKLWLNMLEGEIPQ 460

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 25/75 (33%), Positives = 33/75 (44%), Gaps = 8/75 (10%)

Query: 20  IPKNLNELPHL---DLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLE 71
           IP +L  L  L    L  N L GEI   L ++  +  L + F     +IP  L N   L 
Sbjct: 434 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 493

Query: 72  YFDFSMNMLGGHIPE 86
           +   S N L G IP+
Sbjct: 494 WISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 8/75 (10%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHI--LGILGLYV-QF--KIPPDLCNLVQLE 71
           IP    N   L  + LS N+L GEI  ++  +  L IL L    F   IP +L +   L 
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541

Query: 72  YFDFSMNMLGGHIPE 86
           + D + N+  G IP 
Sbjct: 542 WLDLNTNLFNGTIPA 556

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 53.8 bits (130), Expect = 5e-08
 Identities = 18/74 (24%), Positives = 27/74 (36%), Gaps = 7/74 (9%)

Query: 20  IPKNLNELPHL---DLSCNKLNGEISTFLSHILGILGLYV-QF--KIPPDLC-NLVQLEY 72
             + ++    L   ++S N+  G I       L  L L   +F  +IP  L      L  
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTG 298

Query: 73  FDFSMNMLGGHIPE 86
            D S N   G +P 
Sbjct: 299 LDLSGNHFYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 22/69 (31%), Positives = 31/69 (44%), Gaps = 5/69 (7%)

Query: 23  NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSM 77
           N +EL  L LS N L+G I + L  +  +  L +       +IP +L  +  LE      
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 78  NMLGGHIPE 86
           N L G IP 
Sbjct: 476 NDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 15/71 (21%), Positives = 23/71 (32%), Gaps = 6/71 (8%)

Query: 23  NLNELPHLDLSCNKLNGEISTF--LSHILGILGLYV-QF--KIPPDLCNLVQLEYFDFSM 77
               L  LD+S N  +  I      S  L  L +   +        +    +L+  + S 
Sbjct: 198 RCVNLEFLDVSSNNFSTGIPFLGDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISS 256

Query: 78  NMLGGHIPEKN 88
           N   G IP   
Sbjct: 257 NQFVGPIPPLP 267

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.4 bits (124), Expect = 3e-07
 Identities = 21/75 (28%), Positives = 32/75 (42%), Gaps = 8/75 (10%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHILGILGLYV---QF--KIPPDLCNLVQLE 71
           IP+    +  L  L L  N L GEI + LS+   +  + +   +   +IP  +  L  L 
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517

Query: 72  YFDFSMNMLGGHIPE 86
               S N   G+IP 
Sbjct: 518 ILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 23/78 (29%), Positives = 32/78 (41%), Gaps = 8/78 (10%)

Query: 17  PPIIPKNLNELPHLDLSCNKLNGEISTFLSHI---LGILGLYV-QF--KIPPDLCN--LV 68
           P      +  L  LDLS N+ +GE+   L+++   L  L L    F   I P+LC     
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394

Query: 69  QLEYFDFSMNMLGGHIPE 86
            L+      N   G IP 
Sbjct: 395 TLQELYLQNNGFTGKIPP 412

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 9/94 (9%)

Query: 23  NLNELPHLDLSCNKLNGEISTFLS-------HILGILGLYVQFKIP-PDLCNLVQLEYFD 74
               L  LDLS N L+G ++T  S         L +    + F         L  LE  D
Sbjct: 98  CSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLD 157

Query: 75  FSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKL 108
            S N + G        L      L +  ++ +K+
Sbjct: 158 LSANSISGANVV-GWVLSDGCGELKHLAISGNKI 190

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 22/110 (20%), Positives = 33/110 (30%), Gaps = 31/110 (28%)

Query: 20  IPKNLNELPHL---DLSCNKLNGEI-------------------------STFLSHILGI 51
           IP  L +   L   DL+ N  NG I                         +  +      
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG 589

Query: 52  LGLYVQFK--IPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLD 99
            G  ++F+      L  L      + +  + GGH      D  G +M LD
Sbjct: 590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT-FDNNGSMMFLD 638

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 47.6 bits (114), Expect = 5e-06
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 6/69 (8%)

Query: 23  NLNELPHLDLSCNKLNGEISTFLS-HILGILGL-YVQF--KIPPD--LCNLVQLEYFDFS 76
           +L  L  L LS + +NG +S F     L  L L        +     L +   L++ + S
Sbjct: 75  SLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS 134

Query: 77  MNMLGGHIP 85
            N L     
Sbjct: 135 SNTLDFPGK 143

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.8 bits (112), Expect = 9e-06
 Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 4/70 (5%)

Query: 20  IPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-QF--KIPPDLCNLVQLEYFDFS 76
           +     EL HL +S NK++G++       L  L +    F   IP  L +   L++ D S
Sbjct: 173 LSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231

Query: 77  MNMLGGHIPE 86
            N L G    
Sbjct: 232 GNKLSGDFSR 241

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 19/72 (26%), Positives = 26/72 (36%), Gaps = 10/72 (13%)

Query: 23  NLNELPHLDLSCNKLNGEISTFLSHI-----LGILGLYV-QF--KIPPDLCNLVQLEYFD 74
            LN L  LDLS N ++G              L  L +   +    +   +   V LE+ D
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206

Query: 75  FSMNMLGGHIPE 86
            S N     IP 
Sbjct: 207 VSSNNFSTGIPF 218

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 17/79 (21%), Positives = 27/79 (34%), Gaps = 7/79 (8%)

Query: 15  GMPPIIPKNLNELPHLDLSCN--KLNGEISTFLSHILGILGLYVQF-----KIPPDLCNL 67
           G   +  KN         + N  +  G  S  L+ +       +          P   N 
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

Query: 68  VQLEYFDFSMNMLGGHIPE 86
             + + D S NML G+IP+
Sbjct: 632 GSMMFLDMSYNMLSGYIPK 650

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 32/136 (23%), Positives = 56/136 (41%), Gaps = 25/136 (18%)

Query: 199 IVYEYMVKGSLNDWLRNQA---KHC-IIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           +V  +M    L   ++++         +     +G+ ++H      IIHRD+   N+ +N
Sbjct: 107 LVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVN 162

Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG-----DIYSFSVVLLE 305
           ED E+K+ DFGL R          T    T  Y    ++L         DI+S   ++ E
Sbjct: 163 EDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218

Query: 306 LVIRKQPTGPEFKDKN 321
           ++  K      FK  +
Sbjct: 219 MITGK----TLFKGSD 230

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 41/213 (19%), Positives = 76/213 (35%), Gaps = 64/213 (30%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGS-LNDWLR-------NQAKHC---IIACGTARGIT 231
            +++LL +    E  ++V E  +    L D++          ++     ++A      I 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-----AIQ 153

Query: 232 FLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI-- 288
             H R    ++HRDI   NIL++      K+ DFG   L+ D          GT  Y   
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPP 207

Query: 289 -LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSK 340
             ++          ++S  ++L ++V    P    F+            D  IL A    
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP----FER-----------DQEILEAELHF 252

Query: 341 PSML---------KMLQIVVGCIFDNPTTRPTM 364
           P+ +         + L          P++RP++
Sbjct: 253 PAHVSPDCCALIRRCLAP-------KPSSRPSL 278

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 14/92 (15%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            G+  LH   +  ++HRD++  NILL ++ ++ + DF L R   D      T       Y
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRWY 199

Query: 288 ----ILLACGG-----DIYSFSVVLLELVIRK 310
               +++   G     D++S   V+ E+  RK
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 35/114 (30%), Positives = 50/114 (43%), Gaps = 13/114 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHRF 237
           NI++L       +   +V E+   G L + + N+ K        I      GI +LH   
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH- 165

Query: 238 QPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
             +I+HRDI   NILL   N    +K+ DFGL    S  + +   D  GT  YI
Sbjct: 166 --NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTAYYI 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 9/77 (11%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + +L ++    IIHRD+   NILL+E   V ++DF +  ++      T+  +AGT  Y 
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181

Query: 288 ---ILLACGGDIYSFSV 301
              +  +  G  YSF+V
Sbjct: 182 APEMFSSRKGAGYSFAV 198

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 40/214 (18%), Positives = 63/214 (29%), Gaps = 41/214 (19%)

Query: 183 NIVQLLGY--CPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITF 232
           NIV+L           K+++ E+   GSL   L   +    +              G+  
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 233 LHHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           L       I+HR+I   NI+     +     K++DFG  R + D E   S  + GT  Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182

Query: 289 ---LLACGG-------------DIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDWVLD 331
              +                  D++S  V           TG   F+   G      V+ 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-----TGSLPFRPFEGPRRNKEVMY 237

Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTML 365
             I    S               +         L
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 56/206 (27%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMV-KGSLNDWLRNQAKHC---IIACGTARGITFLHHRF 237
           K +  ++ Y   GE    V++Y+V  G + +    +A+     I++      + + H + 
Sbjct: 87  KTLYLIMEYASGGE----VFDYLVAHGRMKE---KEARSKFRQIVS-----AVQYCHQK- 133

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGY----ILLAC 292
              I+HRD+ A N+LL+ D  +K++DFG     +            G   Y    +    
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPELFQGK 188

Query: 293 G-----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--- 344
                  D++S  V+L  LV    P    F  +N   L + VL       Y  P  +   
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP----FDGQNLKELRERVLRGK----YRIPFYMSTD 240

Query: 345 ------KMLQIVVGCIFDNPTTRPTM 364
                 + L +       NP  R T+
Sbjct: 241 CENLLKRFLVL-------NPIKRGTL 259

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 20/103 (19%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY 287
           +G+ ++H      ++HRD+   N+ +NED E+K+ DFGL R          T    T  Y
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWY 189

Query: 288 ----ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
               ++L+        DI+S   ++ E++  K      FK K+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKD 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 21/125 (16%)

Query: 199 IVYEYMVKGSLNDWLRNQA---KHC-IIACGTARGITFLHHRFQPHIIHRDINASNILLN 254
           +V   M    LN+ ++ Q     H   +     RG+ ++H      IIHRD+  SN+ +N
Sbjct: 111 LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN 166

Query: 255 EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG-----DIYSFSVVLLE 305
           ED E+K+ DFGL R  +D      T    T  Y    I+L         DI+S   ++ E
Sbjct: 167 EDCELKILDFGLARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222

Query: 306 LVIRK 310
           L+  +
Sbjct: 223 LLTGR 227

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 39/190 (20%), Positives = 61/190 (32%), Gaps = 41/190 (21%)

Query: 183 NIVQLLGY--CPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTAR--------GITF 232
           NIV+L           K+++ E+   GSL   L   +    +              G+  
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 233 LHHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           L       I+HR+I   NI+     +     K++DFG  R + D E   S  + GT  Y+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182

Query: 289 ---LLACGG-------------DIYSFSVVLLELVIRKQPTG-PEFKDKNGGNLVDWVLD 331
              +                  D++S  V           TG   F+   G      V+ 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-----TGSLPFRPFEGPRRNKEVMY 237

Query: 332 STILNAYSKP 341
             I    S  
Sbjct: 238 KIITGKPSGA 247

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 36/159 (22%), Positives = 66/159 (41%), Gaps = 38/159 (23%)

Query: 182 KNIVQLLGYC-----PVGEKKLIVY---EYM---VKGSLNDWLRNQAKHCIIACGTA--- 227
           +N+V L+  C     P    K  +Y   ++    + G L++ +  +     I        
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLL 134

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-----VA 282
            G+ ++H      I+HRD+ A+N+L+  D  +K++DFGL R  S  ++          V 
Sbjct: 135 NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 283 GTIGY----ILLACGGDIYSFSV-------VLLELVIRK 310
            T+ Y    +LL  G   Y   +       ++ E+  R 
Sbjct: 191 -TLWYRPPELLL--GERDYGPPIDLWGAGCIMAEMWTRS 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 36/152 (23%), Positives = 60/152 (39%), Gaps = 32/152 (21%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYM---VKGSLNDWLRNQAKHCIIACGTA---RGITFLH 234
           +NI++L         +L +++EY    +K  ++       +   I         G+ F H
Sbjct: 93  RNIIELKSVI-HHNHRLHLIFEYAENDLKKYMDKNPDVSMRV--IKSFLYQLINGVNFCH 149

Query: 235 HRFQPHIIHRDINASNILLNEDF-----EVKVSDFGLVRLISDCESHTSTDVAGTIGY-- 287
            R     +HRD+   N+LL+         +K+ DFGL R          T    T+ Y  
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRP 205

Query: 288 --ILLACGGDIYSFSV-------VLLELVIRK 310
             ILL  G   YS SV       +  E++++ 
Sbjct: 206 PEILL--GSRHYSTSVDIWSIACIWAEMLMKT 235

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 47/208 (22%), Positives = 76/208 (36%), Gaps = 44/208 (21%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NI++L  +        +V E    G L D +          A   I       G+T+LH 
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ--VLSGVTYLHK 154

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---- 288
               +I+HRD+   N+LL    +D  +K+ DFGL  +          +  GT  YI    
Sbjct: 155 H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEV 209

Query: 289 LLACGG---DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL------DSTILNAYS 339
           L        D++S  V+L  L+    P    F  +    ++  V       DS      S
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPP----FGGQTDQEILRKVEKGKYTFDSPEWKNVS 265

Query: 340 KPS---MLKMLQIVVGCIFDNPTTRPTM 364
           + +   + +MLQ        +   R + 
Sbjct: 266 EGAKDLIKQMLQF-------DSQRRISA 286

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 30/162 (18%), Positives = 62/162 (38%), Gaps = 39/162 (24%)

Query: 182 KNIVQLLGYCPV-GEKKL-IVYEYM---VKGSLNDWLRNQAKHCIIACGTA--------- 227
            N++ L        ++K+ ++++Y    +   +     ++A    +              
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 228 -RGITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLVRLISD---CESHTST 279
             GI +LH      ++HRD+  +NIL+  +      VK++D G  RL +      +    
Sbjct: 138 LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 280 DVAGTIGY----ILLACGGDIYSFSV-------VLLELVIRK 310
            V  T  Y    +LL  G   Y+ ++       +  EL+  +
Sbjct: 195 VVV-TFWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTSE 233

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 8/75 (10%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLE 71
           IP     L +L +L ++   ++G I  FLS I  ++ L   +      +PP + +L  L 
Sbjct: 93  IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 72  YFDFSMNMLGGHIPE 86
              F  N + G IP+
Sbjct: 153 GITFDGNRISGAIPD 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 54.8 bits (133), Expect = 1e-08
 Identities = 19/99 (19%), Positives = 32/99 (32%), Gaps = 22/99 (22%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLE 71
                 +      + L+ N L  ++   +     + GL ++       +P  L  L  L 
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 72  YFDFSMNMLGGHIPEK-------------NIDLCGKIMG 97
             + S N L G IP+              N  LCG  + 
Sbjct: 272 SLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 51.4 bits (124), Expect = 1e-07
 Identities = 11/75 (14%), Positives = 25/75 (33%), Gaps = 8/75 (10%)

Query: 20  IPKNLNELP----HLDLSCNKLNGEISTFLSHI-LGILGLYV-QF--KIPPDLCNLVQLE 71
           IP +          + +S N+L G+I    +++ L  + L              +    +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 72  YFDFSMNMLGGHIPE 86
               + N L   + +
Sbjct: 225 KIHLAKNSLAFDLGK 239

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 44.8 bits (107), Expect = 2e-05
 Identities = 19/72 (26%), Positives = 31/72 (43%), Gaps = 8/72 (11%)

Query: 23  NLNELPHLDLSCNKLNGE--ISTFLSHILGILGLYVQF------KIPPDLCNLVQLEYFD 74
               + +LDLS   L     I + L+++  +  LY+         IPP +  L QL Y  
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 75  FSMNMLGGHIPE 86
            +   + G IP+
Sbjct: 108 ITHTNVSGAIPD 119

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 32/116 (27%), Positives = 48/116 (41%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLHH 235
           NI++L  +        +V E    G L D + +        A   I       GIT++H 
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--VLSGITYMHK 144

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
                I+HRD+   N+LL   ++D  +++ DFGL        S    D  GT  YI
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYI 195

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 24/140 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-------IIACGTARGITFLH 234
            NIV+L           +V E +  G L +  R + K          I       ++ +H
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 235 HRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--- 288
                 ++HRD+   N+L    N++ E+K+ DFG  RL    ++        T+ Y    
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLHYAAPE 179

Query: 289 LLACGG-----DIYSFSVVL 303
           LL   G     D++S  V+L
Sbjct: 180 LLNQNGYDESCDLWSLGVIL 199

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 36/213 (16%), Positives = 71/213 (33%), Gaps = 64/213 (30%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMV-KGSLNDWLR-------NQAKHC---IIACGTARGIT 231
            +++LL +    +  +++ E       L D++          A+     ++       + 
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE-----AVR 163

Query: 232 FLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYI-- 288
             H+     ++HRDI   NIL++ +  E+K+ DFG   L+ D          GT  Y   
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPP 217

Query: 289 -LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YSK 340
             +           ++S  ++L ++V    P    F+            D  I+      
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEH-----------DEEIIRGQVFF 262

Query: 341 PSML---------KMLQIVVGCIFDNPTTRPTM 364
              +           L +        P+ RPT 
Sbjct: 263 RQRVSSECQHLIRWCLAL-------RPSDRPTF 288

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 45/172 (26%)

Query: 182 KNIVQLLG-YCPVGEKKL----IVYEYMVKGSLNDWLRNQA---KHC------IIACGTA 227
           +NI+ +     P   +      I+ E M +  L+  +  Q     H        +     
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTL----- 122

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTI-- 285
           R +  LH     ++IHRD+  SN+L+N + ++KV DFGL R+I +  +  S         
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 286 -GY----------ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
             +          ++L         D++S   +L EL +R+    P F  ++
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGRD 227

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 47/235 (20%), Positives = 78/235 (33%), Gaps = 67/235 (28%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDW------------LRNQAKHCIIACGTARGI 230
           N+++            I  E     +L D             L+ +     +    A G+
Sbjct: 70  NVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 231 TFLHHRFQPHIIHRDINASNILL-------------NEDFEVKVSDFGLVRLISDCESHT 277
             LH      IIHRD+   NIL+              E+  + +SDFGL + +   +S  
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 278 ST---DVAGTIGY----ILLACGG-----------DIYSFSVVLLELVIRKQPTGPEFKD 319
            T   + +GT G+    +L                DI+S   V   ++ + +   P F D
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--P-FGD 242

Query: 320 KNGGNLVDWVLDSTILNAYSKPSMLKMLQ----------IVVGCIFDNPTTRPTM 364
           K          +S I+        +K L           ++   I  +P  RPT 
Sbjct: 243 KYSR-------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 42/224 (18%), Positives = 75/224 (33%), Gaps = 72/224 (32%)

Query: 182 KNIVQL---------------LGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC---IIA 223
           KN++QL               + YC  G +++   + + +         QA      +I 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM--LDSVPEKRFPVC---QAHGYFCQLID 120

Query: 224 CGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES----HTST 279
                G+ +LH +    I+H+DI   N+LL     +K+S  G+   +    +     TS 
Sbjct: 121 -----GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS- 171

Query: 280 DVAGTIGY----ILLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
              G+  +    I            DI+S  V L  +     P    F+  N   L + +
Sbjct: 172 --QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFENI 225

Query: 330 LDSTILNAYSKPSML---------KMLQIVVGCIFDNPTTRPTM 364
              +    Y+ P             ML+         P  R ++
Sbjct: 226 GKGS----YAIPGDCGPPLSDLLKGMLEY-------EPAKRFSI 258

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NI++L           IV E    G L D +        + A   I       GIT++H 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--VFSGITYMHK 139

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
               +I+HRD+   NILL    +D ++K+ DFGL       ++    D  GT  YI
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYI 190

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 47/166 (28%), Positives = 64/166 (38%), Gaps = 35/166 (21%)

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAG--- 283
           A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +     A    
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 284 ------TIGYILLACGGDIYSFSVVLLELVIR-KQP-----TGPEFKD--KNGGNLVDWV 329
                 TI   +     D++SF V+L E+      P        EF    K G  +    
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---- 315

Query: 330 LDSTILNAYSKPSM--LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                      P     +M Q ++ C    P+ RPT   + E L  
Sbjct: 316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 9e-05
 Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 3/96 (3%)

Query: 182 KNIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPH 240
            N+V LLG C   G   +++ E+   G+L+ +LR++    +      +G  F   +    
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--TKGARFRQGKDYVG 143

Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH 276
            I  D+      +        S F   + +SD E  
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NI++L           IV E    G L D +        + A   I       GIT++H 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ--VFSGITYMHK 139

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
               +I+HRD+   NILL    +D ++K+ DFGL       ++    D  GT  YI
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYI 190

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 19/106 (17%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTS--TDVAGT 284
           RG+ ++H     +++HRD+  +N+ +N ED  +K+ DFGL R++    SH    ++   T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 285 IGY----ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKN 321
             Y    +LL+        D+++   +  E++  K      F   +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 25/118 (21%), Positives = 45/118 (38%), Gaps = 16/118 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-----ACGTAR----GITFL 233
           +IV+LL          +V+E+M    L   +  +A    +     A    R     + + 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 234 HHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           H     +IIHRD+    +LL        VK+  FG+   + +     +    GT  ++
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTPHFM 200

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 3/53 (5%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
            G  F+H      IIHRD+  +N LLN+D  VKV DFGL R I+  +     +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 26/117 (22%), Positives = 48/117 (41%), Gaps = 17/117 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NI+ L      G+   +V E M  G L D +  Q       A   +      + + +LH 
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--FTITKTVEYLHA 134

Query: 236 RFQPHIIHRDINASNILLNEDFE----VKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           +    ++HRD+  SNIL  ++      +++ DFG  + +   E+        T  ++
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTANFV 187

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 20/52 (38%), Positives = 30/52 (57%), Gaps = 3/52 (5%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST 279
            G+ ++H      I+HRD+  +N L+N+D  VKV DFGL R +   E+  S 
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 16/116 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NIV+L           ++++ +  G L + +  +       A HCI        +   H 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ--ILEAVLHCHQ 128

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
                ++HR++   N+LL    +   VK++DFGL   +   E       AGT GY+
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYL 180

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 24/81 (29%), Positives = 37/81 (45%), Gaps = 11/81 (13%)

Query: 229 GITFLHHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDC---ESHTSTDVAG 283
            + +LH++    I HRDI   N L   N+ FE+K+ DFGL +        E +  T  AG
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236

Query: 284 TIGYI---LLACGGDIYSFSV 301
           T  ++   +L    + Y    
Sbjct: 237 TPYFVAPEVLNTTNESYGPKC 257

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 22/133 (16%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
            I+++  +    E   IV E M  G L D +           K           + +LH 
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--MLLAVQYLHE 257

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----I 288
                IIHRD+   N+LL    ED  +K++DFG  +++   E+     + GT  Y    +
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEV 312

Query: 289 LLACGGDIYSFSV 301
           L++ G   Y+ +V
Sbjct: 313 LVSVGTAGYNRAV 325

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NIV+L           +V++ +  G L + +          A HCI        I + H 
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--ILESIAYCHS 146

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
                I+HR++   N+LL    +   VK++DFGL   ++  +S      AGT GY+
Sbjct: 147 N---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYL 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 52.6 bits (127), Expect = 5e-08
 Identities = 23/116 (19%), Positives = 39/116 (33%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NI++L           +V E    G L + +        + A   +        + + H 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD--VLSAVAYCHK 124

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
               ++ HRD+   N L    + D  +K+ DFGL                GT  Y+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYV 175

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 17/116 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCIIACGTARGITFLHH 235
           NIV+L           +V++ +  G L + +          A HCI        I + H 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--ILESIAYCHS 123

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
                I+HR++   N+LL    +   VK++DFGL   ++  +S      AGT GY+
Sbjct: 124 N---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYL 174

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 25/139 (17%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NI++L        +  +V E +  G L D +  +       A   +        + +LH 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ--ILEAVAYLHE 166

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----I 288
                I+HRD+   N+L      D  +K++DFGL +++          V GT GY    I
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEI 221

Query: 289 LLACG-G---DIYSFSVVL 303
           L  C  G   D++S  ++ 
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 26/171 (15%), Positives = 51/171 (29%), Gaps = 38/171 (22%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----------CIIACGTARGIT 231
             ++           ++V E    G+L + + N  K+              A      I 
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFE-----------VKVSDFGL-VRLISDCESHTST 279
            +H      IIH DI   N +L   F            + + D G  + +    +    T
Sbjct: 187 QVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 280 DVAGTIGY----ILLACG----GDIYSFSVVLLELVIRKQPTGPEFKDKNG 322
               T G+    +L         D +  +  +  ++        + K++ G
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY---MKVKNEGG 291

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 3/57 (5%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGT 284
           + I +LH      ++HRD+  SNILLN +  VKV+DFGL R   +    T+      
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 46/155 (29%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGY 287
            + +L  +    IIHRDI   NI++ EDF +K+ DFG    +   +  +T     GTI Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEY 195

Query: 288 I---LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY 338
               +L          +++S  V L  LV  + P    F +          L+ T+  A 
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP----FCE----------LEETVEAAI 241

Query: 339 SKPSML---------KMLQIVVGCIFDNPTTRPTM 364
             P ++          +LQ         P  R T+
Sbjct: 242 HPPYLVSKELMSLVSGLLQP-------VPERRTTL 269

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 18/136 (13%), Positives = 39/136 (28%), Gaps = 32/136 (23%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKG-SLNDWLRN-----QAKHCIIACGTARGITFLHHR 236
            + ++L         L+V E+ ++G SL +          A         A      H  
Sbjct: 92  GVARVLDVVHTRAGGLVVAEW-IRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA 148

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGGDI 296
               +     + S + ++ D +V ++    +            +              DI
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPATMP---------DANPQ-----------DDI 185

Query: 297 YSFSVVLLELVIRKQP 312
                 L  L++ + P
Sbjct: 186 RGIGASLYALLVNRWP 201

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 34/145 (23%), Positives = 57/145 (39%), Gaps = 31/145 (21%)

Query: 183 NIVQLLGYC---PVGEKKL-IVYEYMVKGSLNDWLRNQAKHCII-----ACGTARGIT-- 231
           +IV+++        G K L IV E +  G L    R Q +         A    + I   
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEA 173

Query: 232 --FLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
             +LH     +I HRD+   N+L      +  +K++DFG  +  +   S   T    T  
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPY 228

Query: 287 YI---LLACGG-----DIYSFSVVL 303
           Y+   +L         D++S  V++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 21/123 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-------IIACGTARGITFLH 234
           +N+++L+ +    ++  +V+E M  GS+        +         ++    A  + FLH
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILS--HIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 235 HRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTS------TDVAGTI 285
           ++    I HRD+   NIL    N+   VK+ DF L   I      +           G+ 
Sbjct: 129 NK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 286 GYI 288
            Y+
Sbjct: 186 EYM 188

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 36/129 (27%), Positives = 55/129 (42%), Gaps = 24/129 (18%)

Query: 183 NIVQLLGYC---PVGEKKL-IVYEYMVKGSLNDWLRNQAKHCII-----ACGTAR----G 229
           +IV+++        G K L IV E +  G L    R Q +         A    +     
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEA 129

Query: 230 ITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDV--AGT 284
           I +LH     +I HRD+   N+L      +  +K++DFG  +  +  +   S D+   G 
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGV 186

Query: 285 IGYILLACG 293
           I YILL CG
Sbjct: 187 IMYILL-CG 194

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 35/128 (27%), Positives = 52/128 (40%), Gaps = 19/128 (14%)

Query: 184 IVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRF 237
           IV +  Y      KL  + + M  G L+  L              A     G+  +H+R 
Sbjct: 254 IVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR- 311

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG 293
              +++RD+  +NILL+E   V++SD GL    S  + H S    GT GY    +L    
Sbjct: 312 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGV 366

Query: 294 GDIYSFSV 301
              Y  S 
Sbjct: 367 A--YDSSA 372

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 34/119 (28%), Positives = 55/119 (46%), Gaps = 23/119 (19%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           G+  LH R   +II+RD+   N+LL++D  V++SD GL   +   ++ T    AGT G+ 
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFM 356

Query: 288 ---ILLACGGDIYSFSV------VLL-ELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN 336
              +LL      Y FSV      V L E++  + P    F+ +        +    +L 
Sbjct: 357 APELLLGEE---YDFSVDYFALGVTLYEMIAARGP----FRARGEKVENKELKQR-VLE 407

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 19/105 (18%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           R + F+H      I HRDI   N+L+N +D  +K+ DFG  + +   E   +  +  +  
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY-IC-SRF 206

Query: 287 Y----ILLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNG 322
           Y    ++L         D++S   V  EL++ K    P F  +  
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGK----PLFSGETS 247

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 39/149 (26%), Positives = 53/149 (35%), Gaps = 44/149 (29%)

Query: 183 NIVQLLGYC----PVGEKKLIVYEYMVKGSLNDWLRNQAKHCII-----ACGTAR----G 229
           +IV +L             LI+ E M  G L    R Q +         A    R     
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIGTA 140

Query: 230 ITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHT--------- 277
           I FLH     +I HRD+   N+L     +D  +K++DFG  +  +     T         
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVA 197

Query: 278 -----------STDV--AGTIGYILLACG 293
                      S D+   G I YILL CG
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILL-CG 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 51.0 bits (123), Expect = 2e-07
 Identities = 32/139 (23%), Positives = 55/139 (39%), Gaps = 26/139 (18%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHH 235
           NIV L           +V + +  G L D +  +       A   I        + +LH 
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ--VLSAVKYLHE 124

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---L 289
                I+HRD+   N+L     E+ ++ ++DFGL ++  +      +   GT GY+   +
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEV 178

Query: 290 LACGG-----DIYSFSVVL 303
           LA        D +S  V+ 
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 13/93 (13%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           R I  LH     ++ HRDI   N+L+N  D  +K+ DFG  + +S  E + +  +  +  
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY-IC-SRY 196

Query: 287 Y----ILLACGG-----DIYSFSVVLLELVIRK 310
           Y    ++          DI+S   +  E+++ +
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 19/95 (20%), Positives = 45/95 (47%), Gaps = 15/95 (15%)

Query: 228 RGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           + + + H      I+HRD+   N++++ E  ++++ D+GL       + +    VA +  
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-VRVA-SRY 195

Query: 287 Y----ILLACGG-----DIYSFSVVLLELVIRKQP 312
           +    +L+         D++S   +L  ++ RK+P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 26/135 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCI--IACGTARGITFL 233
            I+++  +    E   IV E M  G L D +           K     +       + +L
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA----VQYL 130

Query: 234 HHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY--- 287
           H      IIHRD+   N+LL    ED  +K++DFG  +++   E+     + GT  Y   
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185

Query: 288 -ILLACGGDIYSFSV 301
            +L++ G   Y+ +V
Sbjct: 186 EVLVSVGTAGYNRAV 200

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 56/206 (27%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMV-KGSLNDWLRNQAKHC---IIACGTARGITFLHHRF 237
            +   ++ Y   GE    +++Y+   G + +    +A+     I++      + + H   
Sbjct: 84  TDFFMVMEYVSGGE----LFDYICKHGRVEE---MEARRLFQQILS-----AVDYCHRH- 130

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYI---LLACG 293
              ++HRD+   N+LL+     K++DFGL  ++SD E   TS    G+  Y    +++  
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGR 185

Query: 294 G------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--- 344
                  DI+S  V+L  L+    P    F D++   L   +        +  P  L   
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP----FDDEHVPTLFKKIRGGV----FYIPEYLNRS 237

Query: 345 ------KMLQIVVGCIFDNPTTRPTM 364
                  MLQ+       +P  R T+
Sbjct: 238 VATLLMHMLQV-------DPLKRATI 256

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 31/145 (21%), Positives = 53/145 (36%), Gaps = 39/145 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII----ACGTAR----GITFL 233
             +V L        + +++YE+M  G L +  +   +H  +    A    R    G+  +
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 234 HHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCES---------------- 275
           H     + +H D+   NI+       E+K+ DFGL   +   +S                
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 276 -----HTSTDV--AGTIGYILLACG 293
                   TD+   G + YILL  G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILL-SG 352

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 49.9 bits (120), Expect = 4e-07
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 17/118 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----IIACGTAR----GITFL 233
           NI+++           IV E    G L + + +                 +     + + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 234 HHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           H +   H++H+D+   NIL    +    +K+ DFGL  L        ST+ AGT  Y+
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTALYM 193

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 36/159 (22%), Positives = 64/159 (40%), Gaps = 43/159 (27%)

Query: 183 NIVQLLGY-CPVGEKKL-----IVYEYMVKGSLNDWLRNQAK--------HC-IIACGTA 227
           NIV+L  +    GEKK      +V +Y+   ++    R+ ++        +  +      
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           R + ++H      I HRDI   N+LL+ D   +K+ DFG  + +   E + S        
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-------- 215

Query: 287 YI----------LLACGG-----DIYSFSVVLLELVIRK 310
           YI          +          D++S   VL EL++ +
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 48/215 (22%), Positives = 79/215 (36%), Gaps = 57/215 (26%)

Query: 160 VAGTNKFY-----EKNVIRGDDFGIAF----KNIVQL--------LGYCPVGEKKL-IVY 201
           V  T K Y     EK  I+    G A     K I++         L Y    +  L +V 
Sbjct: 205 VRATGKMYACKKLEKKRIKKRK-GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263

Query: 202 EYMVKGSLNDWLRNQAKHCI-----------IACGTARGITFLHHRFQPHIIHRDINASN 250
             M  G L   + +  +              I CG    +  LH      I++RD+   N
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRE---RIVYRDLKPEN 316

Query: 251 ILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGGDIYSFSV----- 301
           ILL++   +++SD GL   + + ++     V GT+GY    ++       Y+FS      
Sbjct: 317 ILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER---YTFSPDWWAL 371

Query: 302 -VLL-ELVIRKQPTGPEFKDKNGGNLVDWVLDSTI 334
             LL E++  + P    F+ +      + V     
Sbjct: 372 GCLLYEMIAGQSP----FQQRKKKIKREEVERLVK 402

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 27/151 (17%), Positives = 51/151 (33%), Gaps = 51/151 (33%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTA-------------- 227
           +NI+ L       E+ ++++E++    + +         I                    
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFER--------INTSAFELNEREIVSYVHQVC 112

Query: 228 RGITFLHHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHT-------- 277
             + FLH     +I H DI   NI+        +K+ +FG  R +   ++          
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 278 -------------STDV--AGTIGYILLACG 293
                        +TD+   GT+ Y+LL  G
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLL-SG 199

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 18/102 (17%)

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD-VAGTIGY- 287
           + +LH +    IIHRD+   NILLNED  ++++DFG  +++S        +   GT  Y 
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 288 ---ILLACG----GDIYSFSVVLLELVIRKQPTG-PEFKDKN 321
              +L         D+++   ++ +LV      G P F+  N
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLV-----AGLPPFRAGN 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 40/155 (25%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGY 287
            I + H      I+HRD+   N+LL+++  VK++DFGL  +++D     TS    G+  Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 173

Query: 288 I---LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY 338
               ++          D++S  +VL  +++ + P    F D+   NL   V        Y
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP----FDDEFIPNLFKKVNSCV----Y 225

Query: 339 SKPSML---------KMLQIVVGCIFDNPTTRPTM 364
             P  L         +M+         +P  R T+
Sbjct: 226 VMPDFLSPGAQSLIRRMIVA-------DPMQRITI 253

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 29/119 (24%), Positives = 47/119 (39%), Gaps = 22/119 (18%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCI--IACGTARGITFL 233
           NI+ L          +++ E +  G L D+L         +A   I  I      G+ +L
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----DGVNYL 131

Query: 234 HHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
           H +    I H D+   NI+L         +K+ DFGL   I D       ++ GT  ++
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFV 185

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 26/111 (23%), Positives = 48/111 (43%), Gaps = 18/111 (16%)

Query: 183 NIVQLLGY-CPVGEKKL-----IVYEYM---VKGSLNDWLRNQAKHCIIACG-----TAR 228
           N+V L  +    G+KK      +V EY+   V  +   + + +    ++          R
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 229 GITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTS 278
            + ++H      I HRDI   N+LL+     +K+ DFG  +++   E + S
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 48.3 bits (116), Expect = 1e-06
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 18/94 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARGITF 232
           N+V+  G+   G  + +  EY   G L D +               H ++A     G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVY 120

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           LH      I HRDI   N+LL+E   +K+SDFGL
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGL 151

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 37/144 (25%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI---IACGTAR----GITFLHH 235
            ++ L        + +++ EY   G +      +    +         +    G+ +LH 
Sbjct: 90  RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149

Query: 236 RFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESHT--------------- 277
               +I+H D+   NILL       ++K+ DFG+ R I                      
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 278 ------STDV--AGTIGYILLACG 293
                 +TD+   G I Y+LL   
Sbjct: 207 YDPITTATDMWNIGIIAYMLL-TH 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 69/218 (31%)

Query: 183 NIVQL-------------LGYCPVGEKKLIVYEYMV-KGSLNDWLRNQAKHC---IIACG 225
           +I++L             + Y   GE    +++Y+   G L++    +++     I++  
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDE---KESRRLFQQILS-- 127

Query: 226 TARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGT 284
              G+ + H      ++HRD+   N+LL+     K++DFGL  ++SD E   TS    G+
Sbjct: 128 ---GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGS 178

Query: 285 IGYI---LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL 335
             Y    +++         DI+S  V+L  L+    P    F D +   L   + D    
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP----FDDDHVPTLFKKICDGI-- 232

Query: 336 NAYSKPSML---------KMLQIVVGCIFDNPTTRPTM 364
             +  P  L          MLQ+       +P  R T+
Sbjct: 233 --FYTPQYLNPSVISLLKHMLQV-------DPMKRATI 261

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 31/145 (21%), Positives = 52/145 (35%), Gaps = 39/145 (26%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCII----ACGTAR----GITFL 233
             ++ L        + +++ E++  G L D  R  A+   +         R    G+  +
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 234 HHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHT-------------- 277
           H      I+H DI   NI+    +   VK+ DFGL   ++  E                 
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222

Query: 278 -------STDV--AGTIGYILLACG 293
                   TD+   G +GY+LL  G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLL-SG 246

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 36/124 (29%), Positives = 50/124 (40%), Gaps = 17/124 (13%)

Query: 184 IVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           I QL  +    E  L +V EY V G L   L    +                 I  +H  
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTDVAGTIGY----ILLA 291
                +HRDI   NILL+    ++++DFG  ++L +D    +   V GT  Y    IL A
Sbjct: 182 ---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237

Query: 292 CGGD 295
            GG 
Sbjct: 238 VGGG 241

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 47.9 bits (115), Expect = 2e-06
 Identities = 32/147 (21%), Positives = 51/147 (34%), Gaps = 44/147 (29%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCI--IACGTARGITFL 233
           NI+ L          +++ E +  G L D+L        ++A   +  I      G+ +L
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL----DGVHYL 124

Query: 234 HHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHT------------ 277
           H +    I H D+   NI+L      +  +K+ DFG+   I                   
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 278 ---------STDV--AGTIGYILLACG 293
                      D+   G I YILL  G
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILL-SG 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 18/94 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARGITF 232
           N+V+  G+   G  + +  EY   G L D +               H ++A     G+ +
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVY 120

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL 266
           LH      I HRDI   N+LL+E   +K+SDFGL
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGL 151

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 23/106 (21%)

Query: 230 ITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTDVAGTIGY- 287
           +  +H       IHRD+   N+LL++   +K++DFG  +++  +      T V GT  Y 
Sbjct: 181 LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236

Query: 288 ---ILLACGG--------DIYSFSVVLLELVIRKQPTG-PEFKDKN 321
              +L + GG        D +S  V L E++      G   F   +
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML-----VGDTPFYADS 277

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL-VRLISDCESHTSTDVAGTIGY 287
            I  +H     H +HRDI   NIL++ +  ++++DFG  ++L+ D    +S  V GT  Y
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242

Query: 288 I 288
           I
Sbjct: 243 I 243

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 34/147 (23%), Positives = 50/147 (34%), Gaps = 44/147 (29%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLR-------NQAKHCI--IACGTARGITFL 233
           N++ L          +++ E +  G L D+L         +A   I  I      G+ +L
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL----DGVNYL 131

Query: 234 HHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHT------------ 277
           H +    I H D+   NI+L         +K+ DFGL   I D                 
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

Query: 278 ---------STDV--AGTIGYILLACG 293
                      D+   G I YILL  G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILL-SG 214

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 42/216 (19%), Positives = 74/216 (34%), Gaps = 57/216 (26%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK----------HCIIACGTARGITF 232
           NIV+            I+ EY   G L + + N  +            +++     G+++
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSY 131

Query: 233 LHHRFQPHIIHRDINASNILLNEDFE--VKVSDFGLVRLISDCES-HTSTDVAGTIGYI- 288
            H      I HRD+   N LL+      +K+ DFG  +         ++    GT  YI 
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIA 185

Query: 289 --LLACGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA-YS 339
             +L          D++S  V L  +++   P    F+D              IL+  YS
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP----FEDPEEPRDYR-KTIQRILSVKYS 240

Query: 340 KPSML-----------KMLQIVVGCIFDNPTTRPTM 364
            P  +           ++          +P TR ++
Sbjct: 241 IPDDIRISPECCHLISRIFVA-------DPATRISI 269

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 24/90 (26%), Positives = 34/90 (37%), Gaps = 29/90 (32%)

Query: 229 GITFLHHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHT--------- 277
           GI  +H     +I+H D+   NIL    +  ++K+ DFGL R     E            
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL 255

Query: 278 ------------STDV--AGTIGYILLACG 293
                        TD+   G I Y+LL  G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLL-SG 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 31/143 (21%), Positives = 47/143 (32%), Gaps = 36/143 (25%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-IIACGTAR----GITFLHHRF 237
           N++ L          +++ E +  G L D+L  +       A    +    G+ +LH   
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL- 133

Query: 238 QPHIIHRDINASNILL----NEDFEVKVSDFGLVRLISDCESHT---------------- 277
              I H D+   NI+L         +K+ DFGL   I                       
Sbjct: 134 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191

Query: 278 -----STDV--AGTIGYILLACG 293
                  D+   G I YILL  G
Sbjct: 192 EPLGLEADMWSIGVITYILL-SG 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           G+ FL  +    II+RD+   N++L+ +  +K++DFG+ +        T T   GT  Y 
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 509

Query: 288 ---ILLACGGDIYSFSV 301
              I+       Y  SV
Sbjct: 510 APEIIAYQP---YGKSV 523

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 16/78 (20%), Positives = 25/78 (32%), Gaps = 6/78 (7%)

Query: 15  GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF------KIPPDLCNLV 68
            +       L+ L  L      L    +  + H+  +  L V        K+P    NL 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 69  QLEYFDFSMNMLGGHIPE 86
            LE+ D S N +      
Sbjct: 150 NLEHLDLSSNKIQSIYCT 167

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 18/83 (21%), Positives = 26/83 (31%), Gaps = 6/83 (7%)

Query: 23  NLNELPHLDLSCNKLNGEI--STFLS-HILGILGL---YVQFKIPPDLCNLVQLEYFDFS 76
            L +L HLD   + L      S FLS   L  L +   + +         L  LE    +
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 77  MNMLGGHIPEKNIDLCGKIMGLD 99
            N    +           +  LD
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLD 476

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 16/60 (26%), Positives = 32/60 (53%), Gaps = 3/60 (5%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
            + +LH      +++RD+   N++L++D  +K++DFGL +      +   T   GT  Y+
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 17/84 (20%)

Query: 20  IPKNLNELP---HLDLSCNKLNG-EISTFLSHILGILG-------LYVQ------FKIPP 62
           +P  L  LP    ++++CN+    E        L           +Y+       F +  
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324

Query: 63  DLCNLVQLEYFDFSMNMLGGHIPE 86
            L  + +L   +   N L G +P 
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 7/70 (10%), Positives = 13/70 (18%), Gaps = 3/70 (4%)

Query: 20  IPKNLNELP---HLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFS 76
           + K +  L       +  +    E                         NL  L   +  
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257

Query: 77  MNMLGGHIPE 86
                  +P 
Sbjct: 258 NCPNLTKLPT 267

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 8/65 (12%), Positives = 20/65 (30%), Gaps = 12/65 (18%)

Query: 22  KNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNMLG 81
           K+++ +  +D S N++                      + P     + +   + S N + 
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFD------------PLDPTPFKGINVSSINLSNNQIS 446

Query: 82  GHIPE 86
               E
Sbjct: 447 KFPKE 451

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 16/97 (16%), Positives = 30/97 (30%), Gaps = 13/97 (13%)

Query: 15  GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHI--LGILGLY----------VQFKIPP 62
            + P   K +N +  ++LS N+++       S    L  + L                  
Sbjct: 424 PLDPTPFKGIN-VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 63  DLCNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLD 99
           +  N   L   D   N L     +        ++G+D
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGID 519

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 10/88 (11%), Positives = 24/88 (27%), Gaps = 14/88 (15%)

Query: 13  NLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLS-------------HILGILGLYVQFK 59
                 +   NL +L  +++       ++ TFL                +    L   ++
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296

Query: 60  IPPDLCNLVQLEYFDFSMNML-GGHIPE 86
              D     +++      N L    +  
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVET 324

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 13/82 (15%), Positives = 30/82 (36%), Gaps = 6/82 (7%)

Query: 10  IRDNLGMPPIIPKNLNELPHLDLSCNKL-NGEISTFLSHI--LGILGLYV-QFK-IPPDL 64
           ++D+       P    ++  + +  N L    + T L  +  LG+L     Q +   P  
Sbjct: 291 LKDDWQALADAP-VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349

Query: 65  CNLVQLEYFDFSMNMLGGHIPE 86
            + ++L   + + N +      
Sbjct: 350 GSEIKLASLNLAYNQITEIPAN 371

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 8/97 (8%), Positives = 20/97 (20%), Gaps = 9/97 (9%)

Query: 4   TQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNG-EISTFLSHILGILGLYVQF---- 58
              +   +  +                DL  + +N       +     I     Q     
Sbjct: 133 MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192

Query: 59  ----KIPPDLCNLVQLEYFDFSMNMLGGHIPEKNIDL 91
                +   +  L +L  F    +        +  + 
Sbjct: 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 18/102 (17%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            +  LH      II+RD+   NILL+E+  +K++DFGL +   D E    +   GT+ Y 
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYM 193

Query: 288 ---ILLACG----GDIYSFSVVLLELVIRKQPTG-PEFKDKN 321
              ++   G     D +SF V++ E++     TG   F+ K+
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEML-----TGTLPFQGKD 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 5/61 (8%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL-ISDCESHTSTDVAGTIGY 287
            +  LH      II+RDI   NILL+ +  V ++DFGL +  ++D          GTI Y
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226

Query: 288 I 288
           +
Sbjct: 227 M 227

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 42.9 bits (102), Expect = 9e-05
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 18/102 (17%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI 288
            +  LH +    II+RD+   NI+LN    VK++DFGL +      + T T   GTI Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYM 188

Query: 289 ---LLACGG-----DIYSFSVVLLELVIRKQPTG-PEFKDKN 321
              +L   G     D +S   ++ +++     TG P F  +N
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDML-----TGAPPFTGEN 225

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 20/121 (16%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + +LH R    II+RD+   N+LL+ +  +K++D+G+ +        TST   GT  Y 
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYI 220

Query: 288 ---ILLACGGDIYSFSV------VLL-ELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILN 336
              IL       Y FSV      VL+ E++  + P       D    N  D++    IL 
Sbjct: 221 APEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILE 276

Query: 337 A 337
            
Sbjct: 277 K 277

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 20/121 (16%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + +LH R    II+RD+   N+LL+ +  +K++D+G+ +        TST   GT  Y 
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYI 177

Query: 288 ---ILLACGGDIYSFSV------VLL-ELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILN 336
              IL       Y FSV      VL+ E++  + P       D    N  D++    IL 
Sbjct: 178 APEILRGED---YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILE 233

Query: 337 A 337
            
Sbjct: 234 K 234

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 8/70 (11%), Positives = 16/70 (22%), Gaps = 3/70 (4%)

Query: 20  IPK---NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFS 76
           I K    L +L  +  + +    +                         NL  L   +  
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 77  MNMLGGHIPE 86
                  +P+
Sbjct: 500 NCPNMTQLPD 509

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 13/84 (15%)

Query: 19  IIPKNLNELP---HLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDF 75
            +P  L +LP    L+++CN+                      ++  D     +++ F  
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWT----------RLADDEDTGPKIQIFYM 555

Query: 76  SMNMLGGHIPEKNIDLCGKIMGLD 99
             N L       ++    K+  LD
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLD 579

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           G+ FL  +    II+RD+   N++L+ +  +K++DFG+ +        T T   GT  Y 
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 188

Query: 288 ---ILLACGGDIYSFSV 301
              I+       Y  SV
Sbjct: 189 APEIIAYQP---YGKSV 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 21/77 (27%), Positives = 37/77 (48%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + +LH R    +++RDI   N++L++D  +K++DFGL +      +   T   GT  Y 
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172

Query: 288 ---ILLACGGDIYSFSV 301
              +L       Y  +V
Sbjct: 173 APEVLEDND---YGRAV 186

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + +LH     +I++RD+   NILL+    + ++DFGL +   +  S TST   GT  Y 
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYL 206

Query: 288 ---ILLACGGDIYSFSV 301
              +L       Y  +V
Sbjct: 207 APEVLHKQP---YDRTV 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
            + FLH +    II+RD+   N+LL+ +   K++DFG+ +        T+T   GT  Y 
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYI 191

Query: 288 ---ILLACGGDIYSFSV 301
              IL       Y  +V
Sbjct: 192 APEILQEML---YGPAV 205

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 26/152 (17%)

Query: 184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHRFQ 238
           +V+L           +V EY+  G +   LR   +         A        +LH    
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-- 160

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACG- 293
             +I+RD+   N+L+++   ++V+DFG  + +      T T + GT       I+L+ G 
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWT-LCGTPEALAPEIILSKGY 215

Query: 294 ---GDIYSFSVVLLELVIRKQPTG-PEFKDKN 321
               D ++  V++ E+       G P F    
Sbjct: 216 NKAVDWWALGVLIYEMA-----AGYPPFFADQ 242

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 41.0 bits (97), Expect = 4e-04
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 11/77 (14%)

Query: 229 GITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY- 287
           G+ FLH +    I++RD+   NILL++D  +K++DFG+ +     ++ T+T   GT  Y 
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYI 185

Query: 288 ---ILLACGGDIYSFSV 301
              ILL      Y+ SV
Sbjct: 186 APEILLGQK---YNHSV 199

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	383
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.98
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.98
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.98
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.98
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.98
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.98
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.98
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.98
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.98
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.98
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.98
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.98
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.98
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.98
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.82
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.59
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.52
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.17
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.07
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.01
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.99
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.96
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.96
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	98.95
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.94
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.94
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.93
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.92
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.91
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.91
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.87
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.86
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.85
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.84
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.82
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.82
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.77
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.77
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.77
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.76
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.76
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.75
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.72
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.7
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.7
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.7
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.67
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.66
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.66
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.66
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.65
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.64
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.64
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.64
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.63
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.63
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.63
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.63
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.62
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.62
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.61
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.6
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.6
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.59
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.58
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.57
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.57
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.57
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.56
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.55
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.55
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.54
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.54
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.54
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.53
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.53
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.53
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.53
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.52
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.51
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.51
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.5
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.5
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.48
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.48
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.47
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.45
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.45
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.44
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.44
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.44
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.42
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.4
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.4
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.4
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.4
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.38
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.35
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.35
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.34
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.34
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.31
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.29
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.27
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.27
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.26
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.25
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.2
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.15
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.1
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.01
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.0
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	97.96
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.86
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.77
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.69
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.67
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.66
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.6
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.58
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.46
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.29
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.28
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.2
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.12
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.11
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.81
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.65
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.48
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.21
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.8
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	94.75
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	94.51
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.37
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	94.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	94.25
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.63
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	93.28
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	93.15
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	92.97
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	92.5
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	91.36
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	91.18
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	91.12
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	91.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	89.4
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	85.95
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	85.9
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	84.48
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	84.06
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	83.95
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	83.28
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	82.51
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	81.61
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	81.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	80.04

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=352.67  Aligned_cols=205  Identities=27%  Similarity=0.438  Sum_probs=160.5

Q ss_pred             CccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          165 KFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++.-.+.||+|+||.||                                      ||||+++|+|.+ +..++|||||++
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            45556789999999999                                      799999999865 568999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Ccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTST  279 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~~~  279 (383)
                      |+|.++|+..      .++..++.|+|.||+|||+.   +|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus       116 GsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~  192 (307)
T 3omv_A          116 SSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE  192 (307)
T ss_dssp             CBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence            9999999642      35688999999999999998   99999999999999999999999999998765432 22334


Q ss_pred             ccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc----cccCChhHHH
Q 046461          280 DVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI----LNAYSKPSML  344 (383)
Q Consensus       280 ~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~----~~~~~~~~~~  344 (383)
                      ...||+.|||||           .++|||||||++|||+||+.||...    +.............    ....+..++.
T Consensus       193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~----~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI----NNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC----CCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC----ChHHHHHHHHhcCCCCCCcccccccchH
Confidence            568999999998           2689999999999999999997432    22222221111111    1122445667


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+.+++.+||+.||++||||.||++.|+.++..
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            899999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-46  Score=354.01  Aligned_cols=186  Identities=22%  Similarity=0.430  Sum_probs=155.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      ||||+++|+|.+++..++|||||++|+|.++|...                     .++..++.|||+||+|||+.   +
T Consensus        89 pNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~  165 (308)
T 4gt4_A           89 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---H  165 (308)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            79999999999999999999999999999999531                     24578999999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCC-CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      |+||||||+|||++.++.+||+|||+++...... ........||+.|||||        .++|||||||++|||+| |+
T Consensus       166 iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~  245 (308)
T 4gt4_A          166 VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL  245 (308)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCC
Confidence            9999999999999999999999999998764432 22334467999999998        67999999999999998 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .||..    ....++.+.+...... +.+..++..+.+++.+||+.||++||||.||+++|+.+.
T Consensus       246 ~Pf~~----~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          246 QPYCG----YSNQDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             CTTTT----CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCC----CCHHHHHHHHHcCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            89543    3444555555444332 335567778999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-46  Score=352.73  Aligned_cols=205  Identities=25%  Similarity=0.491  Sum_probs=168.7

Q ss_pred             CccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      +|.-.+.||+|+||.||                                            ||||+++|+|.+++..++|
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV   93 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   93 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45566789999999998                                            7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEc
Q 046461          201 YEYMVKGSLNDWLRNQ------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVS  262 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~  262 (383)
                      ||||++|+|.++|+..                  .++..++.|+|.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence            9999999999999642                  34678999999999999998   99999999999999999999999


Q ss_pred             cccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecC
Q 046461          263 DFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDS  332 (383)
Q Consensus       263 Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~  332 (383)
                      |||+++........ ......||+.|||||        .++|||||||++|||+| |+.||..    .+..++...+..+
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~----~~~~~~~~~i~~~  246 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ----LSNNEVIECITQG  246 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT----SCHHHHHHHHHHT
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC----CCHHHHHHHHHcC
Confidence            99999876443222 223356899999998        67999999999999999 8999643    2344455555444


Q ss_pred             cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ... ..+..++.++.+++.+||+.||++||||+||.+.|+++.+.
T Consensus       247 ~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          247 RVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            332 23455677899999999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=353.56  Aligned_cols=207  Identities=27%  Similarity=0.449  Sum_probs=163.8

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|...+.||+|+||.||                                            ||||+++|+|.+++..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            345566789999999998                                            799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc--------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          200 VYEYMVKGSLNDWLRNQ--------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~--------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      |||||++|+|.++++..                    .+++.++.|+|.||+|||+.   +|+||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            99999999999999642                    24578999999999999998   99999999999999999999


Q ss_pred             EEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceee
Q 046461          260 KVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v  329 (383)
                      ||+|||+++....... .......||+.|||||        .++|||||||++|||+| |+.||..    ....++.+.+
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~----~~~~~~~~~i  273 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ----LSNTEAIDCI  273 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS----SCHHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC----CCHHHHHHHH
Confidence            9999999987654332 2334467999999998        57899999999999999 8999643    2334444444


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ..... ...+..++.++.+++.+||+.||++||||+||+++|+.+.+..
T Consensus       274 ~~g~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          274 TQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHTCC-CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HcCCC-CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            33321 2234556778999999999999999999999999999987654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.1e-45  Score=342.49  Aligned_cols=215  Identities=25%  Similarity=0.364  Sum_probs=163.1

Q ss_pred             ccccCeeecCCccccc------------------------------------cccceeeeEEEeCC----EEEEEEEecc
Q 046461          166 FYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGE----KKLIVYEYMV  205 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~----~~~lv~e~~~  205 (383)
                      +.-.+.||+|+||.||                                    ||||+++|+|.+++    ..+||||||+
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            4456789999999999                                    79999999998754    6799999999


Q ss_pred             CCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcC-----CCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          206 KGSLNDWLRN----QAKHCIIACGTARGITFLHHRF-----QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       206 ~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      +|+|.++++.    +..+.+++.|+|.||+|||+++     .++|+||||||+|||++.++.+||+|||+++........
T Consensus        85 ~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  164 (303)
T 3hmm_A           85 HGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT  164 (303)
T ss_dssp             TCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred             CCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCc
Confidence            9999999974    3457889999999999999763     458999999999999999999999999999876543322


Q ss_pred             ---cccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCC------CCCCCC-----cccee
Q 046461          277 ---TSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEF------KDKNGG-----NLVDW  328 (383)
Q Consensus       277 ---~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~------~~~~~~-----~~~~~  328 (383)
                         ......||+.|||||              .++|||||||++|||+||+.|+....      .+....     .+.+.
T Consensus       165 ~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  244 (303)
T 3hmm_A          165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV  244 (303)
T ss_dssp             ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred             eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHH
Confidence               223457999999998              26899999999999999988753211      110000     01111


Q ss_pred             ee----cCcccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 046461          329 VL----DSTILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF  380 (383)
Q Consensus       329 v~----~~~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~  380 (383)
                      +.    ++.++... ..+....+.+++.+||+.||++||||.||+++|+++.++++.
T Consensus       245 ~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i  301 (303)
T 3hmm_A          245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence            11    22222211 234566788999999999999999999999999999887654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-45  Score=350.10  Aligned_cols=208  Identities=26%  Similarity=0.400  Sum_probs=168.7

Q ss_pred             HhhCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeC-
Q 046461          162 GTNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVG-  194 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~-  194 (383)
                      ..++|.-.+.||+|+||.||                                              ||||+++|+|.+. 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            34667778899999999998                                              6899999999764 


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +..++|||||++|+|.++|+..                     .+...++.|||+||+|||++   +|+||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence            5689999999999999999742                     23567999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGG  323 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~  323 (383)
                      +.++.+||+|||+|+.+...... ......||+.|||||        .++|||||||++|||+| |+.||...    ...
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~----~~~  294 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KID  294 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CCS
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC----CHH
Confidence            99999999999999976544332 334467899999998        67999999999999998 89996432    222


Q ss_pred             -ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          324 -NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       324 -~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                       .+.+.+.++. ....+...+.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus       295 ~~~~~~i~~g~-~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          295 EEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence             2222222222 2233455667899999999999999999999999999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-44  Score=337.93  Aligned_cols=205  Identities=20%  Similarity=0.241  Sum_probs=166.5

Q ss_pred             hCccccCeeecCCccccc----------------------------------cccceeeeEEEeCCEEEEEEEeccCCCH
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSL  209 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL  209 (383)
                      +.|...+.||+|+||.||                                  ||||++++++.+++..|+|||||++|+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            456777889999999999                                  8999999999999999999999999999


Q ss_pred             HHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccccCCCCCc----ccc
Q 046461          210 NDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRLISDCESH----TST  279 (383)
Q Consensus       210 ~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~~~~~~~~----~~~  279 (383)
                      .++++..     .....++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+|+.+......    ...
T Consensus       138 ~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~  214 (336)
T 4g3f_A          138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD  214 (336)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence            9999743     35678999999999999998   999999999999999987 5999999999987543211    223


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc-ccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL-NAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~-~~~~~~~~~~~~~l~  350 (383)
                      ..+||+.|||||        .++||||+||++|||++|+.||...    ...++...+...... ...+...+..+.+++
T Consensus       215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  290 (336)
T 4g3f_A          215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----FRGPLCLKIASEPPPIREIPPSCAPLTAQAI  290 (336)
T ss_dssp             CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT----CCSCCHHHHHHSCCGGGGSCTTSCHHHHHHH
T ss_pred             ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----CHHHHHHHHHcCCCCchhcCccCCHHHHHHH
Confidence            467999999998        5789999999999999999997533    333444444332221 223455667889999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhccc
Q 046461          351 VGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .+||+.||++|||+.|+++.|.+..
T Consensus       291 ~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          291 QEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-43  Score=328.66  Aligned_cols=181  Identities=25%  Similarity=0.415  Sum_probs=141.8

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ||||++++++.+    ++..++|||||++|+|.++++..     .....++.|++.||+|||++ .++|+||||||+|||
T Consensus        85 pnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NIL  163 (290)
T 3fpq_A           85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIF  163 (290)
T ss_dssp             TTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEE
T ss_pred             CCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhhee
Confidence            899999999865    34579999999999999999743     34577999999999999987 123999999999999


Q ss_pred             EcC-CCceEEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LNE-DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++. ++.+||+|||+|+....   ......+||+.|||||       .++|||||||++|||+||+.||...   .+...
T Consensus       164 l~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~---~~~~~  237 (290)
T 3fpq_A          164 ITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQ  237 (290)
T ss_dssp             ESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC---SSHHH
T ss_pred             EECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CcHHH
Confidence            984 78999999999986433   2234568999999999       6789999999999999999997432   11222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+.+.....+...+...++++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          238 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223332222222222334457889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.3e-43  Score=332.85  Aligned_cols=202  Identities=22%  Similarity=0.322  Sum_probs=166.0

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ..|...+.||+|+||.||                                       ||||++++++.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            347777889999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          205 VKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       205 ~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      ++|+|.+++..    +.....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.... .....
T Consensus       154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  229 (346)
T 4fih_A          154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  229 (346)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCC
T ss_pred             CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccccc
Confidence            99999999974    345678999999999999999   99999999999999999999999999998775432 23345


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc-ccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL-NAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~-~~~~~~~~~~~~~l~~  351 (383)
                      .+||+.|||||        .++||||+||++|||++|+.||..    .+..+..+.+.+.... .......+.++.+++.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            78999999998        678999999999999999999643    2333333333322111 1122345678899999


Q ss_pred             HccccCCCCCCCHHHHHH--HHhc
Q 046461          352 GCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                      +||+.||++|||++|+++  .+.+
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcC
Confidence            999999999999999986  4544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-43  Score=336.90  Aligned_cols=197  Identities=26%  Similarity=0.342  Sum_probs=158.5

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         ||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467788899999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          203 YMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||++|+|.+++...       .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999632       24577999999999999999   99999999999999999999999999998764321 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......+||+.|||||        .++||||+||++|||++|+.||..    .+..++...+...... ..+...+.++.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~~~~-~~~~~~s~~~~  254 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHcCCCC-CCCccCCHHHH
Confidence            1223467999999998        578999999999999999999643    2334444444444332 22344567889


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.|+++
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.7e-43  Score=326.37  Aligned_cols=196  Identities=21%  Similarity=0.345  Sum_probs=165.5

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            468888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-  275 (383)
                      |||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999999999999743     34678999999999999999   999999999999999999999999999998754332 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......+||+.|||||        .++||||+||++|||++|+.||..    .+..++.+.+....+  .++...+.++.
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~  262 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEGLIFAKIIKLEY--DFPEKFFPKAR  262 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHTCC--CCCTTCCHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHcCCC--CCCcccCHHHH
Confidence            2344578999999998        578999999999999999999643    234444444444332  23445566789


Q ss_pred             HHHHHccccCCCCCCCHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~  368 (383)
                      +++.+|++.||++|||++|+.
T Consensus       263 dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHHHHHccCCHhHCcChHHHc
Confidence            999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=334.09  Aligned_cols=202  Identities=22%  Similarity=0.322  Sum_probs=166.1

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      +.|...+.||+|+||.||                                       ||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            457788899999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          205 VKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       205 ~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      ++|+|.++++.    +.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.... .....
T Consensus       231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  306 (423)
T 4fie_A          231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  306 (423)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCC
T ss_pred             CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccccc
Confidence            99999999974    345678999999999999999   99999999999999999999999999998775432 23345


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc-ccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL-NAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~-~~~~~~~~~~~~~l~~  351 (383)
                      .+||+.|||||        .++||||+||++|||++|+.||..    .+..+..+.+.+.... .......+..+.+++.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            78999999998        678999999999999999999643    2333333333322111 1122345668899999


Q ss_pred             HccccCCCCCCCHHHHHH--HHhc
Q 046461          352 GCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                      +||+.||++|||+.|+++  .+++
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcC
Confidence            999999999999999987  4544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-42  Score=323.62  Aligned_cols=196  Identities=23%  Similarity=0.341  Sum_probs=161.6

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|.-.+.||+|+||.||                                            ||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            468888999999999998                                            799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999999753     34678999999999999999   99999999999999999999999999998754332


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       ......+||+.|||||        .++||||+||++|||++|+.||..    .+..++...+.....  ..+...+.++
T Consensus       181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~~~--~~p~~~s~~~  253 (304)
T 3ubd_A          181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKL--GMPQFLSPEA  253 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC----cCHHHHHHHHHcCCC--CCCCcCCHHH
Confidence             2234478999999998        678999999999999999999643    234444444444332  2344556788


Q ss_pred             HHHHHHccccCCCCCCC-----HHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      .+++.+||+.||++|||     ++|+++
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            99999999999999998     467664

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.2e-42  Score=316.34  Aligned_cols=194  Identities=20%  Similarity=0.334  Sum_probs=150.4

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            578888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||| +|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+......  
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence            999 68999998743     35678999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      .....+||+.|||||         .++||||+||++|||++|+.||..    .+...+.+.+.....  ..+...+..+.
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~  240 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----ESIPVLFKNISNGVY--TLPKFLSPGAA  240 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHTCC--CCCTTSCHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence            233468999999998         468999999999999999999643    233333333333322  22344566788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+|++.||++|||++|+++
T Consensus       241 ~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          241 GLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHc
Confidence            9999999999999999999987

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-40  Score=310.92  Aligned_cols=201  Identities=25%  Similarity=0.363  Sum_probs=145.0

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCC--------
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGE--------  195 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~--------  195 (383)
                      ++|...+.||+|+||.||                                        ||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            457888999999999999                                        89999999987644        


Q ss_pred             ----EEEEEEEeccCCCHHHHHhcch--------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          196 ----KKLIVYEYMVKGSLNDWLRNQA--------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       196 ----~~~lv~e~~~~gsL~~~l~~~~--------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                          ..++|||||++|+|.+++....        ....++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                3689999999999999997431        2467899999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCCc-----------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          264 FGLVRLISDCESH-----------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       264 fgla~~~~~~~~~-----------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ||+|+........           ..+..+||+.|||||        .++|||||||++|||++   |+....   +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9999876543211           123457999999998        67899999999999996   643211   1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ....+.....++. .....+...+++.+||+.||++|||+.|+++  .++++
T Consensus       236 ~~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            1111122111111 1223345678999999999999999999987  44443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.8e-38  Score=299.28  Aligned_cols=235  Identities=32%  Similarity=0.599  Sum_probs=192.6

Q ss_pred             CCCCCcccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceee
Q 046461          148 EPSLGKLTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLL  188 (383)
Q Consensus       148 ~~~~~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~  188 (383)
                      ......+++.++..++++|...+.||+|+||.||                                       +||++++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            3455778999999999999999999999999999                                       7999999


Q ss_pred             eEEEeCCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          189 GYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       189 g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      ++|.+.+..++||||+++|+|.+++...         .....++.|++.||+|||+.+.++++||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            9999999999999999999999999743         2457899999999999999877899999999999999999999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCC-CCCCCcc-----
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFK-DKNGGNL-----  325 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~-~~~~~~~-----  325 (383)
                      ||+|||+++..............||..|+|||        .++||||||+++|||++|+.|++.... .......     
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999999877654444445567999999998        578999999999999999999752110 0011111     


Q ss_pred             -------ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCC
Q 046461          326 -------VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGR  382 (383)
Q Consensus       326 -------~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~~~  382 (383)
                             ...+.+.........+....+.+++.+||+.||++|||+.||+++|++....+.+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~  317 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE  317 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence                   111223333445567778899999999999999999999999999998766665543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-38  Score=306.10  Aligned_cols=155  Identities=22%  Similarity=0.290  Sum_probs=131.8

Q ss_pred             HHHHHhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCE
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ++..-.+.|.-.+.||+|+||.||                                         ||||++++++.+.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            344456789999999999999999                                         799999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhc--chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CceEEccccCccccCCC
Q 046461          197 KLIVYEYMVKGSLNDWLRN--QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDC  273 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~--~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-~~~kl~Dfgla~~~~~~  273 (383)
                      .++|||||++|+|.++++.  ..+...++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            9999999999999999974  345678999999999999999   99999999999999877 79999999999865432


Q ss_pred             CC---------------------------ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          274 ES---------------------------HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       274 ~~---------------------------~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ..                           ...+..+||+.|+|||         .++||||+||++|||++|+.||..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            11                           1123357999999998         457999999999999999999843

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.3e-38  Score=319.35  Aligned_cols=197  Identities=23%  Similarity=0.334  Sum_probs=161.6

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...++||+|+||.||                                             ||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            578888999999999999                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      +|||||+||+|.++|...     .....++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999999743     34678999999999999998   9999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      .   ....+||+.|||||         .++||||+||++|||++|+.||..... .+...+...+.....  .++...+.
T Consensus       346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-~~~~~i~~~i~~~~~--~~p~~~S~  419 (689)
T 3v5w_A          346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAV--ELPDSFSP  419 (689)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-CCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred             C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhhcCCCC--CCCccCCH
Confidence            2   23468999999998         457999999999999999999753211 011112222222221  23445567


Q ss_pred             HHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ++.+++.+|++.||++|++     ++||.+
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            8899999999999999998     677764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-36  Score=284.06  Aligned_cols=223  Identities=33%  Similarity=0.578  Sum_probs=180.7

Q ss_pred             CCCcccHHHHHHHhhCcccc------CeeecCCccccc-----------------------------------------c
Q 046461          150 SLGKLTYDQIVAGTNKFYEK------NVIRGDDFGIAF-----------------------------------------K  182 (383)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~------~~lg~g~~g~v~-----------------------------------------~  182 (383)
                      ....+++.++..+|++|+..      +.||+|+||.||                                         |
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45678999999999999988      899999999999                                         7


Q ss_pred             ccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       183 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ||+++++++.+.+..++||||+++|+|.+++...        .....++.|++.||+|||+.   +++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            9999999999999999999999999999999632        34578999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc-cccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          255 EDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      .++.+||+|||+++........ ......|+..|+|||       .++||||||+++|||++|+.|+...........+.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            9999999999999876543221 223457899999997       57899999999999999999975432111111111


Q ss_pred             eee----------ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          327 DWV----------LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       327 ~~v----------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +.+          .++.+ ..........+.+++.+||+.||++|||+.+|++.|+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            100          11111 22345667789999999999999999999999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=302.74  Aligned_cols=203  Identities=20%  Similarity=0.306  Sum_probs=156.6

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe------CCE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV------GEK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~------~~~  196 (383)
                      ++|...+.||+|+||.||                                         ||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            467788999999999999                                         799999998764      357


Q ss_pred             EEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      .|+|||||+ |+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            899999995 7899999743     34678999999999999999   99999999999999999999999999998764


Q ss_pred             CCC---CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC-------
Q 046461          272 DCE---SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS-------  332 (383)
Q Consensus       272 ~~~---~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~-------  332 (383)
                      ...   .......+||+.|||||         .++||||+||++|||++|+.||...    +..+..+.+...       
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~----~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK----NYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS----SHHHHHHHHHHHHCCCCGG
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC----CHHHHHHHHHHhcCCCChH
Confidence            322   22334578999999998         4579999999999999999997432    222221111000       


Q ss_pred             ---------------cccccC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          333 ---------------TILNAY-------SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       333 ---------------~~~~~~-------~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                                     .+....       .......+.+++.+|+..||++|||+.|+++  .+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                           000000       0123457889999999999999999999987  45544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.2e-37  Score=291.70  Aligned_cols=222  Identities=32%  Similarity=0.513  Sum_probs=179.5

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEe
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~  193 (383)
                      ..+++.++..++++|...+.||+|+||.||                                      |||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            345556677788999999999999999999                                      799999999999


Q ss_pred             CCEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccc
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF  264 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Df  264 (383)
                      .+..++||||+++|+|.+++...         .....++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999999998632         34678999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCC-CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce--------
Q 046461          265 GLVRLISDCE-SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD--------  327 (383)
Q Consensus       265 gla~~~~~~~-~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~--------  327 (383)
                      |+++...... ........||..|+|||        .++||||||+++|||++|+.|+...... +.....+        
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-SCCCHHHHTHHHHTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-HHHHHHHHhhhcccc
Confidence            9998754322 22233456899999998        5789999999999999999997643321 1111111        


Q ss_pred             ----eeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          328 ----WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       328 ----~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                          .+.++........+....+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence                12233333444567788899999999999999999999999999987654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=283.76  Aligned_cols=208  Identities=24%  Similarity=0.403  Sum_probs=164.1

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||.||                                       |||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            467778899999999998                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc-
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-  277 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~-  277 (383)
                      ++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......... 
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            999999999752      34678999999999999998   99999999999999999999999999998764332111 


Q ss_pred             ------------ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc
Q 046461          278 ------------STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA  337 (383)
Q Consensus       278 ------------~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~  337 (383)
                                  .....||+.|+|||        .++||||||+++|||++|..|+.......  .... ..........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~  243 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT--MDFG-LNVRGFLDRY  243 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC--TTSS-BCHHHHHHHT
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH--HHHh-hhhhcccccc
Confidence                        11457999999998        57899999999999999999865432211  1110 0111111112


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+...+..+.+++.+||+.||++|||+.++++.|++++..
T Consensus       244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            2334445788999999999999999999999999987643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-36  Score=308.94  Aligned_cols=197  Identities=18%  Similarity=0.289  Sum_probs=162.1

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|.-.+.||+|+||.||                                       ||||++++++.+.+..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            568888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--CceEEccccCccccCCCCCc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED--FEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~--~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ++|+|.+++...      .+...++.|++.||+|||++   +|+||||||+|||++.+  +.+||+|||+++.+....  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            999999999643      34678999999999999999   99999999999999854  889999999999875432  


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      .....+||+.|||||        .++||||+||++|||++|+.||..    .+..+....+.....  ........+..+
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC----SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            233468999999998        468999999999999999999643    233333333332222  111123345678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||+.|+++
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            89999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-36  Score=284.57  Aligned_cols=216  Identities=25%  Similarity=0.373  Sum_probs=165.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------cccceeeeEEEeCC----EEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGE----KKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~----~~~lv~e~  203 (383)
                      ++|...++||+|+||.||                                    ||||++++++.+..    ..++||||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             hhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            467788899999999999                                    79999999998744    46999999


Q ss_pred             ccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcC-------CCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          204 MVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRF-------QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       204 ~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~-------~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +++|+|.++++.    +.....++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~  183 (322)
T 3soc_A          104 HEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA  183 (322)
T ss_dssp             CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECT
T ss_pred             CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccc
Confidence            999999999974    3456889999999999999752       34899999999999999999999999999987654


Q ss_pred             CCC-ccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC------------Cccc
Q 046461          273 CES-HTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG------------GNLV  326 (383)
Q Consensus       273 ~~~-~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~------------~~~~  326 (383)
                      ... .......||..|+|||             .++|||||||++|||++|+.|+.........            .++.
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (322)
T 3soc_A          184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ  263 (322)
T ss_dssp             TSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred             ccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence            332 2233467999999998             2459999999999999999997543221000            0000


Q ss_pred             eeeec----Cccccc-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          327 DWVLD----STILNA-YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       327 ~~v~~----~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ..+..    +.+... ........+.+++.+||+.||++|||+.||++.|+++.+..+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~  321 (322)
T 3soc_A          264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN  321 (322)
T ss_dssp             HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            00011    111111 122345679999999999999999999999999999876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-36  Score=279.65  Aligned_cols=209  Identities=24%  Similarity=0.383  Sum_probs=161.8

Q ss_pred             hhCccccCeeecCCccccc------------------------------------cccceeeeEEEe----CCEEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPV----GEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~----~~~~~lv~e  202 (383)
                      .++|...+.||+|+||.||                                    |||+++++++..    ....++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            3567788999999999998                                    799999999765    245899999


Q ss_pred             eccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHh--------hcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          203 YMVKGSLNDWLRNQ----AKHCIIACGTARGITFLH--------HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       203 ~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      |+++|+|.++++..    .....++.|++.||+|||        +.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  163 (301)
T 3q4u_A           87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMH  163 (301)
T ss_dssp             CCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             hccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence            99999999999742    356789999999999999        65   9999999999999999999999999999876


Q ss_pred             CCCCCcc---ccccccccccccCC--------------CCCcchhHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 046461          271 SDCESHT---STDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIR----------KQPTGPEFKDKNGG  323 (383)
Q Consensus       271 ~~~~~~~---~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg----------~~p~~~~~~~~~~~  323 (383)
                      .......   .....||+.|+|||              .++|||||||++|||++|          +.|+..........
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~  243 (301)
T 3q4u_A          164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF  243 (301)
T ss_dssp             ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence            5433221   22347999999998              268999999999999999          67764332211111


Q ss_pred             ccceee-----ecCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          324 NLVDWV-----LDSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       324 ~~~~~v-----~~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ......     ..+.+.. .........+.+++.+||+.||++|||+.||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            111111     1111111 11234667899999999999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-36  Score=284.20  Aligned_cols=209  Identities=29%  Similarity=0.448  Sum_probs=159.4

Q ss_pred             HHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ...++|...+.||+|+||.||                                       +||+++++++.+.+..++||
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            344678888999999999999                                       79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          202 EYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPH--IIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       202 e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      ||+++|+|.+++...        .....++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999999743        23567899999999999998   7  9999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ... .......||..|+|||        .++|||||||++|||++|+.||...    +..+....+.........+....
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T 3p86_A          191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL----NPAQVVAAVGFKCKRLEIPRNLN  265 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS----CHHHHHHHHHHSCCCCCCCTTSC
T ss_pred             ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCCCccCC
Confidence            322 2233457899999998        5789999999999999999996432    22222222211111122234556


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            6789999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.7e-36  Score=289.18  Aligned_cols=187  Identities=26%  Similarity=0.443  Sum_probs=150.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      |||++++++|.+.+..++||||+++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus       147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~  223 (370)
T 2psq_A          147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---K  223 (370)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            79999999999999999999999999999999742                     23467899999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      |+||||||+|||++.++.+||+|||+++....... .......+++.|+|||        .++|||||||++|||++ |+
T Consensus       224 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987654332 2223356788999998        46899999999999999 88


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .|+..    ....++.+.+.... ....+......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       304 ~p~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          304 SPYPG----IPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             CSSTT----CCGGGHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC----CCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            88643    22233332222221 122234556688999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-35  Score=277.94  Aligned_cols=198  Identities=24%  Similarity=0.349  Sum_probs=161.0

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||.||                                       |||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            568888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          205 VKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       205 ~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      ++|+|.+++..    ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus       100 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  175 (297)
T 3fxz_A          100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  175 (297)
T ss_dssp             TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred             CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCC
Confidence            99999999974    345678999999999999999   999999999999999999999999999987654332 2334


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee-cCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL-DSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~-~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..||+.|+|||        .++|||||||++|||++|+.||...    +.......+. ........+......+.+++.
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            67999999998        5789999999999999999997432    1111111111 111111123345567889999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 046461          352 GCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~  369 (383)
                      +||+.||++|||+.|+++
T Consensus       252 ~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhh
Confidence            999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-35  Score=279.57  Aligned_cols=219  Identities=23%  Similarity=0.376  Sum_probs=167.3

Q ss_pred             HhhCccccCeeecCCccccc------------------------------------cccceeeeEEEeC----CEEEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVG----EKKLIVY  201 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~----~~~~lv~  201 (383)
                      ..++|...+.||+|+||.||                                    +||+++++++...    ...++||
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            34678889999999999999                                    7999999999887    7899999


Q ss_pred             EeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcC-----CCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          202 EYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRF-----QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       202 e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ||+++|+|.++++..    .....++.|++.||+|||+.+     .++|+||||||+||+++.++.+||+|||+++....
T Consensus       115 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~  194 (337)
T 3mdy_A          115 DYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS  194 (337)
T ss_dssp             CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence            999999999999743    356789999999999999762     34899999999999999999999999999987644


Q ss_pred             CCCcc---ccccccccccccCC--------C------CCcchhHHHHHHHHHhC----------CCCCCCCCCCCCCCc-
Q 046461          273 CESHT---STDVAGTIGYILLA--------C------GGDIYSFSVVLLELVIR----------KQPTGPEFKDKNGGN-  324 (383)
Q Consensus       273 ~~~~~---~~~~~gt~~y~ape--------~------~~Dv~SfGvil~Elltg----------~~p~~~~~~~~~~~~-  324 (383)
                      .....   .....||..|+|||        .      ++|||||||++|||++|          +.|+........... 
T Consensus       195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  274 (337)
T 3mdy_A          195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED  274 (337)
T ss_dssp             --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             ccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh
Confidence            32221   12457999999998        2      28999999999999999          445432211111100 


Q ss_pred             cceeeecCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 046461          325 LVDWVLDSTILNAY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF  380 (383)
Q Consensus       325 ~~~~v~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~  380 (383)
                      ....+.........     .......+.+++.+||+.||++|||+.||++.|+++.+..+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  335 (337)
T 3mdy_A          275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI  335 (337)
T ss_dssp             HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred             hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence            11111111111111     235677899999999999999999999999999999887654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-35  Score=272.79  Aligned_cols=207  Identities=24%  Similarity=0.394  Sum_probs=166.2

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     |||+++++++.+++..++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN   87 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence            467777889999999998                                     7999999999999999999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++............
T Consensus        88 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            9999999753      34578999999999999998   99999999999999999999999999998765544333344


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..++..|+|||        .++||||+|++++||++ |+.|+...    ...+....+.... ....+......+.+++.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  239 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY----TNSEVVLKVSQGH-RLYRPHLASDTIYQIMY  239 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHTTC-CCCCCTTSCHHHHHHHH
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc----ChHHHHHHHHcCC-CCCCCCcChHHHHHHHH
Confidence            55678899998        68999999999999999 99996432    2222222111111 11112334557889999


Q ss_pred             HccccCCCCCCCHHHHHHHHhccccCC
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      +||+.||++|||+.|+++.|+.+.+++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          240 SCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             HHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.2e-36  Score=283.32  Aligned_cols=206  Identities=25%  Similarity=0.412  Sum_probs=163.6

Q ss_pred             CccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +|...+.||+|+||.||                                           +||+++++++.+++..++||
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  129 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT  129 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence            34556899999999998                                           79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||+++|+|.++++..      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            999999999999643      34678999999999999998   999999999999999999999999999987654322


Q ss_pred             c--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          276 H--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       276 ~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      .  ......+|..|+|||        .++||||||+++|||++ |+.|+...    ...+....+... .....+...+.
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~  281 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----TNRDVISSVEEG-YRLPAPMGCPH  281 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS----CHHHHHHHHHTT-CCCCCCTTCCH
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC----CHHHHHHHHHcC-CCCCCCCCcCH
Confidence            1  222344677899998        57899999999999999 99996432    222333222222 11222345567


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+.+++.+||+.||++|||+.||++.|+.+....
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            8899999999999999999999999999886653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-35  Score=279.14  Aligned_cols=210  Identities=23%  Similarity=0.331  Sum_probs=169.5

Q ss_pred             CcccHHHHHHHhhC----------ccccCeeecCCccccc---------------------------------------c
Q 046461          152 GKLTYDQIVAGTNK----------FYEKNVIRGDDFGIAF---------------------------------------K  182 (383)
Q Consensus       152 ~~~~~~~l~~~t~~----------f~~~~~lg~g~~g~v~---------------------------------------~  182 (383)
                      ..++++++..+++.          |...+.||+|+||.||                                       +
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            56899999999975          5566789999999999                                       7


Q ss_pred             ccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 046461          183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE  258 (383)
Q Consensus       183 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~  258 (383)
                      ||+++++++...+..++||||+++|+|.+++..    +.....++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~  179 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGR  179 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCc
Confidence            999999999999999999999999999999874    345678999999999999998   9999999999999999999


Q ss_pred             eEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          259 VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      +||+|||+++...... .......||..|+|||        .++||||||+++|||++|+.|+...    ...+....+.
T Consensus       180 ~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~----~~~~~~~~~~  254 (321)
T 2c30_A          180 VKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD----SPVQAMKRLR  254 (321)
T ss_dssp             EEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHH
T ss_pred             EEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHh
Confidence            9999999998765432 2233467999999998        5789999999999999999997432    2222222222


Q ss_pred             cCcccc-cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 DSTILN-AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 ~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..... .........+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            211111 112234567889999999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.4e-36  Score=297.61  Aligned_cols=209  Identities=19%  Similarity=0.215  Sum_probs=169.1

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEE
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~  191 (383)
                      ..+.++...+++|...++||+|+||.||                                          +||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3455666778899999999999999999                                          7999999999


Q ss_pred             EeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          192 PVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       192 ~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      .+++..++|||||++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999999752      23567899999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC
Q 046461          266 LVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS  332 (383)
Q Consensus       266 la~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~  332 (383)
                      +++..............||+.|+|||             .++|||||||++|||++|+.||...    +..+....+...
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~  296 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNH  296 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC----ChhHHHHhhhhc
Confidence            99877654444444568999999998             2689999999999999999997532    223333333221


Q ss_pred             c--c-cccCChhHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 046461          333 T--I-LNAYSKPSMLKMLQIVVGCIFDNPTT--RPTMLRVQE  369 (383)
Q Consensus       333 ~--~-~~~~~~~~~~~~~~l~~~C~~~~P~~--RPs~~~v~~  369 (383)
                      .  + .+......+..+.+++.+|+..+|++  ||+++|+++
T Consensus       297 ~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          297 KERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1  1 01111235567889999999888877  999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.3e-36  Score=290.66  Aligned_cols=207  Identities=23%  Similarity=0.335  Sum_probs=165.1

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .++|...+.||+|+||.||                                        |||++++++|.+++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            3567778899999999999                                        799999999999999999999


Q ss_pred             eccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+++|+|.++++..      .....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999743      24577999999999999998   9999999999999999999999999999865432111


Q ss_pred             cc-cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          277 TS-TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~-~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      .. ....++..|+|||        .++|||||||++|||++ |+.|+...    ...+..+.+... .....+...+..+
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~l  344 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----SNQQTREFVEKG-GRLPCPELCPDAV  344 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS----CHHHHHHHHHTT-CCCCCCTTCCHHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence            11 1123567899998        57999999999999998 88886432    222222222221 1122234456688


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+++.+||+.||++|||+.++++.|+++.++
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            8999999999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-35  Score=296.76  Aligned_cols=209  Identities=24%  Similarity=0.401  Sum_probs=169.2

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ..+|...+.||+|+||.||                                      ||||+++++|.+.+..++||||+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            4567778899999999999                                      79999999999999999999999


Q ss_pred             cCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          205 VKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       205 ~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++|+|.++++..       .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence            999999999742       23577899999999999998   99999999999999999999999999998765433222


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....++..|+|||        .++|||||||++|||++ |+.|+..    .+..++.+.+. .......+...+..+.+
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~l~~  450 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYELLE-KDYRMERPEGCPEKVYE  450 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT----CCGGGHHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC----CCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence            33345678899998        57899999999999999 8888543    22223332222 22222234455678899


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          349 IVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ++.+||+.||++|||+.+|++.|+.+.....
T Consensus       451 li~~cl~~dP~~RPs~~el~~~L~~~~~~~~  481 (495)
T 1opk_A          451 LMRACWQWNPSDRPSFAEIHQAFETMFQESS  481 (495)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred             HHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999866543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3e-35  Score=275.06  Aligned_cols=208  Identities=20%  Similarity=0.353  Sum_probs=160.3

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+++..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            356677888999998888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            999999999999743     35678999999999999998   9999999999999999999999999999876544333


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc---ccccCChhHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNAYSKPSMLK  345 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~---~~~~~~~~~~~~  345 (383)
                      ......||+.|+|||        .++||||+|+++|||++|+.||...    ...+.........   .........+..
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE----TAVSIAIKHIQDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS----CHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHhhccCCCcchhcccCCCHH
Confidence            344467999999998        5789999999999999999997432    1111111111111   111223344567


Q ss_pred             HHHHHHHccccCCCCCC-CHHHHHHHHhccccCC
Q 046461          346 MLQIVVGCIFDNPTTRP-TMLRVQEFLEKYHTGE  378 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RP-s~~~v~~~L~~~~~~~  378 (383)
                      +.+++.+|++.||++|| +++++.+.|+++..+.
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            88999999999999998 9999999999886654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-35  Score=279.92  Aligned_cols=196  Identities=21%  Similarity=0.309  Sum_probs=162.5

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      .++|...+.||+|+||.||                                         |||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            3568888999999999998                                         79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence            999999999999642     34678999999999999998   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......||+.|+|||         .++||||+||++|||++|+.||...    +..++.+.+......  .+...+..+.
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~--~p~~~s~~~~  242 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYR--IPFYMSTDCE  242 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence            234467999999998         3689999999999999999996432    333333333333221  2233456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||++|+++
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-35  Score=294.28  Aligned_cols=209  Identities=25%  Similarity=0.432  Sum_probs=167.5

Q ss_pred             HHHhhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ....++|...+.||+|+||.||                                     ||||++++++. .+..++|||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3445678888999999999999                                     79999999986 567899999


Q ss_pred             eccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          203 YMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |+++|+|.++++..       .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            99999999999743       23567899999999999998   999999999999999999999999999987643222


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      .......++..|+|||        .++|||||||++|||++ |+.|+..    ....++.+.+... .....+...+..+
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~----~~~~~~~~~i~~~-~~~~~~~~~~~~l  414 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG----MSNPEVIRALERG-YRMPRPENCPEEL  414 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHHHHT-CCCCCCTTSCHHH
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence            2223345678899998        57899999999999999 9999643    2233333333222 1112234556788


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+++.+||+.||++|||+.+|++.|+.+...
T Consensus       415 ~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-35  Score=273.96  Aligned_cols=206  Identities=26%  Similarity=0.426  Sum_probs=165.9

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     |||+++++++.+++..++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            456677889999999998                                     7999999999999999999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++............
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            9999999643      34577899999999999998   99999999999999999999999999998765433223334


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..++..|+|||        .++||||+|++++||++ |+.|+...    ...+..+.+... .....+......+.+++.
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTG-FRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTT-CCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHHhcC-ccCCCCCcCCHHHHHHHH
Confidence            55778899998        47899999999999999 88886432    222222222221 111223344567889999


Q ss_pred             HccccCCCCCCCHHHHHHHHhccccC
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +||+.||++|||+.|+++.|+++.+.
T Consensus       242 ~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          242 HCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHccCCcccCcCHHHHHHHHHHHHHc
Confidence            99999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.4e-35  Score=279.78  Aligned_cols=204  Identities=22%  Similarity=0.396  Sum_probs=161.6

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|...+.||+|+||.||                                            |||++++++|.+++ .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            457777889999999988                                            79999999998765 789


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |+||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            99999999999999753      34678999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      .. .......+|..|+|||        .++|||||||++|||++ |+.|+...    ...++.+.+.. ......+....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~-~~~~~~~~~~~  245 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEK-GERLPQPPICT  245 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHT-TCCCCCCTTBC
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC----CHHHHHHHHHc-CCCCCCCccCC
Confidence            32 2223345688999998        57899999999999999 99996432    22222222222 11222344556


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            688999999999999999999999999988754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-35  Score=286.14  Aligned_cols=206  Identities=25%  Similarity=0.411  Sum_probs=154.5

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++.+++..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            467778999999999998                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.++++..      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999999753      24678999999999999998   99999999999999999999999999998765432


Q ss_pred             Ccc--ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          275 SHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       275 ~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ...  .....++..|+|||        .++|||||||++|||++ |+.|+...    ...++.+.+.. ......+...+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~----~~~~~~~~i~~-~~~~~~~~~~~  276 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM----SNQDVIKAVDE-GYRLPPPMDCP  276 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC----CHHHHHHHHHT-TEECCCCTTCB
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHc-CCCCCCCcccc
Confidence            211  11233567899998        46899999999999998 99996432    22222222221 12222234556


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            6889999999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-36  Score=280.67  Aligned_cols=193  Identities=17%  Similarity=0.208  Sum_probs=154.6

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            578888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||+ +|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 77999988643      34678999999999999998   99999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       ......||+.|+|||       .++|||||||++|||++|..|+...       +..+.+................+.+
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          212 -AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG-------EGWQQLRQGYLPPEFTAGLSSELRS  283 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH-------HHHHHHTTTCCCHHHHTTSCHHHHH
T ss_pred             -CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHhccCCCcccccCCCHHHHH
Confidence             233456899999998       5789999999999999997775321       1111111111111112234567899


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.9e-35  Score=277.34  Aligned_cols=204  Identities=24%  Similarity=0.421  Sum_probs=159.8

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|...+.||+|+||.||                                            +||++++++|. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            356677889999999998                                            79999999986 456899


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ||||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999753      34678999999999999999   9999999999999999999999999999887543


Q ss_pred             CC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      .. .......|+..|+|||        .++||||||+++|||++ |+.|+...    ...+..+.+.... ....+....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~  243 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPDLLEKGE-RLAQPQICT  243 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS----CTTHHHHHHHTTC-BCCCCTTBC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc----CHHHHHHHHHcCC-CCCCCCcCc
Confidence            32 2233456788999998        47899999999999999 99996532    2222222222211 112223344


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            567889999999999999999999999988754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.7e-35  Score=288.85  Aligned_cols=204  Identities=28%  Similarity=0.387  Sum_probs=164.8

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------cccceeeeEEEeCC-EEEEEEEeccC
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVGE-KKLIVYEYMVK  206 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~~-~~~lv~e~~~~  206 (383)
                      .++|...+.||+|+||.||                                   ||||+++++|.+.+ ..++||||+++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            3567778899999999999                                   79999999988765 78999999999


Q ss_pred             CCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          207 GSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       207 gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |+|.++++..       .....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....    ..
T Consensus       272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~  344 (450)
T 1k9a_A          272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD  344 (450)
T ss_dssp             CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence            9999999743       23577999999999999998   9999999999999999999999999999864322    11


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~  350 (383)
                      ...++..|+|||        .++|||||||++|||++ |+.|+...    ...+..+.+... .....+...+..+.+++
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~~~-~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKG-YKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS----CTTTHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcC-CCCCCCCcCCHHHHHHH
Confidence            235678899998        57899999999999998 99996432    333333333222 12223455667899999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          351 VGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+||+.||++|||+.++++.|+++.+.+
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-35  Score=284.65  Aligned_cols=216  Identities=25%  Similarity=0.356  Sum_probs=168.7

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc----------------------------------------------ccccee
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQL  187 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l  187 (383)
                      +...+.....++|...+.||+|+||.||                                              |||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3445555667889899999999999997                                              699999


Q ss_pred             eeEEEeCC-EEEEEEEeccCCCHHHHHhcch-------------------------------------------------
Q 046461          188 LGYCPVGE-KKLIVYEYMVKGSLNDWLRNQA-------------------------------------------------  217 (383)
Q Consensus       188 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  217 (383)
                      +++|.+.+ ..++||||+++|+|.+++....                                                 
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998754 4899999999999999996431                                                 


Q ss_pred             ----------------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          218 ----------------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       218 ----------------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                                            ....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                                  2456899999999999999   999999999999999999999999999986643322


Q ss_pred             -ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          276 -HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       276 -~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                       .......||..|+|||        .++|||||||++|||++ |+.|+...    ...+..............+......
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  324 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKEGTRMRAPDYTTPE  324 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CCSHHHHHHHHHTCCCCCCTTCCHH
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc----chhHHHHHHHHcCCCCCCCCCCCHH
Confidence             2233456888999998        47899999999999998 99996432    1111111111111112223445567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            8899999999999999999999999998765

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=283.82  Aligned_cols=188  Identities=27%  Similarity=0.434  Sum_probs=151.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      |||++++++|.+++..++||||+++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus       135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  211 (382)
T 3tt0_A          135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---K  211 (382)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            79999999999999999999999999999999642                     23578999999999999998   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      |+||||||+||+++.++.+||+|||+++....... .......+|..|+|||        .++|||||||++|||++ |+
T Consensus       212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987654322 2233456788999998        47899999999999999 99


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .|+...    ...++.+.+.... ....+......+.+++.+||+.||++|||+.||++.|+++...
T Consensus       292 ~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          292 SPYPGV----PVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             CSSTTC----CHHHHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            886432    2223333222221 1222344566789999999999999999999999999987543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-35  Score=274.03  Aligned_cols=205  Identities=20%  Similarity=0.357  Sum_probs=152.0

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            456677889999999887                                           79999999984 5678999


Q ss_pred             EEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999999999743      34577899999999999998   99999999999999999999999999998765433


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ........+++.|+|||        .++||||||+++|||++ |..|+...    ...+....+..... ...+...+..
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~----~~~~~~~~i~~~~~-~~~~~~~~~~  245 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIENGER-LPMPPNCPPT  245 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTTCC-CCCCTTCCHH
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC----CHHHHHHHHHcCCC-CCCCCCCCHH
Confidence            33333445678899998        46899999999999997 88886432    22333333322221 1223445668


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            88999999999999999999999999988654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-35  Score=270.68  Aligned_cols=204  Identities=25%  Similarity=0.397  Sum_probs=154.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         |||+++++++.+++..++|||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            467777889999999888                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--------CCceEEccccCcccc
Q 046461          203 YMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE--------DFEVKVSDFGLVRLI  270 (383)
Q Consensus       203 ~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~--------~~~~kl~Dfgla~~~  270 (383)
                      |+++|+|.+++...    .....++.|++.||+|||+....+++||||||+||+++.        ++.+|++|||.++..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A           87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             CCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             cCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            99999999999643    356789999999999999983233999999999999986        678999999999865


Q ss_pred             CCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhH
Q 046461          271 SDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS  342 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  342 (383)
                      ....   .....|+..|+|||        .++||||||++++||++|+.|+...    +.......+.........+...
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          167 HRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI----DGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS----CHHHHHHHHHTSCCCCCCCTTC
T ss_pred             cccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHhhhcCCCCCCCCccc
Confidence            4322   22356899999998        4689999999999999999996432    2222222222222222233455


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            66889999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.2e-35  Score=273.67  Aligned_cols=208  Identities=24%  Similarity=0.368  Sum_probs=164.1

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .++|...+.||+|+||.||                                     +||+++++++.+.+..++||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            3467777889999999998                                     799999999999999999999999


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      +|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            99999999752      34678999999999999998   9999999999999999999999999999876443222233


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~  350 (383)
                      ...++..|+|||        .++||||+|+++|||++ |+.|+...    ...+..+.+... .....+......+.+++
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQG-LRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS----CHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc----ChhHHHHHHhcc-cCCCCCCcCCHHHHHHH
Confidence            345678899998        47899999999999998 99996432    222222222221 11122333456788999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          351 VGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+||+.||++|||+.|+++.|+++.+++
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            9999999999999999999999987665

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-35  Score=279.12  Aligned_cols=211  Identities=22%  Similarity=0.353  Sum_probs=166.1

Q ss_pred             HhhCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCC
Q 046461          162 GTNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGE  195 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~  195 (383)
                      ..++|...+.||+|+||.||                                              |||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            34678888999999999997                                              79999999999999


Q ss_pred             EEEEEEEeccCCCHHHHHhcc----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCC
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRDIN  247 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk  247 (383)
                      ..++||||+++|+|.+++...                            .....++.|++.||+|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999643                            12467899999999999998   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEF  317 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~  317 (383)
                      |+||+++.++.+||+|||+++........ ......||+.|+|||        .++||||||+++|||++ |..|+... 
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-  278 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-  278 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC-
Confidence            99999999999999999999866443222 223345788899998        46899999999999998 99996432 


Q ss_pred             CCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          318 KDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                         ..................+......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       279 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          279 ---PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             ---CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             ---CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence               11111111222222222234456688999999999999999999999999998876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8e-35  Score=271.58  Aligned_cols=211  Identities=17%  Similarity=0.209  Sum_probs=165.3

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|...+.||+|+||.||                                      +|++++++++.++...++||||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            467788899999999999                                      68999999999999999999999 


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-----eEEccccCccccCCCC
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE-----VKVSDFGLVRLISDCE  274 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~-----~kl~Dfgla~~~~~~~  274 (383)
                      +|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.     +||+|||+++......
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99999999742      34678999999999999998   9999999999999987766     9999999998765432


Q ss_pred             Cc------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc---ccc
Q 046461          275 SH------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI---LNA  337 (383)
Q Consensus       275 ~~------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~---~~~  337 (383)
                      ..      ......||..|+|||        .++||||||+++|||++|+.|+..... .........+.....   ...
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-ATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS-CCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc-cccHHHHHHHHhhccCccHHH
Confidence            21      233467999999998        468999999999999999999754211 011111111111111   001


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      .....+..+.+++.+||+.||++|||+.+|++.|+++.++.+
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            112345678899999999999999999999999998876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-34  Score=275.18  Aligned_cols=196  Identities=21%  Similarity=0.327  Sum_probs=160.6

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            567788899999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~  160 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence            999999999998742     34677899999999999998   99999999999999999999999999998643322 2


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      ......||+.|+|||        .++||||+||++|||++|+.|+...    +...+.+.+.....  ..+......+.+
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~s~~~~~  234 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLFELILMEEI--RFPRTLSPEAKS  234 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC----CHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence            234467999999998        5789999999999999999996432    22333333332222  123345567889


Q ss_pred             HHHHccccCCCCCC-----CHHHHHH
Q 046461          349 IVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      ++.+||+.||++||     ++.|+++
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            99999999999999     8999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-35  Score=268.69  Aligned_cols=200  Identities=20%  Similarity=0.315  Sum_probs=161.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeC--CEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVG--EKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~--~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                       |||+++++++.+.  +..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            356667888999998888                                       7999999999887  78899999


Q ss_pred             eccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          203 YMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPH--IIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |+++|+|.+++...       .....++.|++.||+|||+.   +  ++||||||+||+++.++.++++|||++..... 
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            99999999999753       24678999999999999987   6  99999999999999999999999988754322 


Q ss_pred             CCccccccccccccccCC--------C---CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhH
Q 046461          274 ESHTSTDVAGTIGYILLA--------C---GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS  342 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~---~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~  342 (383)
                           ....||+.|+|||        .   ++||||||+++|||++|+.|+...    ...+....+.........+...
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL----SNMEIGMKVALEGLRPTIPPGI  236 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS----CHHHHHHHHHHSCCCCCCCTTC
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc----ChHHHHHHHHhcCCCCCCCCCC
Confidence                 2346889999998        1   589999999999999999996432    2222222222222222334455


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ...+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            6688999999999999999999999999998875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-34  Score=273.50  Aligned_cols=218  Identities=23%  Similarity=0.334  Sum_probs=170.2

Q ss_pred             HHHhhCccccCeeecCCccccc------------------------------------cccceeeeEEEeCC----EEEE
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGE----KKLI  199 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~----~~~l  199 (383)
                      ....++|...+.||+|+||.||                                    |||+++++++...+    ..++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            3345678899999999999999                                    79999999998876    7899


Q ss_pred             EEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHh--------hcCCCCeeecCCCCCcEEEcCCCceEEccccCc
Q 046461          200 VYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLH--------HRFQPHIIHRDINASNILLNEDFEVKVSDFGLV  267 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla  267 (383)
                      ||||+++|+|.+++..    ......++.|++.||+|||        +.   +++||||||+||+++.++.+||+|||++
T Consensus       118 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            9999999999999974    2456789999999999999        55   8999999999999999999999999999


Q ss_pred             cccCCCCCc---cccccccccccccCC--------------CCCcchhHHHHHHHHHhC----------CCCCCCCCCCC
Q 046461          268 RLISDCESH---TSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIR----------KQPTGPEFKDK  320 (383)
Q Consensus       268 ~~~~~~~~~---~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg----------~~p~~~~~~~~  320 (383)
                      +........   ......||..|+|||              .++|||||||++|||++|          ..|+.......
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            876543321   223457899999998              258999999999999999          56654322111


Q ss_pred             CC-CccceeeecCcccccC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 046461          321 NG-GNLVDWVLDSTILNAY-----SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF  380 (383)
Q Consensus       321 ~~-~~~~~~v~~~~~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~  380 (383)
                      .. ..+.+.+.........     ..+....+.+++.+||+.||++|||+.||++.|+++.++.+.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence            11 1111111111111111     235567899999999999999999999999999999887654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-35  Score=287.67  Aligned_cols=207  Identities=18%  Similarity=0.238  Sum_probs=168.2

Q ss_pred             HHHHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEe
Q 046461          156 YDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       156 ~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~  193 (383)
                      +.++....++|...++||+|+||.||                                          ||||++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34555567889999999999999999                                          799999999999


Q ss_pred             CCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ++..++||||+++|+|.++++..    .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            99999999999999999999742    34677899999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc
Q 046461          270 ISDCESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA  337 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~  337 (383)
                      .............||+.|+|||            .++|||||||++|||++|+.||...    +..+..+.+........
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~  293 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLT  293 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTHHHHCC
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC----ChhhHHHHHHhcccccc
Confidence            6554333344578999999998            3689999999999999999997432    33333333332211111


Q ss_pred             C--ChhHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 046461          338 Y--SKPSMLKMLQIVVGCIFDNPTT--RPTMLRVQE  369 (383)
Q Consensus       338 ~--~~~~~~~~~~l~~~C~~~~P~~--RPs~~~v~~  369 (383)
                      +  ....+..+.+++.+|+..+|.+  ||+++||++
T Consensus       294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1  1234567889999999999988  999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.2e-35  Score=280.17  Aligned_cols=197  Identities=23%  Similarity=0.339  Sum_probs=158.3

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++|...++||+|+||.||                                           |||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4678888999999999999                                           799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999743     34677999999999999998   99999999999999999999999999998643222


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       ......+||+.|+|||        .++||||+||++|||++|+.||...    +..++.+.+.....  .++......+
T Consensus       179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~  251 (353)
T 3txo_A          179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE----NEDDLFEAILNDEV--VYPTWLHEDA  251 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCC--CCCCCCCHHH
Confidence             2334467999999998        6789999999999999999996432    33344444433332  2233455678


Q ss_pred             HHHHHHccccCCCCCCCH------HHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTM------LRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~------~~v~~  369 (383)
                      .+++.+|++.||++||++      .|+++
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            899999999999999998      67764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=284.82  Aligned_cols=206  Identities=24%  Similarity=0.338  Sum_probs=163.2

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                             +|||++++++.+.+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            456677889999999988                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---ceEEcc
Q 046461          199 IVYEYMVKGSLNDWLRNQ------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---EVKVSD  263 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---~~kl~D  263 (383)
                      +||||+++|+|.+++...            .....++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            999999999999999743            23567999999999999999   999999999999999544   599999


Q ss_pred             ccCccccCCCC-CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCc
Q 046461          264 FGLVRLISDCE-SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDST  333 (383)
Q Consensus       264 fgla~~~~~~~-~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~  333 (383)
                      ||+++...... ........||+.|+|||        .++|||||||++|||++ |..|+..    ....++.+.+....
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~----~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS----KSNQEVLEFVTSGG  303 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHHHTTC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHcCC
Confidence            99998653221 12223356788999998        57899999999999998 8888643    23333333333222


Q ss_pred             ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      . ...+......+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       304 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          304 R-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            1 122344556788999999999999999999999999887653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-35  Score=279.12  Aligned_cols=210  Identities=30%  Similarity=0.496  Sum_probs=167.6

Q ss_pred             HHHhhCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeC
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~  194 (383)
                      ....++|...+.||+|+||.||                                             |||+++++++.++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3345778888899999999988                                             7999999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      +..++||||+++|+|.+++...                             .....++.|++.||+|||+.   +++|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9999999999999999999642                             23467899999999999998   999999


Q ss_pred             CCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCC
Q 046461          246 INASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGP  315 (383)
Q Consensus       246 lk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~  315 (383)
                      |||+||+++.++.+||+|||+++....... .......++..|+|||        .++||||||+++|||++ |+.|+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999986543221 1223356788999998        47899999999999999 9989643


Q ss_pred             CCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          316 EFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       316 ~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .    ...+....+.+.... ..+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       280 ~----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          280 M----AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             S----CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             C----ChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            2    223333333333221 22344556889999999999999999999999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=280.57  Aligned_cols=204  Identities=27%  Similarity=0.460  Sum_probs=151.1

Q ss_pred             ccccCeeecCCccccc-------------------------------------------cccceeeeEEEe-CCEEEEEE
Q 046461          166 FYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPV-GEKKLIVY  201 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~-~~~~~lv~  201 (383)
                      |...+.||+|+||.||                                           |||++++++|.. ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            4455789999999998                                           799999999865 45789999


Q ss_pred             EeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||+++|+|.++++..      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999743      34577899999999999998   999999999999999999999999999986643221


Q ss_pred             ---ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          276 ---HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       276 ---~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                         .......++..|+|||        .++|||||||++|||++ |..|+..    .+..+....+..... ...+...+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~----~~~~~~~~~~~~~~~-~~~p~~~~  322 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYLLQGRR-LLQPEYCP  322 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT----SCSSCHHHHHHTTCC-CCCCTTCC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC----CCHHHHHHHHHcCCC-CCCCCCCC
Confidence               1223345778899998        57899999999999999 4555432    223333333322221 11233455


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            6789999999999999999999999999988654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-34  Score=271.78  Aligned_cols=207  Identities=24%  Similarity=0.412  Sum_probs=165.6

Q ss_pred             hhCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      .++|...+.||+|+||.||                                             |||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            3456677888999998887                                             7999999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc-----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINA  248 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~  248 (383)
                      ++||||+++|+|.+++...                             .....++.|++.||+|||+.   +++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            9999999999999999642                             13567899999999999998   999999999


Q ss_pred             CcEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCC
Q 046461          249 SNILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFK  318 (383)
Q Consensus       249 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~  318 (383)
                      +||+++.++.+||+|||+++........ ......++..|+|||        .++||||||+++|||++ |+.|+...  
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--  256 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--  256 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence            9999999999999999999876543221 222345778899998        57899999999999999 99996432  


Q ss_pred             CCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          319 DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       319 ~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                        ....+.+.+.... ....+......+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       257 --~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 --PPERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             --CGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CHHHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence              2223322222221 1222344566889999999999999999999999999988654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=273.39  Aligned_cols=214  Identities=21%  Similarity=0.341  Sum_probs=160.7

Q ss_pred             hCccccCeeecCCccccc------------------------------------cccceeeeEEEe-----CCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPV-----GEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~-----~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                    +||+++++++..     ....++|||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            567788999999999999                                    699999986543     236789999


Q ss_pred             eccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          203 YMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRF------QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       203 ~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~------~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      |+++|+|.+++...    .....++.|++.||+|||+.+      .++|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~  172 (336)
T 3g2f_A           93 YYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG  172 (336)
T ss_dssp             CCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccc
Confidence            99999999999743    346789999999999999863      33899999999999999999999999999987653


Q ss_pred             CC-------CccccccccccccccCC---------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce---
Q 046461          273 CE-------SHTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD---  327 (383)
Q Consensus       273 ~~-------~~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~---  327 (383)
                      ..       ........||..|+|||               .++|||||||++|||++|..|+.+............   
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  252 (336)
T 3g2f_A          173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV  252 (336)
T ss_dssp             SSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred             ccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence            22       11222456999999998               247999999999999999888643221111000000   


Q ss_pred             ---------------eeecCcccccC--ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          328 ---------------WVLDSTILNAY--SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       328 ---------------~v~~~~~~~~~--~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                                     ....+.+....  ....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence                           00011111111  123566799999999999999999999999999987644

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.5e-35  Score=282.79  Aligned_cols=191  Identities=15%  Similarity=0.196  Sum_probs=145.7

Q ss_pred             cccceeeeEEEeC----CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcE
Q 046461          182 KNIVQLLGYCPVG----EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNI  251 (383)
Q Consensus       182 ~niv~l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~Ni  251 (383)
                      +||+++++++...    ...++||||+ +|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni  183 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL  183 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence            5899999998764    4589999999 99999999743      34678999999999999999   999999999999


Q ss_pred             EEc--CCCceEEccccCccccCCCCCc------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          252 LLN--EDFEVKVSDFGLVRLISDCESH------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       252 Ll~--~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      |++  .++.+||+|||+++........      ......||+.|+|||        .++|||||||++|||++|+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999  8899999999999876432211      112345999999998        568999999999999999999753


Q ss_pred             CCCCCCCCccceee---ecCccc---c-c-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          316 EFKDKNGGNLVDWV---LDSTIL---N-A-YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       316 ~~~~~~~~~~~~~v---~~~~~~---~-~-~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ...   ........   ....+.   . . .....+..+.+++..||+.||++||++.+|++.|+++.+..+
T Consensus       264 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          264 NLK---DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             GTT---CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccc---CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            221   11111110   000110   0 0 012335678899999999999999999999999998766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.4e-35  Score=289.12  Aligned_cols=207  Identities=29%  Similarity=0.436  Sum_probs=160.6

Q ss_pred             HhhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ..++|...+.||+|+||.||                                     |||+++++++.+ +..++||||+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            34567778899999999999                                     799999999876 6789999999


Q ss_pred             cCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          205 VKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       205 ~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++|+|.+++...       .....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.........
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence            999999999742       24578999999999999998   99999999999999999999999999998765433222


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....++..|+|||        .++|||||||++|||++ |+.|+...    ...+..+.+... .....+...+..+.+
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~----~~~~~~~~i~~~-~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERG-YRMPCPPECPESLHD  412 (452)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT-CCCCCCTTSCHHHHH
T ss_pred             ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence            33345678899998        47899999999999999 88886432    222333322222 112223455678899


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          349 IVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++.+||+.||++|||+.++++.|+.+...
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            99999999999999999999999998654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-35  Score=278.62  Aligned_cols=210  Identities=25%  Similarity=0.384  Sum_probs=166.1

Q ss_pred             HHhhCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeC
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~  194 (383)
                      ...++|...+.||+|+||.||                                              |||+++++++.++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345678888999999999998                                              7999999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +..++||||+++|+|.+++...                   .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence            9999999999999999999642                   23567899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          256 DFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      ++.+||+|||+++........ ......++..|+|||        .++||||||+++|||++ |..|+...    .....
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~~~~  275 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI----LVNSK  275 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC----CSSHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc----chhHH
Confidence            999999999999866433221 222345678899998        46899999999999999 88886432    11111


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .............+...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            1111111121222333456788999999999999999999999999987543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-34  Score=273.33  Aligned_cols=211  Identities=21%  Similarity=0.384  Sum_probs=156.0

Q ss_pred             HHhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCE
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ...++|...+.||+|+||.||                                            |||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345678888999999999998                                            699999999988765


Q ss_pred             E------EEEEEeccCCCHHHHHhcc-----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          197 K------LIVYEYMVKGSLNDWLRNQ-----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       197 ~------~lv~e~~~~gsL~~~l~~~-----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      .      ++||||+++|+|.+++...           .....++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      9999999999999999532           24678999999999999999   99999999999999999999


Q ss_pred             EEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceee
Q 046461          260 KVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v  329 (383)
                      ||+|||+++....... .......++..|+|||        .++|||||||++|||++ |+.|+...    +..+..+.+
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~  252 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI----ENAEIYNYL  252 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc----ChHHHHHHH
Confidence            9999999987644322 1222345678899988        47899999999999999 88886432    333333333


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ..... ...+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus       253 ~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          253 IGGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             hcCCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            22221 12234455688999999999999999999999999998876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-34  Score=277.97  Aligned_cols=201  Identities=20%  Similarity=0.317  Sum_probs=159.3

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++|...++||+|+||.||                                           ||||++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3578888999999999999                                           799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999999743     34677999999999999999   99999999999999999999999999998643222


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC-C----ccceeeecCcccccCChh
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG-G----NLVDWVLDSTILNAYSKP  341 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~-~----~~~~~v~~~~~~~~~~~~  341 (383)
                       ......+||+.|+|||        .++||||+||++|||++|+.||......... .    .+.+.+....+  ..+..
T Consensus       208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~  284 (396)
T 4dc2_A          208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRS  284 (396)
T ss_dssp             -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTT
T ss_pred             -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCc
Confidence             2334568999999998        5789999999999999999998532111110 0    01111222221  22344


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 046461          342 SMLKMLQIVVGCIFDNPTTRPTM------LRVQE  369 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RPs~------~~v~~  369 (383)
                      ....+.+++.+||+.||++||++      .|+++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            56678899999999999999995      56654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-34  Score=274.13  Aligned_cols=197  Identities=16%  Similarity=0.265  Sum_probs=160.5

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|...+.||+|+||.||                                      |||+++++++.+.+..++||||++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            567778899999999999                                      799999999999999999999999


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCceEEccccCccccCCCCCcc
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE--DFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      +|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++......  .
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~  159 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence            99999999743      34678999999999999998   9999999999999987  7899999999998765432  2


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc--CChhHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA--YSKPSMLKML  347 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~--~~~~~~~~~~  347 (383)
                      .....||+.|+|||        .++||||+||++|||++|..|+...    ...+..+.+........  .....+..+.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC----CHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            23457899999998        5789999999999999999997432    22333333333222111  0123356788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+|+..||++|||+.|+++
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHhc
Confidence            9999999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-34  Score=272.62  Aligned_cols=194  Identities=21%  Similarity=0.348  Sum_probs=158.7

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467777889999999988                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+ +|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999 78999988642     35678999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......||+.|+|||         .++||||+||++|||++|+.||+..    ....+.+.+.....  ..+...+..+.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~s~~~~  236 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE----FIPNLFKKVNSCVY--VMPDFLSPGAQ  236 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS----SSTTCBCCCCSSCC--CCCTTSCHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHcCCC--CCcccCCHHHH
Confidence            223457999999998         3689999999999999999997543    22333333322221  12334456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||++|+++
T Consensus       237 ~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          237 SLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcCCChhHCcCHHHHHh
Confidence            9999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-34  Score=274.11  Aligned_cols=212  Identities=21%  Similarity=0.250  Sum_probs=164.1

Q ss_pred             HHHHHhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEe
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~  193 (383)
                      ++....++|...+.||+|+||.||                                            |||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            455667789999999999999999                                            799999999999


Q ss_pred             CCEEEEEEEeccCCCHHHHHhc---------------------------------------------chhhhHHHHhHHH
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRN---------------------------------------------QAKHCIIACGTAR  228 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~---------------------------------------------~~~~~~i~~~ia~  228 (383)
                      .+..++||||+++|+|.+++..                                             ......++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999851                                             1224568999999


Q ss_pred             HHHHHhhcCCCCeeecCCCCCcEEEcCCC--ceEEccccCccccCCCC---CccccccccccccccCC----------CC
Q 046461          229 GITFLHHRFQPHIIHRDINASNILLNEDF--EVKVSDFGLVRLISDCE---SHTSTDVAGTIGYILLA----------CG  293 (383)
Q Consensus       229 gL~~LH~~~~~~ivHrdlk~~NiLl~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~ape----------~~  293 (383)
                      ||+|||+.   +|+||||||+||+++.++  .+||+|||+++......   ........||+.|+|||          .+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999   999999999999998766  89999999998654322   11233467899999998          36


Q ss_pred             CcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc--cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--
Q 046461          294 GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--  369 (383)
Q Consensus       294 ~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--  369 (383)
                      +|||||||++|||++|+.|+...    ...+....+.......  .........+.+++.+||+.||++|||+.|+++  
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGV----NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence            89999999999999999996432    2222222222222211  111234567889999999999999999999987  


Q ss_pred             HHhcccc
Q 046461          370 FLEKYHT  376 (383)
Q Consensus       370 ~L~~~~~  376 (383)
                      .++++..
T Consensus       333 ~~~~~~~  339 (345)
T 3hko_A          333 WISQFSD  339 (345)
T ss_dssp             HHHTTSS
T ss_pred             hhccChH
Confidence            5665544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=283.54  Aligned_cols=208  Identities=19%  Similarity=0.192  Sum_probs=166.1

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEE
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~  191 (383)
                      +++.++...+++|...++||+|+||.||                                          +||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            4455666677899999999999999999                                          6999999999


Q ss_pred             EeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          192 PVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       192 ~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      .+.+..++||||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999999753      23567899999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccccCC---------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          266 LVRLISDCESHTSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       266 la~~~~~~~~~~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      +++..............||+.|+|||               .++|||||||++|||++|+.||...    +..+....+.
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~i~  283 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAETYGKIV  283 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC----CHHHHHHHHH
Confidence            99877554433334568999999998               3479999999999999999997432    2223222222


Q ss_pred             cCc--c-cccCChhHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 046461          331 DST--I-LNAYSKPSMLKMLQIVVGCIFDNPTTR---PTMLRVQE  369 (383)
Q Consensus       331 ~~~--~-~~~~~~~~~~~~~~l~~~C~~~~P~~R---Ps~~~v~~  369 (383)
                      ...  . .+......+..+.+++.+|+. +|++|   |+++|+++
T Consensus       284 ~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             THHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            211  1 011123345678899999999 99998   68999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-34  Score=266.03  Aligned_cols=200  Identities=22%  Similarity=0.366  Sum_probs=158.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ++|...+.||+|+||.||                                              +||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            467777888999999888                                              69999999987655  


Q ss_pred             EEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCc-----eEEccc
Q 046461          198 LIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPH--IIHRDINASNILLNEDFE-----VKVSDF  264 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NiLl~~~~~-----~kl~Df  264 (383)
                      ++||||+++|+|.+++...      .....++.|++.||+|||+.   +  ++||||||+||+++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999999988643      34578999999999999998   7  999999999999987776     999999


Q ss_pred             cCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc
Q 046461          265 GLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI  334 (383)
Q Consensus       265 gla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~  334 (383)
                      |+++....    ......||..|+|||          .++||||+|+++|||++|+.|+.....  ........+.....
T Consensus       174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY--GKIKFINMIREEGL  247 (287)
T ss_dssp             TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC--CHHHHHHHHHHSCC
T ss_pred             Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc--cHHHHHHHHhccCC
Confidence            99975432    233457899999998          357999999999999999999753211  11111222222233


Q ss_pred             cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       335 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            3333455667889999999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-34  Score=272.44  Aligned_cols=207  Identities=26%  Similarity=0.414  Sum_probs=164.4

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ++|...+.||+|+||.||                                              |||+++++++.+++..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            467777889999999886                                              7999999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc-----------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++||||+++|+|.+++...                       .....++.|++.||+|||+.   +++||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence            9999999999999999642                       23567899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          255 EDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      .++.+||+|||+++........ ......++..|+|||        .++||||||+++|||++ |+.|+...    ....
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~  255 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDS  255 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CSSH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc----cchh
Confidence            9999999999999876543322 122345678899998        46899999999999999 88886432    1111


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..............+...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11111121222222344556789999999999999999999999999987654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-34  Score=271.70  Aligned_cols=209  Identities=16%  Similarity=0.204  Sum_probs=163.2

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|...+.||+|+||.||                                      +||+++++++.+++..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            567788899999999999                                      79999999999999999999999 


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-----eEEccccCccccCCCC
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE-----VKVSDFGLVRLISDCE  274 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~-----~kl~Dfgla~~~~~~~  274 (383)
                      +|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++......
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99999999742      34678999999999999998   9999999999999998887     9999999998765433


Q ss_pred             Cc------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc---
Q 046461          275 SH------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA---  337 (383)
Q Consensus       275 ~~------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~---  337 (383)
                      ..      ......||..|+|||        .++|||||||++|||++|+.||..... .+..+..+.+........   
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~  243 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKERYQKIGDTKRATPIEV  243 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-SSHHHHHHHHHHHHHHSCHHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-ccHHHHHHHHHhhhccCCHHH
Confidence            21      123467999999998        468999999999999999999754211 111111122211111000   


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .....+ .+.+++..||+.||++||++.+|.+.|+++....
T Consensus       244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            011123 8899999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.9e-34  Score=281.86  Aligned_cols=200  Identities=19%  Similarity=0.238  Sum_probs=160.7

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      -+++|...+.||+|+||.||                                         ||||++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            34668888999999999998                                         7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCceEEccccCccccCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~---~~~~~kl~Dfgla~~~~~  272 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++   .++.+||+|||+++....
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            9999999999998643     35678999999999999999   999999999999998   467899999999987654


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCChhH
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYSKPS  342 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~~~~  342 (383)
                      .. .......||+.|+|||        .++||||+||++|||++|..||...    +..++.+.+......  .......
T Consensus       166 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  240 (444)
T 3soa_A          166 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE----DQHRLYQQIKAGAYDFPSPEWDTV  240 (444)
T ss_dssp             TC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             CC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHhCCCCCCccccccC
Confidence            32 2233467999999998        5789999999999999999996432    333333333332221  1112345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..+.+++.+|++.||++|||+.|+++
T Consensus       241 s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          241 TPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            667889999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.4e-34  Score=266.15  Aligned_cols=213  Identities=17%  Similarity=0.256  Sum_probs=160.2

Q ss_pred             HhhCccccCeeecCCccccc-------------------------------------cccceeeeE-EEeCCEEEEEEEe
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGY-CPVGEKKLIVYEY  203 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~-~~~~~~~~lv~e~  203 (383)
                      ..++|...+.||+|+||.||                                     +|++..+++ +.+++..++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            34678889999999999999                                     344544444 4677889999999


Q ss_pred             ccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCCC
Q 046461          204 MVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       204 ~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      + +|+|.+++..      ......++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||+++......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9 9999999973      235678999999999999999   99999999999999   788999999999998765433


Q ss_pred             C------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc---
Q 046461          275 S------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA---  337 (383)
Q Consensus       275 ~------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~---  337 (383)
                      .      .......||..|+|||        .++|||||||++|||++|+.|+...... ........+........   
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SSSSHHHHHHHHHHHSCHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh-hhhhhhhhhhcccccchhhh
Confidence            2      1223457899999998        4689999999999999999997542211 11122111111111110   


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      .....+..+.+++.+||+.||++|||+.++++.|+++.++.+
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            012234678999999999999999999999999998876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-34  Score=273.54  Aligned_cols=200  Identities=22%  Similarity=0.333  Sum_probs=159.3

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            467778899999999998                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Ccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~  277 (383)
                      +++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            9999999998743     35678999999999999998   99999999999999999999999999998654322 122


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....||+.|+|||         .++||||+||++|||++|+.||.....  .......+... .............+.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEK-KTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT--TSHHHHHHHTT-CTTSTTGGGSCHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhcc-cccCCccccCCHHHHH
Confidence            33467999999998         358999999999999999999753211  11111111111 1111112344567889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       241 li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHccCChhhCcCHHHHhh
Confidence            999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-34  Score=270.43  Aligned_cols=207  Identities=28%  Similarity=0.454  Sum_probs=154.8

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .++|...+.||+|+||.||                                      +||+++++++ ..+..++||||+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~  101 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC  101 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence            3467788999999999999                                      7999999976 455689999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Ccc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHT  277 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~  277 (383)
                      ++++|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            999999999632      34678999999999999998   99999999999999999999999999998654322 222


Q ss_pred             ccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc---ccCChhHH
Q 046461          278 STDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL---NAYSKPSM  343 (383)
Q Consensus       278 ~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~---~~~~~~~~  343 (383)
                      .....||..|+|||           .++||||||+++|||++|+.|+....   ....+.+.+......   .......+
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC---CHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc---hHHHHHHHhcccccCcchhhccccCC
Confidence            23456899999988           26799999999999999999974321   111122222121111   11123455


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            788999999999999999999999999998865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-34  Score=276.62  Aligned_cols=202  Identities=19%  Similarity=0.275  Sum_probs=149.7

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .++|...+.||+|+||.||                                      |||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            3568888999999999998                                      79999999999999999999999


Q ss_pred             cCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--eEEccccCccccCCCCCcc
Q 046461          205 VKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE--VKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       205 ~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~--~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.  +||+|||+++.....  ..
T Consensus        99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~  173 (361)
T 3uc3_A           99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ  173 (361)
T ss_dssp             CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CC
Confidence            999999998642     35678999999999999998   9999999999999987765  999999999754322  12


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....||+.|+|||         .++||||+||++|||++|+.||.............+.+................+.+
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  253 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH  253 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence            23356999999998         237999999999999999999754221111111112222222111111234567889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       254 li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          254 LISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHHh
Confidence            999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.6e-34  Score=276.41  Aligned_cols=199  Identities=22%  Similarity=0.353  Sum_probs=160.9

Q ss_pred             HHHhhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCE
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ....++|...++||+|+||.||                                           |||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            3445788889999999999999                                           799999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      .++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999999742     34677999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          272 DCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ... .......||+.|+|||        .++||||+||++|||++|+.||...    +..++.+.+.....  ..+....
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~s  242 (345)
T 1xjd_A          170 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ----DEEELFHSIRMDNP--FYPRWLE  242 (345)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTSC
T ss_pred             cCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHHhCCC--CCCcccC
Confidence            322 2234468999999998        5689999999999999999996432    33333333322221  2233455


Q ss_pred             HHHHHHHHHccccCCCCCCCHH-HHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTML-RVQ  368 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~-~v~  368 (383)
                      ..+.+++.+||+.||++||++. |+.
T Consensus       243 ~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          243 KEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            6788999999999999999997 654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-34  Score=274.17  Aligned_cols=197  Identities=23%  Similarity=0.356  Sum_probs=161.4

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++|...++||+|+||.||                                           |||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4678888999999999999                                           699999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999742     34678999999999999998   99999999999999999999999999998643222


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       ......+||+.|+|||        .++||||+||++|||++|+.|+..    .+..++.+.+.....  .++......+
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~  248 (353)
T 2i0e_A          176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNV--AYPKSMSKEA  248 (353)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC----CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence             2234467999999998        568999999999999999999643    233334444433322  2234456688


Q ss_pred             HHHHHHccccCCCCCCC-----HHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      .+++.+|++.||++||+     ++|+.+
T Consensus       249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          249 VAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            89999999999999995     466654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.1e-34  Score=278.31  Aligned_cols=200  Identities=19%  Similarity=0.224  Sum_probs=150.3

Q ss_pred             Ccccc-CeeecCCccccc-----------------------------------cccceeeeEEEe----CCEEEEEEEec
Q 046461          165 KFYEK-NVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV----GEKKLIVYEYM  204 (383)
Q Consensus       165 ~f~~~-~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~----~~~~~lv~e~~  204 (383)
                      +|... ++||+|+||.||                                   +||+++++++..    .+..++||||+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            44443 689999999999                                   799999999875    56789999999


Q ss_pred             cCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCCC
Q 046461          205 VKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       205 ~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~~  274 (383)
                      ++|+|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++......
T Consensus       142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            999999999743       24578999999999999998   9999999999999997   7899999999998754322


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSML  344 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~  344 (383)
                        ......||..|+|||        .++|||||||++|||++|+.||...............+.....  ..........
T Consensus       219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  296 (400)
T 1nxk_A          219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE  296 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence              233467899999998        4689999999999999999997543211111111222222211  1111234566


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.+++.+||+.||++|||+.|+++
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            7899999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=275.51  Aligned_cols=188  Identities=18%  Similarity=0.220  Sum_probs=146.0

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      +||+++++++..    ....++||||+ +++|.+++...     .....++.|++.||+|||+.   +|+||||||+||+
T Consensus       108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            689999999988    77899999999 99999999743     35688999999999999998   9999999999999


Q ss_pred             EcCCC--ceEEccccCccccCCCCC------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCC
Q 046461          253 LNEDF--EVKVSDFGLVRLISDCES------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPE  316 (383)
Q Consensus       253 l~~~~--~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~  316 (383)
                      ++.++  .+||+|||+++.......      .......||..|+|||        .++|||||||++|||++|+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99877  999999999987643211      1123457899999998        5789999999999999999997432


Q ss_pred             CCCCCCCccceeeecCcccccCCh---------hHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSK---------PSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~---------~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..  +. ....... .......+.         ..+..+.+++.+||+.||++|||+.+|++.|+++...
T Consensus       264 ~~--~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          264 LK--DP-VAVQTAK-TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             TT--CH-HHHHHHH-HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             cc--cc-HHHHHHH-HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            11  11 1111100 000011111         3445789999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.3e-34  Score=267.73  Aligned_cols=210  Identities=27%  Similarity=0.437  Sum_probs=161.2

Q ss_pred             CccccCeeecCCccccc-------------------------------------------cccceeeeEEEe-CCEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPV-GEKKLIV  200 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~-~~~~~lv  200 (383)
                      .|...+.||+|+||.||                                           |||++++++|.. ++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            45666889999999988                                           799999999754 5678999


Q ss_pred             EEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999742      34577899999999999998   99999999999999999999999999998664322


Q ss_pred             C---ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          275 S---HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       275 ~---~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      .   .......+|..|+|||        .++||||+|+++|||++|..|+.   ......+....+..... ...+....
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~  258 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNTFDITVYLLQGRR-LLQPEYCP  258 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS---TTSCTTTHHHHHHTTCC-CCCCTTCC
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC---ccCCHHHHHHHHhcCCC-CCCCccCC
Confidence            1   1223356778899988        56899999999999999665542   22223333322222211 11133345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFG  381 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~~  381 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++.....-.
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~  296 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  296 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            67889999999999999999999999999987754433

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.3e-34  Score=276.99  Aligned_cols=194  Identities=22%  Similarity=0.306  Sum_probs=158.2

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...++||+|+||.||                                           |||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            568888999999999998                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            9999999999999743     34567899999999999998   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......+||+.|+|||        .++|||||||++|||++|+.||...    +..++.+.+.....  ..+......+.
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~----~~~~~~~~i~~~~~--~~~~~~~~~~~  267 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----NTAEMYDNILNKPL--QLKPNITNSAR  267 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----BHHHHHHHHHHSCC--CCCSSSCHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccc--CCCCCCCHHHH
Confidence            2234467999999998        5789999999999999999997432    33333333333322  12334456788


Q ss_pred             HHHHHccccCCCCCCCHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v  367 (383)
                      +++.+|++.||++||++.+.
T Consensus       268 ~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTT
T ss_pred             HHHHHHcccCHHhCCCCCCC
Confidence            99999999999999998543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-34  Score=272.72  Aligned_cols=207  Identities=25%  Similarity=0.409  Sum_probs=165.0

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------------cccceeeeEEEeC
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------------~niv~l~g~~~~~  194 (383)
                      .++|...+.||+|+||.||                                                |||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            3567777889999999887                                                6999999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +..++||||+++|+|.+++...                     .....++.|++.||+|||+.   +++||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            9999999999999999999742                     23467899999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 046461          254 NEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGG  323 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~  323 (383)
                      +.++.+||+|||+++........ ......++..|+|||        .++||||||+++|||++ |+.|+...    ...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~  266 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PVE  266 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC----CHH
Confidence            99999999999999876543221 223345678899998        57899999999999999 99886432    222


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++.+.+.... ....+......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       267 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          267 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            2222222221 1122334556788999999999999999999999999988643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-34  Score=266.52  Aligned_cols=206  Identities=26%  Similarity=0.409  Sum_probs=163.4

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     |||+++++++.+++..++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            356666788888888888                                     7999999999999999999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++............
T Consensus        88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9999999743      24577899999999999998   99999999999999999999999999998764322222233


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..++..|+|||        .++||||+|+++|||++ |+.|+...    ...+..+.+.... ....+......+.+++.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVEDISTGF-RLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTTC-CCCCCTTSCHHHHHHHH
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC----CHHHHHHHHhcCC-cCCCCccCcHHHHHHHH
Confidence            45678899998        46899999999999999 88886432    2222222222211 11123334567889999


Q ss_pred             HccccCCCCCCCHHHHHHHHhccccC
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +||+.||++|||+.++++.|+++.++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          240 HCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-34  Score=268.95  Aligned_cols=193  Identities=21%  Similarity=0.353  Sum_probs=159.5

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            467778899999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            999999999999743     34577899999999999998   9999999999999999999999999999875432   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       .....||+.|+|||        .++||||+||++|||++|+.|+...    +.....+.+.....  .++......+.+
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~~~  232 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAEL--RFPPFFNEDVKD  232 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence             23467999999998        5789999999999999999997432    22333333333222  123344567889


Q ss_pred             HHHHccccCCCCCC-----CHHHHHH
Q 046461          349 IVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      ++.+|++.||++||     +++|+++
T Consensus       233 li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          233 LLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            99999999999999     8888874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-34  Score=268.02  Aligned_cols=208  Identities=25%  Similarity=0.403  Sum_probs=167.8

Q ss_pred             HhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          162 GTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ..++|...+.||+|+||.||                                      +||+++++++.+++..++||||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            34567778899999999999                                      7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          204 MVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       204 ~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      +++|+|.+++...       .....++.+++.||+|||+.   +++||||||+||+++.++.+||+|||.++........
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence            9999999999742       23577899999999999999   9999999999999999999999999999876554433


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......++..|+|||        .++||||+|+++|||++ |..|+...    +.....+.+. .......+...+..+.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLE-KDYRMERPEGCPEKVY  242 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHH-TTCCCCCCTTCCHHHH
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHh-ccCCCCCCCCCCHHHH
Confidence            344456778899998        47899999999999999 88886432    2222222221 1122223344566889


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +++.+|++.||++|||+.++++.|+++..+
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999999987543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.6e-34  Score=274.88  Aligned_cols=197  Identities=18%  Similarity=0.264  Sum_probs=158.5

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      +.|...+.||+|+||.||                                             |||+++++++.+.+..+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            457777889999999888                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----ceEEccccCccc
Q 046461          199 IVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLVRL  269 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~----~~kl~Dfgla~~  269 (383)
                      +||||+++|+|.+++..     ......++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||+++.
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            99999999999999964     235678999999999999998   999999999999998776    799999999987


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCC
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYS  339 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~  339 (383)
                      .....  ......||+.|+|||        .++||||+||++|||++|..||...    +..+....+.....  .....
T Consensus       169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          169 IEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             CCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcCCCCCchhc
Confidence            65432  233467999999998        4689999999999999999997432    22233332222211  11111


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+..+.+++.+|+..||++|||+.|+++
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            233457889999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.6e-34  Score=270.46  Aligned_cols=212  Identities=25%  Similarity=0.463  Sum_probs=168.2

Q ss_pred             HHHHHHhhCccccCeeecCCccccc---------------------------------------------cccceeeeEE
Q 046461          157 DQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYC  191 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~  191 (383)
                      ++.....++|...+.||+|+||.||                                             +||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            3444456778888999999999998                                             6999999999


Q ss_pred             EeCCEEEEEEEeccCCCHHHHHhcc---------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          192 PVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       192 ~~~~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      .+++..++||||+++|+|.+++...               .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence            9999999999999999999999742               23567899999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          257 FEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      +.+||+|||+++....... .......++..|+|||        .++||||||+++|||++ |+.|+...    ...+..
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~  250 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----SNEQVL  250 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC----CHHHHH
Confidence            9999999999986543221 1122345678899998        46899999999999999 78885432    222333


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +.+...... ..+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       251 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            333332221 1234455678899999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-34  Score=271.66  Aligned_cols=205  Identities=21%  Similarity=0.388  Sum_probs=157.1

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|...+.||+|+||.||                                            |||++++++|..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            467778899999999998                                            79999999998765 789


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |+||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            99999999999999743      34678999999999999998   9999999999999999999999999999876433


Q ss_pred             CC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      .. .......+|..|+|||        .++|||||||++|||++ |+.|+...    ...++.+.+... .....+....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~  245 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKG-ERLPQPPICT  245 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CGGGHHHHHHTT-CCCCCCTTBC
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHcC-CCCCCCccCC
Confidence            22 2222345678899998        47899999999999999 99996432    222332222221 1122234456


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            6788999999999999999999999999987643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-34  Score=266.03  Aligned_cols=190  Identities=26%  Similarity=0.412  Sum_probs=148.6

Q ss_pred             cccceeeeEEEeCCEE-EEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPVGEKK-LIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~-~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      |||+++++++.+.+.. ++||||+.+|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++
T Consensus        82 ~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~  158 (298)
T 3pls_A           82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLD  158 (298)
T ss_dssp             TTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             CCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence            7999999999876655 9999999999999999752      34578899999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCC---CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCE---SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      .++.+||+|||+++......   ........++..|++||        .++||||||+++|||++|..|+...   .+..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~---~~~~  235 (298)
T 3pls_A          159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH---IDPF  235 (298)
T ss_dssp             TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCGG
T ss_pred             CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc---CCHH
Confidence            99999999999998654321   12223356788999987        4689999999999999977775322   2223


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      +..+.+.... ....+......+.+++.+||+.||++|||+.++++.|+++....
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          236 DLTHFLAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             GHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHhhcCC-CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            3333222221 11223345567889999999999999999999999999886653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-34  Score=270.46  Aligned_cols=210  Identities=22%  Similarity=0.378  Sum_probs=157.2

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeC--CEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVG--EKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~--~~~~  198 (383)
                      ++|...+.||+|+||.||                                           +||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            456666788999998886                                           7999999998653  5589


Q ss_pred             EEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          199 IVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +||||+++|+|.+++....      ....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            9999999999999997532      4577899999999999998   999999999999999999999999999987654


Q ss_pred             CCC--ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC-------CCCC-----ccceeee
Q 046461          273 CES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD-------KNGG-----NLVDWVL  330 (383)
Q Consensus       273 ~~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~-------~~~~-----~~~~~v~  330 (383)
                      ...  .......++..|+|||        .++||||||+++|||++|..|+......       ....     ...+. .
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-L  245 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH-H
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH-H
Confidence            322  1222345777899998        5789999999999999999986532110       0000     00000 1


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ........+...+..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11111122345567899999999999999999999999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.4e-34  Score=281.96  Aligned_cols=197  Identities=19%  Similarity=0.314  Sum_probs=160.6

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .++|...+.||+|+||.||                                          |||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            3678888999999999999                                          6999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++......
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999642     3467789999999999998 6   89999999999999999999999999998643322


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       .......||+.|+|||        .++|||||||++|||++|+.|+...    +...+.+.+.....  ..+......+
T Consensus       304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~  376 (446)
T 4ejn_A          304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHEKLFELILMEEI--RFPRTLGPEA  376 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCC--CCCccCCHHH
Confidence             2234467999999998        5789999999999999999996432    33333333322222  1233455678


Q ss_pred             HHHHHHccccCCCCCC-----CHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+++.+||+.||++||     |+.|+++
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            8999999999999999     9999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-34  Score=264.89  Aligned_cols=205  Identities=20%  Similarity=0.307  Sum_probs=158.8

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++|...+.||+|+||.||                                           |||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3567777889999999888                                           799999999865 45689


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999643      24577899999999999998   9999999999999999999999999999876544


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      .........++..|+|||        .++||||||+++|||++ |+.|+...    ...+..+.+..... ...+.....
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~~~  241 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL----ENKDVIGVLEKGDR-LPKPDLCPP  241 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS----CGGGHHHHHHHTCC-CCCCTTCCH
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC----ChHHHHHHHhcCCC-CCCCCCCCH
Confidence            333334456788999998        46899999999999998 99997432    22222222222111 112334456


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            78899999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=266.78  Aligned_cols=208  Identities=18%  Similarity=0.238  Sum_probs=162.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCC--EEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGE--KKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~--~~~lv~  201 (383)
                      +.|...++||+|+||.||                                        |||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            456777889999999998                                        79999999998755  789999


Q ss_pred             EeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCceEEccccCccc
Q 046461          202 EYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRL  269 (383)
Q Consensus       202 e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl----~~~~~~kl~Dfgla~~  269 (383)
                      ||+++|+|.+++...        .....++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            999999999999753        23577999999999999999   99999999999999    7888899999999987


Q ss_pred             cCCCCCccccccccccccccCC----------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee----
Q 046461          270 ISDCESHTSTDVAGTIGYILLA----------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV----  329 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape----------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v----  329 (383)
                      .....  ......||..|+|||                .++|||||||++|||++|+.||..........+....+    
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            65433  223456899999987                36899999999999999999975321111111111111    


Q ss_pred             -----------------ecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          330 -----------------LDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       330 -----------------~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                                       ..+.+  ...........+.+++.+|++.||++|||+.|+++...+...
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence                             01111  112345667788999999999999999999999998876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-34  Score=274.68  Aligned_cols=202  Identities=23%  Similarity=0.319  Sum_probs=161.4

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCCE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ++|...+.||+|+||.||                                               +||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            578888999999999998                                               699999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      .++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999999743     34677899999999999998   99999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChh
Q 046461          272 DCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP  341 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~  341 (383)
                      ...........||+.|+|||          .++|||||||++|||++|+.|+...........+.+.+...  ....+..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--CCCCCcc
Confidence            43333344567999999998          35799999999999999999975332111111111111111  1123344


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 046461          342 SMLKMLQIVVGCIFDNPTTRP-----TMLRVQEF  370 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RP-----s~~~v~~~  370 (383)
                      ....+.+++.+||+.||++||     |+.|+++.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            556788999999999999999     99999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=274.46  Aligned_cols=198  Identities=23%  Similarity=0.343  Sum_probs=159.5

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          ||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            467788999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence            999999999999743     34677899999999999998   9999999999999999999999999999876543  2


Q ss_pred             cccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          277 TSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       277 ~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ......||+.|+|||           .++||||+||++|||++|+.||...... ....+...+....  ..++......
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~--~~~p~~~s~~  246 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTV--VTYPSAWSQE  246 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCC--CCCCTTSCHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcc--cCCCCcCCHH
Confidence            334567999999998           3579999999999999999997532111 1111111111111  1223445668


Q ss_pred             HHHHHHHccccCCCCCCC-HHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPT-MLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs-~~~v~~  369 (383)
                      +.+++.+||+.||++||+ +.++.+
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHc
Confidence            899999999999999998 777764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-34  Score=271.76  Aligned_cols=188  Identities=26%  Similarity=0.420  Sum_probs=143.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+.+..++||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus       106 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~  182 (333)
T 1mqb_A          106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNS  182 (333)
T ss_dssp             TTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             CCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECC
Confidence            79999999999999999999999999999999743      34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++........  ......++..|+|||        .++||||||+++|||++ |+.|+...    ...+
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----~~~~  258 (333)
T 1mqb_A          183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHE  258 (333)
T ss_dssp             TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHH
T ss_pred             CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC----CHHH
Confidence            999999999999876543211  122234677899998        46899999999999999 99996432    2223


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +.+.+.+.. ....+......+.+++.+||+.||++||++.++++.|+++...
T Consensus       259 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          259 VMKAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHHHHTTC-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHCCC-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            333222221 1122334566789999999999999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.9e-34  Score=271.47  Aligned_cols=193  Identities=16%  Similarity=0.255  Sum_probs=160.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            567888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            999999999999742     34677999999999999998   9999999999999999999999999999876432   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       .....||+.|+|||        .++|||||||++|||++|+.|+...    +..++.+.+.....  ..+......+.+
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~~--~~p~~~~~~~~~  267 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----QPIQIYEKIVSGKV--RFPSHFSSDLKD  267 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTCCHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC----CHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence             23457999999998        5789999999999999999996432    33333333333322  223445667889


Q ss_pred             HHHHccccCCCCCCC-----HHHHHH
Q 046461          349 IVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ++.+||+.||++||+     ++|+++
T Consensus       268 li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          268 LLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhcCHHhccCCccCCHHHHHh
Confidence            999999999999998     888875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-34  Score=265.09  Aligned_cols=194  Identities=24%  Similarity=0.384  Sum_probs=146.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+++ .++|+||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        81 ~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~  156 (291)
T 1u46_A           81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLAT  156 (291)
T ss_dssp             TTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE
T ss_pred             CCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcC
Confidence            79999999998765 88999999999999999743      24577999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++........  ......++..|+|||        .++||||||+++|||++ |+.|+...    +..+
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~  232 (291)
T 1u46_A          157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQ  232 (291)
T ss_dssp             TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHH
T ss_pred             CCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC----CHHH
Confidence            999999999999876543321  122345778899998        47899999999999999 99996432    2223


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCCCCC
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENFGRY  383 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~~~~  383 (383)
                      ....+.........+...+..+.+++.+||+.||++|||+.++++.|+++.......+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~e~  291 (291)
T 1u46_A          233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRAEF  291 (291)
T ss_dssp             HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--------
T ss_pred             HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhhcC
Confidence            33322222222222344566889999999999999999999999999999877665543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.6e-34  Score=270.72  Aligned_cols=202  Identities=19%  Similarity=0.286  Sum_probs=160.7

Q ss_pred             hhCccccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      .++|...+.||+|+||.||                                    |||+++++++.+++..++||||+++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            4568888999999999999                                    7999999999999999999999999


Q ss_pred             CCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CceEEccccCccccCCCCCcc
Q 046461          207 GSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED----FEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       207 gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~----~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+|.+++...     .....++.|++.||+|||+.   +|+||||||+||++..+    +.+||+|||+++....... .
T Consensus       101 g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~  176 (342)
T 2qr7_A          101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-L  176 (342)
T ss_dssp             CBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-C
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-c
Confidence            9999998643     34678999999999999999   99999999999998433    3599999999987654322 2


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKML  347 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~~  347 (383)
                      .....||+.|+|||        .++||||+||++|||++|+.||..... ....++.+.+.....  ....+...+..+.
T Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHH
Confidence            23457899999998        578999999999999999999753211 112223333322222  1122344567889


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+|++.||++|||+.|+++
T Consensus       256 ~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhc
Confidence            9999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-33  Score=263.02  Aligned_cols=212  Identities=18%  Similarity=0.292  Sum_probs=161.4

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------cccceeeeEE-EeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYC-PVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~-~~~~~~~lv~e~~  204 (383)
                      .++|...+.||+|+||.||                                     ++++..++++ ..++..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            3578888999999999999                                     3444444444 6678889999999


Q ss_pred             cCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCCCC
Q 046461          205 VKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       205 ~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                       +|+|.+++..      ......++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence             9999999973      234678999999999999998   99999999999999   4789999999999987654332


Q ss_pred             c------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc---C
Q 046461          276 H------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA---Y  338 (383)
Q Consensus       276 ~------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~---~  338 (383)
                      .      ......||..|+|||        .++|||||||++|||++|+.|+..... .........+........   .
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-SSSSSHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc-hhhhhhhhhhcccccCCchHHH
Confidence            1      123457899999998        468999999999999999999754211 111122222211111110   1


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ....+..+.+++.+||+.||++|||+.++++.|+++..+.+
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            12335678899999999999999999999999998876544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.7e-34  Score=269.57  Aligned_cols=205  Identities=25%  Similarity=0.406  Sum_probs=162.1

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            467777889999999888                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          201 YEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      |||+++|+|.+++...                     .....++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            9999999999999643                     23577999999999999998   99999999999999999999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeee
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      ||+|||+++.....  .......++..|+|||        .++||||||+++|||++ |+.|+...    ...++.+.+.
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~----~~~~~~~~~~  255 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELYEKLP  255 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHGG
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC----cHHHHHHHhh
Confidence            99999998743221  1122345678899988        57899999999999998 99996432    2222222222


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .. .....+......+.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus       256 ~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          256 QG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            21 111223345567899999999999999999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.8e-34  Score=273.83  Aligned_cols=198  Identities=22%  Similarity=0.284  Sum_probs=160.3

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      .++|...+.||+|+||.||                                         |||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4678888999999999999                                         79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEccccCccccCCC
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSDFGLVRLISDC  273 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~Dfgla~~~~~~  273 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||+++.....
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999998642     35678999999999999999   99999999999999865   45999999999876533


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCChhHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYSKPSM  343 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~~~~~  343 (383)
                      .  ......||+.|+|||        .++|||||||++|||++|+.||...    +...+...+......  ........
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred             c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCCCCcccccCCC
Confidence            2  233467999999998        5789999999999999999996432    223333333222221  11123345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            67889999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-34  Score=271.03  Aligned_cols=217  Identities=25%  Similarity=0.372  Sum_probs=168.5

Q ss_pred             cHHHHHHHhhCccccCeeecCCccccc----------------------------------------------cccceee
Q 046461          155 TYDQIVAGTNKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLL  188 (383)
Q Consensus       155 ~~~~l~~~t~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~  188 (383)
                      ...+.....++|...+.||+|+||.||                                              |||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            344445556788888999999999997                                              6999999


Q ss_pred             eEEEeCC-EEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCC
Q 046461          189 GYCPVGE-KKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDI  246 (383)
Q Consensus       189 g~~~~~~-~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl  246 (383)
                      +++...+ ..++||||+++|+|.+++...                     .....++.|++.||+|||+.   +++||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9998754 589999999999999999642                     23567899999999999998   9999999


Q ss_pred             CCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCC
Q 046461          247 NASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPE  316 (383)
Q Consensus       247 k~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~  316 (383)
                      ||+||+++.++.+||+|||+++....... .......||..|+|||        .++||||||+++|||++ |+.|+...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987644322 2223355788999998        47899999999999998 99886432


Q ss_pred             CCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          317 FKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       317 ~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ..   .......+.... ....+......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       255 ~~---~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KI---DEEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CC---SHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ch---hHHHHHHhccCc-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11   111111111111 11223344567889999999999999999999999999887643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-34  Score=268.52  Aligned_cols=204  Identities=23%  Similarity=0.360  Sum_probs=152.5

Q ss_pred             hCccccCeeecCCccccc-----------------------------------cccceeeeEEEeCCEEEEEEEeccCCC
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGS  208 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gs  208 (383)
                      ++|...+.||+|+||.||                                   |||+++++++.+  ..++||||+++|+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~   85 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS   85 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence            456677899999999998                                   799999998874  4799999999999


Q ss_pred             HHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-eEEccccCccccCCCCCcccc
Q 046461          209 LNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE-VKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       209 L~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~-~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |.+++...        .....++.|+++||+|||+....+++||||||+||+++.++. +||+|||+++.....    ..
T Consensus        86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~  161 (307)
T 2eva_A           86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MT  161 (307)
T ss_dssp             HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred             HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cc
Confidence            99999743        235678899999999999943238999999999999998876 799999999765321    22


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...||..|+|||        .++||||||+++|||++|+.|+.....  ........+.. ..........+..+.+++.
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~  238 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG--PAFRIMWAVHN-GTRPPLIKNLPKPIESLMT  238 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS--SHHHHHHHHHT-TCCCCCBTTCCHHHHHHHH
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc--cHHHHHHHHhc-CCCCCcccccCHHHHHHHH
Confidence            346899999998        578999999999999999999753211  11111111111 1111222344567889999


Q ss_pred             HccccCCCCCCCHHHHHHHHhcccc
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +||+.||++|||+.++++.|+++.+
T Consensus       239 ~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          239 RCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             HHhcCChhhCcCHHHHHHHHHHHHH
Confidence            9999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-34  Score=269.18  Aligned_cols=197  Identities=18%  Similarity=0.271  Sum_probs=157.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      +.|...+.||+|+||.||                                             |||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457777889999999888                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----ceEEccccCccc
Q 046461          199 IVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLVRL  269 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~----~~kl~Dfgla~~  269 (383)
                      +||||+++|+|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||+++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999999999964     235678999999999999998   999999999999998877    799999999987


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCC
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYS  339 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~  339 (383)
                      .....  ......||+.|+|||        .++|||||||++|||++|+.|+...    ...+....+.....  .....
T Consensus       168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~  241 (326)
T 2y0a_A          168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNYEFEDEYF  241 (326)
T ss_dssp             CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHHTCCCCCHHHH
T ss_pred             CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----CHHHHHHHHHhcCCCcCcccc
Confidence            65332  223457999999998        5689999999999999999996432    22222222211111  11111


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            233457889999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.9e-34  Score=266.32  Aligned_cols=180  Identities=21%  Similarity=0.303  Sum_probs=140.7

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |||+++++++.+  .+..++||||+++|+|.+++..    ......++.|++.||+|||+.   +++||||||+||+++.
T Consensus        96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~  172 (298)
T 2zv2_A           96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGE  172 (298)
T ss_dssp             TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred             CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECC
Confidence            689999999987  5689999999999999887653    335678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++....... ......||+.|+|||           .++|||||||++|||++|+.|+...    ....
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~  247 (298)
T 2zv2_A          173 DGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE----RIMC  247 (298)
T ss_dssp             TSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS----SHHH
T ss_pred             CCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc----cHHH
Confidence            99999999999987654322 223457999999998           1369999999999999999996432    2222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+................+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            222222222111112234567889999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.3e-34  Score=265.02  Aligned_cols=190  Identities=24%  Similarity=0.394  Sum_probs=146.4

Q ss_pred             cccceeeeEEEeC--CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          182 KNIVQLLGYCPVG--EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       182 ~niv~l~g~~~~~--~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +||+++++++.+.  +..++||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||++
T Consensus        83 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~  159 (302)
T 4e5w_A           83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV  159 (302)
T ss_dssp             TTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEE
Confidence            7999999999876  6689999999999999999532      34678999999999999998   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCC--ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC----
Q 046461          254 NEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD----  319 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~----  319 (383)
                      +.++.+||+|||+++.......  .......||..|+|||        .++||||+|+++|||++|+.|+......    
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  239 (302)
T 4e5w_A          160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM  239 (302)
T ss_dssp             EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred             cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc
Confidence            9999999999999987654332  1223456788899998        4789999999999999999885322100    


Q ss_pred             ---CCCC----ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          320 ---KNGG----NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       320 ---~~~~----~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                         ....    .+... .........+...+..+.+++.+||+.||++|||+.|++++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          240 IGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HCSCCGGGHHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCcccccCHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence               0000    00010 1111112223455678899999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-33  Score=265.68  Aligned_cols=208  Identities=16%  Similarity=0.236  Sum_probs=158.1

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+++..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            578888999999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++++|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            999999999999743     34678999999999999998   9999999999999999999999999999876543333


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      ......|+..|+|||        .++||||||+++|||++|+.|+...    ....+...+ ....  ........+..+
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD----QLSVMGAHI-NQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC----HHHHHHHHH-HSCCCCGGGTSTTCCTHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc----hHHHHHHHh-ccCCCCccccCCCCCHHH
Confidence            333457899999998        5799999999999999999996432    111111111 1111  111223445578


Q ss_pred             HHHHHHccccCCCCCC-CHHHHHHHHhccccCCC
Q 046461          347 LQIVVGCIFDNPTTRP-TMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RP-s~~~v~~~L~~~~~~~~  379 (383)
                      .+++.+||+.||++|| |++++++.|+++.....
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            8999999999999999 99999999998766543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-34  Score=291.08  Aligned_cols=206  Identities=29%  Similarity=0.440  Sum_probs=164.6

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .++|...+.||+|+||.||                                     +|||++++++.+ +..++||||++
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            4556777899999999999                                     799999999876 67899999999


Q ss_pred             CCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          206 KGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       206 ~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      +|+|.++++..       .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999742       24578999999999999998   999999999999999999999999999987643221122


Q ss_pred             cccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHH
Q 046461          279 TDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI  349 (383)
Q Consensus       279 ~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  349 (383)
                      ....++..|+|||        .++|||||||++|||++ |+.|+...    ...++.+.+... .....+......+.++
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~----~~~~~~~~i~~~-~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVERG-YRMPCPPECPESLHDL  496 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC----CHHHHHHHHHTT-CCCCCCTTCCHHHHHH
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHHcC-CCCCCCCCCCHHHHHH
Confidence            2345678899998        47899999999999999 88886432    222333332222 1122234556688999


Q ss_pred             HHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          350 VVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +.+||+.||++|||+.+|++.|+.+...
T Consensus       497 i~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-34  Score=267.20  Aligned_cols=184  Identities=22%  Similarity=0.367  Sum_probs=142.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |||+++++++.+++..++||||+++|+|.+++....      ....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        72 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  148 (289)
T 4fvq_A           72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIR  148 (289)
T ss_dssp             TTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEE
T ss_pred             CCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEec
Confidence            799999999999999999999999999999997532      3577899999999999999   9999999999999998


Q ss_pred             CCc--------eEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCC
Q 046461          256 DFE--------VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFK  318 (383)
Q Consensus       256 ~~~--------~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~  318 (383)
                      ++.        +|++|||+++....     .....|+..|+|||         .++||||||+++|||++|..|+.... 
T Consensus       149 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-  222 (289)
T 4fvq_A          149 EEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-  222 (289)
T ss_dssp             CCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             CCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-
Confidence            887        99999999875432     12345788899988         46899999999999999766643221 


Q ss_pred             CCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          319 DKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       319 ~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                        +...........   ...+......+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       223 --~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          223 --DSQRKLQFYEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             --CHHHHHHHHHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             --chHHHHHHhhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence              111111111111   11122234467889999999999999999999999999876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-33  Score=266.11  Aligned_cols=208  Identities=21%  Similarity=0.299  Sum_probs=153.2

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            467788899999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          202 EYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       202 e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ||+++|+|.+++..         ......++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999863         224578999999999999998   999999999999999999999999999886643


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      ... ......|+..|+|||        .++||||||+++|||++|+.|+.....  ....+.+.+...............
T Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C--CHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch--hHHHHHHHhhcccCCCCcccccCH
Confidence            221 222356889999998        468999999999999999999743211  111122222222222111234456


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+.+++.+||+.||++|||+.+|++.|+++...
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            788999999999999999999999999988654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=270.78  Aligned_cols=199  Identities=21%  Similarity=0.309  Sum_probs=151.6

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .+.|...+.||+|+||.||                                     +||+++++++.+.+..++||||++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            4568888999999999999                                     799999999999999999999999


Q ss_pred             CCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCCCCcc
Q 046461          206 KGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       206 ~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      +|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++......  .
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  206 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L  206 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence            99999999743     35678999999999999998   9999999999999975   8899999999998654321  2


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKML  347 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~~  347 (383)
                      .....||+.|+|||        .++|||||||++|||++|+.|+.....   .....+.+.....  ...........+.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~  283 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMFRRILNCEYYFISPWWDEVSLNAK  283 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---HHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---cHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence            23457899999998        578999999999999999999743211   1112222222211  1112234556788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.|+++
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.7e-33  Score=269.32  Aligned_cols=200  Identities=21%  Similarity=0.323  Sum_probs=157.4

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            467778899999999998                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            9999999999999742     34677899999999999998   99999999999999999999999999998643222 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC-----CCccceeeecCcccccCChhH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN-----GGNLVDWVLDSTILNAYSKPS  342 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~-----~~~~~~~v~~~~~~~~~~~~~  342 (383)
                      .......||+.|+|||        .++||||+||++|||++|+.||........     ...+.+.+.....  ..+...
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~  242 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSL  242 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTS
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCC
Confidence            2234468999999998        578999999999999999999753211100     0011111222211  223445


Q ss_pred             HHHHHHHHHHccccCCCCCCCH------HHHHH
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTM------LRVQE  369 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~------~~v~~  369 (383)
                      ...+.+++.+||+.||++||++      .|+++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            6678899999999999999995      56654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=289.96  Aligned_cols=185  Identities=20%  Similarity=0.373  Sum_probs=145.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +|||+++++|.+ +..++||||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       396 pniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~  471 (613)
T 2ozo_A          396 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVN  471 (613)
T ss_dssp             TTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEE
T ss_pred             CCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcC
Confidence            799999999976 5689999999999999999642      34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCcc--ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++.........  .....++..|+|||        .++|||||||++|||++ |+.|+..    ....+
T Consensus       472 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~----~~~~~  547 (613)
T 2ozo_A          472 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----MKGPE  547 (613)
T ss_dssp             TTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----CCSHH
T ss_pred             CCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CCHHH
Confidence            9999999999998764332211  11234567899998        57899999999999998 9999643    23333


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      +.+.+.... ....+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       548 ~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          548 VMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            443333322 12234456678999999999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8e-34  Score=267.55  Aligned_cols=208  Identities=19%  Similarity=0.294  Sum_probs=157.5

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .++|...+.||+|+||.||                                      +||+++++++.+.+..++||||+
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~  111 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC  111 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence            4567788999999999998                                      69999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC----
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE----  274 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~----  274 (383)
                      ++++|.+++...      .....++.|++.||+|||+.   +++||||||+||+++ ++.+||+|||+++......    
T Consensus       112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            999999999753      34678999999999999998   999999999999998 6799999999987653211    


Q ss_pred             CccccccccccccccCC-----------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc
Q 046461          275 SHTSTDVAGTIGYILLA-----------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA  337 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape-----------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~  337 (383)
                      ........|+..|+|||                 .++||||||+++|||++|+.|+...    ........+........
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ----PAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC----CHHHHHHHHHTTCCCCC
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHhccCCCCCC
Confidence            11222345889999987                 1479999999999999999996432    22222222211111111


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ........+.+++.+||+.||++|||+.+++++|+++.+..
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11223456889999999999999999999999999987653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-33  Score=261.76  Aligned_cols=205  Identities=27%  Similarity=0.436  Sum_probs=162.5

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     +||+++++++.+ +..++||||+++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   91 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence            456677889999999988                                     799999999864 568999999999


Q ss_pred             CCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          207 GSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       207 gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++...........
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence            9999999743       24578999999999999998   9999999999999999999999999999876544333333


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~  350 (383)
                      ...++..|+|||        .++||||||++++||++ |+.|+...    ...+..+.+... .....+......+.+++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLERG-YRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc----CHHHHHHHHhcc-cCCCCcccccHHHHHHH
Confidence            445678899998        46899999999999999 88886432    222222222211 11122334556888999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhccccC
Q 046461          351 VGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .+||+.||++|||+.++++.|+++...
T Consensus       244 ~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            999999999999999999999987643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-33  Score=269.81  Aligned_cols=197  Identities=18%  Similarity=0.221  Sum_probs=156.3

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      +.|...+.||+|+||.||                                            |||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            457778899999999998                                            799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---eEEccccCc
Q 046461          200 VYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE---VKVSDFGLV  267 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~---~kl~Dfgla  267 (383)
                      ||||+++|+|.+++...         .....++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999887532         23567899999999999998   9999999999999986554   999999999


Q ss_pred             cccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc--
Q 046461          268 RLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA--  337 (383)
Q Consensus       268 ~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~--  337 (383)
                      +...... .......||+.|+|||        .++||||+||++|||++|+.|+...     ...+.+.+........  
T Consensus       181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-----KERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-----HHHHHHHHHHTCCCCCHH
T ss_pred             eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-----HHHHHHHHHcCCCCCCcc
Confidence            8765432 2233457999999998        5689999999999999999997432     1122222222221110  


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          255 QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            01223567889999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-33  Score=265.53  Aligned_cols=211  Identities=23%  Similarity=0.415  Sum_probs=156.7

Q ss_pred             HHHHhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeC
Q 046461          159 IVAGTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       159 l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~  194 (383)
                      +....++|...+.||+|+||.||                                            |||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445677788899999999998                                            7999999999875


Q ss_pred             CE-----EEEEEEeccCCCHHHHHhc-----------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 046461          195 EK-----KLIVYEYMVKGSLNDWLRN-----------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE  258 (383)
Q Consensus       195 ~~-----~~lv~e~~~~gsL~~~l~~-----------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~  258 (383)
                      +.     .++||||+++|+|.+++..           ......++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            53     4999999999999999842           234678999999999999998   9999999999999999999


Q ss_pred             eEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcccee
Q 046461          259 VKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       259 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~  328 (383)
                      +||+|||+++....... .......++..|+|||        .++||||||+++|||++ |..|+...    ...+..+.
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV----QNHEMYDY  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC----CHHHHHHH
Confidence            99999999987643321 1223345778899987        46899999999999999 78885432    22333332


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +..... ...+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       262 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          262 LLHGHR-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHTTCC-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCC-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            222211 122344556889999999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.1e-33  Score=257.07  Aligned_cols=196  Identities=22%  Similarity=0.388  Sum_probs=144.2

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            456677788888888887                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||+++++|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++.......
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999753      34678999999999999998   999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                       ......|+..|+|||        .++||||||+++|||++|+.|+...    ...+....+.....  ..+......+.
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~  240 (278)
T 3cok_A          168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD----TVKNTLNKVVLADY--EMPSFLSIEAK  240 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCC----SCC-----CCSSCC--CCCTTSCHHHH
T ss_pred             -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh----hHHHHHHHHhhccc--CCccccCHHHH
Confidence             222356899999998        5799999999999999999997532    22222222221111  11233456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.++++
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHcccCHhhCCCHHHHhc
Confidence            9999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.6e-33  Score=268.01  Aligned_cols=203  Identities=13%  Similarity=0.123  Sum_probs=162.0

Q ss_pred             HhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ..++|...+.||+|+||.||                                            +|++++++++..++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            34667888899999999998                                            6899999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----------C
Q 046461          198 LIVYEYMVKGSLNDWLRNQ----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-----------D  256 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-----------~  256 (383)
                      ++||||+++|+|.+++...          .....++.|++.||+|||+.   +|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999631          23678999999999999998   9999999999999998           8


Q ss_pred             CceEEccccCccccCCC-CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDC-ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.+||+|||+++.+... .........||..|+|||        .++|||||||++|||++|+.|+.....       ..
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~  292 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------GE  292 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-------TE
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-------Cc
Confidence            99999999999765422 223344567999999998        578999999999999999999642211       11


Q ss_pred             eeecCcccccCChhHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhccccC
Q 046461          328 WVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTR-PTMLRVQEFLEKYHTG  377 (383)
Q Consensus       328 ~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R-Ps~~~v~~~L~~~~~~  377 (383)
                      +.....+...   .....+.+++..|++.+|.+| |++.++.+.|+++...
T Consensus       293 ~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            2222222111   234466788889999999999 7888888888876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-33  Score=278.74  Aligned_cols=195  Identities=21%  Similarity=0.355  Sum_probs=160.9

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457777889999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            999999999999743     34678999999999999998   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......||+.|+|||         .++||||+||++|||++|+.|++..    ....+.+.+.+....  .+......+.
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~--~p~~~s~~~~  244 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD----HVPTLFKKICDGIFY--TPQYLNPSVI  244 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS----SSHHHHHHHHTTCCC--CCTTCCHHHH
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC----CHHHHHHHHhcCCcC--CCccCCHHHH
Confidence            223457999999998         3689999999999999999996532    333333333333221  1233456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.|+++
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCchhCcCHHHHHh
Confidence            9999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-33  Score=270.63  Aligned_cols=193  Identities=26%  Similarity=0.376  Sum_probs=154.7

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +.|...+.||+|+||.||                                          |||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            457778899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          202 EYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||++ |+|.+++..      +.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 688888853      234678999999999999998   9999999999999999999999999999865432  


Q ss_pred             ccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          276 HTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                         ....||+.|+|||           .++|||||||++|||++|+.|+...    +..+....+...............
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNESPALQSGHWSE  280 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCCCCCCCCH
Confidence               2357899999998           3579999999999999999996432    211211112211111111233455


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.+++.+||+.||++|||+.++++
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhh
Confidence            7889999999999999999999976

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-33  Score=262.06  Aligned_cols=197  Identities=22%  Similarity=0.311  Sum_probs=151.8

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      +.|...+.||+|+||.||                                        |||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            457778999999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccC
Q 046461          204 MVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       204 ~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~  271 (383)
                      +++|+|.+++...         .....++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998532         24578999999999999998   99999999999999   456889999999998654


Q ss_pred             CCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc-cccCChhHH
Q 046461          272 DCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSM  343 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~-~~~~~~~~~  343 (383)
                      ...  ......|+..|+|||       .++||||||+++|||++|+.|+...    ...+.......... .........
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~  252 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT----SLEEVQQKATYKEPNYAVECRPLT  252 (285)
T ss_dssp             ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCC--CCCC
T ss_pred             Ccc--cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC----CHHHHHhhhccCCcccccccCcCC
Confidence            322  233457899999998       5789999999999999999996432    22222211111110 001112234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            57889999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-33  Score=273.07  Aligned_cols=197  Identities=17%  Similarity=0.225  Sum_probs=159.2

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      +.|...+.||+|+||.||                                       +||+++++++.+.+..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            568888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCceEEccccCccccCCCCCc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE--DFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++......  
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  205 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  205 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence            999999999643      34678999999999999998   9999999999999974  4779999999998765432  


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      ......||+.|+|||        .++|||||||++|||++|+.|+...    +..+....+.....  ...........+
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE----DDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            223357899999998        4689999999999999999996432    22222222222111  111223445678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||+.|+++
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhh
Confidence            89999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-33  Score=262.02  Aligned_cols=186  Identities=23%  Similarity=0.359  Sum_probs=146.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++ ..+..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        78 ~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~  153 (291)
T 1xbb_A           78 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ  153 (291)
T ss_dssp             TTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             CCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCC
Confidence            7999999999 567789999999999999999743     34678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCcc--ccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCESHT--STDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      +.+||+|||+++.........  .....++..|+|||        .++||||||+++|||++ |+.|+...    ...++
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~----~~~~~  229 (291)
T 1xbb_A          154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEV  229 (291)
T ss_dssp             TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHH
T ss_pred             CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC----CHHHH
Confidence            999999999998765433221  22234678899998        47899999999999999 99996432    22222


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+.+.... ....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       230 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          230 TAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            22222211 122234556688999999999999999999999999998754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=271.98  Aligned_cols=194  Identities=20%  Similarity=0.280  Sum_probs=150.4

Q ss_pred             cccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEeccCC
Q 046461          167 YEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKG  207 (383)
Q Consensus       167 ~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~g  207 (383)
                      ...++||+|+||.||                                       |||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            345679999999999                                       79999999999999999999999999


Q ss_pred             CHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE--cCCCceEEccccCccccCCCCCcccc
Q 046461          208 SLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       208 sL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl--~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      +|.+++...      .....++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++......  ...
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~  246 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK  246 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence            999988643      24577899999999999998   99999999999999  567899999999998765432  223


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKMLQI  349 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~~~l  349 (383)
                      ...||+.|+|||        .++|||||||++|||++|+.|+...    +..+....+.....  ...........+.++
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD----NDAETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            356999999998        4689999999999999999996432    22222222222211  111112345678899


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 046461          350 VVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+|++.||++|||+.|+++
T Consensus       323 i~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-33  Score=290.26  Aligned_cols=197  Identities=23%  Similarity=0.358  Sum_probs=163.3

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .++|...++||+|+||.||                                           +||+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            3568888899999999999                                           689999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999743     34678999999999999999   99999999999999999999999999998643322


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                       .......||+.|+|||        .++|||||||++|||++|+.||..    .+..++.+.+.....  .++.....++
T Consensus       497 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~  569 (674)
T 3pfq_A          497 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNV--AYPKSMSKEA  569 (674)
T ss_dssp             -CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHSSCC--CCCTTSCHHH
T ss_pred             -cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC----CCHHHHHHHHHhCCC--CCCccCCHHH
Confidence             2334568999999998        578999999999999999999643    233444444444332  2344566788


Q ss_pred             HHHHHHccccCCCCCCCH-----HHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTM-----LRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~-----~~v~~  369 (383)
                      .+++.+|++.||++||++     +||.+
T Consensus       570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          570 VAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            999999999999999997     66654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-33  Score=260.22  Aligned_cols=186  Identities=20%  Similarity=0.374  Sum_probs=148.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      |||+++++++ ..+..++||||+++|+|.+++...      .....++.|++.||.|||+.   +++||||||+||+++.
T Consensus        70 ~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~  145 (287)
T 1u59_A           70 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVN  145 (287)
T ss_dssp             TTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEE
T ss_pred             CCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcC
Confidence            7999999999 556689999999999999999532      34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++........  ......+|..|+|||        .++||||||+++|||++ |+.|+...    ...+
T Consensus       146 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~  221 (287)
T 1u59_A          146 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPE  221 (287)
T ss_dssp             TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----CTHH
T ss_pred             CCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CHHH
Confidence            999999999999876543221  122345688999998        57899999999999998 99996432    2223


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..+.+.... ....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       222 ~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          222 VMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCC-cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            333322221 122334556788999999999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3e-33  Score=258.52  Aligned_cols=198  Identities=19%  Similarity=0.227  Sum_probs=159.2

Q ss_pred             hhCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          163 TNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      .+.|...+.||+|+||.||                                       |||+++++++.+++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            3567778899999999998                                       7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCCCC
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      +++++|.+++...     .....++.|++.||+|||+.   +++||||||+||++   +.++.++|+|||+++...... 
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            9999999988642     35678999999999999998   99999999999999   788999999999998765432 


Q ss_pred             ccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc--CChhHHHHH
Q 046461          276 HTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA--YSKPSMLKM  346 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~--~~~~~~~~~  346 (383)
                       ......||+.|+|||       .++||||||++++||++|+.|+...    ...+....+........  ........+
T Consensus       164 -~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          164 -MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP----TDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             -chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence             223456899999997       6899999999999999999996432    22222222222221110  001235678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+|++.||++|||+.|+++
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            89999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-33  Score=290.87  Aligned_cols=186  Identities=23%  Similarity=0.370  Sum_probs=145.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +|||+++++|.+ +..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       430 pnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~  505 (635)
T 4fl3_A          430 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ  505 (635)
T ss_dssp             TTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred             CCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCC
Confidence            799999999965 5588999999999999999743     34678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCC--ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      +.+||+|||+++.......  .......+|..|+|||        .++|||||||++|||++ |+.|+...    ...++
T Consensus       506 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~----~~~~~  581 (635)
T 4fl3_A          506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEV  581 (635)
T ss_dssp             TEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHH
T ss_pred             CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----CHHHH
Confidence            9999999999987654332  1223345678899998        57899999999999998 99996432    23333


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+.+.... ....+...+..+.+++..||+.||++|||+.+|++.|+++..
T Consensus       582 ~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          582 TAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            33332222 222344566789999999999999999999999999997643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.8e-34  Score=268.69  Aligned_cols=197  Identities=18%  Similarity=0.282  Sum_probs=139.8

Q ss_pred             cCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccCCCHHH
Q 046461          169 KNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLND  211 (383)
Q Consensus       169 ~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  211 (383)
                      .+.||+|+||.||                                     |||+++++++.+++..++||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            4789999999998                                     799999999999999999999999999999


Q ss_pred             HHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---ceEEccccCccccCCCCCcccccccc
Q 046461          212 WLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---EVKVSDFGLVRLISDCESHTSTDVAG  283 (383)
Q Consensus       212 ~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~g  283 (383)
                      ++...     .....++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||+++...... .......|
T Consensus        96 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~  171 (325)
T 3kn6_A           96 RIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCF  171 (325)
T ss_dssp             HHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccCC
Confidence            99743     35678999999999999998   999999999999997665   89999999998654432 22234568


Q ss_pred             ccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCC---CCccceeeecCccccc--CChhHHHHHHHHH
Q 046461          284 TIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKN---GGNLVDWVLDSTILNA--YSKPSMLKMLQIV  350 (383)
Q Consensus       284 t~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~---~~~~~~~v~~~~~~~~--~~~~~~~~~~~l~  350 (383)
                      |..|+|||        .++||||+||++|||++|+.|+........   ..++.+.+........  .....+..+.+++
T Consensus       172 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  251 (325)
T 3kn6_A          172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI  251 (325)
T ss_dssp             ------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHH
T ss_pred             CcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHH
Confidence            99999998        467999999999999999999754321100   1112222222221111  0123456789999


Q ss_pred             HHccccCCCCCCCHHHHHH
Q 046461          351 VGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+|++.||++|||+.|+++
T Consensus       252 ~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          252 QGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHCCCTTTCCCTTTSTT
T ss_pred             HHHCCCChhHCCCHHHHhc
Confidence            9999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-33  Score=259.64  Aligned_cols=195  Identities=23%  Similarity=0.378  Sum_probs=155.8

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .++|...+.||+|+||.||                                          |||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4567778899999999998                                          7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......  
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            9999999999998742     34678999999999999998   9999999999999999999999999998654332  


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                       ......|+..|+|||        .++||||+|+++|||++|+.|+...    ...+..+.+....  ...+......+.
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVE--FTFPDFVTEGAR  235 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTC--CCCCTTSCHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC----cHHHHHHHHHhCC--CCCCCcCCHHHH
Confidence             223457899999988        5789999999999999999996432    2222222221111  122334456788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.|+++
T Consensus       236 ~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          236 DLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccChhhCCCHHHHhh
Confidence            9999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.8e-33  Score=266.14  Aligned_cols=163  Identities=27%  Similarity=0.358  Sum_probs=124.3

Q ss_pred             EEEEEEeccCCCHHHHHhcch--------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          197 KLIVYEYMVKGSLNDWLRNQA--------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~~--------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      .++||||+++|+|.+++....        ....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  212 (332)
T 3qd2_B          136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT  212 (332)
T ss_dssp             EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCccc
Confidence            799999999999999997532        2577999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC-----------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee
Q 046461          269 LISDCES-----------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV  329 (383)
Q Consensus       269 ~~~~~~~-----------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v  329 (383)
                      .......           .......||+.|+|||        .++|||||||++|||++|..|...      .......+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~  286 (332)
T 3qd2_B          213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITDV  286 (332)
T ss_dssp             ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHH
T ss_pred             ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHHh
Confidence            7754321           1223456999999998        578999999999999998776311      11111111


Q ss_pred             ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...... .........+.+++.+||+.||++|||+.|+++
T Consensus       287 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          287 RNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hccCCC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            111111 111233456789999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-33  Score=260.78  Aligned_cols=198  Identities=21%  Similarity=0.293  Sum_probs=152.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         +||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            356777889999999998                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          203 YMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       203 ~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |+++ ++.+.+..      ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-S
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-c
Confidence            9975 66665543      234678999999999999999   99999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----------------
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----------------  331 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----------------  331 (383)
                      ......||..|+|||         .++||||+||+++||++|..|+....   +..+....+..                
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC---CHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            233457899999988         46799999999999999998863221   11111111100                


Q ss_pred             ------C-----cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ------S-----TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ------~-----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                            +     .............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                  0     0000111234567889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-33  Score=265.37  Aligned_cols=204  Identities=21%  Similarity=0.341  Sum_probs=145.2

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .++|...+.||+|+||.||                                        |||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            3567778899999999998                                        799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          203 YMVKGSLNDWLRNQ-----------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      |++ |+|.+++...           .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999998642           23467888999999999998   99999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee------------
Q 046461          272 DCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL------------  330 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~------------  330 (383)
                      ... .......||..|+|||         .++|||||||++|||++|+.||....    ..+....+.            
T Consensus       160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN----DEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCTTTCG
T ss_pred             CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChhHhh
Confidence            322 2223456899999998         45799999999999999999975321    111111000            


Q ss_pred             --------cCcc------------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          331 --------DSTI------------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       331 --------~~~~------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                              .+.+            ...........+.+++.+|++.||++|||+.|+++  .+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                    0000            00011123457889999999999999999999986  455443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-33  Score=260.51  Aligned_cols=204  Identities=27%  Similarity=0.381  Sum_probs=157.0

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------cccceeeeEEEeC-CEEEEEEEeccC
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVG-EKKLIVYEYMVK  206 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~-~~~~lv~e~~~~  206 (383)
                      .++|...+.||+|+||.||                                   +||+++++++.+. +..++||||+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            3567778899999999998                                   7999999997654 478999999999


Q ss_pred             CCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          207 GSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       207 gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......    .
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~  172 (278)
T 1byg_A          100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D  172 (278)
T ss_dssp             EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----c
Confidence            9999999743       23577899999999999998   99999999999999999999999999987654321    2


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~  350 (383)
                      ...++..|+|||        .++||||||+++|||++ |+.|+...    ...+....+... .....+...+..+.+++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKG-YKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHHTTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcC-CCCCCcccCCHHHHHHH
Confidence            235678899998        46899999999999998 99986432    222222222211 11222344566888999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          351 VGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .+||+.||++|||+.|+++.|+++...+
T Consensus       248 ~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          248 KNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            9999999999999999999999987653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.4e-33  Score=278.39  Aligned_cols=212  Identities=19%  Similarity=0.292  Sum_probs=164.0

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|...+.||+|+||.||                                      +++..+..++.+.+..++||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            578888999999999999                                      36666777778889999999999 


Q ss_pred             CCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCCCCc
Q 046461          206 KGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       206 ~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      +++|.+++..      +.....++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++........
T Consensus        86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            9999999973      235678999999999999998   99999999999999   68899999999999876543321


Q ss_pred             ------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc---cCC
Q 046461          277 ------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN---AYS  339 (383)
Q Consensus       277 ------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~---~~~  339 (383)
                            ......||..|++||        .++|||||||++|||++|+.||...... ........+.......   ...
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-SHHHHHHHHHHHHHHSCHHHHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-hHHHHHHHHhhccccccHHHHh
Confidence                  122467999999998        4689999999999999999997542111 1111111111111110   011


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF  380 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~  380 (383)
                      .....++.+++..||+.||++||++.+|++.|+++....++
T Consensus       242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~  282 (483)
T 3sv0_A          242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF  282 (483)
T ss_dssp             TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence            22345789999999999999999999999999988665543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-33  Score=265.73  Aligned_cols=196  Identities=23%  Similarity=0.339  Sum_probs=154.0

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ++|...+.||+|+||.||                                              |||+++++++.+++..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            467777888888888887                                              7999999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999999743     34577899999999999998   999999999999999999999999999976433


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      .. .......||+.|+|||        .++|||||||++|||++|+.||...    +.....+.+.....  ..+.....
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~--~~p~~~~~  246 (327)
T 3a62_A          174 DG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKL--NLPPYLTQ  246 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCC--CCCTTSCH
T ss_pred             CC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCC--CCCCCCCH
Confidence            22 1223457899999998        5689999999999999999996432    22233333332222  12334456


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      .+.+++.+||+.||++||     ++.|+++
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            788999999999999999     7788875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.8e-33  Score=263.79  Aligned_cols=202  Identities=20%  Similarity=0.310  Sum_probs=155.7

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        |||+++++++.+++..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            567778899999999998                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++ |+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       101 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~  175 (311)
T 3niz_A          101 ME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS  175 (311)
T ss_dssp             CS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred             CC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence            97 5888888643      24577899999999999998   99999999999999999999999999998764322 22


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----C------------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----S------------  332 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----~------------  332 (383)
                      .....||..|+|||         .++||||+||++|||++|+.||.....    .+....+..    +            
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD----DDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST----TTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHHCCCChHHhhhhhccc
Confidence            33456899999998         457999999999999999999754321    111111100    0            


Q ss_pred             -----cc---c----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          333 -----TI---L----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       333 -----~~---~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                           ..   .    .........++.+++.+|++.||++|||++|+++  .++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                 00   0    0001123457889999999999999999999987  44443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-33  Score=272.45  Aligned_cols=198  Identities=17%  Similarity=0.284  Sum_probs=154.1

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ..|...+.||+|+||.||                                          +||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            347888999999999999                                          58999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      | +.+|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++........
T Consensus       136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 5688999999743     24678999999999999998   999999999999996 588999999999876543221


Q ss_pred             -cccccccccccccCCC-------------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc
Q 046461          277 -TSTDVAGTIGYILLAC-------------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN  336 (383)
Q Consensus       277 -~~~~~~gt~~y~ape~-------------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~  336 (383)
                       ......||+.|+|||.                   ++|||||||++|||++|+.||.....   .......+.++....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAIIDPNHEI  287 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHCTTSCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---HHHHHHHHhCccccC
Confidence             2334679999999982                   47999999999999999999753211   111222223332222


Q ss_pred             cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       337 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+......+.+++.+||+.||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            223333557889999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-33  Score=265.71  Aligned_cols=192  Identities=25%  Similarity=0.411  Sum_probs=148.7

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      +||+++++++.+  ....++||||+++|+|.+++...    .....++.|++.||+|||+.   +++||||||+||+++.
T Consensus        93 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~  169 (318)
T 3lxp_A           93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDN  169 (318)
T ss_dssp             TTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             cchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcC
Confidence            799999999988  46789999999999999999753    45678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCC-----
Q 046461          256 DFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDK-----  320 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~-----  320 (383)
                      ++.+||+|||+++........  ......++..|+|||        .++||||+|+++|||++|+.|+.......     
T Consensus       170 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~  249 (318)
T 3lxp_A          170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG  249 (318)
T ss_dssp             TCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred             CCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc
Confidence            999999999999877543321  223345788899998        57899999999999999999964321100     


Q ss_pred             -CC-----CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          321 -NG-----GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       321 -~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                       ..     ..+.+ ..........+...+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       250 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          250 IAQGQMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             SCCHHHHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccchhHHHHHH-HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence             00     00000 0111112223445567899999999999999999999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=2.1e-33  Score=268.25  Aligned_cols=198  Identities=17%  Similarity=0.287  Sum_probs=151.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +.|...+.||+|+||.||                                          +||+++++++.+++..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            456777889999999998                                          58999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      | +.+|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++........
T Consensus        89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            9 5688999999743     34678999999999999998   999999999999997 678999999999876543222


Q ss_pred             -cccccccccccccCCC-------------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc
Q 046461          277 -TSTDVAGTIGYILLAC-------------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN  336 (383)
Q Consensus       277 -~~~~~~gt~~y~ape~-------------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~  336 (383)
                       ......||+.|+|||.                   ++|||||||++|||++|+.|+.....   .......+.++....
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAIIDPNHEI  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHHCTTSCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---HHHHHHHHhcCCccc
Confidence             2334679999999982                   57999999999999999999753211   111111222222222


Q ss_pred             cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       337 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+......+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            233334457889999999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.98  E-value=7.2e-33  Score=268.88  Aligned_cols=205  Identities=20%  Similarity=0.267  Sum_probs=156.3

Q ss_pred             hCccccCeeecC--Cccccc-----------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGD--DFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g--~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|  +||.||                                         ||||++++++.+++..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            467788999999  999998                                         7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |||+++|+|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999643       24578999999999999998   9999999999999999999999999998654321


Q ss_pred             C------CccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc---
Q 046461          274 E------SHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI---  334 (383)
Q Consensus       274 ~------~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~---  334 (383)
                      .      ........||..|+|||          .++|||||||++|||++|+.|+....    .......+.....   
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP----ATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC----STTHHHHC--------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHhcCCCCcc
Confidence            1      11122346889999988          35799999999999999999975321    1111110000000   


Q ss_pred             -----------------------------------------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HH
Q 046461          335 -----------------------------------------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FL  371 (383)
Q Consensus       335 -----------------------------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L  371 (383)
                                                               ...........+.+++.+||+.||++|||+.|+++  .+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence                                                     00112223456889999999999999999999986  35


Q ss_pred             hccc
Q 046461          372 EKYH  375 (383)
Q Consensus       372 ~~~~  375 (383)
                      +++.
T Consensus       338 ~~~~  341 (389)
T 3gni_B          338 KQIK  341 (389)
T ss_dssp             GGC-
T ss_pred             HHHh
Confidence            4443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.98  E-value=2.9e-33  Score=282.93  Aligned_cols=200  Identities=22%  Similarity=0.335  Sum_probs=161.5

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      .++|...++||+|+||.||                                          ||||++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            4568888999999999999                                          7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |||+++|+|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999999642       34577899999999999998   9999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      .  ......||+.|+|||        .++|||||||++|||++|+.||...........+.+.+...  ...++...+..
T Consensus       340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~  415 (576)
T 2acx_A          340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQ  415 (576)
T ss_dssp             C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred             c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHH
Confidence            2  223457999999998        57899999999999999999975432111111122222111  12233445678


Q ss_pred             HHHHHHHccccCCCCCC-----CHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      +.+++.+|++.||++||     +++||++
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            89999999999999999     7888875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.98  E-value=2.4e-33  Score=265.77  Aligned_cols=211  Identities=21%  Similarity=0.330  Sum_probs=161.1

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEE--eCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCP--VGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~--~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                           +||+++++++.  +.+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            456677889999999886                                           79999999987  456789


Q ss_pred             EEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999742      34678999999999999998   999999999999999999999999999987654


Q ss_pred             CCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC-------CCCCcccee---eecC
Q 046461          273 CESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD-------KNGGNLVDW---VLDS  332 (383)
Q Consensus       273 ~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~-------~~~~~~~~~---v~~~  332 (383)
                      ....  ......|+..|+|||        .++||||||+++|||++|+.|+......       .........   ....
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            3321  223346788899998        5789999999999999999996432110       000000000   0111


Q ss_pred             cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ......+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111222445567889999999999999999999999999987543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.98  E-value=6.4e-33  Score=257.06  Aligned_cols=198  Identities=22%  Similarity=0.289  Sum_probs=158.4

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      .++|...+.||+|+||.||                                         +||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567788899999999998                                         79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---eEEccccCccccCCC
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE---VKVSDFGLVRLISDC  273 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~---~kl~Dfgla~~~~~~  273 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||.+......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999999888642     34678999999999999998   9999999999999986655   999999999876543


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSM  343 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~  343 (383)
                      .  ......||..|+|||        .++||||+|+++|||++|+.|+...    +.......+.....  .........
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          162 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             c--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC----chhHHHHHHHhccccCCchhhcccC
Confidence            2  223467899999998        5789999999999999999996432    22222222222221  111123445


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            67889999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.98  E-value=1.5e-33  Score=291.09  Aligned_cols=205  Identities=20%  Similarity=0.357  Sum_probs=160.2

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                           |||+++++++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            446667889999999998                                           79999999985 4568999


Q ss_pred             EEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.+++...      .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            9999999999999743      24567899999999999998   99999999999999999999999999998765443


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ........+++.|+|||        .++|||||||++|||++ |..|+...    ...+....+..... ...+...+..
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~----~~~~~~~~i~~~~~-~~~~~~~~~~  620 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIENGER-LPMPPNCPPT  620 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHHTCC-CCCCTTCCHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHcCCC-CCCCccccHH
Confidence            33333455778999998        46899999999999997 88886432    22333333322221 1223445668


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999999988654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.98  E-value=5.2e-33  Score=257.39  Aligned_cols=191  Identities=20%  Similarity=0.326  Sum_probs=153.7

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      +++|...+.||+|+||.||                                          |||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4567788899999999998                                          7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----------------
Q 046461          201 YEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE----------------  255 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~----------------  255 (383)
                      |||+++|+|.+++...         .....++.|++.||+|||+.   +|+||||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999742         34578999999999999998   9999999999999984                


Q ss_pred             ---CCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          256 ---DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       256 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                         ...+|++|||.++......     ...||..|+|||         .++||||||++++||++|..++...       
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-------  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence               4479999999998765422     235899999998         3689999999999999998774211       


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +....+..... ...+......+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 DQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11111122111 1223344567889999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.98  E-value=1.1e-32  Score=262.57  Aligned_cols=190  Identities=23%  Similarity=0.345  Sum_probs=157.0

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCC
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGE  195 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~  195 (383)
                      .++|...+.||+|+||.||                                               |||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4578888999999999999                                               69999999999999


Q ss_pred             EEEEEEEeccCC-CHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          196 KKLIVYEYMVKG-SLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       196 ~~~lv~e~~~~g-sL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..++||||+.+| +|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            999999999877 999999753     34678999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCCh
Q 046461          270 ISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK  340 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~  340 (383)
                      .....  ......||+.|+|||         .++|||||||++|||++|+.|+....      +..    ....  ..+.
T Consensus       180 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~----~~~~--~~~~  245 (335)
T 3dls_A          180 LERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETV----EAAI--HPPY  245 (335)
T ss_dssp             CCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGT----TTCC--CCSS
T ss_pred             CCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHH----hhcc--CCCc
Confidence            65432  223457899999998         35799999999999999999974311      111    1111  1122


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            24457889999999999999999999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.98  E-value=6e-33  Score=258.33  Aligned_cols=195  Identities=24%  Similarity=0.376  Sum_probs=152.5

Q ss_pred             ccccCeeecCCccccc-----------------------------------------cccceeeeEEEe----CCEEEEE
Q 046461          166 FYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV----GEKKLIV  200 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~----~~~~~lv  200 (383)
                      |.....||+|+||.||                                         |||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            4445679999999999                                         799999999875    4568999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCCCcEEEc-CCCceEEccccCccccCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPH--IIHRDINASNILLN-EDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NiLl~-~~~~~kl~Dfgla~~~~~  272 (383)
                      |||+++|+|.+++...     .....++.|++.||+|||+.   +  ++||||||+||+++ .++.+||+|||++.....
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999742     34677899999999999998   6  99999999999997 789999999999975433


Q ss_pred             CCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          273 CESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      .   ......||..|+|||       .++||||+|+++|||++|+.|+....   ........+.........+......
T Consensus       185 ~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          185 S---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             c---ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcC---cHHHHHHHHhccCCccccCCCCCHH
Confidence            2   223456899999998       57899999999999999999974321   1111222222211111122233457


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+++.+||+.||++|||+.|+++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhh
Confidence            889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.98  E-value=7.5e-33  Score=257.83  Aligned_cols=198  Identities=23%  Similarity=0.333  Sum_probs=153.6

Q ss_pred             CccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          165 KFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++....+||+|+||.||                                       +||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34555699999999999                                       799999999999999999999999


Q ss_pred             CCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCceEEccccCccccCCCCCc
Q 046461          206 KGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-DFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       206 ~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      +|+|.+++...        .....++.|++.||+|||+.   +++|+||||+||+++. ++.+||+|||+++....... 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            99999999743        23456889999999999998   9999999999999987 89999999999987643221 


Q ss_pred             cccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      ......|+..|+|||          .++||||||+++|||++|+.|+.....   .................+......+
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHHHHhhccccccccccccCCHHH
Confidence            223456899999987          368999999999999999999642110   0000000000011112234455678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||+.|+++
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            89999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=3.5e-33  Score=258.45  Aligned_cols=202  Identities=24%  Similarity=0.378  Sum_probs=160.5

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------cccceeeeEEEe--------------
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV--------------  193 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~--------------  193 (383)
                      .++|...+.||+|+||.||                                   |||+++++++..              
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            3568888999999999999                                   799999998864              


Q ss_pred             --CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccc
Q 046461          194 --GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF  264 (383)
Q Consensus       194 --~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Df  264 (383)
                        ....++||||+++|+|.+++...       .....++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence              34579999999999999999642       24578999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc
Q 046461          265 GLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN  336 (383)
Q Consensus       265 gla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~  336 (383)
                      |+++......  ......|+..|+|||        .++||||||+++|||++|..|+...      ......+.+..+  
T Consensus       167 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~~--  236 (284)
T 2a19_B          167 GLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SKFFTDLRDGII--  236 (284)
T ss_dssp             TTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTCC--
T ss_pred             hhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcccc--
Confidence            9998765432  223456899999988        5789999999999999999885211      111111112222  


Q ss_pred             cCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          337 AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       337 ~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                        +......+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus       237 --~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          237 --SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence              22334567889999999999999999999999998877644

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.98  E-value=7e-33  Score=260.21  Aligned_cols=197  Identities=24%  Similarity=0.333  Sum_probs=153.8

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCC
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGE  195 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~  195 (383)
                      +++|...+.||+|+||.||                                               |||++++++|....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            5678888999999999988                                               69999999998755


Q ss_pred             -----EEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          196 -----KKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       196 -----~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                           ..++||||++ |+|.+++...       .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence                 5799999996 6999999743       24578999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----
Q 046461          264 FGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----  331 (383)
Q Consensus       264 fgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----  331 (383)
                      ||+++......  ......||..|+|||        .++||||+||++|||++|+.|+....    ..+....+.+    
T Consensus       164 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~  237 (308)
T 3g33_A          164 FGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS----EADQLGKIFDLIGL  237 (308)
T ss_dssp             CSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS----HHHHHHHHHHHHCC
T ss_pred             CccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCC
Confidence            99998764322  234467899999998        67899999999999999999975321    1111111100    


Q ss_pred             --------------Ccccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 --------------STILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 --------------~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                    .....       ....+....+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                          00000       001233467889999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.98  E-value=6.3e-33  Score=270.19  Aligned_cols=209  Identities=18%  Similarity=0.241  Sum_probs=163.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCC--EEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGE--KKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~--~~~lv~  201 (383)
                      +.|...++||+|+||.||                                        |||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            356777899999999998                                        79999999998755  779999


Q ss_pred             EeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCceEEccccCccc
Q 046461          202 EYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL----NEDFEVKVSDFGLVRL  269 (383)
Q Consensus       202 e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl----~~~~~~kl~Dfgla~~  269 (383)
                      ||+++|+|.+++...        .....++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            999999999999743        23577999999999999998   99999999999999    7788899999999987


Q ss_pred             cCCCCCccccccccccccccCC----------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee---
Q 046461          270 ISDCESHTSTDVAGTIGYILLA----------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL---  330 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape----------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~---  330 (383)
                      .....  ......||..|+|||                .++|||||||++|||++|+.||.+........+....+.   
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            65432  223457899999998                258999999999999999999754221111111111110   


Q ss_pred             ------------------cCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          331 ------------------DSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       331 ------------------~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                                        ...+  ...........+.+++.+||+.||++|||+.|+++.++++...
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence                              0111  1122356677888999999999999999999999999877543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=6e-33  Score=279.67  Aligned_cols=200  Identities=22%  Similarity=0.349  Sum_probs=159.9

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...++||+|+||.||                                          |||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            567778899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          202 EYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       202 e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ||+++|+|.+++...         .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999998642         23567899999999999998   999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      ... ......||+.|+|||        .++|||||||++|||++|+.||...........+.+.+.....  .++...+.
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~  418 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSP  418 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCH
Confidence            332 223458999999998        5689999999999999999997543211111222222222221  22345566


Q ss_pred             HHHHHHHHccccCCCCCCCH-----HHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPTM-----LRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~-----~~v~~  369 (383)
                      .+.+++.+||+.||++||++     .++.+
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            88899999999999999975     56653

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=3.3e-33  Score=268.14  Aligned_cols=156  Identities=21%  Similarity=0.323  Sum_probs=134.2

Q ss_pred             CcccHHHHHHHhhCccccCeeecCCccccc-------------------------------------------cccceee
Q 046461          152 GKLTYDQIVAGTNKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLL  188 (383)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~  188 (383)
                      ..+++.+.....++|...+.||+|+||.||                                           +||++++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            344555555556889999999999999999                                           6999999


Q ss_pred             eEEEeCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC------
Q 046461          189 GYCPVGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE------  255 (383)
Q Consensus       189 g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~------  255 (383)
                      +++...+..++||||+ +++|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 99999999743       24577899999999999998   9999999999999975      


Q ss_pred             -------------------CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHh
Q 046461          256 -------------------DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       256 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt  308 (383)
                                         ++.+||+|||+++.....    .....||+.|+|||        .++|||||||++|||++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                               788999999999865432    23457899999998        57899999999999999


Q ss_pred             CCCCCCC
Q 046461          309 RKQPTGP  315 (383)
Q Consensus       309 g~~p~~~  315 (383)
                      |+.||..
T Consensus       255 g~~pf~~  261 (360)
T 3llt_A          255 GSLLFRT  261 (360)
T ss_dssp             SSCSCCC
T ss_pred             CCCCCCC
Confidence            9999753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.98  E-value=2.1e-33  Score=264.60  Aligned_cols=209  Identities=18%  Similarity=0.284  Sum_probs=159.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEe----CCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPV----GEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~----~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                       |||+++++++..    ....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            467788899999999998                                       799999999973    3478999


Q ss_pred             EEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          201 YEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      |||+++|+|.+++...         .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++...
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            9999999999998742         24578999999999999998   99999999999999999999999999987653


Q ss_pred             CCCCc--------cccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC
Q 046461          272 DCESH--------TSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS  332 (383)
Q Consensus       272 ~~~~~--------~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~  332 (383)
                      .....        ......||..|+|||           .++||||||+++|||++|+.|+......  ....... ...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~-~~~  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--GDSVALA-VQN  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--TSCHHHH-HHC
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--cchhhHH-hhc
Confidence            21100        011235788999998           3689999999999999999997432111  1111111 111


Q ss_pred             cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       333 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .............+.+++.+||+.||++|||+.++++.|+++....
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            1111122344567899999999999999999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.98  E-value=6.8e-33  Score=255.64  Aligned_cols=200  Identities=23%  Similarity=0.336  Sum_probs=157.5

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            467777888999998888                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC-cc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~  277 (383)
                      +++|+|.+++...     .....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++....... ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            9999999998743     34678999999999999998   999999999999999999999999999986543221 12


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....|+..|+|||         .++||||||+++|||++|+.|+.....  .......+...... ..........+.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~  240 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTY-LNPWKKIDSAPLA  240 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT--TSHHHHHHHTTCTT-STTGGGSCHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHhhhcccc-cCchhhcCHHHHH
Confidence            33457899999998         358999999999999999999754321  11111111111111 1112334567889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       241 li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCCchhCCCHHHHhc
Confidence            999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.98  E-value=9.9e-33  Score=276.37  Aligned_cols=197  Identities=21%  Similarity=0.316  Sum_probs=156.6

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +.|...+.||+|+||.||                                         ||||++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            457778899999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCCC
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~~  274 (383)
                      |+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++......
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            99999999988642     34678999999999999998   9999999999999976   4559999999998765432


Q ss_pred             CccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc--cCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--AYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~--~~~~~~~~~  345 (383)
                        ......||+.|+|||       .++||||+||++|||++|..||...    ...++...+.......  ......+..
T Consensus       194 --~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          194 --KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ----TDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             --cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCchhcccCCHH
Confidence              233467999999998       6789999999999999999996432    3333333333322211  111234567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+++.+||+.||++|||+.|+++
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHCCCChhhCccHHHHhc
Confidence            889999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=1.4e-33  Score=265.61  Aligned_cols=205  Identities=21%  Similarity=0.325  Sum_probs=148.8

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCC----EE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGE----KK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~----~~  197 (383)
                      ++|...+.||+|+||.||                                          |||+++++++...+    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            467777889999999988                                          79999999987643    34


Q ss_pred             EEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            9999999999999999742     34678999999999999998   999999999999999999999999999987644


Q ss_pred             CCC--ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCCh
Q 046461          273 CES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYSK  340 (383)
Q Consensus       273 ~~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~~  340 (383)
                      ...  .......||..|+|||        .++||||||+++|||++|+.||...    ...+...........  .....
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~  244 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQHVREDPIPPSARHE  244 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCCCCHHHHST
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCCCCCcccccC
Confidence            321  1223356899999998        4689999999999999999997432    221211111111110  01112


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHH-HHHhccc
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQ-EFLEKYH  375 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~-~~L~~~~  375 (383)
                      ..+..+.+++.+||+.||++||++.+++ +.+.+..
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            3456788999999999999999766544 5665543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.98  E-value=9.3e-33  Score=261.13  Aligned_cols=197  Identities=17%  Similarity=0.264  Sum_probs=157.4

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      +.|...+.||+|+||.||                                             |||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            457777889999999888                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----ceEEccccCccc
Q 046461          199 IVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLVRL  269 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~----~~kl~Dfgla~~  269 (383)
                      +||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||+++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999999742     35678999999999999998   999999999999999887    799999999987


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCC
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYS  339 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~  339 (383)
                      .....  ......||..|+|||        .++||||||+++|||++|+.|+...    ...+....+.....  .....
T Consensus       169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~  242 (321)
T 2a2a_A          169 IEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANITSVSYDFDEEFF  242 (321)
T ss_dssp             CCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS----SHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhcccccChhhh
Confidence            65432  223456899999998        5789999999999999999997432    22222222211111  00111


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          243 SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            223457889999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.98  E-value=2.1e-32  Score=257.68  Aligned_cols=183  Identities=20%  Similarity=0.312  Sum_probs=137.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        71 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~  147 (316)
T 2ac3_A           71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHP  147 (316)
T ss_dssp             TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCS
T ss_pred             CCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccC
Confidence            79999999999999999999999999999999642     34677999999999999999   99999999999999887


Q ss_pred             Cc---eEEccccCccccCCCCC------ccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          257 FE---VKVSDFGLVRLISDCES------HTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       257 ~~---~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      +.   +||+|||+++.......      .......||..|+|||             .++|||||||++|||++|+.|+.
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  227 (316)
T 2ac3_A          148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV  227 (316)
T ss_dssp             SSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence            66   99999999876542211      1122346899999998             46899999999999999999975


Q ss_pred             CCCCCCCCC-----------ccceeeecCcccccCC----hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          315 PEFKDKNGG-----------NLVDWVLDSTILNAYS----KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       315 ~~~~~~~~~-----------~~~~~v~~~~~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .........           .+.+.+.....  ..+    ......+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          228 GRCGSDCGWDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCCCSCSCC----CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccccccccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            432211000           01111111111  111    123457889999999999999999999987

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=2.5e-33  Score=272.07  Aligned_cols=200  Identities=25%  Similarity=0.335  Sum_probs=145.4

Q ss_pred             hhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCC--EEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGE--KKL  198 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~--~~~  198 (383)
                      .++|...+.||+|+||.||                                          +||+++++++...+  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            4578888899999999998                                          79999999998644  689


Q ss_pred             EEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      +|||||+ |+|.++++..    .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        88 lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            9999997 6999998742    34567899999999999998   99999999999999999999999999998753211


Q ss_pred             --------------------CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          275 --------------------SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       275 --------------------~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                                          ....+...||+.|+|||         .++||||+||+++||++|+.||...    +..+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~  239 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS----STMNQ  239 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC----CHHHH
Confidence                                11223457999999998         4579999999999999999997432    22111


Q ss_pred             ceeeec---------------------------------Ccccc------------cCChhHHHHHHHHHHHccccCCCC
Q 046461          326 VDWVLD---------------------------------STILN------------AYSKPSMLKMLQIVVGCIFDNPTT  360 (383)
Q Consensus       326 ~~~v~~---------------------------------~~~~~------------~~~~~~~~~~~~l~~~C~~~~P~~  360 (383)
                      .+.+..                                 .....            .........+.+++.+||+.||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            111100                                 00000            000123457889999999999999


Q ss_pred             CCCHHHHHHH
Q 046461          361 RPTMLRVQEF  370 (383)
Q Consensus       361 RPs~~~v~~~  370 (383)
                      |||++|+++.
T Consensus       320 R~t~~e~l~H  329 (388)
T 3oz6_A          320 RISANDALKH  329 (388)
T ss_dssp             SCCHHHHTTS
T ss_pred             CCCHHHHhCC
Confidence            9999999873

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.98  E-value=2.9e-33  Score=265.20  Aligned_cols=206  Identities=24%  Similarity=0.342  Sum_probs=159.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                             |||+++++++.+.+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            567777888999988887                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcch------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEcc
Q 046461          199 IVYEYMVKGSLNDWLRNQA------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSD  263 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~~------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~D  263 (383)
                      +||||+++|+|.+++....            ....++.|++.||.|||+.   +++||||||+||+++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence            9999999999999997431            3577899999999999998   9999999999999984   45699999


Q ss_pred             ccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCc
Q 046461          264 FGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDST  333 (383)
Q Consensus       264 fgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~  333 (383)
                      ||+++....... .......|+..|+|||        .++||||||+++|||++ |+.|+...    ...+..+.+....
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----~~~~~~~~~~~~~  262 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFVTSGG  262 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTTC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc----CHHHHHHHHhcCC
Confidence            999876543221 1223346788999998        57899999999999998 88886432    2223333332221


Q ss_pred             ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      . ...+......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       263 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          263 R-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            1 122334556788999999999999999999999999987543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=5.3e-33  Score=258.67  Aligned_cols=196  Identities=21%  Similarity=0.292  Sum_probs=148.9

Q ss_pred             CccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          165 KFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      +|...+.||+|+||.||                                        |||+++++++.+.+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            46666788888888888                                        79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      ++ +|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY  157 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence            75 999988642      24577899999999999998   99999999999999999999999999998764322 122


Q ss_pred             cccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--------------------
Q 046461          279 TDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--------------------  329 (383)
Q Consensus       279 ~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--------------------  329 (383)
                      ....||..|+|||         .++||||+||++|||++|+.|+....    ..+....+                    
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            3356899999987         45799999999999999999975321    11100000                    


Q ss_pred             ecCcc-------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 LDSTI-------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ~~~~~-------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .++..       ...........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000       00111234567889999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=2.5e-33  Score=259.20  Aligned_cols=206  Identities=20%  Similarity=0.242  Sum_probs=160.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--CCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--GEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                         |||+++++++.+  +...++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            567777889999999888                                         799999998854  6789999


Q ss_pred             EEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCC-----eeecCCCCCcEEEcCCCceEEccccC
Q 046461          201 YEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPH-----IIHRDINASNILLNEDFEVKVSDFGL  266 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~-----ivHrdlk~~NiLl~~~~~~kl~Dfgl  266 (383)
                      |||+++|+|.+++...         .....++.|++.||+|||+.   +     ++||||||+||+++.++.+||+|||.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999642         24578999999999999998   6     99999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY  338 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~  338 (383)
                      ++....... ......|+..|+|||        .++||||||+++|||++|+.|+...    +..++.+.+..... ...
T Consensus       163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~i~~~~~-~~~  236 (279)
T 2w5a_A          163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKIREGKF-RRI  236 (279)
T ss_dssp             HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCC-CCC
T ss_pred             heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc----CHHHHHHHHhhccc-ccC
Confidence            987643221 122346889999998        4689999999999999999996432    22233333322222 122


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      +......+.+++.+||+.||++|||+.|+++.+.......
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            3345567889999999999999999999999877655443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.7e-32  Score=254.52  Aligned_cols=194  Identities=19%  Similarity=0.322  Sum_probs=157.9

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            467777889999999888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......   
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            999999999999742     34678999999999999998   9999999999999999999999999998765432   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      ......|+..|+|||        .++||||||+++|||++|+.|+...    ...+....+.....  ..+......+.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~~  241 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP----SHTETHRRIVNVDL--KFPPFLSDGSKD  241 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTTCC--CCCTTSCHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC----CHhHHHHHHhcccc--CCCCcCCHHHHH
Confidence            223457899999987        5789999999999999999997532    22222222222111  123344567889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+|++.||++|||+.|+++
T Consensus       242 li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhcCHhhCCCHHHHhh
Confidence            999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=8.9e-33  Score=257.67  Aligned_cols=196  Identities=21%  Similarity=0.353  Sum_probs=157.4

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            456677888888888888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++++|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... .
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E  170 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence            99999999999864     235678999999999999998   99999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      ......|+..|+|||        .++||||+|+++|||++|+.|+...    ...+....+.....  ..+......+.+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~~  244 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEY--SIPKHINPVAAS  244 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHTTCC--CCCTTSCHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhhccC--CCccccCHHHHH
Confidence            233456899999998        4789999999999999999997532    11111111111111  122334557889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       245 li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHcccChhhCcCHHHHhh
Confidence            999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=2.5e-32  Score=263.12  Aligned_cols=205  Identities=20%  Similarity=0.335  Sum_probs=163.0

Q ss_pred             HHHHHHHhhCccccCeeecCCccccc------------------------------------------------ccccee
Q 046461          156 YDQIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------------KNIVQL  187 (383)
Q Consensus       156 ~~~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------------~niv~l  187 (383)
                      +.......++|...+.||+|+||.||                                                |||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            33444555678888999999999998                                                699999


Q ss_pred             eeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEc
Q 046461          188 LGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVS  262 (383)
Q Consensus       188 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~  262 (383)
                      ++++......++||||+++|+|.+++...     .....++.|++.||.|||+.   +++|||+||+||+++.++.+|++
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999999742     34678999999999999998   99999999999999999999999


Q ss_pred             cccCccccCCCCCccccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          263 DFGLVRLISDCESHTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      |||++.......  ......||+.|+|||              .++|||||||++|||++|+.|+...    ........
T Consensus       243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~----~~~~~~~~  316 (365)
T 2y7j_A          243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR----RQILMLRM  316 (365)
T ss_dssp             CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHH
T ss_pred             ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC----CHHHHHHH
Confidence            999998765432  233467999999998              2689999999999999999996432    22222222


Q ss_pred             eecCccccc--CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          329 VLDSTILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~--~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +........  ........+.+++.+||+.||++|||+.|+++
T Consensus       317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222211110  01123456889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=7.1e-33  Score=258.81  Aligned_cols=208  Identities=23%  Similarity=0.356  Sum_probs=149.7

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .++|...+.||+|+||.||                                        |||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            3456667778888888777                                        799999999999999999999


Q ss_pred             eccCCCHHHHHhc-------------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          203 YMVKGSLNDWLRN-------------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       203 ~~~~gsL~~~l~~-------------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      |+++|+|.+++..             ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999863             224578999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCC----ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc---
Q 046461          270 ISDCES----HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---  333 (383)
Q Consensus       270 ~~~~~~----~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~---  333 (383)
                      ......    .......||..|+|||         .++||||||+++|||++|+.|+....    ............   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP----PMKVLMLTLQNDPPS  246 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC----GGGHHHHHHTSSCCC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc----hhhHHHHHhccCCCc
Confidence            643221    1123356899999988         46899999999999999999975321    111111000000   


Q ss_pred             c-----cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccccC
Q 046461          334 I-----LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHTG  377 (383)
Q Consensus       334 ~-----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~~  377 (383)
                      .     ...........+.+++.+||+.||++|||+.|+++  .+++...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            0     00111233457889999999999999999999987  44444443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=7.2e-33  Score=260.23  Aligned_cols=205  Identities=23%  Similarity=0.318  Sum_probs=153.0

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         +||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            457777889999999998                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+++++|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  158 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y  158 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence            99999999988642     34678999999999999998   999999999999999999999999999987653222 2


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee------------------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL------------------  330 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~------------------  330 (383)
                      .....||..|+|||         .++||||+|+++|||++|+.|+....    ..+....+.                  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS----DVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhccccccccccccccc
Confidence            23456899999987         46799999999999999999975321    111100000                  


Q ss_pred             ---cCccccc--------CChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          331 ---DSTILNA--------YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       331 ---~~~~~~~--------~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                         .......        ........+.+++.+||+.||++|||++|+++  .++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence               0000000        01233456889999999999999999999986  4444433

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=4.9e-33  Score=258.47  Aligned_cols=199  Identities=21%  Similarity=0.290  Sum_probs=147.8

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      .++|...+.||+|+||.||                                         |||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            3567788899999999998                                         79999999999999999999


Q ss_pred             EeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          202 EYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       202 e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ||++ |+|.+++..         +.....++.|++.||+|||+.+  +++||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9997 588888753         2245789999999999999853  799999999999999999999999999987644


Q ss_pred             CCCccccccccccccccCCC------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCCh
Q 046461          273 CESHTSTDVAGTIGYILLAC------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK  340 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape~------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~  340 (383)
                      ..  ......||..|+|||.            ++||||+|+++|||++|+.|+....   ....................
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS---CHHHHHHHHHHSCCCCCCTT
T ss_pred             cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC---chHHHHHHHhccCCCCcccc
Confidence            32  2223468899999883            5799999999999999999975311   11111111122222122223


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            44567889999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=7.7e-33  Score=265.73  Aligned_cols=201  Identities=25%  Similarity=0.407  Sum_probs=154.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            467788899999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      +++|+|.+++...     .....++.+++.||+|||+.+  +|+||||||+||+++.++.+||+|||+++.....   ..
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~  187 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  187 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence            9999999999753     345789999999999999832  7999999999999999999999999998765321   12


Q ss_pred             cccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC----------------------------
Q 046461          279 TDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG----------------------------  322 (383)
Q Consensus       279 ~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~----------------------------  322 (383)
                      ....||..|+|||        .++|||||||++|||++|+.|+.........                            
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            3357899999998        4689999999999999999997532110000                            


Q ss_pred             ----------CccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 ----------GNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ----------~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                .+..+++................+.+++.+||+.||++|||++|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      00000000011111111223557889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=4.5e-33  Score=264.13  Aligned_cols=204  Identities=17%  Similarity=0.257  Sum_probs=157.0

Q ss_pred             HHHHHHhhCcccc-CeeecCCccccc------------------------------------------cccceeeeEEEe
Q 046461          157 DQIVAGTNKFYEK-NVIRGDDFGIAF------------------------------------------KNIVQLLGYCPV  193 (383)
Q Consensus       157 ~~l~~~t~~f~~~-~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~  193 (383)
                      .....-.+.|... +.||+|+||.||                                          +||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3334444455554 789999999998                                          699999999999


Q ss_pred             CCEEEEEEEeccCCCHHHHHhc-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEcc
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSD  263 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~D  263 (383)
                      .+..++||||+++|+|.+++..       ......++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence            9999999999999999999853       234678999999999999998   9999999999999987   78999999


Q ss_pred             ccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC--c
Q 046461          264 FGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS--T  333 (383)
Q Consensus       264 fgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~--~  333 (383)
                      ||+++......  ......||+.|+|||        .++||||+|+++|||++|+.|+...    +..+....+...  .
T Consensus       178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~  251 (327)
T 3lm5_A          178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE----DNQETYLNISQVNVD  251 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC
T ss_pred             CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CchHHHHHHHhcccc
Confidence            99998764322  223457899999998        5789999999999999999996432    222221111111  1


Q ss_pred             ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ............+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111222345567889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.6e-32  Score=272.81  Aligned_cols=202  Identities=24%  Similarity=0.325  Sum_probs=161.3

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      +.|...+.||+|+||.||                                         |||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            467788999999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCceEEccccCccccCCCC
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~---~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |+++|+|.+++...     .....++.|++.||.|||+.   +|+||||||+||+++   .++.+||+|||+++......
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            99999999988642     35678999999999999998   999999999999995   45679999999998764432


Q ss_pred             CccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc--cCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--AYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~--~~~~~~~~~  345 (383)
                        ......||+.|+|||       .++||||+||++|||++|+.|+...    ...++...+.......  ......+..
T Consensus       179 --~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          179 --KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK----NEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             --ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence              233457999999998       5789999999999999999996432    3333333333322211  112344567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      +.+++.+||+.||++|||+.|+++  .+++.
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            889999999999999999999997  35443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.6e-33  Score=264.00  Aligned_cols=208  Identities=21%  Similarity=0.344  Sum_probs=156.6

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc---------------------------------------cccceeeeEEEe-
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPV-  193 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~-  193 (383)
                      +++.++....++|...+.||+|+||.||                                       +||+++++++.. 
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            4444555667889999999999999999                                       799999999987 


Q ss_pred             -----CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          194 -----GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       194 -----~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                           .+..++||||+++|+|.+++...       .....++.|++.||+|||+.   +++|+||||+||+++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence                 46889999999999999999743       23567899999999999998   9999999999999999999999


Q ss_pred             ccccCccccCCCCCccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcccee
Q 046461          262 SDFGLVRLISDCESHTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDW  328 (383)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~  328 (383)
                      +|||+++...... .......|+..|+|||             .++|||||||++|||++|+.|+...    ........
T Consensus       171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~  245 (326)
T 2x7f_A          171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM----HPMRALFL  245 (326)
T ss_dssp             CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHH
T ss_pred             eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHH
Confidence            9999987654321 1223356899999987             3589999999999999999996432    11111111


Q ss_pred             eecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          329 VLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       329 v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +................+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111111112234567889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=1.7e-32  Score=259.96  Aligned_cols=203  Identities=21%  Similarity=0.288  Sum_probs=144.6

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEE--------eCC
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCP--------VGE  195 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~--------~~~  195 (383)
                      .+|...+.||+|+||.||                                        +||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            467778899999999998                                        79999999994        334


Q ss_pred             EEEEEEEeccCCCHHHHHhc--------chhhhHHHHhHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCceEEcccc
Q 046461          196 KKLIVYEYMVKGSLNDWLRN--------QAKHCIIACGTARGITFLHHRFQPH--IIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~--------~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      ..++||||+. |+|.+++..        +.....++.|++.||+|||+.   +  ++||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence            5799999995 799998864        234678999999999999998   6  9999999999999999999999999


Q ss_pred             CccccCCCCCc-----------cccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          266 LVRLISDCESH-----------TSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       266 la~~~~~~~~~-----------~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++........           ......||+.|+|||           .++|||||||++|||++|+.|+...    ...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~----~~~  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG----AKL  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch----hHH
Confidence            99876543211           111345899999998           2679999999999999999997432    112


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .....    .............+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       260 ~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          260 RIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            22211    1111112223345778999999999999999999999999886543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=9.7e-33  Score=262.73  Aligned_cols=196  Identities=21%  Similarity=0.353  Sum_probs=158.2

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            457777889999999888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++++|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... .
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~  196 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E  196 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence            99999999999864     235678999999999999998   99999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      ......|+..|++||        .++||||||+++|||++|+.|+...    ...+....+.....  ..+......+.+
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~~  270 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEY--SIPKHINPVAAS  270 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCC--CCCTTSCHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC----CHHHHHHHHhcCCC--CCCccCCHHHHH
Confidence            223457899999998        4789999999999999999997432    11121111111111  112334457889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||+.|+++
T Consensus       271 li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=1.9e-32  Score=256.57  Aligned_cols=197  Identities=25%  Similarity=0.380  Sum_probs=159.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      +.|...+.||+|+||.||                                        +||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            457778899999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          204 MVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       204 ~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      +++++|.+++..    ......++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.++...... ....
T Consensus       102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  177 (303)
T 3a7i_A          102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN  177 (303)
T ss_dssp             CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBC
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-cccC
Confidence            999999999974    345678999999999999998   99999999999999999999999999998765432 1223


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...|+..|+|||        .++||||||+++|||++|+.|+...    ........+.... ...........+.+++.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL----HPMKVLFLIPKNN-PPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSC-CCCCCSSCCHHHHHHHH
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc----CHHHHHHHhhcCC-CCCCccccCHHHHHHHH
Confidence            457899999987        5789999999999999999996432    1112211111111 11122334557889999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 046461          352 GCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~  369 (383)
                      +||+.||++|||+.|+++
T Consensus       253 ~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTT
T ss_pred             HHcCCChhhCcCHHHHhh
Confidence            999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=2.2e-32  Score=260.48  Aligned_cols=205  Identities=20%  Similarity=0.250  Sum_probs=140.8

Q ss_pred             hhCccc-cCeeecCCccccc-----------------------------------cccceeeeEEEe----CCEEEEEEE
Q 046461          163 TNKFYE-KNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV----GEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~-~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~----~~~~~lv~e  202 (383)
                      +++|.. .++||+|+||.||                                   +||+++++++..    +...++|||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  106 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME  106 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence            356666 4579999999999                                   799999999976    445899999


Q ss_pred             eccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCC
Q 046461          203 YMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISD  272 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~  272 (383)
                      |+++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||+++....
T Consensus       107 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          107 CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             CCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            99999999999743       24678999999999999999   9999999999999976   45599999999986543


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--ccccCChhH
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--ILNAYSKPS  342 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~~~~~~~~  342 (383)
                      .   ......||+.|+|||        .++||||||+++|||++|+.|+...............+....  .........
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          184 N---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             c---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence            2   223356899999999        468999999999999999999754322111111111111111  111112345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 046461          343 MLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       343 ~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                      ...+.+++.+||+.||++|||+.|+++  .+++
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            667889999999999999999999997  4443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=5.2e-33  Score=268.91  Aligned_cols=192  Identities=14%  Similarity=0.161  Sum_probs=147.8

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceee-------eEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLL-------GYC  191 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~-------g~~  191 (383)
                      ++|...+.||+|+||.||                                             ||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            456667889999999998                                             6899988       555


Q ss_pred             EeCC-----------------EEEEEEEeccCCCHHHHHhcc------------hhhhHHHHhHHHHHHHHhhcCCCCee
Q 046461          192 PVGE-----------------KKLIVYEYMVKGSLNDWLRNQ------------AKHCIIACGTARGITFLHHRFQPHII  242 (383)
Q Consensus       192 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~------------~~~~~i~~~ia~gL~~LH~~~~~~iv  242 (383)
                      .+.+                 ..++||||+ +|+|.+++...            ..+..++.|++.||+|||+.   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            5443                 278999999 68999999742            33456899999999999999   999


Q ss_pred             ecCCCCCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC----C---------------CCcchhHHHHH
Q 046461          243 HRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA----C---------------GGDIYSFSVVL  303 (383)
Q Consensus       243 Hrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape----~---------------~~Dv~SfGvil  303 (383)
                      ||||||+|||++.++.+||+|||+++....    ......| ..|+|||    .               ++|||||||++
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999986432    2334567 8999987    2               57999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          304 LELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       304 ~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      |||++|+.|+...    ......+.+...      ....+..+.+++.+||+.||++|||+.|+++  .++++
T Consensus       304 ~elltg~~Pf~~~----~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          304 YWIWCADLPITKD----AALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHSSCCC----------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCCCccc----ccccchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            9999999997432    222222222111      1233457889999999999999999999986  44443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.7e-32  Score=269.12  Aligned_cols=199  Identities=21%  Similarity=0.278  Sum_probs=150.4

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeC
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~  194 (383)
                      ..++|...+.||+|+||.||                                               |||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            45688889999999999998                                               79999999975 4


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEccccC
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSDFGL  266 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~Dfgl  266 (383)
                      +..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.+   ..+||+|||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5689999999999999988642     34678999999999999998   99999999999999654   4599999999


Q ss_pred             ccccCCCCCccccccccccccccCCC-----------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLAC-----------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL  335 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape~-----------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~  335 (383)
                      ++.....  .......||+.|+|||.           ++|||||||++|||++|+.||....   ....+.+.+......
T Consensus       289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR---TQVSLKDQITSGKYN  363 (419)
T ss_dssp             TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS---SSCCHHHHHHTTCCC
T ss_pred             ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc---chHHHHHHHhcCCCC
Confidence            9876532  22334679999999992           5799999999999999999975321   111222222222111


Q ss_pred             --ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          336 --NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       336 --~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        ..........+.+++.+||+.||++|||+.|+++
T Consensus       364 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              0111233567889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=1e-32  Score=261.41  Aligned_cols=209  Identities=22%  Similarity=0.359  Sum_probs=159.7

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCC--EEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGE--KKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~--~~~  198 (383)
                      ++|...+.||+|+||.||                                           +||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            346667889999999887                                           79999999987644  689


Q ss_pred             EEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999999743      24577899999999999998   999999999999999999999999999987654


Q ss_pred             CCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCC-------CCCC-C----ccceeee
Q 046461          273 CESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFK-------DKNG-G----NLVDWVL  330 (383)
Q Consensus       273 ~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~-------~~~~-~----~~~~~v~  330 (383)
                      ....  ......++..|+|||        .++||||||+++|||++|..|+.....       .... .    .+.+. .
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  276 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-L  276 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH-H
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH-h
Confidence            3321  122345677899998        578999999999999999988642210       0000 0    00011 1


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ........+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111112234456788999999999999999999999999998865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=2.5e-32  Score=252.07  Aligned_cols=195  Identities=21%  Similarity=0.333  Sum_probs=149.5

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            456667788888888888                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+++++|.+++...     .....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            999999999999642     34678999999999999999   99999999999999999999999999998764422  


Q ss_pred             cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          277 TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       277 ~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ......|+..|+|||         .++||||||+++|||++|+.|+...    ......+.+.....  ..+......+.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~--~~~~~~~~~l~  239 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE----HVPTLFKKIRGGVF--YIPEYLNRSVA  239 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCcc--cCchhcCHHHH
Confidence            222356889999998         3689999999999999999996432    22222222222111  11233455788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||+.|+++
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHh
Confidence            9999999999999999999997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=3.5e-33  Score=267.47  Aligned_cols=187  Identities=14%  Similarity=0.227  Sum_probs=142.3

Q ss_pred             eeeEEEe-CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-
Q 046461          187 LLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-  257 (383)
Q Consensus       187 l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-  257 (383)
                      +++++.. ++..++||||+ +|+|.+++...       .....++.|++.||+|||+.   +|+||||||+||+++.++ 
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCC
Confidence            6777776 78899999999 99999999753       24678999999999999999   999999999999999988 


Q ss_pred             -ceEEccccCccccCCCCC------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          258 -EVKVSDFGLVRLISDCES------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       258 -~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                       .+||+|||+++.......      .......||..|+|||        .++|||||||++|||++|+.|+.....  ..
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~  275 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP--NT  275 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--CH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc--CH
Confidence             899999999987643221      1123357899999998        478999999999999999999753221  11


Q ss_pred             Cccceee---ec--CcccccC--ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          323 GNLVDWV---LD--STILNAY--SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       323 ~~~~~~v---~~--~~~~~~~--~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      ..+....   ..  ..+....  .......+.+++.+||+.||++|||+.++++.|+++.+..+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            1111111   00  0010000  11235678899999999999999999999999999876654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=8.2e-33  Score=262.02  Aligned_cols=202  Identities=17%  Similarity=0.263  Sum_probs=151.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        +||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            356777889999999998                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++ |+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence            97 6999988743      24577899999999999998   99999999999999999999999999998654322 22


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec-------C---------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD-------S---------  332 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~-------~---------  332 (383)
                      .....||..|+|||         .++||||+||++|||++|+.||...    +..+....+..       .         
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS----TVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            23356899999988         4579999999999999999997532    11111111100       0         


Q ss_pred             -----cccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          333 -----TILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       333 -----~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                           ....       .........+.+++.+|++.||++|||++|+++  .+.++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                 0000       001123457789999999999999999999987  45444

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=2e-32  Score=264.12  Aligned_cols=164  Identities=10%  Similarity=0.046  Sum_probs=124.6

Q ss_pred             EEEEEEEeccCCCHHHHHhcc------hhh------hHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ------AKH------CIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~------~~~------~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                      ..++||||++ |+|.+++...      ..+      ..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       162 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~D  237 (371)
T 3q60_A          162 NYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGD  237 (371)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECC
T ss_pred             eEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEe
Confidence            4799999998 8999999753      123      46679999999999998   999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee----
Q 046461          264 FGLVRLISDCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV----  329 (383)
Q Consensus       264 fgla~~~~~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v----  329 (383)
                      ||+++.....    .....+|+.|+|||          .++|||||||++|||++|+.|+.......  .......    
T Consensus       238 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~~  311 (371)
T 3q60_A          238 VSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI--KGSWKRPSLRV  311 (371)
T ss_dssp             GGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC--TTCCCBCCTTS
T ss_pred             cceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc--ccchhhhhhhh
Confidence            9999875421    11345669999998          46899999999999999999976442211  1111100    


Q ss_pred             -ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 -LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 -~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                       .............+..+.+++.+||+.||++|||+.|+++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0111111112345668899999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=9.7e-33  Score=275.64  Aligned_cols=197  Identities=22%  Similarity=0.300  Sum_probs=161.2

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      +.|...+.||+|+||.||                                          |||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            457778899999999998                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCC
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.....
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999998643     34678999999999999999   99999999999999   46789999999999876543


Q ss_pred             CCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc--cCChhHHH
Q 046461          274 ESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--AYSKPSML  344 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~--~~~~~~~~  344 (383)
                      .  ......||+.|+|||       .++||||+||++|||++|+.||..    .+..++...+.......  +.....+.
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          183 K--KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             C--SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             c--ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            2  233457999999998       678999999999999999999643    23333344333332211  11234556


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhh
Confidence            7899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=3e-32  Score=273.52  Aligned_cols=179  Identities=25%  Similarity=0.294  Sum_probs=144.5

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENK  182 (504)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESST
T ss_pred             CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecC
Confidence            79999999999999999999999999999998642     35678999999999999998   99999999999999876


Q ss_pred             C---ceEEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          257 F---EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       257 ~---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      +   .+||+|||+++......  ......||+.|+|||       .++||||+||++|||++|..||..    ....++.
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~----~~~~~~~  256 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG----QNDQDII  256 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHH
T ss_pred             CCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC----CCHHHHH
Confidence            5   69999999998765432  233457999999998       678999999999999999999643    2333333


Q ss_pred             eeeecCccccc--CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNA--YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~--~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+........  .....+..+.+++.+|++.||++|||+.|+++
T Consensus       257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33333322111  01233567889999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=3.2e-32  Score=252.17  Aligned_cols=187  Identities=19%  Similarity=0.292  Sum_probs=143.2

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++.+.+..++||||+++++|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        68 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~  144 (283)
T 3bhy_A           68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDK  144 (283)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCS
T ss_pred             CCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecC
Confidence            7999999999999999999999999999999964     235678999999999999998   99999999999999887


Q ss_pred             C----ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          257 F----EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       257 ~----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +    .+||+|||.++......  ......|+..|+|||        .++||||||+++|||++|+.|+...    ...+
T Consensus       145 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~  218 (283)
T 3bhy_A          145 NVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE----TKQE  218 (283)
T ss_dssp             SSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----SHHH
T ss_pred             CCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc----chHH
Confidence            6    79999999998764422  223356899999998        5789999999999999999996432    2222


Q ss_pred             cceeeecCcc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccccC
Q 046461          325 LVDWVLDSTI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHTG  377 (383)
Q Consensus       325 ~~~~v~~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~~  377 (383)
                      ....+.....  ...........+.+++.+||+.||++|||+.|+++  .++.+...
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          219 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             HHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            2211111111  00111223457889999999999999999999997  56655443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=3.1e-32  Score=255.35  Aligned_cols=196  Identities=20%  Similarity=0.317  Sum_probs=157.9

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||.||                                       |||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            457778889999999998                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCceEEccccCccccCCCCCc
Q 046461          205 VKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL---NEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       205 ~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl---~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ++|+|.+++..     ......++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||+++.....   
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---  162 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---  162 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence            99999999864     234678999999999999998   99999999999999   78899999999998764322   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      ......|+..|+|||        .++||||+|+++|||++|+.|+...    ....+.+.+.....  ........+..+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE----TESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            222346899999998        3689999999999999999996432    22222222222221  112223455688


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+|++.||++|||+.|+++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhc
Confidence            99999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=4.2e-32  Score=267.13  Aligned_cols=144  Identities=21%  Similarity=0.257  Sum_probs=125.7

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      ++|...+.||+|+||.||                                            +||+++++++...+..++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            457788999999999999                                            499999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--eEEccccCcccc
Q 046461          200 VYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE--VKVSDFGLVRLI  270 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~--~kl~Dfgla~~~  270 (383)
                      ||||++ |+|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++..
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            999995 6999998743       24578999999999999999   9999999999999999887  999999999765


Q ss_pred             CCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          271 SDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      ...    .....||+.|+|||        .++|||||||++|||++|+.|+..
T Consensus       253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            332    23357899999998        578999999999999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.3e-32  Score=265.00  Aligned_cols=200  Identities=21%  Similarity=0.268  Sum_probs=151.8

Q ss_pred             HHHhhCccccCeeecCCccccc-----------------------------------cccceeeeEEEeC----------
Q 046461          160 VAGTNKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVG----------  194 (383)
Q Consensus       160 ~~~t~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~----------  194 (383)
                      ....++|...+.||+|+||.||                                   +|||++++++...          
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            3456788889999999999999                                   7999999998543          


Q ss_pred             ----------------------------CEEEEEEEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcC
Q 046461          195 ----------------------------EKKLIVYEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRF  237 (383)
Q Consensus       195 ----------------------------~~~~lv~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~  237 (383)
                                                  ...++||||++ |+|.+.+...         .....++.|++.||+|||+. 
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-  160 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-  160 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence                                        34889999998 5888877631         23577899999999999998 


Q ss_pred             CCCeeecCCCCCcEEEc-CCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHH
Q 046461          238 QPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELV  307 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Ell  307 (383)
                        +|+||||||+||+++ .++.+||+|||+++......  ......||..|+|||         .++||||+||++|||+
T Consensus       161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence              999999999999998 68899999999998764432  223456889999988         4679999999999999


Q ss_pred             hCCCCCCCCCCCCCCCccceeee---------------------------cCcccccCChhHHHHHHHHHHHccccCCCC
Q 046461          308 IRKQPTGPEFKDKNGGNLVDWVL---------------------------DSTILNAYSKPSMLKMLQIVVGCIFDNPTT  360 (383)
Q Consensus       308 tg~~p~~~~~~~~~~~~~~~~v~---------------------------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~  360 (383)
                      +|+.||...    +..+....+.                           ........+...+..+.+++.+||+.||++
T Consensus       237 ~g~~pf~~~----~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          237 LGKPLFSGE----TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             hCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            999997532    1111111110                           000011122334567899999999999999


Q ss_pred             CCCHHHHHH
Q 046461          361 RPTMLRVQE  369 (383)
Q Consensus       361 RPs~~~v~~  369 (383)
                      |||+.|+++
T Consensus       313 R~t~~e~l~  321 (383)
T 3eb0_A          313 RINPYEAMA  321 (383)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhc
Confidence            999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=7.8e-32  Score=251.48  Aligned_cols=179  Identities=23%  Similarity=0.321  Sum_probs=144.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      |||+++++++.+++..++||||+++|+|.+++...     .....++.|++.||+|||+.   +++|+||||+||+++.+
T Consensus        84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  160 (298)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             CCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence            79999999999999999999999999999999743     35678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +.+||+|||+++......  ......|+..|+|||              .++||||||++++||++|+.|+...    ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~  234 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQ  234 (298)
T ss_dssp             CCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SH
T ss_pred             CcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc----cH
Confidence            999999999998765432  223456899999997              3679999999999999999996432    22


Q ss_pred             CccceeeecCcccc--cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTILN--AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+.......  ......+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22222222222111  112345567899999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=6.7e-32  Score=255.73  Aligned_cols=206  Identities=14%  Similarity=0.248  Sum_probs=157.6

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEe--CCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPV--GEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~--~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||.||                                     +||+++++++.+  ....++||||+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            567788999999999999                                     699999999988  66789999999


Q ss_pred             cCCCHHHHHhcc--hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccccCCCCCcccccc
Q 046461          205 VKGSLNDWLRNQ--AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       205 ~~gsL~~~l~~~--~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      ++++|.+++...  .....++.|++.||+|||+.   +++||||||+||+++.++ .+||+|||+++......  .....
T Consensus       116 ~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~  190 (330)
T 3nsz_A          116 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVR  190 (330)
T ss_dssp             CCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSC
T ss_pred             CchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccccc
Confidence            999999998753  45678999999999999998   999999999999999776 89999999998765432  22335


Q ss_pred             ccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC----------Cccceee------ec-----
Q 046461          282 AGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG----------GNLVDWV------LD-----  331 (383)
Q Consensus       282 ~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~----------~~~~~~v------~~-----  331 (383)
                      .|+..|+|||         .++||||+||++|||++|+.|+.......+.          ....+++      .+     
T Consensus       191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (330)
T 3nsz_A          191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND  270 (330)
T ss_dssp             CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHH
T ss_pred             cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhh
Confidence            6888999987         4689999999999999999997432110000          0000000      00     


Q ss_pred             -----------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          332 -----------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       332 -----------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                                 ..............+.+++.+|++.||++|||++|+++  .++.+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                       00001111224567899999999999999999999987  44443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=7.7e-32  Score=253.54  Aligned_cols=199  Identities=24%  Similarity=0.356  Sum_probs=153.6

Q ss_pred             hhCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          163 TNKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .+.|...+.||+|+||.||                                     +||+++++++.+.+..++||||++
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            4568888999999999999                                     799999999999999999999999


Q ss_pred             CCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          206 KGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       206 ~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      +|+|.+++..      ......++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||.++...... ....
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  183 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRN  183 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccC
Confidence            9999999862      234678999999999999998   99999999999999999999999999998765432 2223


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc-cccCChhHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI-LNAYSKPSMLKMLQIV  350 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~-~~~~~~~~~~~~~~l~  350 (383)
                      ...|+..|+|||        .++||||||+++|||++|+.|+...    ........+..... ....+......+.+++
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  259 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI----HPMRAIFMIPTNPPPTFRKPELWSDNFTDFV  259 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence            457899999988        5789999999999999999997432    11111111111000 0011223356788999


Q ss_pred             HHccccCCCCCCCHHHHHH
Q 046461          351 VGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       351 ~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+||+.||++|||+.++++
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.9e-32  Score=260.60  Aligned_cols=200  Identities=20%  Similarity=0.342  Sum_probs=152.3

Q ss_pred             HHhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCE
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ...++|...+.||+|+||.||                                            +||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            344667788888999998888                                            799999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .++||||+++ +|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999975 899988743      34678999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----------
Q 046461          271 SDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----------  331 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----------  331 (383)
                      .... .......||..|+|||         .++|||||||++|||++|..|+...    +..+....+..          
T Consensus       163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~----~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCTTTS
T ss_pred             cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHHcCCCChhhh
Confidence            4332 2233457899999998         3579999999999999999886432    11111111100          


Q ss_pred             ------------Ccccc----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ------------STILN----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ------------~~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                  .....    .........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                        00000    001223467899999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=6e-32  Score=256.01  Aligned_cols=198  Identities=23%  Similarity=0.316  Sum_probs=140.3

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         |||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            567778899999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhc----------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          203 YMVKGSLNDWLRN----------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       203 ~~~~gsL~~~l~~----------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      |+++ +|.+++..          ......++.|++.||.|||+..  +++||||||+||+++.++.+||+|||+++....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            9975 88887752          1235678999999999999852  799999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc---cccc
Q 046461          273 CESHTSTDVAGTIGYILLA------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST---ILNA  337 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~---~~~~  337 (383)
                      ..  ......||..|+|||            .++||||||+++|||++|+.|+.....   ..+....+....   +...
T Consensus       179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS---VFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred             cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch---HHHHHHHHhcCCCCCCCCc
Confidence            22  222346899999998            257999999999999999999753211   111111121111   1111


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ........+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            12335567899999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=5.7e-32  Score=266.61  Aligned_cols=197  Identities=21%  Similarity=0.351  Sum_probs=147.3

Q ss_pred             cccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEeccCCCHH
Q 046461          167 YEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVKGSLN  210 (383)
Q Consensus       167 ~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~gsL~  210 (383)
                      ...++||+|+||+||                                    ||||++++++.+++..++||||++ |+|.
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            345789999999986                                    799999999999999999999995 6999


Q ss_pred             HHHhcch------------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-------------CceEEcccc
Q 046461          211 DWLRNQA------------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-------------FEVKVSDFG  265 (383)
Q Consensus       211 ~~l~~~~------------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-------------~~~kl~Dfg  265 (383)
                      +++....            ....++.|++.||+|||+.   +|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            9997432            2356899999999999998   99999999999999754             489999999


Q ss_pred             CccccCCCCCc---cccccccccccccCC---------------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccc
Q 046461          266 LVRLISDCESH---TSTDVAGTIGYILLA---------------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       266 la~~~~~~~~~---~~~~~~gt~~y~ape---------------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~  326 (383)
                      +++........   ......||+.|+|||               .++|||||||++|||++ |+.|+......  ...+.
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~i~  251 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--ESNII  251 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--HHHHH
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--HHHHh
Confidence            99877543321   123457999999998               24899999999999999 89997543221  11111


Q ss_pred             eeeec-CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLD-STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~-~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..... +.............+.+++.+||+.||++|||+.||++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11111 11111123455678999999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=6.3e-32  Score=258.99  Aligned_cols=210  Identities=21%  Similarity=0.291  Sum_probs=149.3

Q ss_pred             HHHHHHhhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCE--
Q 046461          157 DQIVAGTNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEK--  196 (383)
Q Consensus       157 ~~l~~~t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~--  196 (383)
                      .+.....++|...+.||+|+||.||                                      +||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4566777899999999999999999                                      799999999976433  


Q ss_pred             -----EEEEEEeccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHh--hcCCCCeeecCCCCCcEEEcC-CCce
Q 046461          197 -----KLIVYEYMVKGSLNDWLRN---------QAKHCIIACGTARGITFLH--HRFQPHIIHRDINASNILLNE-DFEV  259 (383)
Q Consensus       197 -----~~lv~e~~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH--~~~~~~ivHrdlk~~NiLl~~-~~~~  259 (383)
                           .++||||+++ +|.+.+..         ......++.|++.||.|||  +.   +|+||||||+||+++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                 7899999976 55555432         1235678999999999999  76   9999999999999997 8999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      ||+|||+++......  ......||..|+|||         .++|||||||++|||++|+.||...    +.......+.
T Consensus       172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~----~~~~~~~~~~  245 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD----NSAGQLHEIV  245 (360)
T ss_dssp             EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC----ChHHHHHHHH
Confidence            999999998765432  223456899999988         4679999999999999999997532    1111111110


Q ss_pred             c--------------C----------------cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          331 D--------------S----------------TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       331 ~--------------~----------------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                      .              +                .............+.+++.+||+.||++|||+.|+++  .++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            0              0                0000111224668999999999999999999999987  4555543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=2.5e-32  Score=259.26  Aligned_cols=199  Identities=18%  Similarity=0.273  Sum_probs=148.8

Q ss_pred             HhhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ..++|...+.||+|+||.||                                         +||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            44678888999999999999                                         7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE-----cCCCceEEccccCcccc
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL-----NEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl-----~~~~~~kl~Dfgla~~~  270 (383)
                      |||++ |+|.+++...     .....++.|++.||+|||+.   +|+||||||+||++     +.++.+||+|||+++..
T Consensus       112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99997 5999999743     34678999999999999998   99999999999999     45556999999999876


Q ss_pred             CCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----------
Q 046461          271 SDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----------  331 (383)
Q Consensus       271 ~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----------  331 (383)
                      .... .......||..|+|||         .++|||||||++|||++|+.|+....    ..+....+..          
T Consensus       188 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          188 GIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS----EIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTS
T ss_pred             CCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC----HHHHHHHHHHHhCCCchhhh
Confidence            4322 2233456799999988         46799999999999999999975321    1111110000          


Q ss_pred             ------------------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ------------------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ------------------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                        ..+...........+.+++.+|++.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                              00000001113457889999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1e-31  Score=256.93  Aligned_cols=198  Identities=20%  Similarity=0.300  Sum_probs=151.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--------C
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--------G  194 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--------~  194 (383)
                      ++|...+.||+|+||.||                                         +||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            567888999999999998                                         799999999987        4


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      +..++||||+++ +|.+.+...      .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 788777642      34678999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCC---CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee------
Q 046461          269 LISDCE---SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL------  330 (383)
Q Consensus       269 ~~~~~~---~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~------  330 (383)
                      ......   ........||+.|+|||         .++|||||||++|||++|+.|+....    ..+....+.      
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLCGSI  248 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Confidence            765322   12233457899999998         46799999999999999999975321    111110000      


Q ss_pred             cCc---------------cccc---CChh------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 DST---------------ILNA---YSKP------SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 ~~~---------------~~~~---~~~~------~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.               ....   ....      ....+.+++.+|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000               0000   0000      1345789999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=1.4e-31  Score=250.65  Aligned_cols=201  Identities=21%  Similarity=0.333  Sum_probs=154.5

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEE--eCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCP--VGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~--~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                           +||+++++++.  +.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            567788899999999888                                           79999999985  345789


Q ss_pred             EEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          199 IVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      +||||+++| |.+++...       .....++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++...
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            999999876 77777532       24577899999999999998   99999999999999999999999999998764


Q ss_pred             CCC-CccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCCh
Q 046461          272 DCE-SHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK  340 (383)
Q Consensus       272 ~~~-~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~  340 (383)
                      ... ........|+..|++||          .++||||||+++|||++|+.|+...    +..+..+.+.....  ..+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~i~~~~~--~~~~  234 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSY--AIPG  234 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCC--CCCS
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc----hHHHHHHHHhcCCC--CCCC
Confidence            322 22223456899999988          2589999999999999999996432    22222222222211  1223


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      .....+.+++.+||+.||++|||+.|+++  .+++.
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            44567889999999999999999999996  44443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=3.5e-32  Score=258.23  Aligned_cols=198  Identities=20%  Similarity=0.298  Sum_probs=150.5

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         +||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            456777899999999998                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+++++|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... ..
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  180 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV  180 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence            9999999988753     235678999999999999999   99999999999999999999999999998654322 12


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee-------------------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV-------------------  329 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v-------------------  329 (383)
                      .....|+..|+|||         .++||||+||++|||++|+.|+....    ..+....+                   
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS----DIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            23356899999988         45799999999999999999975321    11111000                   


Q ss_pred             -----ecCccccc-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 -----LDSTILNA-----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 -----~~~~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                           ..+.....     ........+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00000000     01133567899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=2.1e-32  Score=255.88  Aligned_cols=199  Identities=21%  Similarity=0.315  Sum_probs=152.7

Q ss_pred             hhCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          163 TNKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      .+.|...+.||+|+||.||                                       |||+++++++.+++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            3567777899999999999                                       7999999999999999999999


Q ss_pred             ccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          204 MVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      +++|+|.+++..      ......++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  173 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK  173 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence            999999999864      234678999999999999998   99999999999999999999999999975432110 11


Q ss_pred             ccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc-cCChhHH
Q 046461          278 STDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN-AYSKPSM  343 (383)
Q Consensus       278 ~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~-~~~~~~~  343 (383)
                      .....|+..|+|||             .++||||||+++|||++|+.|+...    +.......+....... ..+....
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIAKSDPPTLLTPSKWS  249 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC----CHHHHHHHHhccCCcccCCccccC
Confidence            12346889999987             3689999999999999999996432    1111111111111111 1123345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            67889999999999999999999976

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=5.7e-32  Score=268.74  Aligned_cols=197  Identities=22%  Similarity=0.273  Sum_probs=147.1

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC------C
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG------E  195 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~------~  195 (383)
                      .++|...+.||+|+||.||                                         ||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            3568888999999999998                                         7999999999654      4


Q ss_pred             EEEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          196 KKLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ..++||||+++ +|.+.+..   ......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            67999999976 57666653   345677999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec-------------
Q 046461          273 CESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD-------------  331 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~-------------  331 (383)
                      .  ...+...||+.|+|||        .++||||+||++|||++|+.||...    +..+....+..             
T Consensus       217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~----~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCHHHHHHc
Confidence            2  2234467999999998        5799999999999999999997432    11111111100             


Q ss_pred             -----------Cc-----ccccCC-----------hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 -----------ST-----ILNAYS-----------KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 -----------~~-----~~~~~~-----------~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                 +.     +...++           ......+.+++.+|+..||++|||++|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       00     000000           112567899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=263.83  Aligned_cols=199  Identities=22%  Similarity=0.349  Sum_probs=150.0

Q ss_pred             HhhCccccCeeecCCccccc------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          162 GTNKFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      +..+|...++||+|+||.|+                                    ||||++++++.+.+..++||||++
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            44568888999999999865                                    799999999999999999999996


Q ss_pred             CCCHHHHHhcch------hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCceEEccccCccccCCCC
Q 046461          206 KGSLNDWLRNQA------KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-----DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       206 ~gsL~~~l~~~~------~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-----~~~~kl~Dfgla~~~~~~~  274 (383)
                       |+|.+++....      ....++.|++.||+|||+.   +|+||||||+||+++.     ...+||+|||+++......
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence             69999997532      4578999999999999998   9999999999999943     3468899999998765432


Q ss_pred             C--ccccccccccccccCC-----------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecC-ccc-ccC
Q 046461          275 S--HTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDS-TIL-NAY  338 (383)
Q Consensus       275 ~--~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~-~~~-~~~  338 (383)
                      .  .......||+.|+|||           .++|||||||++|||++ |..|+.....     ......... ... ...
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~  252 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQANILLGACSLDCLHP  252 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHHHHTTCCCCTTSCT
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHHHHhccCCccccCc
Confidence            1  2233467999999998           25799999999999999 8888643211     111111110 010 011


Q ss_pred             ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          339 SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       339 ~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .......+.+++.+||+.||++|||+.||++
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            2334556789999999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=3.9e-32  Score=264.45  Aligned_cols=203  Identities=20%  Similarity=0.277  Sum_probs=152.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------cccceeeeEEEeCC------EEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------KNIVQLLGYCPVGE------KKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------~niv~l~g~~~~~~------~~~lv~e~  203 (383)
                      .+|...++||+|+||.||                                  +||+++++++...+      ..++||||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~  119 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY  119 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence            357788999999999999                                  79999999996543      37899999


Q ss_pred             ccCCCHHHHHhc---------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCceEEccccCccccCCC
Q 046461          204 MVKGSLNDWLRN---------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       204 ~~~gsL~~~l~~---------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~~~~~kl~Dfgla~~~~~~  273 (383)
                      ++++ +.+.+..         ......++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|||+++.....
T Consensus       120 ~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          120 VPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             CSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            9875 4433321         123567899999999999998   999999999999999 7999999999999876443


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee--------------
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL--------------  330 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~--------------  330 (383)
                      ..  .....||..|+|||         .++||||+||++|||++|+.||...    +..+....+.              
T Consensus       196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE----SGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhh
Confidence            22  23457899999998         4679999999999999999997532    1111111100              


Q ss_pred             -------------cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          331 -------------DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       331 -------------~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                                   .......+.......+.+++.+||+.||++|||+.|+++  .+++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                         000001112234567899999999999999999999987  3555443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.3e-31  Score=258.25  Aligned_cols=200  Identities=19%  Similarity=0.316  Sum_probs=150.5

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC------E
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE------K  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~------~  196 (383)
                      +.|...+.||+|+||.||                                         +||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            467778889999999998                                         79999999997653      4


Q ss_pred             EEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      .++||||+ +++|.+++...    .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            59999999 88999998742    34677899999999999998   999999999999999999999999999987543


Q ss_pred             CCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec------------
Q 046461          273 CESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD------------  331 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~------------  331 (383)
                          ..+...+|..|+|||         .++||||+||+++||++|+.||...    +..+....+..            
T Consensus       181 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          181 ----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS----DHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             ----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCCHHHHHH
Confidence                233457899999998         4689999999999999999997532    21111111100            


Q ss_pred             -------------Ccc----cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          332 -------------STI----LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       332 -------------~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                                   +..    ...........+.+++.+|+..||++|||+.|+++  .++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                         000    00111233567889999999999999999999987  455543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=2.4e-31  Score=251.99  Aligned_cols=201  Identities=17%  Similarity=0.284  Sum_probs=156.1

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                             ++++++++++.+.+..+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            467777889999999988                                             25899999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----------------
Q 046461          199 IVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE----------------  255 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~----------------  255 (383)
                      +||||+ +++|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.                
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            999999 89999999743       24578999999999999998   9999999999999987                


Q ss_pred             ---CCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          256 ---DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                         ++.+||+|||+++.....    .....||..|+|||        .++|||||||++|||++|+.|+....    ..+
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~  241 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD----SKE  241 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC----HHH
T ss_pred             cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----hHH
Confidence               668999999999865432    23457899999998        57899999999999999999975321    111


Q ss_pred             cceee---ec------------------C-------------------cc--cccCChhHHHHHHHHHHHccccCCCCCC
Q 046461          325 LVDWV---LD------------------S-------------------TI--LNAYSKPSMLKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       325 ~~~~v---~~------------------~-------------------~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RP  362 (383)
                      ....+   ..                  .                   ..  ...........+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            00000   00                  0                   00  0011234467889999999999999999


Q ss_pred             CHHHHHH--HHhcccc
Q 046461          363 TMLRVQE--FLEKYHT  376 (383)
Q Consensus       363 s~~~v~~--~L~~~~~  376 (383)
                      |+.|+++  .++++++
T Consensus       322 t~~ell~hp~f~~~~~  337 (339)
T 1z57_A          322 TLREALKHPFFDLLKK  337 (339)
T ss_dssp             CHHHHTTSGGGGGGGC
T ss_pred             CHHHHhcCHHHHHHhc
Confidence            9999986  4555543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=2.4e-31  Score=263.72  Aligned_cols=144  Identities=23%  Similarity=0.367  Sum_probs=111.8

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC-----CEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG-----EKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~-----~~~  197 (383)
                      ++|...+.||+|+||.||                                         +|||++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            578888999999999999                                         7999999999543     578


Q ss_pred             EEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ++||||+ +|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            9999998 57999998753     34678999999999999998   999999999999999999999999999987643


Q ss_pred             CCC--------------------------ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCC
Q 046461          273 CES--------------------------HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQ  311 (383)
Q Consensus       273 ~~~--------------------------~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~  311 (383)
                      ...                          ...+...||..|+|||         .++|||||||++|||++|..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            211                          1223457899999998         45799999999999999533

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=7.1e-32  Score=255.04  Aligned_cols=179  Identities=22%  Similarity=0.298  Sum_probs=137.6

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      +||+++++++..++ .++||||+++|+|.+++...     .....++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        75 ~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~  150 (322)
T 2ycf_A           75 PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ  150 (322)
T ss_dssp             TTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSS
T ss_pred             CCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecC
Confidence            79999999987655 89999999999999998643     34577899999999999998   99999999999999876


Q ss_pred             Cc---eEEccccCccccCCCCCccccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC
Q 046461          257 FE---VKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG  322 (383)
Q Consensus       257 ~~---~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~  322 (383)
                      +.   +||+|||+++.....  .......||..|+|||           .++|||||||++|||++|+.|+.....   .
T Consensus       151 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~  225 (322)
T 2ycf_A          151 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---Q  225 (322)
T ss_dssp             SSSCCEEECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC---S
T ss_pred             CCCCeEEEccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---H
Confidence            54   999999999876432  1222356899999988           368999999999999999999753211   1


Q ss_pred             CccceeeecCccc--ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          323 GNLVDWVLDSTIL--NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       323 ~~~~~~v~~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ..+.+.+......  ..........+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1222222222111  0001223567889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=1e-31  Score=250.58  Aligned_cols=198  Identities=22%  Similarity=0.360  Sum_probs=148.0

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEe-----------
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPV-----------  193 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~-----------  193 (383)
                      .++|...+.||+|+||.||                                      |||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            4567888999999999998                                      799999998865           


Q ss_pred             --CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          194 --GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       194 --~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                        .+..++||||+++|+|.+++...      .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence              35679999999999999999742      24567899999999999998   99999999999999999999999999


Q ss_pred             CccccCCCC-------------CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          266 LVRLISDCE-------------SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       266 la~~~~~~~-------------~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++......             ........|+..|+|||         .++||||||+++|||++   |+....   +..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~  235 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERV  235 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHH
Confidence            998654221             11223356889999987         46799999999999998   432111   111


Q ss_pred             ccceeeec--CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          324 NLVDWVLD--STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       324 ~~~~~v~~--~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +..+.+..  ..............+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11111111  11222334455567889999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=3.8e-31  Score=256.26  Aligned_cols=148  Identities=22%  Similarity=0.253  Sum_probs=126.0

Q ss_pred             HhhCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEE
Q 046461          162 GTNKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       162 ~t~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ..++|...+.||+|+||.||                                            ++++++++++...+..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            35688888999999999999                                            2599999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCceEEccccCcc
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN--EDFEVKVSDFGLVR  268 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~--~~~~~kl~Dfgla~  268 (383)
                      ++||||++ |+|.+++...       .....++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            99999995 5999999743       24578999999999999952 23899999999999994  57889999999998


Q ss_pred             ccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCC
Q 046461          269 LISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGP  315 (383)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~  315 (383)
                      .....    .....||..|+|||        .++|||||||++|||++|+.||..
T Consensus       210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            76432    23457899999998        578999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=1.3e-31  Score=257.77  Aligned_cols=199  Identities=22%  Similarity=0.337  Sum_probs=155.1

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeC-----CEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVG-----EKK  197 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~-----~~~  197 (383)
                      .++|...+.||+|+||.||                                        +||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4578888999999999999                                        7999999999764     368


Q ss_pred             EEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ++||||++ |+|.+++...    .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            99999997 5999998743    35678999999999999998   9999999999999999999999999999876432


Q ss_pred             CCc--cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----C------
Q 046461          274 ESH--TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----S------  332 (383)
Q Consensus       274 ~~~--~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----~------  332 (383)
                      ...  ......||+.|+|||         .++||||+||++|||++|+.|+...    +..+....+..    +      
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK----HYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS----SGGGHHHHHHHHHCSCCHHHHH
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHH
Confidence            211  123457999999998         4579999999999999999996432    22222111110    0      


Q ss_pred             ------------ccc--c-----cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          333 ------------TIL--N-----AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       333 ------------~~~--~-----~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                  ...  .     .........+.+++.+|++.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                        000  0     001223457889999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=3.1e-31  Score=261.13  Aligned_cols=209  Identities=22%  Similarity=0.276  Sum_probs=153.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC-----CEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG-----EKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~-----~~~  197 (383)
                      ++|...+.||+|+||.||                                         +||+++++++...     +..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            578888999999999999                                         7999999999775     578


Q ss_pred             EEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ++||||++ |+|.++++..     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            99999996 6999999753     34678999999999999999   999999999999999999999999999987643


Q ss_pred             CCC---------------------ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCC------
Q 046461          273 CES---------------------HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPE------  316 (383)
Q Consensus       273 ~~~---------------------~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~------  316 (383)
                      ...                     ...+...||..|+|||         .++||||+||++|||++|..|+...      
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            221                     1224567899999998         4679999999999999876664321      


Q ss_pred             -CCCCCCC-----------------ccceee------------------------ecCccccc-----CChhHHHHHHHH
Q 046461          317 -FKDKNGG-----------------NLVDWV------------------------LDSTILNA-----YSKPSMLKMLQI  349 (383)
Q Consensus       317 -~~~~~~~-----------------~~~~~v------------------------~~~~~~~~-----~~~~~~~~~~~l  349 (383)
                       |.+.+..                 +....+                        ........     ........+.++
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence             1111100                 000000                        00000000     001235678899


Q ss_pred             HHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          350 VVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                      +.+||+.||++|||++|+++  .++++..
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999997  5665543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=1.5e-31  Score=258.10  Aligned_cols=196  Identities=22%  Similarity=0.257  Sum_probs=144.2

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC------E
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE------K  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~------~  196 (383)
                      ++|...+.||+|+||.||                                         |||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            567888999999999998                                         79999999997654      7


Q ss_pred             EEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          197 KLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      .++||||++ |+|.+++..   ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       105 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             eEEEEEcCC-CCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            899999997 578888863   345677999999999999998   9999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec--------------
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--------------  331 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~--------------  331 (383)
                        .......||..|+|||        .++||||+||++|||++|+.||...    +..+....+..              
T Consensus       181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT----DHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHhh
Confidence              1223457899999998        5789999999999999999997532    11111100000              


Q ss_pred             ----------Ccc-------------cccC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ----------STI-------------LNAY---SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ----------~~~-------------~~~~---~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                +..             .+..   .......+.+++.+|++.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                      000             0000   0122567899999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=2e-31  Score=251.97  Aligned_cols=189  Identities=20%  Similarity=0.367  Sum_probs=154.3

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCC
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGE  195 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~  195 (383)
                      .++|...+.||+|+||.||                                               +||+++++++.+++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            4567788899999999988                                               58999999999999


Q ss_pred             EEEEEEEeccC-CCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCceEEccccCcc
Q 046461          196 KKLIVYEYMVK-GSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVR  268 (383)
Q Consensus       196 ~~~lv~e~~~~-gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~~~~~kl~Dfgla~  268 (383)
                      ..++|+||+.+ ++|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+++
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999976 8999998742     34677999999999999998   999999999999999 78999999999998


Q ss_pred             ccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCC
Q 046461          269 LISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS  339 (383)
Q Consensus       269 ~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~  339 (383)
                      .....   ......||..|+|||         .++||||||+++|||++|+.|+...      ....    ....  ...
T Consensus       199 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~----~~~~--~~~  263 (320)
T 3a99_A          199 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII----RGQV--FFR  263 (320)
T ss_dssp             ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH----HCCC--CCS
T ss_pred             ccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhh----cccc--ccc
Confidence            76532   223456899999998         3579999999999999999996421      1111    1111  112


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            234457889999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=2.3e-31  Score=251.41  Aligned_cols=205  Identities=22%  Similarity=0.340  Sum_probs=157.0

Q ss_pred             HHhhCccccCeeecCCccccc---------------------------------------------cccceeeeEEE---
Q 046461          161 AGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCP---  192 (383)
Q Consensus       161 ~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~---  192 (383)
                      .+.++|...+.||+|+||.||                                             |||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            345677778888888888888                                             79999999997   


Q ss_pred             --eCCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          193 --VGEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       193 --~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                        .....++||||++ |+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence              4567899999997 6999998642       24577999999999999998   999999999999999999999999


Q ss_pred             ccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec----
Q 046461          264 FGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD----  331 (383)
Q Consensus       264 fgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~----  331 (383)
                      ||+++.....  .......|+..|+|||        .++||||||+++|||++|+.|+....    ..+....+.+    
T Consensus       164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCC
T ss_pred             CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHHcCC
Confidence            9999765432  1233457899999998        56899999999999999999975321    1111111000    


Q ss_pred             ---------------------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          332 ---------------------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       332 ---------------------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                                           ..............+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                                 00001112334567889999999999999999999995  454443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.6e-31  Score=248.51  Aligned_cols=203  Identities=24%  Similarity=0.317  Sum_probs=159.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         +||+++++++.+.+..++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            567788899999999888                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CceEEccccCccccCCCC
Q 046461          203 YMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED---FEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       203 ~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~---~~~kl~Dfgla~~~~~~~  274 (383)
                      |+++++|.+++..     ......++.|++.||+|||+.   +++||||||+||+++.+   +.+||+|||+++......
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            9999999998863     235678999999999999998   99999999999999754   469999999998664332


Q ss_pred             CccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC--ChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--SKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~--~~~~~~~  345 (383)
                        ......|+..|+|||       .++||||||+++|||++|+.|+...    +..+..+.+.........  ....+..
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (287)
T 2wei_A          179 --KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK----NEYDILKRVETGKYAFDLPQWRTISDD  252 (287)
T ss_dssp             --SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred             --ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence              222345888999987       5789999999999999999996432    222233322222221111  1234567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                      +.+++.+||+.||++|||+.|+++  .+++..
T Consensus       253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            889999999999999999999997  555543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=1.6e-31  Score=254.91  Aligned_cols=179  Identities=21%  Similarity=0.269  Sum_probs=141.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHH------Hhc-------chhhhHHHHhHHHHHHHHhh-cCCCCeeecCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDW------LRN-------QAKHCIIACGTARGITFLHH-RFQPHIIHRDIN  247 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~------l~~-------~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk  247 (383)
                      |||+++++++.+.+..++||||+++|+|.++      +..       ......++.|++.||+|||+ .   +++|||||
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~  179 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVK  179 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCC
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCC
Confidence            6899999999999999999999999999998      543       13467899999999999998 7   99999999


Q ss_pred             CCcEEEcCCCceEEccccCccccCCCCCccccccccccccccCC---------C-CCcchhHHHHHHHHHhCCCCCCCCC
Q 046461          248 ASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------C-GGDIYSFSVVLLELVIRKQPTGPEF  317 (383)
Q Consensus       248 ~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~-~~Dv~SfGvil~Elltg~~p~~~~~  317 (383)
                      |+||+++.++.+||+|||.++.....   ......|+..|+|||         . ++||||||+++|||++|+.|+....
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876442   233457899999998         2 7899999999999999999975421


Q ss_pred             CCCCCCccceeeecCccccc-----------------CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          318 KDKNGGNLVDWVLDSTILNA-----------------YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       318 ~~~~~~~~~~~v~~~~~~~~-----------------~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .   ..+..+.+........                 ........+.+++.+||+.||++|||+.|+++
T Consensus       257 ~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 S---LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             C---SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1   1222222211111000                 01334567889999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=4.6e-31  Score=246.99  Aligned_cols=193  Identities=17%  Similarity=0.221  Sum_probs=145.3

Q ss_pred             hCcccc-CeeecCCccccc-----------------------------------cccceeeeEEEe----CCEEEEEEEe
Q 046461          164 NKFYEK-NVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV----GEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~-~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~----~~~~~lv~e~  203 (383)
                      ++|... ++||+|+||.||                                   +||+++++++..    ....++||||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~   96 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   96 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence            345544 779999999999                                   799999999987    6778999999


Q ss_pred             ccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCC
Q 046461          204 MVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       204 ~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~  273 (383)
                      +++|+|.+++...       .....++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||+++.....
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  173 (299)
T 3m2w_A           97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE  173 (299)
T ss_dssp             CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTC
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccccc
Confidence            9999999999743       24578999999999999998   9999999999999998   788999999999765321


Q ss_pred             CCccccccccccccccCCCCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccccc--CChhHHHHHHHHHH
Q 046461          274 ESHTSTDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA--YSKPSMLKMLQIVV  351 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~--~~~~~~~~~~~l~~  351 (383)
                                     .+..++||||+||++|||++|+.|+...............+........  ........+.+++.
T Consensus       174 ---------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (299)
T 3m2w_A          174 ---------------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR  238 (299)
T ss_dssp             ---------------GGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHH
T ss_pred             ---------------cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHH
Confidence                           1235789999999999999999997543211111111111111111000  00234567899999


Q ss_pred             HccccCCCCCCCHHHHHH--HHhcc
Q 046461          352 GCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      +||+.||++|||+.|+++  .+.+.
T Consensus       239 ~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          239 NLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHcccChhhCCCHHHHhcChhhccc
Confidence            999999999999999997  44443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.8e-31  Score=251.24  Aligned_cols=204  Identities=16%  Similarity=0.274  Sum_probs=152.8

Q ss_pred             HHHHHhhCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCC
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGE  195 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~  195 (383)
                      .+....++|...+.||+|+||.||                                          +||+++++++.+++
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            333445667788899999999988                                          58999999999999


Q ss_pred             EEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          196 KKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       196 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      ..++||| +.+++|.+++...     .....++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++..
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999999 5688999999743     34678999999999999998   9999999999999974 89999999999876


Q ss_pred             CCCCCc-cccccccccccccCCC-------------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee
Q 046461          271 SDCESH-TSTDVAGTIGYILLAC-------------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL  330 (383)
Q Consensus       271 ~~~~~~-~~~~~~gt~~y~ape~-------------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~  330 (383)
                      ...... ......|+..|+|||.                   ++||||||+++|||++|+.|+.....   .......+.
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~~  253 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAII  253 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---HHHHHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---HHHHHHHHH
Confidence            443221 2233568999999882                   57999999999999999999753221   111111122


Q ss_pred             cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          331 DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++......+......+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            222222223333567889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=2.7e-31  Score=257.43  Aligned_cols=199  Identities=21%  Similarity=0.290  Sum_probs=151.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEE----e
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCP----V  193 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~----~  193 (383)
                      ++|...+.||+|+||.||                                              +||+++++++.    +
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            568888999999999999                                              35999999987    4


Q ss_pred             CCEEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---------
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF---------  257 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~---------  257 (383)
                      +...++||||+ +|+|.+++...       .....++.|++.||+|||+++  +|+||||||+|||++.++         
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhh
Confidence            56889999999 66777766432       246789999999999999854  799999999999998775         


Q ss_pred             ----------------------------------------ceEEccccCccccCCCCCccccccccccccccCC------
Q 046461          258 ----------------------------------------EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA------  291 (383)
Q Consensus       258 ----------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape------  291 (383)
                                                              .+||+|||+++.....    .....||..|+|||      
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSC
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCC
Confidence                                                    7999999999876432    23457899999998      


Q ss_pred             --CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC--ccceeee------------cC-----------cc----------
Q 046461          292 --CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG--NLVDWVL------------DS-----------TI----------  334 (383)
Q Consensus       292 --~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~--~~~~~v~------------~~-----------~~----------  334 (383)
                        .++|||||||++|||++|+.||..........  +....+.            ..           ..          
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence              57899999999999999999975432110000  0000000            00           00          


Q ss_pred             -------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          335 -------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       335 -------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                             ....+......+.+++.+||+.||++|||++|+++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                   00123455678899999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=6.4e-31  Score=244.91  Aligned_cols=187  Identities=10%  Similarity=0.041  Sum_probs=147.9

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          +||+++++++.+++..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            457778899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc---hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          202 EYMVKGSLNDWLRNQ---AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       202 e~~~~gsL~~~l~~~---~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      ||+++++|.++++..   .+...++.|++.||+|||+.   +|+||||||+||+++.++.+||++++...          
T Consensus       111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~----------  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP----------  177 (286)
T ss_dssp             ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCT----------
T ss_pred             EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccC----------
Confidence            999999999999743   24677899999999999999   99999999999999999999998654421          


Q ss_pred             cccccccccccCCCCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce---eeecCccc--ccCChhHHHHHHHHHHHc
Q 046461          279 TDVAGTIGYILLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD---WVLDSTIL--NAYSKPSMLKMLQIVVGC  353 (383)
Q Consensus       279 ~~~~gt~~y~ape~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~---~v~~~~~~--~~~~~~~~~~~~~l~~~C  353 (383)
                                .+..++|||||||++|||++|+.||....    ..+...   ........  .......+..+.+++.+|
T Consensus       178 ----------~~~~~~Di~slG~il~elltg~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  243 (286)
T 3uqc_A          178 ----------DANPQDDIRGIGASLYALLVNRWPLPEAG----VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS  243 (286)
T ss_dssp             ----------TCCHHHHHHHHHHHHHHHHHSEECSCCCS----BCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred             ----------CCCchhHHHHHHHHHHHHHHCCCCCCcCC----cchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHH
Confidence                      12367899999999999999999975432    111111   11111110  011233456789999999


Q ss_pred             cccCCCCCCCHHHHHHHHhccccCC
Q 046461          354 IFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       354 ~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      |+.||++| |+.|+++.|+++....
T Consensus       244 l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          244 VQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cccCCccC-CHHHHHHHHHHHhccC
Confidence            99999999 9999999999876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.8e-31  Score=256.26  Aligned_cols=211  Identities=19%  Similarity=0.218  Sum_probs=154.9

Q ss_pred             ccHHHHHHHhhCccccCeeecCCccccc-------------------------------------------------ccc
Q 046461          154 LTYDQIVAGTNKFYEKNVIRGDDFGIAF-------------------------------------------------KNI  184 (383)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------------~ni  184 (383)
                      ....++...+++|...+.||+|+||.||                                                 |||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456788888999999999999999998                                                 699


Q ss_pred             ceeeeEEEe-----CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 046461          185 VQLLGYCPV-----GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL  253 (383)
Q Consensus       185 v~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl  253 (383)
                      +++++++..     ....++||||++ |+|.+++...      .....++.|++.||+|||+.   +++||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence            999999854     346899999997 6898888643      34678999999999999999   99999999999999


Q ss_pred             cCCCceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      +.++.+||+|||+++......  ......||..|+|||         .++||||+||++|||++|+.|+....    ..+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----FYN  241 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH
T ss_pred             cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----HHH
Confidence            999999999999997544322  233457889999998         45799999999999999999975421    111


Q ss_pred             cceeeec-----------------------Ccc---c----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHh
Q 046461          325 LVDWVLD-----------------------STI---L----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLE  372 (383)
Q Consensus       325 ~~~~v~~-----------------------~~~---~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~  372 (383)
                      ....+..                       ...   .    ..........+.+++.+|++.||++|||+.|+++  .++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  321 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE  321 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence            1111100                       000   0    0001223456889999999999999999999987  444


Q ss_pred             cc
Q 046461          373 KY  374 (383)
Q Consensus       373 ~~  374 (383)
                      .+
T Consensus       322 ~~  323 (362)
T 3pg1_A          322 SL  323 (362)
T ss_dssp             TT
T ss_pred             hc
Confidence            44

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=2e-31  Score=261.55  Aligned_cols=201  Identities=21%  Similarity=0.315  Sum_probs=150.1

Q ss_pred             CccccCeeecCCccccc-----------------------------------cccceeeeEEEeC----C--EEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVG----E--KKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~----~--~~~lv~e~  203 (383)
                      .|...++||+|+||.||                                   +|||++++++...    +  ..++||||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            57778999999999999                                   7999999998642    2  36799999


Q ss_pred             ccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CceEEccccCccccCCC
Q 046461          204 MVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDC  273 (383)
Q Consensus       204 ~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-~~~kl~Dfgla~~~~~~  273 (383)
                      +++ ++.+.+...         .....++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            975 677666421         23567899999999999998   99999999999999965 56899999999876443


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee--------------
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL--------------  330 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~--------------  330 (383)
                      ..  .....||..|+|||         .++|||||||++|||++|+.||...    +..+....+.              
T Consensus       211 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~----~~~~~l~~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          211 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIREM  284 (420)
T ss_dssp             CC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             CC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhh
Confidence            22  23457899999998         4579999999999999999997532    1111111110              


Q ss_pred             c--------Cccc-----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          331 D--------STIL-----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       331 ~--------~~~~-----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                      .        +.+.     ..+.......+.+++.+||+.||++|||+.|+++  .++++.
T Consensus       285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence            0        0000     0012233567899999999999999999999986  455443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=5e-31  Score=257.42  Aligned_cols=184  Identities=20%  Similarity=0.259  Sum_probs=128.7

Q ss_pred             cccceeeeEEEe--CCEEEEEEEeccCCCHHHHHhcc--------------hhhhHHHHhHHHHHHHHhhcCCCCeeecC
Q 046461          182 KNIVQLLGYCPV--GEKKLIVYEYMVKGSLNDWLRNQ--------------AKHCIIACGTARGITFLHHRFQPHIIHRD  245 (383)
Q Consensus       182 ~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrd  245 (383)
                      ||||++++++..  ....++||||++ |+|.+++...              .....++.|++.||+|||+.   +|+|||
T Consensus        78 pniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~D  153 (405)
T 3rgf_A           78 PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRD  153 (405)
T ss_dssp             TTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCC
T ss_pred             CCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCC
Confidence            799999999965  678999999996 5888887521              23567899999999999999   999999


Q ss_pred             CCCCcEEE----cCCCceEEccccCccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCC
Q 046461          246 INASNILL----NEDFEVKVSDFGLVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRK  310 (383)
Q Consensus       246 lk~~NiLl----~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~  310 (383)
                      |||+|||+    +.++.+||+|||+++.......  .......||+.|+|||         .++|||||||++|||++|+
T Consensus       154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  233 (405)
T 3rgf_A          154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  233 (405)
T ss_dssp             CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence            99999999    6788999999999987643221  2233467899999998         3579999999999999999


Q ss_pred             CCCCCCCCCCCC-----Cccceeee----------------------------cCcccc--------cCChhHHHHHHHH
Q 046461          311 QPTGPEFKDKNG-----GNLVDWVL----------------------------DSTILN--------AYSKPSMLKMLQI  349 (383)
Q Consensus       311 ~p~~~~~~~~~~-----~~~~~~v~----------------------------~~~~~~--------~~~~~~~~~~~~l  349 (383)
                      .||.....+...     .+....+.                            ......        .........+.++
T Consensus       234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L  313 (405)
T 3rgf_A          234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL  313 (405)
T ss_dssp             CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred             CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence            997532211000     00000000                            000000        0000113467899


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 046461          350 VVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+|++.||++|||++|+++
T Consensus       314 l~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          314 LQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHccCCcccCCCHHHHhc
Confidence            99999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.4e-31  Score=247.66  Aligned_cols=193  Identities=21%  Similarity=0.359  Sum_probs=150.0

Q ss_pred             HHHHhhCccccCeeecCCccccc-------------------------------------------------cccceeee
Q 046461          159 IVAGTNKFYEKNVIRGDDFGIAF-------------------------------------------------KNIVQLLG  189 (383)
Q Consensus       159 l~~~t~~f~~~~~lg~g~~g~v~-------------------------------------------------~niv~l~g  189 (383)
                      .....++|...+.||+|+||.||                                                 +||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34445678888999999999888                                                 68999999


Q ss_pred             EEEeCCEEEEEEEe-ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCceEEc
Q 046461          190 YCPVGEKKLIVYEY-MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVS  262 (383)
Q Consensus       190 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~~~~~kl~  262 (383)
                      ++.+.+..++|+|| +++++|.+++...     .....++.|++.||+|||+.   +++||||||+||+++ .++.+||+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence            99999999999999 8899999999742     34678999999999999999   999999999999999 78999999


Q ss_pred             cccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc
Q 046461          263 DFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST  333 (383)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~  333 (383)
                      |||+++......   .....|+..|++||         .++||||||+++|||++|+.|+...      .+.    ....
T Consensus       183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~----~~~~  249 (312)
T 2iwi_A          183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEI----LEAE  249 (312)
T ss_dssp             CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH----HHTC
T ss_pred             EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHH----hhhc
Confidence            999998765422   23456899999998         3689999999999999999996421      111    1111


Q ss_pred             ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          334 ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       334 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .  ..+......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 L--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             C--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1  122344557889999999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=4.4e-31  Score=248.52  Aligned_cols=197  Identities=21%  Similarity=0.291  Sum_probs=138.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         +||+++++++.+++..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            456777889999999988                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          203 YMVKGSLNDWLRN------QAKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       203 ~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |+ ++.+..+...      ......++.|++.||+|||+ .   +++||||||+||+++.++.+||+|||+++...... 
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            99 5555555542      23457899999999999998 5   89999999999999999999999999997654322 


Q ss_pred             ccccccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc-cCChh
Q 046461          276 HTSTDVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN-AYSKP  341 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~-~~~~~  341 (383)
                       ......|+..|+|||             .++||||||+++|||++|+.|+....   ...+....+....... .....
T Consensus       180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK---TDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC---SHHHHHHHHHHSCCCCCCSSSC
T ss_pred             -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccHHHHHHHhccCCCCCCccCC
Confidence             223356889999988             25799999999999999999975321   1112222221111110 11123


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            4567889999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=3e-31  Score=253.55  Aligned_cols=208  Identities=22%  Similarity=0.347  Sum_probs=154.2

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeC-----CEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVG-----EKK  197 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~-----~~~  197 (383)
                      .++|...+.||+|+||.||                                        +||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            3577888999999999998                                        7999999988764     678


Q ss_pred             EEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          198 LIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ++||||++ |+|.+++..    ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            99999997 699999864    235678999999999999998   9999999999999999999999999999876432


Q ss_pred             CCc---------cccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCC------------CCC
Q 046461          274 ESH---------TSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDK------------NGG  323 (383)
Q Consensus       274 ~~~---------~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~------------~~~  323 (383)
                      ...         ......||..|+|||         .++|||||||++|||++|+.|+.......            ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            211         122356899999998         35799999999999999999975321000            000


Q ss_pred             ccceeeecC-------cc---c----ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          324 NLVDWVLDS-------TI---L----NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       324 ~~~~~v~~~-------~~---~----~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      .....+...       .+   .    ..........+.+++.+||+.||++|||+.|+++  .++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            000000000       00   0    0001234567889999999999999999999987  45544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=3.8e-31  Score=255.32  Aligned_cols=199  Identities=19%  Similarity=0.283  Sum_probs=151.2

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEE-----
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKK-----  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~-----  197 (383)
                      ++|...+.||+|+||.||                                         |||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            567778899999999999                                         7999999999876654     


Q ss_pred             -EEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          198 -LIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       198 -~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                       ++||||++ |+|.+++..   ......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       122 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             EEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence             99999997 689988863   345678999999999999998   9999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec-------------
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD-------------  331 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~-------------  331 (383)
                          .....||..|+|||         .++|||||||+++||++|+.|+...    +..+....+..             
T Consensus       198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCCcHHHHHHh
Confidence                23456899999987         4689999999999999999997532    11111111100             


Q ss_pred             ---------Ccccc-------cCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          332 ---------STILN-------AYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       332 ---------~~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                               ..+..       .........+.+++.+|++.||++|||+.|+++  .++.+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                     00000       001123567899999999999999999999986  44443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=4.9e-31  Score=248.05  Aligned_cols=202  Identities=19%  Similarity=0.301  Sum_probs=145.5

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEE------------
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCP------------  192 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~------------  192 (383)
                      ++|...+.||+|+||.||                                       |||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            456677888999998888                                       79999999873            


Q ss_pred             --eCCEEEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCceEEcccc
Q 046461          193 --VGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFG  265 (383)
Q Consensus       193 --~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~-~~~~~kl~Dfg  265 (383)
                        +.+..++||||++ |+|.+++...    .....++.|++.||+|||+.   +++||||||+||+++ .++.+||+|||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence              3468899999997 6999999742    34677999999999999998   999999999999997 56799999999


Q ss_pred             CccccCCCCC--ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC--
Q 046461          266 LVRLISDCES--HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS--  332 (383)
Q Consensus       266 la~~~~~~~~--~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~--  332 (383)
                      +++.......  .......++..|+|||         .++||||||+++|||++|+.|+...    ...+..+.+...  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA----HELEQMQLILESIP  242 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHSC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcC
Confidence            9987643211  1222345788899988         3579999999999999999997532    111111111000  


Q ss_pred             --------------------ccc------ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhc
Q 046461          333 --------------------TIL------NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEK  373 (383)
Q Consensus       333 --------------------~~~------~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~  373 (383)
                                          ...      ..........+.+++.+||+.||++|||+.|+++  .++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence                                000      0001224567889999999999999999999986  4543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=3.2e-30  Score=246.02  Aligned_cols=199  Identities=16%  Similarity=0.237  Sum_probs=152.8

Q ss_pred             hCccccCeeecCCccccc---------------------------------------c------ccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------K------NIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~------niv~l~g~~~~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                       +      +++.+.+++...+..+
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            567788899999999998                                       1      2899999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEE------------------
Q 046461          199 IVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILL------------------  253 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl------------------  253 (383)
                      +||||+ +|++.+++...       .....++.|++.||+|||+.   +|+||||||+||++                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 67777777532       24678999999999999998   99999999999999                  


Q ss_pred             -cCCCceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          254 -NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       254 -~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                       +.++.+||+|||+++.....    .....||..|+|||        .++|||||||++|||++|+.|+....    ..+
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~~  246 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE----NRE  246 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH
T ss_pred             ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHH
Confidence             56789999999999864332    23457899999998        56899999999999999999975321    111


Q ss_pred             cceee---------------------ecCcc---------------------cccCChhHHHHHHHHHHHccccCCCCCC
Q 046461          325 LVDWV---------------------LDSTI---------------------LNAYSKPSMLKMLQIVVGCIFDNPTTRP  362 (383)
Q Consensus       325 ~~~~v---------------------~~~~~---------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RP  362 (383)
                      ....+                     .....                     ...........+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            00000                     00000                     0011223456788999999999999999


Q ss_pred             CHHHHHH--HHhcc
Q 046461          363 TMLRVQE--FLEKY  374 (383)
Q Consensus       363 s~~~v~~--~L~~~  374 (383)
                      |+.|+++  .++++
T Consensus       327 t~~e~l~hp~f~~~  340 (355)
T 2eu9_A          327 TLAEALLHPFFAGL  340 (355)
T ss_dssp             CHHHHTTSGGGGGC
T ss_pred             CHHHHhcChhhcCC
Confidence            9999985  44443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=2.4e-31  Score=256.51  Aligned_cols=194  Identities=21%  Similarity=0.310  Sum_probs=135.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC------CE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG------EK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~------~~  196 (383)
                      ++|...+.||+|+||.||                                         +||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            567888899999999998                                         7999999998754      56


Q ss_pred             EEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      .++|+||+ +++|.+++...    .....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            79999999 78999988642    34678999999999999998   999999999999999999999999999986543


Q ss_pred             CCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec------------
Q 046461          273 CESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD------------  331 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~------------  331 (383)
                      .    .+...||..|+|||         .++||||+||+++||++|+.||...    +..+....+.+            
T Consensus       185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHH
Confidence            2    23457899999988         4689999999999999999997432    21111111100            


Q ss_pred             ---C-------cccc--c-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          332 ---S-------TILN--A-----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       332 ---~-------~~~~--~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                         .       .+..  .     ........+.+++.+|++.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence               0       0000  0     00122456889999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=8.4e-31  Score=250.95  Aligned_cols=198  Identities=19%  Similarity=0.279  Sum_probs=151.0

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCE------
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEK------  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~------  196 (383)
                      ++|...+.||+|+||.||                                         |||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            467778899999999998                                         799999999987654      


Q ss_pred             EEEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          197 KLIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      .++||||++ |+|.+++..   ......++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus       104 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             EEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence            499999997 689888753   345678999999999999998   9999999999999999999999999999765322


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec-------------
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD-------------  331 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~-------------  331 (383)
                          .....||..|+|||         .++|||||||++|||++|+.|+...    +..+....+..             
T Consensus       180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK----DYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS----CHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHHhCCCCHHHHHHH
Confidence                23356889999987         4689999999999999999996432    11111110000             


Q ss_pred             -----------------CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          332 -----------------STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       332 -----------------~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                                       ..+ ..........+.+++.+|++.||++|||+.|+++  .++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                             000 0112234567899999999999999999999986  45443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=1.5e-30  Score=250.53  Aligned_cols=204  Identities=18%  Similarity=0.294  Sum_probs=152.4

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------------cccceeeeEEEeC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------------~niv~l~g~~~~~  194 (383)
                      ++|...+.||+|+||.||                                                 +||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            467778899999999998                                                 3899999999864


Q ss_pred             C----EEEEEEEeccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc------CCC
Q 046461          195 E----KKLIVYEYMVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN------EDF  257 (383)
Q Consensus       195 ~----~~~lv~e~~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~------~~~  257 (383)
                      +    ..++||||+ +++|.+++...       .....++.|++.||+|||+.+  +|+||||||+||+++      ..+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence            4    789999999 89999999742       245789999999999999853  799999999999994      445


Q ss_pred             ceEEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCC--Cccce
Q 046461          258 EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNG--GNLVD  327 (383)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~--~~~~~  327 (383)
                      .+||+|||+++.....    .....||..|+|||        .++|||||||++|||++|+.|+.........  .+...
T Consensus       176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  251 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  251 (373)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence            7999999999876432    23357899999998        5789999999999999999997542110000  00000


Q ss_pred             ee-------------------------------ec-------Ccc--cccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          328 WV-------------------------------LD-------STI--LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       328 ~v-------------------------------~~-------~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                      .+                               ..       ...  ....+......+.+++.+||+.||++|||++|+
T Consensus       252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  331 (373)
T 1q8y_A          252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  331 (373)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence            00                               00       000  012245567789999999999999999999999


Q ss_pred             HH--HHhcc
Q 046461          368 QE--FLEKY  374 (383)
Q Consensus       368 ~~--~L~~~  374 (383)
                      ++  .+++.
T Consensus       332 l~hp~f~~~  340 (373)
T 1q8y_A          332 VNHPWLKDT  340 (373)
T ss_dssp             HTCGGGTTC
T ss_pred             hhChhhhcc
Confidence            87  45544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=1e-29  Score=259.93  Aligned_cols=199  Identities=22%  Similarity=0.296  Sum_probs=149.3

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEe------CCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPV------GEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~------~~~~  197 (383)
                      ++|...+.||+|+||.||                                        |||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            578888999999999998                                        799999998765      6678


Q ss_pred             EEEEEeccCCCHHHHHhcc--------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---eEEccccC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ--------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFE---VKVSDFGL  266 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~--------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~---~kl~Dfgl  266 (383)
                      ++||||+++|+|.+++...        .....++.+++.||+|||+.   +++||||||+||+++.++.   +||+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            9999999999999999752        24678999999999999998   9999999999999987654   99999999


Q ss_pred             ccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCC---------CCCCc-ccee
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKD---------KNGGN-LVDW  328 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~---------~~~~~-~~~~  328 (383)
                      ++......  ......||..|+|||        .++||||||+++|||++|+.|+......         ..... ....
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            98765432  223467899999998        5789999999999999999998542100         00000 0000


Q ss_pred             ee------cCc--ccccCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 046461          329 VL------DST--ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV  367 (383)
Q Consensus       329 v~------~~~--~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v  367 (383)
                      ..      ...  ............+.+++.+|++.||++|||+.|+
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            00      011  1112344567889999999999999999999773

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=6.8e-30  Score=265.38  Aligned_cols=189  Identities=21%  Similarity=0.289  Sum_probs=148.5

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCE-----E
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEK-----K  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~-----~  197 (383)
                      ++|...+.||+|+||.||                                         ||||++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            567777888999988888                                         799999999987654     7


Q ss_pred             EEEEEeccCCCHHHHHhc---chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          198 LIVYEYMVKGSLNDWLRN---QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~---~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      ++||||+++++|.+++..   +.....++.|++.||+|||+.   +|+||||||+||+++.+ .+||+|||+++..... 
T Consensus       160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred             EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence            999999999999998864   346788999999999999998   99999999999999975 8999999999876432 


Q ss_pred             CccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC-ChhHHHHH
Q 046461          275 SHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY-SKPSMLKM  346 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~-~~~~~~~~  346 (383)
                          ....||++|++||       .++|||||||+++||++|..|+...+..    .         +.... .......+
T Consensus       235 ----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----~---------~~~~~~~~~~~~~l  297 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD----G---------LPEDDPVLKTYDSY  297 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS----S---------CCTTCHHHHHCHHH
T ss_pred             ----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc----c---------ccccccccccCHHH
Confidence                3457999999999       4789999999999999998885432210    0         00110 11234578


Q ss_pred             HHHHHHccccCCCCCCC-HHHHHHHHhcc
Q 046461          347 LQIVVGCIFDNPTTRPT-MLRVQEFLEKY  374 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs-~~~v~~~L~~~  374 (383)
                      .+++.+||+.||++||+ ++++.+.|..+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            89999999999999995 66666666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.95  E-value=2.1e-29  Score=246.64  Aligned_cols=154  Identities=15%  Similarity=0.217  Sum_probs=118.4

Q ss_pred             EEEEEEeccCCCHHHHHhc------------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccc
Q 046461          197 KLIVYEYMVKGSLNDWLRN------------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF  264 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~------------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Df  264 (383)
                      .+++|+++ +++|.+++..            +..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCG
T ss_pred             eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEec
Confidence            46667665 6899999841            124567889999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccccccCC-C-----------------CCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc
Q 046461          265 GLVRLISDCESHTSTDVAGTIGYILLA-C-----------------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV  326 (383)
Q Consensus       265 gla~~~~~~~~~~~~~~~gt~~y~ape-~-----------------~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~  326 (383)
                      |+++.....    .....| +.|+||| .                 ++|||||||++|||++|+.|+...    ......
T Consensus       256 G~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~----~~~~~~  326 (413)
T 3dzo_A          256 EHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD----AALGGS  326 (413)
T ss_dssp             GGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT----GGGSCS
T ss_pred             cceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc----chhhhH
Confidence            998865432    334567 9999998 1                 789999999999999999997543    222222


Q ss_pred             eeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          327 DWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       327 ~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+...      ....+..+.+++.+||+.||++|||+.|+++
T Consensus       327 ~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          327 EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             GGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            222111      1123457889999999999999999877753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=4.1e-26  Score=216.83  Aligned_cols=158  Identities=18%  Similarity=0.089  Sum_probs=116.9

Q ss_pred             CCEEEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHh-hcCCCCeeecCCCCCcEEEcCCC-----------
Q 046461          194 GEKKLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLH-HRFQPHIIHRDINASNILLNEDF-----------  257 (383)
Q Consensus       194 ~~~~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrdlk~~NiLl~~~~-----------  257 (383)
                      .+..++||||+++|++.+.+..    ......++.|++.||+||| +.   +|+||||||+|||++.++           
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~  210 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGK  210 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred             cCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCc
Confidence            6789999999999976666542    3456889999999999999 88   999999999999999887           


Q ss_pred             ---------ceEEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHH-HHHHHhCCCCCCCCCCCC
Q 046461          258 ---------EVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVV-LLELVIRKQPTGPEFKDK  320 (383)
Q Consensus       258 ---------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvi-l~Elltg~~p~~~~~~~~  320 (383)
                               .+||+|||+++.....      ...||..|+|||       .++||||++++ .+++++|..|+.....  
T Consensus       211 ~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--  282 (336)
T 2vuw_A          211 SSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLW--  282 (336)
T ss_dssp             EEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHH--
T ss_pred             cccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhh--
Confidence                     8999999999876532      247899999999       46899998777 7778889888521000  


Q ss_pred             CCCccceeee-----cCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 046461          321 NGGNLVDWVL-----DSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ  368 (383)
Q Consensus       321 ~~~~~~~~v~-----~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~  368 (383)
                       .....+.+.     ............+..+.+++.+|++.|     |++|++
T Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          283 -LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             -HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             -hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence             000111111     111111112346778999999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=1.7e-24  Score=219.79  Aligned_cols=124  Identities=17%  Similarity=0.141  Sum_probs=96.1

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcch--hhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQA--KHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      +||+++++++.+++..||||||++||+|.++|....  ....|+.||+.||+|+|++   +|+||||||+|||++.++.+
T Consensus       302 ~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~v  378 (569)
T 4azs_A          302 FDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHA  378 (569)
T ss_dssp             CCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCE
T ss_pred             CCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCE
Confidence            799999999999999999999999999999997532  3456899999999999999   99999999999999999999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhC
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIR  309 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg  309 (383)
                      ||+|||+|+....... .....+||++||+||       .++|+||.|++++++.++
T Consensus       379 KL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          379 RLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             EECCCTTEESCC---C-CSHHHHHHHHHHHHHHC-----------------CCCCTT
T ss_pred             EEeecccCeeCCCCCc-cccCceechhhccHHHhCCCCCCcccccccccchhhhccc
Confidence            9999999987654332 233467999999998       468999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.82  E-value=6.9e-21  Score=192.16  Aligned_cols=124  Identities=20%  Similarity=0.210  Sum_probs=106.3

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEE
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKV  261 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl  261 (383)
                      +||+++..++...+..++||||+++|+|.+++..   ...++.|+++||+|||++   +|+||||||+|||++.  .+||
T Consensus       399 ~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL  470 (540)
T 3en9_A          399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI  470 (540)
T ss_dssp             GTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred             CCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence            6999777777788888999999999999999986   678999999999999998   9999999999999998  9999


Q ss_pred             ccccCccccCCCCCcc------ccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCC
Q 046461          262 SDFGLVRLISDCESHT------STDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       262 ~Dfgla~~~~~~~~~~------~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      +|||+++.........      .....||+.|+|||          ..+|+||..+-.+|-+.++.++
T Consensus       471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9999999875432111      12467999999998          4579999999998888887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.59  E-value=1e-15  Score=141.80  Aligned_cols=80  Identities=16%  Similarity=0.191  Sum_probs=67.7

Q ss_pred             ceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccc
Q 046461          185 VQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDF  264 (383)
Q Consensus       185 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Df  264 (383)
                      +++.+++.. +..++||||+++|+|.+ +. ......++.|++.||+|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR-VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cc-hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            556665543 45699999999999999 43 344567999999999999998   999999999999999 999999999


Q ss_pred             cCccccC
Q 046461          265 GLVRLIS  271 (383)
Q Consensus       265 gla~~~~  271 (383)
                      |+++...
T Consensus       237 G~a~~~~  243 (282)
T 1zar_A          237 PQSVEVG  243 (282)
T ss_dssp             TTCEETT
T ss_pred             CCCeECC
Confidence            9997543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.52  E-value=7.9e-15  Score=154.09  Aligned_cols=101  Identities=27%  Similarity=0.297  Sum_probs=93.9

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.++|+.|++ |.+|..++++++|+.|||++|+|+|.||.+++++++|+.|||     +|.||.++.++++|+.||
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~  710 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID  710 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence            35789999999999 899999999999999999999999999999999999999998     568999999999999999


Q ss_pred             cccccccccCCCC-------------CcCCccccCCCCCcc
Q 046461           75 FSMNMLGGHIPEK-------------NIDLCGKIMGLDYQV  102 (383)
Q Consensus        75 ~s~N~l~g~ip~~-------------n~~lcg~~~~~~~~~  102 (383)
                      +|+|+|+|.||..             |+++||.++. +|..
T Consensus       711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~  750 (768)
T 3rgz_A          711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP  750 (768)
T ss_dssp             CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred             CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence            9999999999963             8899999887 7864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.17  E-value=4.4e-11  Score=108.94  Aligned_cols=71  Identities=18%  Similarity=0.280  Sum_probs=60.1

Q ss_pred             EEEEEEEeccC-C----CHHHHHhc--chhhhHHHHhHHHHHHHHh-hcCCCCeeecCCCCCcEEEcCCCceEEccccCc
Q 046461          196 KKLIVYEYMVK-G----SLNDWLRN--QAKHCIIACGTARGITFLH-HRFQPHIIHRDINASNILLNEDFEVKVSDFGLV  267 (383)
Q Consensus       196 ~~~lv~e~~~~-g----sL~~~l~~--~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla  267 (383)
                      ..++||||+.+ |    +|.++...  ......++.|++.|+.||| +.   +|+||||||+|||++.  .++|+|||++
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a  216 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQA  216 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECccc
Confidence            35799999953 4    78877654  3456789999999999999 77   9999999999999998  9999999999


Q ss_pred             cccC
Q 046461          268 RLIS  271 (383)
Q Consensus       268 ~~~~  271 (383)
                      ....
T Consensus       217 ~~~~  220 (258)
T 1zth_A          217 VTLR  220 (258)
T ss_dssp             EETT
T ss_pred             ccCC
Confidence            7653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.15  E-value=1e-11  Score=118.91  Aligned_cols=69  Identities=19%  Similarity=0.152  Sum_probs=57.6

Q ss_pred             EEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----------ceEEccccCc
Q 046461          198 LIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF----------EVKVSDFGLV  267 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~----------~~kl~Dfgla  267 (383)
                      +|||||+++++|.++.. ......++.|++.+|.|||..   +|+||||||.|||++.++          .+.|+||+-+
T Consensus       187 ~LVME~i~G~~L~~l~~-~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          187 TIVMSLVDALPMRQVSS-VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             EEEEECCSCEEGGGCCC-CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTC
T ss_pred             eEEEEecCCccHhhhcc-cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCc
Confidence            69999999988876543 334566889999999999998   999999999999998776          3889999877


Q ss_pred             ccc
Q 046461          268 RLI  270 (383)
Q Consensus       268 ~~~  270 (383)
                      ...
T Consensus       263 V~~  265 (397)
T 4gyi_A          263 VSM  265 (397)
T ss_dssp             EET
T ss_pred             ccC
Confidence            543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.09  E-value=5.5e-11  Score=111.36  Aligned_cols=95  Identities=24%  Similarity=0.293  Sum_probs=73.6

Q ss_pred             ccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCccccccc
Q 046461            4 TQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         4 ~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~~s~   77 (383)
                      |+.|+|+.|.+ +.+|..++.+++|+.|+|++|+++|.+|. +..+++|+.|++     +|.+|.++..+++|+.|++++
T Consensus       199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~  277 (313)
T 1ogq_A          199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF  277 (313)
T ss_dssp             CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred             ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence            66777777777 56777777788888888888888877776 667778888877     346888999999999999999


Q ss_pred             ccccccCCCC-------------CcCCccccCCCCC
Q 046461           78 NMLGGHIPEK-------------NIDLCGKIMGLDY  100 (383)
Q Consensus        78 N~l~g~ip~~-------------n~~lcg~~~~~~~  100 (383)
                      |+++|.+|..             |+.+||.|+. .|
T Consensus       278 N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             SEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             CcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence            9999999863             5667776654 44

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.07  E-value=1.3e-10  Score=100.98  Aligned_cols=85  Identities=21%  Similarity=0.198  Sum_probs=74.1

Q ss_pred             CccEeecccCCC-CCCCC-cCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            3 HTQKKILIRDNL-GMPPI-IPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~-~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      +++.|+|+.|++ ++++. .++++++|+.|+|++|++++.+|..+.++.+|+.|+|++     ..|..+.++++|+.|++
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            688999999999 56664 478999999999999999999999999999999999955     34556889999999999


Q ss_pred             ccccccccCCCC
Q 046461           76 SMNMLGGHIPEK   87 (383)
Q Consensus        76 s~N~l~g~ip~~   87 (383)
                      ++|++++.+|..
T Consensus       110 ~~N~l~~~~~~~  121 (192)
T 1w8a_A          110 YDNQISCVMPGS  121 (192)
T ss_dssp             CSSCCCEECTTS
T ss_pred             CCCcCCeeCHHH
Confidence            999999988864

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.01  E-value=1.9e-10  Score=107.63  Aligned_cols=87  Identities=28%  Similarity=0.413  Sum_probs=78.4

Q ss_pred             CCCccEeeccc-CCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeec-----cccChhhhCCCCCccc
Q 046461            1 MPHTQKKILIR-DNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~-~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~-----g~ip~~~~~~~~L~~l   73 (383)
                      +++|+.|+|+. |++ +.+|..++++++|++|+|++|+++|.+|..++++.+|+.|+++     +.+|..+.++++|+.|
T Consensus        75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  154 (313)
T 1ogq_A           75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI  154 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred             CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence            57899999995 888 7888888999999999999999999999999999999999984     4689999999999999


Q ss_pred             ccccccccccCCCC
Q 046461           74 DFSMNMLGGHIPEK   87 (383)
Q Consensus        74 ~~s~N~l~g~ip~~   87 (383)
                      ++++|+++|.+|..
T Consensus       155 ~L~~N~l~~~~p~~  168 (313)
T 1ogq_A          155 TFDGNRISGAIPDS  168 (313)
T ss_dssp             ECCSSCCEEECCGG
T ss_pred             ECcCCcccCcCCHH
Confidence            99999999999864

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.99  E-value=3.3e-10  Score=106.81  Aligned_cols=84  Identities=17%  Similarity=0.122  Sum_probs=43.8

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|.+...|..++++++|+.|+|++|++++ +|+.++++++|+.|++++     .+|.+++.+++|+.|+++
T Consensus       183 ~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~  261 (328)
T 4fcg_A          183 VNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK  261 (328)
T ss_dssp             TTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECT
T ss_pred             CCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECC
Confidence            45555555555554334444555555555555555553 444555555555555532     345555555555555555


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|++.|.+|.
T Consensus       262 ~n~~~~~~p~  271 (328)
T 4fcg_A          262 DCSNLLTLPL  271 (328)
T ss_dssp             TCTTCCBCCT
T ss_pred             CCCchhhcch
Confidence            5555555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.96  E-value=6.7e-10  Score=98.54  Aligned_cols=85  Identities=11%  Similarity=0.132  Sum_probs=47.7

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|+|++     ..|..+..+++|+.|++
T Consensus        57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  136 (220)
T 2v70_A           57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL  136 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred             CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence            4555556655555 44454555556666666666666555555555555565555533     22445555566666666


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       137 ~~N~l~~~~~~  147 (220)
T 2v70_A          137 YDNQITTVAPG  147 (220)
T ss_dssp             TTSCCCCBCTT
T ss_pred             CCCcCCEECHH
Confidence            66666555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.96  E-value=8.8e-10  Score=93.70  Aligned_cols=76  Identities=16%  Similarity=0.077  Sum_probs=38.8

Q ss_pred             cEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDFSMNM   79 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~s~N~   79 (383)
                      +.+++++|++..+|..+  .++|+.|+|++|++++..|..+.++.+|+.|+|++    .+|. .+..+++|+.|++++|+
T Consensus        12 ~~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           12 TTVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             TEEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            44555555552222211  24555555555555555555555555555555533    2333 23455555555555555


Q ss_pred             ccc
Q 046461           80 LGG   82 (383)
Q Consensus        80 l~g   82 (383)
                      |++
T Consensus        90 l~~   92 (170)
T 3g39_A           90 LKS   92 (170)
T ss_dssp             CCC
T ss_pred             cCE
Confidence            554

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=98.95  E-value=7e-10  Score=116.41  Aligned_cols=86  Identities=27%  Similarity=0.293  Sum_probs=58.6

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.+ |.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|++     +|.+|.+++++++|+.|+
T Consensus       441 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  520 (768)
T 3rgz_A          441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK  520 (768)
T ss_dssp             CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             CCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEE
Confidence            35667777777777 566666666777777777777777777777777777766666     335666666777777777


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|+++|.+|.
T Consensus       521 L~~N~l~~~~p~  532 (768)
T 3rgz_A          521 LSNNSFSGNIPA  532 (768)
T ss_dssp             CCSSCCEEECCG
T ss_pred             CCCCcccCcCCH
Confidence            777777766665

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.94  E-value=1.1e-09  Score=93.46  Aligned_cols=76  Identities=21%  Similarity=0.204  Sum_probs=49.7

Q ss_pred             cEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCccccccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFDFSMNM   79 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~~s~N~   79 (383)
                      +.+++++|+++.+|..+  .++|+.|+|++|++++.+|..++++.+|+.|+|++    .+|.. +.++++|+.|++++|+
T Consensus        15 ~~l~~~~n~l~~iP~~~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             SEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCCccCCCc--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            45667777774333322  26677777777777777777777777777777754    25543 4667777777777777


Q ss_pred             ccc
Q 046461           80 LGG   82 (383)
Q Consensus        80 l~g   82 (383)
                      |++
T Consensus        93 l~~   95 (174)
T 2r9u_A           93 LKS   95 (174)
T ss_dssp             CCC
T ss_pred             cce
Confidence            775

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.94  E-value=7.4e-10  Score=98.27  Aligned_cols=85  Identities=15%  Similarity=0.110  Sum_probs=77.5

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.+ ++++..+..+++|+.|+|++|++++..|..+.++.+|+.|+|++     ..|..+..+++|+.|+
T Consensus        80 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  159 (220)
T 2v70_A           80 ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLN  159 (220)
T ss_dssp             CTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEE
Confidence            57899999999999 78888899999999999999999999999999999999999955     3478899999999999


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +++|.+++..+
T Consensus       160 L~~N~l~c~c~  170 (220)
T 2v70_A          160 LLANPFNCNCY  170 (220)
T ss_dssp             CCSCCEECSGG
T ss_pred             ecCcCCcCCCc
Confidence            99999988655

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.93  E-value=1.4e-09  Score=96.95  Aligned_cols=79  Identities=20%  Similarity=0.200  Sum_probs=37.5

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDFS   76 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~s   76 (383)
                      +|+.|+|+.|++ +++|..+.++++|+.|+|++|++++-.|..+.++.+|+.|+|++    .+|. .+..+++|+.|+++
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            455555555555 44444455555555555555555333223344455555555533    1222 23444555555555


Q ss_pred             ccccc
Q 046461           77 MNMLG   81 (383)
Q Consensus        77 ~N~l~   81 (383)
                      +|+++
T Consensus       121 ~N~l~  125 (229)
T 3e6j_A          121 CNKLT  125 (229)
T ss_dssp             SSCCC
T ss_pred             CCccc
Confidence            55554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.92  E-value=1.3e-09  Score=93.06  Aligned_cols=84  Identities=21%  Similarity=0.339  Sum_probs=71.3

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|++|++ ++++..++++++|+.|+|++|++++..|..+.++.+|+.|++++    .+|. .+.++++|+.|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            5789999999999 78888889999999999999999977667788999999999965    3454 4688999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++ +|.
T Consensus       108 ~~N~l~~-~~~  117 (177)
T 2o6r_A          108 DTNQLKS-VPD  117 (177)
T ss_dssp             CSSCCSC-CCT
T ss_pred             cCCcceE-eCH
Confidence            9999986 443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.91  E-value=4.9e-10  Score=116.81  Aligned_cols=85  Identities=25%  Similarity=0.292  Sum_probs=56.8

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      |++|+.|+|+.|.+..+|..+++|++|+.|||++|+|+ .||.++++|.+|+.|+|++    .||.+|+++++|+.|+++
T Consensus       246 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~  324 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVE  324 (727)
T ss_dssp             CCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECT
T ss_pred             CCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCC
Confidence            45666677777766544455566777777777777776 6677777777777776643    466667777777777777


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|.|+|.+|.
T Consensus       325 ~N~l~~~~p~  334 (727)
T 4b8c_D          325 GNPLEKQFLK  334 (727)
T ss_dssp             TSCCCSHHHH
T ss_pred             CCccCCCChH
Confidence            7777766664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.91  E-value=1.1e-09  Score=95.05  Aligned_cols=81  Identities=21%  Similarity=0.272  Sum_probs=35.9

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ +++|..++++++|+.|+|++|++++..|..+.++.+|+.|+|++     .+|..+..+++|+.|++
T Consensus        54 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (192)
T 1w8a_A           54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL  133 (192)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEe
Confidence            3444444444444 33344444444444444444444444444444444444444422     22334444444444444


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|.++|
T Consensus       134 ~~N~l~c  140 (192)
T 1w8a_A          134 ASNPFNC  140 (192)
T ss_dssp             TTCCBCC
T ss_pred             CCCCccC
Confidence            4444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.89  E-value=2.5e-09  Score=88.48  Aligned_cols=81  Identities=19%  Similarity=0.122  Sum_probs=44.6

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc------cChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK------IPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~------ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+... ..++++++|+.|+|++|++++.+|..+.++++|+.+++++.      .|..+..+++|+.|++
T Consensus        42 ~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l  120 (149)
T 2je0_A           42 EELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL  120 (149)
T ss_dssp             TTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEEC
T ss_pred             CCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeC
Confidence            4555566655555322 34455566666666666666555555555666666665431      2244555666666666


Q ss_pred             cccccccc
Q 046461           76 SMNMLGGH   83 (383)
Q Consensus        76 s~N~l~g~   83 (383)
                      ++|.+++.
T Consensus       121 ~~N~l~~~  128 (149)
T 2je0_A          121 FNCEVTNL  128 (149)
T ss_dssp             TTCGGGGS
T ss_pred             cCCcccch
Confidence            66666553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.87  E-value=1.7e-09  Score=111.05  Aligned_cols=85  Identities=19%  Similarity=0.366  Sum_probs=79.9

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCc-ccc-ccchhHHhh------hccceeeecc----ccCh--hhh
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNK-LNG-EISTFLSHI------LGILGLYVQF----KIPP--DLC   65 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~-l~G-~iP~~~~~~------~~l~~l~l~g----~ip~--~~~   65 (383)
                      |++|+.|+|+.|++ |..|..++++++|+.|+|++|+ ++| .+|..++++      ++|+.|++++    .+|.  +++
T Consensus       248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~  327 (636)
T 4eco_A          248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ  327 (636)
T ss_dssp             CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHT
T ss_pred             cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhc
Confidence            57899999999998 8888999999999999999999 999 999999998      9999999955    6898  999


Q ss_pred             CCCCCcccccccccccccCC
Q 046461           66 NLVQLEYFDFSMNMLGGHIP   85 (383)
Q Consensus        66 ~~~~L~~l~~s~N~l~g~ip   85 (383)
                      ++++|+.|++++|+++|.+|
T Consensus       328 ~l~~L~~L~L~~N~l~g~ip  347 (636)
T 4eco_A          328 KMKKLGMLECLYNQLEGKLP  347 (636)
T ss_dssp             TCTTCCEEECCSCCCEEECC
T ss_pred             cCCCCCEEeCcCCcCccchh
Confidence            99999999999999999999

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.86  E-value=3.2e-09  Score=92.15  Aligned_cols=84  Identities=19%  Similarity=0.225  Sum_probs=72.2

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----cc-ChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KI-PPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~i-p~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|++...|..+.++++|+.|+|++|++++..|..|.++.+|+.|+|++    .+ |..|.++++|+.|+++
T Consensus        31 ~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           31 RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            468999999999976667888999999999999999988888899999999999965    24 4568999999999999


Q ss_pred             cccccccCC
Q 046461           77 MNMLGGHIP   85 (383)
Q Consensus        77 ~N~l~g~ip   85 (383)
                      +|++++-.+
T Consensus       111 ~N~l~~~~~  119 (193)
T 2wfh_A          111 GNDISVVPE  119 (193)
T ss_dssp             SSCCCBCCT
T ss_pred             CCCCCeeCh
Confidence            999986433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.85  E-value=2.4e-09  Score=100.84  Aligned_cols=86  Identities=14%  Similarity=0.145  Sum_probs=66.6

Q ss_pred             CCCccEeecccCCC-CCCCCcCCC---------CCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhC
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKN---------LNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCN   66 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~---------l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~   66 (383)
                      |++|+.|+|+.|++ +..|..++.         +++|+.|+|++|+++ .+|..++++.+|+.|++++    .+|.+++.
T Consensus       149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~  227 (328)
T 4fcg_A          149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH  227 (328)
T ss_dssp             CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGG
T ss_pred             CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhcc
Confidence            46788888888666 666665543         788888888888888 7888888888888888854    47777888


Q ss_pred             CCCCcccccccccccccCCCC
Q 046461           67 LVQLEYFDFSMNMLGGHIPEK   87 (383)
Q Consensus        67 ~~~L~~l~~s~N~l~g~ip~~   87 (383)
                      +++|+.|++++|++.|.+|..
T Consensus       228 l~~L~~L~Ls~n~~~~~~p~~  248 (328)
T 4fcg_A          228 LPKLEELDLRGCTALRNYPPI  248 (328)
T ss_dssp             CTTCCEEECTTCTTCCBCCCC
T ss_pred             CCCCCEEECcCCcchhhhHHH
Confidence            888888888888888888764

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.85  E-value=4.5e-09  Score=91.98  Aligned_cols=85  Identities=20%  Similarity=0.230  Sum_probs=71.4

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ ++++..+.++++|++|+|++|++++..|..+.++.+|+.|++++    .+|. .+.++++|+.|+
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  130 (208)
T 2o6s_A           51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR  130 (208)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence            57899999999999 77777788999999999999999977666788999999999955    2444 478899999999


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +++|++++..+
T Consensus       131 l~~N~l~~~~~  141 (208)
T 2o6s_A          131 LYQNQLKSVPD  141 (208)
T ss_dssp             CCSSCCSCCCT
T ss_pred             CCCCccceeCH
Confidence            99999987444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.84  E-value=2.6e-09  Score=108.15  Aligned_cols=82  Identities=21%  Similarity=0.180  Sum_probs=66.2

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      .|+.|+|+.|++..+|. ++++++|+.|+|++|+++ .||..++++++|+.|+|++    .+| +++++++|+.|++++|
T Consensus       442 ~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N  518 (567)
T 1dce_A          442 DVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNN  518 (567)
T ss_dssp             TCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSS
T ss_pred             CceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCC
Confidence            57788888888843444 688888888999988888 8888888888888888855    367 7888888888888888


Q ss_pred             cccccC-CCC
Q 046461           79 MLGGHI-PEK   87 (383)
Q Consensus        79 ~l~g~i-p~~   87 (383)
                      +|++.+ |..
T Consensus       519 ~l~~~~~p~~  528 (567)
T 1dce_A          519 RLQQSAAIQP  528 (567)
T ss_dssp             CCCSSSTTGG
T ss_pred             CCCCCCCcHH
Confidence            888876 653

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.82  E-value=5.4e-09  Score=88.22  Aligned_cols=80  Identities=20%  Similarity=0.138  Sum_probs=43.4

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC--hhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP--PDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip--~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+... ..+..+++|+.|+|++|++++.+|..+.++++|+.|++++    .+|  ..+..+++|+.|++
T Consensus        49 ~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l  127 (168)
T 2ell_A           49 VNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDL  127 (168)
T ss_dssp             GGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEEC
T ss_pred             CCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEe
Confidence            3455555555555322 3445555566666666666555555555555666655543    122  44555556666666


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|.+++
T Consensus       128 ~~N~l~~  134 (168)
T 2ell_A          128 FNCEVTN  134 (168)
T ss_dssp             CSSGGGT
T ss_pred             eCCcCcc
Confidence            6665554

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.82  E-value=5.7e-09  Score=95.46  Aligned_cols=86  Identities=19%  Similarity=0.304  Sum_probs=73.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|++ ++++..++++++|+.|+|++|++++..|..++++.+|+.|++++    .+| ..+..+++|+.|+
T Consensus       108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  187 (272)
T 3rfs_A          108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR  187 (272)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence            57899999999999 78888889999999999999999987777788999999999955    244 4468899999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       188 L~~N~l~~~~~~  199 (272)
T 3rfs_A          188 LYQNQLKSVPDG  199 (272)
T ss_dssp             CCSSCCSCCCTT
T ss_pred             CCCCcCCccCHH
Confidence            999999986654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.81  E-value=6e-09  Score=94.07  Aligned_cols=85  Identities=20%  Similarity=0.207  Sum_probs=62.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|++++    .+|. .+..+++|+.|+
T Consensus        58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  137 (251)
T 3m19_A           58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR  137 (251)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence            46788888888888 67777777888888888888888876667777778888888754    2443 356777788888


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +++|++++..|
T Consensus       138 Ls~N~l~~~~~  148 (251)
T 3m19_A          138 LNTNQLQSIPA  148 (251)
T ss_dssp             CCSSCCCCCCT
T ss_pred             CcCCcCCccCH
Confidence            88887776444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.81  E-value=4.7e-09  Score=93.05  Aligned_cols=85  Identities=15%  Similarity=0.196  Sum_probs=65.7

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~~   75 (383)
                      ++++.|+|+.|++ ++++..+..+++|+.|+|++|++++..|..+.++.+|+.|+|++    .+|.. +..+++|+.|++
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            3678888888888 67776778888888888888888888788888888888888855    35544 567888888888


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       112 ~~N~l~~~~~~  122 (220)
T 2v9t_B          112 NANKINCLRVD  122 (220)
T ss_dssp             CSSCCCCCCTT
T ss_pred             CCCCCCEeCHH
Confidence            88888776554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.77  E-value=1.1e-08  Score=91.21  Aligned_cols=85  Identities=20%  Similarity=0.281  Sum_probs=76.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~   75 (383)
                      |++|+.|+|+.|++ ++++..+..+++|+.|+|++|++++..|..+..+.+|+.|++++    .+|..+..+++|+.|++
T Consensus        63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L  142 (229)
T 3e6j_A           63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLAL  142 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEEC
T ss_pred             ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEEC
Confidence            57899999999999 67778889999999999999999987777789999999999966    58999999999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|+|++-.+
T Consensus       143 ~~N~l~~~~~  152 (229)
T 3e6j_A          143 DQNQLKSIPH  152 (229)
T ss_dssp             CSSCCCCCCT
T ss_pred             CCCcCCccCH
Confidence            9999997444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.77  E-value=5e-09  Score=99.16  Aligned_cols=77  Identities=17%  Similarity=0.065  Sum_probs=55.6

Q ss_pred             EeecccC-CCCCCCCcCCCCCCCCEEECcC-CccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccccc
Q 046461            6 KKILIRD-NLGMPPIIPKNLNELPHLDLSC-NKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         6 ~~~l~~~-~~~~~~~~~~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      .++++++ ++..+|. ++.+++|+.|+|++ |+|++..|..|+++.+|+.|+|++     ..|..|.++++|+.|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            3567776 6643444 67778888888885 888877777788888888887744     34556788888888888888


Q ss_pred             ccccc
Q 046461           79 MLGGH   83 (383)
Q Consensus        79 ~l~g~   83 (383)
                      +|++-
T Consensus        91 ~l~~~   95 (347)
T 2ifg_A           91 ALESL   95 (347)
T ss_dssp             CCSCC
T ss_pred             cccee
Confidence            88763

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.77  E-value=1.2e-08  Score=89.23  Aligned_cols=84  Identities=21%  Similarity=0.225  Sum_probs=72.4

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ ++++..++++++|+.|+|++|++++..|..+.++.+|+.|++++    .+|. .+.++++|+.|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            5789999999999 78888889999999999999999976666778999999999965    3554 4789999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|++++..|
T Consensus       108 ~~N~l~~~~~  117 (208)
T 2o6s_A          108 NTNQLQSLPD  117 (208)
T ss_dssp             CSSCCCCCCT
T ss_pred             CCCcCcccCH
Confidence            9999987544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.76  E-value=1.2e-08  Score=93.29  Aligned_cols=86  Identities=21%  Similarity=0.242  Sum_probs=75.5

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ ++++..++++++|+.|+|++|++++..|..++++.+|+.|++++    .+| ..+..+++|+.|+
T Consensus        84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  163 (272)
T 3rfs_A           84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD  163 (272)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence            57899999999999 78888889999999999999999988888899999999999965    244 4568999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       164 l~~n~l~~~~~~  175 (272)
T 3rfs_A          164 LSYNQLQSLPEG  175 (272)
T ss_dssp             CCSSCCCCCCTT
T ss_pred             CCCCCcCccCHH
Confidence            999999975553

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.76  E-value=9.9e-09  Score=90.91  Aligned_cols=86  Identities=15%  Similarity=0.131  Sum_probs=74.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ +++|..+.++++|+.|+|++|++++-.|..+.++.+|+.|+|++     ..|..+..+++|+.|+
T Consensus        55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  134 (220)
T 2v9t_B           55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS  134 (220)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence            57899999999999 78788999999999999999999955445578899999999965     3467789999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       135 L~~N~l~~~~~~  146 (220)
T 2v9t_B          135 LYDNKLQTIAKG  146 (220)
T ss_dssp             CCSSCCSCCCTT
T ss_pred             CCCCcCCEECHH
Confidence            999999986654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.75  E-value=1.4e-08  Score=91.61  Aligned_cols=86  Identities=21%  Similarity=0.240  Sum_probs=75.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ ++++..+..+++|+.|+|++|++++..|..+.++.+|+.|++++    .+|. .+..+++|+.|+
T Consensus        82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  161 (251)
T 3m19_A           82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS  161 (251)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence            57899999999999 78888889999999999999999977777788999999999965    3554 688999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       162 L~~N~l~~~~~~  173 (251)
T 3m19_A          162 LSTNQLQSVPHG  173 (251)
T ss_dssp             CCSSCCSCCCTT
T ss_pred             CCCCcCCccCHH
Confidence            999999976553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.75  E-value=8e-09  Score=106.07  Aligned_cols=84  Identities=18%  Similarity=0.072  Sum_probs=69.6

Q ss_pred             CCccEeecccCCCCCCCCcCC--CCCCCCEEECcCCccccccchhHHhhhccceeee-----------ccccChhhhCCC
Q 046461            2 PHTQKKILIRDNLGMPPIIPK--NLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----------QFKIPPDLCNLV   68 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~--~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----------~g~ip~~~~~~~   68 (383)
                      ++|+.|+|+.|.+...|..+.  .+++|+.|+|++|++++ ||..++++++|+.|++           .+.+|.++++++
T Consensus       488 ~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~  566 (636)
T 4eco_A          488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP  566 (636)
T ss_dssp             GGCCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred             CCccEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence            378888999888854445444  88999999999999998 8999999999998888           346888899999


Q ss_pred             CCcccccccccccccCCCC
Q 046461           69 QLEYFDFSMNMLGGHIPEK   87 (383)
Q Consensus        69 ~L~~l~~s~N~l~g~ip~~   87 (383)
                      +|+.|++++|++ +.||..
T Consensus       567 ~L~~L~Ls~N~l-~~ip~~  584 (636)
T 4eco_A          567 SLTQLQIGSNDI-RKVNEK  584 (636)
T ss_dssp             SCCEEECCSSCC-CBCCSC
T ss_pred             CCCEEECCCCcC-CccCHh
Confidence            999999999999 888864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.75  E-value=1.5e-08  Score=86.23  Aligned_cols=76  Identities=18%  Similarity=0.191  Sum_probs=40.0

Q ss_pred             cEeecccCCCC-CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccccccc
Q 046461            5 QKKILIRDNLG-MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDFSMN   78 (383)
Q Consensus         5 ~~~~l~~~~~~-~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~s~N   78 (383)
                      +.+.+..|++. +|...   .++|+.|++++|++++..|..+.++.+|+.|++++    .+|. .+..+++|+.|++++|
T Consensus        10 ~~l~~~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCSSCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCccCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            34555555552 33222   24556666666666654444455566666666643    2332 2455666666666666


Q ss_pred             ccccc
Q 046461           79 MLGGH   83 (383)
Q Consensus        79 ~l~g~   83 (383)
                      ++++.
T Consensus        87 ~l~~~   91 (177)
T 2o6r_A           87 KLQSL   91 (177)
T ss_dssp             CCCCC
T ss_pred             Ccccc
Confidence            66553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.73  E-value=1.3e-08  Score=88.24  Aligned_cols=79  Identities=18%  Similarity=0.107  Sum_probs=54.8

Q ss_pred             cEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----cc-ChhhhCCCCCccccccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KI-PPDLCNLVQLEYFDFSMNM   79 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~i-p~~~~~~~~L~~l~~s~N~   79 (383)
                      +.+++++|++..+|..+  ..+|+.|+|++|+++ .||..+.++.+|+.|+|++    .+ |..|.++++|+.|++++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            45677777774333322  256778888888887 7777788888888888754    23 3457778888888888888


Q ss_pred             ccccCCC
Q 046461           80 LGGHIPE   86 (383)
Q Consensus        80 l~g~ip~   86 (383)
                      +++..|.
T Consensus        90 l~~i~~~   96 (193)
T 2wfh_A           90 LRCIPPR   96 (193)
T ss_dssp             CCBCCTT
T ss_pred             cCEeCHH
Confidence            8775553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.72  E-value=1.3e-08  Score=88.42  Aligned_cols=84  Identities=14%  Similarity=0.071  Sum_probs=57.8

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|.+..++ .+..+++|+.|++++|++++..|..++++++|+.|++++     ..|..+..+++|+.|++
T Consensus        65 l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  143 (197)
T 4ezg_A           65 AHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL  143 (197)
T ss_dssp             CTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred             CCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence            456777777777665444 345677777777777777777777777777777777743     34666777777777777


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|.+-+.+|
T Consensus       144 ~~n~~i~~~~  153 (197)
T 4ezg_A          144 SYNGAITDIM  153 (197)
T ss_dssp             CSCTBCCCCG
T ss_pred             cCCCCccccH
Confidence            7777445454

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.70  E-value=1.4e-08  Score=107.44  Aligned_cols=83  Identities=16%  Similarity=0.087  Sum_probs=66.9

Q ss_pred             CccEeecccCCCCCCCCcCC--CCCCCCEEECcCCccccccchhHHhhhccceeeec-----------cccChhhhCCCC
Q 046461            3 HTQKKILIRDNLGMPPIIPK--NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----------FKIPPDLCNLVQ   69 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~--~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~-----------g~ip~~~~~~~~   69 (383)
                      +|+.|+|+.|++...|..+.  ++++|+.|+|++|+++| ||.+++++++|+.|+|+           +.+|.++.++++
T Consensus       729 ~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~  807 (876)
T 4ecn_A          729 LLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS  807 (876)
T ss_dssp             GCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSS
T ss_pred             CccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCC
Confidence            78888888888854455554  78888888888888887 88888888888888873           367888888888


Q ss_pred             CcccccccccccccCCCC
Q 046461           70 LEYFDFSMNMLGGHIPEK   87 (383)
Q Consensus        70 L~~l~~s~N~l~g~ip~~   87 (383)
                      |+.|++++|++ |.||..
T Consensus       808 L~~L~Ls~N~L-~~Ip~~  824 (876)
T 4ecn_A          808 LIQLQIGSNDI-RKVDEK  824 (876)
T ss_dssp             CCEEECCSSCC-CBCCSC
T ss_pred             CCEEECCCCCC-CccCHh
Confidence            88888888888 888864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.70  E-value=1.2e-08  Score=108.05  Aligned_cols=84  Identities=20%  Similarity=0.357  Sum_probs=78.4

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCc-ccc-ccchhHHhhh-------ccceeeecc----ccCh--hh
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNK-LNG-EISTFLSHIL-------GILGLYVQF----KIPP--DL   64 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~-l~G-~iP~~~~~~~-------~l~~l~l~g----~ip~--~~   64 (383)
                      |++|+.|+|+.|++ |..|..++++++|+.|+|++|+ |+| .||..++++.       +|+.|++++    .||.  ++
T Consensus       490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l  569 (876)
T 4ecn_A          490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL  569 (876)
T ss_dssp             CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHH
T ss_pred             CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhh
Confidence            57899999999997 8888889999999999999998 999 9999999998       999999965    6898  99


Q ss_pred             hCCCCCcccccccccccccCC
Q 046461           65 CNLVQLEYFDFSMNMLGGHIP   85 (383)
Q Consensus        65 ~~~~~L~~l~~s~N~l~g~ip   85 (383)
                      +++++|+.|++++|+++ .||
T Consensus       570 ~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          570 QKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             TTCTTCCEEECTTSCCC-BCC
T ss_pred             hcCCCCCEEECCCCCcc-cch
Confidence            99999999999999999 888

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.70  E-value=1.2e-08  Score=106.39  Aligned_cols=85  Identities=21%  Similarity=0.184  Sum_probs=75.0

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      +++|+.|+|++|.+..+|..+.++++|+.|+|++|+|+ .||.+|+++.+|+.|+|++    .||.+|+++++|++|+++
T Consensus       223 l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          223 DQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECC
T ss_pred             CCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECC
Confidence            46799999999999555555568999999999999999 9999999999999999966    589999999999999999


Q ss_pred             cccccccCCCC
Q 046461           77 MNMLGGHIPEK   87 (383)
Q Consensus        77 ~N~l~g~ip~~   87 (383)
                      +|.|+ .||..
T Consensus       302 ~N~l~-~lp~~  311 (727)
T 4b8c_D          302 DNMVT-TLPWE  311 (727)
T ss_dssp             SSCCC-CCCSS
T ss_pred             CCCCC-ccChh
Confidence            99996 78875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.67  E-value=1.6e-08  Score=102.74  Aligned_cols=87  Identities=18%  Similarity=0.185  Sum_probs=77.0

Q ss_pred             CCCccEeecccCCC--CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-----cChhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL--GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-----IPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~--~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-----ip~~~~~~~~L~~l   73 (383)
                      +++|+.++|+.|+.  +++|..+..+++|+.|||++|++++.+|..|.++++|+.|+|++.     .|..+..+++|+.|
T Consensus       468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L  547 (635)
T 4g8a_A          468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  547 (635)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred             chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence            46788999999876  578888999999999999999999999999999999999999662     45678999999999


Q ss_pred             ccccccccccCCCC
Q 046461           74 DFSMNMLGGHIPEK   87 (383)
Q Consensus        74 ~~s~N~l~g~ip~~   87 (383)
                      |+++|+|++..|..
T Consensus       548 ~Ls~N~l~~~~~~~  561 (635)
T 4g8a_A          548 DYSLNHIMTSKKQE  561 (635)
T ss_dssp             ECTTSCCCBCCSSC
T ss_pred             ECCCCcCCCCCHHH
Confidence            99999999988864

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.66  E-value=2.2e-08  Score=101.27  Aligned_cols=84  Identities=17%  Similarity=0.070  Sum_probs=75.7

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----c--ChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----I--PPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----i--p~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|++...|..++++++|+.|+|++|++++ || .++++++|+.|+|+++    +  |..++.+++|+.|+
T Consensus       462 l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~  539 (567)
T 1dce_A          462 LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN  539 (567)
T ss_dssp             GTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             cccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence            578999999999997667788999999999999999998 88 8999999999999652    3  89999999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|.|++..|.
T Consensus       540 L~~N~l~~~~~~  551 (567)
T 1dce_A          540 LQGNSLCQEEGI  551 (567)
T ss_dssp             CTTSGGGGSSSC
T ss_pred             ecCCcCCCCccH
Confidence            999999997664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.66  E-value=3.5e-08  Score=91.20  Aligned_cols=82  Identities=26%  Similarity=0.304  Sum_probs=55.3

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|.+...|..+..+++|+.|+|++|++++..|..+.++.+|+.|++++    .+|. .+..+++|+.|++
T Consensus        76 l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  155 (290)
T 1p9a_G           76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (290)
T ss_dssp             CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence            4567777777777755555666777777777777777766666677777777777754    2333 3456677777777


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|+|++
T Consensus       156 ~~N~l~~  162 (290)
T 1p9a_G          156 ANNNLTE  162 (290)
T ss_dssp             TTSCCSC
T ss_pred             CCCcCCc
Confidence            7777764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.66  E-value=1.7e-08  Score=98.85  Aligned_cols=84  Identities=17%  Similarity=0.127  Sum_probs=75.0

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ +++|..++++++|+.|+|++|.+++..|..+.++.+|+.|++++     ..|.++..+++|+.|+
T Consensus       298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  377 (455)
T 3v47_A          298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA  377 (455)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence            57899999999999 78888889999999999999999988899999999999999955     3578899999999999


Q ss_pred             cccccccccC
Q 046461           75 FSMNMLGGHI   84 (383)
Q Consensus        75 ~s~N~l~g~i   84 (383)
                      +++|++++..
T Consensus       378 L~~N~l~~~~  387 (455)
T 3v47_A          378 LDTNQLKSVP  387 (455)
T ss_dssp             CCSSCCSCCC
T ss_pred             CCCCccccCC
Confidence            9999998733

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.65  E-value=3.3e-08  Score=90.79  Aligned_cols=85  Identities=18%  Similarity=0.163  Sum_probs=68.4

Q ss_pred             CCCccEeecccCC-C-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDN-L-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~-~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l   73 (383)
                      +++|+.|+|+.|. + +++|..+..+++|+.|+|++|++++..|..+.++.+|+.|++++    .+| ..+..+++|+.|
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            4678899999987 6 56677888889999999999999888888888888899888855    244 347788889999


Q ss_pred             ccccccccccCC
Q 046461           74 DFSMNMLGGHIP   85 (383)
Q Consensus        74 ~~s~N~l~g~ip   85 (383)
                      ++++|++++..+
T Consensus       159 ~l~~n~l~~~~~  170 (285)
T 1ozn_A          159 FLHGNRISSVPE  170 (285)
T ss_dssp             ECCSSCCCEECT
T ss_pred             ECCCCcccccCH
Confidence            999988876433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.64  E-value=1.9e-08  Score=93.91  Aligned_cols=83  Identities=18%  Similarity=0.109  Sum_probs=72.6

Q ss_pred             CCCccEeecccCCC-CCCCCcC--CCCCCCCEEECcCCccccccchhHHhh-----hccceeeecc-----ccChhhhCC
Q 046461            1 MPHTQKKILIRDNL-GMPPIIP--KNLNELPHLDLSCNKLNGEISTFLSHI-----LGILGLYVQF-----KIPPDLCNL   67 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~--~~l~~L~~l~ls~N~l~G~iP~~~~~~-----~~l~~l~l~g-----~ip~~~~~~   67 (383)
                      +++|+.|+|+.|.+ +..|..+  +.+++|+.|+|++|++++. |..++++     ++|+.|++++     ..|..++++
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            46899999999999 6666654  8999999999999999998 9999998     8999999955     344789999


Q ss_pred             CCCcccccccccccccC
Q 046461           68 VQLEYFDFSMNMLGGHI   84 (383)
Q Consensus        68 ~~L~~l~~s~N~l~g~i   84 (383)
                      ++|+.|++++|++.|.+
T Consensus       173 ~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          173 PALSTLDLSDNPELGER  189 (312)
T ss_dssp             SSCCEEECCSCTTCHHH
T ss_pred             CCCCEEECCCCCcCcch
Confidence            99999999999998864

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.64  E-value=2.4e-08  Score=95.21  Aligned_cols=83  Identities=22%  Similarity=0.043  Sum_probs=45.9

Q ss_pred             CccEeecccCCC-CCCCCcCC-CCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPK-NLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~-~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~   75 (383)
                      .++.|+|+.|++ ++++..+. ++++|+.|+|++|++++..|..+.++.+|+.|+|++    .+| ..|.++++|+.|++
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            355566666666 45555444 566666666666666655555555666666666543    122 23555556666666


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|++++..|
T Consensus       120 ~~N~i~~~~~  129 (361)
T 2xot_A          120 YNNHIVVVDR  129 (361)
T ss_dssp             CSSCCCEECT
T ss_pred             CCCcccEECH
Confidence            6666555433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.64  E-value=3.1e-08  Score=100.65  Aligned_cols=85  Identities=16%  Similarity=0.169  Sum_probs=47.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ +++|..++++++|++|+|++|++++..|..++++.+|+.|++++    .+| ..++++++|++|+
T Consensus        55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  134 (606)
T 3vq2_A           55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN  134 (606)
T ss_dssp             CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred             CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence            35566666666666 45555556666666666666666666666666666666666533    122 3445555555555


Q ss_pred             cccccccc-cCC
Q 046461           75 FSMNMLGG-HIP   85 (383)
Q Consensus        75 ~s~N~l~g-~ip   85 (383)
                      +++|++++ .+|
T Consensus       135 L~~n~l~~~~lp  146 (606)
T 3vq2_A          135 VAHNFIHSCKLP  146 (606)
T ss_dssp             CCSSCCCCCCCC
T ss_pred             CCCCcccceech
Confidence            55555543 344

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.63  E-value=4.7e-08  Score=89.14  Aligned_cols=84  Identities=21%  Similarity=0.275  Sum_probs=69.9

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----c-ChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----I-PPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----i-p~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|++++.    + |..+..+++|+.|+
T Consensus        60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            57899999999999 777777888999999999999999777777788999999998652    3 34578899999999


Q ss_pred             cccccccccC
Q 046461           75 FSMNMLGGHI   84 (383)
Q Consensus        75 ~s~N~l~g~i   84 (383)
                      +++|++++..
T Consensus       140 Ls~n~l~~~~  149 (270)
T 2o6q_A          140 LGYNELQSLP  149 (270)
T ss_dssp             CCSSCCCCCC
T ss_pred             CCCCcCCccC
Confidence            9999998643

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.63  E-value=2.7e-08  Score=94.88  Aligned_cols=85  Identities=19%  Similarity=0.183  Sum_probs=73.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-----cChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-----IPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-----ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|++ ++++..+.++++|+.|||++|++++..|..+.++.+|+.|+|+++     .|..|.++++|+.|+
T Consensus        63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  142 (361)
T 2xot_A           63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY  142 (361)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence            57899999999999 778888899999999999999999877778899999999999652     367788999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|+|++ +|.
T Consensus       143 L~~N~l~~-l~~  153 (361)
T 2xot_A          143 LSQNQISR-FPV  153 (361)
T ss_dssp             CCSSCCCS-CCG
T ss_pred             CCCCcCCe-eCH
Confidence            99999987 554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.63  E-value=3.6e-08  Score=90.46  Aligned_cols=87  Identities=18%  Similarity=0.188  Sum_probs=71.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ +++|..+.++++|+.|+|++|++++..|..++++.+|+.|++++    .+|. .+..+++|+.|+
T Consensus       104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  183 (285)
T 1ozn_A          104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (285)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence            46888999999998 67788888899999999999999877777788888999998865    3454 478888899999


Q ss_pred             cccccccccCCCC
Q 046461           75 FSMNMLGGHIPEK   87 (383)
Q Consensus        75 ~s~N~l~g~ip~~   87 (383)
                      +++|++++..|..
T Consensus       184 l~~n~l~~~~~~~  196 (285)
T 1ozn_A          184 LHQNRVAHVHPHA  196 (285)
T ss_dssp             CCSSCCCEECTTT
T ss_pred             CCCCcccccCHhH
Confidence            9999988877653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.63  E-value=2.6e-08  Score=86.43  Aligned_cols=82  Identities=15%  Similarity=0.051  Sum_probs=53.1

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.+.|+.|++...| .+..+++|+.|++++|.+  ..++.+.++++|+.|++++     ..|..+..+++|+.|+++
T Consensus        44 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~--~~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           44 NSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             HTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCC--SCCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CCccEEeccCCCccChH-HHhcCCCCCEEEccCCCC--CcchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            45677777777774333 356677777777777743  3345666777777777743     246667777777777777


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|++++..|.
T Consensus       121 ~n~i~~~~~~  130 (197)
T 4ezg_A          121 HSAHDDSILT  130 (197)
T ss_dssp             SSBCBGGGHH
T ss_pred             CCccCcHhHH
Confidence            7777765543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.62  E-value=1.9e-08  Score=102.28  Aligned_cols=86  Identities=19%  Similarity=0.195  Sum_probs=68.6

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|++ ++++..+.+|++|++|+|++|++++-.|..|.++.+|+.|++++    .+| ..|+++++|+.|+
T Consensus        75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~  154 (635)
T 4g8a_A           75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN  154 (635)
T ss_dssp             CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence            57889999999988 67788888899999999999998877667788888888888855    244 3578888888888


Q ss_pred             cccccccc-cCCC
Q 046461           75 FSMNMLGG-HIPE   86 (383)
Q Consensus        75 ~s~N~l~g-~ip~   86 (383)
                      +++|++++ .+|.
T Consensus       155 Ls~N~l~~~~~~~  167 (635)
T 4g8a_A          155 VAHNLIQSFKLPE  167 (635)
T ss_dssp             CCSSCCCCCCCCG
T ss_pred             cccCccccCCCch
Confidence            88888865 3443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.62  E-value=2.8e-08  Score=90.76  Aligned_cols=87  Identities=18%  Similarity=0.185  Sum_probs=74.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|++++    .++ ..+..+++|+.|+
T Consensus        51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  130 (276)
T 2z62_A           51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN  130 (276)
T ss_dssp             CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred             ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence            57899999999999 67777889999999999999999998888999999999999955    233 3688899999999


Q ss_pred             cccccccc-cCCCC
Q 046461           75 FSMNMLGG-HIPEK   87 (383)
Q Consensus        75 ~s~N~l~g-~ip~~   87 (383)
                      +++|++++ .+|..
T Consensus       131 l~~n~l~~~~l~~~  144 (276)
T 2z62_A          131 VAHNLIQSFKLPEY  144 (276)
T ss_dssp             CCSSCCCCCCCCGG
T ss_pred             CcCCccceecCchh
Confidence            99999987 46653

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.62  E-value=2.5e-08  Score=101.43  Aligned_cols=84  Identities=24%  Similarity=0.246  Sum_probs=44.8

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc------ccChhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF------KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g------~ip~~~~~~~~L~~l~   74 (383)
                      ++|+.|+|+.|.+ +++|..++++++|++|+|++|++++..|..++++.+|+.|++++      .+|..++++++|+.|+
T Consensus        80 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~  159 (606)
T 3vq2_A           80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD  159 (606)
T ss_dssp             TTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEE
T ss_pred             hhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEE
Confidence            4555555555555 44455555555555555555555554445555555555555522      3455555555555555


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +++|++++..|
T Consensus       160 Ls~n~l~~~~~  170 (606)
T 3vq2_A          160 LSYNYIQTITV  170 (606)
T ss_dssp             CCSSCCCEECT
T ss_pred             ccCCcceecCh
Confidence            55555555433

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.61  E-value=3.4e-08  Score=100.53  Aligned_cols=86  Identities=12%  Similarity=0.064  Sum_probs=69.9

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|++ +++|..++++++|+.|+|++|.+++..|..++++++|+.|+|++    .+|.. ++++++|+.|+
T Consensus        74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            46788888888888 67777888888888888888888888787888888888888865    46655 47888888888


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       154 Ls~N~l~~~~~~  165 (597)
T 3oja_B          154 MSNNNLERIEDD  165 (597)
T ss_dssp             CCSSCCCBCCTT
T ss_pred             eeCCcCCCCChh
Confidence            888888886664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.61  E-value=2.3e-08  Score=100.29  Aligned_cols=80  Identities=13%  Similarity=0.020  Sum_probs=47.8

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCcccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDFS   76 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~s   76 (383)
                      +|+.|+|+.|++ +++|..++++++|++|+|++|++++..|..++++.+|+.|++++    .+| ..++++++|++|+++
T Consensus        27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  106 (549)
T 2z81_A           27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM  106 (549)
T ss_dssp             TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred             CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence            456666666666 45555556666666666666666666556666666666666643    123 335666666666666


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|++++
T Consensus       107 ~n~l~~  112 (549)
T 2z81_A          107 GNPYQT  112 (549)
T ss_dssp             TCCCSS
T ss_pred             CCcccc
Confidence            666654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.60  E-value=5.7e-08  Score=82.69  Aligned_cols=82  Identities=16%  Similarity=0.125  Sum_probs=53.2

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhh-hCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDL-CNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~-~~~~~L~~l~~s   76 (383)
                      ++|+.|+|++|++...|......++|+.|||++|++++.  +.++++.+|+.|++++    .+|..+ ..+++|+.|+++
T Consensus        19 ~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   96 (176)
T 1a9n_A           19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   96 (176)
T ss_dssp             TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             CCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence            567777777777744444433334777777777777764  4566777777777754    245433 677777777777


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|+++ .+|.
T Consensus        97 ~N~i~-~~~~  105 (176)
T 1a9n_A           97 NNSLV-ELGD  105 (176)
T ss_dssp             SCCCC-CGGG
T ss_pred             CCcCC-cchh
Confidence            77773 3543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.60  E-value=4.2e-08  Score=96.04  Aligned_cols=86  Identities=17%  Similarity=0.154  Sum_probs=77.9

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.++|+.|.+ +.+|..++++++|+.|+|++|++++..|..+.++.+|+.|++++     ..|..+.++++|+.|++
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            5799999999999 78888899999999999999999999999999999999999965     34677899999999999


Q ss_pred             ccccccccCCCC
Q 046461           76 SMNMLGGHIPEK   87 (383)
Q Consensus        76 s~N~l~g~ip~~   87 (383)
                      ++|++++..|..
T Consensus       355 s~N~l~~~~~~~  366 (455)
T 3v47_A          355 SYNHIRALGDQS  366 (455)
T ss_dssp             CSSCCCEECTTT
T ss_pred             CCCcccccChhh
Confidence            999999987754

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.60  E-value=1.7e-08  Score=85.99  Aligned_cols=83  Identities=12%  Similarity=0.014  Sum_probs=70.0

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh--hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP--DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~--~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+... ..++.+++|+.|+|++|++++..|..+.++++|+.|++++    .+|.  .+..+++|+.+++
T Consensus        42 ~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l  120 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI  120 (176)
T ss_dssp             TCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEe
Confidence            4899999999999544 5668899999999999999965445559999999999965    4676  7899999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|.++. +|.
T Consensus       121 ~~N~i~~-~~~  130 (176)
T 1a9n_A          121 LRNPVTN-KKH  130 (176)
T ss_dssp             CSSGGGG-STT
T ss_pred             cCCCCCC-cHh
Confidence            9999974 554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.59  E-value=4e-08  Score=91.11  Aligned_cols=83  Identities=13%  Similarity=0.077  Sum_probs=55.0

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCcccc-ccchhHHhhhccceeeecc-----ccChhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNG-EISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G-~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l   73 (383)
                      +++|+.|+|+.|.+ +.++..+..+++|+.|+|++|.+++ .+|..+.++.+|+.|++++     ..|..+..+++|+.|
T Consensus       125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  204 (306)
T 2z66_A          125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  204 (306)
T ss_dssp             CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence            35677777777777 5666666667777777777777766 5666666677777776644     235556666666666


Q ss_pred             cccccccccc
Q 046461           74 DFSMNMLGGH   83 (383)
Q Consensus        74 ~~s~N~l~g~   83 (383)
                      ++++|++++.
T Consensus       205 ~L~~N~l~~~  214 (306)
T 2z66_A          205 NMSHNNFFSL  214 (306)
T ss_dssp             ECTTSCCSBC
T ss_pred             ECCCCccCcc
Confidence            6666666653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.58  E-value=3.3e-08  Score=81.61  Aligned_cols=79  Identities=13%  Similarity=0.036  Sum_probs=70.4

Q ss_pred             CCccEeecccCCCC--CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDNLG--MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~~~--~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      ++++.++|+.|++.  ..|..+..+++|+.|++++|.+++.  ..++++++|+.+++++     .+|..+..+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            57899999999996  7777889999999999999999987  7788899999999955     3777788899999999


Q ss_pred             cccccccc
Q 046461           75 FSMNMLGG   82 (383)
Q Consensus        75 ~s~N~l~g   82 (383)
                      +++|++++
T Consensus        95 ls~N~i~~  102 (149)
T 2je0_A           95 LSGNKIKD  102 (149)
T ss_dssp             CTTSCCCS
T ss_pred             CCCCcCCC
Confidence            99999988

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.57  E-value=3.3e-08  Score=83.34  Aligned_cols=85  Identities=25%  Similarity=0.252  Sum_probs=72.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccc-cchhHHhhhccceeeecc----ccCh----hhhCCCCC
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGE-ISTFLSHILGILGLYVQF----KIPP----DLCNLVQL   70 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~-iP~~~~~~~~l~~l~l~g----~ip~----~~~~~~~L   70 (383)
                      |++|+.|+|+.|.+ +.+|..+.++++|+.|+|++|++++. .+..+.++++|+.+++++    .+|.    .+..+++|
T Consensus        70 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L  149 (168)
T 2ell_A           70 LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQL  149 (168)
T ss_dssp             CSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSC
T ss_pred             CCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccC
Confidence            57899999999999 55888878899999999999999874 347889999999999966    3565    78899999


Q ss_pred             cccccccccccccCCC
Q 046461           71 EYFDFSMNMLGGHIPE   86 (383)
Q Consensus        71 ~~l~~s~N~l~g~ip~   86 (383)
                      +.|++++|.+.. +|.
T Consensus       150 ~~L~l~~n~~~~-~~~  164 (168)
T 2ell_A          150 TYLDGYDREDQE-APD  164 (168)
T ss_dssp             CEETTEETTSCB-CCS
T ss_pred             cEecCCCCChhh-ccc
Confidence            999999998854 453

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.57  E-value=9.1e-08  Score=87.23  Aligned_cols=85  Identities=25%  Similarity=0.269  Sum_probs=71.3

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~   75 (383)
                      ++++.|+|+.|++ ++++..+.++++|++|+|++|++++-.+..+.++.+|+.|++++    .+| ..+.++++|+.|++
T Consensus        37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  116 (270)
T 2o6q_A           37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL  116 (270)
T ss_dssp             TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred             CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence            4689999999999 77777889999999999999999955445568899999999965    355 45688999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       117 ~~n~l~~~~~~  127 (270)
T 2o6q_A          117 DRNQLKSLPPR  127 (270)
T ss_dssp             CSSCCCCCCTT
T ss_pred             CCCccCeeCHH
Confidence            99999886553

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.57  E-value=8.3e-08  Score=81.73  Aligned_cols=82  Identities=20%  Similarity=0.205  Sum_probs=72.4

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ +++|..++++++|+.|+|++|+|++-.|..+.++.+|+.|+|++    .+|.. +..+++|+.|++
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            5789999999999 88899999999999999999999986555678999999999966    36654 889999999999


Q ss_pred             cccccccc
Q 046461           76 SMNMLGGH   83 (383)
Q Consensus        76 s~N~l~g~   83 (383)
                      ++|.++..
T Consensus       113 ~~N~~~c~  120 (174)
T 2r9u_A          113 YNNPWDCE  120 (174)
T ss_dssp             CSSCBCTT
T ss_pred             CCCCcccc
Confidence            99999764

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.57  E-value=4.9e-08  Score=89.17  Aligned_cols=84  Identities=15%  Similarity=-0.002  Sum_probs=73.8

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-----cChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-----IPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-----ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|++++.     .|..+.++++|+.|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            3689999999999 677778899999999999999999888888999999999999652     3467899999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|++++..+
T Consensus       108 ~~n~l~~~~~  117 (276)
T 2z62_A          108 VETNLASLEN  117 (276)
T ss_dssp             TTSCCCCSTT
T ss_pred             CCCCccccCc
Confidence            9999988554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.56  E-value=6.3e-08  Score=90.26  Aligned_cols=85  Identities=21%  Similarity=0.146  Sum_probs=61.5

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccc--cchhH--Hhhhccceeeecc-------ccChh-hhCCC
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGE--ISTFL--SHILGILGLYVQF-------KIPPD-LCNLV   68 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~--iP~~~--~~~~~l~~l~l~g-------~ip~~-~~~~~   68 (383)
                      ++|+.|+|+.|++ +++|..++++++|+.|||++|+++|.  +|+.+  +++.+|+.|++++       .+|.. +.+++
T Consensus       149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  228 (312)
T 1wwl_A          149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV  228 (312)
T ss_dssp             TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred             CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence            6778888888888 66767778888888888888888776  34455  6777888888754       22322 34677


Q ss_pred             CCcccccccccccccCCC
Q 046461           69 QLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        69 ~L~~l~~s~N~l~g~ip~   86 (383)
                      +|+.|++++|++++.+|.
T Consensus       229 ~L~~L~Ls~N~l~~~~~~  246 (312)
T 1wwl_A          229 QLQGLDLSHNSLRDAAGA  246 (312)
T ss_dssp             CCSEEECTTSCCCSSCCC
T ss_pred             CCCEEECCCCcCCcccch
Confidence            888888888888886653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.55  E-value=7.1e-08  Score=90.49  Aligned_cols=78  Identities=19%  Similarity=0.110  Sum_probs=36.2

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.++|+.|.+...|...  .++|+.|++++|++++..|..+.++.+|+.|++++     ..|..+..+++|+.|+++
T Consensus       171 ~~L~~L~l~~n~l~~l~~~~--~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  248 (330)
T 1xku_A          171 KKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN  248 (330)
T ss_dssp             TTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred             CCcCEEECCCCccccCCccc--cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECC
Confidence            45555555555552222211  14455555555555554455555555555555432     122244445555555555


Q ss_pred             ccccc
Q 046461           77 MNMLG   81 (383)
Q Consensus        77 ~N~l~   81 (383)
                      +|+++
T Consensus       249 ~N~l~  253 (330)
T 1xku_A          249 NNKLV  253 (330)
T ss_dssp             SSCCS
T ss_pred             CCcCc
Confidence            55554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.55  E-value=6.2e-08  Score=89.81  Aligned_cols=87  Identities=18%  Similarity=0.191  Sum_probs=75.9

Q ss_pred             CCCccEeecccCCC-CCCC-CcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc------ccChhhhCCCCCcc
Q 046461            1 MPHTQKKILIRDNL-GMPP-IIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF------KIPPDLCNLVQLEY   72 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~-~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g------~ip~~~~~~~~L~~   72 (383)
                      +++|+.|+|+.|.+ ++++ ..+..+++|+.|++++|.+++.+|..+.++.+|+.|++++      .+|..+..+++|+.
T Consensus       100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  179 (306)
T 2z66_A          100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  179 (306)
T ss_dssp             CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence            57899999999999 6665 5778999999999999999999999999999999999854      36888999999999


Q ss_pred             cccccccccccCCCC
Q 046461           73 FDFSMNMLGGHIPEK   87 (383)
Q Consensus        73 l~~s~N~l~g~ip~~   87 (383)
                      |++++|++++..|..
T Consensus       180 L~Ls~n~l~~~~~~~  194 (306)
T 2z66_A          180 LDLSQCQLEQLSPTA  194 (306)
T ss_dssp             EECTTSCCCEECTTT
T ss_pred             EECCCCCcCCcCHHH
Confidence            999999999876653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.55  E-value=4.8e-08  Score=103.55  Aligned_cols=85  Identities=19%  Similarity=0.149  Sum_probs=50.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchh--HHhhhccceeeeccc------cChhhhCCCCCc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTF--LSHILGILGLYVQFK------IPPDLCNLVQLE   71 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~--~~~~~~l~~l~l~g~------ip~~~~~~~~L~   71 (383)
                      |++|+.|+|+.|++ +++|..++++++|+.|+|++|.+++.+|..  ++++++|+.|++++.      .|..++++++|+
T Consensus        72 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~  151 (844)
T 3j0a_A           72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK  151 (844)
T ss_dssp             CTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCC
T ss_pred             CCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCC
Confidence            34566666666666 455555666666666666666666655554  556666666666431      224566666666


Q ss_pred             ccccccccccccCC
Q 046461           72 YFDFSMNMLGGHIP   85 (383)
Q Consensus        72 ~l~~s~N~l~g~ip   85 (383)
                      .|++++|++++..|
T Consensus       152 ~L~Ls~N~i~~~~~  165 (844)
T 3j0a_A          152 SIDFSSNQIFLVCE  165 (844)
T ss_dssp             EEEEESSCCCCCCS
T ss_pred             EEECCCCcCCeeCH
Confidence            66666666665544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.54  E-value=7.3e-08  Score=96.98  Aligned_cols=84  Identities=19%  Similarity=0.188  Sum_probs=43.8

Q ss_pred             CCccEeecccCCC-CCCC-CcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc------ccChhhhCCCCCccc
Q 046461            2 PHTQKKILIRDNL-GMPP-IIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF------KIPPDLCNLVQLEYF   73 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~-~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g------~ip~~~~~~~~L~~l   73 (383)
                      ++|+.++|+.|.+ +.++ ..+.++++|+.|++++|.+++.+|..+.++++|+.|++++      .+|..+..+++|+.|
T Consensus       396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L  475 (570)
T 2z63_A          396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  475 (570)
T ss_dssp             TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence            4555555555555 3333 3445555555555555555555555555555555555522      345555555555555


Q ss_pred             ccccccccccCC
Q 046461           74 DFSMNMLGGHIP   85 (383)
Q Consensus        74 ~~s~N~l~g~ip   85 (383)
                      ++++|++++..|
T Consensus       476 ~l~~n~l~~~~~  487 (570)
T 2z63_A          476 DLSQCQLEQLSP  487 (570)
T ss_dssp             ECTTSCCCEECT
T ss_pred             ECCCCccccCCh
Confidence            555555555444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.54  E-value=7.6e-08  Score=92.45  Aligned_cols=86  Identities=12%  Similarity=0.064  Sum_probs=66.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ ++++..+..+++|+.|+|++|++++..|..++++.+|+.|++++    .+|.. +.++++|+.|+
T Consensus        68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence            46788888888888 56666778888888888888888887777788888888888855    46655 47788888888


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       148 L~~n~l~~~~~~  159 (390)
T 3o6n_A          148 MSNNNLERIEDD  159 (390)
T ss_dssp             CCSSCCCBCCTT
T ss_pred             CCCCccCccChh
Confidence            888888775553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.54  E-value=7.3e-08  Score=90.51  Aligned_cols=82  Identities=16%  Similarity=0.110  Sum_probs=69.0

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|.+ ++++..+.++++|+.|+|++|++++..|..+..+++|+.|++++    .+|.++..+++|+.|+++
T Consensus       193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~  272 (332)
T 2ft3_A          193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLH  272 (332)
T ss_dssp             SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECC
T ss_pred             CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECC
Confidence            4678888888888 67777788889999999999999888888888888899888865    588888889999999999


Q ss_pred             ccccccc
Q 046461           77 MNMLGGH   83 (383)
Q Consensus        77 ~N~l~g~   83 (383)
                      +|++++.
T Consensus       273 ~N~l~~~  279 (332)
T 2ft3_A          273 TNNITKV  279 (332)
T ss_dssp             SSCCCBC
T ss_pred             CCCCCcc
Confidence            9998763

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.54  E-value=3.5e-08  Score=98.04  Aligned_cols=80  Identities=16%  Similarity=0.141  Sum_probs=53.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHH-hhhccceeeeccc----cChhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLS-HILGILGLYVQFK----IPPDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~-~~~~l~~l~l~g~----ip~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ +++|..++++++|+.|+|++|.++|.+|..+. ++++|+.|+|++.    +|. +..+++|+.|++
T Consensus       120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L  198 (487)
T 3oja_A          120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDL  198 (487)
T ss_dssp             SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEEC
Confidence            4677777777777 56666677778888888888888887777775 6777777777441    222 234556666666


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|+++|
T Consensus       199 s~N~l~~  205 (487)
T 3oja_A          199 SSNKLAF  205 (487)
T ss_dssp             CSSCCCE
T ss_pred             CCCCCCC
Confidence            6666655

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.53  E-value=1e-07  Score=80.74  Aligned_cols=84  Identities=21%  Similarity=0.198  Sum_probs=74.1

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ +++|..++++++|+.|+|++|++++..|..+.++.+|+.|+|++    .+|. .+.++++|+.|++
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            5789999999999 88899999999999999999999977776788999999999965    3555 5889999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|.+++..+
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            9999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.53  E-value=2.5e-07  Score=83.72  Aligned_cols=87  Identities=14%  Similarity=0.050  Sum_probs=69.8

Q ss_pred             ccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhc--------------------------
Q 046461          183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHR--------------------------  236 (383)
Q Consensus       183 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~--------------------------  236 (383)
                      .+.++++++.+.+..++||||++|.+|.+.+....+...++.+++++++.||+.                          
T Consensus        71 ~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T 3tm0_A           71 PVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             CCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             CCCeEEEEEecCCceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence            466788888888899999999999999887533334456788999999999981                          


Q ss_pred             ------------------------------CCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          237 ------------------------------FQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       237 ------------------------------~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                                                    ..+.++|+|+++.||+++.+....|.||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                          013589999999999998766677999988743

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.53  E-value=4.7e-08  Score=91.03  Aligned_cols=87  Identities=20%  Similarity=0.141  Sum_probs=68.1

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccc--cchh--HHhhhccceeeeccc-c---Ch---h-hhCC
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGE--ISTF--LSHILGILGLYVQFK-I---PP---D-LCNL   67 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~--iP~~--~~~~~~l~~l~l~g~-i---p~---~-~~~~   67 (383)
                      +++|+.|+|+.|.+ ++++..++.+++|+.|||++|++.|.  +|..  ++++++|+.|++++. +   |.   + +..+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l  223 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG  223 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence            46889999999999 78888888999999999999998774  3332  367888888888552 2   32   2 4678


Q ss_pred             CCCcccccccccccccCCCC
Q 046461           68 VQLEYFDFSMNMLGGHIPEK   87 (383)
Q Consensus        68 ~~L~~l~~s~N~l~g~ip~~   87 (383)
                      ++|+.|++|+|++++.+|..
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~  243 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPS  243 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhh
Confidence            99999999999999987754

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.53  E-value=9.4e-08  Score=97.28  Aligned_cols=83  Identities=18%  Similarity=0.113  Sum_probs=72.4

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.+ +++|..++++++|+.|+|++|.+++..|..++++++|+.|++++     ..|..++++++|+.|+
T Consensus        98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  177 (597)
T 3oja_B           98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ  177 (597)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence            57899999999999 88888899999999999999999965555578999999999955     3566799999999999


Q ss_pred             ccccccccc
Q 046461           75 FSMNMLGGH   83 (383)
Q Consensus        75 ~s~N~l~g~   83 (383)
                      +++|++++.
T Consensus       178 L~~N~l~~~  186 (597)
T 3oja_B          178 LSSNRLTHV  186 (597)
T ss_dssp             CTTSCCSBC
T ss_pred             CcCCCCCCc
Confidence            999999874

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.53  E-value=3.9e-08  Score=98.08  Aligned_cols=83  Identities=18%  Similarity=0.101  Sum_probs=56.5

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|.+ +++|..+.++++|++|+|++|++++..|..++++.+|+.|++++    .+|..  .+++|++|+++
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~   98 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLS   98 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEecc
Confidence            3567777777777 56656667777777777777777777777777777777777754    35554  66677777777


Q ss_pred             cccccc-cCCC
Q 046461           77 MNMLGG-HIPE   86 (383)
Q Consensus        77 ~N~l~g-~ip~   86 (383)
                      +|++++ .+|.
T Consensus        99 ~N~l~~~~~p~  109 (520)
T 2z7x_B           99 FNAFDALPICK  109 (520)
T ss_dssp             SSCCSSCCCCG
T ss_pred             CCccccccchh
Confidence            777766 4554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.52  E-value=1.4e-07  Score=87.01  Aligned_cols=83  Identities=25%  Similarity=0.231  Sum_probs=67.6

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|++...+.. +.+++|+.|+|++|+++ .+|..+.++.+|+.|++++    .+| ..|.++++|+.|++
T Consensus        54 l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L  131 (290)
T 1p9a_G           54 YTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (290)
T ss_dssp             CTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence            57899999999999433333 78999999999999998 7888888899999999865    344 56889999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|++++-.|
T Consensus       132 ~~N~l~~~~~  141 (290)
T 1p9a_G          132 KGNELKTLPP  141 (290)
T ss_dssp             TTSCCCCCCT
T ss_pred             CCCCCCccCh
Confidence            9999986433

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.51  E-value=8.1e-08  Score=96.91  Aligned_cols=82  Identities=21%  Similarity=0.137  Sum_probs=57.1

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.|+|+.|.+ +++|..+.++++|++|+|++|++++..|..++++.+|+.|++++    .+|..  .+++|+.|+++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls  129 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLS  129 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECC
Confidence            4577777777777 66666777777777777777777777777777777777777754    35554  66667777777


Q ss_pred             cccccc-cCC
Q 046461           77 MNMLGG-HIP   85 (383)
Q Consensus        77 ~N~l~g-~ip   85 (383)
                      +|++++ ++|
T Consensus       130 ~N~l~~l~~p  139 (562)
T 3a79_B          130 FNDFDVLPVC  139 (562)
T ss_dssp             SSCCSBCCCC
T ss_pred             CCCccccCch
Confidence            777665 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.51  E-value=7.7e-08  Score=96.50  Aligned_cols=86  Identities=21%  Similarity=0.145  Sum_probs=78.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc------ccChhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF------KIPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g------~ip~~~~~~~~L~~l   73 (383)
                      |++|+.|+|+.|++ +++|..++++++|++|||++|++++..|..++++.+|+.|++++      .+|..++++++|+.|
T Consensus        49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  128 (549)
T 2z81_A           49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL  128 (549)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence            57899999999999 78888899999999999999999998888899999999999965      356789999999999


Q ss_pred             ccccccccccCCC
Q 046461           74 DFSMNMLGGHIPE   86 (383)
Q Consensus        74 ~~s~N~l~g~ip~   86 (383)
                      ++++|++.+.+|.
T Consensus       129 ~L~~n~~~~~~~~  141 (549)
T 2z81_A          129 RIGNVETFSEIRR  141 (549)
T ss_dssp             EEEESSSCCEECT
T ss_pred             ECCCCccccccCH
Confidence            9999998888875

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.50  E-value=9.4e-08  Score=95.29  Aligned_cols=83  Identities=19%  Similarity=0.212  Sum_probs=53.4

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-------ccChhhhCCCCCccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-------KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-------~ip~~~~~~~~L~~l~~   75 (383)
                      +|+.++|+.|++.-.+ .+..+++|+.|++++|++++.+|..++++++|+.|++++       .+|..+..+++|+.|++
T Consensus       303 ~L~~L~l~~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~L  381 (520)
T 2z7x_B          303 NIKNFTVSGTRMVHML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI  381 (520)
T ss_dssp             CCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEEC
T ss_pred             ceeEEEcCCCcccccc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEEC
Confidence            4666666666652211 125667777777777777777777777777777777633       34455667777777777


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++.+|.
T Consensus       382 s~N~l~~~l~~  392 (520)
T 2z7x_B          382 SQNSVSYDEKK  392 (520)
T ss_dssp             CSSCCBCCGGG
T ss_pred             CCCcCCccccc
Confidence            77777776664

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.50  E-value=6.8e-08  Score=102.35  Aligned_cols=85  Identities=14%  Similarity=0.081  Sum_probs=51.9

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCcccccc-chhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEI-STFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~i-P~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      ++++.|+|+.|.+ +++|..+.++++|+.|||++|.+.+.| |..+.++.+|+.|+|++     ..|.+++++++|+.|+
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  103 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR  103 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence            4566666666666 555566666666666666666666666 44566666666666643     2355566666666666


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++.+|.
T Consensus       104 Ls~n~l~~~~~~  115 (844)
T 3j0a_A          104 LYFCGLSDAVLK  115 (844)
T ss_dssp             CTTCCCSSCCST
T ss_pred             CcCCCCCccccc
Confidence            666666665543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.48  E-value=1.1e-07  Score=89.97  Aligned_cols=84  Identities=14%  Similarity=0.125  Sum_probs=71.4

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|++ ++++..+.++++|+.|+|++|++++..|..++++.+|+.|++++    .+|.. +.++++|++|++
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            4688999999999 67776888999999999999999988888899999999999965    46665 788999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++ +|.
T Consensus       132 ~~n~l~~-l~~  141 (353)
T 2z80_A          132 LGNPYKT-LGE  141 (353)
T ss_dssp             TTCCCSS-SCS
T ss_pred             CCCCCcc-cCc
Confidence            9999985 554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.48  E-value=8.9e-08  Score=97.28  Aligned_cols=80  Identities=14%  Similarity=0.008  Sum_probs=48.4

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s   76 (383)
                      +++.|+|+.|++ +++|..++++++|++|||++|++++..|..|+++.+|+.|++++     ..|..++++++|++|+++
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            456666666666 55555666666666666666666666666666666666666643     235555666666666666


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|++++
T Consensus       114 ~n~i~~  119 (606)
T 3t6q_A          114 QTGISS  119 (606)
T ss_dssp             TSCCSC
T ss_pred             ccCccc
Confidence            666655

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.47  E-value=1.4e-07  Score=89.08  Aligned_cols=83  Identities=14%  Similarity=0.066  Sum_probs=72.2

Q ss_pred             CCCccEeeccc-CCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIR-DNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~-~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|++ |.+ ++++..+++|++|+.|+|++|+|+|..|..|+++.+|+.|+|++    .+|..+.....|+.|+
T Consensus        30 ~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~  109 (347)
T 2ifg_A           30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELV  109 (347)
T ss_dssp             CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEE
T ss_pred             CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEE
Confidence            46799999996 999 78888899999999999999999999999999999999999966    4676655544599999


Q ss_pred             ccccccccc
Q 046461           75 FSMNMLGGH   83 (383)
Q Consensus        75 ~s~N~l~g~   83 (383)
                      +++|.|...
T Consensus       110 l~~N~~~c~  118 (347)
T 2ifg_A          110 LSGNPLHCS  118 (347)
T ss_dssp             CCSSCCCCC
T ss_pred             eeCCCccCC
Confidence            999999764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.46  E-value=1.6e-07  Score=92.71  Aligned_cols=85  Identities=19%  Similarity=0.128  Sum_probs=48.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.+ +++|..++++++|+.|+|++|++++..+..+.++.+|+.|++++     ..|..+.++++|+.|+
T Consensus        55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~  134 (477)
T 2id5_A           55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE  134 (477)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence            34566666666666 45555566666666666666666644334455666666666633     2344555566666666


Q ss_pred             cccccccccCC
Q 046461           75 FSMNMLGGHIP   85 (383)
Q Consensus        75 ~s~N~l~g~ip   85 (383)
                      +++|++++..|
T Consensus       135 l~~n~l~~~~~  145 (477)
T 2id5_A          135 VGDNDLVYISH  145 (477)
T ss_dssp             ECCTTCCEECT
T ss_pred             CCCCccceeCh
Confidence            66666655444

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.46  E-value=1e-07  Score=95.97  Aligned_cols=86  Identities=13%  Similarity=0.086  Sum_probs=78.0

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccc-cccchhHHhhhccceeeecc-----ccChhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLN-GEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~-G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l   73 (383)
                      +++|+.|+|+.|.+ +.+|..+..+++|+.|+|++|.++ |.+|..+.++++|+.|++++     ..|.++..+++|+.|
T Consensus       420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  499 (570)
T 2z63_A          420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  499 (570)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence            57899999999999 788888999999999999999998 78999999999999999955     358889999999999


Q ss_pred             ccccccccccCCC
Q 046461           74 DFSMNMLGGHIPE   86 (383)
Q Consensus        74 ~~s~N~l~g~ip~   86 (383)
                      ++++|++++..|.
T Consensus       500 ~l~~n~l~~~~~~  512 (570)
T 2z63_A          500 NMASNQLKSVPDG  512 (570)
T ss_dssp             ECCSSCCSCCCTT
T ss_pred             eCCCCcCCCCCHH
Confidence            9999999997664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.45  E-value=1.5e-07  Score=97.07  Aligned_cols=84  Identities=18%  Similarity=0.131  Sum_probs=39.3

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+ +++|..++++++|++|+|++|++++-.|..++++.+|+.|++++    .+| ..++++++|++|++
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            3455555555555 44444444555555555555555432222345555555555432    122 33444555555555


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|++++..|
T Consensus       129 s~n~l~~~~~  138 (680)
T 1ziw_A          129 SHNGLSSTKL  138 (680)
T ss_dssp             CSSCCSCCCC
T ss_pred             CCCcccccCc
Confidence            5555544433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.45  E-value=2.5e-07  Score=90.71  Aligned_cols=84  Identities=17%  Similarity=0.049  Sum_probs=66.5

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      |++|+.|+|+.|++...|. +..+++|+.|+|++|++++..|..+.++.+|+.|++++     ..|..+.++++|+.|++
T Consensus       195 l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  273 (452)
T 3zyi_A          195 LFNLKYLNLGMCNIKDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL  273 (452)
T ss_dssp             CTTCCEEECTTSCCSSCCC-CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCccccccc-ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence            4678888888888844443 46788888999999999988888888889999888854     34667888899999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|+|++..+
T Consensus       274 ~~N~l~~~~~  283 (452)
T 3zyi_A          274 AHNNLSSLPH  283 (452)
T ss_dssp             CSSCCSCCCT
T ss_pred             CCCcCCccCh
Confidence            9999986443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.44  E-value=1.5e-07  Score=89.22  Aligned_cols=85  Identities=19%  Similarity=0.149  Sum_probs=71.6

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh--hhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP--DLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~--~~~~~~~L~~l   73 (383)
                      +++|+.|+|+.|++ +++|..++++++|++|||++|++++..|..+.++.+|+.|++++    .+|.  .+.++++|+.|
T Consensus        75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence            57899999999999 67788889999999999999999965555588999999999966    3665  68899999999


Q ss_pred             ccccccccccCC
Q 046461           74 DFSMNMLGGHIP   85 (383)
Q Consensus        74 ~~s~N~l~g~ip   85 (383)
                      ++++|+..+.+|
T Consensus       155 ~l~~n~~~~~~~  166 (353)
T 2z80_A          155 RVGNMDTFTKIQ  166 (353)
T ss_dssp             EEEESSSCCEEC
T ss_pred             ECCCCccccccC
Confidence            999996444454

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.44  E-value=1.5e-07  Score=92.38  Aligned_cols=81  Identities=17%  Similarity=0.133  Sum_probs=69.7

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++++.|+|+.|++ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|+|++    .+|. .+.++++|+.|++
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            4688999999999 78888889999999999999999988888999999999999965    3554 4778999999999


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|++++
T Consensus       155 ~~N~l~~  161 (452)
T 3zyi_A          155 RNNPIES  161 (452)
T ss_dssp             CSCCCCE
T ss_pred             CCCCcce
Confidence            9999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.44  E-value=2.3e-07  Score=93.63  Aligned_cols=84  Identities=21%  Similarity=0.235  Sum_probs=56.6

Q ss_pred             CCCccEeecccCCC-C-CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-G-MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~-~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ + +|+..+..+++|+.|+|++|+++|.+|..+.  .+|+.|++++    .||.++..+++|+.|+
T Consensus       402 l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~  479 (562)
T 3a79_B          402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN  479 (562)
T ss_dssp             CTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEE
T ss_pred             CCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEE
Confidence            35566666666666 3 5555556666666666666666666666543  5677777754    4777777888888888


Q ss_pred             cccccccccCCCC
Q 046461           75 FSMNMLGGHIPEK   87 (383)
Q Consensus        75 ~s~N~l~g~ip~~   87 (383)
                      +++|+++ .+|..
T Consensus       480 L~~N~l~-~l~~~  491 (562)
T 3a79_B          480 VASNQLK-SVPDG  491 (562)
T ss_dssp             CCSSCCC-CCCTT
T ss_pred             CCCCCCC-CCCHH
Confidence            8888888 46653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.43  E-value=2.5e-07  Score=93.97  Aligned_cols=86  Identities=22%  Similarity=0.123  Sum_probs=58.8

Q ss_pred             CCCccEeecccCCC-CCCC-CcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc------c--ChhhhCCCCC
Q 046461            1 MPHTQKKILIRDNL-GMPP-IIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK------I--PPDLCNLVQL   70 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~-~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~------i--p~~~~~~~~L   70 (383)
                      +++|+.|+|+.|.+ +.++ ..+.++++|+.|++++|.+++.+|..++++++|+.|++++.      +  +..+..+++|
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L  478 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL  478 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred             CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence            45677777777777 4433 34667777777777777777777777777777777777441      2  2456677777


Q ss_pred             cccccccccccccCCC
Q 046461           71 EYFDFSMNMLGGHIPE   86 (383)
Q Consensus        71 ~~l~~s~N~l~g~ip~   86 (383)
                      +.|++++|++++..|.
T Consensus       479 ~~L~Ls~n~l~~~~~~  494 (606)
T 3t6q_A          479 EILVLSFCDLSSIDQH  494 (606)
T ss_dssp             CEEECTTSCCCEECTT
T ss_pred             cEEECCCCccCccChh
Confidence            7777777777776654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.42  E-value=1.9e-07  Score=92.08  Aligned_cols=85  Identities=16%  Similarity=0.119  Sum_probs=73.4

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++++.|+|+.|++ ++++..+.++++|+.|+|++|.+++..|..+.++.+|+.|+|++    .+|. .+.++++|+.|++
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  111 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI  111 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence            4688999999999 77788889999999999999999998899999999999999965    3564 4688999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       112 s~n~i~~~~~~  122 (477)
T 2id5_A          112 SENKIVILLDY  122 (477)
T ss_dssp             TTSCCCEECTT
T ss_pred             CCCccccCChh
Confidence            99999887664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.42  E-value=2.4e-07  Score=95.43  Aligned_cols=85  Identities=13%  Similarity=0.130  Sum_probs=76.5

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      ++++.|+|+.|++ ++++..++++++|+.|||++|.+++..|..++++.+|+.|++++    .+|. .++++++|++|++
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            4789999999999 78888899999999999999999999999999999999999965    4675 5999999999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       105 ~~n~l~~~~~~  115 (680)
T 1ziw_A          105 MSNSIQKIKNN  115 (680)
T ss_dssp             CSSCCCCCCSC
T ss_pred             CCCccCccChh
Confidence            99999875554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.40  E-value=3.1e-07  Score=89.74  Aligned_cols=84  Identities=21%  Similarity=0.112  Sum_probs=64.3

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      |++|+.|+|+.|++...|. +..+++|+.|||++|++++..|..+.++.+|+.|++++     ..|..+.++++|+.|++
T Consensus       184 l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  262 (440)
T 3zyj_A          184 LSNLRYLNLAMCNLREIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL  262 (440)
T ss_dssp             CSSCCEEECTTSCCSSCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEEC
T ss_pred             ccccCeecCCCCcCccccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEEC
Confidence            4577788888888754443 46788888888888888888888888888888888854     24566788888888888


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|+|++..+
T Consensus       263 ~~N~l~~~~~  272 (440)
T 3zyj_A          263 AHNNLTLLPH  272 (440)
T ss_dssp             TTSCCCCCCT
T ss_pred             CCCCCCccCh
Confidence            8888886443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.40  E-value=1.3e-07  Score=84.39  Aligned_cols=84  Identities=21%  Similarity=0.236  Sum_probs=71.0

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCc-cccccchhHHhhhccceeeecc-----ccC-hhhhCCCCCccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNK-LNGEISTFLSHILGILGLYVQF-----KIP-PDLCNLVQLEYF   73 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~-l~G~iP~~~~~~~~l~~l~l~g-----~ip-~~~~~~~~L~~l   73 (383)
                      ++|+.++|+.|++ ++++..+.++++|+.|+|++|+ +++-.|..+.++.+|+.+++++     .+| ..+.++++|+.|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            4689999999999 7777788999999999999997 6655555788999999999975     244 467899999999


Q ss_pred             ccccccccccCCC
Q 046461           74 DFSMNMLGGHIPE   86 (383)
Q Consensus        74 ~~s~N~l~g~ip~   86 (383)
                      ++++|++++ +|.
T Consensus       111 ~l~~n~l~~-lp~  122 (239)
T 2xwt_C          111 GIFNTGLKM-FPD  122 (239)
T ss_dssp             EEEEECCCS-CCC
T ss_pred             eCCCCCCcc-ccc
Confidence            999999988 774

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.40  E-value=1e-08  Score=89.14  Aligned_cols=79  Identities=16%  Similarity=0.229  Sum_probs=64.5

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      +++|+.|+|+.|++...| .+..+++|+.|+|++|+++ .+|..+..+++|+.|++++    .+| .+..+++|+.|+++
T Consensus        47 l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~  123 (198)
T 1ds9_A           47 LKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMS  123 (198)
T ss_dssp             TTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEES
T ss_pred             CCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECC
Confidence            468899999999984445 6678899999999999988 7888888888899998855    255 57888888888888


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|++++
T Consensus       124 ~N~i~~  129 (198)
T 1ds9_A          124 NNKITN  129 (198)
T ss_dssp             EEECCC
T ss_pred             CCcCCc
Confidence            888875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.40  E-value=3.7e-07  Score=87.63  Aligned_cols=82  Identities=18%  Similarity=0.128  Sum_probs=71.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchh-HHhhhccceeeecc-----ccChhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTF-LSHILGILGLYVQF-----KIPPDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l   73 (383)
                      +++|+.|+|+.|.+ +++|..++++++|+.|+|++|+++ .+|.. +.++++|+.|++++     ..|..+..+++|+.|
T Consensus        92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  170 (390)
T 3o6n_A           92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL  170 (390)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred             CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence            57899999999999 788888899999999999999999 56655 58899999999965     235668999999999


Q ss_pred             cccccccccc
Q 046461           74 DFSMNMLGGH   83 (383)
Q Consensus        74 ~~s~N~l~g~   83 (383)
                      ++++|++++.
T Consensus       171 ~l~~n~l~~~  180 (390)
T 3o6n_A          171 QLSSNRLTHV  180 (390)
T ss_dssp             ECCSSCCSBC
T ss_pred             ECCCCcCCcc
Confidence            9999999874

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.38  E-value=3e-07  Score=86.15  Aligned_cols=56  Identities=25%  Similarity=0.243  Sum_probs=26.4

Q ss_pred             CCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccccccccc
Q 046461           26 ELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSMNMLG   81 (383)
Q Consensus        26 ~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s~N~l~   81 (383)
                      .|+.|+|++|++++..|..++++.+|+.|++++     ..|..+.++++|++|++++|+++
T Consensus        53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  113 (330)
T 1xku_A           53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK  113 (330)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC
Confidence            444455555555444444444455555554432     12444444555555555555544

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.35  E-value=3.2e-07  Score=86.06  Aligned_cols=76  Identities=16%  Similarity=0.021  Sum_probs=34.4

Q ss_pred             ccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCcccccccc
Q 046461            4 TQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         4 ~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      ++.++++.+++...|..+  .++|+.|+|++|++++..|..+.++.+|+.|++++     ..|..+.++++|++|++++|
T Consensus        35 l~~l~~~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  112 (332)
T 2ft3_A           35 LRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN  112 (332)
T ss_dssp             TTEEECCSSCCSSCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred             CCEEECCCCCccccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence            444555555442222211  13444555555555544444455555555555432     12344445555555555555


Q ss_pred             ccc
Q 046461           79 MLG   81 (383)
Q Consensus        79 ~l~   81 (383)
                      +++
T Consensus       113 ~l~  115 (332)
T 2ft3_A          113 HLV  115 (332)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.35  E-value=5.4e-07  Score=88.05  Aligned_cols=84  Identities=18%  Similarity=0.141  Sum_probs=42.1

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC-hhhhCCCCCccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~   75 (383)
                      ++|+.|+|+.|.+ ++++..+.++++|+.|+|++|++++..|..+.++.+|+.|++++    .+| ..+.++++|+.|++
T Consensus        88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  167 (440)
T 3zyj_A           88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL  167 (440)
T ss_dssp             SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence            4555555555555 44445555555555555555555544444455555555555533    122 23444555555555


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|+..+.+|
T Consensus       168 ~~~~~l~~i~  177 (440)
T 3zyj_A          168 GELKRLSYIS  177 (440)
T ss_dssp             CCCTTCCEEC
T ss_pred             CCCCCcceeC
Confidence            5544434443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.34  E-value=2.6e-07  Score=93.27  Aligned_cols=79  Identities=19%  Similarity=0.174  Sum_probs=53.4

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhcc-------ceeeecc----ccChhhhCCCCC
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGI-------LGLYVQF----KIPPDLCNLVQL   70 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l-------~~l~l~g----~ip~~~~~~~~L   70 (383)
                      ++|+.|+|++|.++..|. +.  ++|+.|+|++|+++ .||. +..  +|       +.|+|++    .||.++..+++|
T Consensus       160 ~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L  232 (571)
T 3cvr_A          160 TSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPT  232 (571)
T ss_dssp             TTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTT
T ss_pred             CCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCC
Confidence            456666666666632333 33  67777777777777 6666 543  55       7777755    578888888888


Q ss_pred             cccccccccccccCCCC
Q 046461           71 EYFDFSMNMLGGHIPEK   87 (383)
Q Consensus        71 ~~l~~s~N~l~g~ip~~   87 (383)
                      +.|++++|.|+|.+|..
T Consensus       233 ~~L~L~~N~l~~~~p~~  249 (571)
T 3cvr_A          233 CTIILEDNPLSSRIRES  249 (571)
T ss_dssp             EEEECCSSSCCHHHHHH
T ss_pred             CEEEeeCCcCCCcCHHH
Confidence            88888888888887753

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.34  E-value=4.4e-08  Score=85.04  Aligned_cols=81  Identities=26%  Similarity=0.176  Sum_probs=64.3

Q ss_pred             CCccEeecccCCC-CCCCC------cCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCC
Q 046461            2 PHTQKKILIRDNL-GMPPI------IPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQL   70 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~------~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L   70 (383)
                      ..++.+.|..+.+ |..|.      .+.++++|+.|+|++|++++ +| .+.++.+|+.|++++    .+|..+..+++|
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L   95 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTL   95 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHC
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcC
Confidence            3455666777777 55554      56788999999999999987 88 888999999999865    578777788899


Q ss_pred             cccccccccccccCC
Q 046461           71 EYFDFSMNMLGGHIP   85 (383)
Q Consensus        71 ~~l~~s~N~l~g~ip   85 (383)
                      +.|++++|++++ +|
T Consensus        96 ~~L~L~~N~l~~-l~  109 (198)
T 1ds9_A           96 EELWISYNQIAS-LS  109 (198)
T ss_dssp             SEEEEEEEECCC-HH
T ss_pred             CEEECcCCcCCc-CC
Confidence            999999999987 54

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.32  E-value=2.7e-07  Score=85.76  Aligned_cols=82  Identities=18%  Similarity=0.039  Sum_probs=69.5

Q ss_pred             CCccEeecccCCC-CCCCCcC--CCCCCCCEEECcCCccccccc----hhHHhhhccceeeecc-----ccChhhhCCCC
Q 046461            2 PHTQKKILIRDNL-GMPPIIP--KNLNELPHLDLSCNKLNGEIS----TFLSHILGILGLYVQF-----KIPPDLCNLVQ   69 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~--~~l~~L~~l~ls~N~l~G~iP----~~~~~~~~l~~l~l~g-----~ip~~~~~~~~   69 (383)
                      ++|+.|+|+.|.+ +.+|..+  +++++|+.|+|++|++++.+|    ..+..+++|+.|++++     ..|..+..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            5699999999999 7777776  899999999999999999877    3345688999999955     34567889999


Q ss_pred             Cccccccccccccc
Q 046461           70 LEYFDFSMNMLGGH   83 (383)
Q Consensus        70 L~~l~~s~N~l~g~   83 (383)
                      |++|++++|++.|.
T Consensus       171 L~~L~Ls~N~l~~~  184 (310)
T 4glp_A          171 LTSLDLSDNPGLGE  184 (310)
T ss_dssp             CCEEECCSCTTCHH
T ss_pred             CCEEECCCCCCccc
Confidence            99999999998774

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.31  E-value=3.1e-07  Score=85.77  Aligned_cols=83  Identities=14%  Similarity=0.080  Sum_probs=62.6

Q ss_pred             CCCccEeecccCCC-CCCCCcC-CCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIP-KNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~-~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|+.|.+ ++++..+ ..+++|+.|+|++|++++. |. ...+.+|+.|++++    .+|..+..+++|+.|+
T Consensus       143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~  220 (317)
T 3o53_A          143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWIS  220 (317)
T ss_dssp             GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEE
T ss_pred             cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEE
Confidence            36788889998888 5555544 4788888999999888865 33 23477888888865    4677788888888899


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++ +|.
T Consensus       221 L~~N~l~~-l~~  231 (317)
T 3o53_A          221 LRNNKLVL-IEK  231 (317)
T ss_dssp             CTTSCCCE-ECT
T ss_pred             CcCCcccc-hhh
Confidence            98888884 665

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.31  E-value=2.1e-07  Score=83.07  Aligned_cols=82  Identities=15%  Similarity=0.156  Sum_probs=67.0

Q ss_pred             CCCccEeecccCC-C-CCCCCcCCCCCCCCEEECcC-CccccccchhHHhhhccceeeecc----ccChhhhCCCCCc--
Q 046461            1 MPHTQKKILIRDN-L-GMPPIIPKNLNELPHLDLSC-NKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLE--   71 (383)
Q Consensus         1 ~~~~~~~~l~~~~-~-~~~~~~~~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~--   71 (383)
                      +++|+.++|+.|. + ++++..+.++++|+.|+|++ |++++..|..+.++++|+.+++++    .+|. +..+++|+  
T Consensus        54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L  132 (239)
T 2xwt_C           54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIF  132 (239)
T ss_dssp             CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSE
T ss_pred             CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccccc-cccccccccc
Confidence            5788999999996 7 67777788899999999998 999876667788889999999865    3676 77788887  


Q ss_pred             -ccccccc-ccccc
Q 046461           72 -YFDFSMN-MLGGH   83 (383)
Q Consensus        72 -~l~~s~N-~l~g~   83 (383)
                       .+++++| ++++-
T Consensus       133 ~~L~l~~N~~l~~i  146 (239)
T 2xwt_C          133 FILEITDNPYMTSI  146 (239)
T ss_dssp             EEEEEESCTTCCEE
T ss_pred             cEEECCCCcchhhc
Confidence             8999998 77663

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.29  E-value=2.6e-07  Score=91.73  Aligned_cols=83  Identities=16%  Similarity=0.074  Sum_probs=66.7

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccccChhhhCCCCCcccccccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNML   80 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~~~~~~~L~~l~~s~N~l   80 (383)
                      ++|+.|+|++|.+ +++|..++.+++|+.|+|++|.++|.+|  ++.+++|+.|++++.-=..+...++|+.|++++|++
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l  111 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI  111 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence            4799999999999 7888888999999999999999999887  899999999999763112233346777777777777


Q ss_pred             cccCCC
Q 046461           81 GGHIPE   86 (383)
Q Consensus        81 ~g~ip~   86 (383)
                      ++..|.
T Consensus       112 ~~~~~~  117 (487)
T 3oja_A          112 SRVSCS  117 (487)
T ss_dssp             CCEEEC
T ss_pred             CCCCcc
Confidence            775543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.27  E-value=7.9e-07  Score=80.78  Aligned_cols=76  Identities=17%  Similarity=0.071  Sum_probs=50.3

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      ++|+.|+|++|++...+ .+..+++|+.|+|++|++++..|  +.++++|+.|++++    .+|. +.. ++|+.|++++
T Consensus        41 ~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~  115 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDN  115 (263)
T ss_dssp             TTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCS
T ss_pred             CcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccC
Confidence            56777777777775444 34667777788888777776444  77777777777754    2333 222 6677777777


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |++++
T Consensus       116 N~l~~  120 (263)
T 1xeu_A          116 NELRD  120 (263)
T ss_dssp             SCCSB
T ss_pred             CccCC
Confidence            77765

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.27  E-value=1.1e-06  Score=81.02  Aligned_cols=78  Identities=28%  Similarity=0.358  Sum_probs=59.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|++ ++++  +.++++|+.|+|++|.+++ +| .+.++.+|+.|++++    .+ +.+..+++|+.|++
T Consensus        67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l  141 (291)
T 1h6t_A           67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYL  141 (291)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEEC
T ss_pred             CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEc
Confidence            46788888888888 4544  6788888888888888876 34 478888888888855    23 35777888888888


Q ss_pred             cccccccc
Q 046461           76 SMNMLGGH   83 (383)
Q Consensus        76 s~N~l~g~   83 (383)
                      ++|++++.
T Consensus       142 ~~n~l~~~  149 (291)
T 1h6t_A          142 GNNKITDI  149 (291)
T ss_dssp             CSSCCCCC
T ss_pred             cCCcCCcc
Confidence            88888763

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.26  E-value=7.9e-07  Score=82.70  Aligned_cols=80  Identities=18%  Similarity=0.166  Sum_probs=62.3

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      |++|+.|+|+.|++...+. +..+++|+.|++++|++++..|  ++++.+|+.|++++    .+|. +..+++|+.|+++
T Consensus       106 l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~  181 (308)
T 1h6u_A          106 LQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKAD  181 (308)
T ss_dssp             CTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECC
T ss_pred             CCCCCEEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECC
Confidence            5688899999999844443 6788999999999999887544  78888888888865    2444 7888888888888


Q ss_pred             cccccccC
Q 046461           77 MNMLGGHI   84 (383)
Q Consensus        77 ~N~l~g~i   84 (383)
                      +|++++..
T Consensus       182 ~n~l~~~~  189 (308)
T 1h6u_A          182 DNKISDIS  189 (308)
T ss_dssp             SSCCCCCG
T ss_pred             CCccCcCh
Confidence            88887743

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.25  E-value=1.2e-06  Score=80.85  Aligned_cols=78  Identities=17%  Similarity=0.138  Sum_probs=65.1

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc---cChhhhCCCCCcccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK---IPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~---ip~~~~~~~~L~~l~~s~N   78 (383)
                      ++|+.++|+.|.+...+. +..+++|+.|+|++|++++..|  +.++.+|+.|++++.   -++.+..+++|+.|++++|
T Consensus        46 ~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~n  122 (291)
T 1h6t_A           46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN  122 (291)
T ss_dssp             HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGGGTTCTTCCEEECTTS
T ss_pred             CcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChhhccCCCCCEEECCCC
Confidence            578999999999954444 5789999999999999998555  899999999999652   1234899999999999999


Q ss_pred             cccc
Q 046461           79 MLGG   82 (383)
Q Consensus        79 ~l~g   82 (383)
                      ++++
T Consensus       123 ~i~~  126 (291)
T 1h6t_A          123 GISD  126 (291)
T ss_dssp             CCCC
T ss_pred             cCCC
Confidence            9987

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.25  E-value=1.3e-06  Score=81.29  Aligned_cols=80  Identities=19%  Similarity=0.352  Sum_probs=67.8

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      |++|+.|+|+.|.+..++ .+..+++|+.|+|++|++++ +|. +.++++|+.|++++    .+|. +..+++|+.|+++
T Consensus        84 l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~  159 (308)
T 1h6u_A           84 LTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIG  159 (308)
T ss_dssp             CCSCCEEECCSCCCSCCG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECC
T ss_pred             CCCCCEEEccCCcCCCch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEcc
Confidence            578999999999995554 46789999999999999987 454 88999999999965    3444 8899999999999


Q ss_pred             cccccccC
Q 046461           77 MNMLGGHI   84 (383)
Q Consensus        77 ~N~l~g~i   84 (383)
                      +|++++..
T Consensus       160 ~n~l~~~~  167 (308)
T 1h6u_A          160 NAQVSDLT  167 (308)
T ss_dssp             SSCCCCCG
T ss_pred             CCcCCCCh
Confidence            99998743

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.23  E-value=1.6e-06  Score=78.66  Aligned_cols=76  Identities=21%  Similarity=0.343  Sum_probs=51.3

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|++ ++++  +.++++|+.|+|++|++++ +|....  .+|+.|++++    .+| .+..+++|+.|++
T Consensus        62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~L  135 (263)
T 1xeu_A           62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRDTD-SLIHLKNLEILSI  135 (263)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSBSG-GGTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCCCh-hhcCcccccEEEC
Confidence            46788888888888 4444  6778888888888888776 443222  6667777644    233 4666777777777


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|++++
T Consensus       136 s~N~i~~  142 (263)
T 1xeu_A          136 RNNKLKS  142 (263)
T ss_dssp             TTSCCCB
T ss_pred             CCCcCCC
Confidence            7777766

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.23  E-value=1.7e-06  Score=88.10  Aligned_cols=80  Identities=23%  Similarity=0.289  Sum_probs=42.6

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      ++|+.|+|+.|.+..+| .+..+++|+.|+|++|++++ + +.+.++++|+.|+|++    .+ ..+..+++|+.|++++
T Consensus        87 ~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~  162 (605)
T 1m9s_A           87 KNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLED  162 (605)
T ss_dssp             TTCCEEECCSSCCCCCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCS
T ss_pred             CCCCEEECcCCCCCCCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcC
Confidence            45555555555553333 23455556666666666554 2 2355555666665533    12 3455666666666666


Q ss_pred             ccccccCC
Q 046461           78 NMLGGHIP   85 (383)
Q Consensus        78 N~l~g~ip   85 (383)
                      |++++..|
T Consensus       163 N~l~~~~~  170 (605)
T 1m9s_A          163 NQISDIVP  170 (605)
T ss_dssp             SCCCCCGG
T ss_pred             CcCCCchh
Confidence            66665444

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.23  E-value=1.5e-06  Score=78.08  Aligned_cols=83  Identities=13%  Similarity=0.065  Sum_probs=62.7

Q ss_pred             cceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcC--------------------------
Q 046461          184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRF--------------------------  237 (383)
Q Consensus       184 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~--------------------------  237 (383)
                      +.+++++...++..++||||+++.+|.  .. ......++.++++.+..||+..                          
T Consensus        77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~-~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (264)
T 1nd4_A           77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS-HLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV  153 (264)
T ss_dssp             BCCEEEEEECSSCEEEEEECCSSEETT--TS-CCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred             CCeEEEeccCCCCCEEEEEecCCcccC--cC-cCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence            455677777777889999999999884  22 2223356777888888888642                          


Q ss_pred             -----------------------------CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          238 -----------------------------QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       238 -----------------------------~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                                                   ...++|+|+++.||+++.+..+.+.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                         11399999999999998776677999999754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.22  E-value=1.4e-06  Score=82.05  Aligned_cols=82  Identities=15%  Similarity=0.171  Sum_probs=68.8

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.++|+.|.++..+ .+..+++|+.|++++|++++.  +.+..+++|+.|++++     ..|..+..+++|+.|++
T Consensus       242 l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  318 (347)
T 4fmz_A          242 LSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL  318 (347)
T ss_dssp             CTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred             CCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence            578999999999995554 457899999999999999874  4588899999999854     45677899999999999


Q ss_pred             ccccccccCC
Q 046461           76 SMNMLGGHIP   85 (383)
Q Consensus        76 s~N~l~g~ip   85 (383)
                      ++|.+++..|
T Consensus       319 ~~n~l~~~~~  328 (347)
T 4fmz_A          319 SQNHITDIRP  328 (347)
T ss_dssp             CSSSCCCCGG
T ss_pred             cCCccccccC
Confidence            9999998766

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.20  E-value=1.4e-06  Score=85.74  Aligned_cols=77  Identities=22%  Similarity=0.352  Sum_probs=46.5

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----cChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----IPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|.+ ++++  +..+++|+.|+|++|++++..|  ++++++|+.|++++.    +++ +..+++|+.|++
T Consensus       264 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l  338 (466)
T 1o6v_A          264 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFF  338 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEEC
T ss_pred             CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeEC
Confidence            35677777777777 4433  4566677777777777666443  566666666666431    222 555666666666


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|++++
T Consensus       339 ~~n~l~~  345 (466)
T 1o6v_A          339 YNNKVSD  345 (466)
T ss_dssp             CSSCCCC
T ss_pred             CCCccCC
Confidence            6666655

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.19  E-value=3.3e-07  Score=85.50  Aligned_cols=83  Identities=16%  Similarity=0.074  Sum_probs=65.2

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccccChhhhCCCCCcccccccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNLVQLEYFDFSMNML   80 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~~~~~~~L~~l~~s~N~l   80 (383)
                      ++|+.|+|+.|.+ +++|..+.++++|+.|+|++|++++..|  +..+.+|+.|++++.-=..+...++|+.|++++|++
T Consensus        34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l  111 (317)
T 3o53_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI  111 (317)
T ss_dssp             GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred             CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCcc
Confidence            4788999999999 6777778899999999999999998776  888899999999663222334557888888888888


Q ss_pred             cccCCC
Q 046461           81 GGHIPE   86 (383)
Q Consensus        81 ~g~ip~   86 (383)
                      ++..+.
T Consensus       112 ~~~~~~  117 (317)
T 3o53_A          112 SRVSCS  117 (317)
T ss_dssp             SEEEEC
T ss_pred             CCcCcc
Confidence            775543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.16  E-value=1.5e-06  Score=88.79  Aligned_cols=78  Identities=23%  Similarity=0.247  Sum_probs=55.8

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      ++|+.|+|++|++..+|   ..+++|+.|+|++|+++ .||.   .+.+|+.|++++    .||.++.++++|+.|++++
T Consensus       221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCS
T ss_pred             CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecC
Confidence            45666666666663223   34567777777777777 4666   456677777754    5788888999999999999


Q ss_pred             ccccccCCC
Q 046461           78 NMLGGHIPE   86 (383)
Q Consensus        78 N~l~g~ip~   86 (383)
                      |.++|.+|.
T Consensus       294 N~l~~~~~~  302 (622)
T 3g06_A          294 NPLSERTLQ  302 (622)
T ss_dssp             CCCCHHHHH
T ss_pred             CCCCCcCHH
Confidence            999888775

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.15  E-value=9.9e-07  Score=83.50  Aligned_cols=84  Identities=15%  Similarity=0.137  Sum_probs=68.5

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchh-HHhhhccceee-ecc----cc-ChhhhCCCCCccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTF-LSHILGILGLY-VQF----KI-PPDLCNLVQLEYF   73 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~l~~l~-l~g----~i-p~~~~~~~~L~~l   73 (383)
                      ++++.|+|+.|++ ++|+..+.++++|+.|||++|++.+.||.. +.++.+|..+. +.+    .+ |..+..+++|+++
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            4789999999999 677778999999999999999999999874 56777766543 332    24 5678999999999


Q ss_pred             ccccccccccCC
Q 046461           74 DFSMNMLGGHIP   85 (383)
Q Consensus        74 ~~s~N~l~g~ip   85 (383)
                      ++++|++++..+
T Consensus       110 ~l~~n~l~~~~~  121 (350)
T 4ay9_X          110 LISNTGIKHLPD  121 (350)
T ss_dssp             EEEEECCSSCCC
T ss_pred             cccccccccCCc
Confidence            999999987443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.13  E-value=2.5e-07  Score=86.71  Aligned_cols=83  Identities=14%  Similarity=0.035  Sum_probs=68.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccc-cchhHHhhhccceeeecc-----ccChhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGE-ISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~-iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~   74 (383)
                      ++++.+.|..|.+ +.++. ...+++|+.|+|++|.+++. +|..+.++++|+.|++++     .+|..++.+++|+.|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            5788899999998 45554 46799999999999999987 999999999999999855     4677788899999999


Q ss_pred             cccc-ccccc-CC
Q 046461           75 FSMN-MLGGH-IP   85 (383)
Q Consensus        75 ~s~N-~l~g~-ip   85 (383)
                      +++| .+++. +|
T Consensus       149 L~~~~~l~~~~l~  161 (336)
T 2ast_B          149 LSGCSGFSEFALQ  161 (336)
T ss_dssp             CTTCBSCCHHHHH
T ss_pred             CCCCCCCCHHHHH
Confidence            9999 67763 44

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.11  E-value=2.1e-06  Score=84.40  Aligned_cols=77  Identities=23%  Similarity=0.380  Sum_probs=57.4

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~   75 (383)
                      +++|+.|+|+.|++ ++++  ++++++|+.|++++|++++..|  ++++.+|+.|++++    .+|. +.++++|+.|++
T Consensus        67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l  141 (466)
T 1o6v_A           67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLEL  141 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEE
T ss_pred             hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-HcCCCCCCEEEC
Confidence            46778888888888 4444  6778888888888888876655  77888888888854    2443 777888888888


Q ss_pred             ccccccc
Q 046461           76 SMNMLGG   82 (383)
Q Consensus        76 s~N~l~g   82 (383)
                      ++|++++
T Consensus       142 ~~n~l~~  148 (466)
T 1o6v_A          142 SSNTISD  148 (466)
T ss_dssp             EEEEECC
T ss_pred             CCCccCC
Confidence            8888776

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.11  E-value=2.8e-06  Score=83.51  Aligned_cols=75  Identities=16%  Similarity=0.136  Sum_probs=36.3

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      ++|+.|+|+.|++.-.| .++.+++|+.|+|++|++++ +|  ++++.+|+.|++++    .+|  ++++++|+.|++++
T Consensus        42 ~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L~L~~  115 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDT  115 (457)
T ss_dssp             TTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECCS
T ss_pred             CCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceee--cCCCCcCCEEECCC
Confidence            45555555555552222 23455555555555555554 23  44555555555533    122  44445555555555


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |++++
T Consensus       116 N~l~~  120 (457)
T 3bz5_A          116 NKLTK  120 (457)
T ss_dssp             SCCSC
T ss_pred             CcCCe
Confidence            55544

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.11  E-value=3.7e-06  Score=79.01  Aligned_cols=82  Identities=22%  Similarity=0.204  Sum_probs=68.5

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      +++|+.|+|+.|.+...+. +..+++|+.|++++|.+++.  +.+..+++|+.+++++    .+ +.+..+++|+.|+++
T Consensus       220 ~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~  295 (347)
T 4fmz_A          220 MTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLN  295 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECC
T ss_pred             CCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECc
Confidence            5789999999999944443 78899999999999999873  4688899999999966    24 358899999999999


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +|.+++..|.
T Consensus       296 ~n~l~~~~~~  305 (347)
T 4fmz_A          296 NNQLGNEDME  305 (347)
T ss_dssp             SSCCCGGGHH
T ss_pred             CCcCCCcChh
Confidence            9999887664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.11  E-value=2.8e-06  Score=86.44  Aligned_cols=78  Identities=23%  Similarity=0.233  Sum_probs=44.4

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      |++|+.|+|+.|.+..++. +..|++|+.|+|++|++++.  +.+..+.+|+.|+|++    .+++ +..+++|+.|+++
T Consensus       108 l~~L~~L~Ls~N~l~~l~~-l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls  183 (605)
T 1m9s_A          108 LKKLKSLSLEHNGISDING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLS  183 (605)
T ss_dssp             CTTCCEEECTTSCCCCCGG-GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECC
T ss_pred             CCCCCEEEecCCCCCCCcc-ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECc
Confidence            3566666666666633332 45566666666666666653  4455666666666643    1222 5556666666666


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|++++
T Consensus       184 ~N~i~~  189 (605)
T 1m9s_A          184 KNHISD  189 (605)
T ss_dssp             SSCCCB
T ss_pred             CCCCCC
Confidence            666655

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.11  E-value=6.2e-07  Score=85.94  Aligned_cols=82  Identities=16%  Similarity=0.075  Sum_probs=40.9

Q ss_pred             CCccEeecccCCCC--CCC---CcCCCCCCCCEEECcCCccc--c---ccchhHHhhhccceeeecc---------ccCh
Q 046461            2 PHTQKKILIRDNLG--MPP---IIPKNLNELPHLDLSCNKLN--G---EISTFLSHILGILGLYVQF---------KIPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~--~~~---~~~~~l~~L~~l~ls~N~l~--G---~iP~~~~~~~~l~~l~l~g---------~ip~   62 (383)
                      ++|+.|+|+.|+++  ..+   ..+..+++|+.|+|++|+++  |   .+|..+.++++|+.|+|++         .+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            45555556555552  222   12234555555555555555  2   2333455555555555532         2344


Q ss_pred             hhhCCCCCccccccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l~g~   83 (383)
                      .+..+++|+.|++++|++++.
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCHH
T ss_pred             HHccCCCcCEEECCCCCCchh
Confidence            555555555555555555543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.10  E-value=3.3e-06  Score=85.28  Aligned_cols=37  Identities=19%  Similarity=0.164  Sum_probs=15.8

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccch
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEIST   43 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~   43 (383)
                      +|+.|+|+.|+++.+|   ..+++|+.|+|++|+|++ ||.
T Consensus        81 ~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~-ip~  117 (571)
T 3cvr_A           81 QITVLEITQNALISLP---ELPASLEYLDACDNRLST-LPE  117 (571)
T ss_dssp             TCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC
T ss_pred             CCCEEECcCCCCcccc---cccCCCCEEEccCCCCCC-cch
Confidence            3444444444442222   223444444444444444 444

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.08  E-value=6e-07  Score=86.06  Aligned_cols=86  Identities=12%  Similarity=0.075  Sum_probs=73.5

Q ss_pred             CCCccEeecccCCCC------CCCCcCCCCCCCCEEECcCCccc----cccchhHHhhhccceeeeccc---------cC
Q 046461            1 MPHTQKKILIRDNLG------MPPIIPKNLNELPHLDLSCNKLN----GEISTFLSHILGILGLYVQFK---------IP   61 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~------~~~~~~~~l~~L~~l~ls~N~l~----G~iP~~~~~~~~l~~l~l~g~---------ip   61 (383)
                      +++|+.|.|+.|+++      +.+..+..+++|+.|+|++|.++    +.+|..+.++++|+.|+|++.         +|
T Consensus       186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  265 (386)
T 2ca6_A          186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV  265 (386)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred             CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence            468999999999996      56656688999999999999997    889999999999999999652         56


Q ss_pred             hhhh--CCCCCcccccccccccc----cCCC
Q 046461           62 PDLC--NLVQLEYFDFSMNMLGG----HIPE   86 (383)
Q Consensus        62 ~~~~--~~~~L~~l~~s~N~l~g----~ip~   86 (383)
                      ..+.  .+++|+.|++++|.+++    .+|.
T Consensus       266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~  296 (386)
T 2ca6_A          266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKT  296 (386)
T ss_dssp             HHHHTCSSCCCCEEECCSSCCBHHHHHHHHH
T ss_pred             HHHhhccCCCeEEEECcCCcCCHHHHHHHHH
Confidence            6674  49999999999999998    4765

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.04  E-value=2.7e-06  Score=83.63  Aligned_cols=50  Identities=24%  Similarity=0.297  Sum_probs=22.6

Q ss_pred             CCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccccccc
Q 046461           26 ELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        26 ~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N~l~g   82 (383)
                      +|+.|++++|++++ +|..   +.+|+.+++++    .+|.   .+++|+.|++++|+++|
T Consensus       318 ~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          318 SLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSS
T ss_pred             cCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCc
Confidence            44555555555554 4443   23444444432    2333   23445555555555554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.01  E-value=4.7e-06  Score=81.94  Aligned_cols=79  Identities=18%  Similarity=0.115  Sum_probs=43.4

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----cC-hhhhCCC-------C
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----IP-PDLCNLV-------Q   69 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----ip-~~~~~~~-------~   69 (383)
                      ++|+.++|+.|++...+  ++.+++|+.|++++|+++| +|  ++++++|+.+++++.    +| ..+.++.       +
T Consensus       191 ~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~  265 (457)
T 3bz5_A          191 KLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTD  265 (457)
T ss_dssp             TTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCC
T ss_pred             CCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCC
Confidence            45666666666663222  4566666666666666666 55  566666666666431    22 2222222       3


Q ss_pred             CcccccccccccccCC
Q 046461           70 LEYFDFSMNMLGGHIP   85 (383)
Q Consensus        70 L~~l~~s~N~l~g~ip   85 (383)
                      |+.+++++|.+.|.+|
T Consensus       266 L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          266 LLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             CSCCCCTTCTTCCEEE
T ss_pred             CCEEECCCCccCCccc
Confidence            4455555555555555

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.00  E-value=6.4e-06  Score=80.90  Aligned_cols=74  Identities=19%  Similarity=0.110  Sum_probs=33.7

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N   78 (383)
                      +|+.|+|+.|++...| .++++++|++|++++|++++ +|..+   .+|+.|++++    .+| +++++++|+.+++++|
T Consensus       132 ~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N  205 (454)
T 1jl5_A          132 LLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNN  205 (454)
T ss_dssp             TCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSS
T ss_pred             CCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCC
Confidence            3444444444442122 23444445555555554443 44322   2344444422    134 3555555555555555


Q ss_pred             cccc
Q 046461           79 MLGG   82 (383)
Q Consensus        79 ~l~g   82 (383)
                      ++++
T Consensus       206 ~l~~  209 (454)
T 1jl5_A          206 SLKK  209 (454)
T ss_dssp             CCSS
T ss_pred             cCCc
Confidence            5554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=97.96  E-value=3.4e-06  Score=78.89  Aligned_cols=81  Identities=16%  Similarity=0.082  Sum_probs=40.6

Q ss_pred             CCccEeecccCCCC-C-CCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-------cChhhhCCCCCcc
Q 046461            2 PHTQKKILIRDNLG-M-PPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-------IPPDLCNLVQLEY   72 (383)
Q Consensus         2 ~~~~~~~l~~~~~~-~-~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-------ip~~~~~~~~L~~   72 (383)
                      ++|+.|+|+.|.+. . .+..+..+++|+.|+|++|.+++.+|..++++++|+.|++++.       +|..+.++++|+.
T Consensus        93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~  172 (336)
T 2ast_B           93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  172 (336)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence            34555555555542 1 3334445555555555555555555555555555555555331       2333445555555


Q ss_pred             cccccc-cccc
Q 046461           73 FDFSMN-MLGG   82 (383)
Q Consensus        73 l~~s~N-~l~g   82 (383)
                      |++++| ++++
T Consensus       173 L~l~~~~~l~~  183 (336)
T 2ast_B          173 LNLSWCFDFTE  183 (336)
T ss_dssp             EECCCCTTCCH
T ss_pred             EcCCCCCCcCh
Confidence            555555 5543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.86  E-value=5.5e-06  Score=78.66  Aligned_cols=84  Identities=19%  Similarity=0.168  Sum_probs=62.7

Q ss_pred             CCccEeecccCCC-CCCC----CcCCCCC-CCCEEECcCCccccccchhHHhh-----hccceeeeccc-----cChh--
Q 046461            2 PHTQKKILIRDNL-GMPP----IIPKNLN-ELPHLDLSCNKLNGEISTFLSHI-----LGILGLYVQFK-----IPPD--   63 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~----~~~~~l~-~L~~l~ls~N~l~G~iP~~~~~~-----~~l~~l~l~g~-----ip~~--   63 (383)
                      ++|+.|+|+.|.+ +.++    ..+.+++ +|+.|+|++|++++..|..+..+     .+|+.|++++.     .+..  
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            3588899999888 4554    5566777 89999999999988888888876     88888888552     2332  


Q ss_pred             --hhCC-CCCcccccccccccccCC
Q 046461           64 --LCNL-VQLEYFDFSMNMLGGHIP   85 (383)
Q Consensus        64 --~~~~-~~L~~l~~s~N~l~g~ip   85 (383)
                        +..+ ++|+.|++++|++++..+
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~l~~~~~  126 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWNDFSSKSS  126 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred             HHHHhCCCCccEEECcCCcCCcHHH
Confidence              3444 788999999998876543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.77  E-value=2e-05  Score=74.68  Aligned_cols=87  Identities=21%  Similarity=0.291  Sum_probs=65.2

Q ss_pred             ccceeeeEEEeC---CEEEEEEEeccCCCHHH-HHhc--chhhhHHHHhHHHHHHHHhhcC-------------------
Q 046461          183 NIVQLLGYCPVG---EKKLIVYEYMVKGSLND-WLRN--QAKHCIIACGTARGITFLHHRF-------------------  237 (383)
Q Consensus       183 niv~l~g~~~~~---~~~~lv~e~~~~gsL~~-~l~~--~~~~~~i~~~ia~gL~~LH~~~-------------------  237 (383)
                      .+.+++.++.+.   +..++||||+++..+.+ .+..  ..++..++.++++.|+.||...                   
T Consensus        99 pvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3dxp_A           99 PVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQ  178 (359)
T ss_dssp             CCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHH
T ss_pred             CCCcEEEECCCCCccCCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHH
Confidence            467788888765   45799999999987743 2211  2334567888899999999620                   


Q ss_pred             ------------------------------------CCCeeecCCCCCcEEEcCCCc--eEEccccCccc
Q 046461          238 ------------------------------------QPHIIHRDINASNILLNEDFE--VKVSDFGLVRL  269 (383)
Q Consensus       238 ------------------------------------~~~ivHrdlk~~NiLl~~~~~--~kl~Dfgla~~  269 (383)
                                                          .+.++|+|+++.||+++.++.  +.+.||+.+..
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          179 IERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                                247999999999999987653  68999998864

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.69  E-value=4.3e-05  Score=77.93  Aligned_cols=15  Identities=33%  Similarity=0.423  Sum_probs=7.3

Q ss_pred             CCCCEEECcCCcccc
Q 046461           25 NELPHLDLSCNKLNG   39 (383)
Q Consensus        25 ~~L~~l~ls~N~l~G   39 (383)
                      ++|+.|+|++|++++
T Consensus       181 ~~L~~L~Ls~N~l~~  195 (622)
T 3g06_A          181 SGLQELSVSDNQLAS  195 (622)
T ss_dssp             TTCCEEECCSSCCSC
T ss_pred             CCCcEEECCCCCCCC
Confidence            445555555555443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.67  E-value=3e-05  Score=70.38  Aligned_cols=65  Identities=23%  Similarity=0.272  Sum_probs=52.8

Q ss_pred             CCCCCCCEEECcCCcccc--ccchhHHhhhccceeeeccc-cC--hhhhCCC--CCcccccccccccccCCC
Q 046461           22 KNLNELPHLDLSCNKLNG--EISTFLSHILGILGLYVQFK-IP--PDLCNLV--QLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        22 ~~l~~L~~l~ls~N~l~G--~iP~~~~~~~~l~~l~l~g~-ip--~~~~~~~--~L~~l~~s~N~l~g~ip~   86 (383)
                      .++++|+.|+||+|++++  .+|..+..+++|+.|+|+++ |-  .++..+.  +|+.|++++|.+++.+|.
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccCc
Confidence            357899999999999999  88888899999999999652 22  2355555  899999999999998874

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.66  E-value=1.3e-05  Score=76.15  Aligned_cols=81  Identities=19%  Similarity=0.112  Sum_probs=62.5

Q ss_pred             CccEeecccCCC-CCCCCcCCCC-----CCCCEEECcCCccccccchhHHhh-----hccceeeeccc----cC-hh---
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNL-----NELPHLDLSCNKLNGEISTFLSHI-----LGILGLYVQFK----IP-PD---   63 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l-----~~L~~l~ls~N~l~G~iP~~~~~~-----~~l~~l~l~g~----ip-~~---   63 (383)
                      +|+.|+|+.|.+ +..+..+..+     ++|+.|||++|.+++..|..++..     .+|+.|++++.    .+ ..   
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            799999999998 4555555554     899999999999999988887775     78999999552    22 22   


Q ss_pred             -hhC-CCCCccccccccccccc
Q 046461           64 -LCN-LVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        64 -~~~-~~~L~~l~~s~N~l~g~   83 (383)
                       +.. .++|+.|++++|++++.
T Consensus       132 ~l~~~~~~L~~L~Ls~N~l~~~  153 (362)
T 3goz_A          132 AFSNLPASITSLNLRGNDLGIK  153 (362)
T ss_dssp             HHTTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCceeEEEccCCcCCHH
Confidence             333 36899999999999863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.60  E-value=1e-05  Score=74.82  Aligned_cols=117  Identities=15%  Similarity=0.152  Sum_probs=73.2

Q ss_pred             EEEEEEeccCCCHHHHHh---cchhhhHHHHhHHHHHHHHhhc-------------------------------------
Q 046461          197 KLIVYEYMVKGSLNDWLR---NQAKHCIIACGTARGITFLHHR-------------------------------------  236 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~---~~~~~~~i~~~ia~gL~~LH~~-------------------------------------  236 (383)
                      .|+|||+++|.++.+...   ...++..++.++++.++.||..                                     
T Consensus        91 ~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             SCEEEECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             ceEEEcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            478999999988875332   1123445666666666666641                                     


Q ss_pred             ------------------CCCCeeecCCCCCcEEEcC--CCceEEccccCccccCCCCC----ccc-----c----cccc
Q 046461          237 ------------------FQPHIIHRDINASNILLNE--DFEVKVSDFGLVRLISDCES----HTS-----T----DVAG  283 (383)
Q Consensus       237 ------------------~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~~~~~~~----~~~-----~----~~~g  283 (383)
                                        ..+.++|+|+++.||+++.  ...+.+.||+.+........    ...     .    ....
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                              1246899999999999998  45678999999865422100    000     0    0000


Q ss_pred             cccccc-CC------CCCcchhHHHHHHHHHhCCCCC
Q 046461          284 TIGYIL-LA------CGGDIYSFSVVLLELVIRKQPT  313 (383)
Q Consensus       284 t~~y~a-pe------~~~Dv~SfGvil~Elltg~~p~  313 (383)
                      .+++.. |+      ...+.|+++.+++++.+|..++
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            011111 11      1257899999999999998763

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.58  E-value=4.6e-05  Score=69.18  Aligned_cols=73  Identities=22%  Similarity=0.185  Sum_probs=56.1

Q ss_pred             CCCccEeecccCCC-CCC--CCcCCCCCCCCEEECcCCccccccchhHHhhh--ccceeeecc-----ccCh-------h
Q 046461            1 MPHTQKKILIRDNL-GMP--PIIPKNLNELPHLDLSCNKLNGEISTFLSHIL--GILGLYVQF-----KIPP-------D   63 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~--~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~--~l~~l~l~g-----~ip~-------~   63 (383)
                      +++|+.|+|+.|.+ +++  |..+..+++|+.|||++|++++.  .++..+.  +|+.|+|+|     ++|.       -
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i  246 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI  246 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence            57899999999999 543  34456899999999999999986  4566665  889999855     3442       2


Q ss_pred             hhCCCCCccccc
Q 046461           64 LCNLVQLEYFDF   75 (383)
Q Consensus        64 ~~~~~~L~~l~~   75 (383)
                      +..+++|+.||-
T Consensus       247 l~~~P~L~~LDg  258 (267)
T 3rw6_A          247 RERFPKLLRLDG  258 (267)
T ss_dssp             HHHCTTCCEESS
T ss_pred             HHHCcccCeECC
Confidence            677888888763

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.46  E-value=1.9e-05  Score=77.11  Aligned_cols=83  Identities=16%  Similarity=0.083  Sum_probs=60.9

Q ss_pred             CCCccEeecccCCCCCC------CCcCCCCCCCCEEECcCCccccc----cchhHHhhhccceeeeccc-c----Chhhh
Q 046461            1 MPHTQKKILIRDNLGMP------PIIPKNLNELPHLDLSCNKLNGE----ISTFLSHILGILGLYVQFK-I----PPDLC   65 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~------~~~~~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~l~~l~l~g~-i----p~~~~   65 (383)
                      +++|+.|+|+.|.++-.      +.....+++|+.|+|++|++++.    +|..+.++++|+.|++++. +    +..+.
T Consensus       226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  305 (461)
T 1z7x_W          226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  305 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence            46889999999987322      34445688899999999998876    7888888889999988652 2    11222


Q ss_pred             C-----CCCCccccccccccccc
Q 046461           66 N-----LVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        66 ~-----~~~L~~l~~s~N~l~g~   83 (383)
                      .     .++|+.|++++|.+++.
T Consensus       306 ~~l~~~~~~L~~L~L~~n~l~~~  328 (461)
T 1z7x_W          306 ETLLEPGCQLESLWVKSCSFTAA  328 (461)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGG
T ss_pred             HHhccCCccceeeEcCCCCCchH
Confidence            2     26888888888888765

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.42  E-value=2.4e-05  Score=76.37  Aligned_cols=86  Identities=14%  Similarity=0.091  Sum_probs=60.8

Q ss_pred             CCCccEeecccCCCC-CCCCcC-----CCCCCCCEEECcCCccccc----cchhHHhhhccceeeeccc-----cChhhh
Q 046461            1 MPHTQKKILIRDNLG-MPPIIP-----KNLNELPHLDLSCNKLNGE----ISTFLSHILGILGLYVQFK-----IPPDLC   65 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~-~~~~~~-----~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~l~~l~l~g~-----ip~~~~   65 (383)
                      +++|+.|+|+.|.++ ..+..+     ...++|+.|+|++|.+++.    +|..+.++++|+.|++++.     .+..+.
T Consensus       283 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  362 (461)
T 1z7x_W          283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC  362 (461)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred             CCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHH
Confidence            467899999998873 222222     2346889999999998876    6777777888999988552     123333


Q ss_pred             C-----CCCCcccccccccccc----cCCC
Q 046461           66 N-----LVQLEYFDFSMNMLGG----HIPE   86 (383)
Q Consensus        66 ~-----~~~L~~l~~s~N~l~g----~ip~   86 (383)
                      .     .++|+.|++++|++++    .+|.
T Consensus       363 ~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~  392 (461)
T 1z7x_W          363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAA  392 (461)
T ss_dssp             HHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             HHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence            2     6789999999998886    5554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.29  E-value=3.7e-05  Score=73.44  Aligned_cols=81  Identities=20%  Similarity=0.141  Sum_probs=54.5

Q ss_pred             CCccEeecccCCCCCCC-CcC-----CCCCCCCEEECcCCcccc----ccchhHHhhhccceeeeccc---------cCh
Q 046461            2 PHTQKKILIRDNLGMPP-IIP-----KNLNELPHLDLSCNKLNG----EISTFLSHILGILGLYVQFK---------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~-~~~-----~~l~~L~~l~ls~N~l~G----~iP~~~~~~~~l~~l~l~g~---------ip~   62 (383)
                      ++|+.|+|+.|+++-.+ ..+     ...++|+.|+|++|.++.    .++..+..+.+|+.|+|+++         ++.
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~  205 (372)
T 3un9_A          126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA  205 (372)
T ss_dssp             HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred             HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence            35778888888774322 121     245778888888888865    34455566777888888552         345


Q ss_pred             hhhCCCCCcccccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l~g   82 (383)
                      .+...++|+.|++++|+++.
T Consensus       206 ~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          206 QLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             HGGGCSCCCEEECCSSCCCH
T ss_pred             HHhcCCCcCeEECCCCCCCH
Confidence            56677788888888888865

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.28  E-value=0.00022  Score=66.52  Aligned_cols=83  Identities=17%  Similarity=0.173  Sum_probs=69.2

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccc-eeeeccc---cC-hhhhCCCCCccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGIL-GLYVQFK---IP-PDLCNLVQLEYF   73 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~-~l~l~g~---ip-~~~~~~~~L~~l   73 (383)
                      |++|+.++|..|++ .+++..+.+|.+|+.|+|++| ++ .||+ .|.+|.+|+ .+++...   |+ ..|.+|++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPASVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECTTCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcccceEEchhhhhCCccCCEE
Confidence            57899999999989 688888999999999999998 55 4655 578899999 9999654   44 678899999999


Q ss_pred             ccccccccccCCC
Q 046461           74 DFSMNMLGGHIPE   86 (383)
Q Consensus        74 ~~s~N~l~g~ip~   86 (383)
                      +++.|+++. |+.
T Consensus       303 ~l~~n~i~~-I~~  314 (329)
T 3sb4_A          303 LATGDKITT-LGD  314 (329)
T ss_dssp             EECSSCCCE-ECT
T ss_pred             EeCCCccCc-cch
Confidence            999999866 443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.20  E-value=0.0001  Score=74.18  Aligned_cols=77  Identities=9%  Similarity=0.065  Sum_probs=51.5

Q ss_pred             CCCccEeecccCCC-CC----CCCcCCCCCCCCEEECcCCccc----cccchhHHhhhccceeeecc----ccChhhhCC
Q 046461            1 MPHTQKKILIRDNL-GM----PPIIPKNLNELPHLDLSCNKLN----GEISTFLSHILGILGLYVQF----KIPPDLCNL   67 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~----~~~~~~~l~~L~~l~ls~N~l~----G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~   67 (383)
                      |++|+.|+|+.|.+ +.    .+..+.++++|+.|+|++|.++    +.+|..+.++++|+.|++++    .+|..+.++
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~  242 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAA  242 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHC
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhh
Confidence            46788888888876 33    2234456777777888877776    45666666777777777743    255666667


Q ss_pred             CCCccccccc
Q 046461           68 VQLEYFDFSM   77 (383)
Q Consensus        68 ~~L~~l~~s~   77 (383)
                      ++|+.++++.
T Consensus       243 ~~L~~L~l~~  252 (592)
T 3ogk_B          243 ANLEEFCGGS  252 (592)
T ss_dssp             TTCCEEEECB
T ss_pred             hHHHhhcccc
Confidence            7777777664

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.12  E-value=7.3e-05  Score=71.37  Aligned_cols=81  Identities=16%  Similarity=0.060  Sum_probs=61.4

Q ss_pred             CCccEeecccCCCCC--CCCcCCCCCCCCEEECcCCccccccchhHHh-----hhccceeeeccc---------cChhhh
Q 046461            2 PHTQKKILIRDNLGM--PPIIPKNLNELPHLDLSCNKLNGEISTFLSH-----ILGILGLYVQFK---------IPPDLC   65 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~--~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~-----~~~l~~l~l~g~---------ip~~~~   65 (383)
                      ++|+.|+|+.|.++-  ...+...+.+|+.|||++|+++..-...+..     ..+|+.|+|++.         ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            478899999998842  2223334678999999999998776666653     366999999552         455567


Q ss_pred             CCCCCcccccccccccc
Q 046461           66 NLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        66 ~~~~L~~l~~s~N~l~g   82 (383)
                      .+++|+.||+++|+++.
T Consensus       181 ~~~~L~~L~Ls~N~l~~  197 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGD  197 (372)
T ss_dssp             TCSSCCEEECTTSSCHH
T ss_pred             cCCCcCEEeCCCCCCCc
Confidence            88999999999999875

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.12  E-value=0.00016  Score=68.18  Aligned_cols=81  Identities=17%  Similarity=0.115  Sum_probs=56.9

Q ss_pred             CccEeecccCCCC-CCCCcCCCCCCCCEEECcCCccccccchh-HHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            3 HTQKKILIRDNLG-MPPIIPKNLNELPHLDLSCNKLNGEISTF-LSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         3 ~~~~~~l~~~~~~-~~~~~~~~l~~L~~l~ls~N~l~G~iP~~-~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      .++.|+|+.|++. +++.. ....+|+.|++++|+..+.||.. +.++.+|+.|++++    .+|..  .+.+|+.|.+.
T Consensus       155 ~l~~L~L~~N~i~~i~~~~-f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~--~~~~L~~L~~l  231 (350)
T 4ay9_X          155 ESVILWLNKNGIQEIHNSA-FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRAR  231 (350)
T ss_dssp             SCEEEECCSSCCCEECTTS-STTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS--SCTTCCEEECT
T ss_pred             hhhhhccccccccCCChhh-ccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh--hhccchHhhhc
Confidence            5788999999994 55544 45678999999987777788864 68899999999976    46653  24455555554


Q ss_pred             cccccccCCC
Q 046461           77 MNMLGGHIPE   86 (383)
Q Consensus        77 ~N~l~g~ip~   86 (383)
                      +++--..+|.
T Consensus       232 ~~~~l~~lP~  241 (350)
T 4ay9_X          232 STYNLKKLPT  241 (350)
T ss_dssp             TCTTCCCCCC
T ss_pred             cCCCcCcCCC
Confidence            4443455664

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.12  E-value=6.5e-05  Score=75.67  Aligned_cols=83  Identities=6%  Similarity=0.071  Sum_probs=45.7

Q ss_pred             CCCccEeecc----cCCCC-CCC-----CcCCCCCCCCEEECcC--CccccccchhHHh-hhccceeeecc------ccC
Q 046461            1 MPHTQKKILI----RDNLG-MPP-----IIPKNLNELPHLDLSC--NKLNGEISTFLSH-ILGILGLYVQF------KIP   61 (383)
Q Consensus         1 ~~~~~~~~l~----~~~~~-~~~-----~~~~~l~~L~~l~ls~--N~l~G~iP~~~~~-~~~l~~l~l~g------~ip   61 (383)
                      +++|+.|.|.    .|.++ .|.     ..+..+++|+.|+|+.  |.+++..+..++. +++|+.|++++      .+|
T Consensus       402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~  481 (592)
T 3ogk_B          402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM  481 (592)
T ss_dssp             CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred             CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence            3567777775    34442 221     1234466677776653  2366666665554 56666666633      133


Q ss_pred             hhhhCCCCCccccccccccccc
Q 046461           62 PDLCNLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        62 ~~~~~~~~L~~l~~s~N~l~g~   83 (383)
                      ..+..+++|+.|++++|.+++.
T Consensus       482 ~~~~~~~~L~~L~l~~n~l~~~  503 (592)
T 3ogk_B          482 EFSRGCPNLQKLEMRGCCFSER  503 (592)
T ss_dssp             HHHTCCTTCCEEEEESCCCBHH
T ss_pred             HHHhcCcccCeeeccCCCCcHH
Confidence            3445666666666666666543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.11  E-value=0.0016  Score=58.59  Aligned_cols=86  Identities=14%  Similarity=0.123  Sum_probs=59.9

Q ss_pred             cceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-hhhhHHHHhHHHHHHHHhhc--------------------------
Q 046461          184 IVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-AKHCIIACGTARGITFLHHR--------------------------  236 (383)
Q Consensus       184 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~i~~~ia~gL~~LH~~--------------------------  236 (383)
                      +-++++++.+++..++|||++++.++.+..... .....+..+++..+.-||..                          
T Consensus        82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (272)
T 4gkh_A           82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL  161 (272)
T ss_dssp             CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTC
T ss_pred             cCeEEEEEEECCeEEEEEEeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhh
Confidence            567788899999999999999998887654321 11223333444444444421                          


Q ss_pred             -----------------------------CCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          237 -----------------------------FQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       237 -----------------------------~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                                                   ..+.++|+|+.+.||+++.+..+-|.||+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          162 VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                         112479999999999999877778999988754

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.81  E-value=0.00019  Score=61.27  Aligned_cols=82  Identities=16%  Similarity=0.150  Sum_probs=61.2

Q ss_pred             CCccEeecccC-CCCCC-----CCcCCCCCCCCEEECcCCccccc----cchhHHhhhccceeeeccc---------cCh
Q 046461            2 PHTQKKILIRD-NLGMP-----PIIPKNLNELPHLDLSCNKLNGE----ISTFLSHILGILGLYVQFK---------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~-~~~~~-----~~~~~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~l~~l~l~g~---------ip~   62 (383)
                      ++|+.|+|+.| .++-.     ...+...++|+.|||++|+++..    +...+....+|+.|+|++.         +..
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            57899999988 77532     33345678999999999999764    3344445578999999552         455


Q ss_pred             hhhCCCCCccccc--cccccccc
Q 046461           63 DLCNLVQLEYFDF--SMNMLGGH   83 (383)
Q Consensus        63 ~~~~~~~L~~l~~--s~N~l~g~   83 (383)
                      .+...++|+.|++  ++|.++..
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~  138 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNN  138 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHH
Confidence            6777889999999  88998664

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.71  E-value=0.00062  Score=58.03  Aligned_cols=62  Identities=13%  Similarity=0.078  Sum_probs=45.4

Q ss_pred             CCCCCCCCEEECcCC-ccccc----cchhHHhhhccceeeeccc---------cChhhhCCCCCcccccccccccc
Q 046461           21 PKNLNELPHLDLSCN-KLNGE----ISTFLSHILGILGLYVQFK---------IPPDLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        21 ~~~l~~L~~l~ls~N-~l~G~----iP~~~~~~~~l~~l~l~g~---------ip~~~~~~~~L~~l~~s~N~l~g   82 (383)
                      +...+.|+.|+|++| .+...    +...+....+|+.|+|++.         +...+...++|+.|++++|+++.
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            346788999999999 88754    3333444578999999552         34456667889999999999866

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.51  E-value=0.0012  Score=66.26  Aligned_cols=85  Identities=9%  Similarity=0.042  Sum_probs=65.6

Q ss_pred             CCCccEeecccCCC----CCCCCc------------CCCCCCCCEEECcCCccccccchhHH-hhhccceeeeccc----
Q 046461            1 MPHTQKKILIRDNL----GMPPII------------PKNLNELPHLDLSCNKLNGEISTFLS-HILGILGLYVQFK----   59 (383)
Q Consensus         1 ~~~~~~~~l~~~~~----~~~~~~------------~~~l~~L~~l~ls~N~l~G~iP~~~~-~~~~l~~l~l~g~----   59 (383)
                      +++|+.+.|..+..    ++.|..            ...+++|+.|+|++|.+++..+..+. ++++|+.|++++.    
T Consensus        65 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~  144 (594)
T 2p1m_B           65 FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS  144 (594)
T ss_dssp             CTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEE
T ss_pred             CCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCC
Confidence            36788888888753    333322            23678999999999999999998887 7899999999642    


Q ss_pred             ---cChhhhCCCCCcccccccccccccCC
Q 046461           60 ---IPPDLCNLVQLEYFDFSMNMLGGHIP   85 (383)
Q Consensus        60 ---ip~~~~~~~~L~~l~~s~N~l~g~ip   85 (383)
                         ++..+.++++|+.|++++|.+++..+
T Consensus       145 ~~~l~~~~~~~~~L~~L~L~~~~i~~~~~  173 (594)
T 2p1m_B          145 TDGLAAIAATCRNLKELDLRESDVDDVSG  173 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEECTTCEEECCCG
T ss_pred             HHHHHHHHHhCCCCCEEeCcCCccCCcch
Confidence               45555689999999999999877543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.48  E-value=0.0063  Score=56.01  Aligned_cols=32  Identities=28%  Similarity=0.523  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCcEEEcC---CCc-eEEccccCccc
Q 046461          238 QPHIIHRDINASNILLNE---DFE-VKVSDFGLVRL  269 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~---~~~-~kl~Dfgla~~  269 (383)
                      .+.++|+|+++.||+++.   ++. ..|.||+.+..
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            446799999999999987   345 58999998764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.09  E-value=0.003  Score=59.83  Aligned_cols=82  Identities=18%  Similarity=0.145  Sum_probs=43.6

Q ss_pred             CCccEeecccCCCCCC-CCcC--CCCCCCCEEECcC--Cccccc--c---chhH--Hhhhccceeeecc-c----cChhh
Q 046461            2 PHTQKKILIRDNLGMP-PIIP--KNLNELPHLDLSC--NKLNGE--I---STFL--SHILGILGLYVQF-K----IPPDL   64 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~-~~~~--~~l~~L~~l~ls~--N~l~G~--i---P~~~--~~~~~l~~l~l~g-~----ip~~~   64 (383)
                      ++|+.|.|..++++.- ...+  ..+++|+.|+|+.  |...|.  +   -..+  ..+++|+.|+|.. .    .+..+
T Consensus       193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l  272 (362)
T 2ra8_A          193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF  272 (362)
T ss_dssp             TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred             CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence            5677777776654211 1111  2577788777753  332222  1   1111  2356777777732 1    12223


Q ss_pred             h---CCCCCccccccccccccc
Q 046461           65 C---NLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        65 ~---~~~~L~~l~~s~N~l~g~   83 (383)
                      .   .+++|+.|++|.|.+++.
T Consensus       273 a~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          273 LESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             HHCSSGGGCSEEECCSSCCBHH
T ss_pred             HhCccCCCCCEEECCCCCCChH
Confidence            2   467788888888887663

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.07  E-value=0.0008  Score=67.60  Aligned_cols=83  Identities=19%  Similarity=0.195  Sum_probs=60.9

Q ss_pred             CCCccEeeccc------CCCC-CCC-----CcCCCCCCCCEEECcCCccccccchhHHh-hhccceeeeccc-c----Ch
Q 046461            1 MPHTQKKILIR------DNLG-MPP-----IIPKNLNELPHLDLSCNKLNGEISTFLSH-ILGILGLYVQFK-I----PP   62 (383)
Q Consensus         1 ~~~~~~~~l~~------~~~~-~~~-----~~~~~l~~L~~l~ls~N~l~G~iP~~~~~-~~~l~~l~l~g~-i----p~   62 (383)
                      +++|+.|.|..      |+++ .|.     .++..+++|+.|+|++ .+++..+..++. +++|+.|++++. +    +.
T Consensus       396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~  474 (594)
T 2p1m_B          396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH  474 (594)
T ss_dssp             CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred             CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence            57899999993      3333 221     1245789999999987 788888888877 889999999542 2    23


Q ss_pred             hh-hCCCCCcccccccccccccC
Q 046461           63 DL-CNLVQLEYFDFSMNMLGGHI   84 (383)
Q Consensus        63 ~~-~~~~~L~~l~~s~N~l~g~i   84 (383)
                      .+ ..+++|+.|++++|.+++..
T Consensus       475 ~l~~~~~~L~~L~L~~n~~~~~~  497 (594)
T 2p1m_B          475 HVLSGCDSLRKLEIRDCPFGDKA  497 (594)
T ss_dssp             HHHHHCTTCCEEEEESCSCCHHH
T ss_pred             HHHhcCCCcCEEECcCCCCcHHH
Confidence            33 67899999999999996543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.80  E-value=0.0071  Score=56.69  Aligned_cols=32  Identities=28%  Similarity=0.454  Sum_probs=26.4

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      .+.++|+|+.+.||+++.+..+.|.||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35799999999999999644578999988754

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=94.75  E-value=0.021  Score=48.06  Aligned_cols=74  Identities=14%  Similarity=0.036  Sum_probs=40.0

Q ss_pred             ccEeecccCCCCCC-CCcCCCCCCCCEEECcCCc-cccccchhHHh----hhccceeeecc--ccCh----hhhCCCCCc
Q 046461            4 TQKKILIRDNLGMP-PIIPKNLNELPHLDLSCNK-LNGEISTFLSH----ILGILGLYVQF--KIPP----DLCNLVQLE   71 (383)
Q Consensus         4 ~~~~~l~~~~~~~~-~~~~~~l~~L~~l~ls~N~-l~G~iP~~~~~----~~~l~~l~l~g--~ip~----~~~~~~~L~   71 (383)
                      |+.++|+.+.++-. -..+..|++|+.|+|+++. ++..-=..++.    +.+|+.|++++  .|.+    .+..+++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            55666666654111 1123466777777777664 55443334443    23567777755  2432    355666777


Q ss_pred             cccccc
Q 046461           72 YFDFSM   77 (383)
Q Consensus        72 ~l~~s~   77 (383)
                      .|++++
T Consensus       143 ~L~L~~  148 (176)
T 3e4g_A          143 YLFLSD  148 (176)
T ss_dssp             EEEEES
T ss_pred             EEECCC
Confidence            776665

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=94.51  E-value=0.032  Score=44.38  Aligned_cols=53  Identities=15%  Similarity=0.009  Sum_probs=38.6

Q ss_pred             cEeecccCCCC--CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc
Q 046461            5 QKKILIRDNLG--MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK   59 (383)
Q Consensus         5 ~~~~l~~~~~~--~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~   59 (383)
                      ..++.+++++.  .+|..  --.+|+.|||++|+|+.--+..|..+.+|+.++|+|+
T Consensus        11 ~~v~Cs~~~L~~~~vP~~--lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   65 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTA--FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGAN   65 (130)
T ss_dssp             TEEECCSSCCCTTTSCSC--CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSS
T ss_pred             CEEEeCCCCCccccCCCC--CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCC
Confidence            35677888775  44532  1245889999999999655556778899999999774

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.37  E-value=0.05  Score=52.25  Aligned_cols=32  Identities=19%  Similarity=0.309  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .+.++|+|+++.||+++.++ +++.||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45799999999999998776 999999988653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=94.32  E-value=0.042  Score=52.58  Aligned_cols=75  Identities=9%  Similarity=-0.037  Sum_probs=40.7

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccc----cccch-hHHhhhccceeeeccc---cC-hhhhCCCCCccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLN----GEIST-FLSHILGILGLYVQFK---IP-PDLCNLVQLEYF   73 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~----G~iP~-~~~~~~~l~~l~l~g~---ip-~~~~~~~~L~~l   73 (383)
                      +|+.+.|..+-..+....+.+|.+|+.+++++|.+.    ..|+. .|.+|.+|+.+++...   |+ ..|.+|++|+.+
T Consensus       249 ~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~i~~I~~~aF~~c~~L~~l  328 (401)
T 4fdw_A          249 GITTVKLPNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPESIRILGQGLLGGNRKVTQL  328 (401)
T ss_dssp             CCSEEEEETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTTCCEECTTTTTTCCSCCEE
T ss_pred             CccEEEeCCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCceEEEhhhhhcCCCCccEE
Confidence            455566633222555666667777777777666654    12332 4555666666666332   22 234555666666


Q ss_pred             cccc
Q 046461           74 DFSM   77 (383)
Q Consensus        74 ~~s~   77 (383)
                      ++..
T Consensus       329 ~lp~  332 (401)
T 4fdw_A          329 TIPA  332 (401)
T ss_dssp             EECT
T ss_pred             EECc
Confidence            6643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=94.25  E-value=0.12  Score=47.66  Aligned_cols=33  Identities=33%  Similarity=0.414  Sum_probs=27.7

Q ss_pred             CCCeeecCCCCCcEEEcCC----CceEEccccCcccc
Q 046461          238 QPHIIHRDINASNILLNED----FEVKVSDFGLVRLI  270 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~----~~~kl~Dfgla~~~  270 (383)
                      ...++|+|+.+.||+++.+    ..+.+.||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3478999999999999874    67899999988653

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.63  E-value=0.047  Score=34.35  Aligned_cols=21  Identities=14%  Similarity=0.233  Sum_probs=12.0

Q ss_pred             cceeeehhhhhHHHHHHHhhh
Q 046461          107 KLALFGTVVGSVLAIAIIVSM  127 (383)
Q Consensus       107 ~~~~~~~~~~~~~~~~~~~~~  127 (383)
                      ...+++++++++++++++++.
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~   30 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALG   30 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHH
T ss_pred             cceEEeehhHHHHHHHHHHHH
Confidence            344667777766655554434

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=93.28  E-value=0.064  Score=49.52  Aligned_cols=73  Identities=11%  Similarity=-0.080  Sum_probs=58.4

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCC-EEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELP-HLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~-~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~   74 (383)
                      |++|+.+.|..|-..+++..+.+|.+|+ .+++++ +++---+..|.+|.+|+.+++++    .|+. .|.++++|+.+.
T Consensus       249 ~~~L~~l~l~~ni~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          249 KKYLLKIKLPHNLKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CTTCCEEECCTTCCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             CCCCCEEECCcccceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            5789999999983378888999999999 999998 66543346788999999999954    3554 678888998764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=93.15  E-value=0.067  Score=50.44  Aligned_cols=74  Identities=12%  Similarity=0.095  Sum_probs=47.5

Q ss_pred             CCCccEeecccCCCC---C-------CCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-ccccChh----hh
Q 046461            1 MPHTQKKILIRDNLG---M-------PPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-QFKIPPD----LC   65 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~---~-------~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-~g~ip~~----~~   65 (383)
                      +++|+.|.|..+..+   +       .+..+..+++|+.|+|++|.- -.+|. + .+.+|+.|+| .+.++.+    +.
T Consensus       138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~-l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~  214 (362)
T 2ra8_A          138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN-LSIGK-K-PRPNLKSLEIISGGLPDSVVEDIL  214 (362)
T ss_dssp             HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT-CBCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred             cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC-ceecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence            367888888655332   1       223335678999999988731 13444 3 3678888888 3456543    33


Q ss_pred             --CCCCCccccccc
Q 046461           66 --NLVQLEYFDFSM   77 (383)
Q Consensus        66 --~~~~L~~l~~s~   77 (383)
                        .+++|+.|+++.
T Consensus       215 ~~~lp~L~~L~L~~  228 (362)
T 2ra8_A          215 GSDLPNLEKLVLYV  228 (362)
T ss_dssp             HSBCTTCCEEEEEC
T ss_pred             HccCCCCcEEEEec
Confidence              688999998863

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=92.97  E-value=0.14  Score=40.61  Aligned_cols=51  Identities=20%  Similarity=0.194  Sum_probs=31.9

Q ss_pred             CEEECcCCccc-cccchhHHhhhccceeeecc----ccCh-hhhCCCCCcccccccccc
Q 046461           28 PHLDLSCNKLN-GEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDFSMNML   80 (383)
Q Consensus        28 ~~l~ls~N~l~-G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~s~N~l   80 (383)
                      ..+|-++|.|+ ..+|..+.  .+|+.|+|++    .||. .|..+++|+.|++++|.+
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            36777777776 45665432  3466777755    3553 356677777777777655

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=92.50  E-value=0.098  Score=48.11  Aligned_cols=32  Identities=31%  Similarity=0.529  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ...++|+|+++.||+++.++.+.+.||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            45899999999999998788899999998753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=91.36  E-value=0.22  Score=47.47  Aligned_cols=74  Identities=19%  Similarity=0.171  Sum_probs=48.6

Q ss_pred             CccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc---ccC-hhhhCCCCCccccccc
Q 046461            3 HTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF---KIP-PDLCNLVQLEYFDFSM   77 (383)
Q Consensus         3 ~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g---~ip-~~~~~~~~L~~l~~s~   77 (383)
                      +|+.+.|.. ++ .+.+..+.+|.+|+.++|++|+++ .||.....+.+|+.+.+..   .|+ ..|.++++|+.+++..
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCT
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCC
Confidence            355555554 33 555666777888888888887776 5666555567777777743   233 3466777888887775


Q ss_pred             c
Q 046461           78 N   78 (383)
Q Consensus        78 N   78 (383)
                      |
T Consensus       236 ~  236 (401)
T 4fdw_A          236 N  236 (401)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=91.18  E-value=0.33  Score=44.61  Aligned_cols=27  Identities=22%  Similarity=0.366  Sum_probs=23.6

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEcccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFG  265 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfg  265 (383)
                      .+.++|+|+.+.|++++.++ +.+.|+.
T Consensus       206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          206 KPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            56899999999999999877 8888873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=91.12  E-value=0.22  Score=47.15  Aligned_cols=32  Identities=28%  Similarity=0.355  Sum_probs=26.4

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCcccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLI  270 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~  270 (383)
                      .+.++|+|+.+.||+++.+ .+++.||..+..-
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            3478999999999999865 4899999887643

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=91.04  E-value=0.12  Score=32.45  Aligned_cols=19  Identities=16%  Similarity=0.338  Sum_probs=10.7

Q ss_pred             eeeehhhhhHHHHHHHhhh
Q 046461          109 ALFGTVVGSVLAIAIIVSM  127 (383)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~  127 (383)
                      .+++++++++++++++++.
T Consensus        11 aIA~gVVgGv~~v~ii~~~   29 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLT   29 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEeehHHHHHHHHHHHH
Confidence            4666677666555444433

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=89.40  E-value=0.3  Score=44.31  Aligned_cols=30  Identities=17%  Similarity=0.164  Sum_probs=25.0

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          239 PHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       239 ~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..++|+|+.+.||+ ..++.+.+.||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            35899999999999 5567789999988754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=85.95  E-value=3.2  Score=35.97  Aligned_cols=85  Identities=16%  Similarity=0.087  Sum_probs=49.8

Q ss_pred             CHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccccc
Q 046461          208 SLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       208 sL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      +|.+.|..      +.+.+.++.|.+.+|.-+-.... + ..+=..+..|++..+|.+...+ ..+..        .   
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~~--------~---   99 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADDA--------G---   99 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-ccccc--------c---
Confidence            78888873      34678888888888766521101 1 1222346888999999888764 11100        0   


Q ss_pred             ccccccccCC-------CCCcchhHHHHHHHHHh
Q 046461          282 AGTIGYILLA-------CGGDIYSFSVVLLELVI  308 (383)
Q Consensus       282 ~gt~~y~ape-------~~~Dv~SfGvil~Ellt  308 (383)
                        ...+.+|+       .+.=|||+|+++|.-+-
T Consensus       100 --~~~~~~pe~~~~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          100 --EPPPVAGKLGYSQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccCCCChhhccccchHHHHHHHHHHHHHHHhh
Confidence              00111222       45579999999999885

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=85.90  E-value=0.92  Score=42.75  Aligned_cols=52  Identities=8%  Similarity=0.128  Sum_probs=22.1

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccceeee
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYV   56 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l   56 (383)
                      .|+.+.+..+-..+....+.++.+|+.+.+.. .++ .|+. .|.+|.+|+.+++
T Consensus       266 ~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~~-~i~-~I~~~aF~~c~~L~~i~l  318 (394)
T 4gt6_A          266 YLASVKMPDSVVSIGTGAFMNCPALQDIEFSS-RIT-ELPESVFAGCISLKSIDI  318 (394)
T ss_dssp             SCCEEECCTTCCEECTTTTTTCTTCCEEECCT-TCC-EECTTTTTTCTTCCEEEC
T ss_pred             cccEEecccccceecCcccccccccccccCCC-ccc-ccCceeecCCCCcCEEEe
Confidence            44444444333334444444555555555532 222 2332 2334455555544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=84.48  E-value=0.39  Score=30.03  Aligned_cols=9  Identities=33%  Similarity=0.674  Sum_probs=5.2

Q ss_pred             eeehhhhhH
Q 046461          110 LFGTVVGSV  118 (383)
Q Consensus       110 ~~~~~~~~~  118 (383)
                      ++++++|.+
T Consensus        14 Ia~~vVGvl   22 (44)
T 2jwa_A           14 IISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             hHHHHHHHH
Confidence            556666633

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=84.06  E-value=1.2  Score=41.54  Aligned_cols=72  Identities=8%  Similarity=0.141  Sum_probs=29.4

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccceeeecc----ccC-hhhhCCCCCcccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYVQF----KIP-PDLCNLVQLEYFDFS   76 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l~g----~ip-~~~~~~~~L~~l~~s   76 (383)
                      .|+.+.+..+--.+....+.++.+|+.+++..+ +. .|+. .+.+|.+|+.+.+.+    .|+ ..|.++.+|+.+++.
T Consensus       241 ~L~~i~lp~~v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp  318 (379)
T 4h09_A          241 ALDEIAIPKNVTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP  318 (379)
T ss_dssp             SCCEEEECTTCCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred             cceEEEcCCCccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence            344444433322333334444555555554432 11 2222 233445555554422    132 234444555555443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=83.95  E-value=0.91  Score=42.80  Aligned_cols=57  Identities=11%  Similarity=0.186  Sum_probs=26.0

Q ss_pred             cCCCCCCCCEEECcCCccccccch-hHHhhhccceeeecc---ccC-hhhhCCCCCcccccccc
Q 046461           20 IPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYVQF---KIP-PDLCNLVQLEYFDFSMN   78 (383)
Q Consensus        20 ~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l~g---~ip-~~~~~~~~L~~l~~s~N   78 (383)
                      .+..+.+|+.+.+..| ++ .|++ .+.+|.+|+.+++..   .|+ ..|.++.+|+.+++..|
T Consensus       292 ~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYLVEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTTCCEECTTTTTTCTTCCEECCCTT
T ss_pred             cccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCcccEEhHHhccCCCCCCEEEECcc
Confidence            3445555555555433 22 2322 344455555555522   222 23445555555555433

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=83.28  E-value=0.38  Score=43.91  Aligned_cols=32  Identities=22%  Similarity=0.246  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ...++|+|+.+.||+++.+....+.||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            34789999999999998876668999988743

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=82.51  E-value=0.53  Score=40.14  Aligned_cols=77  Identities=8%  Similarity=-0.052  Sum_probs=39.9

Q ss_pred             CCccEeecccC-CCCCC-----CCcCCCCCCCCEEECcCCccccccchhHH----hhhccceeeecc-c--------cCh
Q 046461            2 PHTQKKILIRD-NLGMP-----PIIPKNLNELPHLDLSCNKLNGEISTFLS----HILGILGLYVQF-K--------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~-~~~~~-----~~~~~~l~~L~~l~ls~N~l~G~iP~~~~----~~~~l~~l~l~g-~--------ip~   62 (383)
                      +.|+.|.|+.| ++|..     ...+..=+.|+.|+|++|++...--..|+    .-.+|+.|+|+. .        |-.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~  120 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR  120 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence            35666777654 44422     12223346677788888877643322333    224566666632 1        222


Q ss_pred             hhhCCCCCcccccccc
Q 046461           63 DLCNLVQLEYFDFSMN   78 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N   78 (383)
                      .+..-+.|+.|++++|
T Consensus       121 aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          121 STLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HTTTTCCCSEEECCCC
T ss_pred             HHhhCCceeEEECCCC
Confidence            3444455667776653

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=81.61  E-value=1.2  Score=42.01  Aligned_cols=79  Identities=15%  Similarity=0.169  Sum_probs=58.9

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccceeeecc---ccC-hhhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYVQF---KIP-PDLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l~g---~ip-~~~~~~~~L~~l~~   75 (383)
                      ++.|+.+.+..+--.++...+.+|.+|+.++|..| ++ .|.+ .|.+|.+|+.+.+..   .|+ ..|.+|++|+.+++
T Consensus       287 c~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~sv~~I~~~aF~~C~~L~~i~~  364 (394)
T 4gt6_A          287 CPALQDIEFSSRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSSVTKIPESAFSNCTALNNIEY  364 (394)
T ss_dssp             CTTCCEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTTCCBCCGGGGTTCTTCCEEEE
T ss_pred             ccccccccCCCcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcccCEEhHhHhhCCCCCCEEEE
Confidence            45677777754333677788899999999999865 33 4543 577899999999844   354 35789999999999


Q ss_pred             cccccc
Q 046461           76 SMNMLG   81 (383)
Q Consensus        76 s~N~l~   81 (383)
                      ++|...
T Consensus       365 ~~~~~~  370 (394)
T 4gt6_A          365 SGSRSQ  370 (394)
T ss_dssp             SSCHHH
T ss_pred             CCceee
Confidence            887653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=81.36  E-value=0.76  Score=38.40  Aligned_cols=55  Identities=7%  Similarity=-0.043  Sum_probs=41.5

Q ss_pred             CCCCEEECcCCccccccchhHHhhhccceeeecc--ccChh----hhCC----CCCccccccccc
Q 046461           25 NELPHLDLSCNKLNGEISTFLSHILGILGLYVQF--KIPPD----LCNL----VQLEYFDFSMNM   79 (383)
Q Consensus        25 ~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g--~ip~~----~~~~----~~L~~l~~s~N~   79 (383)
                      ..|+.||||++.++..=-..+.+|.+|+.|+|++  .|.++    +..+    ++|+.|++|++.
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~  125 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCG  125 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCC
Confidence            5789999999998766555678899999999976  34432    4543    479999998854

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=80.04  E-value=1.5  Score=39.81  Aligned_cols=30  Identities=30%  Similarity=0.281  Sum_probs=25.6

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ...++|+|+++.||+++ + .+.+.||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            34689999999999998 4 899999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	383
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-28
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-27
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-27
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-27
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-27
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-27
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-26
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-26
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-26
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-26
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-26
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-23
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-22
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-21
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-20
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-20
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-19
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-17
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-17
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-16
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-16
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-16
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-16
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-16
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-15
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-15
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-15
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-14
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-13
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-12
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-12
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-08
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-06
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-05
d1u09a_	476	e.8.1.4 (A:) Viral RNA polymerase {Foot-and-mouth	3e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-35
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            NI+  +GY     +  IV ++    SL   L              IA  TA+G+ +LH 
Sbjct: 64  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTSTDVAGTIGYI------ 288
           +    IIHRD+ ++NI L+ED  VK+ DFGL  + S    SH    ++G+I ++      
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 289 -----LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI----LNAYS 339
                  +   D+Y+F +VL EL+  + P    + + N  + + +++        L+   
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                 M +++  C+      RP   ++   +E 
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 3e-34
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 23/210 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
           + +V+L       E   I+ EYM  GSL D+L+  +   +       +A   A G+ F+ 
Sbjct: 68  QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLA 291
            R   + IHRD+ A+NIL+++    K++DFGL RLI D E          I +     + 
Sbjct: 127 ER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
            G      D++SF ++L E+V   +   P   +      ++        +   +    ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE----EL 239

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEKYHT 376
            Q++  C  + P  RPT   ++  LE + T
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 5e-33
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 33/249 (13%)

Query: 151 LGKLTYDQIVAGTNKFYEKNVIRGDDF--------GIAFKNIVQLLGYCPVGEKKLIVYE 202
           +G       VA   K  +   +  + F         +  + +VQL           IV E
Sbjct: 35  MGTWNGTTRVA--IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 91

Query: 203 YMVKGSLNDWLRNQAKHCI-------IACGTARGITFLHHRFQPHIIHRDINASNILLNE 255
           YM KGSL D+L+ +    +       +A   A G+ ++      + +HRD+ A+NIL+ E
Sbjct: 92  YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 148

Query: 256 DFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--LLACGG------DIYSFSVVLLELV 307
           +   KV+DFGL RLI D E          I +     A  G      D++SF ++L EL 
Sbjct: 149 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208

Query: 308 IRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRV 367
            + +   P   ++   + V+            +     +  ++  C    P  RPT   +
Sbjct: 209 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYL 264

Query: 368 QEFLEKYHT 376
           Q FLE Y T
Sbjct: 265 QAFLEDYFT 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-31
 Identities = 49/206 (23%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
             +VQL G C       +V+E+M  G L+D+LR Q           +      G   + +
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAY 116

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLAC 292
             +  +IHRD+ A N L+ E+  +KVSDFG+ R + D +  +ST     + +    + + 
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 293 GG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML 347
                  D++SF V++ E+    +     +++++   +V+ +     L      S   + 
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIP---YENRSNSEVVEDISTGFRLYKPRLAST-HVY 232

Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEK 373
           QI+  C  + P  RP   R+   L +
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 25/210 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
            N++ L G        +I+ E+M  GSL+ +LR             +  G A G+ +L  
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH----TSTDVAGTIGYI--- 288
               + +HRD+ A NIL+N +   KVSDFGL R + D  S     ++      I +    
Sbjct: 147 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 289 -----LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
                      D++S+ +V+ E++   +     + D    ++++ +     L        
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYRLP-PPMDCP 259

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             + Q+++ C   +   RP   ++   L+K
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-30
 Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 31/244 (12%)

Query: 151 LGKLTYDQIVAGTNKFYEKNVIRGDDF--------GIAFKNIVQLLGYCPVGEKKLIVYE 202
            GK      VA   K  ++  +  D+F         ++ + +VQL G C       I+ E
Sbjct: 22  YGKWRGQYDVA--IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79

Query: 203 YMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED 256
           YM  G L ++LR         +   +       + +L  +     +HRD+ A N L+N+ 
Sbjct: 80  YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ 136

Query: 257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG-----DIYSFSVVLLELVI 308
             VKVSDFGL R + D E  +S      + +    +L         DI++F V++ E+  
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

Query: 309 RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQ 368
             +     F +      +   L     +  S+    K+  I+  C  +    RPT   + 
Sbjct: 197 LGKMPYERFTNSETAEHIAQGLRLYRPHLASE----KVYTIMYSCWHEKADERPTFKILL 252

Query: 369 EFLE 372
             + 
Sbjct: 253 SNIL 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 45/229 (19%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--------------------- 221
           NIV+LLG C VG+   +++EYM  G LN++LR+ + H +                     
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 222 --------IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
                   IA   A G+ +L        +HRD+   N L+ E+  VK++DFGL R I   
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 274 E-SHTSTDVAGTIGYIL--------LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN 324
           +      + A  I ++              D++++ VVL E+          +       
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---YYGMAHEE 250

Query: 325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           ++ +V D  IL        L++  ++  C    P  RP+   +   L++
Sbjct: 251 VIYYVRDGNILACPENCP-LELYNLMRLCWSKLPADRPSFCSIHRILQR 298

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 52/244 (21%), Positives = 86/244 (35%), Gaps = 46/244 (18%)

Query: 182 KNIVQLLGYC----PVGEKKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFL 233
           +NI+  +           +  +V +Y   GSL D+L            +A  TA G+  L
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116

Query: 234 HHRF-----QPHIIHRDINASNILLNEDFEVKVSDFGLVRLI---SDCESHTSTDVAGTI 285
           H        +P I HRD+ + NIL+ ++    ++D GL       +D          GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 286 GY----ILLACGG----------DIYSFSVVLLELVIRKQPTGPEFKDKNG--------- 322
            Y    +L               DIY+  +V  E+  R    G     +           
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 323 ------GNLVDWVLDSTILNAYSKPSMLK-MLQIVVGCIFDNPTTRPTMLRVQEFLEKYH 375
                   + +  L   I N +     L+ M +I+  C + N   R T LR+++ L +  
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 376 TGEN 379
             E 
Sbjct: 297 QQEG 300

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 5e-29
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 22/207 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFLH 234
            N+VQLLG C       I+ E+M  G+L D+LR   +  +       +A   +  + +L 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLA 291
              + + IHRD+ A N L+ E+  VKV+DFGL RL++             I +     LA
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D+++F V+L E+        P         L++            +    K+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE----KV 245

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            +++  C   NP+ RP+   + +  E 
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFET 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-28
 Identities = 40/207 (19%), Positives = 84/207 (40%), Gaps = 24/207 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
             IV+L+G C   E  ++V E    G L+ +L  + +         +    + G+ +L  
Sbjct: 69  PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLAC- 292
           +   + +HRD+ A N+LL      K+SDFGL + +   +S+    +     + +    C 
Sbjct: 128 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 293 -------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++S+ V + E +   Q     +K   G  ++ ++     +    +    +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKGPEVMAFIEQGKRMECPPECPP-E 240

Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLE 372
           +  ++  C       RP  L V++ + 
Sbjct: 241 LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-28
 Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 38/224 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
            NIV LLG C +G   L++ EY   G L ++LR +    I                    
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 222 ---IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT- 277
               +   A+G+ FL  +   + IHRD+ A NILL      K+ DFGL R I +  ++  
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 278 STDVAGTIGYILLACGGD--------IYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV 329
             +    + ++      +        ++S+ + L EL          +      +    +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSKFYKM 260

Query: 330 LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           +         + +  +M  I+  C   +P  RPT  ++ + +EK
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 4e-28
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 182 KNIVQLLGYCPVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGITFL 233
            N+VQLLG     +  L IV EYM KGSL D+LR++ +  +        +      + +L
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
                 + +HRD+ A N+L++ED   KVSDFGL +  S  +      V  T    L    
Sbjct: 120 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 176

Query: 294 ----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI 349
                D++SF ++L E+    +     +      ++V  V     ++A        + ++
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPRVEKGYKMDAPDGCPP-AVYEV 232

Query: 350 VVGCIFDNPTTRPTMLRVQEFLEKYHTGE 378
           +  C   +   RP+ L+++E LE   T E
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-27
 Identities = 47/221 (21%), Positives = 80/221 (36%), Gaps = 38/221 (17%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------------------C 220
            NI+ LLG C       +  EY   G+L D+LR                           
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 221 IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             A   ARG   + +  Q   IHRD+ A NIL+ E++  K++DFGL R        T   
Sbjct: 131 HFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-- 185

Query: 281 VAGTIGYILLACGG--------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS 332
               + ++ +            D++S+ V+L E+V         +       L + +   
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEKLPQG 242

Query: 333 TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             L         ++  ++  C  + P  RP+  ++   L +
Sbjct: 243 YRLEKPLNCDD-EVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-27
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 18/144 (12%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK-----HCIIACGTARGITFLHHR 236
             IV   G      +  I  E+M  GSL+  L+   +        ++    +G+T+L  +
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACG 293
               I+HRD+  SNIL+N   E+K+ DFG+   + D     +    GT  Y+    L   
Sbjct: 124 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGT 178

Query: 294 G-----DIYSFSVVLLELVIRKQP 312
                 DI+S  + L+E+ + + P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (269), Expect = 3e-27
 Identities = 44/199 (22%), Positives = 76/199 (38%), Gaps = 28/199 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHR 236
            N +Q  G         +V EY +  + +    ++          +  G  +G+ +LH  
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI----LLAC 292
              ++IHRD+ A NILL+E   VK+ DFG   ++       +    GT  ++    +LA 
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAM 186

Query: 293 GG-------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D++S  +  +EL  RK P      + N  + +  +  +      S      
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPALQSGHWSEY 242

Query: 346 MLQIVVGCIFDNPTTRPTM 364
               V  C+   P  RPT 
Sbjct: 243 FRNFVDSCLQKIPQDRPTS 261

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 182 KNIVQLLGYCPVGEKK-LIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLH 234
            N++ LLG C   E   L+V  YM  G L +++RN+  +             A+G   + 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---MK 144

Query: 235 HRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE---SHTSTDVAGTIGYILLA 291
                  +HRD+ A N +L+E F VKV+DFGL R + D E    H  T     + ++ L 
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 292 CG--------GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
                      D++SF V+L EL+ R  P    + D N  ++  ++L    L        
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQGRRLLQPEYCPD 261

Query: 344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             + ++++ C       RP+   +   +  
Sbjct: 262 -PLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 4e-27
 Identities = 42/208 (20%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHR 236
             IV+++G C   E  ++V E    G LN +L+            +    + G+ +L   
Sbjct: 68  PYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYI---LLA 291
              + +HRD+ A N+LL      K+SDFGL + +   E++    T     + +     + 
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D++SF V++ E     Q     ++   G  +   +     +   +     +M
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKP---YRGMKGSEVTAMLEKGERMGCPAGCPR-EM 239

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEKY 374
             ++  C   +   RP    V+  L  Y
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 6e-27
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 24/199 (12%)

Query: 183 NIVQLLGYCPVGEKK----LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFL 233
           NIV+         K     ++V E M  G+L  +L+                  +G+ FL
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 234 HHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---L 289
           H R  P IIHRD+   NI +      VK+ D GL  L     +  +  V GT  ++   +
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184

Query: 290 LACG----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D+Y+F + +LE+   + P     + +N   +   V       ++ K ++ +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 346 MLQIVVGCIFDNPTTRPTM 364
           + +I+ GCI  N   R ++
Sbjct: 242 VKEIIEGCIRQNKDERYSI 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 41/203 (20%), Positives = 70/203 (34%), Gaps = 27/203 (13%)

Query: 183 NIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGIT 231
           NIV+              IV EY   G L   +    K            +       + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 232 FLHHR--FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI- 288
             H R      ++HRD+  +N+ L+    VK+ DFGL R+++   S       GT  Y+ 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182

Query: 289 --LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP 341
              +         DI+S   +L EL     P    F   +   L   + +        + 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREGKFRRIPYRY 238

Query: 342 SMLKMLQIVVGCIFDNPTTRPTM 364
           S  ++ +I+   +      RP++
Sbjct: 239 SD-ELNEIITRMLNLKDYHRPSV 260

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-26
 Identities = 47/207 (22%), Positives = 92/207 (44%), Gaps = 23/207 (11%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
           NI++L G     +  +I+ EYM  G+L+ +LR +           +  G A G+    + 
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM---KYL 126

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE--SHTSTDVAGTIGYI---LLA 291
              + +HRD+ A NIL+N +   KVSDFGL R++ D    ++T++     I +     ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 292 CGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D++SF +V+ E++   +     + + +   ++  + D   L          +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHEVMKAINDGFRLP-TPMDCPSAI 242

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEK 373
            Q+++ C       RP    +   L+K
Sbjct: 243 YQLMMQCWQQERARRPKFADIVSILDK 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-26
 Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 23/208 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
           +N+++L G       K +V E    GSL D LR    H         A   A G+ +L  
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYI---LL 290
           +     IHRD+ A N+LL     VK+ DFGL+R +   + H            +     L
Sbjct: 130 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 291 ACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                    D + F V L E+    Q     +   NG  ++  +          +     
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 346 MLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
           +  ++V C    P  RPT + +++FL +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (259), Expect = 3e-26
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 21/198 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHR 236
           +N+V+  G+   G  + +  EY   G L D +                    G+ +LH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLI-SDCESHTSTDVAGTIGYI---LLAC 292
               I HRDI   N+LL+E   +K+SDFGL  +   +        + GT+ Y+   LL  
Sbjct: 123 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 293 GG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D++S  +VL  ++  + P   +    +     DW    T LN + K      
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKIDS-AP 236

Query: 347 LQIVVGCIFDNPTTRPTM 364
           L ++   + +NP+ R T+
Sbjct: 237 LALLHKILVENPSARITI 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-26
 Identities = 38/203 (18%), Positives = 75/203 (36%), Gaps = 28/203 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
            NIV+LL          I+ E+   G+++  +    +        ++   T   + +LH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLA 291
                IIHRD+ A NIL   D ++K++DFG+    +       +   GT  +    +++ 
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMC 184

Query: 292 CGG---------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPS 342
                       D++S  + L+E+   + P      + N   ++  +  S          
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLLKIAKSEPPTLAQPSR 240

Query: 343 MLKMLQ-IVVGCIFDNPTTRPTM 364
                +  +  C+  N   R T 
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTT 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 4e-26
 Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 21/196 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH----CIIACGTARGITFLHHRF 237
            NIV  L    VG++  +V EY+  GSL D +            +     + + FLH   
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--------L 289
              +IHRDI + NILL  D  VK++DFG    I+  +S  ST V GT  ++         
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 290 LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ- 348
                DI+S  ++ +E++  + P    + ++N    +  +  +      +   +  + + 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248

Query: 349 IVVGCIFDNPTTRPTM 364
            +  C+  +   R + 
Sbjct: 249 FLNRCLDMDVEKRGSA 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-26
 Identities = 38/206 (18%), Positives = 79/206 (38%), Gaps = 22/206 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHH 235
            +IV+L+G         I+ E    G L  +L+ +      A   + A   +  + +L  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE- 125

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYIL------ 289
                 +HRDI A N+L++ +  VK+ DFGL R + D   + ++     I ++       
Sbjct: 126 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 290 --LACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML 347
                  D++ F V + E+++         K+ +    ++      +           + 
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP----TLY 239

Query: 348 QIVVGCIFDNPTTRPTMLRVQEFLEK 373
            ++  C   +P+ RP    ++  L  
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQLST 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-26
 Identities = 41/195 (21%), Positives = 76/195 (38%), Gaps = 25/195 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHRF 237
           NI++L GY     +  ++ EY   G++   L+  +K             A  +++ H + 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 125

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG 294
              +IHRDI   N+LL    E+K++DFG           T   + GT+ Y+   ++    
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRM 180

Query: 295 -----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI 349
                D++S  V+  E ++ K P    F+          +               + L  
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDL-- 234

Query: 350 VVGCIFDNPTTRPTM 364
           +   +  NP+ RP +
Sbjct: 235 ISRLLKHNPSQRPML 249

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 7e-26
 Identities = 42/228 (18%), Positives = 84/228 (36%), Gaps = 43/228 (18%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--------------------- 220
           +NIV LLG C +     +++EY   G L ++LR++ +                       
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 221 -------IIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC 273
                    A   A+G+ FL  +     +HRD+ A N+L+     VK+ DFGL R I   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 274 ESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN 324
            ++    +    + ++        +     D++S+ ++L E+          +       
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPVDA 274

Query: 325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE 372
               ++ +         +  ++  I+  C   +   RP+   +  FL 
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-24
 Identities = 47/216 (21%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------AKHCIIACGT 226
            ++V+LLG    G+  L++ E M +G L  +LR+                +K   +A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 227 ARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTI 285
           A G+ +L+       +HRD+ A N ++ EDF VK+ DFG+ R I + +           +
Sbjct: 143 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 286 GYI--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNA 337
            ++        +     D++SF VVL E+    +     ++  +   ++ +V++  +L+ 
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGLLDK 256

Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                   + +++  C   NP  RP+ L +   +++
Sbjct: 257 PDNCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 2e-23
 Identities = 41/207 (19%), Positives = 82/207 (39%), Gaps = 23/207 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC------IIACGTARGITFLHH 235
            ++ +LLG C +     ++ + M  G L D++R    +             A+G+ +L  
Sbjct: 71  PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLAC-- 292
           R    ++HRD+ A N+L+     VK++DFGL +L+   E  + +      I ++ L    
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 293 ------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                   D++S+ V + EL+         +       +   +     L      + + +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASEISSILEKGERLPQPPICT-IDV 242

Query: 347 LQIVVGCIFDNPTTRPTMLRVQEFLEK 373
             I+V C   +  +RP    +     K
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.5 bits (237), Expect = 8e-23
 Identities = 28/199 (14%), Positives = 68/199 (34%), Gaps = 23/199 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
           +NI+ L       E+ ++++E++    + + +   A                  + FLH 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 236 RFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
               +I H DI   NI+        +K+ +FG  R +   ++      A       +   
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 294 G------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--K 345
                  D++S   ++  L+    P    F  +    +++ ++++           +  +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 346 MLQIVVGCIFDNPTTRPTM 364
            +  V   +     +R T 
Sbjct: 234 AMDFVDRLLVKERKSRMTA 252

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 2e-22
 Identities = 44/204 (21%), Positives = 76/204 (37%), Gaps = 21/204 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTARGITFLHHRFQP 239
              V+L       EK      Y   G L  ++R             TA  ++ L +    
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-STDVAGTIGYI---LLACGG- 294
            IIHRD+   NILLNED  ++++DFG  +++S       +    GT  Y+   LL     
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 295 ----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--KMLQ 348
               D+++   ++ +LV    P    F+  N   +   ++       Y  P     K   
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQKIIKLE----YDFPEKFFPKARD 239

Query: 349 IVVGCIFDNPTTRPTMLRVQEFLE 372
           +V   +  + T R     ++ +  
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGP 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.8 bits (235), Expect = 2e-22
 Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 21/205 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----IIACGTARGITFLHHR 236
             IV +       +K   + + M  G L+  L              A     G+  +H+R
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG-- 294
               +++RD+  +NILL+E   V++SD GL    S  + H S    G +   +L  G   
Sbjct: 127 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 183

Query: 295 ----DIYSFSVVLLELVIRKQP-TGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI 349
               D +S   +L +L+    P    + KDK+  + +   +   + +++S     ++  +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP----ELRSL 239

Query: 350 VVGCIFDNPTTRPTMLR--VQEFLE 372
           + G +  +   R   L    QE  E
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKE 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 3e-22
 Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 37/222 (16%)

Query: 183 NIVQLLGYC-PVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           N+V LLG C   G   +++ E+   G+L+ +LR++    +                    
Sbjct: 78  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT-ST 279
             +   A+G+ FL  R     IHRD+ A NILL+E   VK+ DFGL R I     +    
Sbjct: 138 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 280 DVAGTIGYILLAC--------GGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           D    + ++              D++SF V+L E+          +            L 
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLK 251

Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
                     +  +M Q ++ C    P+ RPT   + E L  
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 3e-22
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 37/222 (16%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI-------------------- 221
           KNI+ LLG C       ++ EY  KG+L ++L+ +    +                    
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 222 -IACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD 280
             A   ARG   + +      IHRD+ A N+L+ ED  +K++DFGL R I   + +  T 
Sbjct: 139 SCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 281 V-AGTIGYI---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
                + ++    L         D++SF V+L E+          +       L   + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVPVEELFKLLKE 252

Query: 332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEK 373
              ++  S  +  ++  ++  C    P+ RPT  ++ E L++
Sbjct: 253 GHRMDKPSNCTN-ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 92.8 bits (230), Expect = 4e-22
 Identities = 45/215 (20%), Positives = 80/215 (37%), Gaps = 32/215 (14%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHRF 237
           NI+QL           +V++ M KG L D+L  +          I       I  LH   
Sbjct: 71  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL- 129

Query: 238 QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG 294
             +I+HRD+   NILL++D  +K++DFG    +         +V GT  Y+   ++ C  
Sbjct: 130 --NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSM 185

Query: 295 -----------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM 343
                      D++S  V++  L+    P    F  +    ++  ++         +   
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 344 L--KMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY 374
               +  +V   +   P  R T        F ++Y
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 91.7 bits (227), Expect = 3e-21
 Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 27/201 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHH 235
             +V L        + +++YE+M  G L + + ++                 +G+  +H 
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 236 RFQPHIIHRDINASNILLN--EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LL 290
               + +H D+   NI+       E+K+ DFGL   +   +S   T   GT  +    + 
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197

Query: 291 ACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML- 344
                    D++S  V+   L+    P    F  +N    +  V         S  S + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 345 -KMLQIVVGCIFDNPTTRPTM 364
                 +   +  +P TR T+
Sbjct: 254 EDGKDFIRKLLLADPNTRMTI 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 90.1 bits (223), Expect = 5e-21
 Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 21/198 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHR 236
            NIV L      G    ++ + +  G L D +  +  +       +       + +LH  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACG 293
              H   +  N     L+ED ++ +SDFGL ++         +   GT GY+   +LA  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQK 184

Query: 294 G-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--KM 346
                 D +S  V+   L+    P    F D+N   L + +L +           +    
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 347 LQIVVGCIFDNPTTRPTM 364
              +   +  +P  R T 
Sbjct: 241 KDFIRHLMEKDPEKRFTC 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 34/214 (15%), Positives = 71/214 (33%), Gaps = 29/214 (13%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHH 235
             ++ L        + +++ E++  G L D +  +      A+          G+  +H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 236 RFQPHIIHRDINASNILL--NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LL 290
                I+H DI   NI+    +   VK+ DFGL   ++            T  +    ++
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIV 200

Query: 291 ACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML- 344
                    D+++  V+   L+    P    F  ++    +  V            S + 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDWEFDEDAFSSVS 256

Query: 345 -KMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH 375
            +    +   +   P  R T+    E  +L+  H
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 6e-20
 Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 23/196 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFLHHR 236
             +  +       E    V EY+  G L   +++  K         A     G   L   
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG---LQFL 119

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACG 293
               I++RD+   NILL++D  +K++DFG+ +     ++ T+T   GT  YI   +L   
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQ 178

Query: 294 G-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ 348
                 D +SF V+L E++I + P    F  ++   L   +               K   
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPFYPRWLEKEAK--D 232

Query: 349 IVVGCIFDNPTTRPTM 364
           ++V      P  R  +
Sbjct: 233 LLVKLFVREPEKRLGV 248

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.5 bits (211), Expect = 2e-19
 Identities = 39/203 (19%), Positives = 85/203 (41%), Gaps = 22/203 (10%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH--CIIACGTARGITFLHHRFQP 239
             I+++ G     ++  ++ +Y+  G L   LR   +    +     A     L +    
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG-- 294
            II+RD+   NILL+++  +K++DFG  + + D     +  + GT  YI   +++     
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYN 179

Query: 295 ---DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV 351
              D +SF +++ E++    P    F D N     + +L++ +         +K   ++ 
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAELRFPPFFNEDVK--DLLS 233

Query: 352 GCIFDNPTTRPTMLR--VQEFLE 372
             I  + + R   L+   ++   
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKN 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 79.8 bits (196), Expect = 1e-17
 Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 23/215 (10%)

Query: 182 KNIVQLLGYC----PVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTARGITFLHH 235
             IV +        P G    IV EY+   +L D +  +            A     L+ 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 236 RFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYI----- 288
             Q  IIHRD+  +NI+++    VKV DFG+ R I+D  +    +  V GT  Y+     
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 289 ---LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML- 344
               +    D+YS   VL E++  + P    F   +  ++    +    +   ++   L 
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 345 -KMLQIVVGCIFDNPTTRP-TMLRVQEFLEKYHTG 377
             +  +V+  +  NP  R  T   ++  L + H G
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 4e-17
 Identities = 42/206 (20%), Positives = 73/206 (35%), Gaps = 20/206 (9%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--IIACGTARGITFLHHRFQPH 240
            +V L        K  ++ +Y+  G L   L  + +     +       +  L H  +  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149

Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------ 294
           II+RDI   NILL+ +  V ++DFGL +     E+  + D  GTI Y+            
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209

Query: 295 ----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML--KMLQ 348
               D +S  V++ EL+    P    F      N    +    + +    P  +      
Sbjct: 210 DKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265

Query: 349 IVVGCIFDNPTTRPTMLR--VQEFLE 372
           ++   +  +P  R         E  E
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKE 291

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (191), Expect = 8e-17
 Identities = 32/197 (16%), Positives = 72/197 (36%), Gaps = 18/197 (9%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--IIACGTARGITFLHHRFQP 239
            N++ L          +++ E +  G L D+L  +             + +  +++    
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132

Query: 240 HIIHRDINASNILLNED----FEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLAC 292
            I H D+   NI+L +       +K+ DFGL   I     +   ++ GT  ++   ++  
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNY 190

Query: 293 GG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML 347
                  D++S  V+   L+    P   + K +   N+     +       +  ++ K  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK-- 248

Query: 348 QIVVGCIFDNPTTRPTM 364
             +   +  +P  R T+
Sbjct: 249 DFIRRLLVKDPKKRMTI 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.2 bits (192), Expect = 9e-17
 Identities = 42/211 (19%), Positives = 79/211 (37%), Gaps = 37/211 (17%)

Query: 182 KNIVQLLGYC---PVGEKKL-IVYEYMVKGSLNDWLRNQAKHCI-------IACGTARGI 230
            +IV+++        G K L IV E +  G L   ++++            I       I
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 231 TFLHHRFQPHIIHRDINASNILLNEDFE---VKVSDFGLVRLISDCESHTSTDVAGTIGY 287
            +LH     +I HRD+   N+L         +K++DFG  +  +   S T+     T  Y
Sbjct: 125 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYY 179

Query: 288 I---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYS 339
           +   +L         D++S  V++  L+    P    F   +G  +   +     +  Y 
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYE 235

Query: 340 KPSML------KMLQIVVGCIFDNPTTRPTM 364
            P+        ++  ++   +   PT R T+
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (188), Expect = 2e-16
 Identities = 37/199 (18%), Positives = 71/199 (35%), Gaps = 32/199 (16%)

Query: 181 FKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITF-----LHH 235
           F  +++LL +    +  +++ E               +   +    AR   +     + H
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRH 125

Query: 236 RFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLA 291
                ++HRDI   NIL++ +  E+K+ DFG   L+ D      TD  GT  Y     + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIR 182

Query: 292 CGG------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK 345
                     ++S  ++L ++V    P    F+               +       S  +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFFRQRV------SSECQ 232

Query: 346 MLQIVVGCIFDNPTTRPTM 364
              ++  C+   P+ RPT 
Sbjct: 233 --HLIRWCLALRPSDRPTF 249

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 3e-16
 Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 22/153 (14%)

Query: 182 KNIVQLLGYCPVGEKK--------LIVYEYMVKGSLNDWLRNQAKHCI--IACGTARGIT 231
           +N+V L+  C               +V+++              K  +  I       + 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES---HTSTDVAGTIGY- 287
            L++  +  I+HRD+ A+N+L+  D  +K++DFGL R  S  ++   +  T+   T+ Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 288 ---ILLACGG-----DIYSFSVVLLELVIRKQP 312
              +LL         D++    ++ E+  R   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (186), Expect = 3e-16
 Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 12/142 (8%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--IACGTARGITFLHHRFQP 239
            NI+ LL          +V+++M          N        I       +  L +  Q 
Sbjct: 60  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----ILLACGG- 294
            I+HRD+  +N+LL+E+  +K++DFGL +      +   T    T  Y    +L      
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 295 ----DIYSFSVVLLELVIRKQP 312
               D+++   +L EL++R   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPF 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 7e-16
 Identities = 40/202 (19%), Positives = 78/202 (38%), Gaps = 19/202 (9%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--IIACGTARGITFLHHRFQPH 240
            +  L       ++   V EY   G L   L  +            A  ++ L +     
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI---LLACGG--- 294
           +++RDI   N++L++D  +K++DFGL +      +   T   GT  Y+   +L       
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184

Query: 295 --DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVG 352
             D +   VV+ E++  + P    F +++   L + +L   I    +     K   ++ G
Sbjct: 185 AVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILMEEIRFPRTLSPEAK--SLLAG 238

Query: 353 CIFDNPTTRPTMLR--VQEFLE 372
            +  +P  R        +E +E
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVME 260

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.9 bits (183), Expect = 9e-16
 Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 28/168 (16%)

Query: 183 NIVQLLGYCPVGEKK-----LIVYEYMVKGSLNDWLRNQAK------HCIIACGTARGIT 231
           N+V+L   C V          +V+E++ +       +             +     RG+ 
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 232 FLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYI--- 288
           FLH      ++HRD+   NIL+    ++K++DFGL R+ S   + TS  V  T+ Y    
Sbjct: 131 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPE 185

Query: 289 LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD 331
           +L         D++S   +  E+  RK      F+  +  + +  +LD
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILD 229

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 73.3 bits (179), Expect = 3e-15
 Identities = 31/225 (13%), Positives = 65/225 (28%), Gaps = 31/225 (13%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC-----IIACGTARGITFLHHRF 237
            I  +  +   G   ++V + +     +       K       + A      +  +H + 
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK- 120

Query: 238 QPHIIHRDINASNILLNEDF-----EVKVSDFGLVRLISDCESHT------STDVAGTIG 286
              +++RDI   N L+          + V DFG+V+   D  +          +++GT  
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 287 YI---LLACGG-----DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD---STIL 335
           Y+              D+ +   V +  +    P     K        + + +   ST L
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPL 237

Query: 336 NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF 380
                    +  + +           P    +Q    K     N 
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 73.0 bits (178), Expect = 4e-15
 Identities = 34/223 (15%), Positives = 69/223 (30%), Gaps = 28/223 (12%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH------CIIACGTARGITFLHHR 236
             +  + +C       ++   ++  SL D     ++        ++A      I ++H +
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 237 FQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCESHT------STDVAGTIGY 287
              + IHRD+   N L+        V + DFGL +   D  +H       + ++ GT  Y
Sbjct: 123 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 288 I--------LLACGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD--STILNA 337
                      +   D+ S   VL+   +   P                     ST +  
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF 380
             K    +    +  C       +P    +++        + F
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 71.8 bits (175), Expect = 9e-15
 Identities = 35/215 (16%), Positives = 72/215 (33%), Gaps = 33/215 (15%)

Query: 183 NIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAK--HCIIACGTARGITFLHHRFQPH 240
           NIV+L       ++ ++V+E++ +         +             + +  + +     
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG------ 294
           ++HRD+   N+L+N + E+K++DFGL R         + ++            G      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 295 --DIYSFSVVLLELVIRKQP------------------TGPEFKDKNGGNLVDWVLDSTI 334
             DI+S   +  E+V                       T       N   L  +  + T+
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 335 LNAYSKPSMLK-----MLQIVVGCIFDNPTTRPTM 364
                  S LK      + ++   +  +P  R T 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 1e-14
 Identities = 33/150 (22%), Positives = 62/150 (41%), Gaps = 22/150 (14%)

Query: 182 KNIVQLLGYCPVGE----KKLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFL 233
           +NI+ +            K + +  +++   L   L+ Q       C       RG+ ++
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYI--- 288
           H     +++HRD+  SN+LLN   ++K+ DFGL R+      H    T+   T  Y    
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 289 LLACG------GDIYSFSVVLLELVIRKQP 312
           ++          DI+S   +L E++  +  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 1e-14
 Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 11/142 (7%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC---IIACGTARGITFLHHRFQ 238
            NIV+LL       K  +V+E++ +        +        +I     + +  L     
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 239 PHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY---ILLACGG- 294
             ++HRD+   N+L+N +  +K++DFGL R         + +V         ILL C   
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 295 ----DIYSFSVVLLELVIRKQP 312
               DI+S   +  E+V R+  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRAL 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 1e-13
 Identities = 39/230 (16%), Positives = 78/230 (33%), Gaps = 36/230 (15%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHC--IIACGTARGITFLHHRFQP 239
           KNIV+L       +K  +V+E+  +     +          I+     + +  L      
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 240 HIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG----- 294
           +++HRD+   N+L+N + E+K+++FGL R         S +V            G     
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 295 ---DIYSFSVVLLELVIRKQP-------------------TGPEFKDKNGGNLVDWVLDS 332
              D++S   +  EL    +P                   T  E +  +   L D+    
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 333 TILNAYSKPSMLKML-----QIVVGCIFDNPTTRPTMLRVQE--FLEKYH 375
                 S  +++  L      ++   +  NP  R +     +  +   + 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 66.8 bits (162), Expect = 7e-13
 Identities = 36/197 (18%), Positives = 72/197 (36%), Gaps = 18/197 (9%)

Query: 179 IAFKNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH-----CIIACGTARGITFL 233
           + F  +V+L           +V EY+  G +   LR   +         A        +L
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACG 293
           H      +I+RD+   N+L+++   ++V+DFG  + +                 I+L+ G
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 294 ----GDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI 349
                D ++  V++ E+     P    F       + + ++   +       S LK L  
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRFPSHFSSDLKDL-- 268

Query: 350 VVGCIFDNPTTRPTMLR 366
           +   +  + T R   L+
Sbjct: 269 LRNLLQVDLTKRFGNLK 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.4 bits (161), Expect = 1e-12
 Identities = 35/153 (22%), Positives = 58/153 (37%), Gaps = 25/153 (16%)

Query: 182 KNIVQLLGYC-PVGEKK-----LIVYEYMVKGSLNDWLRNQAKH--------CIIACGTA 227
            NIV+L  +    GEKK      +V +Y+ +                      +      
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 228 RGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRLISDCESHTSTDVAGTIG 286
           R + ++H      I HRDI   N+LL+ D   +K+ DFG  + +   E + S   +    
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 287 YILLACGG-------DIYSFSVVLLELVIRKQP 312
              L  G        D++S   VL EL++ +  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 66.0 bits (160), Expect = 1e-12
 Identities = 28/179 (15%), Positives = 66/179 (36%), Gaps = 19/179 (10%)

Query: 182 KNIVQLLGYC--PVGEKKLIVYEYMVKGSLNDWLRNQAKHCI--IACGTARGITFLHHRF 237
            NI+ L      PV     +V+E++         +    + I        + + + H   
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM- 148

Query: 238 QPHIIHRDINASNILL-NEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLACGG-- 294
              I+HRD+   N+++ +E  ++++ D+GL       + +       +  +         
Sbjct: 149 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDY 204

Query: 295 -------DIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM 346
                  D++S   +L  ++ RK+P      + +    +  VL +  L  Y     +++
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.2 bits (132), Expect = 4e-09
 Identities = 28/145 (19%), Positives = 53/145 (36%), Gaps = 17/145 (11%)

Query: 182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKH---------CIIACGTARGITF 232
           +N++ LL      E      ++ +          +              +     +G+ +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC 292
           +H      IIHRD+   N+ +NED E+K+ DFGL R      +            ++L  
Sbjct: 137 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193

Query: 293 GG-----DIYSFSVVLLELVIRKQP 312
                  DI+S   ++ E++  K  
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTL 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (122), Expect = 7e-08
 Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 17/145 (11%)

Query: 182 KNIVQLLGYCPVGEK-----KLIVYEYMVKGSLNDWLRNQAKHCIIAC----GTARGITF 232
           +N++ LL              + +  +++   LN+ ++ Q               RG+ +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 233 LHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLAC 292
           +H      IIHRD+  SN+ +NED E+K+ DFGL R   D  +            I+L  
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193

Query: 293 GG-----DIYSFSVVLLELVIRKQP 312
                  DI+S   ++ EL+  +  
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (116), Expect = 4e-07
 Identities = 39/147 (26%), Positives = 56/147 (38%), Gaps = 21/147 (14%)

Query: 182 KNIVQLLGYCPV------GEKKLIVYEYMVKGSLNDWLRNQ--AKHCIIACGTARGITFL 233
           KNI+ LL            +   +V E M               +   +      GI  L
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 234 HHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTDVAGTIGY----IL 289
           H      IIHRD+  SNI++  D  +K+ DFGL R  +   S   T    T  Y    ++
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190

Query: 290 LACGG----DIYSFSVVLLELVIRKQP 312
           L  G     DI+S   ++ E+V  K  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 15/95 (15%), Positives = 33/95 (34%), Gaps = 10/95 (10%)

Query: 181 FKNIVQLLGYCPVG----EKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHR 236
           F+ + +L G         E   ++ E +    L            +       +   +HR
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAKFYHR 122

Query: 237 FQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS 271
               I+H D++  N+L+  +  + + DF     + 
Sbjct: 123 ---GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 34/172 (19%), Positives = 67/172 (38%), Gaps = 24/172 (13%)

Query: 165 KFYEKNVIRGDDFGIAFKNIVQLLGYC----PVGEKKLIVYEYMVKGSLNDWLRNQAKHC 220
           +  + +  + D  G    +I++LL +     P G   ++V+E + +  L    + + +  
Sbjct: 65  RVNDADNTKEDSMGA--NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 221 ------IIACGTARGITFLHHRFQPHIIHRDINASNILLN-EDFEVKVSDFGLVRLISDC 273
                  I+     G+ ++H   +  IIH DI   N+L+   D    +    +  L + C
Sbjct: 123 PLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 274 ESHTS-TDVAGTIGYI--------LLACGGDIYSFSVVLLELVIRKQPTGPE 316
                 T+   T  Y            CG DI+S + ++ EL+       P+
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 9e-05
 Identities = 15/78 (19%), Positives = 23/78 (29%), Gaps = 1/78 (1%)

Query: 13  NLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGL-YVQFKIPPDLCNLVQLE 71
           N         NL  L +L L  N ++          L  L     +      L NL  + 
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLANLTNIN 354

Query: 72  YFDFSMNMLGGHIPEKNI 89
           +     N +    P  N+
Sbjct: 355 WLSAGHNQISDLTPLANL 372

>d1u09a_ e.8.1.4 (A:) Viral RNA polymerase {Foot-and-mouth disease virus [TaxId: 12110]} Length = 476

class: Multi-domain proteins (alpha and beta)
fold: DNA/RNA polymerases
superfamily: DNA/RNA polymerases
family: RNA-dependent RNA-polymerase
domain: Viral RNA polymerase
species: Foot-and-mouth disease virus [TaxId: 12110]

 Score = 40.3 bits (94), Expect = 3e-04
 Identities = 15/106 (14%), Positives = 35/106 (33%), Gaps = 8/106 (7%)

Query: 65  CNLVQLEYFDFSMNMLGGHIPEKNIDLCGKIMGLDYQVLTFSKLALFGTVVGSVLAIAII 124
              ++  +      +      +K   L   I  + +    F      G     V+A   +
Sbjct: 350 FEALKPHFKSLGQTITPADKSDKGFVLGHSITDVTFLKRHFHMDYGTGFYKP-VMASKTL 408

Query: 125 VSMLWWIQRGNRQQHL-SINLAMFEPSLGKLTYDQIVAGTNKFYEK 169
            ++L + +RG  Q+ L S+         G   Y ++     + ++ 
Sbjct: 409 EAILSFARRGTIQEKLISVAGLAVH--SGPDEYRRLF----EPFQG 448

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	383
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.52
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.04
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	98.93
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.71
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.7
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.7
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.49
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.48
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.45
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.44
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.41
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.38
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.35
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.35
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.07
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.05
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	97.95
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.93
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.91
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.88
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.85
d2ifga3	156	High affinity nerve growth factor receptor, N-term	97.85
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.8
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.49
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.44
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.31
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.1
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.93
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.93
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	96.7
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.5
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.31
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	96.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	95.88
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.51
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.46
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	92.31
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	91.95
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	87.34
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	86.25
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	82.05

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-45  Score=344.32  Aligned_cols=218  Identities=23%  Similarity=0.407  Sum_probs=167.6

Q ss_pred             cccHHHHHHHhhCccc---------cCeeecCCccccc------------------------------------------
Q 046461          153 KLTYDQIVAGTNKFYE---------KNVIRGDDFGIAF------------------------------------------  181 (383)
Q Consensus       153 ~~~~~~l~~~t~~f~~---------~~~lg~g~~g~v~------------------------------------------  181 (383)
                      .+||+++.+++.+|+.         .++||+|+||.||                                          
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            4677888888877753         3689999999999                                          


Q ss_pred             -cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 -KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 -~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                       ||||+++|+|.+++..++|||||++|+|.+++...      .++..++.|+|+||+|||+.   +|+||||||+|||++
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~  162 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN  162 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence             79999999999999999999999999999988743      34678999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc----cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESH----TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKN  321 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~----~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~  321 (383)
                      .++.+||+|||+++........    ......||+.|+|||        .++|||||||++|||+| |+.|+..    ..
T Consensus       163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~----~~  238 (299)
T d1jpaa_         163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----MT  238 (299)
T ss_dssp             TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----CC
T ss_pred             CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC----CC
Confidence            9999999999999876543221    122245789999998        46899999999999998 8888643    23


Q ss_pred             CCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          322 GGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       322 ~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      ..++.+.+.... ....+.+.+..+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus       239 ~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         239 NQDVINAIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            334444433322 22234556678999999999999999999999999999876544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=332.28  Aligned_cols=206  Identities=28%  Similarity=0.435  Sum_probs=160.6

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|.-.+.||+|+||.||                                      ||||+++|++.+ +..++|||||+
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            456777899999999999                                      799999999865 56899999999


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Cccc
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHTS  278 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~~  278 (383)
                      +|+|.+++...      ..+..++.|+|+||+|||++   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            99999999632      34678999999999999998   99999999999999999999999999998765432 2233


Q ss_pred             cccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccc-eeeecCcc---cccCChhHH
Q 046461          279 TDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLV-DWVLDSTI---LNAYSKPSM  343 (383)
Q Consensus       279 ~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~-~~v~~~~~---~~~~~~~~~  343 (383)
                      ....||+.|||||           .++|||||||++|||+||+.||...    ...... ..+.....   ....+...+
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~----~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC----CCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC----ChHHHHHHHHhcCCCCCcchhccccch
Confidence            4567999999998           2579999999999999999996432    221111 11111111   112234456


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            7889999999999999999999999999988753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=331.12  Aligned_cols=207  Identities=25%  Similarity=0.409  Sum_probs=158.0

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     ||||+++|+|.+++..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            356667889999999999                                     7999999999999999999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.+++...      ..+..++.|+|.||+|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence            9999998743      34578999999999999998   99999999999999999999999999998776544444445


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVG  352 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~  352 (383)
                      ..||..|+|||        .++|||||||++|||+|+..|+..   .....++.+.+.... ....+...+.++.+++.+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~---~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC---SCCHHHHHHHHHHTC-CCCCCTTSCHHHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC---CCCHHHHHHHHHhcC-CCCCccccCHHHHHHHHH
Confidence            67899999998        578999999999999996666432   222333333333221 122234556688999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhccccC
Q 046461          353 CIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       353 C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ||+.||++||||+||++.|+++.+.
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999998653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-43  Score=329.11  Aligned_cols=210  Identities=25%  Similarity=0.414  Sum_probs=172.4

Q ss_pred             hhCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          163 TNKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      .++|...+.||+|+||.||                                      ||||+++|+|.+++..++|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            3467777899999999999                                      79999999999999999999999


Q ss_pred             cCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          205 VKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       205 ~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ++|+|.+++...       ..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            999999998642       24578999999999999998   99999999999999999999999999999876554444


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQI  349 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l  349 (383)
                      .....|++.|+|||        .++|||||||++|||++|..|+...   .+...+.+. .........+...+..+.++
T Consensus       173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~---~~~~~~~~~-i~~~~~~~~~~~~~~~l~~l  248 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYEL-LEKDYRMERPEGCPEKVYEL  248 (287)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT---CCHHHHHHH-HHTTCCCCCCTTCCHHHHHH
T ss_pred             eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc---chHHHHHHH-HhcCCCCCCCccchHHHHHH
Confidence            44566889999998        5799999999999999988876332   122222222 22222233345566789999


Q ss_pred             HHHccccCCCCCCCHHHHHHHHhccccCCC
Q 046461          350 VVGCIFDNPTTRPTMLRVQEFLEKYHTGEN  379 (383)
Q Consensus       350 ~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~  379 (383)
                      +.+||+.||++||||+||++.|+.+.++.+
T Consensus       249 i~~cl~~dP~~Rps~~ei~~~L~~~~~~~~  278 (287)
T d1opja_         249 MRACWQWNPSDRPSFAEIHQAFETMFQESS  278 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence            999999999999999999999998876543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=324.68  Aligned_cols=205  Identities=27%  Similarity=0.435  Sum_probs=166.5

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|...+.||+|+||.||                                     ||||+++|+|.+ +..++||||+++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            456667889999999999                                     799999998855 567999999999


Q ss_pred             CCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          207 GSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       207 gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |+|.+++...       ..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence            9999988642       34678999999999999998   9999999999999999999999999999987655444445


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...||+.|+|||        .++|||||||++|||+||..|+...   ....++.+.+... .....+...+..+.+++.
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~---~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~  244 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVIQNLERG-YRMVRPDNCPEELYQLMR  244 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC---CCHHHHHHHHHhc-CCCCCcccChHHHHHHHH
Confidence            567899999998        5789999999999999987775332   2223333333222 122223455668899999


Q ss_pred             HccccCCCCCCCHHHHHHHHhcccc
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      +||+.||++||||.||++.|+.+..
T Consensus       245 ~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         245 LCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999997654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=331.79  Aligned_cols=202  Identities=23%  Similarity=0.381  Sum_probs=165.9

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ++|...++||+|+||.||                                              ||||+++|+|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            467777899999999998                                              7999999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ----------------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINAS  249 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~  249 (383)
                      ++|||||++|+|.++++..                            .....++.|++.||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            9999999999999999642                            23567999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEccccCccccCCCCCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCC
Q 046461          250 NILLNEDFEVKVSDFGLVRLISDCESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKD  319 (383)
Q Consensus       250 NiLl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~  319 (383)
                      ||+++.++.+||+|||+|+........ ......||+.|||||        .++|||||||++|||+| |+.||..    
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~----  269 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG----  269 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT----
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC----
Confidence            999999999999999999876543322 233456899999998        57899999999999998 8888643    


Q ss_pred             CCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 046461          320 KNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLE  372 (383)
Q Consensus       320 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~  372 (383)
                      .........++........+...+.++.+++.+||+.||++||||+||+++|.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22222222233333333334556678999999999999999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-43  Score=323.06  Aligned_cols=207  Identities=25%  Similarity=0.416  Sum_probs=162.3

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      +.|...++||+|+||.||                                            ||||+++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            457788999999999999                                            799999999999999999


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      |||||.+|++.+++...      .++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999988643      34678999999999999998   9999999999999999999999999999876543


Q ss_pred             CC--ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ES--HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~--~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ..  .......||+.|+|||        .++|||||||++|||+++..|+....   ...++.+.+.++ .....+...+
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~-~~~~~~~~~~  239 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDG-FRLPTPMDCP  239 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTT-CCCCCCTTCB
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHHHHHHhcc-CCCCCchhhH
Confidence            22  2233456899999998        57999999999999999877753322   233344333332 2233345566


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            7899999999999999999999999999987554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=316.29  Aligned_cols=203  Identities=24%  Similarity=0.368  Sum_probs=170.1

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|.-.+.||+|+||.||                                     ||||+++|+|.+++..++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            467788999999999999                                     7999999999999999999999999


Q ss_pred             CCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          207 GSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       207 gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      |+|.+++...      ..+..++.|+|+||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            9999997643      34678999999999999998   99999999999999999999999999998776554445555


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..||..|+|||        .++|||||||++|||+| |+.|+..    ....++.+.+.... ....+...+..+.+++.
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~----~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER----FTNSETAEHIAQGL-RLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----SCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC----CCHHHHHHHHHhCC-CCCCcccccHHHHHHHH
Confidence            67899999998        57999999999999998 7888543    23334444443322 22334556678899999


Q ss_pred             HccccCCCCCCCHHHHHHHHhcc
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      +||+.||++||||+|+++.|.++
T Consensus       236 ~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHccCCHhHCcCHHHHHHHhhCC
Confidence            99999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=320.83  Aligned_cols=185  Identities=21%  Similarity=0.382  Sum_probs=150.4

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      ||||+++|+|.+ +..++|||||++|+|.+++...      ..+..++.|+|.||+|||++   +|+||||||+||+++.
T Consensus        69 pnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~  144 (285)
T d1u59a_          69 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVN  144 (285)
T ss_dssp             TTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEE
T ss_pred             CCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeecc
Confidence            799999999865 5689999999999999998642      34678999999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 046461          256 DFEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGN  324 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~  324 (383)
                      ++.+||+|||+++........  ......||+.|+|||        .++|||||||++|||+| |+.||..    ....+
T Consensus       145 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~----~~~~~  220 (285)
T d1u59a_         145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----MKGPE  220 (285)
T ss_dssp             TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT----CCTHH
T ss_pred             CCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC----CCHHH
Confidence            999999999999987543322  223456899999998        57899999999999998 8999643    23334


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      +...+..+.. ...+...+.++.+++.+||+.||++||||.+|.+.|+.+.
T Consensus       221 ~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         221 VMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC-CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            4444433222 2334556678999999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-42  Score=318.69  Aligned_cols=184  Identities=23%  Similarity=0.377  Sum_probs=148.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ||||+++|+|.+ +..++|||||++|+|.++++..     .....++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        68 pnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~  143 (277)
T d1xbba_          68 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ  143 (277)
T ss_dssp             TTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             CCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhccccc
Confidence            799999999965 4578999999999999999753     35688999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 046461          257 FEVKVSDFGLVRLISDCESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~  325 (383)
                      +.+|++|||+++........  ......||+.|+|||        .++|||||||++|||+| |+.||..    ....++
T Consensus       144 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~----~~~~~~  219 (277)
T d1xbba_         144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----MKGSEV  219 (277)
T ss_dssp             TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT----CCHHHH
T ss_pred             CcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC----CCHHHH
Confidence            99999999999876543322  223456899999998        68999999999999998 8999643    233333


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      ...+..+. ....+...+.++.+++.+||+.||++||||++|.++|+..
T Consensus       220 ~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         220 TAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCC-CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            33333322 2233455667889999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=317.94  Aligned_cols=200  Identities=21%  Similarity=0.293  Sum_probs=161.2

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||.||                                        ||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            467777899999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-Ccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-SHT  277 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~~~  277 (383)
                      |++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+...... ...
T Consensus        85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            9999999999643     34678999999999999998   99999999999999999999999999998765432 223


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .+...||+.|+|||         .++||||+||++|||++|+.|+.....   .....................+..+.+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD---SCQEYSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST---TSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCccccCCHHHHH
Confidence            34568999999999         458999999999999999999753211   111111111111111112344567889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||++|+++
T Consensus       239 li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999999976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=314.79  Aligned_cols=194  Identities=22%  Similarity=0.381  Sum_probs=162.5

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            357777899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence            999999999999743     34678999999999999998   9999999999999999999999999999876542   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      ......||+.|+|||        .++|||||||++|||++|+.||..    .+..+..+.+.....  ..+...+.++.+
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~~  233 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEF--TFPDFVTEGARD  233 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHTTCC--CCCTTSCHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCC--CCCccCCHHHHH
Confidence            233467999999998        689999999999999999999643    233333333333222  223445667889


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 046461          349 IVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ++.+||+.||++|||++|+++
T Consensus       234 li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         234 LISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCCHhHCcCHHHHHc
Confidence            999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=318.76  Aligned_cols=206  Identities=25%  Similarity=0.388  Sum_probs=158.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeC-CE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVG-EK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~-~~  196 (383)
                      ++|.-.+.||+|+||.||                                              +|||++++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            467777899999999998                                              6999999998764 46


Q ss_pred             EEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE  255 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~  255 (383)
                      .++|||||++|+|.++++..                     .....++.|+++||+|||++   +|+||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            89999999999999999632                     23577899999999999998   9999999999999999


Q ss_pred             CCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc-c
Q 046461          256 DFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN-L  325 (383)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~-~  325 (383)
                      ++.+||+|||+++....... .......||+.|+|||        .++|||||||++|||++|..|+.   ......+ +
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~---~~~~~~~~~  246 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEF  246 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS---TTCCCSHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC---CCCCHHHHH
Confidence            99999999999987654332 2334567999999998        57899999999999999765432   2112222 2


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      .+.+.++ .....+...+.++.+++.+||+.||++||||.||+++|+++.+
T Consensus       247 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 CRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcC-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222222 2223344556788999999999999999999999999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-42  Score=322.42  Aligned_cols=212  Identities=28%  Similarity=0.485  Sum_probs=172.3

Q ss_pred             HHHHHhhCccccCeeecCCccccc---------------------------------------------cccceeeeEEE
Q 046461          158 QIVAGTNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCP  192 (383)
Q Consensus       158 ~l~~~t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~  192 (383)
                      +++-..++|...+.||+|+||.||                                             |||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            334456788888999999999998                                             69999999999


Q ss_pred             eCCEEEEEEEeccCCCHHHHHhcc-----------------------------hhhhHHHHhHHHHHHHHhhcCCCCeee
Q 046461          193 VGEKKLIVYEYMVKGSLNDWLRNQ-----------------------------AKHCIIACGTARGITFLHHRFQPHIIH  243 (383)
Q Consensus       193 ~~~~~~lv~e~~~~gsL~~~l~~~-----------------------------~~~~~i~~~ia~gL~~LH~~~~~~ivH  243 (383)
                      +.+..+++|||+++|+|.+++...                             ..+..++.|++.||+|||+.   +++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            999999999999999999999631                             23577999999999999998   9999


Q ss_pred             cCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCC
Q 046461          244 RDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTG  314 (383)
Q Consensus       244 rdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~  314 (383)
                      |||||+|||+|.++.+||+|||+++....... ...+...|++.|+|||        .++|||||||++|||++|..|+ 
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p-  242 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-  242 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT-
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC-
Confidence            99999999999999999999999987644322 2233467889999988        5889999999999999997543 


Q ss_pred             CCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          315 PEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       315 ~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                        |.+.+..++...+.++.. ...+...+.++.+++.+||+.||++||||.||+++|+++.+
T Consensus       243 --~~~~~~~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         243 --YYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --TTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --CCCCCHHHHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              233344455555555443 22345566789999999999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=313.49  Aligned_cols=198  Identities=24%  Similarity=0.341  Sum_probs=162.6

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||.||                                       ||||++++++.+++..++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            358888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          205 VKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       205 ~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      ++|+|.+++..    ......++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus       100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  175 (293)
T d1yhwa1         100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST  175 (293)
T ss_dssp             TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred             CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence            99999998864    235678999999999999998   99999999999999999999999999998775433 22344


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecC-cccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDS-TILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~-~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..||+.|+|||        .++||||+||++|||++|+.||...    +..+....+... ......+...+..+.+++.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----NPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC----CHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            67999999998        6789999999999999999996432    222222222211 1111223445678899999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 046461          352 GCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~  369 (383)
                      +||+.||++|||+.|+++
T Consensus       252 ~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-42  Score=314.88  Aligned_cols=205  Identities=20%  Similarity=0.357  Sum_probs=155.7

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|.-.+.||+|+||.||                                           ||||+++|+|. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            356667889999999998                                           89999999996 4678999


Q ss_pred             EEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      |||+++|+|.+++...      .....++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999987642      34678999999999999998   99999999999999999999999999998776544


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHH
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLK  345 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~  345 (383)
                      ........||+.|+|||        .++|||||||++|||++ |..|+..    ....++.+.+..... ...+...+..
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~----~~~~~~~~~i~~~~~-~~~~~~~~~~  237 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG----VKNNDVIGRIENGER-LPMPPNCPPT  237 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT----CCGGGHHHHHHTTCC-CCCCTTCCHH
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC----CCHHHHHHHHHcCCC-CCCCCCCCHH
Confidence            44445567899999998        57899999999999998 7878543    234444444433322 2234556678


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +.+++.+||+.||++|||+.||++.|+++.++
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999988654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-42  Score=314.75  Aligned_cols=200  Identities=21%  Similarity=0.256  Sum_probs=150.3

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--CCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--GEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--~~~~~lv  200 (383)
                      ++|...+.||+|+||.||                                         ||||++++++.+  ++..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            467788999999999999                                         899999999975  4568999


Q ss_pred             EEeccCCCHHHHHhcc---------hhhhHHHHhHHHHHHHHhhcC--CCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          201 YEYMVKGSLNDWLRNQ---------AKHCIIACGTARGITFLHHRF--QPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ||||++|+|.+++...         .....++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998632         346789999999999999862  12499999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChh
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP  341 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~  341 (383)
                      ...... ......||+.|+|||        .++|||||||++|||++|+.||..    .+..++.+.+...... ..+..
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~----~~~~~~~~~i~~~~~~-~~~~~  237 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RIPYR  237 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHTCCC-CCCTT
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC----CCHHHHHHHHHcCCCC-CCCcc
Confidence            754322 233467999999998        578999999999999999999643    2333444444443332 22344


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          342 SMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            5668899999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=309.83  Aligned_cols=181  Identities=25%  Similarity=0.409  Sum_probs=141.3

Q ss_pred             cccceeeeEEEe----CCEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 046461          182 KNIVQLLGYCPV----GEKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNIL  252 (383)
Q Consensus       182 ~niv~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiL  252 (383)
                      ||||++++++.+    +...++||||+++|+|.+++...     .....++.|++.||+|||++ .++|+||||||+|||
T Consensus        68 pnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NIL  146 (270)
T d1t4ha_          68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIF  146 (270)
T ss_dssp             TTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEE
T ss_pred             CCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhce
Confidence            799999999875    35679999999999999999743     34577999999999999987 123999999999999


Q ss_pred             Ec-CCCceEEccccCccccCCCCCccccccccccccccCC-------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 046461          253 LN-EDFEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA-------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN  324 (383)
Q Consensus       253 l~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape-------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~  324 (383)
                      ++ .++.+||+|||+++.....   ......||+.|+|||       .++|||||||++|||++|+.||....   +...
T Consensus       147 l~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~---~~~~  220 (270)
T d1t4ha_         147 ITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQ  220 (270)
T ss_dssp             ESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS---SHHH
T ss_pred             eeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcc---cHHH
Confidence            96 5789999999999864332   233468999999999       67899999999999999999974321   1222


Q ss_pred             cceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+.+.........+...++++.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            223222222222223334567889999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-41  Score=312.30  Aligned_cols=216  Identities=25%  Similarity=0.359  Sum_probs=164.3

Q ss_pred             CccccCeeecCCccccc------------------------------------cccceeeeEEEeCC----EEEEEEEec
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------KNIVQLLGYCPVGE----KKLIVYEYM  204 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------~niv~l~g~~~~~~----~~~lv~e~~  204 (383)
                      ++.-.+.||+|+||.||                                    ||||+++|+|.+.+    ..++|||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~   83 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence            34556789999999999                                    79999999998754    679999999


Q ss_pred             cCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcC-----CCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          205 VKGSLNDWLRN----QAKHCIIACGTARGITFLHHRF-----QPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       205 ~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ++|+|.++++.    +.++..++.|+|.||+|+|+..     ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~  163 (303)
T d1vjya_          84 EHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             TTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             cCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence            99999999984    3456789999999999999731     34899999999999999999999999999987754332


Q ss_pred             c---cccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC-c----------cce
Q 046461          276 H---TSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG-N----------LVD  327 (383)
Q Consensus       276 ~---~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~-~----------~~~  327 (383)
                      .   ......||+.|+|||              .++|||||||++|||+||..|+.......... .          +.+
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (303)
T d1vjya_         164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK  243 (303)
T ss_dssp             EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH
Confidence            2   223467999999998              25799999999999999988764221110000 0          000


Q ss_pred             eeec----CcccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCCCC
Q 046461          328 WVLD----STILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGENF  380 (383)
Q Consensus       328 ~v~~----~~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~~~  380 (383)
                      .+.+    +.+.... ..+....+.+++.+||+.||++||||.||++.|+++.++++.
T Consensus       244 ~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            1111    1221111 223456789999999999999999999999999999876653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=313.33  Aligned_cols=206  Identities=29%  Similarity=0.439  Sum_probs=160.8

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEeCCEEEEEEEeccC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPVGEKKLIVYEYMVK  206 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~~~~~~lv~e~~~~  206 (383)
                      ++|.-.+.||+|+||.||                                     +|||+++|+|.+ +..++||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            467778899999999999                                     799999999854 568999999999


Q ss_pred             CCHHHHHhc-------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          207 GSLNDWLRN-------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       207 gsL~~~l~~-------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      |+|.+++..       +..++.++.|++.||+|||+.   +|+||||||+|||+|.++++||+|||+++...........
T Consensus        96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence            999999864       235688999999999999998   9999999999999999999999999999877554444445


Q ss_pred             ccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          280 DVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       280 ~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ...||+.|+|||        .++|||||||++|||++|..|+...   ....++..++... ...+.+...+.++.+++.
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~---~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~  248 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERG-YRMPCPPECPESLHDLMC  248 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC---CCHHHHHHHHHhc-CCCCCCcccCHHHHHHHH
Confidence            567899999998        6789999999999999987775332   2223333333322 222334556678999999


Q ss_pred             HccccCCCCCCCHHHHHHHHhccccC
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      +||+.||++||||.+|+++|++....
T Consensus       249 ~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         249 QCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            99999999999999999999986643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=316.35  Aligned_cols=205  Identities=25%  Similarity=0.402  Sum_probs=166.6

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|.-.++||+|+||.||                                           ||||+++|+|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567777899999999999                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCce
Q 046461          201 YEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEV  259 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~  259 (383)
                      |||+++|+|.++++..                     ..+..++.|+|.||.|+|+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999632                     23577999999999999998   99999999999999999999


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD  331 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~  331 (383)
                      ||+|||+++......  ......||..|+|||        .++|||||||++|||++|..|+   +.+.+..++.+.+..
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p---~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT---TTTCCHHHHHHHGGG
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCC---CCCCCHHHHHHHHHh
Confidence            999999998654322  222356899999998        5799999999999999987653   333344444444443


Q ss_pred             CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          332 STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       332 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      .. ....+...+.++.+++.+||+.||++||||+||++.|+++.++
T Consensus       242 ~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         242 GY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             TC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            32 2223445667899999999999999999999999999987654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-41  Score=313.58  Aligned_cols=189  Identities=28%  Similarity=0.484  Sum_probs=151.7

Q ss_pred             cccceeeeEEEe-CCEEEEEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          182 KNIVQLLGYCPV-GEKKLIVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       182 ~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ||||+++|+|.+ +...++|||||++|+|.+++...      ..+..++.|+|.||.|+|+.   +|+||||||+|||++
T Consensus        88 pnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~  164 (311)
T d1r0pa_          88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLD  164 (311)
T ss_dssp             TTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             CCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeEC
Confidence            799999999876 46899999999999999998743      34678999999999999998   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCCc---cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 046461          255 EDFEVKVSDFGLVRLISDCESH---TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG  323 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~  323 (383)
                      +++.+||+|||+++........   ......||..|+|||        .++||||||+++|||++|+.|+....   +..
T Consensus       165 ~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~---~~~  241 (311)
T d1r0pa_         165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTF  241 (311)
T ss_dssp             TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------
T ss_pred             CCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC---CHH
Confidence            9999999999999876543322   223356899999998        57899999999999999888865432   233


Q ss_pred             ccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          324 NLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       324 ~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ++..++..... ...+......+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       242 ~~~~~i~~g~~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         242 DITVYLLQGRR-LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -CHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHcCCC-CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            34444433322 222344566889999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=312.68  Aligned_cols=197  Identities=21%  Similarity=0.290  Sum_probs=159.8

Q ss_pred             CccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          165 KFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      .|...+.||+|+||.||                                       ||||++++++.+++..++|||||+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            45667889999999999                                       799999999999999999999999


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcccc
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTST  279 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (383)
                      +|+|.+++...      .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~  168 (288)
T d2jfla1          93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  168 (288)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHT
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccc
Confidence            99999997532      34678999999999999999   99999999999999999999999999997653211 1223


Q ss_pred             ccccccccccCC-------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc-cCChhHHHH
Q 046461          280 DVAGTIGYILLA-------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN-AYSKPSMLK  345 (383)
Q Consensus       280 ~~~gt~~y~ape-------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~-~~~~~~~~~  345 (383)
                      ...||+.|+|||             .++|||||||++|||++|+.||...    +..+....+....... ..+...+..
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~s~~  244 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL----NPMRVLLKIAKSEPPTLAQPSRWSSN  244 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS----CGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC----CHHHHHHHHHcCCCCCCCccccCCHH
Confidence            467999999998             3579999999999999999996432    3333333333322211 123445678


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+++.+||+.||++|||++|+++
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhc
Confidence            899999999999999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-41  Score=313.24  Aligned_cols=193  Identities=24%  Similarity=0.337  Sum_probs=158.6

Q ss_pred             CccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          165 KFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .|...+.||+|+||.||                                          ||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            47788899999999999                                          799999999999999999999


Q ss_pred             eccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ||++|+|..++..     +.....++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....     
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence            9999999877653     235678999999999999998   999999999999999999999999999986543     


Q ss_pred             ccccccccccccCC-----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHH
Q 046461          278 STDVAGTIGYILLA-----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKM  346 (383)
Q Consensus       278 ~~~~~gt~~y~ape-----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~  346 (383)
                      .....||+.|+|||           .++|||||||++|||++|+.|+...    ...+....+.........+...+..+
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~s~~~  243 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNESPALQSGHWSEYF  243 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC----CHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            23457999999998           3589999999999999999996432    22222222322222222233445678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||++|+++
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCcCChhHCcCHHHHHh
Confidence            99999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-41  Score=307.47  Aligned_cols=203  Identities=24%  Similarity=0.387  Sum_probs=159.4

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|.-.+.||+|+||.||                                             ||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            356667789999999998                                             799999999976 4678


Q ss_pred             EEEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +||||+++|++.+++...      .....++.|+|.||+|||++   +|+||||||+||+++.++.+|++|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988643      34678999999999999998   999999999999999999999999999998754


Q ss_pred             CCCc--cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChh
Q 046461          273 CESH--TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKP  341 (383)
Q Consensus       273 ~~~~--~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~  341 (383)
                      ....  ......|+..|+|||        .++|||||||++|||+| |+.||.    +.+..+..+++.......+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~----~~~~~~~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI----GLNGSQILHKIDKEGERLPRPED  239 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT----TCCHHHHHHHHHTSCCCCCCCTT
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC----CcCHHHHHHHHHhCCCCCCCccc
Confidence            3322  223356788999998        57999999999999998 888853    33444555555444433333455


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 046461          342 SMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKY  374 (383)
Q Consensus       342 ~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~  374 (383)
                      .+..+.+++.+||+.||++||||.||.+.|+++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            567889999999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=314.01  Aligned_cols=206  Identities=25%  Similarity=0.395  Sum_probs=159.6

Q ss_pred             hhCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          163 TNKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      .++|...+.||+|+||+||                                        ||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4678888999999999999                                        799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      ||++|+|.+++...     .....++.|++.||+|||+.+  +|+||||||+|||++.++.+||+|||+|+.....   .
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  159 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence            99999999999743     345779999999999999731  7999999999999999999999999999876432   2


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce----------------e-----
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD----------------W-----  328 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~----------------~-----  328 (383)
                      .....||+.|+|||        .++||||+||++|||++|+.||......  ......                +     
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK--ELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT--HHHHHC----------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhcCCcccCCcccccccccc
Confidence            23468999999998        6899999999999999999997542110  000000                0     


Q ss_pred             ---eecC---------------cccccC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          329 ---VLDS---------------TILNAY-SKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       329 ---v~~~---------------~~~~~~-~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                         ..+.               ...+.. ....+.++.+++.+|+..||++|||++|+++  .+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence               0000               000000 1112457889999999999999999999987  565543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-41  Score=305.62  Aligned_cols=203  Identities=27%  Similarity=0.383  Sum_probs=158.4

Q ss_pred             hCccccCeeecCCccccc-----------------------------------cccceeeeEEEe-CCEEEEEEEeccCC
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV-GEKKLIVYEYMVKG  207 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~-~~~~~lv~e~~~~g  207 (383)
                      ++|.-.+.||+|+||.||                                   ||||+++|+|.+ .+..++||||+++|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            345566889999999999                                   799999999965 45689999999999


Q ss_pred             CHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccccc
Q 046461          208 SLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTSTD  280 (383)
Q Consensus       208 sL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (383)
                      +|.+++...       ..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.....    ...
T Consensus        87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~  159 (262)
T d1byga_          87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDT  159 (262)
T ss_dssp             EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----Ccc
Confidence            999999642       34678999999999999998   9999999999999999999999999999875432    223


Q ss_pred             cccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHH
Q 046461          281 VAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVV  351 (383)
Q Consensus       281 ~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~  351 (383)
                      ..++..|+|||        .++|||||||++|||+| |+.|+.    .....++..++... ...+.+...+.++.+++.
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~----~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP----RIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT----TSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHH
T ss_pred             ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC----CCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHH
Confidence            45788999998        57999999999999998 566643    22344445444332 223334556678899999


Q ss_pred             HccccCCCCCCCHHHHHHHHhccccCC
Q 046461          352 GCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       352 ~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      +||+.||++||||.|++++|+++++.+
T Consensus       235 ~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-41  Score=310.32  Aligned_cols=197  Identities=20%  Similarity=0.327  Sum_probs=160.2

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            467888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC-C
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE-S  275 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~-~  275 (383)
                      |||++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999999999998743     34678999999999999998   99999999999999999999999999999875432 2


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      .......||+.|+|||        .++||||+||++|||++|+.||..    .+..++.+.+.....  ..+...+.++.
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~  238 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEY--DFPEKFFPKAR  238 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHTTCC--CCCTTCCHHHH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC----cCHHHHHHHHHcCCC--CCCccCCHHHH
Confidence            2334467999999998        578999999999999999999643    233333333333222  22344566789


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+||+.||++|||++|+.+
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTC
T ss_pred             HHHHHHccCCHhHCcCHHHHcC
Confidence            9999999999999999998743

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=311.95  Aligned_cols=208  Identities=25%  Similarity=0.416  Sum_probs=168.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------------cccceeeeEEEeCCEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------------KNIVQLLGYCPVGEKK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------------~niv~l~g~~~~~~~~  197 (383)
                      ++|.-.+.||+|+||.||                                              ||||+++|+|.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            456667899999999998                                              7999999999999999


Q ss_pred             EEEEEeccCCCHHHHHhcc-----------------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----------------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN  254 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----------------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~  254 (383)
                      ++|||||++|+|.++++..                       ..+..++.|++.||+|||++   +++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            9999999999999999642                       23567999999999999999   999999999999999


Q ss_pred             CCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 046461          255 EDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNL  325 (383)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~  325 (383)
                      .++.+|++|||+++....... .......||+.|+|||        .++|||||||++|||+|+..|+....   ...+.
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~---~~~~~  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM---PVDSK  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CSSHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC---CHHHH
Confidence            999999999999987754332 2334467899999998        57899999999999999666643221   22232


Q ss_pred             ceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          326 VDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       326 ~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ...+++.......+...+..+.+++.+||+.||++||||+||+++|+++..+
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3233333333333445567889999999999999999999999999876443

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=309.68  Aligned_cols=207  Identities=24%  Similarity=0.466  Sum_probs=168.7

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...+.||+|+||.||                                             ||||+++|+|..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            456677889999999998                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc---------------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEcc
Q 046461          199 IVYEYMVKGSLNDWLRNQ---------------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSD  263 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~---------------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~D  263 (383)
                      +|||||++|+|.+++...               ..+..++.|+|+||.|||+.   +|+||||||+|||++.++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence            999999999999998743               23577999999999999998   999999999999999999999999


Q ss_pred             ccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc
Q 046461          264 FGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI  334 (383)
Q Consensus       264 fgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~  334 (383)
                      ||+++....... .......||+.|++||        .++||||||+++|||+||..|+   +.+....+..+.+.++..
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p---~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT---TTTSCHHHHHHHHHTTCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHhCCC
Confidence            999987644322 2233456899999998        4789999999999999986553   233334444444444433


Q ss_pred             cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          335 LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       335 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      . ..+...+..+.+++.+||+.||++||||.||+++|++..+.
T Consensus       254 ~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         254 L-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             C-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            2 22345567899999999999999999999999999987653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=309.18  Aligned_cols=186  Identities=27%  Similarity=0.445  Sum_probs=152.0

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhcc---------------------hhhhHHHHhHHHHHHHHhhcCCCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQ---------------------AKHCIIACGTARGITFLHHRFQPH  240 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------~~~~~i~~~ia~gL~~LH~~~~~~  240 (383)
                      ||||+++++|.+++..++|||||++|+|.+++...                     .....++.|++.||+|||+.   +
T Consensus        79 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~  155 (299)
T d1fgka_          79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---K  155 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---C
Confidence            79999999999999999999999999999999632                     23578999999999999999   9


Q ss_pred             eeecCCCCCcEEEcCCCceEEccccCccccCCCCC-ccccccccccccccCC--------CCCcchhHHHHHHHHHh-CC
Q 046461          241 IIHRDINASNILLNEDFEVKVSDFGLVRLISDCES-HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RK  310 (383)
Q Consensus       241 ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~  310 (383)
                      |+||||||+|||++.++.+||+|||+++....... .......|++.|+|||        .++|||||||++|||++ |.
T Consensus       156 ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~  235 (299)
T d1fgka_         156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  235 (299)
T ss_dssp             CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCC
Confidence            99999999999999999999999999987754332 2334467899999998        57899999999999998 56


Q ss_pred             CCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccc
Q 046461          311 QPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYH  375 (383)
Q Consensus       311 ~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~  375 (383)
                      .|+.    +.....+.+.+.++ .....+...+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       236 ~p~~----~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         236 SPYP----GVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             CSST----TCCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----CCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            6643    22333333333332 222334556678999999999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=311.01  Aligned_cols=204  Identities=22%  Similarity=0.408  Sum_probs=162.0

Q ss_pred             hCccccCeeecCCccccc--------------------------------------------cccceeeeEEEeCCEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------------KNIVQLLGYCPVGEKKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------------~niv~l~g~~~~~~~~~l  199 (383)
                      .+|...++||+|+||.||                                            ||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358888999999999998                                            7999999999875 5678


Q ss_pred             EEEeccCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          200 VYEYMVKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      ++||+.+|+|.+++...      ..+..++.|+|.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999988743      34678999999999999998   9999999999999999999999999999987543


Q ss_pred             CCc-cccccccccccccCC--------CCCcchhHHHHHHHHHh-CCCCCCCCCCCCCCCccceeeecCcccccCChhHH
Q 046461          274 ESH-TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVI-RKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSM  343 (383)
Q Consensus       274 ~~~-~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Ellt-g~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~  343 (383)
                      ... ......||+.|+|||        .++|||||||++|||+| |+.|++.    ....++.+.+..+. ....+...+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~----~~~~~~~~~i~~~~-~~~~p~~~~  239 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILEKGE-RLPQPPICT  239 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----SCGGGHHHHHHHTC-CCCCCTTBC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHcCC-CCCCCcccC
Confidence            322 233456899999998        57999999999999999 6777532    23333333333222 222344566


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcccc
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHT  376 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~  376 (383)
                      ..+.+++.+||+.||++|||+.||++.|+++..
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            788999999999999999999999999887643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-40  Score=308.67  Aligned_cols=197  Identities=21%  Similarity=0.312  Sum_probs=151.1

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      +.|.-.+.||+|+||.||                                        ||||++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            457777899999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCceEEccccCccccCCCCC
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN---EDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~---~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||++.   .++.+||+|||+++...... 
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            9999999999643     35678999999999999998   999999999999994   57899999999998764432 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCChhHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYSKPSMLK  345 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~~~~~~~  345 (383)
                       ......||+.|+|||        .++||||+||++|||++|+.||...    ...++...+......  .......+..
T Consensus       165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE----NDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHhccCCCCCCccccCCCHH
Confidence             223467999999998        6799999999999999999996432    333333333333221  1223445678


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 046461          346 MLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       346 ~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +.+++.+||+.||++|||++|+++
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhc
Confidence            899999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-39  Score=304.24  Aligned_cols=196  Identities=21%  Similarity=0.325  Sum_probs=163.7

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          ||||++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            568888999999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence            999999999998743     34677899999999999999   99999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                      .....+||+.|+|||        .++||||+||++|||++|+.|+..    .+..++.+.+....+  .++...+.++.+
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~d  234 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEI--RFPRTLSPEAKS  234 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC----cCHHHHHHHHhcCCC--CCCccCCHHHHH
Confidence            334578999999999        689999999999999999999643    233344444433332  234455667889


Q ss_pred             HHHHccccCCCCCCC-----HHHHHH
Q 046461          349 IVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ++.+|++.||++||+     ++|+++
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhhccCCchhhcccccccHHHHHc
Confidence            999999999999995     788875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-39  Score=307.28  Aligned_cols=197  Identities=23%  Similarity=0.325  Sum_probs=159.9

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      ++|...++||+|+||.||                                             ||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            578888999999999999                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCC
Q 046461          199 IVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~  273 (383)
                      +|||||++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999999999743     35678999999999999999   9999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHH
Q 046461          274 ESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSML  344 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~  344 (383)
                      .   .....||+.|+|||         .++||||+||++|||++|+.||..... .+...+.+......  ...+...+.
T Consensus       161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~~~~~~~~~--~~~~~~~s~  234 (364)
T d1omwa3         161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMA--VELPDSFSP  234 (364)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-SCHHHHHHHSSSCC--CCCCSSSCH
T ss_pred             c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccCC--CCCCCCCCH
Confidence            2   33467999999998         568999999999999999999753211 01111111111111  122334566


Q ss_pred             HHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          345 KMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       345 ~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      .+.+++.+||+.||++|||     ++|+++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            7899999999999999999     688865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-39  Score=299.93  Aligned_cols=197  Identities=18%  Similarity=0.271  Sum_probs=160.1

Q ss_pred             hCccccCeeecCCccccc---------------------------------------------cccceeeeEEEeCCEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPVGEKKL  198 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~~~~~~  198 (383)
                      +.|...+.||+|+||.||                                             ||||++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            457777899999999999                                             79999999999999999


Q ss_pred             EEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----ceEEccccCccc
Q 046461          199 IVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF----EVKVSDFGLVRL  269 (383)
Q Consensus       199 lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~----~~kl~Dfgla~~  269 (383)
                      +|||||++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+||+++.++    .+|++|||+++.
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999999999743     34678999999999999999   999999999999998776    499999999987


Q ss_pred             cCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCC
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYS  339 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~  339 (383)
                      .....  ......||+.|+|||        .++||||+||++|||++|+.||...    +..+..+.+......  ...+
T Consensus       167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD----TKQETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC----CHHHHHHHHHhcCCCCCchhc
Confidence            65432  233467899999998        6789999999999999999996432    333333333222211  1111


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      ...+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            234567889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.7e-39  Score=307.33  Aligned_cols=197  Identities=18%  Similarity=0.291  Sum_probs=161.5

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      ++|.-.+.||+|+||.||                                       ||||++++++.+++..++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            468888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCceEEccccCccccCCCCCc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN--EDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~--~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ++|+|.+++...      .....++.|++.||+|||++   +|+||||||+|||++  .++.+||+|||+++......  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            999999999532      34678999999999999999   999999999999995  46789999999998765432  


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc--ccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL--NAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~--~~~~~~~~~~~  346 (383)
                      ......||+.|+|||        .++||||+||++|||++|+.||..    .+..+..+.+......  .......+..+
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  256 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDG  256 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC----CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            233467999999998        578999999999999999999643    2333333333322221  11123345678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||++|+++
T Consensus       257 ~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         257 KDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            89999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.8e-39  Score=296.16  Aligned_cols=197  Identities=22%  Similarity=0.309  Sum_probs=162.7

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------------cccceeeeEEEeC
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------------KNIVQLLGYCPVG  194 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------------~niv~l~g~~~~~  194 (383)
                      ++|...+.||+|+||+||                                                 ||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            467778899999999999                                                 6999999999999


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +..++|||||++|+|.++++..     .+...++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999999999999743     35688999999999999998   999999999999999999999999999988


Q ss_pred             cCCCCCccccccccccccccCC--------------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc
Q 046461          270 ISDCESHTSTDVAGTIGYILLA--------------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL  335 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape--------------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~  335 (383)
                      .....  ..+...||..|++||              .++||||+||+++||++|+.||...    +..+..+.+......
T Consensus       160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~----~~~~~~~~i~~~~~~  233 (277)
T d1phka_         160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMIMSGNYQ  233 (277)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCC
T ss_pred             ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC----CHHHHHHHHHhCCCC
Confidence            75432  234467999999987              3689999999999999999996532    333333333333221


Q ss_pred             --ccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          336 --NAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       336 --~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                        .......++++.+++.+||+.||++|||+.||++
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1222345678999999999999999999999865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.2e-39  Score=305.61  Aligned_cols=197  Identities=17%  Similarity=0.223  Sum_probs=162.3

Q ss_pred             hCccccCeeecCCccccc---------------------------------------cccceeeeEEEeCCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF---------------------------------------KNIVQLLGYCPVGEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~---------------------------------------~niv~l~g~~~~~~~~~lv~e~~  204 (383)
                      +.|...+.||+|+||.||                                       ||||++++++.+++..++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            457888999999999999                                       79999999999999999999999


Q ss_pred             cCCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCceEEccccCccccCCCCCc
Q 046461          205 VKGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLN--EDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       205 ~~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~--~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ++|+|.+++...      .+...++.|++.||+|||+.   +|+||||||+|||++  .++.+||+|||+++......  
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            999999987642      34678999999999999998   999999999999998  57899999999998875432  


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCChhHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYSKPSMLKM  346 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~~~~~~~~  346 (383)
                      ......||+.|+|||        .++||||+||++|||++|+.||..    .+..+....+.....  ........+.++
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC----SSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            233467899999998        578999999999999999999643    233333333333222  222234456788


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 046461          347 LQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       347 ~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+++.+||+.||++|||+.|+++
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-39  Score=302.30  Aligned_cols=196  Identities=22%  Similarity=0.368  Sum_probs=162.2

Q ss_pred             hCccccCeeecCCccccc-------------------------------------------cccceeeeEEEeCCEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------------KNIVQLLGYCPVGEKKLIV  200 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------------~niv~l~g~~~~~~~~~lv  200 (383)
                      ++|.-.+.||+|+||+||                                           ||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            467778899999999999                                           7999999999999999999


Q ss_pred             EEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          201 YEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       201 ~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      ||||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+++...... 
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            9999999999999743     34678999999999999999   99999999999999999999999999998664432 


Q ss_pred             ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHH
Q 046461          276 HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKML  347 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~  347 (383)
                      ...+...||+.|+|||        .++||||+||++|||++|+.||..    .+..++.+.+.....  ..+...+..+.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~  231 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNP--FYPRWLEKEAK  231 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC----CCHHHHHHHHHcCCC--CCCccCCHHHH
Confidence            2334468999999998        678999999999999999999643    233333333332222  22344566789


Q ss_pred             HHHHHccccCCCCCCCHH-HHHH
Q 046461          348 QIVVGCIFDNPTTRPTML-RVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~-~v~~  369 (383)
                      +++.+||+.||++|||+. |+++
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HHHHHhcccCCCCCcCHHHHHHh
Confidence            999999999999999985 6753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-38  Score=298.40  Aligned_cols=193  Identities=21%  Similarity=0.353  Sum_probs=161.1

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            467778899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      |||++|+|.+++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            999999999998743     23567889999999999998   9999999999999999999999999999876532   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       .....||+.|+|||        .++||||+||++|||++|+.||..    .+..++.+.+.....  ..+...+..+.+
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~~  230 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAEL--RFPPFFNEDVKD  230 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC----cCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence             23468999999998        678999999999999999999643    233344444433332  223345567889


Q ss_pred             HHHHccccCCCCCC-----CHHHHHH
Q 046461          349 IVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      ++.+|++.||++||     |++|+++
T Consensus       231 li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         231 LLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhhCHHhccccchhhHHHHHc
Confidence            99999999999996     8999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-38  Score=298.04  Aligned_cols=201  Identities=18%  Similarity=0.216  Sum_probs=154.5

Q ss_pred             hCcccc-CeeecCCccccc-----------------------------------cccceeeeEEEe----CCEEEEEEEe
Q 046461          164 NKFYEK-NVIRGDDFGIAF-----------------------------------KNIVQLLGYCPV----GEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~-~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~----~~~~~lv~e~  203 (383)
                      ++|.-. ++||+|+||.||                                   ||||++++++.+    ....++||||
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy   90 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   90 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence            456544 579999999999                                   799999999875    4568999999


Q ss_pred             ccCCCHHHHHhcc-------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCC
Q 046461          204 MVKGSLNDWLRNQ-------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDC  273 (383)
Q Consensus       204 ~~~gsL~~~l~~~-------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~  273 (383)
                      |++|+|.+++...       .....++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus        91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCC
Confidence            9999999999742       24678999999999999998   9999999999999985   467999999999876543


Q ss_pred             CCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccC--ChhHH
Q 046461          274 ESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAY--SKPSM  343 (383)
Q Consensus       274 ~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~--~~~~~  343 (383)
                      .  ......||+.|+|||        .++||||+||++|||+||+.||...........+...+.......+.  ....+
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         168 N--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             C--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred             C--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence            3  233467999999999        57899999999999999999974321111111122222222221111  12345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          344 LKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       344 ~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .++.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHc
Confidence            67899999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-38  Score=293.52  Aligned_cols=206  Identities=22%  Similarity=0.328  Sum_probs=157.6

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCC----EE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGE----KK  197 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~----~~  197 (383)
                      ++|.-.+.||+|+||.||                                          ||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            457778899999999999                                          79999999997643    47


Q ss_pred             EEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      ++||||+++|+|.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.++..+++|||.++....
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcc
Confidence            8999999999999988643     35678999999999999998   999999999999999999999999999876543


Q ss_pred             CC--CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCc--ccccCCh
Q 046461          273 CE--SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDST--ILNAYSK  340 (383)
Q Consensus       273 ~~--~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~--~~~~~~~  340 (383)
                      ..  ........||+.|+|||        .++||||+||++|||+||+.||...    +..+....+....  .......
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD----SPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHCCCCCGGGTSS
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc----CHHHHHHHHHhcCCCCCchhcc
Confidence            22  12334467999999998        5789999999999999999996432    2222222222111  1112233


Q ss_pred             hHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcccc
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRP-TMLRVQEFLEKYHT  376 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RP-s~~~v~~~L~~~~~  376 (383)
                      ..+..+.+++.+|++.||++|| |++++.+.|.++..
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            4556889999999999999999 89999999988764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-38  Score=295.20  Aligned_cols=197  Identities=16%  Similarity=0.266  Sum_probs=159.3

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|.-.+.||+|+||.||                                      ||||++++++.+++..|+|||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            456777899999999999                                      799999999999999999999999


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCceEEccccCccccCCCCCcc
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE--DFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~--~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      +|+|.+++...      .+...++.|++.||+|||+.   +|+||||||+|||++.  ...+|++|||+++......  .
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~  159 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence            99999999743      34677999999999999998   9999999999999985  4579999999998764432  2


Q ss_pred             ccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccc--cCChhHHHHHH
Q 046461          278 STDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILN--AYSKPSMLKML  347 (383)
Q Consensus       278 ~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~--~~~~~~~~~~~  347 (383)
                      .....+|+.|++||        .++||||+||++|||++|+.||...    +..+....+.......  ......+.++.
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE----TNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS----SHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            33457899999987        5789999999999999999996432    3333444343332211  11112355788


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 046461          348 QIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       348 ~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      +++.+|+..||++|||+.|+++
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-37  Score=296.40  Aligned_cols=193  Identities=16%  Similarity=0.252  Sum_probs=161.6

Q ss_pred             hCccccCeeecCCccccc------------------------------------------cccceeeeEEEeCCEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF------------------------------------------KNIVQLLGYCPVGEKKLIVY  201 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~------------------------------------------~niv~l~g~~~~~~~~~lv~  201 (383)
                      ++|...+.||+|+||.||                                          ||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            468888899999999999                                          79999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCc
Q 046461          202 EYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       202 e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      ||+.+|+|.+++...     .....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            999999999998643     35678999999999999998   9999999999999999999999999999876532   


Q ss_pred             cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCChhHHHHHHH
Q 046461          277 TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSKPSMLKMLQ  348 (383)
Q Consensus       277 ~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~  348 (383)
                       .....||+.|||||        .++||||+||++|||++|+.||..    .+...+...+.....  ..+...+..+.+
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~~~--~~p~~~s~~~~~  267 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKV--RFPSHFSSDLKD  267 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCC--CCCTTCCHHHHH
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC----cCHHHHHHHHhcCCC--CCCccCCHHHHH
Confidence             23467999999998        578999999999999999999643    233333333333322  223445567889


Q ss_pred             HHHHccccCCCCCC-----CHHHHHH
Q 046461          349 IVVGCIFDNPTTRP-----TMLRVQE  369 (383)
Q Consensus       349 l~~~C~~~~P~~RP-----s~~~v~~  369 (383)
                      ++.+|++.||++|+     |++|+++
T Consensus       268 li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         268 LLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHHHHhhhCHHhccccccccHHHHHc
Confidence            99999999999994     8999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=290.05  Aligned_cols=180  Identities=22%  Similarity=0.280  Sum_probs=139.9

Q ss_pred             cccceeeeEEEeCCEEEEEEEeccCCCHHHHHhc-----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 046461          182 KNIVQLLGYCPVGEKKLIVYEYMVKGSLNDWLRN-----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED  256 (383)
Q Consensus       182 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~  256 (383)
                      ||||++++++.+++..++||||++++++..+...     ......++.|++.||+|||++   +|+||||||+|||++.+
T Consensus        60 pnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~  136 (299)
T d1ua2a_          60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN  136 (299)
T ss_dssp             TTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             CCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCC
Confidence            7999999999999999999999998877766653     235678999999999999998   99999999999999999


Q ss_pred             CceEEccccCccccCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccce
Q 046461          257 FEVKVSDFGLVRLISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVD  327 (383)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~  327 (383)
                      +.+||+|||+++....... ......||+.|+|||         .++||||+||++|||++|+.||...    ...+...
T Consensus       137 ~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~----~~~~~l~  211 (299)
T d1ua2a_         137 GVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD----SDLDQLT  211 (299)
T ss_dssp             CCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHH
T ss_pred             CccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC----CHHHHHH
Confidence            9999999999987654332 223457899999998         4679999999999999999987432    1111111


Q ss_pred             ee----------------------ecCccccc----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          328 WV----------------------LDSTILNA----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       328 ~v----------------------~~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .+                      ........    ........+.+++.+|++.||++|||++|+++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00                      00000000    01123457889999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-37  Score=284.36  Aligned_cols=193  Identities=19%  Similarity=0.370  Sum_probs=155.8

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCCE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ++|.-.++||+|+||.||                                               ||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            457777899999999999                                               589999999999999


Q ss_pred             EEEEEEeccC-CCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CceEEccccCccc
Q 046461          197 KLIVYEYMVK-GSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNED-FEVKVSDFGLVRL  269 (383)
Q Consensus       197 ~~lv~e~~~~-gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~-~~~kl~Dfgla~~  269 (383)
                      .++||||+.+ +++.+++...     .....++.|++.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence            9999999975 6888887642     34678999999999999998   99999999999999854 7899999999987


Q ss_pred             cCCCCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcccccCCh
Q 046461          270 ISDCESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTILNAYSK  340 (383)
Q Consensus       270 ~~~~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~~~~~~  340 (383)
                      ....   ..+...||+.|+|||         .++||||+||++|||++|+.||...      .++.    ....  ..+.
T Consensus       161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~----~~~~--~~~~  225 (273)
T d1xwsa_         161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII----RGQV--FFRQ  225 (273)
T ss_dssp             CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHH----HCCC--CCSS
T ss_pred             cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHh----hccc--CCCC
Confidence            5432   234467999999998         3579999999999999999996421      1111    1111  1123


Q ss_pred             hHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcc
Q 046461          341 PSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKY  374 (383)
Q Consensus       341 ~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~  374 (383)
                      ..+.++.+++.+||+.||++|||++|+++  .++++
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            34567889999999999999999999987  45543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-36  Score=279.29  Aligned_cols=208  Identities=20%  Similarity=0.301  Sum_probs=157.0

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||.||                                         ||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            468888999999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHh-c------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          203 YMVKGSLNDWLR-N------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       203 ~~~~gsL~~~l~-~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      |+.++ +.+++. .      +.....++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+++...... 
T Consensus        82 ~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            99754 444443 2      234678999999999999998   99999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCC------------CCCCc--cceee--e
Q 046461          276 HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKD------------KNGGN--LVDWV--L  330 (383)
Q Consensus       276 ~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~------------~~~~~--~~~~v--~  330 (383)
                      .......||+.|+|||         .++||||+||++|||++|+.||......            .....  .....  .
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2333457999999988         5689999999999999999997532100            00000  00000  0


Q ss_pred             cCccccc-------CChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          331 DSTILNA-------YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       331 ~~~~~~~-------~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                      .......       .....+..+.+++.+|+..||++|||+.|+++  .++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            0000000       01123457889999999999999999999998  3666544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=283.42  Aligned_cols=199  Identities=23%  Similarity=0.294  Sum_probs=161.9

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------------cccceeeeEEEeCCE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------------KNIVQLLGYCPVGEK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------------~niv~l~g~~~~~~~  196 (383)
                      ++|...+.||+|+||+||                                               |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            568888999999999998                                               699999999999999


Q ss_pred             EEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLIS  271 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~  271 (383)
                      .+++|||+.+|+|.+++...     .....++.|++.|++|+|+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999999743     34567889999999999998   99999999999999999999999999998765


Q ss_pred             CCCCccccccccccccccCC----------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc--cccCC
Q 046461          272 DCESHTSTDVAGTIGYILLA----------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI--LNAYS  339 (383)
Q Consensus       272 ~~~~~~~~~~~gt~~y~ape----------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~--~~~~~  339 (383)
                      ...........|++.|++||          .++||||+||++|||++|+.||....    ..+....+.....  ....+
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~----~~~~~~~i~~~~~~~~~~~~  256 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----EKNSQAEISRRILKSEPPYP  256 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT----SCCCHHHHHHHHHHCCCCCC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHhcccCCCCCc
Confidence            44444444567899999987          46899999999999999999975432    2222222211111  11223


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPT-----MLRVQE  369 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs-----~~~v~~  369 (383)
                      ...+..+.+++.+||+.||++|||     ++|+++
T Consensus       257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            456678999999999999999994     788875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=277.25  Aligned_cols=204  Identities=21%  Similarity=0.302  Sum_probs=155.9

Q ss_pred             hhCccccCeeecCCccccc---------------------------------------------cccceeeeEEEe----
Q 046461          163 TNKFYEKNVIRGDDFGIAF---------------------------------------------KNIVQLLGYCPV----  193 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~---------------------------------------------~niv~l~g~~~~----  193 (383)
                      .++|.-.+.||+|+||+||                                             ||||+++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            4678888899999999999                                             799999999863    


Q ss_pred             -CCEEEEEEEeccCCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccC
Q 046461          194 -GEKKLIVYEYMVKGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGL  266 (383)
Q Consensus       194 -~~~~~lv~e~~~~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgl  266 (383)
                       ....+++|||+++|++......      ......++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence             3467999999988877655432      224567999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee---------
Q 046461          267 VRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV---------  329 (383)
Q Consensus       267 a~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v---------  329 (383)
                      ++.....  .......||+.|+|||        .++||||+||++|||++|+.||....    ..+....+         
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS----DVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCG
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCch
Confidence            8765332  2334567999999998        68999999999999999999975321    11100000         


Q ss_pred             ----------------ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          330 ----------------LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       330 ----------------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                                      ................+.+++.+|++.||++|||+.|+++  .++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                            0000011122234567889999999999999999999987  466553

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.3e-36  Score=277.51  Aligned_cols=209  Identities=18%  Similarity=0.266  Sum_probs=154.4

Q ss_pred             hCccccCeeecCCccccc-------------------------------------c-ccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------K-NIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~-niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|.-.+.||+|+||.||                                     + +|+.+.++..+++..++||||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            357778999999999999                                     3 4555566667788999999999 


Q ss_pred             CCCHHHHHhc------chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCceEEccccCccccCCCCCc
Q 046461          206 KGSLNDWLRN------QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE---DFEVKVSDFGLVRLISDCESH  276 (383)
Q Consensus       206 ~gsL~~~l~~------~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~---~~~~kl~Dfgla~~~~~~~~~  276 (383)
                      +|++.+.+..      ......++.|++.||+|||++   +|+||||||+||+++.   +..+|++|||+++........
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            5667666642      234678999999999999998   9999999999999753   567999999999987543321


Q ss_pred             ------cccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCccc---ccCC
Q 046461          277 ------TSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTIL---NAYS  339 (383)
Q Consensus       277 ------~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~~---~~~~  339 (383)
                            ......||+.|+|||        .++|||||||++|||++|+.||........ .............   +...
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSCHHHHT
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH-HHHHHHhhcccCCCChhHhc
Confidence                  233467999999998        578999999999999999999754322111 1111111111110   1112


Q ss_pred             hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccC
Q 046461          340 KPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTG  377 (383)
Q Consensus       340 ~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~  377 (383)
                      ...+.++.+++..||+.+|++||+++++.+.|+++..+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            23456788999999999999999999999988876443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-35  Score=275.01  Aligned_cols=198  Identities=20%  Similarity=0.246  Sum_probs=152.0

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCCEEEEEEEe
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGEKKLIVYEY  203 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~~~~lv~e~  203 (383)
                      ++|...+.||+|+||+||                                        ||||++++++.+++..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            467777899999999999                                        7999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCccc
Q 046461          204 MVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHTS  278 (383)
Q Consensus       204 ~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~  278 (383)
                      +.++.+..+....     .....++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.+........ ..
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~  157 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY  157 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence            9887777776533     34678999999999999998   999999999999999999999999999987654322 22


Q ss_pred             cccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--------------------
Q 046461          279 TDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--------------------  329 (383)
Q Consensus       279 ~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--------------------  329 (383)
                      ....|++.|++||         .++||||+||+++||++|+.||....    ..+....+                    
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS----EADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC----HHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            3346888999887         57899999999999999999975321    10000000                    


Q ss_pred             -------ecCcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 -------LDSTILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 -------~~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                             ..+.............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0000011112233567889999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.8e-35  Score=271.57  Aligned_cols=210  Identities=16%  Similarity=0.202  Sum_probs=162.1

Q ss_pred             hCccccCeeecCCccccc--------------------------------------cccceeeeEEEeCCEEEEEEEecc
Q 046461          164 NKFYEKNVIRGDDFGIAF--------------------------------------KNIVQLLGYCPVGEKKLIVYEYMV  205 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~--------------------------------------~niv~l~g~~~~~~~~~lv~e~~~  205 (383)
                      ++|.-.+.||+|+||.||                                      +|++.+++++.++...++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            467778899999999999                                      69999999999999999999999 


Q ss_pred             CCCHHHHHhcc------hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCceEEccccCccccCCCC
Q 046461          206 KGSLNDWLRNQ------AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNE-----DFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       206 ~gsL~~~l~~~------~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~-----~~~~kl~Dfgla~~~~~~~  274 (383)
                      +|+|.+++...      .....++.|++.||+|||+.   +|+||||||+||+++.     ++.+|++|||+++......
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            78999998643      24577999999999999998   9999999999999974     5679999999999865432


Q ss_pred             C------ccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeecCcc---ccc
Q 046461          275 S------HTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLDSTI---LNA  337 (383)
Q Consensus       275 ~------~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~~~~---~~~  337 (383)
                      .      .......||+.|+|||        .++|||||||++|||++|+.||...... ......+.+.....   ...
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-CHHHHHHHHHHHHHHSCHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-hHHHHHHHHHhccCCCChHH
Confidence            1      1233467999999998        5689999999999999999997532111 11111111111111   011


Q ss_pred             CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccccCC
Q 046461          338 YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEFLEKYHTGE  378 (383)
Q Consensus       338 ~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~L~~~~~~~  378 (383)
                      .....++++.+++..||+.+|++||+++.+.+.|+++.+..
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            11233457889999999999999999999999888765443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-35  Score=277.84  Aligned_cols=203  Identities=20%  Similarity=0.261  Sum_probs=151.5

Q ss_pred             CccccCeeecCCccccc-----------------------------------cccceeeeEEEeC------CEEEEEEEe
Q 046461          165 KFYEKNVIRGDDFGIAF-----------------------------------KNIVQLLGYCPVG------EKKLIVYEY  203 (383)
Q Consensus       165 ~f~~~~~lg~g~~g~v~-----------------------------------~niv~l~g~~~~~------~~~~lv~e~  203 (383)
                      +|...++||+|+||+||                                   +|||++++++...      ...++||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            47778899999999999                                   7999999998653      347899999


Q ss_pred             ccCCCHHHHHh--------cchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccccCCCC
Q 046461          204 MVKGSLNDWLR--------NQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRLISDCE  274 (383)
Q Consensus       204 ~~~gsL~~~l~--------~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~~~~~~  274 (383)
                      |++|.+.....        .+.....++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++......
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            98764443332        1234577999999999999998   999999999999999775 89999999998765432


Q ss_pred             CccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee----------------
Q 046461          275 SHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV----------------  329 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v----------------  329 (383)
                        ......||..|+|||         .++||||+||++|||++|+.||...    +..+....+                
T Consensus       178 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~----~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         178 --PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD----SGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             --CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             --ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC----CHHHHHHHHHHHhCCChHHhhhhhc
Confidence              223357899999987         5789999999999999999997432    111111000                


Q ss_pred             ---ecCc--------ccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          330 ---LDST--------ILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       330 ---~~~~--------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                         .+..        ............+.+++.+|+..||++|||+.|+++  .++++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence               0000        001112234567889999999999999999999996  4665543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-34  Score=271.62  Aligned_cols=200  Identities=19%  Similarity=0.304  Sum_probs=150.1

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCC------E
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGE------K  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~------~  196 (383)
                      +.|...+.||+|+||+||                                         ||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            467777899999999999                                         79999999997654      5


Q ss_pred             EEEEEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          197 KLIVYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      .++||||+ +++|.++.+.    ......++.|++.||+|||++   +|+||||||+|||++.++.+|++|||+++....
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence            79999999 5688887763    235678999999999999998   999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee-------------
Q 046461          273 CESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL-------------  330 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~-------------  330 (383)
                      .    .+...||+.|+|||         .++||||+||+++||++|+.|+...    +..+......             
T Consensus       174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS----DHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC----ChHHHHHHHHhccCCCcHHHHhh
Confidence            2    34467899999998         5789999999999999999997532    1111100000             


Q ss_pred             ------------cCcc----cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhccc
Q 046461          331 ------------DSTI----LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYH  375 (383)
Q Consensus       331 ------------~~~~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~  375 (383)
                                  .+..    ...........+.+++.+|+..||++|||+.|+++  .++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                        0000    00111233457789999999999999999999997  466554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=265.56  Aligned_cols=199  Identities=21%  Similarity=0.245  Sum_probs=154.2

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeCCEEEEEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVGEKKLIVYE  202 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~~~~~lv~e  202 (383)
                      ++|...+.||+|+||+||                                         +|||++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            357778899999999999                                         799999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCCcc
Q 046461          203 YMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCESHT  277 (383)
Q Consensus       203 ~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~~~  277 (383)
                      |+.+++|..++...     .....++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.++....... .
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence            99999998887643     34578999999999999998   999999999999999999999999999987654332 2


Q ss_pred             ccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee-------------------
Q 046461          278 STDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV-------------------  329 (383)
Q Consensus       278 ~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v-------------------  329 (383)
                      .....++..|++||         .++||||+||+++||++|+.|+...-   +..+..+.+                   
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            22344666777765         56899999999999999999963211   111111100                   


Q ss_pred             ---ecC-----cccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ---LDS-----TILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ---~~~-----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                         ..+     .-...........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000     0001112233457889999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=265.53  Aligned_cols=199  Identities=19%  Similarity=0.230  Sum_probs=148.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe--------C
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV--------G  194 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~--------~  194 (383)
                      ++|...+.||+|+||+||                                         +|++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            577888999999999999                                         799999999865        3


Q ss_pred             CEEEEEEEeccCCCHHHHHhcc-----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          195 EKKLIVYEYMVKGSLNDWLRNQ-----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~~-----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      +..++||||++++.+..+....     .....++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence            4579999999887776555422     34577899999999999998   999999999999999999999999999987


Q ss_pred             cCCCCC---ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee--------
Q 046461          270 ISDCES---HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV--------  329 (383)
Q Consensus       270 ~~~~~~---~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v--------  329 (383)
                      ......   .......||+.|+|||         .++||||+||++|||++|+.||....    ..+....+        
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLCGSIT  242 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCC
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC----HHHHHHHHHHhcCCCC
Confidence            653321   1222356899999998         57899999999999999999975321    11100000        


Q ss_pred             ----------------ecCcccccCCh------hHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 ----------------LDSTILNAYSK------PSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 ----------------~~~~~~~~~~~------~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                      ...........      .....+.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                            00000000000      11345678999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.7e-34  Score=267.97  Aligned_cols=201  Identities=12%  Similarity=0.206  Sum_probs=153.6

Q ss_pred             hCccccCeeecCCccccc-------------------------------------cccceeeeEEEe--CCEEEEEEEec
Q 046461          164 NKFYEKNVIRGDDFGIAF-------------------------------------KNIVQLLGYCPV--GEKKLIVYEYM  204 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-------------------------------------~niv~l~g~~~~--~~~~~lv~e~~  204 (383)
                      ++|...+.||+|+||+||                                     |||+++++++..  ....++|||||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            468888999999999999                                     799999999975  35689999999


Q ss_pred             cCCCHHHHHhc--chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-ceEEccccCccccCCCCCcccccc
Q 046461          205 VKGSLNDWLRN--QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDF-EVKVSDFGLVRLISDCESHTSTDV  281 (383)
Q Consensus       205 ~~gsL~~~l~~--~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~  281 (383)
                      ++|+|.++.+.  ......++.|++.||+|||++   +|+||||||+|||++.++ .+|++|||+++......  .....
T Consensus       115 ~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~  189 (328)
T d3bqca1         115 NNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVR  189 (328)
T ss_dssp             CSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--CCCSC
T ss_pred             CCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--ccccc
Confidence            99999887653  345678999999999999999   999999999999998655 68999999998765432  23345


Q ss_pred             ccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCC----------------------------c
Q 046461          282 AGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGG----------------------------N  324 (383)
Q Consensus       282 ~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~----------------------------~  324 (383)
                      .+|..|+|||         .++||||+||+++||++|+.|+.......+..                            .
T Consensus       190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  269 (328)
T d3bqca1         190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND  269 (328)
T ss_dssp             CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGG
T ss_pred             ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccch
Confidence            7899999998         45799999999999999999975321100000                            0


Q ss_pred             cceeeec----CcccccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          325 LVDWVLD----STILNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       325 ~~~~v~~----~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                      .......    .............++.+++.+|+..||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000    00001111223467889999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-34  Score=272.25  Aligned_cols=204  Identities=21%  Similarity=0.321  Sum_probs=150.6

Q ss_pred             hCccccCeeecCCccccc----------------------------------------cccceeeeEEEeCC----EEEE
Q 046461          164 NKFYEKNVIRGDDFGIAF----------------------------------------KNIVQLLGYCPVGE----KKLI  199 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~----------------------------------------~niv~l~g~~~~~~----~~~l  199 (383)
                      .+|...+.||+|+||+||                                        ||||++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            457778999999999999                                        79999999997643    2345


Q ss_pred             EEEeccCCCHHHHHhc----chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCCC
Q 046461          200 VYEYMVKGSLNDWLRN----QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCES  275 (383)
Q Consensus       200 v~e~~~~gsL~~~l~~----~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~~  275 (383)
                      +++|+.+|+|.+++..    ......++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            5567779999999964    235678999999999999998   999999999999999999999999999987643322


Q ss_pred             --ccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeee--------------
Q 046461          276 --HTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVL--------------  330 (383)
Q Consensus       276 --~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~--------------  330 (383)
                        .......||+.|+|||         .++||||+||+++||++|+.||....    ..+......              
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH----YLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC----HHHHHHHHhhhccCCChhhhhhh
Confidence              1233467899999998         46799999999999999999975321    111000000              


Q ss_pred             --------cCcccc--c-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhcc
Q 046461          331 --------DSTILN--A-----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQEF--LEKY  374 (383)
Q Consensus       331 --------~~~~~~--~-----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~~--L~~~  374 (383)
                              ......  .     .......++.+++.+|++.||++|||+.|+++.  +++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                    000000  0     011223468899999999999999999999973  5543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-33  Score=263.84  Aligned_cols=203  Identities=20%  Similarity=0.323  Sum_probs=151.8

Q ss_pred             hhCccccCeeecCCccccc-----------------------------------------cccceeeeEEEeC-----CE
Q 046461          163 TNKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPVG-----EK  196 (383)
Q Consensus       163 t~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~~-----~~  196 (383)
                      +++|...+.||+|+||+||                                         +|+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            3567788899999999999                                         7999999998643     34


Q ss_pred             EEEEEEeccCCCHHHHHhcc----hhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          197 KLIVYEYMVKGSLNDWLRNQ----AKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~~----~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      .+++++|+.+|+|.+++...    .....++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++.....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            46777888899999999642    35678999999999999999   999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccCC---------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceeeec------------
Q 046461          273 CESHTSTDVAGTIGYILLA---------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWVLD------------  331 (383)
Q Consensus       273 ~~~~~~~~~~gt~~y~ape---------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v~~------------  331 (383)
                          ......|+..|+|||         .++||||+||++|||++|+.||...    +.......+..            
T Consensus       174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcCCCChHHhhh
Confidence                233467889999987         5789999999999999999997432    11111111100            


Q ss_pred             ----------Ccc---ccc----CChhHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcccc
Q 046461          332 ----------STI---LNA----YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE--FLEKYHT  376 (383)
Q Consensus       332 ----------~~~---~~~----~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~--~L~~~~~  376 (383)
                                ...   ...    ........+.+++.+|+..||++|||++|+++  .+++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                      000   000    01123456789999999999999999999997  5665543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-32  Score=258.90  Aligned_cols=197  Identities=22%  Similarity=0.242  Sum_probs=140.7

Q ss_pred             hCccccCeeecCCccccc-----------------------------------------cccceeeeEEEe------CCE
Q 046461          164 NKFYEKNVIRGDDFGIAF-----------------------------------------KNIVQLLGYCPV------GEK  196 (383)
Q Consensus       164 ~~f~~~~~lg~g~~g~v~-----------------------------------------~niv~l~g~~~~------~~~  196 (383)
                      +.|...++||+|+||+||                                         ||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            457778899999999999                                         799999999964      368


Q ss_pred             EEEEEEeccCCCHHHHHhc--chhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCCCC
Q 046461          197 KLIVYEYMVKGSLNDWLRN--QAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISDCE  274 (383)
Q Consensus       197 ~~lv~e~~~~gsL~~~l~~--~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~~~  274 (383)
                      .++|||||.++.+..+...  ......++.|++.||+|||+.   +|+||||||+|||++.++..|++|||+++......
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~  173 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc
Confidence            8999999976554443322  345678999999999999999   99999999999999999999999999988654422


Q ss_pred             CccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCccceee-----------------
Q 046461          275 SHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGNLVDWV-----------------  329 (383)
Q Consensus       275 ~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~~~~~v-----------------  329 (383)
                        ......+|..|+|||        .++||||+||+++||++|+.||...    +.......+                 
T Consensus       174 --~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR----DYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             --ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC----CHHHHHHHHHHhccCCCHHHHHHhhh
Confidence              334457899999998        6799999999999999999996422    111000000                 


Q ss_pred             -----ec---------------Cccccc---CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          330 -----LD---------------STILNA---YSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       330 -----~~---------------~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                           ..               ......   .....+..+.+++.+|+..||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 00               000000   01224567899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=1.7e-28  Score=233.55  Aligned_cols=202  Identities=19%  Similarity=0.242  Sum_probs=144.3

Q ss_pred             ccccCeeecCCccccc-------------------------------------------------cccceeeeEEEe--C
Q 046461          166 FYEKNVIRGDDFGIAF-------------------------------------------------KNIVQLLGYCPV--G  194 (383)
Q Consensus       166 f~~~~~lg~g~~g~v~-------------------------------------------------~niv~l~g~~~~--~  194 (383)
                      |.-.++||+|+||+||                                                 +|||++++++..  .
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            6677899999999999                                                 589999998864  4


Q ss_pred             CEEEEEEEeccCCCHHHHHhc--------chhhhHHHHhHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCC------ce
Q 046461          195 EKKLIVYEYMVKGSLNDWLRN--------QAKHCIIACGTARGITFLHH-RFQPHIIHRDINASNILLNEDF------EV  259 (383)
Q Consensus       195 ~~~~lv~e~~~~gsL~~~l~~--------~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NiLl~~~~------~~  259 (383)
                      ...+++++++..+........        ......++.|++.|++|||+ .   +|+||||||+|||++.++      .+
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccccee
Confidence            567778877766543333221        12357789999999999998 5   899999999999998654      38


Q ss_pred             EEccccCccccCCCCCccccccccccccccCC--------CCCcchhHHHHHHHHHhCCCCCCCCCCCCCCCc---ccee
Q 046461          260 KVSDFGLVRLISDCESHTSTDVAGTIGYILLA--------CGGDIYSFSVVLLELVIRKQPTGPEFKDKNGGN---LVDW  328 (383)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~ape--------~~~Dv~SfGvil~Elltg~~p~~~~~~~~~~~~---~~~~  328 (383)
                      +++|||.++....    ......||+.|+|||        .++||||+||+++||++|+.||.+.-.......   +...
T Consensus       172 kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         172 KIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            9999999986543    223467999999998        679999999999999999999754211000000   0000


Q ss_pred             -----------e--------------ecCcc--------------cccCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 046461          329 -----------V--------------LDSTI--------------LNAYSKPSMLKMLQIVVGCIFDNPTTRPTMLRVQE  369 (383)
Q Consensus       329 -----------v--------------~~~~~--------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPs~~~v~~  369 (383)
                                 .              ....+              ...........+.+++.+|+..||++|||++|+++
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       0              00000              11123456678999999999999999999999987


Q ss_pred             --HHhcc
Q 046461          370 --FLEKY  374 (383)
Q Consensus       370 --~L~~~  374 (383)
                        .+++.
T Consensus       328 Hp~f~~~  334 (362)
T d1q8ya_         328 HPWLKDT  334 (362)
T ss_dssp             CGGGTTC
T ss_pred             CcccCCC
Confidence              35543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.52  E-value=5e-15  Score=126.89  Aligned_cols=69  Identities=17%  Similarity=0.219  Sum_probs=57.0

Q ss_pred             EEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCceEEccccCccccCC
Q 046461          198 LIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHRFQPHIIHRDINASNILLNEDFEVKVSDFGLVRLISD  272 (383)
Q Consensus       198 ~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~~~~  272 (383)
                      +++|||++++.+.+..  ......++.|++.+++|||+.   +|+||||||+|||++.+ .++++|||.|+....
T Consensus        86 ~lvme~~~~~~~~~l~--~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~  154 (191)
T d1zara2          86 AVLMELIDAKELYRVR--VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGE  154 (191)
T ss_dssp             EEEEECCCCEEGGGCC--CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTS
T ss_pred             EEEEEeeccccccchh--hHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCC
Confidence            6999999887655432  234567899999999999998   99999999999999865 589999999977643

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.04  E-value=4.8e-11  Score=109.32  Aligned_cols=94  Identities=24%  Similarity=0.288  Sum_probs=73.5

Q ss_pred             cEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeee-----ccccChhhhCCCCCcccccccc
Q 046461            5 QKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYV-----QFKIPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         5 ~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l-----~g~ip~~~~~~~~L~~l~~s~N   78 (383)
                      ..+++..+.. |.+|...+.+.+|+.+++++|+++|.+| +++.+.+|+.+++     +|.+|.+++++++|++||+++|
T Consensus       200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N  278 (313)
T d1ogqa_         200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN  278 (313)
T ss_dssp             SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence            3455666666 7777777888888999999999988876 4777788888877     5678999999999999999999


Q ss_pred             cccccCCCC-------------CcCCccccCCCCC
Q 046461           79 MLGGHIPEK-------------NIDLCGKIMGLDY  100 (383)
Q Consensus        79 ~l~g~ip~~-------------n~~lcg~~~~~~~  100 (383)
                      +|+|.||+.             |..+||.|+. +|
T Consensus       279 ~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c  312 (313)
T d1ogqa_         279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             EEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             cccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence            999999863             5567777665 45

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=98.93  E-value=2.2e-10  Score=104.82  Aligned_cols=85  Identities=29%  Similarity=0.350  Sum_probs=68.5

Q ss_pred             CccEeecccCCC-C--CCCCcCCCCCCCCEEECcC-CccccccchhHHhhhccceeeecc-----ccChhhhCCCCCccc
Q 046461            3 HTQKKILIRDNL-G--MPPIIPKNLNELPHLDLSC-NKLNGEISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYF   73 (383)
Q Consensus         3 ~~~~~~l~~~~~-~--~~~~~~~~l~~L~~l~ls~-N~l~G~iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l   73 (383)
                      +++.|+|++|++ |  .+|+.+++|++|++|||++ |+|+|.||++|+++++|+.|++++     ..|..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            577888998888 4  3567778999999999986 899999999999999999998843     356667777778888


Q ss_pred             ccccccccccCCCC
Q 046461           74 DFSMNMLGGHIPEK   87 (383)
Q Consensus        74 ~~s~N~l~g~ip~~   87 (383)
                      +++.|++.+.+|..
T Consensus       131 ~l~~N~~~~~~p~~  144 (313)
T d1ogqa_         131 DFSYNALSGTLPPS  144 (313)
T ss_dssp             ECCSSEEESCCCGG
T ss_pred             ccccccccccCchh
Confidence            88888887777754

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.76  E-value=4.8e-09  Score=82.42  Aligned_cols=75  Identities=23%  Similarity=0.205  Sum_probs=62.1

Q ss_pred             cEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMNML   80 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N~l   80 (383)
                      |+|+|+.|++..++. +.++.+|++||+++|+++ .+|+.++.+.+|+.+++++    .+| .+.++++|+.+++++|++
T Consensus         1 R~L~Ls~n~l~~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           1 RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             SEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCC
T ss_pred             CEEEcCCCCCCCCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCcc
Confidence            578899999965554 578899999999999997 6888888999999999865    355 488899999999999998


Q ss_pred             cc
Q 046461           81 GG   82 (383)
Q Consensus        81 ~g   82 (383)
                      +.
T Consensus        78 ~~   79 (124)
T d1dcea3          78 QQ   79 (124)
T ss_dssp             CS
T ss_pred             CC
Confidence            75

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.71  E-value=6.5e-09  Score=88.00  Aligned_cols=85  Identities=22%  Similarity=0.206  Sum_probs=74.3

Q ss_pred             CCccEeecccCCC-C-CCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----cC-hhhhCCCCCcccc
Q 046461            2 PHTQKKILIRDNL-G-MPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----IP-PDLCNLVQLEYFD   74 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~-~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----ip-~~~~~~~~L~~l~   74 (383)
                      ++++.|+|+.|.+ + +++..++++++|+.|+|++|++++.+|..+..+..|+.|+|++.    +| ..|.++++|+.|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            4789999999999 5 45667789999999999999999999999999999999999763    54 5688999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|+|++--|.
T Consensus       109 L~~N~l~~i~~~  120 (192)
T d1w8aa_         109 LYDNQISCVMPG  120 (192)
T ss_dssp             CCSSCCCEECTT
T ss_pred             cCCccccccCHH
Confidence            999999985553

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.70  E-value=9.7e-09  Score=80.62  Aligned_cols=80  Identities=18%  Similarity=0.116  Sum_probs=68.4

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC--hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP--PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip--~~~~~~~~L~~l~   74 (383)
                      |++|++|+|+.|.+...|..++.+++|+.|++++|.+++ +| .++++++|+.+++++    .+|  ..+..+++|+.++
T Consensus        19 l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~   96 (124)
T d1dcea3          19 LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN   96 (124)
T ss_dssp             GTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             CCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence            578999999999995555567889999999999999985 55 489999999999965    244  4688999999999


Q ss_pred             cccccccc
Q 046461           75 FSMNMLGG   82 (383)
Q Consensus        75 ~s~N~l~g   82 (383)
                      +++|.++.
T Consensus        97 l~~N~i~~  104 (124)
T d1dcea3          97 LQGNSLCQ  104 (124)
T ss_dssp             CTTSGGGG
T ss_pred             CCCCcCCc
Confidence            99999976

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.70  E-value=7.5e-09  Score=87.59  Aligned_cols=79  Identities=15%  Similarity=0.114  Sum_probs=59.5

Q ss_pred             ccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccc-hhHHhhhccceeeecc-----ccChhhhCCCCCcccccc
Q 046461            4 TQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEIS-TFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         4 ~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP-~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s   76 (383)
                      .+.++++++++ .+|+.++   +++++|+|++|++++.++ ..+.++.+|+.|++++     ..+..+..+++|+.|+++
T Consensus        10 ~~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcCccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            35678888888 4555443   578889999999987664 4567888899888855     345677888899999999


Q ss_pred             cccccccCC
Q 046461           77 MNMLGGHIP   85 (383)
Q Consensus        77 ~N~l~g~ip   85 (383)
                      +|++++-.|
T Consensus        87 ~N~l~~l~~   95 (192)
T d1w8aa_          87 ENKIKEISN   95 (192)
T ss_dssp             SCCCCEECS
T ss_pred             cccccccCH
Confidence            999986444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.49  E-value=4.1e-08  Score=88.01  Aligned_cols=86  Identities=20%  Similarity=0.197  Sum_probs=74.7

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeec-----cccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQ-----FKIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~-----g~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.+++..|++ ++++..+..+++|+.|++++|++++-.|..+.++.+|+.++++     +..|.+|..+++|+++|
T Consensus       128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~  207 (284)
T d1ozna_         128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY  207 (284)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence            35788999999999 7778888899999999999999998888888999999999884     34688899999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|++++..|.
T Consensus       208 l~~N~i~~~~~~  219 (284)
T d1ozna_         208 LFANNLSALPTE  219 (284)
T ss_dssp             CCSSCCSCCCHH
T ss_pred             cccccccccccc
Confidence            999999886553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=6e-08  Score=79.14  Aligned_cols=81  Identities=15%  Similarity=0.030  Sum_probs=44.6

Q ss_pred             cEeecccCCCCCCCCcCCCCCCCCEEECcCCc-cccccchhHHhhhccceeeecc----cc-ChhhhCCCCCcccccccc
Q 046461            5 QKKILIRDNLGMPPIIPKNLNELPHLDLSCNK-LNGEISTFLSHILGILGLYVQF----KI-PPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         5 ~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~-l~G~iP~~~~~~~~l~~l~l~g----~i-p~~~~~~~~L~~l~~s~N   78 (383)
                      ..+.++.+++...|..+..+++|+.|++++|+ ++.--|..|.++.+|+.|++++    .| |..|..+++|+.|++++|
T Consensus        11 ~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             SCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             CeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            34555555553334444456666666665553 4433334456666666666643    23 344666666777777777


Q ss_pred             cccccCCC
Q 046461           79 MLGGHIPE   86 (383)
Q Consensus        79 ~l~g~ip~   86 (383)
                      +|+ .+|.
T Consensus        91 ~l~-~l~~   97 (156)
T d2ifga3          91 ALE-SLSW   97 (156)
T ss_dssp             CCS-CCCS
T ss_pred             CCc-ccCh
Confidence            665 3443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=1.2e-07  Score=84.02  Aligned_cols=86  Identities=22%  Similarity=0.191  Sum_probs=72.4

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----cc-ChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KI-PPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~i-p~~~~~~~~L~~l~   74 (383)
                      +++|+.++|+.|.+ ++++..+..+.++..|++++|.+++-.|..+..+..|+.+++++    .+ |..+..+++|+.|+
T Consensus        99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~  178 (266)
T d1p9ag_          99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL  178 (266)
T ss_dssp             CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred             ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence            57899999999999 77888888899999999999999977677777888899988855    24 45578899999999


Q ss_pred             cccccccccCCCC
Q 046461           75 FSMNMLGGHIPEK   87 (383)
Q Consensus        75 ~s~N~l~g~ip~~   87 (383)
                      +++|+|+ .||..
T Consensus       179 Ls~N~L~-~lp~~  190 (266)
T d1p9ag_         179 LQENSLY-TIPKG  190 (266)
T ss_dssp             CCSSCCC-CCCTT
T ss_pred             cccCCCc-ccChh
Confidence            9999998 78864

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=1.1e-07  Score=85.07  Aligned_cols=87  Identities=17%  Similarity=0.159  Sum_probs=75.5

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----c-ChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----I-PPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----i-p~~~~~~~~L~~l~   74 (383)
                      |++|+.++|+.|.+ ++++..++.+.+|+.+++++|++++..|..+.++..|+.|++++.    + |..+.++++|+.++
T Consensus       104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~  183 (284)
T d1ozna_         104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (284)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence            57899999999999 678888889999999999999999777778888999999998652    3 56788999999999


Q ss_pred             cccccccccCCCC
Q 046461           75 FSMNMLGGHIPEK   87 (383)
Q Consensus        75 ~s~N~l~g~ip~~   87 (383)
                      +++|++++..|..
T Consensus       184 l~~N~l~~i~~~~  196 (284)
T d1ozna_         184 LHQNRVAHVHPHA  196 (284)
T ss_dssp             CCSSCCCEECTTT
T ss_pred             hhhccccccChhH
Confidence            9999999877754

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.41  E-value=1.8e-07  Score=76.77  Aligned_cols=79  Identities=15%  Similarity=0.110  Sum_probs=65.1

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChh-hhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPD-LCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~-~~~~~~L~~l~~s   76 (383)
                      ..++.|+|++|.+..++.....+++|+.||||+|+++ .++ .+..+++|+.|++++    .+|.. +..+++|+.|+++
T Consensus        18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             CcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence            4688999999999666777778999999999999988 565 477889999999966    36654 4679999999999


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|+++.
T Consensus        96 ~N~i~~  101 (162)
T d1a9na_          96 NNSLVE  101 (162)
T ss_dssp             SCCCCC
T ss_pred             cccccc
Confidence            999865

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.38  E-value=1.5e-07  Score=84.97  Aligned_cols=83  Identities=20%  Similarity=0.219  Sum_probs=65.1

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.++|..|.. +.++..+..++.++.|++++|.+++..|..+.++++|+.|+|++    .||.++.++++|+.|+++
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls  250 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH  250 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECC
Confidence            5677777777777 56666777788888888888888887777888888888888866    478788888888888888


Q ss_pred             cccccccCC
Q 046461           77 MNMLGGHIP   85 (383)
Q Consensus        77 ~N~l~g~ip   85 (383)
                      +|+++. |+
T Consensus       251 ~N~i~~-i~  258 (305)
T d1xkua_         251 NNNISA-IG  258 (305)
T ss_dssp             SSCCCC-CC
T ss_pred             CCccCc-cC
Confidence            888874 54

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=3.8e-07  Score=80.77  Aligned_cols=86  Identities=24%  Similarity=0.271  Sum_probs=69.7

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-hhhCCCCCccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-DLCNLVQLEYFDF   75 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-~~~~~~~L~~l~~   75 (383)
                      |++|+.|+|+.|.+...+..+.++++|+.|++++|.+.+..+..+..+.++..+++++    .+|. .+..+++|+.+++
T Consensus        76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l  155 (266)
T d1p9ag_          76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (266)
T ss_dssp             CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence            5788999999999966677778899999999999998887777788888888888855    3454 4567889999999


Q ss_pred             ccccccccCCC
Q 046461           76 SMNMLGGHIPE   86 (383)
Q Consensus        76 s~N~l~g~ip~   86 (383)
                      ++|++++..|.
T Consensus       156 ~~N~l~~~~~~  166 (266)
T d1p9ag_         156 ANNNLTELPAG  166 (266)
T ss_dssp             TTSCCSCCCTT
T ss_pred             ccccccccCcc
Confidence            99999885554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=1.3e-07  Score=77.68  Aligned_cols=81  Identities=12%  Similarity=0.048  Sum_probs=60.6

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccC--hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIP--PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip--~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|++|.+...+. +..+++|+.|+|++|+++.--|..+..+++|+.|++++    .++  ..+..+++|+.++
T Consensus        40 l~~L~~L~Ls~N~i~~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~  118 (162)
T d1a9na_          40 LDQFDAIDFSDNEIRKLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC  118 (162)
T ss_dssp             TTCCSEEECCSSCCCEECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEE
T ss_pred             cccCCEEECCCCCCCccCC-cccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhh
Confidence            4678888899888854433 46788888899999988865455566788888888865    234  2567788888888


Q ss_pred             cccccccc
Q 046461           75 FSMNMLGG   82 (383)
Q Consensus        75 ~s~N~l~g   82 (383)
                      +++|.++.
T Consensus       119 l~~N~i~~  126 (162)
T d1a9na_         119 ILRNPVTN  126 (162)
T ss_dssp             CCSSGGGG
T ss_pred             cCCCcccc
Confidence            88888754

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.07  E-value=1.6e-06  Score=79.99  Aligned_cols=80  Identities=19%  Similarity=0.245  Sum_probs=61.4

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      +.++.+.+..|++..++. +..+++++.|++++|++++..|  +.++++|+.|++++    .+| ++.++++|+.|++++
T Consensus       285 ~~l~~l~~~~n~l~~~~~-~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~  360 (384)
T d2omza2         285 TALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGH  360 (384)
T ss_dssp             TTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccc-cchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCC
Confidence            566778888888744433 4678888999999999887533  77888899998866    244 588889999999999


Q ss_pred             ccccccCC
Q 046461           78 NMLGGHIP   85 (383)
Q Consensus        78 N~l~g~ip   85 (383)
                      |++++-.|
T Consensus       361 N~l~~l~~  368 (384)
T d2omza2         361 NQISDLTP  368 (384)
T ss_dssp             SCCCBCGG
T ss_pred             CcCCCChh
Confidence            99987554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.05  E-value=2.6e-07  Score=78.34  Aligned_cols=80  Identities=18%  Similarity=0.225  Sum_probs=62.1

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc-c--ChhhhCCCCCccccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK-I--PPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~-i--p~~~~~~~~L~~l~~s~   77 (383)
                      |++|++|+|+.|++..++. +..+++|+.|+|++|+++ .||.....+..|+.|+++++ |  .+.+..+++|+.|++++
T Consensus        47 L~~L~~L~Ls~n~I~~i~~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l~~~~~l~~L~~L~L~~  124 (198)
T d1m9la_          47 LKACKHLALSTNNIEKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSN  124 (198)
T ss_dssp             TTTCCEEECSEEEESCCCC-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCHHHHHHHHHSSEEEESE
T ss_pred             ccccceeECcccCCCCccc-ccCCccccChhhcccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence            5788999999999855543 577899999999999987 67876677778888888652 2  13477788899999999


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |+++.
T Consensus       125 N~i~~  129 (198)
T d1m9la_         125 NKITN  129 (198)
T ss_dssp             EECCC
T ss_pred             chhcc
Confidence            98865

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.95  E-value=3e-06  Score=76.12  Aligned_cols=85  Identities=18%  Similarity=0.050  Sum_probs=71.0

Q ss_pred             CCCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccCh-------hhhCCC
Q 046461            1 MPHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPP-------DLCNLV   68 (383)
Q Consensus         1 ~~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~-------~~~~~~   68 (383)
                      ++.++.|.++.|.+ ++++..+.++++|+.|+|++|+++ .||+.+.++++|+.|++++    .|+.       .+..+.
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~  272 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA  272 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSC
T ss_pred             cccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccC
Confidence            46788999999999 788888899999999999999998 7899999999999999966    2332       234567


Q ss_pred             CCccccccccccc-ccCCC
Q 046461           69 QLEYFDFSMNMLG-GHIPE   86 (383)
Q Consensus        69 ~L~~l~~s~N~l~-g~ip~   86 (383)
                      +|+.+++++|.++ +++|.
T Consensus       273 ~L~~L~L~~N~~~~~~~~~  291 (305)
T d1xkua_         273 SYSGVSLFSNPVQYWEIQP  291 (305)
T ss_dssp             CCSEEECCSSSSCGGGSCG
T ss_pred             CCCEEECCCCcCccCcCCH
Confidence            8999999999985 66664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.93  E-value=6.2e-06  Score=70.05  Aligned_cols=77  Identities=18%  Similarity=0.197  Sum_probs=53.1

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      .+++.++++.|.+..++. +..+++|+.|+|++|++++ +| .++++.+|+.+++++    .+| .+.++++|+.+++++
T Consensus        46 ~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~  121 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEH  121 (210)
T ss_dssp             HTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECTT
T ss_pred             cCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccccc-ccccccccccccccc
Confidence            356777888777744433 3567888888888888876 33 256777788888754    244 477778888888887


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |.+..
T Consensus       122 ~~~~~  126 (210)
T d1h6ta2         122 NGISD  126 (210)
T ss_dssp             SCCCC
T ss_pred             ccccc
Confidence            77653

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.91  E-value=7.2e-06  Score=68.95  Aligned_cols=78  Identities=18%  Similarity=0.182  Sum_probs=55.7

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      .+++.|+|+.|++...+. +..+++|++|+|++|++++..|  ++++++|+.+++++    .+| .+.+++.|+.+++++
T Consensus        40 ~~l~~L~l~~~~i~~l~~-l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~  115 (199)
T d2omxa2          40 DQVTTLQADRLGIKSIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFN  115 (199)
T ss_dssp             TTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCS
T ss_pred             cCCCEEECCCCCCCCccc-cccCCCcCcCccccccccCccc--ccCCccccccccccccccccc-ccccccccccccccc
Confidence            467788888888754433 3568888888888888886433  77788888888854    233 377777888888887


Q ss_pred             cccccc
Q 046461           78 NMLGGH   83 (383)
Q Consensus        78 N~l~g~   83 (383)
                      |.....
T Consensus       116 ~~~~~~  121 (199)
T d2omxa2         116 NQITDI  121 (199)
T ss_dssp             SCCCCC
T ss_pred             cccccc
Confidence            777653

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.88  E-value=4.5e-07  Score=76.77  Aligned_cols=84  Identities=20%  Similarity=0.160  Sum_probs=69.2

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc----cC--hhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK----IP--PDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~----ip--~~~~~~~~L~~l~   74 (383)
                      |++|+.|+|+.|.+...|.....+++|+.|++++|+++. +| .+.++++|+.|++++.    ++  ..+..+++|+.|+
T Consensus        69 l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~  146 (198)
T d1m9la_          69 MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             HTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred             CccccChhhcccccccccccccccccccccccccccccc-cc-cccccccccccccccchhccccccccccCCCccceee
Confidence            478999999999996666665667789999999999985 44 5889999999999762    34  3588999999999


Q ss_pred             cccccccccCCC
Q 046461           75 FSMNMLGGHIPE   86 (383)
Q Consensus        75 ~s~N~l~g~ip~   86 (383)
                      +++|.+....+.
T Consensus       147 L~~N~l~~~~~~  158 (198)
T d1m9la_         147 LAGNPLYNDYKE  158 (198)
T ss_dssp             ECSSHHHHHHCT
T ss_pred             cCCCccccCccc
Confidence            999998776554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.85  E-value=8.2e-06  Score=68.60  Aligned_cols=79  Identities=20%  Similarity=0.230  Sum_probs=63.3

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc---cChhhhCCCCCccccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK---IPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~---ip~~~~~~~~L~~l~~s~   77 (383)
                      |++|++|+|++|++...+. ++++++|+.|++++|.+.. +| .+.++..|+.+++++.   -...+..+++|+.+++++
T Consensus        61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~  137 (199)
T d2omxa2          61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS  137 (199)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred             CCCcCcCccccccccCccc-ccCCccccccccccccccc-cc-ccccccccccccccccccccccccchhhhhHHhhhhh
Confidence            5789999999999943333 6889999999999999764 44 3888899999998552   224578899999999999


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |++..
T Consensus       138 n~l~~  142 (199)
T d2omxa2         138 NTISD  142 (199)
T ss_dssp             SCCCC
T ss_pred             hhhcc
Confidence            99865

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.85  E-value=1.3e-05  Score=64.73  Aligned_cols=81  Identities=15%  Similarity=0.075  Sum_probs=69.6

Q ss_pred             CCCccEeecccCC-C-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccc
Q 046461            1 MPHTQKKILIRDN-L-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFD   74 (383)
Q Consensus         1 ~~~~~~~~l~~~~-~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~   74 (383)
                      +++|+.|+|.+|+ + .+++..+.++++|+.|+|++|+++.--|..|..+++|+.++|++    .+|..+....+|+.|+
T Consensus        30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~  109 (156)
T d2ifga3          30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELV  109 (156)
T ss_dssp             CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEE
T ss_pred             ccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccc
Confidence            4678999997765 6 67777899999999999999999987788899999999999976    4787776667899999


Q ss_pred             ccccccc
Q 046461           75 FSMNMLG   81 (383)
Q Consensus        75 ~s~N~l~   81 (383)
                      +++|.+.
T Consensus       110 L~~Np~~  116 (156)
T d2ifga3         110 LSGNPLH  116 (156)
T ss_dssp             CCSSCCC
T ss_pred             cCCCccc
Confidence            9999884

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.84  E-value=9.5e-06  Score=69.55  Aligned_cols=77  Identities=16%  Similarity=0.123  Sum_probs=54.7

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~   77 (383)
                      +.++.+.+..+.+..... +.++++|+.|++++|.+++..+  ++++++|+.+++++    .+| .+.++++|++|++++
T Consensus       129 ~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~  204 (227)
T d1h6ua2         129 SNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKN  204 (227)
T ss_dssp             TTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTT
T ss_pred             cchhhhhchhhhhchhhh-hccccccccccccccccccchh--hcccccceecccCCCccCCCh-hhcCCCCCCEEECcC
Confidence            456667776666643332 3567888888888888775433  77788888888865    244 377888888888888


Q ss_pred             ccccc
Q 046461           78 NMLGG   82 (383)
Q Consensus        78 N~l~g   82 (383)
                      |++++
T Consensus       205 N~lt~  209 (227)
T d1h6ua2         205 NQISD  209 (227)
T ss_dssp             SCCCB
T ss_pred             CcCCC
Confidence            88876

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.80  E-value=5.3e-06  Score=71.68  Aligned_cols=81  Identities=15%  Similarity=0.171  Sum_probs=63.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccch-hHHhhhccceeeecc------ccChhhhCCCCCccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEIST-FLSHILGILGLYVQF------KIPPDLCNLVQLEYF   73 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~-~~~~~~~l~~l~l~g------~ip~~~~~~~~L~~l   73 (383)
                      ++++.|+|++|.+ ++++..+.++++|++|+|++|.+...+|. .+.++..+..+++..      ..|..+.++++|+.+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            3688999999998 56666788899999999999998887765 456677777776622      234567889999999


Q ss_pred             ccccccccc
Q 046461           74 DFSMNMLGG   82 (383)
Q Consensus        74 ~~s~N~l~g   82 (383)
                      ++++|++..
T Consensus       109 ~l~~~~l~~  117 (242)
T d1xwdc1         109 LISNTGIKH  117 (242)
T ss_dssp             EEESCCCCS
T ss_pred             ccchhhhcc
Confidence            999998865

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.76  E-value=1.5e-05  Score=73.18  Aligned_cols=76  Identities=21%  Similarity=0.320  Sum_probs=41.6

Q ss_pred             CCccEeecccCCC-CCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccc
Q 046461            2 PHTQKKILIRDNL-GMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFS   76 (383)
Q Consensus         2 ~~~~~~~l~~~~~-~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s   76 (383)
                      ++|+.++++.+.+ ++++  +..+..++.++++.|++++  +..+..+.+++.+++++    .++ .+..+++|+.|+++
T Consensus       263 ~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~  337 (384)
T d2omza2         263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFA  337 (384)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECC
T ss_pred             ccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECC
Confidence            4556666666665 3332  2455666666666666655  22355555666666543    122 25566666666666


Q ss_pred             cccccc
Q 046461           77 MNMLGG   82 (383)
Q Consensus        77 ~N~l~g   82 (383)
                      +|++++
T Consensus       338 ~n~l~~  343 (384)
T d2omza2         338 NNKVSD  343 (384)
T ss_dssp             SSCCCC
T ss_pred             CCCCCC
Confidence            666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.49  E-value=8.8e-05  Score=62.58  Aligned_cols=80  Identities=25%  Similarity=0.226  Sum_probs=62.6

Q ss_pred             CCCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc---cChhhhCCCCCccccccc
Q 046461            1 MPHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK---IPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~---ip~~~~~~~~L~~l~~s~   77 (383)
                      |++|+.|+|++|.+.-.+. ++++++|+.|++++|++++ +| .+.++++|+.+++++.   -...+..++.|+.+++++
T Consensus        67 l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~  143 (210)
T d1h6ta2          67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN  143 (210)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECCS
T ss_pred             CCCCCEEeCCCccccCccc-cccCccccccccccccccc-cc-ccccccccccccccccccccccccccccccccccccc
Confidence            5789999999999943433 4789999999999999985 66 4888899999998552   234577777888888888


Q ss_pred             cccccc
Q 046461           78 NMLGGH   83 (383)
Q Consensus        78 N~l~g~   83 (383)
                      |.+++.
T Consensus       144 n~l~~~  149 (210)
T d1h6ta2         144 NKITDI  149 (210)
T ss_dssp             SCCCCC
T ss_pred             cccccc
Confidence            887653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.44  E-value=7.9e-05  Score=63.52  Aligned_cols=78  Identities=17%  Similarity=0.098  Sum_probs=38.2

Q ss_pred             CCccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccc---cChhhhCCCCCcccccccc
Q 046461            2 PHTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFK---IPPDLCNLVQLEYFDFSMN   78 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~---ip~~~~~~~~L~~l~~s~N   78 (383)
                      ++|+.+.++.+.....+. +.....+..++++.+.+.+..+  +.++.+|+.+++++.   -...+.++++|+.+++++|
T Consensus       107 ~~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n  183 (227)
T d1h6ua2         107 QSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN  183 (227)
T ss_dssp             TTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             ccccccccccccccccch-hccccchhhhhchhhhhchhhh--hccccccccccccccccccchhhcccccceecccCCC
Confidence            445555555554422221 2334555556665555554332  444555555555431   1123555566666666666


Q ss_pred             cccc
Q 046461           79 MLGG   82 (383)
Q Consensus        79 ~l~g   82 (383)
                      ++++
T Consensus       184 ~l~~  187 (227)
T d1h6ua2         184 KISD  187 (227)
T ss_dssp             CCCC
T ss_pred             ccCC
Confidence            6554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.31  E-value=0.00011  Score=66.03  Aligned_cols=76  Identities=29%  Similarity=0.351  Sum_probs=50.7

Q ss_pred             CccEeecccCCCCCCCCcCCCCCCCCEEECcCCccccccchhHHhhhccceeeeccccChhhhCC-CCCccccccccccc
Q 046461            3 HTQKKILIRDNLGMPPIIPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQFKIPPDLCNL-VQLEYFDFSMNMLG   81 (383)
Q Consensus         3 ~~~~~~l~~~~~~~~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g~ip~~~~~~-~~L~~l~~s~N~l~   81 (383)
                      +++.|+|+.++++..|+.   +++|++|+|++|+++ .||..++   +|+.|++++.-=..+..+ +.|++|++++|.++
T Consensus        39 ~l~~LdLs~~~L~~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l~  111 (353)
T d1jl5a_          39 QAHELELNNLGLSSLPEL---PPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE  111 (353)
T ss_dssp             TCSEEECTTSCCSCCCSC---CTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCSCCCSCCTTCCEEECCSSCCS
T ss_pred             CCCEEEeCCCCCCCCCCC---CCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccchhhhhccccccccccccccc
Confidence            578899999998655554   467899999999998 8888765   455555533100112222 35788888888876


Q ss_pred             ccCCC
Q 046461           82 GHIPE   86 (383)
Q Consensus        82 g~ip~   86 (383)
                      . +|.
T Consensus       112 ~-lp~  115 (353)
T d1jl5a_         112 K-LPE  115 (353)
T ss_dssp             S-CCC
T ss_pred             c-ccc
Confidence            3 553

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.10  E-value=0.00079  Score=58.06  Aligned_cols=85  Identities=14%  Similarity=0.043  Sum_probs=58.1

Q ss_pred             ceeeeEEEeCCEEEEEEEeccCCCHHHHHhcchhhhHHHHhHHHHHHHHhhc----------------------------
Q 046461          185 VQLLGYCPVGEKKLIVYEYMVKGSLNDWLRNQAKHCIIACGTARGITFLHHR----------------------------  236 (383)
Q Consensus       185 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~i~~~ia~gL~~LH~~----------------------------  236 (383)
                      -+++.++.+++..++||+++++.++.+..........++.++++.++.||+.                            
T Consensus        73 P~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          73 PKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             CCEEEEEEETTEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             CcEEEEEecCCceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            4566778888899999999999888665433222223334444444444421                            


Q ss_pred             ----------------------------CCCCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          237 ----------------------------FQPHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       237 ----------------------------~~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                                                  ..+.++|+|+.+.||+++++....+.||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                        012378999999999999877778999988754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.93  E-value=5.1e-05  Score=67.31  Aligned_cols=54  Identities=20%  Similarity=0.186  Sum_probs=23.9

Q ss_pred             CCCCCEEECcCCccccc-cchhHHhhhccceeeecc-----ccChhhhCCCCCccccccc
Q 046461           24 LNELPHLDLSCNKLNGE-ISTFLSHILGILGLYVQF-----KIPPDLCNLVQLEYFDFSM   77 (383)
Q Consensus        24 l~~L~~l~ls~N~l~G~-iP~~~~~~~~l~~l~l~g-----~ip~~~~~~~~L~~l~~s~   77 (383)
                      ..+|++|||+++.+++. ++..+.+|++|+.|++++     ..+..++.+++|+.|++++
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            34455555555444433 222333444555554432     2233344445555555544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.93  E-value=3e-05  Score=62.92  Aligned_cols=61  Identities=23%  Similarity=0.206  Sum_probs=36.0

Q ss_pred             CCCCCEEECcCCcccc--ccchhHHhhhccceeeeccc----cCh-hhhCCCCCcccccccccccccC
Q 046461           24 LNELPHLDLSCNKLNG--EISTFLSHILGILGLYVQFK----IPP-DLCNLVQLEYFDFSMNMLGGHI   84 (383)
Q Consensus        24 l~~L~~l~ls~N~l~G--~iP~~~~~~~~l~~l~l~g~----ip~-~~~~~~~L~~l~~s~N~l~g~i   84 (383)
                      +++|+.||||+|+++.  .++..+..+.+|+.|++++.    ++. .......|+.+++++|.+++..
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            5667777777777764  24455666677777777552    222 2223345677777777766543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.92  E-value=0.00014  Score=58.64  Aligned_cols=74  Identities=20%  Similarity=0.099  Sum_probs=53.4

Q ss_pred             CCCccEeecccCCCCCCCC---cCCCCCCCCEEECcCCccccccchhHHhhhccceeeecc-ccCh-----------hhh
Q 046461            1 MPHTQKKILIRDNLGMPPI---IPKNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF-KIPP-----------DLC   65 (383)
Q Consensus         1 ~~~~~~~~l~~~~~~~~~~---~~~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g-~ip~-----------~~~   65 (383)
                      |++|+.|+|++|.+...+.   .+..+++|+.|||++|+++.--+-.......|+.++++| ++..           -+.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~  143 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE  143 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence            5789999999999954433   345799999999999999853332333445688888876 3432           145


Q ss_pred             CCCCCcccc
Q 046461           66 NLVQLEYFD   74 (383)
Q Consensus        66 ~~~~L~~l~   74 (383)
                      .+|+|+.||
T Consensus       144 ~~P~L~~LD  152 (162)
T d1koha1         144 RFPKLLRLD  152 (162)
T ss_dssp             TSTTCCEET
T ss_pred             HCCCCCEEC
Confidence            688888876

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=96.70  E-value=0.00099  Score=59.51  Aligned_cols=57  Identities=25%  Similarity=0.328  Sum_probs=42.6

Q ss_pred             CCCCCCCEEECcCCccccccchhHHhhhccceeeecc----ccChhhhCCCCCcccccccccccccCCC
Q 046461           22 KNLNELPHLDLSCNKLNGEISTFLSHILGILGLYVQF----KIPPDLCNLVQLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        22 ~~l~~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~l~g----~ip~~~~~~~~L~~l~~s~N~l~g~ip~   86 (383)
                      ..+++|++|+|++|+++ .||..+   .+|+.|++++    .+|.   .+++|+.|++++|+|+ .+|.
T Consensus       281 ~~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~L~~N~L~~l~~---~~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCS-SCCC
T ss_pred             ccCCCCCEEECCCCccC-cccccc---CCCCEEECCCCcCCcccc---ccCCCCEEECcCCcCC-CCCc
Confidence            44678889999999888 688653   5677777754    4554   3468999999999997 5775

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.50  E-value=0.00079  Score=59.28  Aligned_cols=77  Identities=16%  Similarity=0.066  Sum_probs=54.2

Q ss_pred             CCccEeecccCCCCC----CCCcCCCCCCCCEEECcCC-ccccccchhHHhhhccceeeecc--ccC----hhhhCCCCC
Q 046461            2 PHTQKKILIRDNLGM----PPIIPKNLNELPHLDLSCN-KLNGEISTFLSHILGILGLYVQF--KIP----PDLCNLVQL   70 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~----~~~~~~~l~~L~~l~ls~N-~l~G~iP~~~~~~~~l~~l~l~g--~ip----~~~~~~~~L   70 (383)
                      ++|+.+.|++....+    ...+..++++|+.||+++| .+++..+..++++++|+.|++++  .|.    ..++++++|
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence            467778777543322    2223356788888888875 57888888888888888888865  333    357778888


Q ss_pred             cccccccc
Q 046461           71 EYFDFSMN   78 (383)
Q Consensus        71 ~~l~~s~N   78 (383)
                      +.++++++
T Consensus       228 ~~L~l~~~  235 (284)
T d2astb2         228 KTLQVFGI  235 (284)
T ss_dssp             CEEECTTS
T ss_pred             CEEeeeCC
Confidence            88888765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.31  E-value=0.00036  Score=64.76  Aligned_cols=81  Identities=22%  Similarity=0.130  Sum_probs=44.8

Q ss_pred             CCccEeecccCCCCC-----CCCcCCCCCCCCEEECcCCccccccchhHHh-----hhccceeeecc-c--------cCh
Q 046461            2 PHTQKKILIRDNLGM-----PPIIPKNLNELPHLDLSCNKLNGEISTFLSH-----ILGILGLYVQF-K--------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~-----~~~~~~~l~~L~~l~ls~N~l~G~iP~~~~~-----~~~l~~l~l~g-~--------ip~   62 (383)
                      .+++.+.|++|+++.     .+..+..+++|+.|||++|.++..--..+.+     ..+|+.|+|++ .        ++.
T Consensus        27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~  106 (460)
T d1z7xw1          27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS  106 (460)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence            456677777665531     1222345677777777777765321112222     13566676643 1        334


Q ss_pred             hhhCCCCCcccccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l~g   82 (383)
                      .+..+++|+.|++++|.++.
T Consensus       107 ~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1         107 TLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             HTTSCTTCCEEECCSSBCHH
T ss_pred             hhhccccccccccccccchh
Confidence            45566777777777777653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.31  E-value=0.0016  Score=55.25  Aligned_cols=59  Identities=20%  Similarity=0.153  Sum_probs=40.9

Q ss_pred             CCCEEECcCCccccccchhHHhhhccceee-ecc----ccChh-hhCCCCCcccccccccccccCCC
Q 046461           26 ELPHLDLSCNKLNGEISTFLSHILGILGLY-VQF----KIPPD-LCNLVQLEYFDFSMNMLGGHIPE   86 (383)
Q Consensus        26 ~L~~l~ls~N~l~G~iP~~~~~~~~l~~l~-l~g----~ip~~-~~~~~~L~~l~~s~N~l~g~ip~   86 (383)
                      .++.|++++|+++ .+|....+...+..+. +.+    .||.+ |.++++|+.|++++|+++ .+|.
T Consensus       154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~  218 (242)
T d1xwdc1         154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS  218 (242)
T ss_dssp             SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCS
T ss_pred             cceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCH
Confidence            4556788888877 4555555555555443 332    47765 678999999999999998 5765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=95.88  E-value=0.0047  Score=52.61  Aligned_cols=30  Identities=20%  Similarity=0.236  Sum_probs=25.9

Q ss_pred             CeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          240 HIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       240 ~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      .++|+|+.+.||+++.+..+.|.||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            479999999999999877678999988754

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.51  E-value=0.0018  Score=58.27  Aligned_cols=81  Identities=12%  Similarity=0.049  Sum_probs=57.2

Q ss_pred             CCccEeecccCCCCC------CCCcCCCCCCCCEEECcCCccccc----cchhHHhhhccceeeeccc-cCh--------
Q 046461            2 PHTQKKILIRDNLGM------PPIIPKNLNELPHLDLSCNKLNGE----ISTFLSHILGILGLYVQFK-IPP--------   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~------~~~~~~~l~~L~~l~ls~N~l~G~----iP~~~~~~~~l~~l~l~g~-ip~--------   62 (383)
                      +.++.+.|..|+++.      ....+..+++|+.|+|++|.++..    +...+..+++|+.|+|++. |..        
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~  265 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD  265 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred             hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence            578889998888743      223456788899999999998654    4445567788999998552 221        


Q ss_pred             hhhC--CCCCcccccccccccc
Q 046461           63 DLCN--LVQLEYFDFSMNMLGG   82 (383)
Q Consensus        63 ~~~~--~~~L~~l~~s~N~l~g   82 (383)
                      .+..  .+.|+.|++++|+++.
T Consensus       266 ~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         266 AFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             HHHTCSSCCCCEEECCSSCCBH
T ss_pred             HhhhccCCCCCEEECCCCcCCh
Confidence            2333  3568899999998865

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.50  E-value=0.0022  Score=59.18  Aligned_cols=82  Identities=17%  Similarity=0.105  Sum_probs=56.2

Q ss_pred             CCccEeecccCCCCCC-----CCcCCCCCCCCEEECcCCccccc----cchhHH-hhhccceeeecc-c--------cCh
Q 046461            2 PHTQKKILIRDNLGMP-----PIIPKNLNELPHLDLSCNKLNGE----ISTFLS-HILGILGLYVQF-K--------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~-----~~~~~~l~~L~~l~ls~N~l~G~----iP~~~~-~~~~l~~l~l~g-~--------ip~   62 (383)
                      +.|+.+.+..+.++..     ...+....+|+.|||++|++++.    ++..+. ....|+.|+|++ .        ++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            4577888888877322     11223567899999999998764    344443 345688888855 2        344


Q ss_pred             hhhCCCCCccccccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l~g~   83 (383)
                      .+..+++|++||+++|+++..
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCCHH
T ss_pred             HHhcCCCCCEEECCCCcCCHH
Confidence            566778999999999998753

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.46  E-value=0.003  Score=56.74  Aligned_cols=82  Identities=16%  Similarity=0.076  Sum_probs=60.2

Q ss_pred             CCccEeecccCCCCCC-----CCcCCCCCCCCEEECcCCccccc-----cchhHHhhhccceeeeccc---------cCh
Q 046461            2 PHTQKKILIRDNLGMP-----PIIPKNLNELPHLDLSCNKLNGE-----ISTFLSHILGILGLYVQFK---------IPP   62 (383)
Q Consensus         2 ~~~~~~~l~~~~~~~~-----~~~~~~l~~L~~l~ls~N~l~G~-----iP~~~~~~~~l~~l~l~g~---------ip~   62 (383)
                      ..|+.+.++.|.++-.     ...+..++.|+.|+|++|+++..     +...+..+..|+.|++++.         +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            4677888888877422     22234678999999999998753     3334566788999999652         344


Q ss_pred             hhhCCCCCccccccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNMLGGH   83 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l~g~   83 (383)
                      .+..+++|+.|++++|++++.
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHH
T ss_pred             cccccccchhhhhhcCccCch
Confidence            577889999999999998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=92.31  E-value=0.064  Score=48.83  Aligned_cols=30  Identities=27%  Similarity=0.348  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCcEEEcCCCceEEccccCccc
Q 046461          239 PHIIHRDINASNILLNEDFEVKVSDFGLVRL  269 (383)
Q Consensus       239 ~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~~  269 (383)
                      ..++|+|+.+.||+++.+. +++.||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            3689999999999998764 89999988764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=91.95  E-value=0.038  Score=43.90  Aligned_cols=79  Identities=8%  Similarity=-0.056  Sum_probs=42.3

Q ss_pred             CCccEeecccC-CCCCC-----CCcCCCCCCCCEEECcCCccccccchhH----Hhhhccceeeecc-cc--------Ch
Q 046461            2 PHTQKKILIRD-NLGMP-----PIIPKNLNELPHLDLSCNKLNGEISTFL----SHILGILGLYVQF-KI--------PP   62 (383)
Q Consensus         2 ~~~~~~~l~~~-~~~~~-----~~~~~~l~~L~~l~ls~N~l~G~iP~~~----~~~~~l~~l~l~g-~i--------p~   62 (383)
                      ++|+.+.|+++ .++..     ...+...+.|+.|+|++|.+...-...+    .....|+.|+|++ .|        -.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence            45677777643 23211     1123455677788888877764333223    3345566676644 12        12


Q ss_pred             hhhCCCCCcccccccccc
Q 046461           63 DLCNLVQLEYFDFSMNML   80 (383)
Q Consensus        63 ~~~~~~~L~~l~~s~N~l   80 (383)
                      .+...++|+.|++++|..
T Consensus        95 aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HTTTTCCCSEEECCCCSS
T ss_pred             HHHhCCcCCEEECCCCcC
Confidence            344556677777776654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=87.34  E-value=0.12  Score=40.69  Aligned_cols=61  Identities=11%  Similarity=0.066  Sum_probs=41.1

Q ss_pred             CCCCCCCEEECcCC-cccccc----chhHHhhhccceeeeccc-c--------ChhhhCCCCCcccccccccccc
Q 046461           22 KNLNELPHLDLSCN-KLNGEI----STFLSHILGILGLYVQFK-I--------PPDLCNLVQLEYFDFSMNMLGG   82 (383)
Q Consensus        22 ~~l~~L~~l~ls~N-~l~G~i----P~~~~~~~~l~~l~l~g~-i--------p~~~~~~~~L~~l~~s~N~l~g   82 (383)
                      .+.+.|+.|+|+++ .++..-    =..+.....|+.|+|++. +        -..+...+.|+.|++++|.++.
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence            45688999999974 455331    112334467888888652 2        2345567889999999998865

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=86.25  E-value=0.11  Score=45.19  Aligned_cols=31  Identities=23%  Similarity=0.286  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCcEEEcCCCceEEccccCcc
Q 046461          238 QPHIIHRDINASNILLNEDFEVKVSDFGLVR  268 (383)
Q Consensus       238 ~~~ivHrdlk~~NiLl~~~~~~kl~Dfgla~  268 (383)
                      ..+++|+|+.+.|++++.+...-+.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4479999999999999988878899999874

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=82.05  E-value=0.37  Score=37.54  Aligned_cols=34  Identities=12%  Similarity=0.070  Sum_probs=19.2

Q ss_pred             CCCCCCEEECcCCccccccchhHH----hhhccceeee
Q 046461           23 NLNELPHLDLSCNKLNGEISTFLS----HILGILGLYV   56 (383)
Q Consensus        23 ~l~~L~~l~ls~N~l~G~iP~~~~----~~~~l~~l~l   56 (383)
                      ..+.|+.|+|++|.++..--..++    ....++.+++
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l   81 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNV   81 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEEC
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhh
Confidence            456777777777776654333332    2344555555